National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review, 24090-24203 [2024-05905]
Download as PDF
24090
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Parts 60 and 63
[EPA–HQ–OAR–2019–0178; FRL–7055–02–
OAR]
RIN 2060–AU37
National Emission Standards for
Hazardous Air Pollutants: Ethylene
Oxide Emissions Standards for
Sterilization Facilities Residual Risk
and Technology Review
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This action finalizes the
residual risk and technology review
(RTR) conducted for the Commercial
Sterilization Facilities source category
regulated under national emission
standards for hazardous air pollutants
(NESHAP) under the Clean Air Act. The
EPA is finalizing decisions concerning
the RTR, including definitions for
affected sources, emission standards for
previously unregulated sources,
amendments pursuant to the risk review
to address ethylene oxide (EtO)
emissions from certain sterilization
chamber vents (SCVs), aeration room
vents (ARVs), chamber exhaust vents
(CEVs), and room air emissions, and
amendments pursuant to the technology
review for certain SCVs and ARVs. In
addition, we are taking final action to
correct and clarify regulatory provisions
related to emissions during periods of
startup, shutdown, and malfunction
(SSM), including removing exemptions
for periods of SSM. We are also taking
final action to require owners and
operators to demonstrate compliance
through the use of EtO continuous
emissions monitoring systems (CEMS),
with exceptions for very small users of
EtO; add provisions for electronic
reporting of performance test results and
other reports; and include other
technical revisions to improve
consistency and clarity. We estimate
that these final amendments will reduce
EtO emissions from this source category
by approximately 21 tons per year (tpy).
DATES: This final rule is effective on
April 5, 2024. The incorporation by
reference (IBR) of certain material listed
in the rule is approved by the Director
of the Federal Register April 5, 2024.
The incorporation by reference (IBR) of
certain other material listed in the rule
was approved by the Director of the
Federal Register before February 27,
2021.
ADDRESSES: The U.S. Environmental
Protection Agency (EPA) has established
khammond on DSKJM1Z7X2PROD with RULES2
SUMMARY:
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
a docket for this action under Docket ID
No. EPA–HQ–OAR–2019–0178. All
documents in the docket are listed on
the https://www.regulations.gov/
website. Although listed, some
information is not publicly available,
e.g., Confidential Business Information
or other information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
is not placed on the internet and will be
publicly available only in hard copy
form. Publicly available docket
materials are available either
electronically through https://
www.regulations.gov/, or in hard copy at
the EPA Docket Center, WJC West
Building, Room Number 3334, 1301
Constitution Ave. NW, Washington, DC.
The Public Reading Room hours of
operation are 8:30 a.m. to 4:30 p.m.
Eastern Standard Time (EST), Monday
through Friday. The telephone number
for the Public Reading Room is (202)
566–1744, and the telephone number for
the EPA Docket Center is (202) 566–
1742.
FOR FURTHER INFORMATION CONTACT: For
questions about this final action, contact
U.S. EPA, Attn: Jonathan Witt, Mail
Drop: E143–05, 109 T.W. Alexander
Drive, P.O. Box 12055, RTP, North
Carolina 27711; telephone number:
(919) 541–5645; and email address:
witt.jon@epa.gov. For specific
information regarding the risk modeling
methodology, contact U.S. EPA, Attn:
Matthew Woody, Mail Drop: C539–02,
109 T.W. Alexander Drive, P.O. Box
12055, RTP, North Carolina 27711;
telephone number: (919) 541–1535; and
email address: woody.matt@epa.gov.
SUPPLEMENTARY INFORMATION:
Preamble acronyms and
abbreviations. We use multiple
acronyms and terms in this preamble.
While this list may not be exhaustive, to
ease the reading of this preamble and for
reference purposes, the EPA defines the
following terms and acronyms here:
ADAF age-dependent adjustment factor
AEGL acute exposure guideline level
APCD air pollution control device
ARV aeration room vent
ASME American Society of Mechanical
Engineers
BTF Beyond-the-Floor
BMP best management practice
CAA Clean Air Act
CDX Central Data Exchange
CEDRI Compliance and Emissions Data
Reporting Interface
CEMS continuous emission monitoring
system
CEV chamber exhaust vent
CFR Code of Federal Regulations
cfs cubic feet per second
dscfm dry standard cubic feet per minute
EJ environmental justice
EPA Environmental Protection Agency
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
ERT Electronic Reporting Tool
EtO ethylene oxide
FDA Food and Drug Administration
FIFRA Federal Insecticide, Fungicide, and
Rodenticide Act
FR Federal Register
FRFA final regulatory flexibility analysis
FTIR Fourier Transform Infrared
Spectroscopy
GACT generally available control
technology
HAP hazardous air pollutants(s)
HEM Human Exposure Model
HQ hazard quotient
ICR Information Collection Request
ID Interim Decision
IFU instructions for use
IRFA initial regulatory flexibility analysis
IRIS Integrated Risk Information System
ISO International Organization for
Standardization
km kilometer
lb pound
lb/h pounds per hour
LEL lower explosive limit
LPL lower prediction limit
MACT maximum achievable control
technology
MIR maximum individual risk
mg/L milligrams per liter
NAICS North American Industry
Classification System
NDO natural draft opening
NESHAP national emission standards for
hazardous air pollutants
OMB Office of Management and Budget
OPP Office of Pesticide Programs
OSHA Occupational Safety and Health
Administration
PID Proposed Interim Decision
ppbv parts per billion by volume
ppm parts per million
ppmv parts per million by volume
PTE permanent total enclosure
REL reference exposure level
RDL Representative detection level
RFA Regulatory Flexibility Act
RIA regulatory impact assessment
RTR risk and technology review
SAB Science Advisory Board
SBA Small Business Administration
SBAR Small Business Advocacy Review
SCV sterilization chamber vent
SER small entity representative
SSM startup, shutdown, and malfunction
TOSHI target organ-specific hazard index
tpy tons per year
UPL upper prediction limit
mg/m3 micrograms per cubic meter
UMRA Unfunded Mandates Reform Act
URE unit risk estimate
VCS voluntary consensus standards
Background information. On April 13,
2023, the EPA proposed revisions to the
Commercial Sterilization Facilities
NESHAP based on our RTR. In this
action, we are finalizing decisions and
revisions for the rule. We summarize
some of the more significant comments
we timely received regarding the
proposed rule and provide our
responses in this preamble. A summary
of all other public comments on the
proposal and the EPA’s responses to
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
those comments is available in
Summary of Public Comments and
Responses for the Risk and Technology
Review for Commercial Sterilization
Facilities, Docket ID No. EPA–HQ–
OAR–2019–0178. A ‘‘track changes’’
version of the regulatory language that
incorporates the changes in this action
is available in the docket.
Organization of this document. The
information in this preamble is
organized as follows:
I. General Information
A. Executive Summary
B. Does this action apply to me?
C. Where can I get a copy of this document
and other related information?
D. Judicial Review and Administrative
Reconsideration
II. Background
A. What is the statutory authority for this
action?
B. What is the Commercial Sterilization
Facilities source category and how does
the NESHAP regulate HAP emissions
from the source category?
C. What changes did we propose for the
Commercial Sterilization Facilities
source category in our April 13, 2023,
RTR proposal?
III. What is included in this final rule?
A. What are the final rule amendments
addressing the affected source
definitions?
B. What are the final rule amendments
pursuant to CAA sections 112(d)(2),
112(d)(3), and 112(d)(5) for the
Commercial Sterilization Facilities
source category?
C. What are the final rule amendments
based on the risk review for the
Commercial Sterilization Facilities
source category?
D. What are the final rule amendments
based on the technology review for the
Commercial Sterilization Facilities
source category?
E. What are the final rule amendments
addressing emissions during periods of
startup, shutdown, and malfunction?
F. What other changes have been made to
the NESHAP?
G. What are the effective and compliance
dates of the standards?
IV. What is the rationale for our final
decisions and amendments for the
Commercial Sterilization Facilities
source category?
A. Amendments Addressing the Affected
Source Definitions
B. Amendments Pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) for the
Commercial Sterilization Facilities
Source Category
C. Residual Risk Review for the
Commercial Sterilization Facilities
Source Category
D. Technology Review for the Commercial
Sterilization Facilities Source Category
E. Amendments Addressing Emissions
During Periods of SSM
F. Other Amendments to the Standards
V. Summary of Cost, Environmental, and
Economic Impacts and Additional
Analyses Conducted
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
A. What are the affected facilities?
B. What are the air quality impacts?
C. What are the cost impacts?
D. What are the economic impacts?
E. What are the benefits?
F. What analysis of environmental justice
did we conduct?
VI. Statutory and Executive Order Reviews
A. Executive Orders 12866: Regulatory
Planning and Review and Executive
Order 13563: Improving Regulation and
Regulatory Review
B. Paperwork Reduction Act (PRA)
C. Regulatory Flexibility Act (RFA)
D. Unfunded Mandates Reform Act
(UMRA)
E. Executive Order 13132: Federalism
F. Executive Order 13175: Consultation
and Coordination With Indian Tribal
Governments
G. Executive Order 13045: Protection of
Children From Environmental Health
Risks and Safety Risks
H. Executive Order 13211: Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use
I. National Technology Transfer and
Advancement Act (NTTAA) and 1 CFR
Part 51
J. Executive Order 12898: Federal Actions
To Address Environmental Justice in
Minority Populations and Low-Income
Populations and Executive Order 14096:
Revitalizing Our Nation’s Commitment
to Environmental Justice for All
K. Congressional Review Act (CRA)
I. General Information
A. Executive Summary
1. Purpose of the Regulatory Action
Exercising authority under multiple
provisions of section 112 of the Clean
Air Act (CAA), we are finalizing
revisions to the NESHAP for
Commercial Sterilization Facilities (40
CFR part 63, subpart O) by both
amending the current standards and
establishing standards for previously
unregulated emissions within this
source category. First, we are finalizing
emission standards under CAA sections
112(d)(2)–(3) and (d)(5) for previously
unregulated emission sources of EtO.
Second, we are finalizing risk-based
standards under CAA section 112(f)(2)
to protect public health with an ample
margin of safety. Third, we are
finalizing emission standards under
CAA section 112(d)(6) based on our
review of developments in practices,
processes, and control technologies for
this source category.
This final rulemaking reflects the EtO
toxicological assessment that EPA’s
Integrated Risk Information System
(IRIS) Program completed in December
2016,1 which indicated that EtO is a far
1 Evaluation of the Inhalation Carcinogenicity of
Ethylene Oxide, December 2016, EPA/635/R–16/
350Fc.
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
24091
more potent carcinogen than we had
understood when the RTR for this
source category was conducted in 2006.
There are 88 commercial sterilization
facilities in this source category, many
of which are located near residences,
schools, and other public facilities.
Many of these facilities are also located
in communities with environmental
justice (EJ) concerns. We have
determined that approximately 23 of
these facilities pose high lifetime cancer
risks to the surrounding communities,
and some facilities pose exceptionally
high risks that are among some of the
highest for a CAA section 112(f)(2) risk
assessment. Throughout this rulemaking
process, we have engaged in outreach
activities to these communities, along
with their State and local governments,
to discuss their concerns, along with the
need and potential solutions for
reducing emissions and increasing
transparency on exposure and potential
impacts to communities, which this
final rule will achieve.
This important action will reduce EtO
emissions and lifetime cancer risks in
multiple communities across the
country, including communities with EJ
concerns, and it updates our standards
using proven and cost-effective control
technologies that are already in use at
some facilities in this source category.
The protections offered by these
standards will be especially important
for children. In addition, this rule will
advance the President’s Cancer
Moonshot,2 by preventing cancer before
it starts. Recognizing that we now have
additional information about the health
risks of EtO that was not available at the
time of the 2006 RTR, and in order to
ensure that our standards for this source
category adequately protect public
health, we have conducted a second
residual risk review under CAA section
112(f)(2), as discussed in section I.A.3 of
this preamble.
In deciding to conduct this second
residual risk review, we considered the
health effects of EtO exposure, the
impacts to surrounding communities,
the advantages of EtO reductions, and
the distribution of those reductions
consistent with the clear goal of CAA
section 112(f)(2) to protect the most
exposed and susceptible populations.
While commercial sterilizers provide a
critical benefit for the health of all,
protecting people who live near
commercial sterilization facilities from
the disproportionate risk of being
significantly harmed by toxic air
2 https://www.whitehouse.gov/briefing-room/
statements-releases/2023/09/13/fact-sheet-as-partof-president-bidens-unity-agenda-white-housecancer-moonshot-announces-new-actions-andcommitments-to-end-cancer-as-we-know-it/.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24092
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
pollution is also a core responsibility for
the EPA under the CAA.
At the same time, we recognize that
commercial sterilization facilities play a
vital role in maintaining an adequate
supply of sterilized medical devices for
public health needs in the U.S.
According to the U.S. Food and Drug
Administration (FDA), ‘‘Literature
shows that about fifty percent of all
sterile medical devices in the U.S. are
sterilized with ethylene oxide.’’ FDA
also notes that, ‘‘For many medical
devices, sterilization with ethylene
oxide may be the only method that
effectively sterilizes and does not
damage the device during the
sterilization process.’’ 3 In developing
this final rule, therefore, we carefully
considered the important function these
facilities serve, drawing from extensive
engagement with industry stakeholders
as well as Federal agencies with
expertise in and responsibility for the
medical device supply chain.
To ensure our actions with respect to
this source category are based on the
most accurate and complete information
possible, we have had many interactions
with the EtO commercial sterilization
industry in recent years, including
meetings, requests for information, and
outreach specific to this final
rulemaking. This has enabled us to work
from the best possible information when
conducting the analyses to support this
final rulemaking, including the current
configuration of facilities and the
performance of control technologies that
are currently used.
We have engaged with the U.S.
Department of Health and Human
Services, particularly FDA, regarding
the potential impacts of this final rule
on commercial facilities that sterilize
medical devices. These discussions
have focused on identifying and
discussing any concerns regarding the
potential impact on the availability of
certain medical devices that are
sterilized with EtO, in cases where
alternative sterilization methods are not
readily available, in particular, devices
that are (1) experiencing or at risk of
experiencing a shortage, (2) intended to
provide life-supporting, life-sustaining
care or that is intended for use in
emergency medical care or during
surgery, (3) used in pediatric services,
and/or (4) sterilized exclusively at a
particular facility.
Mindful of the vital role that
commercial sterilizers play in supplying
the nation with sterile medical devices,
and the core objective of protecting
3 https://www.fda.gov/medical-devices/generalhospital-devices-and-supplies/sterilization-medicaldevices.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
public health under CAA section 112,
the EPA has carefully evaluated the
feasibility and cost of compliance with
this rule, and potential implications for
the medical device supply chain.4 The
EPA notes that a number of the facilities
covered by this final rule have already
implemented one or more of the
controls that will be needed for
compliance. Moreover, the EPA’s own
experience working with facility
owners, as well as State and local
agencies that have regulated EtO
emissions from these facilities, confirms
that it is feasible for individual facilities
to install the required controls well
within the deadlines provided in this
rule, and for multiple facilities to do so
simultaneously.
In addition, as a result of the
comments received, as well as the EPA’s
consultation with FDA and other
Federal partners, the final rule
incorporates several key changes from
the proposed rule, including
modifications to the format of certain
standards and compliance flexibilities.
We are also providing sufficient
compliance time to enable these
facilities to continue sterilizing products
while installing and testing new control
systems and associated equipment that
will afford ample protection for nearby
communities. These modifications to
the proposed rule are intended to
facilitate cost-effective compliance, and
to avoid any impacts to the integrity of
the medical device supply chain, while
ensuring that these standards reduce
cancer risks for communities exposed to
EtO emissions.
Given that key industry players are
already planning for compliance, and in
light of the significant changes made
between the proposal and this final rule,
the EPA does not anticipate that the
implementation of these standards will
have any adverse impacts on the
medical supply chain. However, as the
Agency proceeds to implement this final
rule, we intend to continue to work
closely with FDA, the relevant trade
associations, and facility owners to
monitor the process of planning for
compliance, to proactively identify any
anticipated changes in facility
operations that might implicate the
medical supply chain, and to take
appropriate steps to address any such
impacts. In addition, in order to
increase the resilience of the medical
supply chain, we support the
development and implementation of
4 For more information, see the document
Regulatory Impact Analysis for the Final National
Emission Standards for Hazardous Air Pollutants:
Ethylene Oxide Commercial Sterilization and
Fumigation Operations, available in the docket for
this rulemaking.
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
viable, safe, and cost-effective
alternatives to EtO sterilization.
On April 13, 2023, the Office of
Pesticide Programs (OPP) published a
notice announcing the availability of a
proposed interim decision (PID) as part
of its periodic review of the registration
of EtO under the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA)
(88 FR 22447). The PID contained a
number of measures aimed at protecting
workers from excessive EtO exposure.
Since the issuance of the PID, OPP has
been actively collaborating with the
Office of Air and Radiation to ensure
that the requirements of the FIFRA
Interim Decision (ID) do not interfere
with the requirements of this rule, and
vice versa. The ID will contain the final
requirements to mitigate worker
exposure to EtO, considering the
comments received on the PID.
Furthermore, OPP has been consulting
regularly with other Federal agencies
and with industry trade groups, to
discuss how best to harmonize the
requirements of the FIFRA ID with the
requirements of this rule, and to ensure
that the operative standards, once
finalized, will protect both workers and
neighboring communities from the risks
of EtO exposure while mitigating and
managing any risk to the supply chain
for sterile medical devices.
2. Summary of the Major Provisions of
the Regulatory Action in Question
We are finalizing numeric emission
limits, operating limits, and
management practices under CAA
sections 112(d)(2)–(3), (d)(5), and (d)(6)
for EtO emissions from certain emission
sources, and also finalizing standards
under CAA section 112(f)(2) for certain
emission sources in order to ensure that
the standards provide an ample margin
of safety to protect public health.5
For the following, previously
unregulated emission sources at
commercial sterilization facilities, we
are setting standards under CAA
sections 112(d)(2)–(3) or (d)(5): SCVs
and ARVs at facilities where EtO use is
less than 1 tpy,6 ARVs at facilities where
5 In 1992, pursuant to CAA section 112(c)(1), we
published a list of major and area sources for
regulation under CAA section 112, including major
and area sources at commercial sterilization
facilities. 57 FR 31576, 31586 (July 16, 1992). Area
sources at commercial sterilization facilities were
listed for regulation under CAA section 112(c)(3)
based on our finding that they present a threat of
adverse effects to human health or the environment
(by such sources individually or in the aggregate)
warranting regulation under that section. Id. at
31586.
6 In developing the original rule, EPA considered
potential standards for SCV and ARV at area source
facilities where EtO use is less than 1 tpy but the
Agency understood these sources at the time to
have low emission contributions (e.g., a facility
E:\FR\FM\05APR2.SGM
05APR2
24093
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
EtO use is at least 1 tpy but less than
10 tpy,7 CEVs,8 and room air
emissions.9
Next, based on our assessment of the
residual risk after considering the
emission reductions from the previous
standards in subpart O, as well as the
standards under CAA sections
112(d)(2)–(3) or (d)(5) for the previously
unregulated sources, we are finalizing
more stringent standards under CAA
section 112(f)(2) to address risk at the
following types of sources:
• SCVs at facilities where EtO use is at
least 30 tpy
• SCVs at facilities where EtO use is at
least 10 tpy but less than 30 tpy
• SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy
• ARVs at facilities where EtO use is at
least 30 tpy
• CEVs at area source facilities 10 where
EtO use is at least 400 tpy
• CEVs at area source facilities where
EtO use is at least 60 but less than 400
tpy
• Group 1 room air emissions 11 at area
source facilities where EtO use is at
least 40 tpy
• Group 2 room air emissions 12 at area
source facilities where EtO use is at
least 20 tpy
• Group 2 room air emissions at area
source facilities where EtO use is at
least 4 tpy but less than 20 tpy
Finally, under CAA section 112(d)(6),
we are revising current standards for the
following sources that were regulated in
the previous 40 CFR part 63, subpart O:
• SCVs at facilities where EtO use is at
least 10 tpy
• SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy
• ARVs at facilities where EtO use is at
least 10 tpy
Table 1 summarizes the final CAA
section 112(d) and 112(f)(2) standards.
TABLE 1—SUMMARY OF STANDARDS AFTER TAKING ACTIONS PURSUANT TO CAA SECTIONS 112(d)(2), 112(d)(3),
112(d)(5), 112(f)(2), AND 112(d)(6)
Emission source
Existing or new?
EtO use
Standards
SCV ......................................
Existing and new .................
99.99 percent emission reduction .............
99.9 percent emission reduction ...............
112(f)(2).
112(f)(2).
99.9 percent emission reduction ...............
99.8 percent emission reduction ...............
112(d)(6).
112(f)(2) and 112(d)(6).
99 percent emission reduction ..................
99.9 percent emission reduction ...............
99.6 percent emission reduction ...............
112(d)(5).
112(f)(2).
112(f)(2).
99.6 percent emission reduction ...............
99 percent emission reduction ..................
112(d)(6).
112(d)(5).
99 percent emission reduction ..................
99.9 percent emission reduction ...............
99.9 percent emission reduction ...............
99 percent emission reduction ..................
112(d)(5).
112(f)(2).
112(d)(6).
112(d)(5).
Existing and new .................
At least 30 tpy .....................
At least 10 tpy but less than
30 tpy.
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ...................
At least 30 tpy .....................
At least 10 tpy but less than
30 tpy.
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ...................
At least 30 tpy .....................
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ...................
N/A ......................................
99 percent emission reduction ..................
99.94 percent emission reduction 1 ...........
112(d)(5).
112(d)(2) and 112(d)(3).
Existing and new .................
At least 400 tpy ...................
99.9 percent emission reduction ...............
112(f)(2).
99.9 percent emission reduction ...............
112(f)(2).
Existing and new .................
At least 60 but less than
400 tpy.
Less than 60 tpy .................
N/A ......................................
99 percent emission reduction ..................
97 percent emission reduction 2 3 ..............
112(d)(5).
112(d)(2) and 112(d)(3).
Existing and new .................
At least 40 tpy .....................
98 percent emission reduction 3 ................
112(f)(2).
Less than 40 tpy .................
80 percent emission reduction 3 ................
112(d)(5).
ARV ......................................
Existing ................................
New .....................................
CEVs at major source facilities.
CEVs at area source facilities.
khammond on DSKJM1Z7X2PROD with RULES2
Group 1 room air emissions
at major sources.
Group 1 room air emissions
at area sources.
with EtO use of 1,999 lb/yr would have roughly less
than 167 lb/month of usage and emissions, and less
than 41 lb/week usage and emissions.) At the time,
EPA considered costs for monitoring,
recordkeeping, and reporting under the rule.
Threshold cutoffs for area sources are at the
discretion of the Agency.
7 EPA considered standards for ARV and CEV at
area source facilities where EtO use is at least 1 tpy
and less than 10 tpy. As noted, the Agency
understood at the time that the largest emission
source of EtO occurred from the SCV, and therefore
finalized emission reduction standards for all SCV
at facilities where EtO use is at least 1 tpy. At the
time ARV sources were understood to have low
emission contributions. As noted, threshold cutoffs
for area sources are at the discretion of the Agency.
8 The standards for CEVs were originally
promulgated on December 6, 1994. Following
promulgation of the rule, we suspended certain
compliance deadlines and ultimately removed the
standards for CEVs due to safety concerns. In the
late 1990s, there were multiple explosions at EtO
commercial sterilization facilities using oxidizers to
control emissions from the CEV. For CEVs, it was
determined that the primary contributing issue
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
leading to the explosions was that EtO
concentrations were above a safe level (i.e., above
the lower explosive limit (LEL)) within the CEV gas
streams. We could not conclude at the time that the
CEVs could be safely controlled, so the standards
for CEVs were removed on November 2, 2001 (66
FR 55583). However, as discussed in section III.B.5
of the proposal preamble (88 FR 22790), facilities
with controlled CEVs have revised their operating
procedures to address the explosion issue by not
exceeding 10 to 25 percent of the LEL. We have,
therefore, determined that CEVs can be safely
controlled.
9 As discussed in section III.A, room air emissions
include emissions resulting from indoor EtO
storage, EtO dispensing, vacuum pump operation,
pre-aeration handling of sterilized material, and
post-aeration handling of sterilized material.
10 As discussed in section III.B of the proposal
preamble (88 FR 22790, April 13, 2023), CAA
section 112(a) defines a major source as ‘‘any
stationary source or group of stationary sources
located within a contiguous area and under
common control that emits or has the potential to
emit considering controls, in the aggregate, 10 tpy
or more of any HAP or 25 tpy or more of any
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
CAA section
combination of HAPs. . .’’. It further defines an
area source as ‘‘any stationary source of HAPs that
is not a major source’’. A synthetic area source
facility is one that otherwise has the potential to
emit HAPs in amounts that are at or above those
for major sources of HAP, but that has taken a
restriction so that its potential to emit is less than
the threshold amounts for major sources. Most of
the EtO used at these facilities is released through
SCVs and ARVs, and subpart O contains emission
standards for these sources at facilities where EtO
use is at least 10 tpy. Some State and local
governments also regulate EtO emissions from these
facilities. Based on these facts, as well as our review
of the permits for these facilities, it is our
understanding that all facilities that use more than
10 tpy are synthetic area sources.
11 As discussed in section III.A, Group 1 room air
emissions cover indoor EtO storage, EtO dispensing,
vacuum pump operation, and pre-aeration handling
of sterilized material.
12 As discussed in section III.A, Group 2 room air
emissions cover post-aeration handling of sterilized
material.
E:\FR\FM\05APR2.SGM
05APR2
24094
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE 1—SUMMARY OF STANDARDS AFTER TAKING ACTIONS PURSUANT TO CAA SECTIONS 112(d)(2), 112(d)(3),
112(d)(5), 112(f)(2), AND 112(d)(6)—Continued
Emission source
Existing or new?
EtO use
Standards
Group 2 room air emissions
at major sources.
Group 2 room air emissions
at area sources.
Existing and new .................
N/A ......................................
86 percent emission reduction 1 3 ..............
112(d)(2) and 112(d)(3).
Existing ................................
At least 20 tpy .....................
98 percent emission reduction 3 ................
112(f)(2).
At least 4 but less than 20
tpy.
Less than 4 tpy ...................
80 percent emission reduction 3 ................
112(f)(2).
Lower the EtO concentration within each
sterilization chamber to 1 ppm before
the chamber can be opened 4.
98 percent emission reduction 3 ................
80 percent emission reduction 3 ................
112(d)(5).
80 percent emission reduction 3 ................
112(d)(5).
New .....................................
At least 20 tpy .....................
At least 4 but less than 20
tpy.
Less than 4 tpy ...................
CAA section
112(f)(2).
112(f)(2).
1 MACT
floor.
2 Beyond-the-Floor (BTF) standard.
3 To assure compliance with the emission limit, we are requiring each facility to operate area sources with these emissions in accordance with the PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
4 Owners and operators may also apply for an alternative means of emission limitation under CAA section 112(h)(3).
To demonstrate compliance with the
emission limits, we are finalizing
capture requirements. We are also
finalizing a requirement for facilities to
monitor with an EtO continuous
emissions monitoring system (CEMS),
with exceptions for small users.
3. EPA Authority
We note that the EPA completed a
residual risk and technology review
under CAA sections 112(f)(2) and
112(d)(6), respectively, for this source
category in 2006 (71 FR 17712). While
CAA section 112(f)(2) requires only a
one-time risk review, which is to be
conducted within eight years of the date
the initial standards are promulgated, it
does not limit our discretion or
authority to conduct another risk review
should we consider that such review is
warranted. As discussed in more detail
in section IV.C of this preamble, as our
understanding of the health effects of
EtO developed, we conducted a second
residual risk review under CAA section
112(f)(2) for commercial sterilization
facilities using EtO in order to ensure
that the standards provide an ample
margin of safety to protect public health.
As discussed in further detail in
section IV.C, this second residual risk
review also encompasses certain area
sources for which we did not evaluate
residual risk in our 2006 rulemaking.
Although CAA section 112(f)(5) states
that a risk review is not required for
categories of area sources subject to
generally available control technology
(GACT) standards, it does not prohibit
such review. In 2006, we undertook a
CAA section 112(f)(2) analysis only for
area source emissions standards that
were issued as maximum achievable
control technology (MACT) standards
and exercised our discretion under CAA
section 112(f)(5) not to do a CAA section
112(f)(2) analysis for those emission
points for which GACT standards were
established (67 FR 17715). However, as
we made clear in that prior risk
assessment, ‘‘[w]e have the authority to
revisit (and revise, if necessary) any
rulemaking if . . . significant
improvements to science [suggest that]
the public is exposed to significant
increases in risk as compared to the
[2006 risk assessment].’’ Id. In light of
the updated IRIS cancer unit risk
estimate (URE) for EtO, which is
approximately 60 times greater than the
value we used in our previous risk
assessment, we are now exercising our
discretionary authority to conduct
another CAA section 112(f)(2) analysis
and to include in this analysis area
source commercial sterilizers using EtO
for which we have promulgated, or have
considered, GACT standards.
Section 112(d)(6) of the CAA requires
EPA to review and revise, as necessary,
standards promulgated under CAA
section 112 at least every eight years,
taking into account developments in
practices, processes, and control
technologies. We last completed this
required technology review for the
Ethylene Oxide Commercial
Sterilization NESHAP (40 CFR 63,
subpart O) in 2006. Accordingly, in this
final action, we are also conducting a
CAA section 112(d)(6) review of the
current standards in this source
category.
4. Costs and Benefits
Table 2 of this preamble summarizes
the costs of this final action for 40 CFR
part 63, subpart O (Ethylene Oxide
Commercial Sterilization NESHAP).
TABLE 2—TOTAL CAPITAL INVESTMENT AND TOTAL ANNUAL COST
[2021$]
Number of facilities
w/costs associated
with new
requirements
khammond on DSKJM1Z7X2PROD with RULES2
Requirement
Total capital
investment
Total annual
costs
Permanent total enclosure ...................................................................................................
Additional control devices ....................................................................................................
Monitoring and testing .........................................................................................................
Recordkeeping and reporting ..............................................................................................
28
83
89
1 90
$77,500,000
187,000,000
48,100,000
........................
$8,280,000
43,000,000
19,400,000
2 2,600,000
Total ..............................................................................................................................
1 90
313,000,000
74,000,000
1 This
includes the 88 facilities that are currently operating, as well as two planned facilities that are expected to start operating within the next
few years.
2 This includes $763,000 of one-time annual costs for reading the rule and developing record systems.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24095
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
The capital costs for permanent total
enclosure (PTE) and additional gas/solid
reactors were annualized to 20 years.
We estimate that these amendments will
reduce EtO emissions from this source
category by 21 tpy. Table 3 of this
preamble summarizes the cancer risk
reductions that will result from the final
amendments, which are updated based
on revisions made in the final rule and
described in more detail in section
IV.C.2.
TABLE 3—SUMMARY OF CANCER RISK REDUCTIONS
Maximum Individual Risk (MIR) 1 ....................................
Number of People with Cancer Risks >100-in-1 million
Number of People with Cancer Risks ≥1-in-1 million .....
Estimated Annual Cancer Incidence (cases per year) ...
Cancer risks after
implementation of final
amendments
Current cancer risks—
actual emissions
Current cancer risks—
allowable emissions
6,000-in-1 million ...............
19,000 ................................
8.5 million ..........................
0.9 ......................................
8,000-in-1 million 3 .............
260,000 ..............................
62 million ...........................
8 .........................................
100-in-1 million.
0.
700,000 to 1.4 million.2
0.1 to 0.2.2
1 The MIR or maximum individual lifetime cancer risk is defined as the increase in estimated cancer risk associated with a 70-year lifetime of
continuous exposure at the highest concentration of HAP where people are likely to live.
2 Ranges in values account for if all facilities were performing at the level of the standards (high end) to considering facilities that are currently
performing better than the standards (low end).
As indicated in table 3, we project
that the standards in the final rule will
significantly reduce incremental
lifetime cancer risks associated with
emissions of EtO from this source
category. We estimate that the current
maximum increase in lifetime cancer
risk associated with any facility in this
source category is 6,000-in-1 million
based on estimated actual emissions (or
8,000-in-1 million based on allowable
emissions) under the existing standards,
and that approximately 19,000 people
are exposed to EtO from this source
category at levels that would correspond
to a lifetime cancer risk of greater than
100-in-1 million (which is our
presumptive upper bound threshold for
acceptable health risks), based on actual
emissions. When considering allowable
emissions, this number increases to
260,000. Under the final rule, no
individual will be exposed to EtO at
levels that correspond to a lifetime
cancer risk of greater than 100-in-1
million, and the number of people with
a potential risk of greater than or equal
to 1-in-1 million will be reduced by
approximately 92 percent.
See section V of this preamble for
further discussion of the costs and a
discussion of the benefits of the final
standards. See section IV.F of this
preamble for discussion of the revisions
to monitoring, recordkeeping, reporting,
and testing requirements. See section
IV.C for a discussion of the risk
assessment results.
B. Does this action apply to me?
Regulated entities. Categories and
entities potentially regulated by this
action are shown in table 4 of this
preamble.
TABLE 4—NESHAP AND INDUSTRIAL SOURCE CATEGORIES AFFECTED BY THIS FINAL ACTION
Industrial category
Surgical and Medical Instrument Manufacturing ..........................................................
Surgical Appliance and Supplies Manufacturing .........................................................
Pharmaceutical Preparation Manufacturing .................................................................
Spice and Extract Manufacturing .................................................................................
Dried and Dehydrated Food Manufacturing .................................................................
Packaging and Labeling Services ................................................................................
khammond on DSKJM1Z7X2PROD with RULES2
1 North
NAICS 1 code
NESHAP
40
40
40
40
40
40
CFR
CFR
CFR
CFR
CFR
CFR
part
part
part
part
part
part
63,
63,
63,
63,
63,
63,
subpart
subpart
subpart
subpart
subpart
subpart
O
O
O
O
O
O
.......................
.......................
.......................
.......................
.......................
.......................
339112
339113
325412
311942
311423
561910
American Industry Classification System.
Table 4 of this preamble is not
intended to be exhaustive, but rather to
provide a guide for readers regarding
entities likely to be affected by the final
action for the source category listed. To
determine whether your facility is
affected, you should examine the
applicability criteria in the appropriate
NESHAP. If you have any questions
regarding the applicability of any aspect
of this NESHAP, please contact the
appropriate person listed in the
preceding FOR FURTHER INFORMATION
CONTACT section of this preamble.
C. Where can I get a copy of this
document and other related
information?
In addition to being available in the
docket, an electronic copy of this final
action will also be available on the
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
internet. Following signature by the
EPA Administrator, the EPA will post a
copy of this final action at: https://
www.epa.gov/stationary-sources-airpollution/ethylene-oxide-emissionsstandards-sterilization-facilities.
Following publication in the Federal
Register, the EPA will post the Federal
Register version and key technical
documents at this same website.
Additional information is available on
the RTR website at https://
www.epa.gov/stationary-sources-airpollution/risk-and-technology-reviewnational-emissions-standardshazardous. This information includes
an overview of the RTR program and
links to project websites for the RTR
source categories.
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
D. Judicial Review and Administrative
Reconsideration
Under Clean Air Act (CAA) section
307(b)(1), judicial review of this final
action is available only by filing a
petition for review in the United States
Court of Appeals for the District of
Columbia Circuit (the Court) by June 4,
2024. Under CAA section 307(b)(2), the
requirements established by this final
rule may not be challenged separately in
any civil or criminal proceedings
brought by the EPA to enforce the
requirements.
Section 307(d)(7)(B) of the CAA
further provides that only an objection
to a rule or procedure which was raised
with reasonable specificity during the
period for public comment (including
any public hearing) may be raised
E:\FR\FM\05APR2.SGM
05APR2
24096
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
during judicial review. This section also
provides a mechanism for the EPA to
reconsider the rule if the person raising
an objection can demonstrate to the
Administrator that it was impracticable
to raise such objection within the period
for public comment or if the grounds for
such objection arose after the period for
public comment (but within the time
specified for judicial review) and if such
objection is of central relevance to the
outcome of the rule. Any person seeking
to make such a demonstration should
submit a Petition for Reconsideration to
the Office of the Administrator, U.S.
EPA, Room 3000, WJC South Building,
1200 Pennsylvania Ave. NW,
Washington, DC 20460, with a copy to
both the person(s) listed in the
preceding FOR FURTHER INFORMATION
CONTACT section, and the Associate
General Counsel for the Air and
Radiation Law Office, Office of General
Counsel (Mail Code 2344A), U.S. EPA,
1200 Pennsylvania Ave. NW,
Washington, DC 20460.
khammond on DSKJM1Z7X2PROD with RULES2
II. Background
A. What is the statutory authority for
this action?
The statutory authority for this action
is provided by sections 112 and 301 of
the Clean Air Act (CAA), as amended
(42 U.S.C. 7401 et seq.). The discussion
that follows identifies the relevant
statutory sections and briefly explains
the contours of the methodology used to
implement these statutory requirements.
A more comprehensive discussion
appears in the document titled CAA
Section 112 Risk and Technology
Reviews: Statutory Authority and
Methodology, in the docket for this
rulemaking. Section 112 of the CAA
establishes a two-stage regulatory
process to address emissions of
hazardous air pollutants (HAP) from
stationary sources. In the first stage, we
must identify categories of sources
emitting one or more of the HAP listed
in CAA section 112(b) and then
promulgate technology-based NESHAP
for those sources. Sources of HAP
emissions are either major sources or
area sources, and CAA section 112
establishes different requirements for
major source standards and area source
standards. ‘‘Major sources’’ are those
that emit, or have the potential to emit,
any single HAP at a rate of 10 tons per
year (tpy) or more, or 25 tpy or more of
any combination of HAP. All other
sources are ‘‘area sources.’’ For major
sources, these standards are commonly
referred to as maximum achievable
control technology (MACT) standards
and must reflect the maximum degree of
emission reductions of HAP achievable
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(after considering cost, energy
requirements, and non-air quality health
and environmental impacts). In
developing MACT standards, CAA
section 112(d)(2) directs the EPA to
consider the application of measures,
processes, methods, systems, or
techniques, including, but not limited
to, those that reduce the volume of or
eliminate HAP emissions through
process changes, substitution of
materials, or other modifications;
enclose systems or processes to
eliminate emissions; collect, capture, or
treat HAP when released from a process,
stack, storage, or fugitive emissions
point; are design, equipment, work
practice, or operational standards; or
any combination of the above.
For these MACT standards, the statute
specifies certain minimum stringency
requirements, which are referred to as
MACT floor requirements, and which
may not be based on cost
considerations. See CAA section
112(d)(3). For new sources, the MACT
floor cannot be less stringent than the
emission control achieved in practice by
the best-controlled similar source. The
MACT standards for existing sources
can be less stringent than floors for new
sources, but they cannot be less
stringent than the average emission
limitation achieved by the bestperforming 12 percent of existing
sources in the category or subcategory
(or the best-performing five sources for
categories or subcategories with fewer
than 30 sources). In developing MACT
standards, we must also consider
control options that are more stringent
than the floor under CAA section
112(d)(2). We may establish standards
more stringent than the floor, based on
the consideration of the cost of
achieving the emissions reductions, any
non-air quality health and
environmental impacts, and energy
requirements. For area sources, CAA
section 112(d)(5) allows the EPA to set
standards based on GACT in lieu of
MACT standards. For categories of
major sources and any area source
categories subject to MACT standards,
the second stage in standard-setting
focuses on identifying and addressing
any remaining (i.e., ‘‘residual’’) risk
pursuant to CAA section 112(f). Section
112(f) specifically states that the EPA
‘‘shall not be required’’ to conduct risk
review under this subsection for
categories of area sources subject to
GACT standards but does not limit the
EPA’s authority or discretion from
conducting such review. As discussed
in more detail in section III.C of this
preamble, in light of the updated URE
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
regarding EtO, the EPA is choosing to
exercise that discretion.
In the second stage of the regulatory
process, the CAA requires the EPA to
undertake two different analyses, which
we refer to as the technology review and
the residual risk review. Under the
technology review, we must review the
technology-based standards and revise
them ‘‘as necessary (taking into account
developments in practices, processes,
and control technologies)’’ no less
frequently than every 8 years, pursuant
to CAA section 112(d)(6). In conducting
this review, the EPA is not required to
recalculate the MACT floors that were
established in earlier rulemakings.
Natural Resources Defense Council
(NRDC) v. EPA, 529 F.3d 1077, 1084
(D.C. Cir. 2008). Association of Battery
Recyclers, Inc. v. EPA, 716 F.3d 667
(D.C. Cir. 2013). The EPA may consider
cost in deciding whether to revise the
standards pursuant to CAA section
112(d)(6). The EPA is required to
address regulatory gaps, such as missing
standards for listed air toxics known to
be emitted from the source category, and
any new MACT standards must be
established under CAA sections
112(d)(2) and (3), or, in specific
circumstances, CAA sections 112(d)(4)
or (h). Louisiana Environmental Action
Network (LEAN) v. EPA, 955 F.3d 1088
(D.C. Cir. 2020).
The residual risk review in the second
stage of the regulatory process focuses
on identifying and addressing any
remaining (i.e., ‘‘residual’’) risk
pursuant to CAA section 112(f). For
source categories subject to MACT
standards, section 112(f)(2) of the CAA
requires the EPA to determine whether
promulgation of additional standards is
needed to provide an ample margin of
safety to protect public health or to
prevent an adverse environmental
effect. Section 112(d)(5) of the CAA
provides that this residual risk review is
not required for categories of area
sources subject to GACT standards.
Section 112(f)(2)(B) of the CAA further
expressly preserves the EPA’s use of the
two-step approach for developing
standards to address any residual risk
and the Agency’s interpretation of
‘‘ample margin of safety’’ developed in
the National Emissions Standards for
Hazardous Air Pollutants: Benzene
Emissions from Maleic Anhydride
Plants, Ethylbenzene/Styrene Plants,
Benzene Storage Vessels, Benzene
Equipment Leaks, and Coke By-Product
Recovery Plants (Benzene NESHAP) (54
FR 38044, September 14, 1989). The
EPA notified Congress in the Residual
Risk Report that the Agency intended to
use the Benzene NESHAP approach in
making CAA section 112(f) residual risk
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
determinations (EPA–453/R–99–001, p.
ES–11). The EPA subsequently adopted
this approach in its residual risk
determinations, and the United States
Court of Appeals for the District of
Columbia Circuit upheld the EPA’s
interpretation that CAA section 112(f)(2)
incorporates the approach established in
the Benzene NESHAP. See NRDC v.
EPA, 529 F.3d 1077, 1083 (D.C. Cir.
2008).
The approach incorporated into the
CAA and used by the EPA to evaluate
residual risk and to develop standards
under CAA section 112(f)(2) is a twostep approach. In the first step, the EPA
determines whether risks are acceptable.
This determination ‘‘considers all health
information, including risk estimation
uncertainty, and includes a presumptive
limit on maximum individual lifetime
[cancer] risk (MIR) 13 of approximately
1-in-10 thousand.’’ (54 FR 38045). If
risks are unacceptable, the EPA must
determine the emissions standards
necessary to reduce risk to an acceptable
level without considering costs. In the
second step of the approach, the EPA
considers whether the emissions
standards provide an ample margin of
safety to protect public health ‘‘in
consideration of all health information,
including the number of persons at risk
levels higher than approximately 1-in-1
million, as well as other relevant factors,
including costs and economic impacts,
technological feasibility, and other
factors relevant to each particular
decision.’’ Id. The EPA must promulgate
emission standards necessary to provide
an ample margin of safety to protect
public health or determine that the
standards being reviewed provide an
ample margin of safety without any
revisions. After conducting the ample
margin of safety analysis, we consider
whether a more stringent standard is
necessary to prevent an adverse
environmental effect, taking into
consideration costs, energy, safety, and
other relevant factors. For more
information on the statutory authority
for this rule, see 88 FR 22790, April 13,
2023.
B. What is the Commercial Sterilization
Facilities source category and how does
the NESHAP regulate HAP emissions
from the source category?
The EPA promulgated the EtO
Commercial Sterilization Facilities
NESHAP on December 6, 1994 (59 FR
62585). The standards are codified at 40
CFR part 63, subpart O. The EtO
commercial sterilization industry
consists of facilities operating a
sterilizer process that uses EtO to
sterilize or fumigate materials (e.g.,
medical equipment and supplies,
spices, and other miscellaneous
products and items). The source
category covered by this MACT
standard currently includes 88 facilities.
The original 1994 rulemaking for this
source category set standards for EtO
emissions originating from three
emission points: sterilization chamber
vents (SCV), aeration room vents (ARV),
and chamber exhaust vents (CEV). The
SCV evacuates EtO from the sterilization
chamber following sterilization,
fumigation, and any subsequent gas
washes before the chamber door is
opened. The ARV evacuates EtO-laden
air from the aeration room or chamber
that is used to facilitate off-gassing of
the sterile product and packaging. The
CEV evacuates EtO-laden air from the
sterilization chamber after the chamber
door is opened for product unloading
following the completion of sterilization
and associated gas washes. Other
sources of emissions within this source
category are room air emissions from
equipment used to charge EtO into
sterilization chambers, as well as EtO
residuals desorbing from sterilized
products within the facility, but the
current EtO Commercial Sterilization
24097
NESHAP does not include standards for
room air emissions.
In the chamber EtO sterilization
process, items to be sterilized are placed
in a chamber and exposed to EtO gas at
a predetermined concentration,
temperature, humidity, and pressure for
a period of time known as the dwell
period. Following the dwell period, the
EtO gas is evacuated from the chamber,
and the sterilized materials are then
aerated to remove EtO residuals from
the product. After the aeration step,
sterilized materials are typically moved
to a shipping/warehouse area for storage
until they are ready to be distributed to
the customer. Sterilizer process
equipment and emission control
configurations vary across facilities. The
most common sterilizer process
equipment configuration includes a
separate sterilizer chamber, separate
aeration room, and chamber exhaust on
the sterilizer chamber (also referred to
as a back-vent). Another common
configuration includes a combination
sterilizer where the sterilization and
aeration steps of the process occur
within the same chamber.
Another EtO sterilization process is
single-item sterilization where small
individual items are sterilized in sealed
pouches. EtO gas is introduced into the
sealed pouch, either by injection or use
of an EtO ampule, and the sealed pouch
is then placed in a chamber where the
sterilization step and aeration step
occur.
In 2006, we finalized a residual risk
review and a technology review under
CAA section 112(f)(2) and CAA section
112(d)(6), respectively (71 FR 17712,
April 7, 2006). No changes were made
to the EtO Commercial Sterilization
NESHAP in that action.
The current emission standards for
commercial sterilization facilities in 40
CFR part 63, subpart O are shown in
table 5:
TABLE 5—CURRENT ETO STANDARDS FOR COMMERCIAL STERILIZERS
khammond on DSKJM1Z7X2PROD with RULES2
Existing and new sources
subcategory
(in any consecutive
12-month period) 1
Sterilization chamber vent
(SCV)
Aeration room vent
(ARV)
Chamber exhaust vent
(CEV) 2
Sources using 10 tons or more of EtO ..
99 percent emission reduction (see 40
CFR 63.362(c)).
Sources using 1 ton or more of EtO but
less than 10 tons of EtO.
Sources using less than 1 ton of EtO ...
99 percent emission reduction (see 40
CFR 63.362(c)).
No control required; minimal recordkeeping requirements apply (see 40
CFR 63.367(c)).).
1 part per million (ppm) maximum outlet concentration or 99 percent emission reduction (see 40 CFR
63.362(d)).
No control ..............................................
No control.
No control required; minimal recordkeeping requirements apply (see 40
CFR 63.367(c)).).
No control required; minimal recordkeeping requirements apply (see 40
CFR 63.367(c)).).
No control.
1 Determined
2 The
on a rolling 12-month basis.
CEV emission source was included in the original standard but was later eliminated from the 40 CFR part 63, subpart O regulation in 2001.
13 Although defined as ‘‘maximum individual
risk,’’ MIR refers only to cancer risk and reflects the
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
estimated risk if an individual were exposed to the
maximum level of a pollutant for a 70-year lifetime.
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24098
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
For more information on the
commercial sterilization industry and
the current standards under 40 CFR part
63, subpart O, see 88 FR 22790, April
13, 2023.
We note that hospital sterilizers are
regulated under a different NESHAP (40
CFR part 63, subpart WWWWW), which
is not addressed in this rulemaking.14
We are aware of the potential risk posed
by EtO emissions from this source
category and will address hospital
sterilizers in a future rulemaking.
C. What changes did we propose for the
Commercial Sterilization Facilities
source category in our April 13, 2023,
RTR proposal?
On April 13, 2023, the EPA published
a proposed rule in the Federal Register
for the EtO Commercial Sterilization
NESHAP, 40 CFR part 63, subpart O,
that took into consideration the RTR
analyses. In the proposed rule, we
proposed emission standards under
CAA sections 112(d)(2)–(3) or (d)(5) for
a number of unregulated emission
sources of EtO. We then proposed
tightening certain of these proposed
standards and existing standards with
risk-based standards under CAA section
112(f)(2) in order to protect public
health with an ample margin of safety.
Finally, we proposed revisions to
certain existing standards under CAA
section 112(d)(6) based on our review of
developments in practices, processes,
and control technologies for this source
category.
For the following emission sources
that were unregulated, we proposed to
set standards under CAA sections
112(d)(2)–(3) or (d)(5):
• SCVs, ARVs, and CEVs at facilities
where EtO use is less than 1 tpy,
• ARVs and CEVs at facilities where
EtO use is at least 1 tpy but less than
10 tpy,
• CEVs at facilities where EtO use is
at least 10 tpy, and
• Room air emissions.
Next, based on our assessment of the
residual risk after considering the
emission reductions from the standards
in subpart O, as well as the proposed
standards for the unregulated sources,
we proposed more stringent standards
under CAA section 112(f)(2) to address
risk for the following types of sources:
• SCVs at facilities where EtO use is
at least 40 tpy,
• SCVs at facilities where EtO use is
at least 10 tpy but less than 40 tpy,
• SCVs at facilities where EtO use is
at least 1 tpy but less than 10 tpy, and
• Group 2 room air emissions at area
source facilities where EtO use is at
least 20 tpy.
Finally, under CAA section 112(d)(6),
we proposed to revise standards for the
following sources that were regulated in
the previous 40 CFR part 63, subpart O:
• SCVs at facilities where EtO use is
at least 10 tpy,
• SCVs at facilities where EtO use is
at least 1 tpy but less than 10 tpy, and
• ARVs at facilities where EtO use is
at least 10 tpy.
Table 6 summarizes the proposed
section CAA section 112(d) and
112(f)(2) standards.
TABLE 6—SUMMARY OF STANDARDS AFTER PROPOSED ACTIONS PURSUANT TO CAA SECTIONS 112(d)(2), 112(d)(3),
112(d)(5), 112(f)(2), AND 112(d)(6)
Emission source
Existing or new?
EtO use
Standards
SCV .............................
Existing and new ...
99.94 percent emission reduction ..............
99.94 percent emission reduction ..............
112(f)(2).
112(f)(2).
99.94 percent emission reduction ..............
99.8 percent emission reduction ................
99 percent emission reduction ...................
99.6 percent emission reduction ................
99 percent emission reduction ...................
112(d)(6).
112(f)(2) and
112(d)(6).
112(d)(5).
112(d)(6).
112(d)(5).
99 percent emission reduction ...................
99.9 percent emission reduction ................
99 percent emission reduction ...................
112(d)(5).
112(d)(6).
112(d)(5).
99 percent emission reduction ...................
3.2E–4 lb/h ..................................................
99.9 percent emission reduction ................
112(d)(5).
112(d)(2) and (3).
112(d)(5).
99 percent emission reduction ...................
1.3E–3 lb/h 1 ...............................................
112(d)(5).
112(d)(2) and
112(d)(3).
112(d)(5).
CEV .............................
Existing and new ...
Group 1 room air
sions.
Group 1 room air
sions at area
sources.
Group 2 room air
sions at major
sources.
Group 2 room air
sions at area
sources.
emis-
Existing and new ...
At least 40 tpy .....................
At least 10 tpy but less than
40 tpy.
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
At least 10 tpy .....................
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
N/A .......................................
emis-
Existing and new ...
N/A .......................................
1.3E–3 lb/h 1 ...............................................
emis-
Existing and new ...
N/A .......................................
2.8E–3 lb/h 1 ...............................................
112(d)(2) and
112(d)(3).
emis-
Existing ..................
At least 20 tpy .....................
Less than 20 tpy ..................
2.8E–3 lb/h 1 ...............................................
Follow either the Cycle Calculation Approach or the Bioburden/Biological Indicator Approach to achieve sterility assurance in accordance with ISO
11135:2014 (July 15, 2014) and ISO
11138–1:2017 (March 2017).
112(f)(2).
112(d)(5).
ARV .............................
Existing ..................
New ........................
khammond on DSKJM1Z7X2PROD with RULES2
CAA section
14 Hospitals are defined at 40 CFR 63.10448 to
mean facilities that provide medical care and
treatment for patients who are acutely ill or
chronically ill on an inpatient basis under
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
supervision of licensed physicians and under
nursing care offered 24 hours per day. Hospitals
include diagnostic and major surgery facilities but
exclude doctor’s offices, clinics, or other facilities
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
whose primary purpose is to provide medical
services to humans or animals on an outpatient
basis.
E:\FR\FM\05APR2.SGM
05APR2
24099
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE 6—SUMMARY OF STANDARDS AFTER PROPOSED ACTIONS PURSUANT TO CAA SECTIONS 112(d)(2), 112(d)(3),
112(d)(5), 112(f)(2), AND 112(d)(6)—Continued
Emission source
Existing or new?
EtO use
Standards
New ........................
N/A .......................................
2.8E–3 lb/h 1 ...............................................
CAA section
112(d)(5).
1 To
assure compliance with the emission limit, we proposed requiring each facility to operate areas with these emissions in accordance with
the PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
khammond on DSKJM1Z7X2PROD with RULES2
To demonstrate compliance with the
emission limits, we proposed capture
requirements. We also proposed that
facilities either monitor with an EtO
CEMS or conduct initial and annual
performance tests with continuous
parameter monitoring.
We also proposed the following
amendments:
• Corrections and clarifications to
regulatory provisions related to
emissions during periods of SSM,
including removing general exemptions
for periods of SSM and adding work
practice standards for periods of SSM
where appropriate.
• Revisions to monitoring and
performance testing requirements and
addition of provisions for electronic
reporting of performance test results and
reports, performance evaluation reports,
and compliance reports.
• Requiring all area source facilities
to obtain a title V operating permit, and
• Compliance requirements for
facilities using combined emission
streams.
III. What is included in this final rule?
This action finalizes the EPA’s
determinations pursuant to the RTR
provisions of CAA section 112 for the
Commercial Sterilization Facilities
source category and amends the EtO
Commercial Sterilization NESHAP
based on those determinations. This
action also finalizes other changes to the
NESHAP, including adding
requirements and clarifications for
periods of SSM; requiring the use of
CEMS to demonstrate compliance for
facilities where EtO use is at least 100
pounds (lb)/year; adding provisions for
electronic reporting of performance test
results and reports, performance
evaluation reports, and compliance
reports; and other minor editorial and
technical changes. This action also
reflects several changes to the April
2023 proposal in consideration of
comments received during the public
comment period described in section IV
of this preamble.
A. What are the final rule amendments
addressing the affected source
definitions?
The previous subpart O did not
contain definitions for affected sources,
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
which meant that the definition of an
‘‘affected source’’ at 40 CFR 63.2
applied.15 We did not believe that this
was appropriate because a facility may
not route all emissions from a particular
type of point source to the same control
system, thus making compliance
demonstration with the standards
difficult. For SCVs, ARVs, and CEVs, we
are finalizing, as proposed, the affected
source definition as the individual vent.
For Group 1 and Group 2 room air
emissions, we are finalizing, as
proposed, the affected source definition
as the collection of all room air
emissions for each group at any
sterilization facility. Group 1 room air
emissions are defined as emissions from
indoor EtO storage, EtO dispensing,
vacuum pump operations, and preaeration handling of sterilized material.
Group 2 room air emissions are defined
as emissions from post-aeration
handling of sterilized material.
Section IV.A.3 of this preamble
provides a summary of key comments
we received on the affected source
definitions and our responses.
B. What are the final rule amendments
pursuant to CAA sections 112(d)(2),
112(d)(3), and 112(d)(5) for the
Commercial Sterilization Facilities
source category?
We are finalizing EtO emissions
standards pursuant to CAA sections
112(d)(2)–(3) and 112(d)(5) for major
and area sources that were previously
unregulated. Please note that the final
standards for some of these sources are
further tightened pursuant to CAA
section 112(f)(2), as shown in table 1 in
section I.A above and discussed in more
detail below in sections III.C and IV.16
Pursuant to CAA section 112(d)(2)–(3)
or 112(d)(5), we are establishing in this
final rule the following emission
15 40 CFR 63.2 defines an affected source as ‘‘the
collection of equipment, activities, or both within
a single contiguous area and under common control
that is included in a section 112(c) source category
or subcategory for which a section 112(d) standard
or other relevant standard is established pursuant
to section 112 of the Act.’’
16 These sources include CEVs at area source
facilities where EtO use is at least 60 tpy, Group 1
room air emissions at area source facilities where
EtO use is at least 40 tpy, and Group 2 room air
emissions at area source facilities where EtO use is
at least 4 tpy.
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
standards for the previously unregulated
sources:
• 99 percent reduction for new and
existing SCVs at facilities where EtO use
is less than 1 tpy,
• 99 percent reduction for new and
existing ARVs facilities where EtO use
is at least 1 tpy less than 10 tpy,
• 99 percent reduction for new and
existing ARVs at facilities where EtO
use is less than 1 tpy,
• 99.94 percent reduction for new
and existing CEVs at major source
facilities,
• 99 percent emission reduction for
new and existing CEVs at area source
facilities,
• 97 percent reduction for new and
existing Group 1 room air emissions at
major source facilities,
• 80 percent emission reduction for
new and existing Group 1 room air
emissions at area source facilities,
• 86 percent reduction for new and
existing Group 2 room air emissions at
major source facilities, and
• 80 percent emission reduction for
new Group 2 room air emissions at area
source facilities.
As discussed in more detail below in
section IV.C.3 of this notice, we are not
finalizing any of the alternative
emission limits for percent reduction
standards on which we had solicited
comment as part of the proposed
rulemaking. Further, based on
comments received on the proposed
rulemaking, we are finalizing a revised
best management practice (BMP) as the
GACT standard under CAA section
112(d)(5) for existing Group 2 room air
emissions at area sources. The BMP
requires the in-chamber EtO
concentration to be lowered to 1 part
per million (ppm) before the chamber
can be opened, as opposed to the
proposed measure that would have
required these facilities to follow either
the Cycle Calculation Approach or the
Bioburden/Biological Indicator
Approach to achieve sterility assurance
in accordance with International
Organization for Standardization (ISO)
11135:2014 and ISO 11138–1:2017. In
addition, we are finalizing, as proposed,
a requirement that facilities operate all
areas with room air emissions subject to
an emission standard in accordance
with the PTE requirements of EPA
E:\FR\FM\05APR2.SGM
05APR2
24100
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
Method 204, irrespective of which CAA
section 112 authority is invoked. Lastly,
we are finalizing the removal of the 1
ppm alternative for ARVs at facilities
where EtO use is at least 10 tpy. Section
IV.B of this preamble provides in more
detail the standards we are finalizing
pursuant to CAA section 112(d)(2),
112(d)(3), and 112(d)(5), our rationales
for the final standards and for changes
since proposal, and a summary of key
comments we received on the proposed
standards and our responses.
C. What are the final rule amendments
based on the risk review for the
Commercial Sterilization Facilities
source category?
This section introduces the final
amendments to the Commercial
Sterilization Facilities NESHAP being
promulgated pursuant to CAA section
112(f). As in the proposal, we
determined that the risks for this source
category were unacceptable under the
previous provisions, and we are making
a final determination of unacceptability
as part of this final action, warranting
necessary emission reductions as
directed under the provisions we are
finalizing pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) in
this rulemaking. When risks are
unacceptable after considering the
emission reductions from the standards
in subpart O, we must determine the
emissions standards necessary to reduce
risk to an acceptable level. As such, we
are promulgating final amendments to
the Commercial Sterilization Facilities
NESHAP pursuant to CAA section
112(f)(2) that will reduce risk to an
acceptable level and will also provide
an ample margin of safety to protect
public health (see section IV.C of the
preamble for further discussion). Based
on comments received during the
proposed rulemaking, we are finalizing
the following EtO emissions standards
under CAA section 112(f)(2):
• 99.99 percent reduction for SCVs at
facilities where EtO use is at least 30
tpy,
• 99.9 percent reduction for SCVs at
facilities where EtO use is at least 10 tpy
but less than 30 tpy,
• 99.8 percent reduction for SCVs at
facilities where EtO use is at least 1 tpy
but less than 10 tpy,
• 99.9 percent reduction for ARVs at
facilities where EtO use is at least 30
tpy,
• 99.9 percent reduction for CEVs at
area source facilities where EtO use is
at least 60 tpy,
• 98 percent reduction for Group 1
room air emissions at area sources
facilities where EtO use is at least 40
tpy,
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
• 98 percent reduction for Group 2
room air emissions at area sources
facilities where EtO use is at least 20
tpy, and
• 80 percent reduction for Group 2
room air emissions at area source
facilities where EtO use is at least 4 tpy
but less than 20 tpy.
We are not finalizing alternative
emission limits for percent reduction
standards for the same reasons
discussed in section III.B of this
preamble. Further, based on comments
received during the proposed
rulemaking, we are not finalizing any of
the work practice standards that were
proposed for facilities where the MIR
remained greater than 100-in-1 million
after the imposition of requirements
under ‘‘Control Option 1’’.17 These
standards would have required facilities
to limit their Group 2 room air
emissions to a maximum volumetric
flow rate of 2,900 dry standard cubic
feet per minute (dscfm) and a maximum
EtO concentration of 30 parts-per-billion
by volume (ppbv).
Section IV.C.3 of this preamble
provides a summary of key comments
we received regarding the risk review
and our responses.
D. What are the final rule amendments
based on the technology review for the
Commercial Sterilization Facilities
source category?
We determined that there are
developments in practices, processes,
and control technologies that warrant
revisions to the previous standards for
this source category. Therefore, to
satisfy the requirements of CAA section
112(d)(6), we are revising the standards
to include, as in the proposed rule:
• 99.8 percent reduction for SCVs at
facilities where EtO use is at least 1 tpy
but less than 10 tpy,
• 99.6 percent reduction for existing
ARVs at facilities where EtO use is at
least 10 tpy, and
• 99.9 percent reduction for new
ARVs at facilities where EtO use is at
least 10 tpy.
Based on comments received during
the proposed rulemaking, we are
finalizing a 99.9 percent emission
reduction standard for SCVs at facilities
where EtO use is at least 10 tpy, which
is different from the 99.94 percent
emission reduction standard that was
proposed (see section IV.D.3.a of this
document for further discussion). We
are not finalizing any of the alternative
emission limits for percent reduction
standards that we had solicited
17 Refer to section III.D.1.b of the proposal
preamble (88 FR 22790, April 13, 2023) for further
discussion of Control Option 1.
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
comment on as part of the proposed
rulemaking. As part of the technology
review, we also identified regulatory
gaps (previously unregulated processes
or pollutants) and are establishing new
standards to fill those gaps as described
in section III.B of this preamble. Section
IV.D.3 of this preamble provides a
summary of key comments we received
regarding the technology review and our
responses.
E. What are the final rule amendments
addressing emissions during periods of
startup, shutdown, and malfunction?
In its 2008 decision in Sierra Club v.
EPA, 551 F.3d 1019 (D.C. Cir. 2008), the
United States Court of Appeals for the
District of Columbia Circuit vacated
portions of two provisions in our CAA
section 112 regulations governing the
emissions of HAP during periods of
SSM. Specifically, the court vacated the
SSM exemption contained in 40 CFR
63.6(f)(1) and 40 CFR 63.6(h)(1), holding
that under section 302(k) of the CAA,
emissions standards or limitations must
be continuous in nature and that the
SSM exemption violates the CAA’s
requirement that some section 112
standards apply continuously. We have
eliminated the SSM exemption in this
rule. Consistent with Sierra Club v.
EPA, the EPA has established standards
in this rule that apply at all times. We
have also revised table 6 in subpart O
(the General Provisions Applicability
Table) in several respects as is
explained in section III.G.1 of the
proposal preamble (88 FR 22790). For
example, we have eliminated and
revised certain recordkeeping that is
related to the SSM exemption as
described in detail in the proposed rule
and summarized again in section IV.E.1
of this preamble.
In establishing standards in this rule,
we have considered startup and
shutdown periods and, for the reasons
explained in section III.G.1 of the
proposal preamble and section IV.E of
this preamble, have not established
alternate standards for those periods.
The EPA is also finalizing provisions
related to malfunctions as proposed.
Periods of startup, normal operations,
and shutdown are all predictable and
routine aspects of a source’s operations.
Malfunctions, in contrast, are neither
predictable nor routine. Instead, they
are, by definition, sudden, infrequent,
and not reasonably preventable failures
of emissions control, process, or
monitoring equipment. (40 CFR 63.2)
(Definition of malfunction). The EPA
interprets CAA section 112 as not
requiring emissions that occur during
periods of malfunction to be factored
into development of CAA section 112
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
standards. This reading has been upheld
as reasonable by the D.C. Circuit in U.S.
Sugar Corp. v. EPA, 830 F.3d 579, 606–
610 (2016).
Section IV.E.3 of this preamble
provides a summary of key comments
we received on the SSM provisions and
our responses.
F. What other changes have been made
to the NESHAP?
This rule also finalizes, as proposed,
revisions to several other requirements
in the Commercial Sterilization
Facilities NESHAP. We describe these
revisions in this section as well as other
proposed provisions that have changed
since proposal.
khammond on DSKJM1Z7X2PROD with RULES2
1. Demonstrating Compliance
In the majority of instances,
parametric monitoring is used to good
effect as an ongoing means of ensuring
that these devices continue to get
necessary emission reductions.18
However, given the nature of EtO, in
which small amounts can have large
risk impacts, parametric monitoring
alone will not be sensitive enough to
detect very small fluctuations in EtO
concentration. Based on comments
received during the proposed
rulemaking, the EPA is finalizing a
requirement to use EtO CEMS for
demonstrating compliance. However,
facilities where EtO use is less than 100
lb/year will have the option to use EtO
CEMS or performance testing and
parametric monitoring to demonstrate
compliance. Based on comments
received during the proposed
rulemaking, we are promulgating the
following requirements:
• Quarterly reporting of EtO CEMS
data,
• Minimum data availability of 90
percent for EtO CEMS, and
• Use of either outlet volumetric flow
rate monitors or differential pressure
monitors to demonstrate continuous
compliance with EPA Method 204.
Based on comments received during
the proposed rulemaking, we are not
finalizing a requirement for the mass of
EtO being routed to a control device
from an SCV to be determined through
inlet testing. Based on comments
received during the proposed
rulemaking, we are finalizing revisions
to parametric monitoring requirements,
and we are finalizing technical edits to
18 Parametric monitoring is an approach that
measures one or more key indicators of process
operation or emission control device operation,
typically on a continuous basis. The parameters are
known to affect emission levels associated with the
process or the control efficiency of the source’s air
pollution control device.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Performance Specification 19 and QA
Procedure 7.
2. Electronic Reporting
To increase the ease and efficiency of
data submittal and data accessibility, we
are finalizing, as proposed, a
requirement that owners or operators of
commercial sterilization facilities
submit compliance reports (being
finalized at 40 CFR 63.366(b) and (c)),
performance test reports (being finalized
at 40 CFR 63.366(f)), and performance
evaluation reports (being finalized at 40
CFR 63.366(g)) electronically through
the EPA’s Central Data Exchange (CDX)
using the Compliance and Emissions
Data Reporting Interface (CEDRI). The
final rule requires that performance test
results collected using test methods that
are supported by the EPA’s Electronic
Reporting Tool (ERT) as listed on the
ERT website 19 at the time of the test be
submitted in the format generated
through the use of the ERT and that
other performance test results be
submitted in portable document format
(PDF) using the attachment module of
the ERT. Similarly, performance
evaluation results of CEMS measuring
relative accuracy test audit pollutants
that are supported by the ERT at the
time of the test must be submitted in the
format generated through the use of the
ERT and other performance evaluation
results be submitted in PDF using the
attachment module of the ERT. For
compliance reports, the final rule
requires that owners or operators use
the appropriate spreadsheet template to
submit information to CEDRI. The final
version of the template for these reports
is in the docket and will be located on
the CEDRI website.20 Furthermore, we
are finalizing as proposed provisions
that allow facility operators the ability
to seek extensions for submitting
electronic reports for circumstances
beyond the control of the facility, i.e.,
for a possible outage in the CDX or
CEDRI or for a force majeure event in
the time just prior to a report’s due date,
as well as the process to seek such an
extension.
For a more detailed discussion of
these final amendments to the
Commercial Sterilization Facilities
NESHAP, see section IV.G.2.g of the
proposal preamble (88 FR 22790, April
13, 2023), as well as section VI.B below
on compliance with the Paperwork
Reduction Act. For a more thorough
discussion of electronic reporting, see
the memorandum, Electronic Reporting
19 https://www.epa.gov/electronic-reporting-airemissions/electronic-reporting-tool-ert.
20 https://www.epa.gov/electronic-reporting-airemissions/cedri.
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
24101
Requirements for New Source
Performance Standards (NSPS) and
National Emission Standards for
Hazardous Air Pollutants (NESHAP)
Rules, which is available in the docket
for this rulemaking (see Docket Item No.
EPA–HQ–OAR–2019–0178–0398).
3. Title V Permitting
Because of the lack of other Federal
requirements under the CAA that
commercial sterilization facilities are
subject to, as well as the robust
monitoring and reporting requirements
of the final rule, we are not finalizing a
requirement for area source facilities
subject to subpart O to obtain a title V
permit from the delegated authority in
which the source is located.
4. Combined Emission Streams
To increase the ease and efficiency of
complying with the revised NESHAP,
we are finalizing, based on comments
received during the proposed
rulemaking, alternative compliance
approaches for combined emission
streams. For these streams, facilities will
now be allowed to demonstrate
compliance with a mass emission limit
that is determined based on the
emission standards to which the
component streams are subject, as well
as characteristics specific to those
facilities. In addition, we are finalizing
an option for owners and operators to
demonstrate compliance with a sitewide emission limitation, as opposed to
demonstrating compliance for each
individual and combined emission
stream.
5. Minor Clarifications and Corrections
We are including several additional
minor clarifying edits in the final rule
based on comments received during the
public comment period. The comments
and our specific responses to these
items can be found in the document,
Summary of Public Comments and
Responses for the 2024 Risk and
Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
G. What are the effective and
compliance dates of the standards?
The revisions to the standards being
promulgated in this action are effective
on April 5, 2024. The compliance date
for the standards promulgated pursuant
to CAA section 112(f)(2) for the
following existing sources is April 6,
2026:
• SCVs at facilities where EtO use is
at least 1 tpy,
• ARVs at facilities where EtO use is
at least 30 tpy,
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24102
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
• CEVs at area source facilities where
EtO use is at least 60 tpy,
• Group 1 room air emissions at area
source facilities where EtO use is at
least 40 tpy, and
• Group 2 room air emissions at area
source facilities where EtO use is at
least 4 tpy.
The compliance date for the standards
promulgated pursuant to CAA section
112(d)(2)–(3), 112(d)(5) or 112(d)(6) for
the following existing sources is April 5,
2027:
• SCVs at facilities where EtO use is
less than 1 tpy,
• ARVs at facilities where EtO use is
less than 30 tpy,
• CEVs at major source facilities,
• CEVs at area source facilities where
EtO use is less than 60 tpy,
• Room air emissions at major source
facilities,
• Group 1 room air emissions at area
source facilities where EtO use is less
than 40 tpy, and
• Group 2 room air emissions at area
source facilities where EtO use is less
than 4 tpy.
As required by CAA section 112(i)(1),
new sources must comply with each
applicable standard immediately upon
its effective date, which is April 5, 2024,
or upon startup, whichever is later.
The compliance schedules for existing
sources have changed since proposal.
We had proposed an 18-months
compliance deadline for all of the
proposed standards for existing sources.
Based on the comments received, we
have determined that 18 months is not
a sufficient period for sources to comply
with the CAA section 112(d)(2)–(3),
112(d)(5) and 112(d)(6) standards for
existing sources, for the following
reasons:
• Most commercial sterilization
facilities were not initially designed to
be compliant with the PTE requirements
of EPA Method 204. We have learned
from the comments received that for
these facilities, the capture requirements
associated with the emission reduction
standards for Group 1 and Group 2 room
air emissions in the final rule will likely
require a redesign of a portion if not all
of the facility. Many facilities will also
need to purchase additional equipment
(e.g., fans, transformers, variable
frequency drives, etc.) to meet the
capture requirements. Moreover,
compliance with the final emission
standards will likely require the
installation of additional control
devices. We have reviewed the time that
it has taken for previous projects of this
nature to be completed, from
submission of the initial State or local
permit application to installation of the
continuous compliance mechanisms.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Based on this analysis, we find that the
process of bringing a facility into
compliance with the PTE requirements
of EPA Method 204, as well as installing
and verifying additional emission
controls, can take approximately a year
from permit submission to project
completion. However, this estimate does
not account for the time needed to
design and plan before the initial permit
application is submitted, nor for the
time needed to avoid impacts on
medical device supply chains, to
procure control devices from a limited
number of vendors, and to account for
the other complexities identified below.
• The process of redesigning a facility
or installing additional controls will
require some reduction in sterilization
capacity. Moreover, the process of
coming into compliance with the
standards may require multiple facilities
to reduce their sterilization capacity
simultaneously. Based on comments
received during the proposed
rulemaking, the average reduction in
capacity during the re-design and
installation period can range from 10
percent 21 to 20 percent.22 In addition,
there is already strain on the medical
device supply chain, and it is difficult
for most facilities to absorb any
additional demand for sterilized
product. Three years is needed to ensure
that owners and operators can come into
compliance with the emissions
standards while at the same time
minimizing any potential impacts to the
medical device supply chain, for which
reliability is important to protect public
health.
• There are a limited number of
vendors that specialize in the redesign
of facilities to be compliant with the
PTE requirements of EPA Method 204.
In addition, there are a limited number
of control technology vendors that
supply the types of advanced control
systems that the EPA expects will be
necessary for facilities to comply with
the final standards. Three years is
needed to ensure that all owners and
operators can receive the necessary
services and have the proper equipment
in place by the compliance date.
For the same reasons explained above,
existing sources will need more than the
proposed 18 months to comply with the
standards promulgated under CAA
21 Commenter provided the following statement:
‘‘For example, a 10% reduction in capacity across
the 83 commercial sterilizers in the U.S. implies
that an additional 8 sterilization facilities will be
required to maintain existing throughput’’ (see
Docket Item No. EPA–HQ–OAR–2019–0178–0618).
22 Commenter provided the following statement:
‘‘During . . . upgrades, EtO sterilization capacity
was reduced by more than 20 percent as emissions
control equipment was installed and tested.’’ (see
Docket Item No. EPA–HQ–OAR–2019–0178–0566).
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
section 112(f)(2). As with standards
promulgated under section 112(d)(2)–
(3), 112(d)(5) and 112(d)(6), in most
instances compliance with the section
112(f)(2) standards will require sources
to plan, purchase, and install equipment
for EtO control. For example, for SCVs
at facilities where EtO use is at least 30
tpy, if an existing affected source
currently does not achieve 99.99 percent
control of EtO emissions and a new
control system is needed to meet that
limit, the facility will need time to
properly engineer the project, obtain
capital authorization and funding,
procure the equipment, construct the
equipment, start up the equipment, set
up new software, develop operating
procedures, and train operators on the
new equipment. The additional factors
identified above, such as avoiding
impacts to medical device supply
chains and securing control devices
from a limited number of vendors, apply
similarly to section 112(f)(2) standards
as to standards promulgated under
section 112(d)(2)–(3), 112(d)(5) and
112(d)(6).
If facilities commence work on these
emissions reduction efforts immediately
after this rule becomes effective, we
believe that sources will be able to
comply with the standards in this final
rule within the two year compliance
window set by § 112(f)(4), without
substantial interruption in operations.
Specifically, we offer the following
timeline as a general guide to
completing the necessary upgrades in a
timely manner:
• Step 1: Secure vendors for facility
retrofits, control devices, EtO CEMS,
and any other equipment and services
that will be needed in order to comply
with the NESHAP.
• Step 2: Work with vendors on (1)
any new facility designs that will be
required in order to meet the PTE
requirements of EPA Method 204, (2)
any new control system designs that
will be required in order to meet the
emission standards, (3) a schedule to
ensure timely compliance with the
NESHAP, and (4) purchase of the
equipment that will be required in order
to meet items (1) and (2), along with EtO
CEMS.
• Step 3: Submit a permit application
to the relevant permitting authority.
• Step 4: Complete the necessary
facility retrofits, control device
installations, and EtO CEMS
installations.
• Step 5: Test the control systems and
facility air handling systems in order to
ensure that the NESHAP is being met.
We recognize that this is a significant
undertaking for the industry, and we
encourage facilities to engage in these
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
steps as early as practicable, as opposed
to delaying action until closer to the end
of the compliance period.
Although we believe sources that
follow this timeline will be able to
comply with these standards within two
years, to minimize any potential impact
to the medical device supply chain, we
are allowing up to three years for
existing sources to comply with section
112(d)(2)–(3), 112(d)(5) and 112(d)(6)
standards, the maximum timeframe
authorized under CAA section
112(i)(3)(A). Further, CAA section
112(i)(3)(B) and EPA’s regulation at 40
CFR 63.6(i)(4)(i)(A) authorize States
with delegated authority to implement
and enforce this NESHAP to grant an
existing source an additional year to
comply with section 112(d) standards, if
such additional period is necessary for
the installation of controls.23 In
addition, for each standard, owners and
operators will have 180 days after the
end of the relevant compliance period to
begin demonstrating compliance with
that standard. See 40 CFR 63.7(a)(2).
Lastly, if more time is needed to
comply with any standard in this final
rule, CAA section 112(i)(4) provides that
‘‘The President may exempt any
stationary source from compliance with
any standard or limitation under this
section for a period of not more than 2
years if the President determines that
the technology to implement such
standard is not available and that it is
in the national security interests of the
United States to do so. An exemption
under this paragraph may be extended
for 1 or more additional periods, each
period not to exceed 2 years. The
President shall report to Congress with
respect to each exemption (or extension
thereof) made under this paragraph.’’
khammond on DSKJM1Z7X2PROD with RULES2
IV. What is the rationale for our final
decisions and amendments for the
Commercial Sterilization Facilities
source category?
For each issue, this section provides
a description of what we proposed and
what we are finalizing for the issue, the
EPA’s rationale for the final decisions
and amendments, and a summary of key
comments and responses. For all
comments not discussed in this
preamble, comment summaries and the
EPA’s responses can be found in the
comment summary and response
document available in the docket.
23 This flexibility has been available since the
NESHAP was first promulgated (59 FR 62585,
December 6, 1994) and continues to be available in
the current NESHAP.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
A. Amendments Addressing the
Affected Source Definitions
1. What amendments did we propose to
address the affected source definitions?
For SCVs, ARVs, and CEVs, we
proposed to define the affected source
as the individual vent. For Group 1 and
Group 2 room air emissions we
proposed to define the affected source
as the collection of all room air
emissions for each group at any
sterilization facility. More information
concerning the affected source
definitions is in section III.A. of the
proposal preamble (88 FR 22790, April
13, 2023).
2. How did the affected source
definitions change since proposal?
We are finalizing the affected source
definitions as proposed (88 FR 22790,
April 13, 2023).
3. What key comments did we receive
on the affected source definitions and
what are our responses?
Comment: Two commenters suggested
that the definition of an affected source
should be based on control system
outlets, stating that when emission
streams are combined, the limit must be
based on the actual achievable rate of
control with further consideration for
the modeled risk of the facility. One
commenter suggested that the affected
source should be defined as the
sterilization facility as a whole, and
another commenter stated the affected
source definition(s) should consider
destruction efficiency. Additionally,
commenters expressed concerns that the
affected source definitions for point
sources (i.e., SCVs, ARVs, and CEVs)
would disproportionately favor facilities
with smaller capacity and facilities with
multiple individual vents regardless of
size. Specifically, one commenter stated
that a facility with multiple individual
vents would have a higher ‘‘emission
rate ceiling’’ with respect to mass rate
(i.e., lb/h) emission limits.
Response: We disagree with the
commenters’ suggestion that the
definition of an affected source should
be based on control system outlets or
the sterilization facility as a whole.
There are many different ways in which
emission sources can be combined and
controlled at commercial sterilization
facilities. If affected source definitions
were based on control system outlets, it
is not clear which outlets (and, by
extension, emission source
combinations) would be selected and
what the criteria for selecting those
outlets would be. It is not feasible to set
an emission standard for every
conceivable combination of emission
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
24103
sources. Furthermore, the commenters
do not provide any suggestions on
which control system outlets should be
considered when defining affected
sources. The most straightforward
approach is to define the affected source
as the emission source itself and to have
owners and operators decide how best
to combine and control emissions from
affected sources at their facilities. With
respect to defining the affected source as
the sterilization facility as a whole,
there is very limited data available
where a performance test has been
conducted for an entire facility.
Furthermore, defining the affected
source as the sterilization facility would
require a compliance mechanism that
some facilities may find unnecessarily
complicated, given that compliance
demonstration has typically been
conducted on a source-by-source basis.
It is not clear and the commenter does
not provide any explanation on how to
base an affected source definition on
destruction efficiency.
Lastly, regarding the comment that
the definition of affected sources for
point sources is disproportionally
favorable to facilities with smaller
capacity or with multiple individual
vents, this is not an issue in the final
rule. All of the emission standards in
this final rule are in a percent reduction
format, which is the same regardless of
facility size or how many vents are in
place. Therefore, concerns regarding
‘‘emission rate ceilings’’ are no longer
relevant.
Comment: One commenter stated that
there is unnecessary complexity to the
proposed definitions of Group 1 and
Group 2 room air emissions due to the
variability in size and facility
configuration, particularly as they apply
to the proposed format of the emission
standards for these sources (i.e., lb/h).
The commenter also stated that the
definitions favor facilities which have
smaller capacity and noted that
individual facility characteristics must
be considered for Group 1 and Group 2
emissions. Specifically, the commenter
stated that emission rates should be
based on technological feasibility to
control emissions, including feasibility
limitations regarding low inlet
concentrations.
Response: We disagree with one
commenter’s assertion that there is
unnecessary complexity to the proposed
definitions of Group 1 and Group 2
room air emissions due to the variability
in size and facility configuration. All
sterilization facilities, regardless of size
or configuration, follow the same basic
procedure: sterilization and its
associated activities (e.g., EtO storage
and dispensing, vacuum pump
E:\FR\FM\05APR2.SGM
05APR2
24104
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
operation, handling of pre-aeration
sterilized product), aeration, and
shipping. Group 1 room air emissions
simply cover all activities that occur
prior to aeration, and Group 2 room air
emissions cover all activities that occur
after aeration. Combining room air
emissions based on whether they occur
before or after aeration is a clear way to
defining room air emissions affected
sources. It also reflects the most
common controlled room air
configuration that we have observed.
With respect to considering individual
facility characteristics The simplest
breakdown of controlled room air
emissions that we have observed
involves capturing and routing all
emissions from post-aeration handling
of sterilization material to one control
system, and then capturing and routing
all other room air emission sources (i.e.,
Group 1 room air emissions) to another
control system. It is important to define
the affected sources for room air
emissions in this manner so that owners
and operators can have flexibility in
how they chose to control their
emissions,24 and so that facilities who
have already chosen to control their
emissions in this manner can continue
to do so while minimizing any potential
compliance issues. With respect to the
comment that the definition of affected
sources for room air emissions is
disproportionally favorable to facilities
with smaller capacity, the comment
appears to pertain more to the setting of
the emission standards themselves,
rather than the affected source
definition. As discussed in section
IV.B.3.b of this preamble, we are no
longer finalizing mass rate emission
standards, and we are accounting for
technical feasibility (e.g., manufacturer
guarantees, emission reductions
achieved in performance tests) when
finalizing emission standards. The
emission standards in this final rule for
room air emissions are in a percent
reduction format, which is the same
regardless of facility size.
khammond on DSKJM1Z7X2PROD with RULES2
4. What is the rationale for our final
approach and final decisions to address
the affected source definitions?
We evaluated the comments on our
proposed affected source definitions.
For the reasons explained in the
proposed rule (88 FR 22790, April 13,
2023), we determined that these
amendments are necessary because the
definition of an ‘‘affected source’’ at 40
CFR 63.2 is not appropriate for this
24 The EPA has not observed any instance where
a facility is routing a portion of its Group 1 room
air emissions to one control system, and the other
portion to a different control system.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
source category. More information
concerning the amendments we are
finalizing for affected source definitions
is in the preamble to the proposed rule
and in the comments and our specific
responses to the comments in the
document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking. Therefore,
we are finalizing the affected source
definitions as proposed.
B. Amendments Pursuant to CAA
Sections 112(d)(2), 112(d)(3), and
112(d)(5) for the Commercial
Sterilization Facilities Source Category
1. What did we propose pursuant to
CAA sections 112(d)(2), 112(d)(3), and
112(d)(5) for the Commercial
Sterilization Facilities source category?
We proposed to establish standards
under CAA sections 112(d)(2)–(3) and
112(d)(5) for the following emission
sources that were unregulated: SCVs,
ARVs, and CEVs at facilities where EtO
use is less than 1 tpy, ARVs and CEVs
at facilities where EtO use is at least 1
tpy but less than 10 tpy, CEVs at
facilities where EtO use is at least 10
tpy, and room air emissions. We also
proposed a technical correction to the
emission standard for ARVs at facilities
where EtO use is at least 10 tpy. We
proposed the following emission
standards pursuant to CAA section
112(d)(2)–(3):
• 3.2E–4 lb/h for new and existing
CEVs at facilities where EtO use is at
least 10 tpy,
• 1.3E–3 lb/h for new and existing
Group 1 room air emissions at major
source facilities, and
• 2.8E–3 lb/h for new and existing
Group 2 room air emissions at major
source facilities.
For more information, see section III.B
of the proposal preamble (88 FR 22790,
April 13, 2023). We proposed the
following emission standards pursuant
to CAA section 112(d)(5):
• 99 percent emission reduction for
new and existing SCVs at facilities
where EtO use is less than 1 tpy,
• 99 percent emission reduction for
new and existing ARVs at facilities
where EtO use is at least 1 tpy but less
than 10 tpy,
• 99 percent emission reduction for
new and existing ARVs at facilities
where EtO use is less than 1 tpy,
• 99 percent emission reduction for
new and existing CEVs at facilities
where EtO use is at least 1 tpy but less
than 10 tpy,
• 99 percent emission reduction for
new and existing CEVs at facilities
where EtO use less than 1 tpy.
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
• 1.3E–3 lb/h emission limit for new
and existing Group 1 room air emissions
at area source facilities, and
• 2.8E–3 lb/h emission limit for new
Group 2 room air emissions at area
source facilities.
These are emissions standards that
reflect the use of generally available
control technologies. For more
information, see section III.B of the
proposal preamble (88 FR 22790, April
13, 2023).
For existing Group 2 room air
emissions at area source facilities,
pursuant to CAA section 112(d)(5), we
proposed a requirement for facilities to
follow either the Cycle Calculation
Approach or the Bioburden/Biological
Indicator Approach to achieve sterility
assurance in accordance with ISO
11135:2014 and ISO 11138–1:2017. This
is a BMP that would reduce EtO use per
sterilization cycle (i.e., pollution
prevention). For more information, see
section III.B.8.g of the proposal
preamble (88 FR 22790, April 13, 2023).
In order to ensure complete capture of
EtO emissions and, in turn, compliance
with the proposed standards, we
proposed to require each facility to
operate areas with room air emissions
subject to an emission standard in
accordance with the PTE requirements
of EPA Method 204 of appendix M to 40
CFR part 51. For more information, see
section III.B of the proposal preamble
(88 FR 22790, April 13, 2023).
We addressed a necessary correction
to the emission standards for these
sources in 40 CFR 63.362(d) that allow
facilities to either achieve 99 percent
emission reduction or limit the outlet
concentration to a maximum of 1 part
per million by volume (ppmv),
‘‘whichever is less stringent, from each
aeration room vent.’’ We proposed
removing the less stringent 1 ppmv
concentration alternative for these
sources because it is not equivalent and
therefore not an appropriate alternative
to 99 percent emission reduction
standard. For more information, see
section III.B.2 of the proposal preamble
(88 FR 22790, April 13, 2023).
2. How did the revisions pursuant to
CAA sections 112(d)(2), 112(d)(3), and
112(d)(5) change since proposal for the
Commercial Sterilization Facilities
source category?
We are finalizing as proposed the
following standards under CAA section
112(d)(5):
• 99 percent emission reduction for
new and existing SCVs at facilities
where EtO use is less than 1 tpy,
• 99 percent emission reduction for
new and existing ARVs at facilities
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
where EtO use is at least 1 tpy but less
than 10 tpy, and
• 99 percent emission reduction for
new and existing ARVs at facilities
where EtO use is less than 1 tpy.
In addition, we are finalizing a
requirement for each facility to operate
areas with room air emissions subject to
an emission standard in accordance
with the PTE requirements of EPA
Method 204 of appendix M to 40 CFR
part 51. We are also finalizing the
removal of the 1 ppm alternative for
ARVs at facilities where EtO use is at
least 10 tpy, as proposed.
Based on comments received during
the proposed rulemaking, we have
revised the proposed standards for the
following affected sources. The final
emission standards pursuant to CAA
sections 112(d)(2), 112(d)(3), and
112(d)(5) are as follows:
• 99.94 percent emission reduction
for new and existing CEVs at major
source facilities,
• 99 percent emission reduction for
new and existing CEVs at area source
facilities,
• 97 percent emission reduction for
new and existing Group 1 room air
emissions at major source facilities,
• 80 percent emission reduction for
new and existing Group 1 room air
emissions at area source facilities,
• 86 percent emission reduction for
new and existing Group 2 room air
emissions at major source facilities,
• For existing Group 2 room air
emissions at area source facilities, lower
the EtO concentration within each
sterilization chamber to 1 ppm before
the chamber can be opened, and
• 80 percent emission reduction for
new Group 2 room air emissions at area
source facilities.
For new and existing CEVs at major
source facilities, as well as new and
existing room air emissions at major
source facilities, based on comments
received during the proposed
rulemaking, we have re-calculated the
MACT floor based on percent emission
reduction, as opposed to mass rate
emissions. The primary reason for
finalizing this change is that there is a
serious concern that mass rate emission
standards could result in operational
reductions that could adversely impact
the medical supply chain. The revised
MACT floor for new and existing CEVs
at major source facilities is 99.94
percent emission reduction. Because we
were unable to identify more stringent
(i.e., beyond the floor or ‘‘BTF’’) options
that are cost-effective, we are finalizing
99.94 percent emission reduction as the
MACT standard under CAA section
112(d)(2)–(3) for new and existing CEVs
at major source facilities. The revised
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
MACT floor for new and existing Group
1 room air emissions at major source
facilities is 90 percent emission
reduction. We were able to identify a
more stringent (i.e., 97 percent control)
and cost-effective BTF option and,
therefore, we are finalizing a 97 percent
emission reduction standard as the
MACT standard under CAA section
112(d)(2)–(3) for new and existing
Group 1 room air emissions at major
source facilities. The revised MACT
floor for new and existing Group 2 room
air emissions at major source facilities is
86 percent emission reduction. Because
the concentration that corresponds to
this emission reduction is three times
the representative detection level (RDL)
for EtO, there are no BTF options to
consider due to the potential difficulty
of demonstrating compliance with
limits lower than the MACT floor.
Therefore, we are finalizing 86 percent
emission reduction as the MACT
standards for new and existing Group 2
room air emissions at major source
facilities. For more information, see
section IV.B.3.b of this preamble.
For both new and existing Group 1
room air emissions at area source
facilities, as well as new Group 2 room
air emissions at area source facilities,
based on comments received during the
proposed rulemaking, we are finalizing
an 80 percent emission reduction
standard, consistent with the
manufacturer guarantee for the control
technology on which the standard is
based. The primary reason for the
change from mass rate to percent
reduction is that there is a serious
concern that mass rate emission
standards could result in operational
reductions in order to meet the
standards while still ensuring work
health and safety, but that could
adversely impact the medical supply
chain. In addition, while some sources
have demonstrated emission reductions
higher than 80 percent, those reductions
are limited to facilities with higher EtO
usage rates, and we cannot determine
whether smaller users of EtO can meet
those emission reductions. For more
information, see section IV.B.3.b of this
preamble.
For existing Group 2 room air
emissions at area source facilities, based
on comments received during the
proposed rulemaking, we are finalizing
a revised BMP due to concerns that the
BMP that we proposed (as well as
alternatives for which we solicited
comment in the proposal), would
adversely impact the medical supply
chain due to inefficiencies that would
arise, as well as having to lengthen cycle
dwell times in order to ensure sterility.
The final requirement reduces existing
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
24105
Group 2 room air emissions at area
source facilities by 20 percent, does not
interfere with sterility assurance, and is
expected to impact only 20 percent of
facilities. We do not anticipate any
severe negative impacts to the medical
supply chain as a result of finalizing
this requirement. For more information,
see section IV.B.3.a of this preamble.
3. What key comments did we receive
on the proposal revisions pursuant to
CAA section 112(d)(2), 112(d)(3), and
112(d)(5), and what are our responses?
This section provides comment and
responses for the key comments
received regarding BMPs, mass rate
emission standards, PTE, and
warehouses. Other comment summaries
and our responses for additional issues
raised regarding these activities, as well
as issues raised regarding our proposed
emission standards for SCVs and ARVs
at facilities where EtO use is less than
1 tpy, ARVs at facilities where EtO use
is a least 1 tpy but less than 10 tpy,
room air emissions at major source
facilities, and our proposed technical
correction to the emission standard for
ARVs at facilities where EtO use is at
least 10 tpy can be found in the
document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
a. BMP
Comment: Several commenters
contended that we should not require
facilities to follow either the Cycle
Calculation Approach or the Bioburden/
Biological Indicator Approach to
achieve sterility assurance in
accordance with ISO 11135:2014 and
ISO 11138–1:2017. They stated that
owners and operators should have the
flexibility to optimize cycles using a
variety of ISO/AAMI 11135 methods
and that we should not limit or restrict
the validation method that may be used.
One commenter stated that requiring
facilities to follow the Cycle Calculation
or Bioburden/Biological Indicator
Approach would result in more
dedicated product loads, more cycles
needed to sterilize different project
mixes, and most chambers not being
filled to capacity. The commenter stated
that de-consolidation of existing cycles
to implement an appropriate Cycle
Calculation or Bioburden/Biological
Indicator approach would require (1)
creation and validation of new product
families, new process challenge devices,
and biological indicators, (2) cycle
development, and (3) maintenance
through requalification and annual
reporting. The commenter noted that the
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24106
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
extra burden associated with
maintaining more cycles would create
more work and require more chamber
time, resulting in less sterilization
capacity. Two commenters stated that
requiring either the Cycle Calculation or
Bioburden/Biological Indicator
approach could limit research for
product innovation as available
development time in EtO sterilization
chambers would be taken up for
optimizing existing products.
Two commenters stated the ISO
standards were intended for the process
of EtO sterilization and not emission
reduction or controls. One commenter
further contended it is a faulty approach
to base emission standards on
international standards, as these
standards are revised periodically and
may continue to evolve. Another
commenter noted that ISO/AAMI
standards are currently being revised to
be more flexible to achieve optimized
cycles, while minimizing impact on
sterilization capacity. The commenter
contended that cycle validation must
focus on achieving sterility required for
patient safety and assuring product
performance and reliability, and that
reducing EtO use cannot take priority
over patient safety.
One commenter stated that
conducting Cycle Calculation studies for
every product type or category would
not be feasible with the current
capacity. The commenter stated this
would require effort to redesign
sterilization cycles, evaluate product
and packaging performance, and
validate the redesigned cycles. The
commenter also stated that the new
validation work will impact sterilization
capacity as sterilizer equipment is not
available for production use during
study times (i.e., production capacity is
diverted to cycle validation). The
commenter further stated that sites that
use more than one vendor would have
to redesign sterilization cycles at each
vendor and that, given the limited
resources and expertise, this would not
be possible to achieve on this scale.
Another commenter stated they have
not been able to ensure product sterility
using Cycle Calculation approach.
Finally, one commenter stated that
the Bioburden/Biological Indicator
methods limit the number of products
that can be validated in a single cycle.
The commenter stated that the
Bioburden/Biological Indicator
approach may be limited to a range of
products with similar attributes and
drive up the number of required cycles.
The commenter also stated that each
validated cycle will require
requalification every few years, and the
additional testing at sterilizers and
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
testing laboratories will decrease
available sterilization capacity. The
commenter stated that the inability to
fill a sterilization chamber fully with
product and waiting until full can lead
to inefficient use of sterilization
chambers and supply issues. Another
commenter stated the Bioburden/
Biological Indicator approach results in
additional cost and delays, as it requires
that the product bioburden levels be
enumerated and characterized, and that
consistency in the bioburden population
and the bioburden’s resistance to the
sterilization process remain relatively
stable over a multi-year period. The
commenter also stated that it may take
many years to establish the range in
numbers and types of bioburden to
properly perform a validation using this
proposed Bioburden/Biological
Indicator approach. Another commenter
stated that the Bioburden approach
would require upgrades to supplier
facilities, manufacturing facility, and
microbiological control practices.
Response: We agree with the
commenters’ concerns regarding
potential inefficiencies in the
sterilization process that may arise from
requiring facilities to follow either the
Cycle Calculation Approach or the
Bioburden/Biological Indicator
Approach to achieve sterility assurance
in accordance with ISO 11135:2014 and
ISO 11138–1:2017, along with the
potentially adverse impacts to the
medical supply chain that could result
from the proposed approach. These
inefficiencies include reduced cycle
optimization (i.e., not being able to
sterilize as much product per load or
chamber), having to run more cycles
overall in order to meet the demand for
sterile medical devices, and diverting
already strained resources away from
normal operations to developing new
cycle validations. We also agree with
the commenters’ concerns that requiring
facilities to follow this requirement
would limit research for product
innovation. Given the current strain on
resources, some companies may not be
able to invest in additional chambers to
conduct research. In addition, we agree
with the commenters’ concerns that
because this requirement is based on
international standards, which are
revised periodically, this could result in
potential future complications.
Therefore, we are not including this
requirement in the final rule.
Comment: As mentioned above, the
EPA solicited comments on several
other BMPs, including limiting EtO
concentration limit and limiting
packaging and pallet material. Two
commenters stated that it is not
technically feasible for facilities and
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
products to meet a 290 milligrams per
liter (mg/L) EtO concentration limit.
One commenter stated that many
industry guidelines and studies show
that 400 mg/L is the minimum
recommended concentration, and many
products use higher concentrations to
meet sterility assurance and product
quality requirements as set forth by
FDA. Another commenter stated that
process efficiency is reduced with
concentrations below 400 mg/L and that
efficiency is constant at concentrations
greater than 500 mg/L. One commenter
indicated that an EtO concentration
range of 400 to 650 mg/L is common
practice because it achieves
microbiological lethality for most
products within a reasonable exposure
time. Another commenter stated that
product design, stability poststerilization, and lethality are the
drivers behind the choice of EtO
concentration. The commenter also
stated that research and development
with biological indicators is routinely
conducted using 600 mg/L cycles and
that enforcing a lower limit may have an
unintended negative consequence on
the availability of biological indicators
required for sterilization process
validation and routine monitoring. One
commenter stated we should not
propose to limit the EtO concentration
to 290 mg/L for small facilities and that
we should, instead, allow performancebased standards. In addition, several
commenters stated that an upper-bound
limit on EtO concentration may lead to
longer cycle times and dwell times and
that longer dwell times would impact
sterilization capacity and would lead to
offshoring, as well as the construction of
additional facilities.
One commenter stated limiting
packaging and pallet material will
interrupt trade, reduce innovation,
increase the cost of medical devices,
and disrupt the medical device
manufacturing industry without a
quantifiable reduction in EtO emissions.
Two commenters stated that packaging
and pallet material selection will drive
the design of medical products. Two
commenters noted that packaging
requirements are in place to ensure a
sterile barrier until use and to prevent
product damage. One commenter stated
packaging must pass rigorous test
requirements, according to industry
standards. Another commenter
indicated that facilities use barcode
instructions for use (IFUs) in place of
paper IFUs when possible. However,
paper IFUs are regulated by FDA. Two
commenters noted that paper IFUs have
not been documented to be a source of
residual emissions. Another commenter
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
stated that there is no evidence that
barcode materials would have less EtO
retention than paper, and that labeling
decisions have practical and legal
considerations. One commenter noted
that a minimal amount of plastic wrap
is used to ensure the structural integrity
of pallets during shipping and that
excessive plastic is not in the interest of
sterilization facilities, as it slows EtO
penetration. The commenter also stated
that kits are transported in cardboard to
protect from punctures, and it is not
possible to eliminate cardboard. A
puncture to a kit means the kit needs to
be re-sterilized, requiring use of
additional EtO. One commenter stated
that changes to pallet material could
have supply chain issues given
interoperability and weight
requirements. Finally, another
commenter stated that pallet materials
impact the strength and design of pallet,
and any issues would have implications
for the entre medical device supply
chain.
Response: We agree with the
commenters’ concerns regarding the
issues with prescribing an upper-bound
limit on in-chamber EtO concentration,
as well as the negative impacts to the
medical supply chain that could result
from increasing the dwell time to
maintain sterility as an outcome of such
a requirement. Therefore, we are not
including this requirement in the final
rule. We also agree with the
commenters’ concerns regarding the
need to ensure a sterile barrier through
sufficient packaging, as well as the
potential supply chain impacts from
placing limits on the types of pallets
that may be used. Therefore, we are not
requiring limits on packaging or
transport materials as part of this
rulemaking.
Comment: One commenter
recommended an end of sterilization
cycle chamber limit of less than 1 ppm
(with a zero mg/L reading) in the
sterilization chamber (EtO remaining
calculated measurement) as a BMP. The
commenter stated that removing EtO
from the sterilization chamber is the
most efficient stage for EtO removal.
The commenter further stated that
longer EtO dwell times, as well as the
potential for the elimination of nitrogen
gas washes to keep total cycle time
equivalent, could result in more EtO
residual at aeration and the greater
potential for room air emissions after
aeration.
Response: We agree with the
commenter’s suggestion of a
requirement to limit the in-chamber EtO
concentration to 1 ppm. It does not
interfere with sterility assurance, and,
based on responses to the December
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
2019 questionnaire and September 2021
Information Collection Request (ICR), 80
percent of all commercial sterilization
facilities, regardless of annual EtO use,
are already meeting this limit. Those
who are not meeting the limit currently
are close to the limit,25 so we do not
anticipate any severe negative impacts
to the medical device supply chain as a
result of finalizing this requirement. We
estimate that the emission reductions
from applying this requirement to the
source category would be 20 percent. In
addition, since 80 percent of facilities
are already meeting this limit, this
would result in an 80 percent reduction
in costs. We have evaluated the changes
in cost, emissions, and costeffectiveness for this BMP, and it is
more cost-effective than the other
options we considered. Therefore, for
Group 2 room air emissions we are
finalizing the BMP such that the inchamber EtO concentration is to be
lowered to 1 ppm before the chamber
can be opened. We note that, even
though this BMP is expected to result in
fewer emission reductions than the BMP
we proposed, this rule will still reduce
EtO emissions (and, therefore, lifetime
cancer risks) in multiple communities
across the country. As discussed in
section IV.C.2.a.iii, this BMP will
ultimately apply only to facilities where
EtO use is less than 4 tpy. We are
finalizing the requirement that area
source facilities whose EtO usage is at
least 4 tpy but less than 20 tpy and area
source facilities whose EtO usage is at
least 20 tpy are required to reduce
Group 2 room air emissions by 80
percent and 98 percent, respectively
(see section IV.C.2.a.iii for more
information). For SCVs and ARVs at
facilities where EtO use is less than 1
tpy, as well as ARVs at facilities where
EtO use is less than 10 tpy, our general
rationale for proposing emission
standards over the BMP was that
emission standards would both achieve
greater emission reduction and incur
fewer annual costs than the BMP.
However, even considering lower
annual costs for the BMP, the emission
standards would still achieve greater
emission reduction. Therefore, for SCVs
and ARVs at facilities where EtO use is
less than 1 tpy, as well as ARVs at
facilities where EtO use is less than 10
tpy, we are finalizing the emission
standards as proposed pursuant to CAA
section 112(d)(5). For CEVs at area
source facilities, as well as room air
25 The highest concentration that was reported
prior to opening the chamber door was 20 ppm.
While this may seem high, this is reduced from
starting EtO concentrations of several thousand
ppm (see section IV.F.3 of this preamble for further
discussion).
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
24107
emissions at area source facilities, we
are also evaluating percent emission
reduction standards, as opposed to mass
rate emission standards. The revised
GACT analyses for those emission
sources are presented in section IV.B.3.b
of this preamble.
Comment: Several commenters stated
that we do not have the legislative
authority or expertise to regulate
sterilization cycles and that FDA is the
Federal agency that has authority to
regulate medical device sterilization.
They stated that Congress gave FDA the
authority to ensure the availability of
safe and effective medical products and
that we must not finalize any regulatory
requirements that are under FDA
purview.
Response: The EPA proposed the
BMP (i.e., require facilities to follow
either the Cycle Calculation Approach
or the Bioburden/Biological Indicator
Approach) pursuant to CAA section
112(d)(5), which authorizes the EPA to
set standards for area sources that
provide for the use of generally
available control technologies or
management practices to reduce
emissions. In addition, CAA section
112(h)(1) authorizes the EPA to
promulgate a design, equipment, work
practice or operational standard, or a
combination thereof, if the EPA does not
think it can prescribe an emission
standard. We have identified
modification of the post-sterilization
process (e.g., reducing the EtO
concentration within the sterilization
chamber prior to opening the chamber)
as a BMP that can reduce EtO emissions
from certain affected sources at
commercial sterilization area source
facilities. Neither CAA section 112(d)(5)
nor section 112(h)(1) limits the scope of
management or work practices that the
EPA may consider in setting standards
to control HAP, nor did the commenter
identify any such legal limitation in the
CAA or other applicable legal
authorities. As discussed above, we are
not finalizing the proposed BMP; in
response to comment, we are finalizing
a requirement for area source facilities
with existing Group 2 room air
emissions to lower the in-chamber EtO
concentration to 1 ppm before the
chamber is opened.26 As discussed in
26 We have previously regulated the in-chamber
EtO concentration when we established standards
for CEVs at facilities where EtO use is at least 1 tpy
but less than 10 tpy (59 FR 62586, December 6,
1994). These requirements were removed initially
due to safety concerns regarding the regulation of
emissions from CEVs, not related to any limitations
on our authority. See discussion in section III.B.5
of the proposal preamble (88 FR 22790, April 13,
2023) for more information regarding why safety is
E:\FR\FM\05APR2.SGM
Continued
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
section IV.C.2.a.iii of this preamble, this
requirement will ultimately apply only
to existing Group 2 room air emissions
at facilities where EtO use is less than
4 tpy. Based on responses to the
December 2019 questionnaire and the
September 2021 ICR, we have not
identified any facilities where EtO use
is less than 4 tpy that are not currently
meeting this requirement. Therefore, in
general, we do not anticipate that any
facilities will need to go through a new
cycle validation as a result of this
requirement. Based on our
conversations with FDA, this
requirement is not anticipated to have
an adverse impact on the medical
device supply chain.
b. Mass Rate Emission Standards
Comment: Several commenters were
opposed to mass rate emission
standards, stating that they do not
account for the substantial variability
among volumetric flow rates in
sterilization operations. The
commenters expressed concerns with
potential operational reductions needed
in order to meet the standards while
still ensuring worker health and safety,
as well as compliance with EPA Method
204. The commenters suggested that we
finalize emission reduction and outlet
concentration standards instead. In
addition, these commenters
recommended that these standards be
based on control device manufacturer
guarantees. One commenter stated that,
based on their discussions with control
device manufacturers, they believe that
the best and most advanced
technologies will be guaranteed to meet
a 99 percent emission reduction
standard for CEVs and an 80 percent
emission reduction standard for room
air emissions.
Response: We agree with the
commenters’ concerns regarding the
potential impacts of mass rate emission
standards. Given the low outlet EtO
concentration of these streams, along
with current EtO detection levels, a
mass rate emission standard essentially
functions as an upper-bound limit on
volumetric flow rate. It may not be
appropriate to limit volumetric flow rate
in this fashion, as additional flow may
be needed in order to demonstrate
compliance with EPA Method 204 or to
ensure worker health and safety. If
volumetric flow rate is limited, a facility
may be forced to reduce its sterilization
capacity in order to meet the mass rate
emission standards. However, we
disagree with the commenters’
suggestion that outlet concentration
not a concern regarding the requirements finalized
in this action.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
standards be considered. We are
concerned that some owners and
operators may choose to dilute the air
flow of the emissions stream rather than
control emissions, in order to meet an
outlet concentration standard, which
would not result in emission reductions.
In order to ensure emission reductions
from an outlet concentration standard,
an upper-bound limit on the volumetric
flow rate would be necessary. As we
have discussed before, this may be
inappropriate for the source category.
Therefore, although we proposed mass
emission rate standards, we are
finalizing percentage emission
reduction standards in their place, and
those specific standards are discussed
later in this section.
We re-calculated the MACT floor for
existing CEVs at major source facilities.
We ranked the percent reduction
performance of the CEVs ‘‘for which the
EPA has emissions information’’ and
found the best performing 12 percent of
CEVs consists of one CEV that is being
controlled by a gas/solid reactor.27
Because the variability and uncertainty
associated using available, short-term
data would tend to reduce the minimum
percent reduction, we then used the
lower, not upper, prediction limit
approach to develop the MACT floor for
existing sources.28 The LPL approach
predicts the level of emissions that the
27 See CAA section 112(d)(3). See also, National
Ass’n of Clean Water Agencies v. EPA, 734 F.3d
1115, 1131 (2013) (citing Sierra Club v. EPA, 167
F.3d 658, 661 and 662) (‘‘We accorded Chevron
deference to EPA’s . . . estimate of the MACT floor,
noting that the requirement that the existing unit
floors ‘not be less stringent than the average
emissions limitation achieved by the best
performing 12 percent of units’ does not, on its
own, dictate ‘how the performance of the best units
is to be calculated, . . . [and] recognizing that ‘EPA
typically has wide latitude in determining the
extent of data gathering necessary to solve a
problem.’ ’’
28 The variability for a DRE format limit requires
use of a lower prediction limit (LPL), the UPL
template was therefore modified for use to
determine the LPL; rather than use of the 99th
percentile that captures the ‘‘right tail’’ of the data
distribution, the LPL template uses the 1st
percentile, i.e., captures the ‘‘left tail’’ of the data
distribution (the t-statistic is 0.01). The LPL differs
from the more commonly used UPL in that
variability and uncertainty associated with percent
reduction limits tend to make the predicted limits
smaller than their averages; for UPL applications,
variability and uncertainty associated with
emission limits tend to make those predicted limits
larger than their averages. Both approaches—UPL
and LPL—rely on the same set of equations
developed for the UPL; they only differ in the
selected percentile. In other words, the LPL relies
on calculations associated with the first percentile
(LPL 1) of the data distribution, which is below the
fiftieth percentile (LPL 50), or average for data with
a normal distribution, while the UPL relies on
calculations associated with the ninety-ninth
percentile (UPL 99) of the data distribution, which
is above the fiftieth percentile (UPL 50), or average
for data with a normal distribution. Also note that
for data in a normal distribution, LPL 50 = UPL 50.
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
sources upon which the floor is based
are expected to meet over time,
considering both the average emissions
level achieved as well as emissions
variability and the uncertainty that
exists in the determination of emissions
variability given the available, shortterm data. For LPLs, our practice is to
use the first percentile, or LPL 1, as that
is the level of emission reductions that
we are 99 percent confident is achieved
by the average source represented in a
dataset over a long-term period based on
its previous, measured performance
history as reflected in short term stack
test data. The LPL 1 value of the existing
source MACT floor is 99.94 percent
emission reduction. The LPL 1 EtO
concentration that corresponds to this
emission reduction rate is 49 ppbv.
Based on our review of available EtO
measurement instruments and our
demonstration program, we find the instack detection level for EtO, given the
current technology, and potential
makeup of emission streams, is
approximately 10 ppbv. Some EtO
CEMS manufacturers claim instrument
detection levels much lower than 10
ppbv. However, we believe at the
current time, 10 ppbv is the lowest level
that can be consistently demonstrated
and replicated across a wide range of
emission profiles. We expect that EtO
CEMS manufacturers, measurement
companies, and laboratories will
continue to improve EtO detection
levels (making them lower). In the
meantime, consistent with our practice
regarding reducing relative
measurement imprecision by applying a
multiplication factor of three to the
RDL, the average detection level of the
best performers, or, in this case, the
better performing instruments, so that
measurements at or above this level
have a measurement accuracy within 10
to 20 percent—similar to that contained
in the American Society of Mechanical
Engineers (ASME) ReMAP study,29 we
apply a multiplication factor of three to
the RDL of 10 ppbv, which yields a
workable-in-practice lower measurable
value of 30 ppbv. For reference, below
is the equation that relates the percent
emission reduction, inlet EtO
concentration, and outlet EtO
concentration:
ER=
Et01M - EtOaM
Where, ER is the percent emission
reduction, EtOIM is the inlet EtO mass,
and EtOOM is the outlet EtO mass. Since
29 See the discussion in the MATS rule preamble
at 77 FR 9370, February 16, 2012.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.000
24108
24109
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
the outlet EtO concentration that
corresponds to the MACT floor of 99.94
percent emission reduction is above
3×RDL, there are more stringent (i.e.,
BTF) options to consider.30 We
considered two BTF options for
reducing EtO emissions from this
source: the first option is 99.95 percent
emission reduction, and the second
option reflects the most stringent
emission reduction for which
compliance can be demonstrated. With
respect to the second option, the most
plant for existing CEVs at a synthetic
area source facility with the following
assumptions reflecting the average of
each of the parameters at synthetic area
source facilities:
stringent emission reduction for which
compliance can be demonstrated is that
which corresponds to an outlet
concentration of 30 ppbv (i.e., 3xRDL).
This emission reduction is 99.96
percent, which is lower than all of the
reported emission reductions in the test
runs that were used to calculate the
MACT floor. The impacts of these
options are presented in table 7.
Because we have not identified any
major source facilities with existing
CEVs, the impacts are based on a model
• Annual EtO use: 200 tpy.
• Annual operating hours: 8,000.
• Portion of EtO going to CEVs: 1
percent.
• CEV flow rate: 278 cubic feet per
second (cfs).
khammond on DSKJM1Z7X2PROD with RULES2
TABLE 7—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF BTF OPTIONS CONSIDERED UNDER CAA
SECTIONS 112(d)(2) AND 112(d)(3) FOR CEVS AT MAJOR SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed
standard
MACT Floor ..
1 ....................
2 ....................
99.94 percent emission reduction .................................
99.95 percent emission reduction .................................
99.96 percent emission reduction .................................
Total annual
costs
($/yr)
$830,000
184,000
184,000
$176,000
65,500
66,200
EtO emission
reductions
(tpy)
Cost effectiveness
($/ton EtO)
2.4E–2 [480 lb/yr] ..............
2.0E–4 [0.4 lb/year] ...........
2.0E–4 [0.4 lb/year] ...........
$735,000 [$370/lb].
328,000,000 [$164,000/lb].
331,000,000 [$166,000/lb].
While we acknowledge that EtO is a
highly toxic HAP, the cost estimates
above are far outside the range of the
cost-effectiveness values that we have
determined to be cost-effective for
highly toxic HAPs (e.g., we finalized a
requirement with a cost-effectiveness of
$15,000/lb ($30,000,000/ton) for
existing small hard chromium
electroplating to provide an ample
margin of safety (taking into account
cost among other factors) (77 FR 58227–
8, 58239). Based on the estimates above,
we find neither option to be cost
effective. Therefore, the final MACT
standard for existing CEVs at major
source facilities is 99.94 percent
emission reduction.
For new sources, CAA section
112(d)(3) requires that the standard
shall not be less stringent than the
emission control that is achieved in
practice by the best controlled similar
source. In this case, the best controlled
similar source is also the CEV that is
being controlled by a gas/solid reactor
and the data of which is used to
determine the MACT floor for existing
sources. Therefore, the new source
MACT floor is equivalent to the existing
source MACT floor, which is 99.94
percent emission reduction. As
explained above, because this emission
reduction limit is above the lowest level
at which compliance can be
demonstrated, the EPA considered more
stringent (i.e., BTF) options. We
considered the same BTF options as
those evaluated for existing CEVs at
major source facilities, for the same
reasons explained above. The first BTF
option would require achieving 99.95
percent emission reduction, and the
second BTF option would require
achieving 99.96 percent emission
reduction. The impacts of these options
are presented in table 7 of this
preamble. Because we have not
identified any major source facilities
with existing CEVs, the impacts are
based on a model plant for existing
CEVs at a synthetic area source facility.
Based on the estimates above and for the
reason explained above, we find neither
option to be cost effective. Therefore,
the final MACT standard for new CEVs
at major source facilities is 99.94
percent emission reduction. For the
reasons explained above, our final
MACT standards under CAA sections
112(d)(2) and (3) for both new and
existing CEVs at major source facilities
require these facilities to reduce the EtO
emissions from new and existing CEVs
by 99.94 percent.
For existing CEVs at area source
facilities, we considered two potential
GACT options for reducing EtO
emissions from this group: the first
option reflects the use of emission
controls on the CEVs, and the second
option reflects applying a BMP to lower
the in-chamber EtO concentration to 1
ppm before the chamber is opened (i.e.,
pollution prevention). With respect to
the first option, because 34 out of 40
area source facilities with CEVs already
using controls to reduce CEV emissions,
and we have no reason to believe that
the other six cannot do the same, we
consider emission controls to be
generally available for existing CEVs at
these facilities. Evaluating the available
information on controls, including the
documented control efficiency for 12
facilities in the category, we determined
that a control efficiency of 99 percent is
generally available for existing CEVs at
area source facilities. The second
potential GACT option we considered
was the same management practice
discussed in section IV.B.3.a of this
preamble, which would require
facilities to lower the in-chamber EtO
concentration to 1 ppm before the
chamber is opened. The impacts of
these two options are presented in table
8.
30 As Judge Williams explained in his concurring
opinion in Sierra Club v. EPA, CAA ‘‘Section
112(d)(2) calls for emissions standards that are the
most stringent that the EPA finds to be ‘achievable,’
taking into account a variety of factors including
cost. . . . The ‘‘achievable’’ standards have come to
be known as the ‘‘beyond-the-floor’’ standards, . . .
meaning, obviously, ones more stringent than the
‘‘floors’’ established under § 112(d)(3).’’ 479 F.3d
875, 884 (D.C. Cir. 2007).
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00021
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24110
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE 8—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR EXISTING CEVS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 .................
2 .................
99 percent emission reduction ...............................
BMP (estimated 20 percent emission reduction) ...
1 This
$1,750,000
0
I
Total annual costs
($/yr)
EtO emission
reductions
(tpy)
$740,000 ........................
$3,560,000 (one-time annual cost) 1.
3.84 [7,680 lb/year] ........
0.796 [1,590 lb/year] ......
I
Cost effectiveness
($/ton EtO)
193,000 [$96/lb]
$4,470,000 [$2,240/lb]
includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the chamber is opened,
as well as preparing and submitting the necessary paperwork to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized capital costs plus annual
costs) in the analysis.
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers of these options are within the
range of the values that we have
determined to be cost-effective for
highly toxic HAPs. Such values include
hexavalent chromium, where we
finalized a requirement with a costeffectiveness of $15,000/lb
($30,000,000/ton) for existing small
hard chromium electroplating to
provide an ample margin of safety
(taking into account cost among other
factors) (77 FR 58227–8, 58239). We are
finalizing Option 1 for the following
reasons. First, while both options are
considered generally available under
CAA section 112(d)(5), Option 1 would
achieve much greater emission
reduction than Option 2. Second,
Option 1 would incur fewer annual
costs than Option 2. Therefore, pursuant
to CAA section 112(d)(5), we are
finalizing Option 1 for existing CEVs at
area source facilities. Specifically, we
are finalizing a requirement for these
facilities to continuously reduce
emissions from existing CEVs by 99
percent.
For new CEVs at area source facilities,
we considered two potential GACT
options similar to those evaluated for
existing CEVs at area source facilities.
The first potential GACT option would
require achieving 99 percent emission
reduction. The second potential GACT
option we considered is a BMP
described in section IV.B.3.a, which
would require facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened. The
impacts of these options, which are
presented in table 9 of this preamble,
are based on a model plant for new
CEVs at a new area source facility with
the following assumptions reflecting the
average of each of the parameters at
existing area source facilities:
• Annual EtO use: 100 tpy.
• Annual operating hours: 8,000.
• Portion of EtO going to CEVs: 1
percent.
• CEV flow rate: 200 cubic feet per
second (cfs).
• Number of unique cycles: nine.
TABLE 9—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR NEW CEVS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 .................
2 .................
99 percent emission reduction ...............................
BMP (estimated 20 percent emission reduction) ...
1 This
I
$553,000
0
Total annual costs
($/yr)
EtO emission
reductions
(tpy)
$142,000 ........................
$80,000 (one-time annual cost) 1.
0.99 [1,980 lb/year] ........
0.20 [400 lb/year] ...........
I
Cost effectiveness
($/ton EtO)
$144,000 [$72/lb]
$400,000 [$200/lb]
khammond on DSKJM1Z7X2PROD with RULES2
includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the chamber is opened,
as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of compliance,
but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized capital costs plus annual costs) in the analysis.
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
number of Option 2 is within the range
of the values that we have determined
to be cost-effective for highly toxic
HAPs. While both options are
considered generally available under
CAA section 112(d)(5), Option 1 would
achieve greater emission reductions
than Option 2, and it is more costeffective. Therefore, we are finalizing
Option 1 as the standard for new CEVs
at area source facilities under CAA
section 112(d)(5). The standard requires
these facilities to continuously reduce
emissions from new CEVs by 99
percent.
We have re-calculated the MACT floor
for existing Group 1 room air emissions
at major source facilities. We ranked the
performance of the facilities with Group
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
1 room air emissions for which data are
available based on percent emission
reduction. There are only three
performance tests that are currently
available, only one of which contains
three test runs. Therefore, the best
performing 12 percent of facilities for
which data are available consists of one
facility with three test runs that is
controlling its Group 1 room air
emissions with a gas/solid reactor. That
facility reported an emission reduction
of 98 percent. We then used the LPL
approach, as mentioned previously, to
develop the MACT floor for existing
sources. The LPL 1 value of the existing
source MACT floor is 90 percent
emission reduction. The outlet EtO
concentration (UPL 99 value) that
corresponds to this emission reduction
is 93 ppbv. Since this is above 3×RDL,
there are more stringent (i.e., BTF)
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
options to consider. We considered two
BTF options for reducing EtO emissions
from this source: the first option we
considered was 95 percent emission
reduction. The first option reflects the
lowest emission reduction that we have
observed in performance tests, and The
second option reflects the most stringent
emission reduction for which
compliance can be demonstrated. With
respect to the second option, the most
stringent emission reduction for which
compliance can be demonstrated is that
which corresponds to an outlet
concentration of 30 ppbv (i.e., 3xRDL).
This emission reduction is 97 percent,
which is lower than two of the three
reported values in the test runs that
were used to calculate the MACT floor.
The impacts of these options are
presented in table 10 (along with the
MACT floor impacts). Because we have
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
not identified any major source facilities
with existing Group 1 room air
emissions, the impacts are based on a
model plant for existing Group 1 room
air emissions at a synthetic area source
facility with the following assumptions
reflecting the average of each of the
parameters at synthetic area source
facilities:
• Annual EtO use: 140 tpy.
24111
• Annual operating hours: 8,000.
• Portion of EtO going to Group 1
RAE: 0.4 percent.
• Group 1 room air emission flow
rate: 400 cubic feet per second (cfs).
khammond on DSKJM1Z7X2PROD with RULES2
TABLE 10—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF BTF OPTIONS CONSIDERED UNDER CAA
SECTIONS 112(d)(2) AND 112(d)(3) FOR GROUP 1 ROOM AIR EMISSIONS AT MAJOR SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
MACT floor
1 ................
2 ................
90 percent emission reduction ........................
95 percent emission reduction ........................
97 percent emission reduction ........................
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers are within the range of the
values that we have determined to be
cost-effective for highly toxic HAPs.
While both options are considered BTF
under CAA sections 112(d)(2), Option 2
would achieve greater emission
reductions than Option 1. Therefore, the
final MACT standard under CAA
sections 112(d)(2) and (3) for existing
Group 1 room air emissions at major
source facilities is 97 percent emission
reduction.
For new sources, CAA section
112(d)(3) requires that the standard
shall not be less stringent than the
emission control that is achieved in
practice by the best controlled similar
source. In this case, the best controlled
similar source is also the Group 1 room
air emissions that are being controlled
by a gas/solid reactor and the data of
which is used to determine the MACT
floor for existing sources. Therefore, the
new source MACT floor is equivalent to
the existing source MACT floor, which
is 90 percent emission reduction. We
considered the same BTF options as
those evaluated for existing Group 1
room air emissions at major source
facilities for the same reasons explained
above. The first BTF option would
require achieving 95 percent emission
reduction, and the second BTF option
would require achieving 97 percent
emission reduction. The impacts of
these options are presented in table 10
of this preamble. Because we have not
identified any major source facilities
with existing Group 1 room air
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Total annual
costs
($/yr)
$830,000
553,000
461,000
$176,000
129,000
113,000
emissions, the impacts are based on a
model plant for new Group 1 room air
emissions at a synthetic area source
facility. Based on the estimates above,
and considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers are within the range of the
values that we have determined to be
cost-effective for highly toxic HAPs.
While both options are considered BTF
under CAA sections 112(d)(2), Option 2
would achieve greater emission
reductions than Option 1. Therefore, the
final standard for new Group 2 room air
emissions at major source facilities is 97
percent emission reduction. We also
considered non-air quality health and
environmental impacts and energy
requirements when evaluating the BTF
options. Further discussion of these
considerations is presented in the
document MACT Floor Analysis for
Ethylene Oxide Commercial
Sterilization—Chamber Exhaust Vents
and Room Air Emission Sources—
Promulgation Rule Review for the
Ethylene Oxide Commercial
Sterilization Source Category, available
in the docket for this rulemaking.
For existing Group 1 room air
emissions at area source facilities, we
considered two potential GACT options
for reducing EtO emissions from this
group: the first option reflects the use of
emission controls on Group 1 room air
emissions, and the second option is the
same BMP discussed above (lowering
the in-chamber EtO concentration to 1
ppm before the chamber is opened).
With respect to the first option, 32 out
of 74 area source facilities with Group
1 room air emissions are already using
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
EtO emission
reductions
(tpy)
Cost effectiveness
($/ton EtO)
0.168 [336 lb/year] .....
2.80E–2 [56.0 lb/year]
1.12E–2 [22.4 lb/year]
$1,050,000 [$525/lb].
$4,610,000 [$2,300/lb].
$10,100,000 [$5,040/
lb].
controls to reduce those emissions.31
We considered a standard of 80 percent
emission reduction, which is the
manufacturer guarantee for room air
emissions controls provided by one of
the commenters. We find this standard
to be reasonable for existing Group 1
room air emissions at area source
facilities because it is the manufacturer
guarantee, which means that it is a level
of emission reduction that all sources
can achieve. While some sources have
demonstrated emission reductions
higher than 80 percent, those reductions
are limited to facilities with higher EtO
usage rates, and we cannot determine
whether smaller users of EtO can meet
those emission reductions. The second
potential GACT option we considered
was the same management practice
discussed in section IV.B.3.a, which
would require facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened. During
the sterilization process, EtO becomes
trapped within the material and
continues to off-gas after the
sterilization process is complete.
Therefore, if more EtO is driven out of
the product prior to opening the
chamber, this can lead to a reduction in
post-sterilization EtO emissions,
including those from pre-aeration
handling of sterilized material. The
impacts of these options are presented
in table 11.
31 The Group 1 room air emission reduction at
these facilities ranges from 52 percent to 99.8
percent. It should be noted that the facility with the
emission reduction at the upper bound of this range
uses 135 tpy of EtO.
E:\FR\FM\05APR2.SGM
05APR2
24112
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE 11—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR EXISTING GROUP 1 ROOM AIR EMISSIONS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 ..............
80 percent emission reduction ...................
2 ..............
BMP (estimated 20 percent emission reduction).
Total annual costs
($/yr)
EtO emission
reductions
(tpy)
$91,000,000
$12,900,000 .............
3.66 [7,320 lb/year] ..
$0
$5,040,000 (one-time
annual cost) 1.
1.13 [2,260 lb/year] ..
Cost effectiveness
($/ton EtO)
$3,530,000 [$1,770/
lb].
$4,460,000 [$2,230/
lb].
1 This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to
be incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized
capital costs plus annual costs) in the analysis.
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers of these options are within the
range of the values that we have
determined to be cost effective for
highly toxic HAPs. We are finalizing
Option 1 because while both options are
considered generally available under
CAA section 112(d)(5), Option 1 would
achieve greater emission reduction than
Option 2. Therefore, pursuant to CAA
section 112(d)(5), we are finalizing
Option 1 for existing Group 1 room air
emissions at area source facilities.
Specifically, we are finalizing a
requirement for these facilities to
continuously reduce emissions from
existing Group 1 room air emissions by
80 percent.
For new Group 1 room air emissions
at area source facilities, we considered
the same two potential GACT options as
those evaluated for existing Group 1
room air emissions at area source
facilities for the same reasons explained
above. The first potential GACT option
(Option 1) would require achieving an
emission reduction of 80 percent. The
second potential GACT option we
considered (Option 2) is a BMP that
would require facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened. The
impacts of these options, which are
presented in table 12 of this preamble,
are based on a model plant for new
Group 1 room air emissions at an area
source facility with the assumptions
reflecting the average of each of the
parameters at area source facilities with
new Group 1 room air emissions as
described in section III.B.8.c of the
proposal preamble.
TABLE 12—MODEL PLANT EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR NEW GROUP 1 ROOM AIR EMISSIONS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 ..............
2 ..............
80 percent emission reduction ...................
BMP ............................................................
(estimated 20 percent emission reduction)
$922,000
0
Total annual costs
($/yr)
EtO emission
reductions
(tpy)
Cost effectiveness
($/ton EtO)
$192,000 ..................
$80,000 (one-time
annual cost) 1.
0.288 [576 lb/year] ...
7.20E–2 [144 lb/year]
$666,000 [$333/lb].
$1,110,000 [$556/lb].
khammond on DSKJM1Z7X2PROD with RULES2
1 This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to
be incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized
capital costs plus annual costs) in the analysis.
Based on the estimates above, we find
both options to be cost effective. While
both options are considered generally
available under CAA section 112(d)(5),
Option 1 would achieve greater
emission reductions than Option 2.
Therefore, pursuant to CAA section
112(d)(5), we are finalizing standards for
new Group 1 room air emissions at area
source facilities. Specifically, we are
finalizing a requirement for these
facilities to continuously reduce
emissions from new Group 1 room air
emissions by 80 percent.
We re-calculated the MACT floor for
existing Group 2 room air emissions at
major source facilities. We ranked the
performance of the facilities with Group
2 room air emissions for which data are
available based on percent emission
reduction. There are only three
performance tests that are currently
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
available, only one of which contains
three test runs. Therefore, the best
performing 12 percent of facilities for
which data are available consists of one
facility with three test runs that is
controlling its Group 2 room air
emissions with a gas/solid reactor. That
facility reported an emission reduction
of 96 percent. As mentioned previously,
we then used the LPL approach to
develop the MACT floor for existing
sources. The LPL 1 value of the existing
source MACT floor is 94 percent
emission reduction. The outlet EtO
concentration (LPL 1 value) that
corresponds to this emission reduction
is 10 ppbv. Since this is below 3×RDL,
we adjusted the MACT floor by
determining the emission reduction
using 30 ppbv and the LPL 1 value of
the inlet EtO concentration of the Group
2 room air emissions stream at the
PO 00000
Frm 00024
Fmt 4701
Sfmt 4700
facility, which is 0.12 ppmv. This
results in an adjusted MACT floor of 86
percent emission reduction. Since this
represents 3×RDL, there are no more
stringent (i.e., BTF) options to consider,
as there would be difficulty
demonstrating compliance at any such
lower limit. Therefore, the final MACT
standard under CAA sections 112(d)(2)
and (3) for existing Group 2 room air
emissions at major source facilities is 86
percent emission reduction.
For new sources, CAA section
112(d)(3) requires that the standard
shall not be less stringent than the
emission control that is achieved in
practice by the best controlled similar
source. In this case, the best controlled
similar source is also the Group 2 room
air emissions that are being controlled
by a gas/solid reactor and the data of
which is used to determine the MACT
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
floor for existing sources. Therefore, the
new source MACT floor is equivalent to
the existing source MACT floor, which
is 86 percent emission reduction. As
explained above, because this emission
limit represents the lowest level at
which compliance can be demonstrated,
the EPA did not consider more stringent
(i.e., BTF) options. Therefore, the
proposed standard for new Group 2
room air emissions at major source
facilities is 86 percent emission
reduction.
For existing Group 2 room air
emissions at area source facilities, we
considered two potential GACT options
for reducing EtO emissions from this
group: the first option reflects the use of
emission controls on Group 2 room air
emissions, and the second option is the
same BMP discussed above (lowering
the in-chamber EtO concentration to 1
ppm before the chamber is opened).
With respect to the first option, 30 out
of 80 area source facilities with Group
2 room air emissions are already using
controls to reduce those emissions.32
We considered a standard of 80 percent
emission reduction, which is the
manufacturer guarantee for room air
emissions controls provided by one of
the commenters. We find this standard
to be reasonable for existing Group 2
room air emissions at area source
facilities because it is the manufacturer
guarantee, which means that it is a level
of emission reduction that all sources
can achieve. While some sources have
demonstrated emission reductions
higher than 80 percent, those reductions
are limited to facilities with higher EtO
usage rates, and we cannot determine
24113
whether smaller users of EtO can meet
those emission reductions. The second
potential GACT option we considered
was the same management practice
discussed in section IV.B.3.a, which
would require facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened. During
the sterilization process, EtO becomes
trapped within the material and
continues to off-gas after the
sterilization process is complete.
Therefore, if more EtO is driven out of
the product prior to opening the
chamber, this can lead to a reduction in
post-sterilization EtO emissions,
including those from post-aeration
handling of sterilized material. The
impacts of these options are presented
in table 13.
TABLE 13—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR EXISTING GROUP 2 ROOM AIR EMISSIONS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 ...................
2 ...................
80 percent emission reduction .................
BMP (estimated 20 percent emission reduction).
1 This
I
$236,000,000
0
Total annual costs
($/yr)
EtO emission reductions
(tpy)
$32,700,000 .......................
$5,440,000 (one-time annual cost) 1.
1.10 [2,200 lb/year] ............
0.311 [622 lb/year] .............
I
Cost effectiveness
($/ton EtO)
$29,700,000 [$14,900/lb].
$17,500,000 [$8,750/lb].
khammond on DSKJM1Z7X2PROD with RULES2
includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the chamber is opened,
as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of compliance,
but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized capital costs plus annual costs) in the analysis.
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers of these options are within the
range of the values that we have
determined to be cost-effective for
highly toxic HAPs. Further, as discussed
in section III.B.8.g of the proposal
preamble (88 FR 28790, April 13, 2023),
there are multiple factors we consider in
assessing the cost of the emission
reductions. See NRDC v. EPA, 749 F.3d
1055, 1060 (D.C. Cir. April 18, 2014)
(‘‘Section 112 does not command the
EPA to use a particular form of cost
analysis.’’). These factors include, but
are not limited to, total capital costs,
total annual costs, cost-effectiveness,
and annual costs compared to total
revenue (i.e., costs to sales ratios). Our
established methodology for assessing
economic impacts of regulations
indicates that the potential for adverse
economic impacts begins when the cost
to sales ratio exceeds three percent.
According to our estimates, the annual
cost of the emission control option for
most of the affected sources discussed
above is well below three percent.33
However, reducing existing Group 2
room air emissions at area source
facilities using emission control devices
(Option 1), would significantly impact
several companies operating a total of
nine area source facilities with Group 2
room air emissions. We estimate that the
annual cost of controls at the level
under Option 1 would exceed three
percent of revenue for these
companies.34 Based on the available
economic information, assuming market
conditions remain approximately the
same, we are concerned that these
companies would not be able to sustain
the costs associated with Option 1. In
addition, according to FDA, six of these
facilities could impact the availability of
the medical devices described in section
I.A.1 of this preamble. Therefore,
pursuant to CAA section 112(d)(5), we
are finalizing Option 2 as the GACT
standard for existing Group 2 room air
emissions at area source facilities.
Specifically, this GACT standard
requires facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened.35
For new Group 2 room air emissions
at area sources facilities, we considered
the same two potential GACT options as
those evaluated for existing Group 1
room air emissions at area source
facilities for the same reasons explained
above. The first potential GACT option
(Option 1) would require achieving an
emission reduction of 80 percent. The
second potential GACT option we
considered (Option 2) is a BMP that
would require facilities to lower the inchamber EtO concentration to 1 ppm
before the chamber is opened. The
impacts of these options, which are
presented in table 14 of this preamble,
are based on a model plant for new
Group 2 room air emissions at an area
source facility with the assumptions
reflecting the average of each of the
parameters at area source facilities with
32 The Group 2 room air emission reduction at
these facilities ranges from 30 percent to 99.97
percent. It should be noted that the facility with the
emission reduction at the upper bound of this range
uses 135 tpy of EtO.
33 See memorandum, Technical Support
Document for Proposed Rule—Industry Profile,
Review of Unregulated Emissions, CAA Section
112(d)(6) Technology Review, and CAA Section
112(f) Risk Assessment for the Ethylene Oxide
Emissions Standards for Sterilization Facilities
NESHAP, located at Docket ID No. EPA–HQ–OAR–
2019–0178.
34 The issue of high cost-to-sales ratios is present
only for this option and, thus, is not discussed for
other options.
35 As discussed in section IV.C.2.a.iii of this
preamble, this GACT standard will ultimately apply
only to facilities where EtO use is less than 4 tpy.
Facilities where EtO use is at least 4 tpy will be
required to meet an emission standard established
under CAA section 112(f)(2).
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00025
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24114
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
new Group 1 room air emissions as
described in section III.B.8.h of the
proposal preamble.
TABLE 14—MODEL PLANT EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(5) FOR NEW GROUP 2 ROOM AIR EMISSIONS AT AREA SOURCE FACILITIES
Total capital
investment
($)
Option
Proposed standard
1 ...................
2 ...................
80 percent emission reduction .................
BMP (estimated 20 percent emission reduction).
I
1 This
$1,840,000
0
Total annual costs
($/yr)
EtO emission reductions
(tpy)
$332,000 ............................
$40,000 (one-time annual
cost)1.
3.6E–2 [72 lb/year] .............
9.1E–3 [18 lb/year] .............
I
Cost effectiveness
($/ton EtO)
$9,170,000 [$4,560/lb].
$4,375,000 [$2,190/lb].
includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the chamber is opened,
as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of compliance,
but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized capital costs plus annual costs) in the analysis.
khammond on DSKJM1Z7X2PROD with RULES2
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
numbers of these options are within the
range of the values that we have
determined to be cost-effective for
highly toxic HAPs. As discussed earlier
in this section, this includes hexavalent
chromium, where we finalized a
requirement with a cost-effectiveness of
$15,000/lb ($30,000,000/ton) for
existing small hard chromium
electroplating to provide an ample
margin of safety (taking into account
cost among other factors) (77 FR 58227–
8, 58239). Although both options are
considered generally available under
CAA section 112(d)(5), Option 1 would
achieve four times the emission
reductions of Option 2. Therefore,
pursuant to CAA section 112(d)(5), we
are finalizing standards for new Group
2 room air emissions at area source
facilities. Specifically, we are finalizing
a requirement for these facilities to
continuously reduce emissions from
new Group 2 room air emissions by 80
percent.
c. PTE
Comment: We received extensive
comment on our proposal to require that
each facility must operate areas with
room air emissions subject to an
emission standard under the PTE
requirements of EPA Method 204. Some
commenters were supportive of this
requirement, stating that other
regulatory bodies have already required
this and that this is the correct protocol
for ensuring that emissions are captured
and routed to a control system. Other
commenters were opposed to this
requirement, stating that EPA Method
204 was established for smaller point
source operations (e.g., paint booths,
spray coating), as opposed to larger
sterilization facilities. Several
commenters cited other technical
concerns, including the fact that not
every facility is currently configured to
meet the PTE requirements of EPA
Method 204. The commenters suggested
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
broad alternatives, including a simple
requirement to operate areas with room
air emissions subject to an emission
standard under negative pressure.
Response: We strongly disagree with
the commenters that EPA Method 204 is
not appropriate to apply to this source
category. The design requirements of
EPA Method 204 are agnostic to the
industry it is applied. It has been
applied widely to any industrial
processes that needs to control VOC
emissions, including several existing
commercial sterilizers that have already
been complying with EPA Method 204.
In order to meet the emission standards,
it is necessary to ensure that all
emissions are captured and routed to a
control system. Our established protocol
in numerous new source performance
standards, NESHAPs, and federally
enforceable State and local programs
(e.g., title V permits, State
implementation plans) for ensuring
complete capture of room air emissions
is EPA Method 204. We recognize that
many commercial sterilizers will need
to retrofit their facilities to meet the PTE
requirements of EPA Method 204,
similar to facilities that have already
done so. We have accounted for the cost
to retrofit facilities by scaling the cost
from a large facility that conducted a
retrofit. Furthermore, based on our
knowledge regarding the application of
EPA Method 204 in general, retrofitting
to meet this method can be complicated,
depending on the size of the facility.
However, commercial sterilization
facilities tend to be simple buildings (in
some cases, re-purposed warehouses)
with a relatively small footprint, which
helps the retrofitting process. The
emission standards for room air
emissions that we evaluated assume 100
percent capture of EtO emissions,36 and
the costs of complying with the PTE
36 Section
2 of EPA Method 204 states, in part, ‘‘If
the criteria are met and if all the exhaust gases from
the enclosure are ducted to a control device, then
the volatile organic compounds (VOC) capture
efficiency (CE) is assumed to be 100 percent, and
CE need not be measured.’’
PO 00000
Frm 00026
Fmt 4701
Sfmt 4700
requirements of EPA Method 204 were
included in our BTF and GACT
evaluations. We found each emission
standard that we evaluated to be costeffective (see section IV.B.3.b of this
preamble for more information). In
addition, the term ‘‘negative pressure’’
is vague and can imply any capture
efficiency between zero and 100
percent. The commenters did not
provide specific suggestions for
alternative capture efficiencies, nor did
they provide the criteria that would be
used to demonstrate that those
efficiencies are being met, and we are
unable to evaluate alternative negative
pressure requirements as a result.
Therefore, EPA Method 204 is
appropriate to apply to this source
category in order to ensure complete
capture of room air emissions.
Comment: Several commenters
requested various flexibilities and
clarifications with respect to the PTE
requirements of EPA Method 204.
Several commenters expressed concern
with Criterion 5.1 of EPA Method 204,
stating that it would not be possible to
always ensure that doors are ‘‘at least
four equivalent opening diameters’’
from all EtO storage media or postaeration sterilized product, particularly
during loading and unloading
operations. Two commenters
recommended that we revise the
standards to permit implementation of
cascading air systems to capture room
air emissions.37 One commenter stated
that these systems would provide
greater flexibility to accommodate
sterilization operations that could not
implement a PTE, would offer EtO
capture and control efficiency that was
as effective as a PTE, and would have
fewer manufacturing implications and
potential adverse impacts. Finally, two
37 These are systems that move air from ambient
pressure, through warehouse ventilation, secondary
aeration, primary aeration, the sterilizer chamber,
and ultimately to an air pollution control device to
capture and control EtO emissions. This is opposed
to other systems where air from one source is
captured and then directly sent to a control system.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
commenters expressed concern with
Criteria 5.2, 5.3, and 5.5 of EPA Method
204.
Response: Criterion 5.1 of EPA
Method 204 states that ‘‘Any natural
draft opening (NDO) shall be at least
four equivalent opening diameters from
each VOC emitting point unless
otherwise specified by the
Administrator.’’ 38 We disagree with the
commenters’ concerns that Criterion 5.1
of EPA Method 204 will not be possible
to meet for doors where either EtO
storage media is moved into a PTE or
post-aeration sterilized material is
moved out of a PTE. There may be
certain facility designs where such an
exemption is either necessary or
unnecessary in order to ensure complete
capture of room air emissions. However,
the EPA does not have enough
information to make that determination
for all facilities within the source
category as part of this rulemaking.
Criterion 5.1 of EPA Method 204 allows
delegated authorities to exempt any
NDO from this requirement, as needed.
Therefore, we are not exempting
Criterion 5.1 of EPA Method 204 for
doors where either EtO storage media is
moved into a PTE or post-aeration
sterilized material is moved out of a PTE
as part of this final rule. Instead, we are
relying on the delegated authorities to
make that determination for their
commercial sterilization facilities, as
provided in Criterion 5.1., as they are in
a better place to determine whether
there are sufficient measures in place to
capture any emission points within four
equivalent opening diameters of an
NDO. With respect to cascading air
systems, we disagree with the
commenters’ suggestion that they be
permitted in place of the PTE
requirements of EPA Method 204, as
they are insufficient on their own to
ensure complete capture of room air
emissions. However, it is not our intent
to discourage or prohibit the use of
these systems altogether. Cascading air
systems may be used to capture and
route room air emissions to a control
device. However, in order to ensure
complete capture of room air emissions,
if such a system contains one or more
areas that are subject to the PTE
requirements of EPA Method 204, then
the entire system must be treated as a
single enclosure that is subject to those
requirements.
For all other flexibilities suggested by
the commenters, we provide the
following responses:
• Criterion 5.2 of EPA Method 204
states that ‘‘Any exhaust point from the
enclosure shall be at least four
38 Per
40 CFR 51.100(s), EtO is a VOC.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
equivalent duct or hood diameters from
each NDO.’’ One commenter stated that
Criterion 5.2 may not be possible for all
facilities due to preexisting layouts.
This criterion only applies to temporary
total enclosures, as opposed to PTEs,
and is not required in the final rule.
• Criterion 5.3 of EPA Method 204
states that ‘‘The total area of all NDO’s
shall not exceed 5 percent of the surface
area of the enclosure’s four walls, floor,
and ceiling.’’ One commenter stated that
the presence of garage doors could
exceed the requirement that NDOs not
exceed five percent of the PTE total
floor space. However, we note that
facilities can be, and have been, redesigned in order to meet the PTE
requirements of EPA Method 204,
including Criterion 5.3. Therefore, we
are not finalizing any exceptions for this
criterion.
• Criterion 5.5 of EPA Method 204
states that ‘‘All access doors and
windows whose areas are not included
in section 5.3 and are not included in
the calculation in section 5.4 shall be
closed during routine operation of the
process’’. Two commenters expressed
concern with Criterion 5.4 of EPA
Method 204. However, the commenters
did not provide any explanation as to
why exceptions for Criterion 5.5 of EPA
Method 204 should be made. Therefore,
we are not finalizing any exceptions for
this criterion.
d. Warehouses
Comment: We received extensive
comments on the regulation of
warehouses, particularly stand-alone
(i.e., off-site) warehouses. Most
commenters were supportive of
regulating emissions from all
warehouses, stating that sterilized
materials can continue to off-gas
significant quantities of EtO after being
moved to a warehouse. Several
commenters pointed to a stand-alone
warehouse in Georgia, where the State
estimated that potential pre-control EtO
emissions were approximately 5,000 lb/
year. One commenter was opposed to
including standards for stand-alone
warehouses as part of this final rule,
stating that we could, instead, identify
potentially applicable facilities, collect
data from these facilities, and then
determine if further regulation is
necessary.
Response: It is our understanding that
there are three types of warehouses
within this industry: attached
warehouses, co-located warehouses, and
stand-alone warehouses. Attached
warehouses are those that are part of an
EtO sterilization building. Co-located
warehouses are those that are detached
from but ‘‘contiguous’’ (including
PO 00000
Frm 00027
Fmt 4701
Sfmt 4700
24115
adjacent) to and ‘‘under common
control’’ with the EtO sterilization
building, including leased properties.39
Stand-alone warehouses are those that
are not attached to or co-located with an
EtO sterilization building. According to
our record at the time of category listing,
‘‘the Commercial Sterilization Facilities
source category includes ‘‘facilities
which use ethylene oxide in any
equipment which destroys bacteria,
viruses, fungi, insects, or other
unwanted microorganisms or materials
when such facilities are engaged in the
growth, manufacture, construction,
transportation, retail or wholesale trade,
or storage of commercial products, or
when such facilities are engaged in the
operation of museums, art galleries,
arboreta, or botanical or zoological
gardens or exhibits. Not included in this
category are hospitals, doctor offices,
veterinary offices, clinics, and other
facilities where medical services are
rendered’’ (emphasis added).40 Under
this definition, warehouses that are part
of facilities which use EtO, including
attached and co-located warehouses, are
part of the source category and,
therefore, subject to the standards for
Group 2 room air emissions. However,
because stand-alone warehouses do not
use EtO, they are not included in the
source category definition. Furthermore,
we do not have sufficient information to
understand where these warehouses are
located, who owns them, how they are
operated, or what level of emissions
potential they may have. While several
commenters note that emissions
information is available for at least one
stand-alone warehouse, it is unknown
whether the emissions information for
this facility is representative of all
stand-alone warehouses. Thus,
standards for these facilities are not
included as part of this final rule.
However, as suggested by one
commenter, we are planning to gather
information from stand-alone
warehouses as soon as possible to
39 This final rule establishes standards under
CAA section 112 for both major and area sources
of commercial sterilization facilities. As the EPA
explained in its final rule promulgating the General
Provisions for NESHAP pursuant to section 112,
‘‘[f]or the purposes of implementing section 112,
the major/area source determination is made on a
plant-wide basis; that is, HAP emissions from all
sources located within a contiguous area and under
common control are considered in the
determination.’’ 59 FR 12408, 12411 (March 16,
1994). The EPA noted that ‘‘the common dictionary
term ‘‘contiguous’’ consists, in part, of ‘‘nearby,
neighboring, adjacent,’’ and that ‘‘the EPA has
historically interpreted ‘contiguous property’ to
mean the same as ‘contiguous or adjacent property’
in the development of numerous regulations to
implement the Act.’’ Id. at 12412.
40 Documentation for Developing the Initial
Source Category List, Final Report, page A–83 (see
EPA–450/3–91–030, July 1992).
E:\FR\FM\05APR2.SGM
05APR2
24116
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
understand what the source category
looks like and its emission potential
and, if necessary, develop a regulatory
action that both lists a new source
category and proposes standards for
stand-alone warehouses handling EtO
sterilized medical devices. This
information gathering effort may
include engaging with State and local
agencies and non-governmental
organizations, as well as conducting an
ICR(s) pursuant to CAA section 114.
The remaining comments and our
specific responses can be found in the
document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
4. What is the rationale for our final
approach and final decisions for the
revisions pursuant to CAA section
112(d)(2), 112(d)(3), and 112(d)(5)?
We evaluated the comments on our
proposed standards for SCVs, ARVs,
and CEVs at facilities where EtO use is
less than 1 tpy, ARVs and CEVs at
facilities where EtO use is at least 1 tpy
but less than 10 tpy, CEVs at facilities
where EtO use is at least 10 tpy, and
room air emissions, as well as our
proposed technical correction to the
emission standard for ARVs at facilities
where EtO use is at least 10 tpy. As
explained above in section IV.B.3 and in
Chapter 4 of the document, Summary of
Public Comments and Responses for the
Risk and Technology Review for
Commercial Sterilization Facilities, we
made changes in the final rule based on
comments received during the proposed
rulemaking. More information and
rationale concerning all the
amendments we are finalizing pursuant
to CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5) is in the preamble to the
proposed rule (88 FR 22790, April 13,
2023), in section IV.B.3 of this
preamble, and in the comments and our
specific responses to the comments in
the document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, which is
available in the docket for this
rulemaking. Therefore, we are finalizing
the proposed standards for SCVs and
ARVs at facilities where EtO use is less
than 1 tpy, finalizing the proposed
standards for ARVs at facilities where
EtO use is at least 1 tpy but less than
10 tpy, finalizing standards for CEVs,
finalizing the proposed emission
standards for room air emissions at
major sources facilities, finalizing
emission standards for room air
emissions at area source facilities, and
finalizing the proposed revisions for
ARVs at facilities where EtO use is at
least 10 tpy.
C. Residual Risk Review for the
Commercial Sterilization Facilities
Source Category
1. What did we propose pursuant to
CAA section 112(f) for the Commercial
Sterilization Facilities source category?
Pursuant to CAA section 112(f), we
conducted a residual risk review and
presented the results of this review,
along with our proposed decisions
regarding risk acceptability and ample
margin of safety, in the April 13, 2023,
proposed rule for 40 CFR part 63,
subpart O (88 FR 22790). The results of
the risk assessment for the proposal are
presented briefly in table 15 of this
preamble. As discussed in section III.A
of the proposed rule, all baseline risk
results were developed using the best
estimates of actual emissions, and we
did not conduct a separate assessment
of allowables at proposal. More detail is
in the residual risk technical support
document, Residual Risk Assessment for
the Commercial Sterilization Facilities
Source Category in Support of the 2023
Risk and Technology Review Proposed
Rule, which is available in the docket
for this rulemaking (see Docket Item No.
EPA–HQ–OAR–2019–0178–0482).
TABLE 15—COMMERCIAL STERILIZATION FACILITIES SOURCE CATEGORY BASELINE RISK ASSESSMENT RESULTS IN THE
PROPOSAL
Number of
facilities 1
97 3 ...............................................
Estimated population at
increased risk of cancer
Maximum
individual
cancer risk
(in 1 million) 2
>100-in-1
million
6,000
18,000
≥1-in-1
million
Estimated
annual cancer
incidence
(cases per
year)
Maximum
chronic
noncancer
TOSHI
8,300,000
0.9
0.04
Maximum screening
acute noncancer
hazard quotient
(HQ)
0.002 (REL).
1 Number
of facilities evaluated in the risk analysis.
individual excess lifetime cancer risk due to HAP emissions from the source category.
part of the risk assessment for the proposed rulemaking, there were 86 facilities in the Commercial Sterilization Facilities source category
in operation and 11 research and development facilities, for a total of 97 facilities. To exercise caution with respect to this source category, we
included research facilities in our assessment because there was a lack of certainty over whether these were true research facilities, for which
CAA section 112(c)(7) requires that a separate category be established. However, EtO use at these facilities tends to be very low (less than 1
tpy), and these facilities had low risk.
2 Maximum
khammond on DSKJM1Z7X2PROD with RULES2
3 As
The results of the proposed chronic
baseline inhalation cancer risk
assessment at proposal indicated that,
based on estimates of current actual
emissions, the MIR posed by the source
category was 6,000-in-1 million. At
proposal, the total estimated cancer
incidence from this source category was
estimated to be 0.9 excess cancer cases
per year, or one case in every 1.1 years.
Approximately 8.3 million people were
estimated to have cancer risks at or
above 1-in-1 million from HAP emitted
from the facilities in this source
category. At proposal, the estimated
maximum chronic noncancer target
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
organ-specific hazard index (TOSHI) for
the source category was 0.04, indicating
low likelihood of adverse noncancer
effects from long-term inhalation
exposures.
As shown in table 15 of this preamble,
the acute risk screening assessment of
reasonable worst-case inhalation
impacts indicates a maximum acute HQ
of 0.002 for propylene oxide based on
the reference exposure level (REL) acute
health reference value.41 For EtO, the
maximum HQ is 0.0005 based on the
acute exposure guideline level (AEGL)–
2 acute health reference value.42
At proposal, the maximum lifetime
individual cancer risk posed by the 97
modeled facilities, based on whole
facility emissions, was 6,000-in-1
million, with EtO emissions from SCVs
and Group 2 room air emissions from
the Commercial Sterilization Facilities
source category driving the risk.
Regarding the noncancer risk
41 Not to be confused with the ‘‘recommended
exposure limit’’, which is used by the National
Institute for Occupational Safety and Health.
42 Acute RELs, ERPG–1, and AEGL–1 acute health
reference values are not available for ethylene
oxide.
PO 00000
Frm 00028
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
assessment, the maximum chronic
noncancer TOSHI posed by whole
facility emissions was estimated to be
0.04 (for the neurological system as the
target organ), driven by emissions of EtO
from source category sources.
We weighed all health risk factors,
including those shown in table 15 of
this preamble, in our risk acceptability
determination and proposed that the
risks posed by this source category
under the current provisions are
unacceptable. At proposal, we identified
several options to control EtO emissions
from SCVs and Group 2 room air
emissions.
To reduce risks, we considered two
additional control options after
implementation of controls under CAA
sections 112(d)(2), 112(d)(3), and
112(d)(5). Control Option 1 would have
required a 99.94 percent emission
reduction standard for SCVs at facilities
where EtO use is at least 40 tpy, as well
as a 2.8 E–3 lb/h standard for existing
Group 2 room air emissions at area
source facilities where EtO use is at
least 20 tpy. We determined that this
would have resulted in a source
category MIR of 400-in-1 million.
Control Option 2 would have imposed
the same requirements as Control
Option 1, but it would also have
required facilities where the MIR is
greater than 100-in-1 million after
Control Option 1 is imposed to limit
their existing Group 2 room air
emissions to a maximum volumetric
flow rate of 2,900 dscfm and a
maximum EtO concentration of 30
ppbv. This would have resulted in a
source category MIR of 100-in-1 million.
We proposed Control Option 2 and
solicited comment on Control Option 1.
We proposed that, after
implementation of the proposed
controls for SCVs and Group 2 room air
emissions at commercial sterilization
facilities, the resulting risks would be
acceptable for this source category. In
our proposal, we presented the risk
impacts using health risk measures and
information, including the MIR, cancer
incidence, and associated uncertainty in
emissions estimates after application of
the proposed options to control EtO
emissions from Group 2 room air
emissions (88 FR 22790, April 13, 2023).
At proposal, we determined application
of the controls for SCVs and Group 2
room air emissions would reduce the
estimated MIR from 6,000-in-1 million
to 100-in-1 million.
We then considered whether the
standards provide an ample margin of
safety to protect public health and
whether, taking into consideration costs,
energy, safety, and other relevant
factors, additional standards are
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
required to prevent an adverse
environmental effect. To determine
whether the rule provides an ample
margin of safety, we considered the
requirements that we proposed to
achieve acceptable risks. In addition, we
considered more stringent controls for
SCVs, as well as expanding the emission
standard and work practice standards
for existing Group 2 room air emissions
to all facilities in the source category. In
considering whether the standards
should be tightened to provide an ample
margin of safety to protect public health,
we considered the same risk factors that
we considered for our acceptability
determination and also examined the
costs, technological feasibility, and
other relevant factors related to
emissions control options that might
reduce risk associated with emissions
from the source category. Based on these
considerations, we proposed that the
standards that we proposed to achieve
acceptable risks, along with a 99.94
percent emission reduction standard for
SCVs at facilities where EtO use is at
least 10 tpy but less than 40 tpy and a
99.8 percent emission reduction
standard for SCVs at facilities where
EtO use is at least 1 tpy but less than
10 tpy, would provide an ample margin
of safety to protect public health
(section III.D.2 of the proposal
preamble, 88 FR 22790, April 13, 2023).
We also solicited comment on which of
the available control options should be
applied in order to provide an ample
margin of safety to protect public health.
2. How did the risk review change for
the Commercial Sterilization Facilities
source category?
a. Commercial Sterilization Facilities
Source Category Risk Assessment and
Determination of Risk Acceptability
(Step 1)
As part of the final risk assessment,
the EPA reanalyzed risks to include
allowable emissions (which we did not
include at the proposal stage), changes
since proposal to certain emission
standards being finalized for previously
unregulated sources, and three
additional facilities identified by
commenters. Allowable emissions are
the maximum amount that facilities are
allowed to emit under CAA section
112(d) standards. For previously
unregulated sources, since there were
no CAA section 112(d) standards in
place, the allowable emissions in the
baseline risk assessment are equal to the
uncontrolled emissions from these
sources. In some instances, the actual
emissions for these sources are lower
than the allowable emissions. This is
because some facilities are already
PO 00000
Frm 00029
Fmt 4701
Sfmt 4700
24117
controlling these sources as a result of
local requirements or through voluntary
control measures.43 The revised
emissions used to reanalyze risks are
available in the docket for this
rulemaking (see section IV.C.3 of this
preamble and Appendix 1 of the
Residual Risk Assessment for the
Commercial Sterilization Facilities
Source Category in Support of the 2024
Risk and Technology Review Final
Rule).
Based on the actual emission
estimates, the results of the chronic
inhalation cancer risk from the risk
assessment indicate that the maximum
lifetime individual cancer risk posed by
the 88 facilities could be as high as
6,000-in-1 million, with EtO as the
major contributor to the risk. The total
estimated cancer incidence from the
revised risk assessment is 0.9 excess
cancer cases per year, or one excess case
in every 1.1 years. Of the approximately
115 million people that live within 50
kilometers (km) of the 88 facilities
included in the risk assessment, 8.5
million people were estimated to have
cancer risks greater than or equal to 1in-1 million from HAP emitted from the
facilities in this source category, and
approximately 19,000 are estimated to
have cancer risks greater than 100-in-1
million (table 16 of this preamble).
The estimated maximum chronic
noncancer TOSHI for the source
category remained unchanged from the
proposal at 0.04, indicating low
likelihood of adverse noncancer effects
from long-term inhalation exposures.
Additionally, the worst-case acute HQ
remained unchanged from proposal
(0.002 for propylene oxide based on the
REL acute health reference value).
The maximum lifetime individual
cancer risk based on whole facility
emissions was 6,000-in-1 million driven
by EtO emissions from the Commercial
Sterilization Facilities source category.
The maximum chronic noncancer
TOSHI posed by whole facility
emissions was estimated to be 0.04 (for
the neurological system as the target
organ), driven by emissions of EtO from
source category sources.
43 As discussed later in this section, for
previously unregulated sources, the allowable
emissions in the risk assessment that considers
controls we are promulgating under CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) are equal to the
controlled emissions from these sources assuming
that they are only controlled to the degree that we
are requiring pursuant to CAA sections 112(d)(2),
112(d)(3), and 112(d)(5). In some instances, the
actual emissions for these sources may still be
lower than the allowable emissions. This is because
some facilities are already controlling these sources
to a degree greater than what we are finalizing
pursuant to CAA sections 112(d)(2), 112(d)(3), and
112(d)(5) as a result of local requirements or
through voluntary control measures.
E:\FR\FM\05APR2.SGM
05APR2
24118
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Based on allowable emission
estimates, the maximum lifetime
individual cancer risk could be as high
as 8,000-in-1 million, with EtO driving
the risk. The total estimated cancer
incidence is 8 excess cancer cases per
year, or 1 excess case in every 1.5
months. Approximately 62 million
people were estimated to have cancer
risks greater than or equal to 1-in-1
million from allowable emissions, and
approximately 260,000 are estimated to
have cancer risks greater than 100-in-1
million (table 16 of this preamble).
TABLE 16—COMMERCIAL STERILIZATION FACILITIES SOURCE CATEGORY BASELINE RISK ASSESSMENT RESULTS BASED
ON REVISED EMISSIONS IN FINAL RULE
Maximum
individual
cancer risk
(in 1 million) 2
Number of facilities 1
Estimated population at
increased risk of cancer
>100-in-1
million
I
Estimated
annual cancer
incidence
(cases per
year)
≥1-in-1
million
Maximum
chronic
noncancer
TOSHI
Maximum screening
acute noncancer HQ
Actual Emissions
88 3
...............................................
6,000
19,000
8,500,000
0.9
0.04
8
0.05
0.002 (REL).
Allowable Emissions
88 3 ...............................................
8,000
260,000
62,000,000
1 Number
of facilities evaluated in the risk analysis.
2 Maximum individual excess lifetime cancer risk due to HAP emissions from the source category.
3 Two of the 90 facilities identified in the source category are planned or under construction and therefore were not included in the risk
assessment.
Risks were then estimated after
application of the controls finalized in
this rulemaking pursuant to CAA
sections 112(d)(2), 112(d)(3), and
112(d)(5). A summary of those controls
is presented in table 17.
TABLE 17—SUMMARY OF STANDARDS AFTER TAKING ACTIONS PURSUANT TO CAA SECTIONS 112(d)(2), 112(d)(3), AND
112(d)(5)
Emission source
Existing or
new?
EtO use
Standards
SCV ................................
Existing and
new.
At least 10 tpy ..................................
99 percent emission reduction .........
Current standard.
At least 1 but less than 10 tpy .........
Less than 1 tpy .................................
At least 10 tpy ..................................
99 percent emission reduction .........
99 percent emission reduction .........
99 percent emission reduction .........
Current standard.
112(d)(5).
Current standard.
and
At least 1 but less than 10 tpy .........
Less than 1 tpy .................................
N/A ....................................................
99 percent emission reduction .........
99 percent emission reduction .........
99.94 percent emission reduction 1 ..
112(d)(5).
112(d)(5).
112(d)(2) and 112(d)(3).
and
N/A ....................................................
99 percent emission reduction 1 .......
112(d)(5).
ARV ................................
Existing and
new.
CEV at major sources ...
Existing
new.
CEV at area sources ..... Existing
new.
Group 1 room air emisExisting
sions at major sources.
new.
Group 1 room air emisExisting
sions at area sources.
new.
Group 2 room air emisExisting
sions at major sources.
new.
Group 2 room air emisExisting
sions at area sources.
CAA section
reduction 1 2
and
N/A ....................................................
97 percent emission
and
N/A ....................................................
80 percent emission reduction 1 2 .....
reduction 1 2
.....
and
N/A ....................................................
86 percent emission
.....
......
N/A ....................................................
New ...........
N/A ....................................................
Lower the EtO concentration within
each sterilization chamber to 1
ppm before the chamber can be
opened.1
80 percent emission reduction 1 2 .....
112(d)(2) and 112(d)(3).
112(d)(5).
112(d)(2) and 112(d)(3).
112(d)(5).
112(d)(5).
1 This
khammond on DSKJM1Z7X2PROD with RULES2
standard is different from what was proposed.
2 To assure compliance with the emission limit, we are requiring each facility to operate areas with these emissions in accordance with the
PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
Based on the risk assessment
considering controls finalized under
CAA sections 112(d)(2), 112(d)(3), and
112(d)(5), the maximum lifetime
individual cancer risk could be as high
as 6,000-in-1 million, with EtO driving
the risk. For previously unregulated
sources, the allowable emissions in this
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
risk assessment are equal to the
controlled emissions from these sources
assuming that they are only controlled
to the degree that we are requiring
pursuant to CAA sections 112(d)(2),
112(d)(3), and 112(d)(5). In some
instances, the actual emissions for these
sources may still be lower than the
PO 00000
Frm 00030
Fmt 4701
Sfmt 4700
allowable emissions. This is because
some facilities are already controlling
these sources to a degree greater than
what we are finalizing pursuant to CAA
sections 112(d)(2), 112(d)(3), and
112(d)(5) as a result of local
requirements or through voluntary
control measures. The total estimated
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
cancer incidence could be as high as 4
excess cancer cases per year, or 1 excess
case in every 3 months. As many as 38
million people are estimated to have
cancer risks greater than or equal to 1in-1 million, and approximately 85,000
people are estimated to have cancer
risks greater than 100-in-1 million (table
18 of this preamble).
However, as noted above, some
facilities are currently performing better
than the controls finalized under CAA
sections 112(d)(2), 112(d)(3), and
112(d)(5), and in that case we estimate
the maximum lifetime individual cancer
risk as 5,000-in-1 million, with EtO
driving the risk. The total estimated
cancer incidence is estimated to be 0.4
excess cancer cases per year, or 1 excess
24119
case in every 2.5 years. Approximately
4.2 million people were estimated to
have cancer risks greater than or equal
to 1-in-1 million, and approximately
3,900 are estimated to have cancer risks
greater than 100-in-1 million (table 18 of
this preamble), based only on the
application of the CAA section
112(d)(2), 112(d)(3), and 112(d)(5)
actions being finalized.
TABLE 18—COMMERCIAL STERILIZATION FACILITIES SOURCE CATEGORY RISK ASSESSMENT RESULTS BASED ON
EMISSIONS AFTER CONTROLS PROMULGATED UNDER CAA SECTIONS 112(d)(2)–(3) AND 112(d)(5)
Number of
Maximum individual cancer
risk
(in 1 million) 2
facilities 1
88 3 ...................................................................................................................
4 5,000–6,000
Estimated population at
increased risk of cancer 2
>100-in-1 million
≥1-in-1 million
4 3,900–
4 4,200,000–
260,000
62,000,000
Estimated
annual cancer
incidence
(cases per
year) 2
4 0.4–4
1 Number
of facilities evaluated in the risk analysis.
individual excess lifetime cancer risk due to HAP emissions from the source category.
of the 90 facilities identified in the source category are planned or under construction and therefore were not included in the risk assess-
2 Maximum
3 Two
ment.
4 Ranges in values account for if all facilities were performing at the level of the standards (high end) to considering facilities that are currently
performing better than the standards (low end).
Based on the revised risk assessment
results considering controls finalized
under CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5), we continue to find that
the risks are unacceptable, as we did
during the proposal due to emissions of
EtO from SCVs, ARVs, Group 1 room air
emission, Group 2 room air emissions,
and CEVs. Pursuant to CAA section
112(f)(2), the EPA must first determine
the emission standards necessary to
reduce risks to an acceptable level, and
then determine whether further HAP
emissions reductions are necessary to
provide an ample margin of safety to
protect public health or to prevent,
taking into consideration costs, energy,
safety, and other relevant factors, an
adverse environmental effect.
Immediately below is a discussion of
the standards the EPA has evaluated for
bringing risks to an acceptable level
(step 1).
khammond on DSKJM1Z7X2PROD with RULES2
i. SCV Emissions
There are 26 facilities within the
source category where the ‘‘revised
allowable emissions’’ from SCVs (i.e.,
allowable emissions after implementing
existing and newly promulgated 112(d)
standards in this final rule) contribute to
the facilities’ MIRs exceeding 100-in-1
million, and EtO usage at these facilities
ranges from four tpy to 446 tpy. The
previous subpart O required 99 percent
emission reduction for SCVs at facilities
where EtO use is at least 1 tpy. An
emission reduction of 99 percent is also
the final standard under CAA section
112(d)(5) for the previously unregulated
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
SCVs, which were those at facilities
where EtO use is less than 1 tpy (see
section IV.B.2).
Our data do not identify any add-on
controls beyond those we have already
considered when promulgating or
reviewing the SCV standards in the
previous subpart O or finalizing the
standards for the previously unregulated
SCVs in section IV.B. However, our
evaluation of the performance test data
and manufacturer guarantees shows that
these controls can achieve greater than
99 percent reduction. We therefore
considered more stringent SCV
standards for facilities where EtO use is
at least 1 tpy, which would include all
26 facilities where the revised allowable
emissions from SCVs contribute to the
facilities’ MIRs exceeding 100-in-1
million.
We evaluated 99.8 percent reduction
of SCV emissions from facilities using at
least 1 tpy but less than 10 tpy of EtO.44
As discussed in section III.D.2 of the
proposal preamble (88 FR 22790, April
13, 2023), 99.8 percent is the maximum
emission reduction from SCV with
which compliance can be demonstrated
at all facilities with EtO usage within
this range.45 A 99.8 percent reduction
would eliminate SCV emissions as a
contributor to a facility’s MIR exceeding
100-in-1 million for facilities using at
44 The MIRs of facilities with EtO usage less than
1 tpy are all below 100-in-a-million.
45 i.e., Based on facility characteristics, there is no
compliance demonstration issue because the
required EtO concentration to meet this limit would
be at or above 30 ppbv (which is 3 × RDL).
PO 00000
Frm 00031
Fmt 4701
Sfmt 4700
least 1 tpy but less than 10 tpy of EtO.46
We have determined that a 99.8 percent
emission reduction standard is feasible
because of one commenter’s statement
that, based on their discussions with
control device manufacturers, the best
and most advanced technologies will be
guaranteed to meet a 99.9 percent
emission reduction standard for SCVs.
For facilities using at least 10 tpy,
further reduction would be needed to
eliminate SCV emissions as a
contributor to a facility’s MIR exceeding
100-in-a-million. We evaluated 99.9
percent reduction, which as mentioned
above reflects the manufacturer
guaranteed control level. A 99.9 percent
reduction would eliminate SCV
emissions as a contributor to facilities’
MIRs exceeding 100-in-1 million for
facilities using at least 10 tpy but less
than 30 tpy of EtO. As discussed in
section III.D.2 of the proposal preamble
(88 FR 22790, April 13, 2023), we
evaluated a 99.94 percent emission
reduction standard for these facilities as
part of Control Option A under the
second step of the residual risk review.
However, as discussed in section IV.C.3
of this preamble, several commenters
stated that we do not have
representative performance tests for
SCVs. While this is not true for the
whole source category, it is true for
facilities where EtO use is at least 10 tpy
but less than 30 tpy. Therefore, as part
of this final rule, we did not evaluate an
46 A facility with usage amount in this range may
still have a MIR exceeding 100-in-a-million due to
other emissions.
E:\FR\FM\05APR2.SGM
05APR2
24120
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
emission reduction standard more
stringent than the manufacturer
guarantee for SCVs at these facilities.
For facilities using at least 30 tpy,
further reduction would be needed to
eliminate SCV emissions as a
contributor to a facility’s MIR exceeding
100-in-1 million. We evaluated 99.99
percent reduction based on a
performance test showing this level of
reduction from a facility within this
group. A 99.99 percent reduction would
eliminate SCV emissions as a
contributor to a facility’s MIR exceeding
100-in-a-million for facilities using at
least 30 tpy of EtO. We received
comment on the technical feasibility of
emission standards that exceed the
manufacturer guarantee for SCVs (i.e.,
99.9 percent emission reduction), but
we do not have any information
suggesting that any facility within this
group cannot achieve 99.99 percent
emission reduction. See section IV.C.3
of this preamble for more information.
ii. ARV Emissions
There are three facilities where
revised allowable ARV emissions
contribute to the facility’s MIR
exceeding 100-in-1 million, and EtO use
at these facilities currently ranges from
44 tpy to 446 tpy of EtO. The previous
subpart O required a 1 ppm maximum
outlet concentration or 99 percent
emission reduction for ARVs at facilities
where EtO use is at least 10 tpy. As
discussed in section IV.B, we are
removing the 1 ppm maximum outlet
concentration alternative standard, and
we are finalizing 99 percent emission
reduction standards under CAA section
112(d)(5) for previously unregulated
ARVs, which were those at facilities
where EtO use is less than 10 tpy. As
a result, the final 112(d) standard for
ARV emissions at all facilities is 99
percent reduction.
Our data do not identify any add-on
controls beyond those we have already
considered when promulgating, or
proposing revisions to the previous ARV
standards in subpart O or finalizing the
standards for the previously unregulated
ARVs in section IV.B. However, as
discussed in section III.F.3 of the
proposal preamble (88 FR 22790, April
13, 2023), our evaluation of the
performance test data shows that these
controls can achieve greater than 99
percent emission reduction.47 We
47 While the types of controls used for ARVs are
the same as those used for SCVs, the distribution
of these controls is different. For example, the use
of catalytic oxidizers and gas/solid reactors is more
prominent when controlling ARV emissions, while
the use wet scrubbers is more prominent when
controlling SCV emissions. See memorandum,
Technical Support Document for Proposed Rule—
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
evaluated 99.9 percent reduction of
ARV emissions from facilities using at
least 30 tpy of EtO,48 which is feasible
because it is currently achieved by onethird of these facilities. Of these 12
facilities that are currently achieving
this emission reduction, nine use
catalytic oxidizers, two use a catalytic
oxidizer and gas/solid reactor in series,
one uses a thermal oxidizer, and one
uses a gas/solid reactor. Note that this
does not sum to 12 because one facility
uses two different types of control
systems to reduce its ARV emissions.49
A 99.9 percent emission reduction
would eliminate ARV emissions as a
contributor to a facility’s MIR to exceed
100-in-1 million for facilities using at
least 30 tpy of EtO.50
iii. Group 2 Room Air Emissions
There are 13 facilities, all area
sources, where revised allowable Group
2 room air emissions contribute to the
facilities’ MIRs exceeding 100-in-1
million and the EtO usage at these
facilities ranges from 4 tpy to 446 tpy.51
Because Group 2 room air emissions
contribute to unacceptable risks from
existing area sources in this source
category, we evaluated available control
options for reducing risks from Group 2
room air emissions.
As discussed in section IV.B of this
preamble, we are finalizing a GACT
standard for previously unregulated
Group 2 room air emissions at existing
area source facilities. Specifically, we
are finalizing under CAA section
112(d)(5) that area source facilities
lower the EtO concentration within each
sterilization chamber to 1 ppm before
Industry Profile, Review of Unregulated Emissions,
CAA Section 112(d)(6) Technology Review, and
CAA Section 112(f) Risk Assessment for the
Ethylene Oxide Emissions Standards for
Sterilization Facilities NESHAP, located at Docket
ID No. EPA–HQ–OAR–2019–0178.
48 As discussed above, one of the facilities where
allowable ARV emissions contribute to the facility’s
MIR exceeding 100-in-1 million uses 44 tpy.
Evaluating the emission reduction for facilities
where EtO use is at least 30 tpy provides a
sufficient buffer in case the EtO use at this facility
drops to below 40 tpy.
49 As part of the proposed rulemaking, a similar
analysis was conducted for ARVs at facilities where
EtO use is at least 10 tpy. See section III.F.3.a of
the proposal preamble for more details on that
analysis (88 FR 22790, April 13, 2023).
50 As part of the proposed rulemaking, we
evaluated a 99.9 percent emission reduction
standard for ARVs at facilities where EtO use is at
least 10 tpy as part of the technology review (see
section III.F.3 of the proposal preamble (88 FR
22790, April 13, 2023)). For existing sources, this
option was rejected in favor of a more cost-effective
option (i.e., 99.6 percent emission reduction).
However, we proposed a 99.9 percent emission
reduction standard for new sources pursuant to
CAA section 112(d)(6).
51 As discussed earlier, the EPA has the authority
to conduct an (f)(2) review of GACT standards and
is exercising that authority in this action.
PO 00000
Frm 00032
Fmt 4701
Sfmt 4700
the chamber can be opened.52 Because
there is still unacceptable risk from
facilities where EtO usage is above 4
tpy, this requirement will ultimately
apply only to existing Group 2 room air
emissions at facilities where EtO use is
less than 4 tpy.
In evaluating the appropriate GACT
standard for previously unregulated
existing Group 2 room air emissions at
area source facilities, we considered an
emission reduction of 80 percent that
reflects the use of control devices
(Option 1) but did not finalize that
option under CAA section 112(d)(5) for
reasons stated in section IV.B.3.b.
However, having determined under
CAA section 112(f)(2) that the risk for
the source category is unacceptable, we
are determining the emissions standards
necessary to reduce risk to an acceptable
level without considering costs. We
evaluated 80 percent emission reduction
of Group 2 room air emissions from area
source facilities using at least 4 tpy but
less than 20 tpy of EtO. As discussed in
section IV.B.3.b of this preamble, 80
percent is the manufacturer guarantee
for room air emissions controls
provided by one of the commenters. We
do not have any performance test data
for Group 2 room air emissions at these
facilities, so it is unknown whether
these sources can achieve greater than
80 percent emission reduction. An 80
percent reduction would eliminate
Group 2 room air emissions as a
contributor to a facility’s MIRs
exceeding 100-in-1 million for area
source facilities using at least 4 tpy but
less than 20 tpy.
For area source facilities using at least
20 tpy, further reduction would be
needed to eliminate Group 2 room air
emissions as a contributor to a facility’s
MIR exceeding 100-in-a-million. Our
data do not identify any add-on controls
beyond those we have already
considered when finalizing the
standards for the previously unregulated
Group 2 room air emission in section
IV.B. However, our evaluation of the
performance data shows that these
controls can achieve greater than 80
percent emission reduction at area
source facilities where EtO use is at
least 20 tpy. We therefore considered a
more stringent Group 2 room air
emission standard for these facilities.
We evaluated 98 percent reduction of
Group 2 room air emissions from area
source facilities using at least 20 tpy,
which is the emission reduction that has
been achieved in one-third of the
52 As discussed in section IV.B of this preamble,
we are finalizing an 80 percent emission reduction
standard for all new Group 2 room air emissions at
area source facilities, regardless of EtO use, under
CAA section 112(d)(5).
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
available performance test runs for these
facilities.53 98 percent reduction would
eliminate Group 2 room air emissions as
a contributor to a facility’s MIR
exceeding 100-in-a-million for area
source facilities where EtO use is at
least 20 tpy.
khammond on DSKJM1Z7X2PROD with RULES2
iv. CEV Emissions
There is one facility within the source
category where revised allowable
emissions from CEVs contribute to the
facility’s MIR exceeding 100-in-1
million, and this is an area source
facility that currently uses 446 tpy of
EtO. The previous subpart O did not
regulate CEVs at area source facilities.
As discussed in section IV.B of this
preamble, we are finalizing a GACT
standard for these sources. Specifically,
pursuant to CAA section 112(d)(5), we
are finalizing a 99 percent emission
reduction standard for CEVs at area
source facilities.
Our data do not identify any add-on
controls beyond those we have already
considered when finalizing the
standards for CEVs in section IV.B.
However, our evaluation of the
performance test data shows that these
controls can achieve greater than 99
percent reduction. We therefore
considered a more stringent CEV
emission standard for area source
facilities where EtO use is at least 400
tpy. We evaluated 99.9 percent
reduction of CEV emissions from
facilities where EtO use is at least 400
tpy, which is the emission reduction
that is currently achieved by 75 percent
of these facilities.54 A 99.9 percent
reduction would eliminate CEV
emissions as a contributer to a facility’s
MIR exceeding 100-in-1-million for
facilities where EtO use is at least 400
tpy.
v. Group 1 Room Air Emissions
There are four area source facilities
within the source category where
revised allowable Group 1 room air
emissions contribute to the facilities’
MIRs exceeding 100-in-1 million, and
the EtO usage at these facilities ranges
from 44 to 446 tpy. The previous
subpart O did not regulate Group 1
room air emissions at area source
facilities. As discussed in section IV.B
of this preamble, we are finalizing a
GACT standard for these sources.
Specifically, pursuant to CAA section
112(d)(5), we are finalizing an 80
percent emission reduction as the GACT
53 All of these facilities use gas/solid reactors to
control their Group 2 room air emissions.
54 There are three facilities that are currently
achieving this emission reduction. Of these three
facilities, two use catalytic oxidizers, and one uses
a wet scrubber.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
standard for Group 1 room air emissions
at area source facilities.
Our data do not identify any add-on
controls beyond those we have already
considered when finalizing the
standards for Group 1 room air
emissions in section IV.B. However, our
evaluation of the performance test data
shows that these controls can achieve
greater than 80 percent reduction. We
therefore considered a more stringent
Group 1 room air emission standard for
area source facilities where EtO use is
at least 40 tpy. We evaluated 98 percent
emission reduction of Group 1 room air
emissions from area source facilities
using at least 40 tpy, which is the
emission reduction that has been
achieved in all but one of the six
available performance test runs for these
facilities.55 A 98 percent reduction
would eliminate Group 1 room air
emissions as a contributor to a facility’s
MIRs exceeding 100-in-1-million for
area source facilities where EtO use is
at least 40 tpy.
Considering all of the emission
reductions that we evaluated above, the
source category MIR would be reduced
to 100-in-1 million. This means that all
facilities would have an MIR at or below
100-in-1 million,56 and the population
exposed to risk levels greater 100-in-1
million would be reduced to zero. In
addition, the population exposed to risk
levels greater than or equal to 1-in-1
million living within 50 km of a facility
would be reduced to between 710,000
(when considering some facilities are
currently performing better than the
standards) and 1.41 million people
(when considering all facilities perform
at the level of the standards). Finally,
the cancer incidence would be reduced
from 0.9 to between 0.1 (when
considering some facilities are currently
performing better than the standards)
and 0.2 (when considering all facilities
perform at the level of the standards), or
from 1 cancer case every 1.1 years to 1
cancer case every 5 to 10 years. For
these reasons, we find that the
preceding emission reductions that we
evaluated reduce risks to an acceptable
level. These emission reduction
measures are:
• 99.99 percent emission reduction
for SCVs at facilities where EtO use is
at least 30 tpy,
• 99.9 percent emission reduction for
SCVs at facilities where EtO use is at
least 10 tpy but less than 30 tpy,
55 All of these facilities use gas/solid reactors to
control their Group 1 room air emissions.
56 Considering actual emissions, most facilities
(i.e., 87 out of 88) would have an MIR less than 100in-1 million.
PO 00000
Frm 00033
Fmt 4701
Sfmt 4700
24121
• 99.8 percent emission reduction for
SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy,
• 99.9 percent emission reduction for
ARVs at facilities where EtO use is at
least 30 tpy,
• 99.9 percent emission reduction for
CEVs at facilities where EtO use is at
least 400 tpy,
• 98 percent emission reduction for
Group 1 room air emissions at area
source facilities where EtO use is at
least 40 tpy,
• 98 percent emission reduction for
Group 2 room air emissions at area
source facilities where EtO use is at
least 20 tpy, and
• 80 percent emission reduction for
Group 2 room air emissions at area
source facilities where EtO use is at
least 4 tpy but less than 20 tpy.
b. Ample Margin of Safety (Step 2)
At step 1 of our review of residual
risks under CAA section 112(f)(2), we
have identified a suite of standards and
determined that they are necessary to
reduce risks to an acceptable level.
These include standards for SCVs at
facilities with EtO usage of at least 1
tpy, ARVs at facilities with EtO usage of
at least 30 tpy, CEVs at area source
facilities with EtO usage of at least 400
tpy, Group 1 room air emissions at area
source facilities with EtO usage of at
least 40 tpy, and Group 2 room air
emissions at area source facilities with
EtO usage of at least four tpy. For step
2 of our review of residual risks, we
evaluate whether more stringent
standards are necessary to provide an
ample margin of safety to protect public
health. While we do not consider costs
in the step 1 analysis, costs are a factor
we consider in the step 2 analysis. For
details on the assumptions and
methodologies used in the costs and
impacts analyses, see the technical
memorandum titled Ample Margin of
Safety Analysis for Ethylene Oxide
Commercial Sterilization—
Promulgation Rule Review for the
Ethylene Oxide Commercial
Sterilization Source Category, which is
available in the docket for this
rulemaking.
As part of the proposed rulemaking,
we considered six options (which are
identified in the proposal preamble
table 22 (88 FR 22829) and proposed
Control Options A and C as part of the
ample margin of safety analysis. Control
Option A would have required 99.94
percent emission reduction for SCVs at
facilities where EtO use is at least 10 tpy
but less than 40 tpy. We are not
finalizing Control Option A for the
following reasons. First, this option is
less stringent than the standard we have
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24122
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
already identified in Step 1 (99.99
percent emission reduction) for SCV
emissions at facilities where EtO use is
at least 30 tpy.57 Second, for facilities
where EtO use is less than 30 tpy, we
do not have any performance tests
showing that these facilities can perform
better than the manufacturer guarantee
(i.e., 99.9 percent emission reduction for
SCVs). For these reasons, we are not
finalizing Control Option A as part of
this rulemaking. Control Option C
would have required 99.8 percent
emission reduction for SCVs at facilities
where EtO use is at least 1 tpy but less
than 10 tpy. As discussed in section
IV.C.2.a of this preamble (step 1 of risk
review), Control Option C is one of the
standards identified under the revised
Step 1 analysis as necessary to reduce
risks to an acceptable level.
In addition, we evaluated the
following options but rejected them for
the reasons discussed below:
Æ For ARVs at facilities where EtO
use is at least 30 tpy, we do not have
data showing that it is technically
feasible for all facilities to achieve
greater than 99.9 percent emission
reduction (which is the standard
applicable to these sources that we have
determined under step 1 as necessary to
reduce risks to an acceptable level).
• For ARVs at facilities where EtO
use is less than 10 tpy, we were unable
to identify any cost-effective options
that achieve emission reduction greater
than the current 99 percent emission
reduction standard (GACT). More
information is presented in the
technical memorandum titled Ample
Margin of Safety Analysis for Ethylene
Oxide Commercial Sterilization—
Promulgation Rule Review for the
Ethylene Oxide Commercial
Sterilization Source Category, which is
available in the docket for this
rulemaking.
• For Group 2 room air emissions at
area source facilities where EtO use is
at least 20 tpy, we do not have data
indicating that it is technically feasible
for all facilities to achieve greater than
98 percent emission reduction (which is
the standard applicable to these sources
that we have determined under step 1
as necessary to reduce risks to an
acceptable level).
• For Group 2 room air emissions at
area source facilities where EtO use is
less than 20 tpy, we do not have any
performance tests showing that these
facilities can perform better than the
manufacturer guarantee (i.e., 80 percent
57 For facilities where use is less than 30 tpy, we
do not have performance test data indicating that
99.99 percent emission reduction for SCVs is
technical feasible.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
emission reduction for room air
emissions, which is the standard for
facilities using at least 4 tpy but less
than 20 tpy of EtO that we have
determined under step 1 as necessary to
reduce risks to an acceptable level).
• For Group 2 room air emissions at
area source facilities where EtO use is
less than 4 tpy, 80 percent emission
reduction is not cost effective.58
• For Group 1 room air emissions at
area source facilities where EtO use is
at least 40 tpy, we do not have data
indicating that it is technically feasible
for all facilities to achieve greater than
98 percent emission reduction (which is
the standard for these affected sources
that we have identified in Step 1 as
necessary to reduce risks to an
acceptable level).
• For Group 1 room air emissions at
area source facilities where EtO use is
less than 40 tpy, we do not have any
performance tests showing that these
facilities can perform better than the
manufacturer guarantee (i.e., 80 percent
emission reduction for room air
emissions, which we have established
in this final rule as the GACT standard
for Group 1 room air emissions at these
facilities).
However, there are two potential
options. One potential option is 99.6
percent emission reduction for ARVs at
facilities where EtO use is at least 10 tpy
but less than 30 tpy. This is cost
effective and is already being achieved
by these facilities. The other potential
option is to further reduce CEV
emissions at area source facilities.59
Under this option, which would reduce
CEV emissions by 99.9 percent at area
source facilities where EtO use is at
least 60 tpy less than 400 tpy,60 costs
were found to be a $6,820,000 total
capital investment and a $1,670,000
total annualized cost. The estimated EtO
emissions reductions are 1.9 tpy (i.e.,
3,720 lb/year) with a cost effectiveness
of $895,000 per ton of EtO (i.e., $448 per
lb of EtO). Considering EtO is a highly
potent carcinogen, the cost-effectiveness
number of this option is within the
range of the values that we have
58 As discussed in section IV.B.3.b of this
preamble, we analyzed this option as part of the
GACT analysis and found it to be cost-effective.
However, this analysis included all facilities in the
source category (i.e., not just those where EtO use
is less than 4 tpy).
59 As discussed in section IV.B.3.b of this
preamble, pursuant to CAA sections 112(d)(2) and
112(d)(3), we are finalizing a 99.94 percent
emission reduction standard for CEVs at major
source facilities. We did not identify any costeffective BTF options.
60 As discussed in step 1 analysis, pursuant to
CAA section 112(f)(2), this standard for CEVs at
area source facilities where EtO usage is at least 400
tpy is necessary to reduce risks to an acceptable
level.
PO 00000
Frm 00034
Fmt 4701
Sfmt 4700
determined to be cost-effective for
highly toxic HAPs. As explained in
section IV.B.3.b of this preamble, this
includes hexavalent chromium, where
we finalized a requirement with a costeffectiveness of $15,000/lb
($30,000,000/ton) for existing small
hard chromium electroplating to
provide an ample margin of safety
(taking into account cost among other
factors) (77 FR 58227–8, 58239). While
we do not know what the full extent of
risk reductions would be, we estimate
that, compared to the measures in step
1, this control option would further
reduce the population exposed to risk
levels greater than or equal to 1-in-1
million by additional 10,000–30,000
people. For area sources where EtO use
is less than 60 tpy, we do not have any
performance test data showing that
existing controls can achieve greater
than 99 percent reduction for CEVs
(which is the GACT standard we have
established in this final rule for CEV at
area sources). In addition, for area
source facilities where EtO use is at
least 400 tpy, we were unable to identify
any cost-effective options. Therefore, we
did not consider a more stringent CEV
standard for facilities where EtO use at
least 400 tpy.
In the post control scenario (i.e., with
the implementation of the standards
identified under step 1 and the two
potential options discussed immediately
above in this step 2 analysis, we
estimated that the baseline cancer MIR
of 6,000-in-1 million for actual
emissions and 8,000-in-1 million for
allowable emissions would be reduced
to 100-in-1 million, with EtO driving the
risk. While the MIR for the source
category will be 100-in-1 million, we
estimate that most facilities (i.e., 87 out
of 88) will have an MIR less than 100in-1 million. There is an estimated
reduction in cancer incidence to 0.2
excess cancer cases per year (or one
excess case every 5 years), down from
0.9 excess cancer cases per year (or one
excess cancer case every 1.1 years) for
baseline actual emissions and down
from 8 excess cancer cases per year (or
one excess cancer case every 1.5
months) for baseline allowable
emissions. We estimate that, after full
implementation of this final rule, 0
people would have cancer risks greater
than 100-in-1 million, down from
19,000 people for actual emissions and
260,000 people for allowable emissions.
In addition, the number of people
estimated to have a cancer risk greater
than or equal to 1-in-1 million would be
reduced to 1.38 million people, down
from 8.5 million people for actual
emissions and 62 million people for
E:\FR\FM\05APR2.SGM
05APR2
24123
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
allowable emissions (table 19 of this
preamble).
Again, we note that some facilities are
currently performing better than the
controls finalized under CAA sections
112(f)(2), and in that case we estimate
the maximum lifetime individual cancer
risk as 100-in-1 million, with EtO
driving the risk. The total estimated
cancer incidence is estimated to be 0.1
excess cancer cases per year, or 1 excess
case in every 10 years, with
approximately 700,000 people estimated
to have cancer risks greater than or
equal to 1-in-1 million and 0 people
estimated to have cancer risks greater
than 100-in-1 million (table 19 of this
preamble).
TABLE 19—BASELINE AND POST-CONTROL RISK (AFTER CONTROLS PROMULGATED UNDER CAA SECTIONS 112(F)(2)
SUMMARY FOR THE COMMERCIAL STERILIZATION FACILITIES SOURCE CATEGORY BASED ON EMISSIONS IN THE FINAL
RULE
Inhalation cancer risk
Maximum
individual risk
(in 1 million)
Actual Emissions Baseline Risk ...........................
Allowable Emissions Baseline Risk ......................
Post-control Risk ...................................................
6,000
8,000
100
Population cancer risk
Risk driver
ethylene oxide ..............
ethylene oxide ..............
ethylene oxide ..............
Cancer
incidence
(cases per
year)
0.9
8
1 0.1–0.2
>100-in-1
million
19,000
260,000
0
≥1-in-1 million
8,500,000
62,000,000
1 700,000–
1,380,000
1 Ranges in values account for if all facilities were performing at the level of the standards (high end) to considering facilities that are currently
performing better than the standards (low end).
Additional details of the analyzed
risks can be found in the Residual Risk
Assessment for the Commercial
Sterilization Facilities Source Category
in Support of the 2024 Risk and
Technology Review Final Rule, available
in the docket for this rulemaking.
Based on our ample margin of safety
analysis, including all health
information and the associated cost and
feasibility discussed above, we find that
requiring the standards that, based on
our analysis, would bring risks to an
acceptable level, along with 99.6
percent emission reduction for ARVs at
facilities where EtO use is at least 10 tpy
but less than 30 tpy and 99.9 percent
emission reduction for CEVs at area
source facilities where EtO use is at
least 60 tpy but less than 400 tpy, would
provide an ample margin of safety to
protect public health.
khammond on DSKJM1Z7X2PROD with RULES2
c. Environmental Effects
As explained in our proposed rule,
the emissions data indicate that no
environmental HAP are emitted by
sources within this source category. In
addition, we are unaware of any adverse
environmental effects caused by HAP
emitted by this source category.
Therefore, we do not expect there to be
an adverse environmental effect as a
result of HAP emissions from this
source category. For the reason stated
above, it is not necessary to set a more
stringent standard to prevent, taking
into consideration costs, energy, safety,
and other relevant factors, an adverse
environmental effect.
d. Rule Changes
Based on comments received on the
proposed rulemaking, we are finalizing
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
the following emissions standards
pursuant to CAA section 112(f)(2):
• 99.99 percent emission reduction
for SCVs at facilities where EtO use is
at least 30 tpy,
• 99.9 percent emission reduction for
SCVs at facilities where EtO use is at
least 10 tpy but less than 30 tpy,
• 99.8 percent emission reduction for
SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy,
• 99.9 percent emission reduction for
ARVs at facilities where EtO use is at
least 30 tpy,
• 99.6 percent emission reduction for
ARVs at facilities where EtO use is at
least 10 tpy but less than 30 tpy,
• 99.9 percent emission reduction for
CEVs at area source facilities where EtO
use is at least 60 tpy,
• 98 percent emission reduction for
Group 1 room air emissions at area
source facilities where EtO use is at
least 40 tpy,
• 98 percent emission reduction for
Group 2 room air emissions at area
source facilities where EtO use is at
least 20 tpy, and
• 80 percent emission reduction for
Group 2 room air emissions at area
source facilities where EtO use is at
least 4 tpy but less than 20 tpy.
We are not finalizing the work
practice standards that were proposed
for facilities where the MIR remained
greater than 100-in-1 million after the
imposition of requirements under
‘‘Control Option 1’’, which would have
required facilities to limit their existing
Group 2 room air emissions to a
maximum volumetric flow rate of 2,900
dscfm and a maximum EtO
concentration of 30 ppbv. We had
proposed these standards based on the
PO 00000
Frm 00035
Fmt 4701
Sfmt 4700
risk review we conducted during the
proposal stage, which has been
substantially revised. As discussed
above, based on the revised risk review,
we are finalizing a different suite of
standards pursuant to CAA section
112(f)(2) to reduce risks to an acceptable
level and provide an ample margin of
safety to protect public health.
3. What key comments did we receive
on the risk review, and what are our
responses?
This section provides comment
summaries and responses for the key
comments received regarding our
exclusion of allowable emissions from
the risk assessment, the control
requirements proposed for SCVs, and
the work practice standards that were
proposed for facilities where the MIR
remained greater than 100-in-1 million
after the imposition of requirements
under ‘‘Control Option 1’’ evaluated in
the residual risk assessment during the
proposal stage, as well as the proposed
GACT standards that were incorporated
into the residual risk assessment. We
received comments against the
exclusion of allowable emissions from
the risk assessment, the control
requirements proposed for SCVs, and
the work practice standards that were
proposed for facilities where the MIR
remained greater than 100-in-1 million
after the imposition of requirements
under ‘‘Control Option 1.’’ Other
comments on these issues, as well as on
additional issues regarding the residual
risk review and our proposed changes
based on the residual risk review, can be
found in the document, Summary of
Public Comments and Responses for the
Risk and Technology Review for
E:\FR\FM\05APR2.SGM
05APR2
24124
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
Commercial Sterilization Facilities,
available in the docket for this
rulemaking.
Comment: Two commenters
contended that we should use allowable
emissions when conducting residual
risk assessments. One commenter stated
that actual emissions only provide a
snapshot in time and that there is no
legal requirement at the Federal level to
maintain emissions beyond the
NESHAP requirements in any given
year. The commenter also referenced a
2010 Science Advisory Board (SAB)
report that recommended we use
‘‘facility-specific allowable emissions
reflecting current regulatory limits.’’ 61
Response: We agree with commenters
that allowable emissions should be
considered as part of the residual risk
assessment. As discussed in section III.C
of the proposed rulemaking (88 FR
22790), because allowable emissions
and risks were higher than actual
emissions, and in light of our finding
that risks were unacceptable based on
actual emissions, we determined that a
separate assessment of allowable
emissions was unnecessary. However,
for the reasons stated by the
commenters, we have incorporated
allowable emissions into our revised
risk assessment as part of this final
rulemaking.
Comment: Two commenters
expressed the following concerns with
the 99.94 percent emission reduction
standard for SCVs:
• Our technical publications on
reduction ranges for add-on control
equipment for HAPs do not show that
a destruction and removal efficiency of
99.94 percent is achievable under
normal continuous operation.
• The proposed requirement does not
require additional controls based on
new technology, but requires achieving
greater efficiency from existing controls.
Specifically, one commenter stated that
nothing in the proposal preamble
suggests that the control systems
installed in order to meet the current
SCV standard need to be replaced or
their performance upgraded. The
commenter further stated that our cost
estimates include nothing with respect
to controls for SCVs.
• Emission control device
manufacturers do not guarantee a
destruction removal efficiency of 99.94
percent for SCVs.
61 Commenter provided the following reference:
EPA Science Advisory Board, Review of EPA’s draft
entitled, ‘‘Risk and Technology Review (RTR) Risk
Assessment Methodologies: For Review by the
EPA’s Science Advisory Board with Case Studies—
MACT I Petroleum Refining Sources and Portland
Cement Manufacturing’’, at ii, (May 7, 2010),
https://www.regulations.gov/document/EPA-HQOAR-2010-0682-0103.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Two commenters stated that
emissions standards should be based on
achievable, manufacturer guaranteed
destruction removal efficiency of
emission control equipment. One
commenter stated that, based on their
discussions with control device
manufacturers, they believe that the best
and most advanced technologies will be
guaranteed to meet a 99.9 percent
emission reduction standard for SCVs.
Response: We disagree with the
commenters that our technical
publications on reduction ranges for
add-on control equipment for HAPs do
not show that an emission reduction of
99.94 percent (and, therefore, any
greater emission reduction) is
achievable under normal continuous
operation for SCVs. Such a performance
test was conducted for at least two
systems that control SCV emissions, and
the reported emission reduction for both
of these systems was 99.99 percent.
Below is a discussion on the relevant
points for each performance test:
• The first performance test was
conducted on November 17, 1999.62 It is
unknown what the EtO use at this
facility was at the time of the
performance test, but it is expected that
it was somewhere between 10 tpy and
30 tpy. At the time of the performance
test, the facility used a wet scrubber to
control its SCV emissions.63 Prior to
November 2, 2001, we required facilities
to test the both the first and last
evacuations of the SCV. The SCV
concentration decreases over time, so
any emission reductions between the
first and last evacuations are going to be
at least as high as that of the last
evacuation. For this performance test,
the average emission reduction at the
first evacuation was 99.9946 percent,
and the average emission reduction at
the last evacuation was 99.99 percent.
This means that the emission reduction
over all the SCV cycles exceeded 99.99
percent. While this performance test
data is almost 25 years old, emission
control technology has continued to
improve over time, and emission
reductions today are likely higher.
• The data from this performance test
indicates that, for facilities where EtO
use is at least 30 tpy, any SCV control
system that is achieving higher than
99.9946 percent emission reduction on
the first evacuation is likely achieving at
least 99.99 percent emission reduction
overall. Our current performance test
data indicates that at least 15 facilities
where EtO use is at least 30 tpy are
62 https://www.regulations.gov/document/EPAHQ-OAR-2019-0178-0297.
63 This facility continues to use a wet scrubber to
control its SCV emissions to this day.
PO 00000
Frm 00036
Fmt 4701
Sfmt 4700
currently achieving greater than 99.9946
percent emission reduction on the first
evacuation, and the highest emission
reduction on the first evacuation that we
have observed is 99.99999982 percent.
Of these 15 facilities that are currently
achieving this emission reduction, eight
use wet scrubbers, three use a wet
scrubber and gas/solid reactor in series,
two use thermal oxidizers, one uses a
catalytic oxidizer, and one uses a wet
scrubber and catalytic oxidizer in series.
• The second performance test was
conducted on March 10, 11, and 12,
2020,64 and EtO use at this facility is
229.2 tpy. This facility uses wet
scrubbers and gas/solid reactors in
series to control its SCV emissions. Due
to the configuration of the control
system at this facility, there is no
mechanism to test the SCVs on their
own. Therefore, this performance test
was conducted for all emission sources
at the facility. For lower concentration
streams like ARVs, CEVs, and room air
emissions, emission reductions tend to
be lower. Therefore, it is likely that the
SCV emission reduction at this facility
exceeds 99.99 percent.
As a general matter, it is not our
policy to simply rely on manufacturer
guarantees when setting or revising
emission standards. Typically, we
evaluate performance tests to see what
the controls are actually achieving in
practice and then set or revise the
standards based on that evaluation.
However, if representative performance
test data are not available, then
manufacturer guarantees may be
considered. We also note that it is
common within this industry to
combine different types of control
devices in series when reducing
emissions. Since these control devices
are often made by different
manufacturers, there is no manufacturer
guarantee available for these systems.
We do not share the commenters’
concerns that emission control device
manufacturers do not guarantee a
destruction removal efficiency of 99.94
percent for SCVs, as representative
performance test data is available and
indicates that these emission reductions
(and, in fact, higher emission
reductions) are achievable for higher use
facilities. However, such performance
test data are not available for smaller
users, and it is not known whether those
facilities can meet the emission
reduction that the higher use facility is
demonstrating. Therefore, we agree with
commenters that consideration of
manufacturer guarantees is warranted
for lower use facilities, and the
64 https://www.regulations.gov/document/EPAHQ-OAR-2019-0178-0349.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
standards that we are finalizing for
SCVs at facilities where EtO use is less
than 30 tpy do not exceed the
manufacturer guarantee.
In addition, we disagree with one
commenter’s assertion that there is
nothing in the proposal preamble to
suggest that the control systems
installed in order to meet the current
SCV standard need to be replaced or
their performance upgraded.
Furthermore, the commenter’s assertion
that our cost estimates include nothing
with respect to controls for SCVs is
incorrect. As discussed in section II.A of
this preamble, under the first step of the
residual risk assessment, if risks are
unacceptable, the EPA must determine
the emissions standards necessary to
reduce risk to an acceptable level
without considering costs. While we did
not conduct a cost analysis for the SCV
standards that we are finalizing
pursuant to CAA section 112(f)(2) step
1 (risk acceptability analysis), we
assume that new controls would be
needed in order to achieve those
standards, and the cost of those controls
are included in the total costs of the
rule. However, we note that the final
standard is simply an emission
reduction standard, and owners and
operators may choose to meet the
standard however they see fit (e.g.,
either through process changes, the
replacement of a control system, or the
use of additional control devices to
further reduce emissions from an
existing control system). In some cases,
existing controls may already be
achieving the standard, and in that case,
no changes are required.
Comment: Several commenters stated
that reducing the volumetric flow rate
from Group 2 room air emissions to
2,900 dscfm would be detrimental to
sterilization operations and may make it
impossible to achieve the proposed PTE
requirement.
Response: Based on comments
received on the proposed rulemaking,
we revised the risk assessment, which
resulted in different emission reduction
measures than what we proposed to
bring the risk to the acceptable level.
The proposed work practice standards
are no longer necessary to bring the MIR
of Group 2 room air emissions at area
source facilities to 100-in-1 million.
Therefore, we are not including a work
practice standard that would require
any facilities to reduce their throughput
as part of this final rule.
4. What is the rationale for our final
approach and final decisions for the risk
review?
As noted in our proposal, we set
standards under CAA section 112(f)(2)
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
using ‘‘a two-step standard-setting
approach, with an analytical first step to
determine an ‘acceptable risk’ that
considers all health information,
including risk estimation uncertainty,
and includes a presumptive benchmark
on MIR of approximately 1-in-10
thousand’’ (88 FR 22790, April 13, 2023;
see also 54 FR 38045, September 9,
1989). We weigh all health risk factors
in our risk acceptability determination,
including the cancer MIR, cancer
incidence, the maximum TOSHI, the
maximum acute HQ, the extent and the
distribution of cancer and noncancer
risks in the exposed population,
multipathway risks, and the risk
estimation uncertainties. In the second
step of the approach, the EPA considers
whether the emissions standards
provide an ample margin of safety to
protect public health ‘‘in consideration
of all health information, including the
number of persons at risk levels higher
than approximately 1-in-1 million, as
well as other relevant factors, including
costs and economic impacts,
technological feasibility, and other
factors relevant to each particular
decision.’’ Id. The EPA must promulgate
emission standards necessary to provide
an ample margin of safety to protect
public health or determine that the
standards being reviewed provide an
ample margin of safety without any
revisions. After conducting the ample
margin of safety analysis, we consider
whether a more stringent standard is
necessary to prevent an adverse
environmental effect, taking into
consideration costs, energy, safety, and
other relevant factors.
Since proposal, our determinations
regarding risk acceptability, ample
margin of safety, or adverse
environmental effects have not changed.
The revised risk assessment (see
document, Residual Risk Assessment for
the Commercial Sterilization Facilities
Source Category in Support of the 2024
Risk and Technology Review Final Rule,
which is available in the docket for this
rulemaking) shows that, after
application of controls finalized in this
rulemaking, the MIR for the source
category is 100-in-1 million. Therefore,
after application of the controls for
SCVs at facilities where EtO use is at
least 1 tpy, ARVs at facilities where EtO
use is at least 30 tpy, CEVs at area
source facilities where EtO use is at
least 400 tpy, Group 1 room air
emissions at area source facilities where
EtO use is at least 40 tpy, and Group 2
room air emissions at area source
facilities where EtO use is at least four
tpy, we find that the risks are acceptable
and that the final standards will achieve
PO 00000
Frm 00037
Fmt 4701
Sfmt 4700
24125
an ample margin of safety to protect
public health.
D. Technology Review for the
Commercial Sterilization Facilities
Source Category
1. What did we propose pursuant to
CAA section 112(d)(6) for the
Commercial Sterilization Facilities
source category?
Based on our technology review for
the Commercial Sterilization Facilities
source category, we proposed under
CAA section 112(d)(6) changes to the
standards for SCVs where EtO use is at
least 10 tpy, SCVs where EtO use is at
least 1 tpy but less than 10 tpy, and
ARVs where EtO use is at least 10 tpy.
We provide a summary of our findings,
as proposed, in this section. In general,
while the types of controls have
essentially remained the same since
promulgation of subpart O, available
information show greater emission
reduction since then for some of these
control options.
For SCVs, we proposed the following
emission standards pursuant to CAA
section 112(d)(6):
• 99.94 percent reduction for new
and existing SCVs at facilities where
EtO use is at least 10 tpy, and
• 99.8 percent reduction for new and
existing SCVs at facilities where EtO use
is at least 1 tpy but less than 10 tpy.
These are the maximum SCV
emission reductions with which
compliance can be demonstrated. We
evaluated these standards against the
maximum SCV emission reductions that
all facilities are currently meeting
within each subcategory. For more
information, see sections III.F.1 and
III.F.2 of the proposal preamble (88 FR
22790, April 13, 2023).
For ARVs, we proposed the following
emission standards pursuant to CAA
section 112(d)(6):
• 99.6 percent emission reduction for
existing ARVs at facilities where EtO
use is at least 10 tpy, and
• 99.9 percent emission reduction for
new ARVs at facilities where EtO use is
at least 10 tpy.
These are the emission reductions
that have been demonstrated by 75
percent and 50 percent of all available
performance tests, respectively. We
evaluated both emission reductions for
new and existing ARVs. For more
information, see section III.F.3 of the
proposal preamble (88 FR 22790, April
13, 2023).
2. How did the technology review
change for the Commercial Sterilization
Facilities source category?
We are finalizing the following
emission standards as a result of the
E:\FR\FM\05APR2.SGM
05APR2
24126
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
technology review for the Commercial
Sterilization Facilities source category,
as proposed:
• 99.8 percent emission reduction for
new and existing SCVs at facilities
where EtO use is at least 1 tpy but less
than 10 tpy,
• 99.6 percent emission reduction for
existing ARVs at facilities where EtO
use is at least 10 tpy, and
• 99.9 percent emission reduction for
new ARVs at facilities where EtO use is
at least 10 tpy.
For new and existing SCVs at
facilities where EtO use is at least 10
tpy, based on comments received on the
proposal, we are finalizing a 99.9
percent emission reduction, which is
the manufacturer guarantee. There is a
lack of representative performance test
data for these SCVs, and we are unable
to determine whether all facilities can
achieve an emission reduction higher
than the manufacturer guarantee. For
more information, see section IV.D.3.a
of this preamble.
khammond on DSKJM1Z7X2PROD with RULES2
3. What key comments did we receive
on the technology review, and what are
our responses?
This section provides comment and
responses for the major comments on
our proposed CAA section 112(d)(6)
standards. Other comment summaries
and our responses for additional issues
raised regarding these activities, as well
as issues raised regarding our proposed
revisions, can be found in the document
Summary of Public Comments and
Responses for the Risk and Technology
Review for Commercial Sterilization
Facilities, available in the docket for this
rulemaking.
a. SCVs at Facilities Where EtO Use Is
at Least 10 tpy
Comment: Several commenters
questioned whether the proposed
emission standards for SCVs at facilities
where EtO use is at least 10 tpy could
be achieved with existing technology
and stated that we should consider
manufacturer guarantees when revising
the standard, along with a maximum
concentration limit. The commenters
stated that we arrived at a 99.94 percent
emission reduction standard based on
performance tests that used the previous
testing procedures in Subpart O. These
consisted of one-hour test runs that
occurred during the initial vacuum
event, when EtO loading to the control
system (and, therefore, emission
reduction) is high. The commenters
further stated that we proposed
extending the duration of each test run
to 24 hours, which would cover a
variety of operating conditions,
including periods of low inlet
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
concentration, which have not been
required to be tested. The commenters
contended that the performance test
results based on the proposed testing
procedures would be lower than those
under the previous testing procedures.
One commenter stated that there are no
data confirming whether state-of-the-art
control systems can meet a 99.94
percent emission reduction standard for
SCVs where each performance test run
is 24 hours, and another commenter
stated that we must ensure that any
required emission reduction standards
that are finalized for SCVs are proven
and achievable as part of performance
tests consisting of 24-hour test runs.
One commenter stated that, based on
their discussions with control device
manufacturers, they believe that the best
and most advanced technologies will be
guaranteed to meet a 99.9 percent
emission reduction standard for SCVs.
Response: We agree with the
commenters that it is not appropriate to
use performance test data based on the
previous testing procedures in Subpart
O to justify revisions to the emission
standards for SCVs. We disagree with
one commenter’s statement that there
are no data confirming whether state-ofthe-art control systems can meet a 99.94
percent emission reduction standard for
SCVs where each test run is 24 hours.
As discussed in section IV.C.3, such
data exist for at least one system that
controls SCV emissions. However, the
EtO usage at this facility is fairly high,
and we are unable to determine whether
smaller users can meet this emission
standard. With respect to the suggestion
by some commenters that we consider a
manufacturer guarantee reduction level,
which one commenter stated is 99.9
percent emission reduction for SCVs,
we have no data disputing such level or
reason to question the manufacturer’s
guarantee. Further, as discussed in our
response to the next comment below,
we find the cost of this option to be
reasonable. Therefore, pursuant to CAA
section 112(d)(6), we are finalizing a
99.9 percent emission reduction
standard for SCVs at facilities where
EtO use is at least 10 tpy.65
We disagree with the commenter’s
suggestion that we should consider a
maximum concentration limit along
with the percentage reduction standard.
As discussed in section IV.B.3.a, we are
65 We
also note that, as discussed in section
IV.F.3 of this preamble, we are finalizing a
requirement for owners and operators to include a
representative performance test period for SCVs,
along with a justification, in their stack test
protocol, so that the delegated authorities can
review and approve or deny the protocol as
appropriate. This will ensure that performance tests
provide a more accurate representation of SCVs
emission reductions.
PO 00000
Frm 00038
Fmt 4701
Sfmt 4700
concerned that some owners and
operators may dilute the air flow of the
emissions stream to meet a
concentration standard, which would
not result in any actual emission
reductions. Furthermore, it is not
appropriate to establish upper-bound
limitations on air flow within this
source category, as additional flow may
be necessary in order to mitigate any
potential safety issues that may arise.
Therefore, we are not finalizing any
concentration standards as part of this
rulemaking.
Comment: One commenter stated that,
for the SCV technology rule under CAA
section 112(d)(6), we merely referred
back to, and repeated the proposed
standards of, the residual risk review.
The commenter further stated that we
did not conduct the technology review
as a separate analysis, but rather, it was
inseparably intertwined with the
residual risk review. Finally, the
commenter stated there is no true
technology review in the record and that
cost considerations of the proposed
CAA section 112(d)(6) emissions
standard for existing SCVs at facilities
where EtO use is at least 40 tpy were
never considered, even though section
112(d)(6) requires considerations of
cost.66
Response: We disagree with the
commenter’s statement that a ‘‘true’’
technology review was never
conducted. In the proposal preamble (88
FR 22839–41), the EPA discussed
control options that can achieve further
emission reductions compared to the
existing subpart O standards. While the
types of controls have essentially
remained the same, available
information shows improvement in
emission reduction potential for some of
these control options, which we
consider to be a development in control
technologies; we analyzed this
development and proposed revisions to
the standards pursuant to CAA section
112(d)(6). The commenter appears to
take issue with the fact that these are the
same options as those we evaluated
under CAA section 112(f)(2),
specifically under step 2 (ample margin
of safety) analysis. However, in
evaluating whether we can achieve
further emission reduction and thus
lower risks, we naturally would
66 In support of its comment that control costs
must be considered under section 112(d)(6) review,
the commenter cited to Nat’l Ass’n for Surface
Finishing, 795 F.3d at 5 (‘‘in the technology review,
EPA periodically assess, no less often than every
eight years, whether standards should be tightened
in view of developments in technologies and
practices since the standard’s promulgation or last
revision, and, in particular, the cost and feasibility
of developments and corresponding emissions
savings’’).
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
consider controls that reflect the current
developments in processes and
technology by this industry (i.e., well
performing air pollution control), which
we are also required to evaluate under
CAA section 112(d)(6). For the reason
stated above, we find the comment that
our technology review was not a ‘‘true’’
review to be without merit.
We acknowledge that in proposing a
99.94 percent standard pursuant to CAA
section 112(d)(6) for SCV at facilities
using at least 10 tpy EtO, we
inadvertently evaluated the control
costs for facilities using between 10 to
40 tpy only. However, as discussed in
our comment response above, we no
longer consider the proposed 99.94
percent emission reduction standard to
be appropriate. As suggested by several
commenters, we evaluated a
manufacturer guarantee. Based on one
24127
commenter’s discussions with control
device manufacturers, the best and most
advanced technologies will be
guaranteed to meet 99.9 percent
emission reduction for SCVs. The
impacts of this option and the 99.6
percent reduction option that we
considered during the proposal stage are
presented below in table 20 for existing
sources:
TABLE 20—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(6) FOR EXISTING SCVS AT FACILITIES WHERE ETO USE IS AT LEAST 10 TPY
Total capital
investment
($)
Option
Standard evaluated
1 ................
2 ................
99.9 percent emission reduction .....................
99.6 percent emission reduction .....................
Based on the estimates above, and
considering EtO is a highly potent
carcinogen, the cost-effectiveness
number of this option is within the
range of the values that we have
determined to be cost-effective for
highly toxic HAPs. As explained in
section IV.B.3.b of this preamble, this
includes hexavalent chromium, where
we finalized a requirement with a costeffectiveness of $15,000/lb
($30,000,000/ton) for existing small
hard chromium electroplating to
provide an ample margin of safety
Total annual
costs
($/yr)
$1,840,000
0
$752,000
0
(taking into account cost among other
factors) (77 FR 58227–8, 58239). As part
of the proposed rulemaking, the highest
cost-effectiveness number that we found
was $19,420,188/ton. We did not
receive adverse comment on our finding
that this is cost-effective. While Option
2 would prevent backsliding, it does not
achieve additional emission reduction.
Therefore, pursuant to CAA section
112(d)(6), we are revising the standard
to require facilities where EtO use is at
least 10 tpy to reduce their emissions
from existing SCVs by 99.9 percent.
EtO emission
reductions
(tpy)
1.14 [2,280 lb] ............
0 .................................
Cost effectiveness
($/ton EtO)
$661,000 [$330/lb].
N/A.
The impacts of these options for new
sources, which are presented in table 21
of this preamble, are based on a model
plant for new SCVs at a facility using at
least 10 tpy of EtO with the following
assumptions reflecting the average of
each of the parameters at existing
facilities using at least 10 tpy of EtO:
• Annual EtO use: 120 tpy.
• Annual operating hours: 8,000.
• Portion of EtO going to SCVs: 94.41
percent.
• SCV flow rate: 200 cfs.
khammond on DSKJM1Z7X2PROD with RULES2
TABLE 21—NATIONWIDE EMISSIONS REDUCTION AND COST IMPACTS OF OPTIONS CONSIDERED UNDER CAA SECTION
112(d)(6) FOR NEW SCVS AT FACILITIES WHERE ETO USE IS AT LEAST 10 TPY
Total capital
investment
($)
Option
Standard evaluated
1 ................
2 ................
99.9 percent emission reduction .....................
99.6 percent emission reduction .....................
Based on the estimates above, we find
both options to be cost effective. Option
1 would achieve greater emission
reductions than Option 2, and Option 1
would be more cost-effective. Therefore,
pursuant to CAA section 112(d)(6), we
are revising the standard to require
facilities where EtO use is at least 10 tpy
to reduce their emissions from new
SCVs by 99.9 percent.
Comment: In response to the EPA’s
solicitation of comment on whether to
include a mass emission rate standard
as an alternative to the percent emission
reduction standard, two commenters
were opposed to such an alternative.
One commenter stated that mass
emission rate standards for individual
vents do not account for variability
between facilities or variability within
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Total annual
costs
($/yr)
$523,000
348,000
$136,000
106,000
facilities. The commenter also stated
that any standard that fails to reflect
individual facility dynamics that
materially affect the ability to comply is
inappropriate and not achievable.
Response: We agree with the
commenters’ concerns regarding the
alternative, equivalent mass rate
emission standards. Therefore, they are
not included in this final rule.
b. SCVs at Facilities Where EtO Use Is
at Least 1 Tpy but Less Than 10 Tpy
Comment: One commenter stated that
they support emission reduction
standards based on manufacturer
guarantees for control equipment, along
with a maximum concentration limit, to
ensure that compliance can be achieved
and demonstrated. In addition, the
commenter did not agree with our
PO 00000
Frm 00039
Fmt 4701
Sfmt 4700
EtO emission
reductions
(tpy)
1.02 [2,040 lb] ............
0.68 [1,360 lb] ............
Cost effectiveness
($/ton EtO)
$134,000 [$67/lb].
158,000 [$79/lb].
method to calculate alternative,
equivalent mass rate emission
standards. Another commenter stated
that, based on their discussions with
control device manufacturers, they
believe that the best and most advanced
technologies will be guaranteed to meet
a 99.9 percent emission reduction
standard for SCVs.
Response: We agree with the
commenter’s suggestion that
manufacturer guarantees be considered
when finalizing the standard. Most of
the performance tests that are currently
available for SCVs are based on the
previous testing procedures, which are
not reflective of actual operating
conditions. The one performance test
we have that is based on actual
operating conditions is for a facility
E:\FR\FM\05APR2.SGM
05APR2
24128
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
where EtO use exceeds 30 tpy and thus
not appropriate for the group of
facilities at issue here (i.e., those using
at least 1 tpy but less than 10 tpy of
EtO). Therefore, a manufacturer
guarantee is appropriate to consider in
this instance, and a 99.8 percent
emission reduction standard falls within
the manufacturer guarantee range for
SCV controls as provided by one of the
commenters (99.9 percent emission
reduction). However, this does not
change our rationale for a 99.8 percent
reduction standard during the proposal
stage, which was that this is the
maximum emission SCV reduction with
which compliance can be demonstrated
at all facilities where EtO use is at least
1 tpy but less than 10 tpy considering
current emission profiles.
We disagree with the commenter’s
recommendation for a maximum
concentration limit. As discussed in
section IV.B.3.a, we are concerned that
some owners and operators may dilute
the air flow of the emissions stream to
meet a concentration standard, which
would not result in any actual emission
reductions. Furthermore, it is not
appropriate to establish upper-bound
limitations on air flow within this
source category, as additional flow may
be necessary in order to mitigate any
potential safety issues that may arise.
Finally, as discussed in section IV.D.3.a,
we are not including any alternative,
equivalent mass rate emission standards
in the final rule. Therefore, the
commenter’s concerns regarding the
methodology used to calculate the limits
are no longer relevant.
khammond on DSKJM1Z7X2PROD with RULES2
c. ARVs at Facilities Where EtO Use Is
at Least 10 Tpy
Comment: Several commenters
objected to the proposed emission
reduction standards and stated that they
are not achievable as written. One
commenter stated that we should
require emission reduction standards
based on manufacturer guarantees,
along with a maximum concentration
limit. Another commenter stated that
sterilization is a batch process and that
the concentration from the aeration area
is subject to constant fluctuation due to
differences in product, cycles, facility
design, and EtO decline curve, which
makes a consistent emission reduction
challenging to determine. Finally,
several commenters expressed concerns
with the use, and our development, of
the alternative, equivalent mass rate
emission standards due to the wide
variations in ARV parameters across this
group of facilities, as well as the
difficulty in demonstrating compliance
with this standard for larger facilities.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Response: We disagree with the
commenters’ position that the proposed
emission reduction standards are not
achievable. As discussed in section
III.F.3.a of the proposal preamble (88 FR
22790, April 13, 2023), most existing
sources (i.e., 75 percent) are already
achieving 99.6 percent emission
reduction. In addition, 99.9 percent
emission reduction has been
demonstrated by 50 percent of existing
sources. We also disagree with one
commenter’s suggestion that
manufacturer guarantees be considered
in this instance for two reasons. First,
there is no need to rely on manufacturer
guaranteed emission levels because
there are available performance test data
for ARVs that are representative of
actual operating conditions. Unlike
SCVs, which go through different active
phases with wildly varying
concentrations, fluctuations in ARV
concentrations are slight; an aeration
room serves one purpose, which is to
hold product at an elevated
temperature, and the resulting ARV
concentration is relatively constant.
Therefore, a one-hour test period for this
source is appropriate, and the resulting
performance test data are representative
of actual operating conditions. To that
end, we disagree with another
commenter’s statement that fluctuations
in the ARV make it difficult to comply
with an emission reduction standard.
Second, performance test data for ARVs
are plentiful. As discussed in section
III.F.3.a of the proposal preamble, there
are 47 facilities where EtO use is at least
10 tpy, 41 of which have ARVs. Of these
41 facilities, 32 (78 percent) have
performance test data. Because the
performance test data from ARVs at
these facilities are both plentiful and
representative of actual operating
conditions, there is no need to rely on
a manufacturer guaranteed emission
reduction level in this instance. We also
disagree with the commenters’
recommendation for a maximum
concentration standard. As discussed in
section IV.B.3.a, we are concerned that
some owners and operators may dilute
the air flow of the emissions stream to
meet a concentration standard, which
would not result in any actual emission
reductions. Furthermore, it is not
appropriate to establish upper-bound
limitations on air flow within this
source category, as additional flow may
be necessary in order to mitigate any
potential safety issues that may arise.
Finally, with respect to the alternative
equivalent mass rate emission
standards, we agree with the
commenters’ concerns, and we are not
PO 00000
Frm 00040
Fmt 4701
Sfmt 4700
including these standards in the final
rule.
Comment: One commenter stated that
if the lowest practicably measured
concentration is 30 ppbv (our presumed
workable-in-practice detection limit for
CEMS), then a source with an inlet
concentration that is too low will be
unable to show the required emission
reduction, even if the control system is
providing that level of reduction,
because the monitoring approach will
be unable to distinguish the true outlet
concentration from 30 ppbv. The
commenter further stated that existing
sources would need to have pre-control
aeration room concentrations of at least
7.5 ppmv to make this demonstration.
Two commenters stated that the
increased 99.6 percent (existing
facilities) or 99.9 percent (new facilities)
ARV emission reduction standards
penalize facilities that have reduced EtO
concentrations during the sterilization
cycle. Several commenters noted that
facilities have reduce EtO
concentrations during the sterilization
cycle (i.e., use of vacuum and/or
nitrogen wash cycles) prior to moving
the sterilized load to aeration to reduce
inlet ARV concentrations, and that
removals, on a percent basis, are only
achievable with elevated inlet
concentrations.
Response: One commenter is correct
that, given the lowest practicable
measured concentration (30 ppbv), the
pre-control concentration would need to
be 7.5 ppmv in order to demonstrate
compliance with the proposed standard
for existing sources. The performance
test data that are available for ARVs at
these facilities consist of 86 test runs. Of
these 86 test runs, only five (six percent)
had a measured concentration less than
7.5 ppmv, which suggests low
likelihood that facilities will have
difficulty demonstrating compliance
due to low pre-control concentration.
based on the current operating
conditions Furthermore, regarding the
comment that these standards would
penalize sources who have already
worked to reduce their EtO
concentrations during sterilization and,
by extension, their inlet ARV
concentrations, as discussed in section
III.F.3 of the proposal preamble, 75
percent of existing sources are already
meeting the proposed standard; it is
unclear, and the commenter does not
explain, why a requirement that retains
facilities’ status quo is a punishment to
those facilities. Most of the industry is
either (1) currently meeting the
proposed standard or (2) capable of
meeting the proposed standard based on
current operating conditions. In
addition, if a facility with existing ARVs
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
wishes to further reduce their EtO
concentrations during sterilization, then
operational changes can be made to the
aeration room so that the facility can
continue to demonstrate compliance
with the emission reduction standard.
Since new facilities are not currently in
operation, there has been no reduction
in EtO concentrations during
sterilization and, therefore, no penalty
has been incurred.
4. What is the rationale for our final
approach for the technology review?
Our technology review focused on the
identification and evaluation of
developments in practices, processes,
and control technologies that have
occurred since the standards for
Commercial Sterilization Facilities were
originally promulgated on December 6,
1994 (59 FR 62585) and further
amended on November 2, 2001 (66 FR
55577). Specifically, we focused our
technology review on all previous
standards for the various emission
sources in the Commercial Sterilization
Facilities source category, including
SCVs at facilities where EtO use is at
least 10 tpy, SCVs at facilities where
EtO use is at least 1 tpy but less than
10 tpy, and ARVs at facilities where EtO
use is at least 10 tpy. In the proposal,
we identified developments for all
emission sources, and we proposed to
revise the standards for these emissions
sources under the technology review.
Further information regarding the
technology review can be found in the
proposed rule (88 FR 22790, April 13,
2023) and in the supporting materials in
the rulemaking docket at Docket ID No.
EPA–HQ–OAR–2019–0178.
During the public comment period,
we received several comments on our
proposed determinations for the
technology review. No information
presented by commenters has led us to
change our proposed determination
under CAA section 112(d)(6) for SCVs at
facilities where EtO use is at least 1 tpy
but less than 10 tpy and ARVs at
facilities where EtO use is at least 10
tpy, and we are finalizing the changes
to those standards as proposed. For
SCVs at facilities where EtO use is at
least 10 tpy, based on comments
received on the proposal, we are
finalizing a 99.9 percent emission
reduction standard, which is the
manufacturer guarantee. There is at least
one representative performance test
available for SCVs, but it was conducted
at a facility with a higher EtO usage rate,
and we are unable to determine whether
smaller facilities can achieve the
emission reduction from that
performance test. The key comments
and our specific responses can be found
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
in section IV.D.3 of this preamble and
in the document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
E. Amendments Addressing Emissions
During Periods of SSM
1. What amendments did we propose to
address emissions during periods of
SSM?
For all emission points in the
Commercial Sterilization Facilities
source category, we proposed
eliminating the SSM exemptions and to
have the standards apply at all times.
More information concerning the
elimination of SSM provisions is in
section III.G. of the proposal preamble
(88 FR 22790, April 13, 2023).
2. How did the SSM provisions change
since proposal?
We are finalizing the SSM provisions
as proposed (88 FR 22790, April 13,
2023).
3. What key comments did we receive
on the SSM revisions and what are our
responses?
This section provides comment
summaries and responses for the key
comments received regarding our
proposed revisions. Other comment
summaries and the EPA’s responses for
additional issues raised regarding these
activities as well as issues raised
regarding our proposed revisions can be
found in the document, Summary of
Public Comments and Responses for the
Risk and Technology Review for
Commercial Sterilization Facilities,
available in the docket for this
rulemaking.
Comment: One commenter stated that
the EPA should consider other
approaches to adequately account for
SSM contingencies. The commenter
suggested that the EPA classify sources
in SSM states as sub-sources subject to
different emissions limitations or work
practice standards. Another commenter
stated that EtO sterilizers do not create
emissions during startup or shut down
because, unlike other industrial
processes regulated under the NESHAP
program, EtO is not emitted as a
byproduct of combustion or chemical
reaction but is released intentionally in
a highly controlled manner. The
commenter further stated that
sterilization never begins before control
equipment is activated and always ends
before control equipment is deactivated.
Similarly, another commenter stated
that the EPA inaccurately assumed that
startup and shutdown are no different
PO 00000
Frm 00041
Fmt 4701
Sfmt 4700
24129
than normal operation. The commenter
further stated that constructing and
starting new abatement equipment
includes periods of troubleshooting and
acceptance testing. The commenter also
stated that the proposal does not
address the permit-to-construct process
and related requirements before
transferring to an operating permit.
Finally, one commenter suggested that
the malfunction exemption should not
be eliminated because, due to the nature
of sterilization operations and various
stages of cycles, commercial sterilizers
must be able to address malfunctions
that could result in a potential risk to
employees or the facility without the
risk of being in noncompliance.
Response: As discussed in section
III.G.1 of the proposal preamble (88 FR
22790, April 13, 2023), it is common
practice in this source category to start
an air pollution control device (APCD)
prior to startup of the emissions source
it is controlling, so the APCD would be
operating before emissions are routed to
it, which has been confirmed by one of
the commenters. In addition, based on
responses to the December 2019
questionnaire and the September 2021
ICR, many facilities already have
measures in place to ensure that the
emission standards are met during
periods of SSM, including holding
emissions within the process unit or the
APCD itself, or the use of onsite
generators in the event of a power
outage.67 The comments provided do
not support establishing emission
standards that apply only during
periods of SSM. With respect to
classifying sources in SSM states as subsources subject to different emissions
limitations or work practice standards,
the commenter does not provide any
rationale for why this should be done or
any suggestions for what those emission
standards should be. With respect to
emission spikes from troubleshooting
control devices, as discussed in section
IV.F.3 of this preamble, the EPA is
finalizing a requirement for emission
limits to be based on 30-operating day
rolling sums of EtO entering the control
system(s) for EtO CEMS, which will
help to mitigate these spikes over time.
However, the commenter does not
provide any rationale for why the
permitting process should be
considering when evaluating SSM.
Finally, we cannot agree with the
commenter’s recommendation to keep
the malfunction exemption in
67 See memorandum, Review of Startup,
Shutdown, and Malfunction of Process and APCD
Equipment in the Ethylene Oxide Commercial
Sterilization Source Category Technology Review
Project, located at Docket ID No. EPA–HQ–OAR–
2019–0178.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24130
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
contradiction with Sierra Club v. EPA,
551 F.3d 1019 (D.C. Cir. 2008), in which
the court vacated two provisions that
exempted sources from the requirement
to comply with otherwise applicable
CAA section 112(d) emission standards
during periods of SSM. As discussed in
section III.G.1 of the proposal preamble,
in its 2008 decision in Sierra Club v.
EPA, 551 F.3d 1019 (D.C. Cir. 2008), the
court held that emissions standards or
limitations must be continuous in
nature, which means that there cannot
be exemptions for periods of
malfunction. Further, while the EPA
could consider establishing a different
standard during malfunction if
warranted and still be consistent with
the Sierra Club decision, the commenter
does not provide any specific
information regarding instances where
compliance with the standards during
malfunction could result in potential
risks to the employees or the facility or
suggestions for what emission standards
the EPA should consider to address the
concern. Therefore, the EPA is not
finalizing any emission standards that
apply only during periods of SSM.
Comment: One commenter stated that
a specific area of concern is the ability
to demonstrate compliance during
startup and shutdown, asserting that the
proposed rule offered no means for a
source to remain in compliance during
the inevitable and foreseeable, but not
predictable, failure of monitoring
equipment. The commenter further
suggested that the EPA should consider
specific reporting and monitoring
alternative requirements for these
scenarios. The commenter provided the
example of a requirement specific to
releases from sterilizer pressure relief
devices (PRDs) resulting from
malfunctions or required during
shutdown events that the commenter
suggested could be modeled after recent
PRD requirements in 40 CFR 63.648(j).
Another commenter recommended that
facilities should only be required to
report malfunction events that result in
unpermitted releases to the atmosphere.
The commenter stated that, in the
example situation where control
equipment unexpectedly goes offline
during operations but EtO remains
trapped within the facilities ducts under
negative pressure, there would be no
need to create additional administrative
compliance requirements for the
facility.
Response: With respect to accounting
for the failure of monitoring equipment
when demonstrating compliance, as
discussed in section IV.F.3 of this
preamble, the EPA is finalizing a
minimum data availability requirement
of 90 percent for EtO CEMS. With
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
respect to specific reporting and
monitoring alternative requirements that
apply during periods of SSM, the
commenter did not provide any
recommendations for what those
requirements should be. In addition, we
agree with one commenter’s suggestion
that facilities should only be required to
report malfunction events that result in
unpermitted releases to the atmosphere.
However, to be clear, we are finalizing
reporting requirements for malfunction
events that occur with emissions or
parametric monitoring equipment.
Comment: One commenter suggested
that the EPA should not include the
general duty clause in the final rule. The
commenter stated that it is not clear on
what basis the EPA is claiming authority
to impose a general standard of behavior
on regulated sources. The commenter
asserted that CAA section 112 grants the
EPA authority to set emissions limits
and certain specific alternative
standards but does not grant authority to
impose a ‘‘vague and subjective code of
conduct.’’ The commenter stated that
the general duty clause is redundant to
proposed amendment to 40 CFR
63.632(b) that would require
compliance ‘‘at all times.’’ The
commenter asserted that if compliance
with the specific requirements of the
rule will satisfy the general duty, then
there is no need for the EPA to reserve
the authority to evaluate a source’s good
air pollution control practices.
Furthermore, the commenter asserted
that the general duty provisions date
back to a regulatory period during
which air quality control rules lacked
the specificity of monitoring, reporting,
and recordkeeping that are included in
the proposed rule. The commenter
suggested that either the EPA should not
finalize the proposed general duty
clause at 40 CFR 63.632(j) or that the
general duty clause from the General
Provisions should be incorporated. The
commenter stated that the General
Provision contains language that more
clearly explains the EPA’s exercise of
enforcement discretion during SSM
periods.
Response: As part of the proposed
rulemaking, we proposed to add the
following general duty clause to 40 CFR
63.362(j):
‘‘At all times, you must operate and
maintain any affected source, including
associated air pollution control
equipment and monitoring equipment,
in a manner consistent with safety and
good air pollution control practices for
minimizing emissions. The general duty
to minimize emissions does not require
the owner or operator to make any
further efforts to reduce emissions if
levels required by the applicable
PO 00000
Frm 00042
Fmt 4701
Sfmt 4700
standard have been achieved.
Determination of whether a source is
operating in compliance with operation
and maintenance requirements will be
based on information available to the
Administrator which may include, but
is not limited to, monitoring results,
review of operation and maintenance
procedures, review of operation and
maintenance records, and inspection of
the source.’’
We disagree with the commenter’s
suggestion to not finalize the general
duty clause. We do not consider this
duty clause to be redundant just because
the emission standards apply at all
times; the provision imposes a general
duty to operate and maintain any
affected source, including associated air
pollution control equipment and
monitoring equipment, in a manner
consistent with safety and good air
pollution control practices for
minimizing emissions. Commenters did
not provide data supporting the
suggestion that this general duty clause
is redundant. Even assuming it were
redundant, which it is not, the
commenter does not explain why it
must be removed. In addition, the
inclusion of a general duty clause like
the one proposed is standard practice
for other NESHAPs. Furthermore, we
disagree with the commenter’s
suggestion to incorporate the general
duty clause from Subpart A. As
discussed in earlier in this section, in its
2008 decision in Sierra Club v. EPA, 551
F.3d 1019 (D.C. Cir. 2008), the court
held that under section 302(k) of the
CAA, emissions standards or limitations
must be continuous in nature, which
means that there cannot be exemptions
for periods of SSM. The general duty
clause in Subpart A contains certain
exemptions for periods of SSM. We are
therefore finalizing the general duty
provision as proposed.
4. What is the rationale for our final
approach and final decisions to address
emissions during periods of SSM?
We evaluated all of the comments on
the EPA’s proposed amendments to the
SSM provisions. As explained in section
III.G of the proposed rule (88 FR 22790,
April 13, 2023), in its 2008 decision in
Sierra Club v. EPA, the court held that
under CAA section 302(k), emissions
standards or limitations must be
continuous in nature and that the SSM
exemption violates the CAA’s
requirement that some CAA section 112
standards apply continuously. In
addition, as part of this rulemaking, we
have gathered information that indicates
many facilities already have measures in
place to ensure that the emission
standards are met during periods of
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
SSM. Therefore, we determined that
these amendments, which remove and
revise provisions related to SSM, are
necessary to be consistent with the
requirement that the standards apply at
all times. More information concerning
the amendments we are finalizing for
SSM is in the preamble to the proposed
rule and in the comments and our
specific responses to the comments in
the document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking. Therefore,
we are finalizing our approach for the
SSM provisions as proposed.
F. Other Amendments to the Standards
khammond on DSKJM1Z7X2PROD with RULES2
1. What other amendments did we
propose for the Commercial
Sterilization Facilities source category?
We proposed that owners and
operators would be required to
demonstrate compliance via annual
performance testing and parametric
monitoring of EtO through the use of
CEMS. As discussed in section III.G.2.c
of the proposal preamble (88 FR 22790,
April 13, 2023), we did not propose to
include requirements for fenceline or
ambient air monitoring as part of this
rule for the following reasons:
• Typically for this type of
monitoring, we require the fenceline
monitor to be located at least 50 meters
from the source of emissions to allow
for some dispersion.
• In contrast to the large number of
dispersed and difficult-to-monitor
emission points for other source
categories for which we have either
finalized or proposed fenceline
monitoring requirements (e.g.,
refineries), current room air releases at
commercial sterilization facilities are
typically at ground-level and consist of
uncontrolled building emissions
through doorways, loading points, and
ventilation exhausts, all of which can be
captured while inside the building and
routed through a vent to a control
device.
• The proposed PTE design criteria,
room air emission standards, and
associated parametric monitoring would
effectively and continuously ensure
these previously uncontrolled emissions
are captured and routed to exhaust
points that are then subject to removal
or emission rate standards.
With respect to fenceline monitoring,
we solicited comment on (1) whether
fenceline monitoring should be required
regardless of the proposed PTE design
criteria, proposed room air emission
standards, and proposed continuous
parametric monitoring; (2) the technical
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
feasibility of fenceline monitoring and
available technology able to measure at
any potential action level; and (3) the
potential cost of continuous fenceline
monitoring and associated work
practices if implemented.
With respect to ambient air
monitoring, we solicited comment on
how this could be used to screen for
elevated concentrations of EtO above
the ambient baseline and how this
information could be used to trigger a
root cause analysis to identify potential
source(s) of emission and to perform
corrective action, if a potential source of
the emissions was part of an affected
source under the commercial
sterilization proposed rule. We also
solicited comment on (1) the feasibility
of other types of air monitoring that
could be applied to this sector for
compliance assurance and the costs
associated with this type of monitoring,
(2) how frequently this monitoring
should occur, (3) the recordkeeping and
reporting requirements for this type of
monitoring, and (4) how should any
action-level be defined.
We proposed various changes to the
performance testing requirements to
ensure that the results are as accurate as
possible, including the approved test
methods, requirements for SCV inlet
testing, and 24-hour test runs for larger
users. Furthermore, we proposed
various changes to the parametric
monitoring requirements, as well as
requirements for demonstrating
continuous compliance with the PTE
requirements given in EPA Method 204.
We also proposed that owners or
operators submit electronic copies of
required compliance reports (at 40 CFR
63.366(b) and (c)), performance test
reports (at 40 CFR 63.366(f)), and
performance evaluation reports (at 40
CFR 63.366(g)) through the EPA’s CDX
using CEDRI, and we proposed two
narrow circumstances in which owners
or operators may, within five business
days of the reporting deadline, seek
extensions of that deadline if they are
prevented from reporting by conditions
outside of their control. We proposed at
40 CFR 63.366(h) that an extension may
be warranted due to outages of the
EPA’s CDX or CEDRI that precludes an
owner or operator from accessing the
system and submitting required reports.
We also proposed at 40 CFR 63.366(i)
that an extension may be warranted due
to a force majeure event, such as an act
of nature, act of war or terrorism, or
equipment failure or safety hazards
beyond the control of the facility.
Finally, we proposed to reinstate title
V permitting requirements for all area
source facilities, and we proposed
compliance mechanisms for owners and
PO 00000
Frm 00043
Fmt 4701
Sfmt 4700
24131
operators of combined emission
streams. We also proposed revisions to
clarify text or correct typographical
errors, grammatical errors, and crossreference errors.
2. How did the other amendments for
the Commercial Sterilization Facilities
source category change since proposal?
We are finalizing a requirement for
owners and operators to use EtO CEMS
to demonstrate compliance. In addition,
for affected sources with a percent
emission reduction standard, we are
finalizing a requirement for source
owners or operators to obtain and record
hourly average ppbvd of EtO
concentration, dscfm of flow rate, and
weight differential in pounds of EtO
used, to calculate and record each day
of operation—where any operation less
values obtained during periods of SSM
constitute a day of operation—and the
emission limit(s) based on the 30operating day rolling sum of EtO
entering the control system(s), as
determined using values from the
current operating day and the previous
29 operating days. However, owners and
operators of facilities where EtO use is
less than 100 lb/year will have the
option to demonstrate compliance
through annual performance testing and
parametric monitoring. We are not
including requirements for fenceline or
ambient air monitoring in this final rule.
For EtO CEMS, based on comments
received during the proposed
rulemaking, we are finalizing a
requirement for quarterly reporting, as
well as a minimum data availability of
90 percent. For performance testing, we
are finalizing the incorporation of
additional test methods. Based on
comments received during the proposed
rulemaking, we are also retaining
currently approved test methods that we
proposed to remove, and we are not
finalizing a requirement to conduct SCV
inlet testing. For performance test
duration, based on comments received
during the proposed rulemaking, we are
not finalizing a requirement for 24-hour
test runs. Instead, owners and operators
may continue to conduct 1-hour test
runs for ARVs, CEVs, room air
emissions, or any combination thereof.
For emission streams that contain an
SCV, we are finalizing a requirement for
owners and operators to include a
representative test period as part of their
test protocol, which is subject to
approval from the delegated authority.
Based on comments received during the
proposed rulemaking, we are finalizing
numerous revisions to the proposed
requirements for parametric monitoring.
Furthermore, based on comments
received during the proposed
E:\FR\FM\05APR2.SGM
05APR2
24132
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
rulemaking, we are not finalizing a
requirement for owners and operators
that are required to comply with EPA
Method 204 to conduct daily
inspections of all applicable NDOs.
Instead, we a finalizing a requirement
for owners and operators to demonstrate
continuous compliance with EPA
Method 204 through the use of either
outlet volumetric flow rate monitors or
differential pressure monitors.
We are not finalizing a requirement
for all area source facilities to obtain a
title V operating permit. In addition,
based on comments received during the
proposed rulemaking, we are finalizing
revised compliance mechanisms for
combined emission streams. We are also
finalizing an option for owners and
operators to demonstrate compliance
with a site-wide emission limitation, as
opposed to demonstrating compliance
for each individual and combined
emission stream.
3. What key comments did we receive
on the other amendments for the
Commercial Sterilization Facilities
source category and what are our
responses?
Comment: We received extensive
comment on our proposal to allow
either the use of EtO CEMS or annual
performance testing with parametric
monitoring for demonstrating
compliance with emission standards.
Some commenters stated that EtO CEMS
should be the only mechanism allowed
for demonstrating compliance, as it will
yield more real-time data that will allow
for potential issues to be identified and
resolved more quickly. Other
commenters stated that EtO CEMS are a
relatively new technology and that the
available supply, reliability in industrial
facilities, and maintenance support for
EtO CEMS is questionable. Commenters
also expressed concerns with parametric
monitoring and pointed to our
requirements for CEMS in other rules, as
well as the fact that EtO CEMS are used
in a number of sterilization facilities.
Response: In the majority of instances,
parametric monitoring is used to good
effect as an ongoing means of ensuring
that control devices continue to get
necessary emission reductions.
However, given the nature of EtO, in
which small amounts can have large
risk impacts, parametric monitoring
alone will not be sensitive enough to
detect very small fluctuations. In
addition, many facilities in this source
category are controlling their EtO
emissions using systems that contain
one or more control devices, each with
their own parametric monitoring
requirements. While this has proven to
be effective in reducing EtO emissions,
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
it can lead to multiple, simultaneous
parameter collection and processing,
increasing system complexity and
increasing the time necessary for
diagnosis and correction of control
device or process problems.
Therefore, the EPA is finalizing a
requirement to only use CEMS for
demonstrating compliance. However,
facilities where EtO use is less than 100
lb/year will still have the option to use
CEMS or performance testing and
parametric monitoring to demonstrate
compliance. This is because risk
remains at acceptable levels for these
facilities even when considering
uncontrolled emissions. In addition,
these facilities tend to have relatively
simple control systems. Although EtO
CEMS is a relatively new technology in
this industry, it has been proven as a
highly effective method for
demonstrating compliance. While the
use of these CEMS systems for low-level
measurements of EtO is relatively new,
they are in use in this sector; because of
this, we find it technically feasible to
require their use more broadly.
Additionally, the EtO instruments used
as part of these CEMS are readily
available and although the low-level
detection levels are recent, they have
been demonstrated in the field.
Comment: We received extensive
comments on our decision to not
include fenceline or ambient air
monitoring as part of the proposed
rulemaking. Some commenters were
supportive of this exclusion, stating that
this source category is comprised of
enclosed facilities with defined
emission points (e.g., windows, doors,
ventilation exhaust) and that PTE is
sufficient to ensure the containment of
emissions. Other commenters were
opposed to this exclusion, stating that
fenceline and ambient air monitoring
are necessary in order to ensure that
commercial sterilization facilities are
complying with the rule requirements,
as well as to provide important
information about emissions, exposure,
and the efficacy of control equipment to
nearby communities, regulatory
agencies, and workers. The commenters
pointed to other source categories where
we have either required fenceline
monitoring (i.e., petroleum refineries) or
proposed it (i.e., the Synthetic Organic
Chemical Manufacturing Industry and
the Polymers and Resins industry).
Response: We acknowledge that many
commenters expressed their strong
support for fenceline monitoring
requirements as part of this rule. As a
general matter, fenceline monitoring is
considered a particularly useful
compliance monitoring approach if it is
infeasible to enclose an emission
PO 00000
Frm 00044
Fmt 4701
Sfmt 4700
source(s). This is the case for source
categories where we have either
required or proposed fenceline
monitoring, such as refineries, because
facilities within these source categories
cover a wide variety of emission sources
where PTE is not feasible. At such
sources, it is frequently impossible to
rapidly detect and remedy a leak or
other unauthorized release without the
use of fenceline monitoring.
By contrast, as discussed in section
IV.B.3.c, PTE in accordance with EPA
Method 204 has been demonstrated to
be feasible for commercial sterilization
facilities. As part of the PTE
requirements the EPA is finalizing in
this rule, the EPA is also requiring
monitoring of either the volumetric flow
rate from each outlet or differential
pressure in order to ensure that the PTE
is operating effectively on a continuous
basis. Furthermore, as discussed above,
we are requiring EtO CEMS at facilities
where EtO use is at least 100 lb/year,
which includes most facilities within
the source category. The data from these
CEMS will help to ensure that
commercial sterilization facilities are
complying with the rule requirements,
and the data will be made available to
the public, providing important
information about emissions, exposure,
and the efficacy of control equipment to
nearby communities, regulatory
agencies, and workers. As noted above,
the physical configuration of
commercial sterilizer facilities can also
make the implementation of fenceline
monitoring challenging at these sources.
For these reasons, the EPA is not
finalizing fenceline monitoring
requirements as part of this rule.
Comment: We received extensive
comments on our proposed requirement
that EtO CEMS data be reported on a
daily basis. Some commenters were
supportive, stating that daily reporting
provides assurance to the public that
emission control devices are working as
designed. Other commenters were
opposed, stating that facilities need
sufficient time to conduct QA/QC to
verify the accuracy and reliability of the
data and that reporting inaccurate data
due to insufficient QA/QC would
undermine public confidence of the
CEMS monitoring and potentially
adversely impact the medical supply
chain if there is undue public concern.
One commenter questioned whether
there is a precedent for daily reporting,
and another was unaware of any other
NESHAP that requires daily reporting
for CEMS. Several commenters stated
that quarterly or semi-annual reporting
is sufficient and more consistent with
other NESHAPs.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Response: We agree with the
commenters’ concern that daily
reporting of CEMS data is not
appropriate. Sufficient time is needed so
that the proper QA/QC procedures can
be conducted to verify the accuracy and
reliability of the data. Therefore, we are
finalizing a requirement that CEMS data
be reported quarterly, which is
consistent with other NESHAPs that
regulate pollutants of significant
concern, as well as at least one
sterilization facility that uses CEMS to
demonstrate compliance with local
requirements.
Comment: One commenter stated we
did not address CEMS downtime and
how downtime will be assessed or
impact reporting. In addition, two
commenters stated that there should be
allowances or an exemption from
sampling during periods of nonoperation (e.g., power outages, plant
shutdowns).
Response: Our general policy is to
require source owners and operators to
have working monitoring while the
emissions-producing process is
operating and to identify those periods
where monitoring is not working while
the emissions-producing process is
operating, as well as to quickly correct
monitoring issues so that such periods
are minimized. Recognizing that EtO
CEMS are a newer technology that may
pose challenges to users who may be
unfamiliar with instrument
characteristics, the rule will provide a
period of data unavailability for up to
ten percent of process operating time for
EtO CEMS in operation before requiring
additional corrective activity by owners
or operators. Such an allowance,
referred to as a minimum data
availability requirement, has been used
to good effect for other types of CEMS
as they were introduced. As familiarity
with those CEMS increased, so did their
minimum data availability
requirements; the EPA expects this
pattern to continue for EtO CEMS such
that in the future, the minimum data
availability requirement for EtO CEMS
will be replaced by the agency’s general
policy. Until then, the rule will have a
minimum data availability for EtO
CEMS of ninety percent. This means
that EtO emissions data must be
collected over at least ninety percent of
the process operating time in order to
avoid non-compliance and potential
penalties. Data availability will be
determined by assessment of the ratio of
periods of valid EtO CEMS values to
process operation periods, where valid
EtO CEMS values occur when a
minimum of 4 equally spaced values
occur over an hour of process operation.
Periods associated with normal quality
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
assurance activities, such as daily
calibrations, do not count as periods of
data unavailability, however, periods of
out-of-control monitor operation or
when the EtO CEMS is unable to
provide quality-assured data, such as
those periods associated with monitor
or data acquisition and handling system
failure, do count as periods of data
unavailability. Note that source owners
or operators are to record EtO CEMS
values during all periods of operation,
include SSM, to the extent that the
values are available. Source owners or
operators will need to keep records of
periods of process operation, EtO CEMS
availability, and EtO CEMS
unavailability; cause and duration of
EtO CEMS unavailability; and of activity
taken to correct and prevent future
periods of EtO CEMS unavailability.
Moreover, owners or operators will be
required to provide immediate notice of
failure to meet the data availability of 90
percent, as well as root cause analysis
of periods of EtO CEMS monitor
unavailability and specific corrective
actions—along with schedule and
enumerated expenditures—planned to
address EtO CEMS unavailability.
Comment: Several commenters stated
that the requirement to measure SCV
inlets can create significant safety
hazards. Two commenters stated that
EtO concentrations in abatement system
inlets coming from SCVs can reach
several hundred thousand ppm. The
commenters noted that these
concentrations exceed the lower
explosion limit of 30,000 ppm, thereby
posing a significant explosion risk.
Commenters noted that this situation
could also expose workers to EtO levels
above the Immediately Dangerous to
Life or Health limit set by the U.S.
Occupational Safety and Health
Administration (OSHA), resulting in
hazardous working conditions. Several
commenters stated that we should retain
the option to determine emission
reduction using mass balance
calculations and pounds of EtO injected
into the sterilization chamber to ensure
safe testing practices.
Response: We agree with the
commenters’ concerns regarding the
safety risks associated with testing the
SCV inlet. Therefore, we are removing
this requirement for SCVs from the final
rule. Owners and operators must instead
determine the mass of EtO emissions
from the SCV by measuring the daily
change in weight of the EtO drums that
are used to charge the sterilization
chamber.
Comment: Several commenters were
opposed to our proposed requirement
for each performance test run to be
conducted over a 24 hour period for
PO 00000
Frm 00045
Fmt 4701
Sfmt 4700
24133
facilities where EtO use is at least 10
tpy, stating that this requirement is
difficult, infeasible, and of limited
value. The commenters stated that there
are a limited number of testing
companies with both the experience to
conduct performance tests of this
length, as well as the personnel to
remain at facilities during these long
performance test periods. The
commenters stated that multiple
companies will be in demand for these
limited services and that scheduling
these performance tests so that the
medical supply chain is not adversely
impacted will be difficult. In general,
the commenters agreed that a
performance test run longer than one
hour is necessary but were divided on
what constitutes a representative period,
with one commenter stating that eight to
10 hours is representative, and another
stating that six to 12 hours is
representative. Several commenters
stated the performance test duration
should be determined by the facility and
accompanied with a justification of how
normal operations are captured over this
duration. One commenter stated that
ARV and room air emissions are
continuous in nature and that one-hour
performance test runs are sufficient for
these sources. The commenter also
stated the CEV operations are started
and completed within an hour and,
therefore, one-hour performance test
runs are appropriate for these sources as
well. Finally, one commenter suggested
that each performance test run for
facilities where EtO use is less than 10
tpy should be longer than one hour.
Response: As discussed earlier, we are
finalizing a requirement to only use EtO
CEMS for demonstrating compliance. In
addition, owners or operators of affected
sources subject to a percent emission
reduction standard will obtain and
record EtO concentration in ppbvd, flow
rate in dscfm, and daily EtO use in
pounds; determine daily amounts of EtO
entering and exiting control systems;
use those daily amounts to calculate and
record 30-operating day rolling sums;
and calculate emission limits and
determine compliance based on those
rolling sums. However, facilities where
EtO use is less than 100 lb/year will still
have the option to use CEMS or
performance testing and parametric
monitoring to demonstrate compliance.
Therefore, our proposal for each
performance test run to be conducted
over a 24-hour period for facilities
where EtO use is at least 10 tpy is no
longer applies and is not included in the
final rule. For facilities where EtO use
is less than 100 lb/year, we agree that a
one-hour performance test period for
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24134
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
ARVs and room air emissions is
appropriate, as these operations are
continuous in nature, with minimal
variations in emissions. We also agree
that a one-hour performance test period
is appropriate for CEVs, as these
operations are typically started and
concluded in less than one hour. For
SCVs, the emissions profile can vary
significantly depending on the number
of chambers at a facility and how the
emissions are staggered. Therefore, we
are finalizing a requirement for owners
and operators to include a
representative performance test period
for SCVs, along with a justification, in
their stack test protocol, so that the
delegated authorities can review and
approve or deny the protocol as
appropriate.
Comment: We received comments on
continuous compliance requirements for
verifying EPA Method 204. Several
commenters contended that
continuously verifying the direction of
airflow through daily inspections of
each NDO presents significant safety
risks and are redundant or impractical.
They noted that NDOs may be located
at ceiling levels (such as a makeup air
unit) in processing areas or in other
hard to reach areas where EtO
concentrations may require the use of
specialized protective equipment. One
commenter stated that streamers are not
practical, may not be observable, and
often get stuck or wrapped around
objects. Another commenter noted that
smoke testing in EtO facilities is
discouraged due to safety concerns, as
any indication of fire in an EtO facility
is highly problematic, and seeing smoke
within the facility should not be
routine. Finally, two commenters
questioned the value of daily NDO
inspections when other relevant
parameters are being continuously
monitored.
One commenter recommended the
use of differential pressure monitoring
to verify EPA Method 204, accompanied
by a data recording system to
demonstrate continuous compliance.
Other commenters were opposed to any
continuous compliance requirements for
verifying EPA Method 204, stating that
they would be burdensome, expensive,
and difficult to maintain. Two
commenters stated that we should
change the criteria for demonstrating
continuous compliance with EPA
Method 204 from ‘‘maintained above
0.007 inches of water’’ to ‘‘at least 0.007
inches of water’’ to align to the Method
204 definition of facial velocity
equivalence.
Response: We agree with the
commenters’ concerns regarding the
safety and practical aspects of daily
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
NDO inspections. Therefore, we are not
including this requirement in the final
rule. In order to ensure that emissions
are not leaving through uncontrolled
spaces, it is critical to demonstrate
continuous compliance with EPA
Method 204. In the absence of daily
NDO inspections, differential pressure
monitoring and outlet volumetric flow
rate monitoring are viable options for
verifying the continuous flow of air into
a control device, and both of these
options were included in the proposed
rulemaking. Therefore, we are finalizing
a requirement for owners and operators
to demonstrate continuous compliance
with EPA Method 204 either through
outlet volumetric flow rate monitoring
or through differential pressure
monitoring. We also agree with
commenters that, if differential pressure
monitoring is used, the pressure
differential should be maintained at or
above 0.007 inch of water in order to
demonstrate continuous compliance, as
this is what is required in EPA Method
204.
Comment: We received extensive
comments on our proposed requirement
for all area source facilities within the
source category to obtain a title V
operating permit. Several commenters
were supportive, citing the serious
health concerns of EtO. The commenters
stated that facilities with title V
operating permits tend to receive more
oversight and that this, along with
increased community engagement, will
ensure that these facilities are
complying with the rule requirements.
Other commenters were opposed,
stating the current and proposed
NESHAP included substantial
compliance, parametric monitoring,
recordkeeping, and reporting
obligations. One commenter stated that
subjecting area source EtO commercial
sterilizers to the title V permitting
program requires additional regulatory
fees; burdensome permitting,
recordkeeping and reporting
requirements; increased administrative
costs; as well as Clean Air Act citizen
suits. Two commenters suggested that
the proposed requirements could be
incorporated into a State minor source
permit without the additional burden of
title V permitting, and that title V
permits should apply only to major
sources. Multiple commenters also
indicated that the four-factor balancing
test still weighs in favor of continued
exclusion of area source facilities within
this source category from title V
permitting requirements.
With respect to the first factor (i.e.,
whether title V would result in
significant improvements to the
compliance requirements, including
PO 00000
Frm 00046
Fmt 4701
Sfmt 4700
monitoring, recordkeeping, and
reporting that are proposed for the area
source category), several commenters
stated that requiring title V operating
permits would not provide significant
improvements to compliance
requirements. Two commenters agreed
with our 2005 analysis that the NESHAP
requirements applicable to area sources
already subjected them to continuous
monitoring and assessment, reporting,
and certification of compliance status
on a semiannual basis, which was
similar to what was required by title V.
Commenters stated that the proposed
rule addressed increased transparency
and further strengthened monitoring,
recordkeeping, and reporting
requirements, including developing a
new performance specification and
associated QA procedures for CEMS
capable of detecting EtO at very low
levels. One commenter stated that we
recognized that modern NESHAPs have
sufficient parametric monitoring. The
commenter also stated that the only gain
that we identified that was not already
satisfied was the public comment period
for title V permitting; however, the
commenter noted that many facilities
may need construction permits to come
into compliance with the updated
requirements, during which many States
have an option to hold a public
comment period and a public meeting(s)
for changes that may be of interest to the
community. The commenter noted that,
as part of this rulemaking process, the
EPA held numerous public meetings for
local communities regarding specific
facilities and additional public outreach
meetings for transparency. This
commenter stated these outreach efforts
and the potential construction
permitting actions will eliminate the
need to have the title V public comment
period. Three commenters stated that
one of the primary purposes of the title
V program was to clarify in a single
document the various and complex
regulations that applied to a facility in
order to improve compliance. Two
commenters stated that we agreed that
EtO sterilizers were still subject only to
a single NESHAP. Three commenters
stated the benefit of requiring a title V
permit to house all applicable
regulations into a single document
would not apply to those area sources
and was not needed, and one
commenter added that area sources
should be exempt from title V on that
basis alone. One commenter stated that,
in response to a comment on our 2005
proposed rule, we also indicated that
NESHAP provisions independently
required schedules of compliance,
provided inspection and entry
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
authority, and established emissions
limitations and standards that were
enforceable regardless of title V
permitting. This commenter noted the
proposed rule asserted that the
compliance benefits of title V were
greater today than in 2005 and so the
benefits would be greater, but the
commenter argued that we made these
statements without providing
supporting analysis.
With respect to the second factor (i.e.,
whether title V permitting would
impose significant burdens on the area
source category and whether the
burdens would be aggravated by any
difficulty in obtaining assistance from
permitting authorities), several
commenters noted that requiring area
sources to obtain a title V permit would
pose significant burdens on sterilization
facilities, with one commenter stating
that it would pose significant burden
‘‘within the time frame being
proposed.’’ 68 Additionally, the
commenter stated the State permitting
agencies may be overly burdened in
issuing title V permits at a facility with
such low emissions. Several
commenters stated that the proposed
title V permitting requirement for area
sources would be a significant burden
for small businesses, as these permits
required businesses to prepare
significant amounts of paperwork,
negotiate compliance with the
permitting authority, and subject their
operations and permit application to
public comment or petitions that would
potentially delay operations and create
additional regulatory burdens that, per
OMB analysis, may be biased against
small businesses. One commenter noted
that small businesses in this industry
had no experience with title V
permitting and that obtaining these
permits would require additional
resources. The commenter stated that
we ignored the significant cost of
uncertainty that title V permitting
introduced to small business planning.
The commenter explained that rather
than hiring an engineer to determine
how a facility could meet the
requirements, a small business would
have to engage in a process with
multiple partners, develop supporting
material that may or may not be
sufficient in the eyes of the regulatory
authority, and prepare a public relations
strategy in anticipation of community
opposition to their operations, and that
this investment must be made without
68 Commenter provided the following statement:
‘‘Requiring areas sources to obtain a title V permit
would pose significant burdens on sterilization
facilities especially within the time frame being
proposed.’’ (see Docket Item No. EPA–HQ–OAR–
2019–0178–0632, Attachment 2, page 20).
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
the certainty of an outcome that will
allow continued operation. One
commenter noted that many Small
Business Environmental Assistance
Programs are precluded from assisting
with title V permitees and, as such, this
rule could strip small businesses of the
assistance mandated under CAA section
507. One commenter stated that our
justification seemed premised on an
expectation of noncompliance, although
clarified that we had not alleged that
small commercial sterilizers have a
history of noncompliance. The
commenter noted that recent
controversies around EtO facilities had
centered around large facilities owned
by large businesses. The commenter
indicated it was not clear how title V
permitting of area sources would create
additional incentives for compliance or
give State enforcement authorities the
resources and expertise they would not
otherwise have to enforce this NESHAP.
One commenter stated the addition of
title V permitting for area sources
formalized community involvement in
the authorization of area source
commercial sterilizers, and that this
level of community review was
unnecessary and overly burdensome.
Another commenter noted that the
public already had access to commercial
sterilizer locations, emissions, and
current standards to which they were
subject via our website and regulations,
as well as our community outreach to
advise the public of the hazards of EtO.
With respect to the third factor (i.e.,
whether the costs of title V permitting
for area sources would be justified
taking into consideration any potential
gains in compliance likely to occur for
such sources), two commenters stated
there would be no justification for
imposing the burden of title V
permitting. One commenter stated that
we could have separated the cost
estimate for the 86 area sources in order
to provide more accurate numbers.
Additionally, the commenter stated that
the 2019 cost estimates were not
accurate, as the new rules would require
facilities to change not only their
equipment, but also their calculation
methods, monitoring, and testing. The
commenter stated that those costs
needed to be considered in a title V cost
analysis. Three commenters stated that
our cost estimate for obtaining a title V
permit underestimated the cost of this
requirement and that we should not add
to the burdens for area sources. One
commenter stated that the time and cost
of getting a title V permit did not
correlate to the potential gains and that
we provided no supporting data for our
conclusion that the average costs
PO 00000
Frm 00047
Fmt 4701
Sfmt 4700
24135
associated with title V ($67,211 for the
first year, as calculated in 2019) will
likely be less for area sources. This
commenter suggested that our cost
determination did not align with the
proposed rule, which said ‘‘the rule
amendments proposed provide for a
greater degree of complexity and
requirements to achieve and
demonstrate compliance for area
sources.’’ One commenter noted that we
stated that the burden was not
insignificant, but justified the costs
because it represented a small portion of
the anticipated costs related to the
amendments of the proposed rule. One
commenter stated that the analysis on
title V applicability did not ask how the
burden compared to the cost of
complying [with] some other measure,
but that the question was whether the
potential compliance benefits
outweighed the steep costs, the answer
to which we seemed to concede was
‘‘no.’’
With respect to the fourth factor (i.e.,
whether adequate oversight by State and
local permitting authorities could
achieve high compliance with the
NESHAP requirements without relying
on title V permitting), one commenter
stated that CAA sections 112, 113, and
114 required implementation and
enforcement programs to be conducted
by the EPA or delegated to the proper
State authority and a small business
assistance program to assist area sources
exempted from title V with compliance.
The commenter noted that States and
the EPA routinely conducted voluntary
compliance assistance outreach and
education programs. The commenter
noted that the EPA’s review of Stateprovided empirical data demonstrated
that area sources were adequately
compliant with their requirements
without title V permitting. The
commenter stated that the proposed rule
is silent on whether permitting
authorities could effectively implement
NESHAPs without title V, and that the
EPA alluded to its 2019 ICR, implying
that the responses thereto supported the
EPA’s title V decision, but the EPA
never identified specific data or
explained how it would support any of
EPA’s cursory statements. The
commenter concluded that there was no
more difficulty enforcing the single
NESHAP for area sources now versus in
2005, when EPA unequivocally
determined title V would provide no
benefits to its ability to enforce CAA
regulations in tandem with its State and
local partners. The commenter stated
that requiring title V now would only
make enforcement more difficult, as
State agencies would be flooded with
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24136
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
title V applications that would require
time and State funds to implement and
could potentially shift attention away
from major source compliance in a way
that would compromise (and not
improve) implementation of any final
NESHAP program. Another commenter
stated there was already sufficient
oversight by State and local permitting
authorities, as well as subpart O
requirements. One commenter stated
that, as a State regulatory agency, they
had the ability to adequately ensure
compliance with the proposed standard
for facilities within their jurisdiction
regardless of whether the facility is
subject to title V permitting. Another
commenter stated the proposed removal
of the title V permitting exemption for
area sources meant a significant number
of small operations would be required to
obtain title V permits for the first time,
and as many of these area sources were
subject to a limited set of applicable
requirements and permits, there was
little apparent benefit from the
consolidation of these requirements
within a title V permit. One commenter
stated that the EPA failed to discuss
whether there was a history of
noncompliance with the EtO
Commercial Sterilization NESHAP,
which indicated that that there are few
potential gains from the increased
burdens. Finally, one commenter stated
that State operating permits (e.g.,
Synthetic Minor or Federally
Enforceable State Operating Permits) are
abundant and adequate to deal with
these GACT sources without the added
expense, complication, and delays
associated with title V permitting.
Response: We agree with commenters
that the four-factor balancing test
continues to weigh in favor of
exempting area source facilities from
title V permitting. In particular, we
agree with commenters that one of the
primary benefits of the title V program
is to clarify, in a single document, the
various and complex regulations that
apply to a facility in order to improve
compliance, and that this benefit is not
realized in this case because commercial
sterilization facilities are subject to only
one NESHAP (Subpart O). In addition,
we agree with commenters that, in light
of the robust monitoring, recordkeeping
and reporting requirements in the final
rule, a title V permit would likely not
add any substantial monitoring,
recordkeeping and reporting
requirements. We further note that, even
in the absence of title V permitting
requirements, this final rule will ensure
transparency around the emissions from
these facilities by requiring that EtO
CEMS data be reported on a quarterly
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
basis, and this data will be made
available to the public.
In summary, the benefits of requiring
title V permitting for area source
facilities are not outweighed by the
concerns. For the reasons stated above,
we agree with commenters that the fourfactor balancing test continues to weigh
in favor of exempting area source
facilities from title V permitting on the
basis that title V is unnecessarily
burdensome. Therefore, we are not
finalizing title V permitting
requirements for area source facilities.
Comment: One commenter suggested
that we require only a single combined
performance test for the outlet point and
that the most stringent applicable
standard (i.e., the control level required
for the SCV) should be applied. Two
commenters stated that our affected
source proposal is unnecessarily
complicated. One commenter stated that
where control equipment has a single
inlet and outlet, the facility should not
be required to test individual source
inlets or outlets. The commenter also
stated that it is logical that point sources
routed to the same emission control
system should be defined as a single
unit. The commenter stated it is
important to set emission limits that
reflect this reality and test methods that
allow for combined system testing at the
outlet of the system. The commenter
also stated that the proposed language
implies that the SCV, CEV, and ARV
must be tested separately, which is
challenging given the complexity in
design of existing duct work and access
to inlets. The commenter stated that
testing the combined inlet to the APCD
would be the safest, most accurate, and
most cost-effective method for
determining compliance for facilities
with combined emissions. Another
commenter stated that applying the
most restrictive removal efficiency
standard when different sources are
combined is impractical.
Response: The EPA is finalizing
approaches that will provide facilities
with flexibility in terms of how they
choose to demonstrate compliance with
the standards for instances where
emission streams are combined prior to
entering a control system. Facilities can
determine compliance via one of two
options:
• Option 1: Determine the mass of
EtO entering the control device at a
point after the emission streams are
combined, and apply the most stringent
emission reduction standard that the
component streams are subject to.
• Option 2: Determine the mass of
EtO entering the control device at points
before the emission streams are
combined, and apply the emission
PO 00000
Frm 00048
Fmt 4701
Sfmt 4700
reduction standards that the component
streams are subject to.
Option 1 is consistent with what was
proposed, and Option 2 has been added
in order to provide more flexibility for
facilities in terms of how they chose to
demonstrate compliance. As an
example, suppose an area source facility
uses at least 30 tpy but less than 60 tpy,
and the facility chooses to control all of
its ARVs and CEVs with one control
system. The emission reduction
standards that apply to the ARVs and
CEVs are 99.9% and 99%, respectively.
In this example, suppose the mass of
EtO emissions from the ARVs is 4 lb,
and the mass of EtO emissions from the
CEVs is 1 lb, meaning that the mass of
EtO emissions from the combined
stream is 5 lb. Under Option 1, the
facility would need to apply an
emission reduction of 99.9% to the
combined stream, resulting in an
emission limit of 0.005 lb. Under Option
2, the facility would apply an emission
reduction of 99.9% to the ARV stream
and an emission reduction of 99% to the
CEV stream, resulting in an emission
limit of 0.014 lb. When an affected
source is subject to a relatively high
emission reduction standard, it can be
difficult to demonstrate compliance
with that standard when the
concentration of pollutants going into
the control device is low. By combining
emission streams and increasing the
concentration of pollutants in the air
stream, it is easier to demonstrate
compliance.
Comment: One commenter
recommended the creation of the option
for a site-wide emission limitation. This
limitation could take the form of either
overall removal efficiency, or a total
mass rate per hour. Another commenter
suggested a site-wide emission
limitation based upon EtO usage and
end-state emissions and identified as
precedent an Illinois construction
permit containing monthly and annual
mass emissions caps. The commenter
also suggested a compliance option by
emission reduction or emission rate
standards and identified as precedent
Illinois legislation requiring 99.9
percent emission reduction at each
exhaust point or limitation of EtO
emissions to 0.2 ppm.
Response: We agree with the creation
of an option for a site-wide emission
limitation and have included this in the
final rulemaking. Specifically, we are
finalizing two options for determining
compliance on a site-wide basis:
• Option 1: Determine the mass of
EtO being used at the facility and apply
the SCV emission reduction standard,
which is the most stringent emission
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
reduction standard that any emission
stream at the facility is subject to.
• Option 2: Determine the mass of
EtO being emitted from each affected
source, and apply the emission
reduction standards that each affected
source is subject to. For SCVs, the mass
of EtO may be determined by measuring
how much is used and then applying a
facility-specific factor that accounts for
EtO entering the control systems from
other affected sources.
We disagree with the suggestion to set
an emissions cap, as the amount of EtO
that a facility will use in a given month
is unknown.
4. What is the rationale for our final
approach and final decisions for the
other amendments for the Commercial
Sterilization Facilities source category?
khammond on DSKJM1Z7X2PROD with RULES2
We are not finalizing a requirement
for all area sources facilities to obtain a
title V operating permit, and we are not
including requirements for fenceline or
ambient air monitoring as part of this
final rule. Based on the comments
received during the proposed
rulemaking, we are requiring EtO CEMS
for facilities where EtO use is at least
100 lb/year, and we are finalizing a
requirement for EtO CEMS data to be
reported quarterly. We are not finalizing
a requirement for owners and operators
to conduct SCV inlet testing, and we are
not finalizing a requirement for each
performance test run to be conducted
over a 24-hour period. Lastly, we are
finalizing revised compliance
mechanisms for combined emission
streams, as well as the option for
facilities to demonstrate compliance
with a site-wide emission limit, as
opposed to having to demonstrate
compliance for each individual and
combined emission stream. See section
IV.F.3 of this preamble for further
discussion.
In a few instances, we received
comments that led to additional minor
editorial corrections and technical
clarifications being made in the final
rule, and our rationale for these
corrections and technical clarifications
can be found in the document,
Summary of Public Comments and
Responses for the Risk and Technology
Review for Commercial Sterilization
Facilities, available in the docket for this
rulemaking.
V. Summary of Cost, Environmental,
and Economic Impacts and Additional
Analyses Conducted
A. What are the affected facilities?
As part of the proposed rulemaking,
we estimated that there were 86 existing
commercial sterilization facilities and
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
two planned facilities. However, based
on comments received on the proposed
rulemaking, we understand that one of
the existing facilities has closed. In
addition, the commenters identified
three existing commercial sterilization
facilities that were unknown during the
proposed rulemaking. However, it
should be noted that EtO use at the
three facilities that were previously
unknown is very small (i.e., less than 1
tpy). A complete list of the known 88
Commercial Sterilization Facilities that
are affected by this rulemaking is
available in Appendix 1 of the
document, Residual Risk Assessment for
the Commercial Sterilization Facilities
Source Category in Support of the 2024
Risk and Technology Review Final Rule,
which is available in the docket for this
rulemaking.
B. What are the air quality impacts?
At the current level of control prior to
the amendments being finalized in this
action, the EPA estimates that EtO
emissions were approximately 23 tpy
(actuals) and 160 tpy (allowables) from
commercial sterilization facilities. At
the level of control required by the
amendments being finalized in this
action, which includes standards for
previously unregulated sources and
amendments to all sources where
standards were already in place, we
estimated EtO emissions reductions of
21 tpy (actuals) and 150 tpy (allowables)
for the source category.
C. What are the cost impacts?
The total capital investment cost of
the final amendments and standards is
estimated to be approximately $313
million in 2021 dollars. We estimate
total annual costs of the final
amendments to be approximately $74
million.
The present value (PV) of the
estimated compliance costs over the 20year timeframe from 2025 to 2044 for
the final rule is $773 million in 2021
dollars, discounted at a 7 percent rate.
The equivalent annualized value (EAV)
of the costs is $88 million, using a 7
percent discount rate. Using a 3 percent
discount rate, the PV and EAV of the
costs from 2025 to 2044 are estimated to
be $932 million and $63 million,
respectively.
The nationwide costs of the different
amendments being finalized in this
action are presented in table 2 of this
preamble. As described in this
preamble, we are finalizing standards
for previously unregulated sources, as
well as amendments for sources where
standards were already in place. Many
of the emissions capture and control
technologies that are needed to comply
PO 00000
Frm 00049
Fmt 4701
Sfmt 4700
24137
with the final rule will impact multiple
sources at once, and those costs form
the basis of our impact estimates. These
costs are presented in table 2 of this
preamble. There are 90 facilities
(including the 88 existing facilities and
the two planned facilities) affected by
the amendments, and the number of
facilities associated with each of the
specific costs is indicated in table 2. The
facility list was developed using
methods described in section II.C of the
proposal preamble (88 FR 22790, April
13, 2023). A complete list of known
commercial sterilization facilities is
available in Appendix 1 of the
document, Residual Risk Assessment for
the Commercial Sterilization Facilities
Source Category in Support of the 2024
Risk and Technology Review Final Rule,
which is available in the docket for this
rulemaking.
D. What are the economic impacts?
The economic impact analysis is
designed to inform decision makers
about the potential economic
consequences of the compliance costs
outlined in section V.C of this preamble.
The EPA performed a screening analysis
that compared compliance costs to
revenues at the ultimate parent
company level (several companies own
more than one affected facility). This is
known as the cost-to-revenue or cost-tosales test, or the ‘‘sales test.’’ The use of
a sales test for estimating small business
impacts for a rulemaking is consistent
with EPA guidance on compliance with
the Regulatory Flexibility Act (RFA) and
is consistent with guidance published
by the U.S. Small Business
Administration’s Office of Advocacy
that suggests that cost as a percentage of
total revenues is a metric for evaluating
cost increases on small entities in
relation to increases on large entities.
There are 88 existing commercial
sterilization facilities and 2 planned
commercial sterilization facilities,
owned by 50 parent companies, affected
by the final amendments. Of the parent
companies, 22 companies, or 44
percent, are small entities based on the
U.S. Small Business Administration’s
table of size standards. Next, we
determined the magnitude of the costs
of the amendments being finalized in
this action for each entity and then
calculated a cost-to-sales ratio for each
entity by comparing estimated costs to
the annual revenues of each parent
company. We then assessed whether
there would be potential for a
significant impact on small entities
based on the cost-to-sales ratios. For all
entities, the average cost-to-sales ratio is
approximately 8 percent; the median
cost-to-sales ratio is 0.2 percent; and the
E:\FR\FM\05APR2.SGM
05APR2
24138
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
maximum cost-to-sales ratio is
approximately 69 percent. For large
firms, the average cost-to-sales ratio is
approximately 0.2 percent; the median
cost-to-sales ratio is 0.03 percent; and
the maximum cost-to-sales ratio is 1.3
percent. This rule has potentially
significant impacts on small entities.
For small firms, the average cost-to-sales
ratio is approximately 18 percent, the
median cost-to-sales ratio is 4.7 percent,
and the maximum cost-to-sales ratio is
69 percent. There are 13 small entities
(59 percent of all affected small entities)
with estimated cost-to-sales ratios of 3
percent or greater. See the Regulatory
Impact Analysis for further detail on the
cost estimates, small entity impact
analysis, and a discussion of potential
market and economic impacts.
The EtO sterilization industry is an
integral part of the supply chain for
many medical devices and capacity
constraints have been reported. Based
on the data we analyzed, we expect that
the largest impacts of this rule are
limited to a handful of the companies
that play a key role in the availability
of certain medical devices, and several
of them are already in the planning
stage for additional controls.
Some companies involved in medical
device sterilization have installed, or are
already planning for installation of,
additional emissions controls. The
controls necessary to meet the
requirements of this final rule include
PTEs and gas/solid reactors, along with
(in some cases) alterations to facility
design to ensure adequate capture of
EtO emissions. Such controls rely on
existing technologies that are
commercially available from
manufacturers and are already well
established in this industry. In addition,
a few companies have constructed, or
are in the process of constructing, new
facilities with state-of-the-art design and
control installations to ensure full
capture and control of EtO emissions.
These early actions by industry
demonstrate the feasibility of
implementing the requirements in this
final rule.
Over the last several years, the
industry has demonstrated the
capability to install controls on multiple
facilities simultaneously without
interfering with medical supply chains.
For example, three companies redesigned their Illinois and Georgia
facilities to comply with the PTE
requirements of EPA Method 204, as
well as installed emission controls at
these facilities during overlapping
timeframes from May 2019 through
August 2020 without disruption to the
medical supply chain. As discussed in
section III.G of this preamble, we have
reviewed the time that it has taken for
these projects to be completed, from
submission of the initial permit
application to installation of the
continuous compliance mechanisms.
Based on this review, we found that the
process of bringing a facility into
compliance with the PTE requirements
of EPA Method 204, as well as installing
and verifying additional emission
controls, takes approximately a year
from permit submission to project
completion.
The EPA has evaluated available
information about the state of control
installations at existing commercial
sterilization facilities. Of the 88 existing
facilities, seven appear have already met
the emission standards and will not
need to install additional emission
controls. Another 55 facilities appear to
only need additional abatement devices.
We expect that 28 facilities still need to
meet the PTE requirements of EPA
Method 204 and install additional
abatement devices. Table 22 presents
the apparent compliance status with the
final rule for each relevant emission
source and facility EtO use combination,
based on controls that are currently in
place.
TABLE 22—APPARENT COMPLIANCE STATUS WITH FINAL RULE AND COMPLIANCE TIMEFRAMES
Emission source
Facility EtO use
SCV .........................................................................
At least 30 tpy ......................
At least 10 but less than 30
tpy.
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
At least 30 tpy ......................
At least 10 but less than 30
tpy.
At least 1 but less than 10
tpy.
Less than 1 tpy ....................
N/A .......................................
At least 60 tpy ......................
Less than 60 tpy ..................
N/A .......................................
At least 40 tpy ......................
Less than 40 tpy ..................
N/A .......................................
At least 20 tpy ......................
At least 4 but less than 20
tpy.
Less than 4 tpy ....................
ARV .........................................................................
CEVs at major source facilities ...............................
CEVs at area source facilities .................................
khammond on DSKJM1Z7X2PROD with RULES2
Group 1 room air emissions at major sources .......
Group 1 room air emissions at area sources .........
Group 2 room air emissions at major sources .......
Group 2 room air emissions at area sources .........
Number of
facilities with this
affected source
Number of
facilities
appearing to
achieve final
standard 1
Compliance
timeframe
38
9
19
9
Two years.
Two years.
18
16
Two years.
23
36
5
22
12
5
Three years.
Two years.
Three years.
10
7
Three years.
4
0
25
15
0
36
38
1
44
13
2
N/A
12
8
N/A
16
7
0
17
1
27
27
1 The
Three
Three
Two
Three
Three
Two
Three
Three
Two
Two
years.
years.
years.
years.
years.
years.
years.
years.
years.
years.
Three years.
phrase ‘‘appearing to achieve’’ is used (as opposed to ‘‘achieving’’) to account for uncertainties in the data. A notable example is the
SCVs where, for a given facility, the emission reduction on the first evacuation may not high enough to ensure that the standard is being met
across all evacuations. Another uncertainty is the fraction of EtO going to each emission stream. In some instances, there is facility-specific information available, and in others, there is no information available and default fractions are applied as a result.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00050
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
E. What are the benefits?
The EPA did not monetize the
benefits from the estimated emission
reductions of HAP associated with this
final action. The EPA currently does not
have sufficient methods to monetize
benefits associated with HAP, HAP
reductions, and risk reductions for this
rulemaking. However, we estimate that
the final rule amendments would
reduce EtO emissions by 21 tons per
year and expect that these reductions
will lower the risk of adverse health
effects, including cancer, for individuals
in communities near commercial
sterilization facilities. For example, the
estimated cancer incidence due to
emissions from the source category
would be reduced from 0.9 to between
0.1 to 0.2, or from 1 cancer case every
1.1 years to 1 cancer case every 5 to 10
years.
khammond on DSKJM1Z7X2PROD with RULES2
F. What analysis of environmental
justice did we conduct?
Consistent with applicable executive
orders and EPA policy, the EPA has
carefully analyzed the environmental
justice implications of the benefits
associated with the reductions in EtO
emissions as a result of this final rule.
The EPA conducted this analysis for the
purpose of providing the public with as
full as possible an understanding of the
potential impacts of this final action.
The EPA believes that analyses like this
can inform the public’s understanding,
place EPA’s action in context, and help,
identify and illustrate the extent of
potential burdens and protections.
As part of understanding the impacts
of this source category and of this final
rule, we examined the potential for the
88 facilities that were assessed to pose
concerns to communities with EJ
concerns both in the baseline i.e., under
the current standards) standards
considered in this final rule.
To examine the potential for EJ
concerns in the pre-control baseline, we
conducted two baseline demographic
analyses, a proximity analysis and a
risk-based analysis. The baseline
proximity demographic analysis is an
assessment of individual demographic
groups in the total population living
within 10 kilometers (km) and 50 km of
the facilities. In this preamble, we focus
on the 10 km radius for the health risk
assessment and for the demographic
analysis because it encompasses all the
facility MIR locations and captures 100
percent of the population with risks
greater than 100-in-1 million. The
results of the proximity analysis for
populations living within 50 km are
included in the technical report
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
included in the docket for this final rule
for the public’s understanding.
The baseline risk-based demographic
analysis is an assessment of risks to
individual demographic groups in the
population living within the 10 km and
50 km radii around the facilities prior to
the implementation of any controls
finalized by this action (‘‘baseline’’).
Again, in this preamble, we present for
the public’s understanding the results
for populations living within 10 km of
facilities. Results for populations living
within 50 km are included in the
technical report included in the docket
for this final rule.
Overall, the results of the proximity
demographic analysis (see first three
columns of table 23) indicate that the
percent of the population living within
10 km of the 88 facilities that is
Hispanic or Latino is substantially
higher than the national average (36
percent versus 19 percent), driven
largely by the seven facilities in Puerto
Rico. The baseline proximity analysis
indicates that the proportion of other
demographic groups living within 10
km of commercial sterilizers is closer to
the national average. The baseline riskbased demographic analysis (see
‘‘baseline’’ column in tables 23 to 25),
which presents information for
individuals that are expected to have
higher cancer risks (greater than or
equal to 1-in-1 million, greater than or
equal to 50-in-1 million, and greater
than 100-in-1 million), suggests that the
African American, Hispanic or Latino,
below the poverty level, over 25 and
without a high school diploma, and
linguistically isolated demographic
groups are also disproportionally
represented at the higher risk levels.
The post-control risk-based
demographic analysis presents
information on current health risks and
how the standards considered in this
final regulatory action would affect the
distribution of these risks across the
populations and communities identified
in the baseline. The CAA section
112(d)(2), (3), and (5) post-control
scenario is shown in tables 23 to 25 and
the residual risk post-control options are
shown in tables 26 to 28. The postcontrol options show a substantial
reduction in the number of individuals
at each risk level, as well as a significant
reduction in the proportion of African
Americans that experience higher risk
levels from facilities in this source
category. We project that a majority of
the individuals that would remain at
risk after implementation of the final
standards are Hispanic or Latino, driven
largely by the facilities in Puerto Rico.
These three distinct but
complementary analyses indicate the
PO 00000
Frm 00051
Fmt 4701
Sfmt 4700
24139
potential for EJ concerns associated with
this source category in the baseline, as
well as the substantial anticipated
benefits these final standards will have
in reducing EtO emissions and
associated health risks for all of the
affected public, including people living
in communities with EJ concerns. Those
benefits include that no individual is
expected to be exposed to inhalation
cancer risk levels above 100-in-1 million
due to emissions from this source
category after implementation of all the
CAA standards finalized in this action.
The methodology and detailed results
of the demographic analysis are
presented in a technical report, Analysis
of Demographic Factors for Populations
Living Near Ethylene Oxide Commercial
Sterilization and Fumigation
Operations, available in the docket for
this action, but a synopsis is provided
below. We also received comments on
the demographic analysis. Those
comments and our specific responses
can be found in the document,
Summary of Public Comments and
Responses for the 2024 Risk and
Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
1. Demographics
The first three columns of tables 23,
24, and 25 of this document show the
total population, population
percentages, and population count for
each demographic group for the
nationwide population and the total
population living within 10 km of EtO
sterilization facilities. A total of 17.3
million people live within 10 km of the
88 facilities that were assessed. The
results of the proximity demographic
analysis indicate that the percent of the
population that is Hispanic or Latino is
substantially higher than the national
average (36 percent versus 19 percent),
driven by the seven facilities in Puerto
Rico, where an average of 99 percent of
the 658,000 people living within 10 km
of the facilities in PR are Hispanic or
Latino. The percent of the population
that is ‘‘Other and multiracial’’ (11
percent) is higher than the national
average (8 percent). The percent of
people living below the poverty level
(15 percent) and those over the age of
25 without a high school diploma (16
percent) are higher than the national
averages (13 percent and 12 percent,
respectively). The percent of people
living in linguistic isolation 69 is double
69 Linguistic Isolation is defined in the U.S.
Census Bureau’s American Community Survey as
‘‘a household in which all members age 14 years
and over speak a non-English language and also
E:\FR\FM\05APR2.SGM
Continued
05APR2
24140
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
the national average (10 percent versus
5 percent). We note that this estimate of
linguistic isolation is largely driven by
the facilities in Puerto Rico, where an
average of 67 percent of the population
is in linguistic isolation in comparison
to the national average.
In summary, the baseline proximity
analysis indicates that the percent of
Hispanic or Latino populations living
near commercial sterilizers (within 10
km) is higher than what would be
expected based on the national average
distribution. This is largely driven by
the seven facilities located in Puerto
Rico where, on average, the population
of 658,000 people living within 10 km
of these seven facilities is 99 percent
Hispanic or Latino. In addition, the
population around the facilities in
Puerto Rico has 67 percent living in
linguistic isolation, 45 percent living
below the poverty level, and 24 percent
over 25 without a high school diploma.
2. Baseline Risk-Based Demographics
The baseline risk-based demographic
analysis results are shown in the
‘‘baseline’’ column of tables 23, 24, and
25. This analysis presented information
on the populations living within 10 km
of the facilities with estimated actual
cancer risks greater than or equal to 1in-1 million (table 23), greater than or
equal to 50-in-1 million (table 24), and
greater than 100-in-1 million (table 25).
The risk analysis indicated that
emissions from the source category,
prior to the reductions we are finalizing,
expose a total of 5.3 million people to
a cancer risk greater than or equal to 1in-1 million around 75 facilities,
124,000 people to a cancer risk greater
than or equal to 50-in-1 million around
38 facilities, and 19,000 people to a
cancer risk greater than 100-in-1 million
around 16 facilities. The demographics
of the baseline population with
estimated cancer risks greater than or
equal to 1-in-1 million are very similar
to the total population within 10 km.
Specifically, the percent of the
population that is Hispanic or Latino is
more than two times larger than the
national average (39 percent versus 19
percent), the percent below the poverty
level is above national average (16
percent versus 13 percent), the percent
over 25 without a high school diploma
is above the national average (18 percent
versus 12 percent), and the percent
linguistic isolation is two times the
national average (11 percent versus 5
percent).
In contrast, the smaller populations
with baseline cancer risk greater than or
speak English less than ‘‘very well’’ (have difficulty
with English).’’
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
equal to 50-in-1 million (124,000
people), and greater than 100-in-1
million (19,000 people) are
predominantly made up of African
Americans (43 and 31 percent versus 12
percent nationally), and have a higher
percentage of the population below the
poverty level (22 and 25 percent versus
13 percent nationally). For this same
group, the percent over 25 without a
high school diploma is above the
national average (17 and 18 percent
versus 12 percent), and linguistic
isolation is above the national average (9
and 16 percent versus 5 percent). This
shows that risks tend to be higher both
where more African American residents
reside, and where poverty is higher than
in the rest of the area within 10 km. It
should be noted that the higher
percentage African American
population with baseline cancer risk
greater than or equal to 50-in-1 million
is driven largely by seven facilities
located in or near communities that
have African American populations that
are between two and eight times the
national average. The higher percentage
African American population with
baseline cancer risk greater than 100-in1 million is driven largely by three
facilities that are located in
communities where the proportion of
African American residents is between
2.5 and 8 times the national average.
The population with higher baseline
cancer risks living within 10 km of the
facilities consists of a substantially
smaller percentage of Hispanic or Latino
(22 and 26 percent) than the total
population living within 10 km (36
percent Hispanic or Latino) and is above
the national average (19 percent).
In summary, the baseline risk-based
demographic analysis, which presents
information on those specific locations
that are expected to have higher cancer
risks, suggests that African Americans,
those living below poverty, and those
living in linguistic isolation are
disproportionally represented where
risk is highest. The population with
risks greater than 100-in-1 million living
within 10 km of a commercial sterilizer
has a proportion of African Americans
(31 percent), those living below poverty
(25 percent) and those living in
linguistic isolation (16 percent) that is
more than twice as large as the
respective national average.
3. Risks Across Demographics
Anticipated After Standards Under CAA
Sections 112(d)(2), 112(d)(3), and
112(d)(5)
This analysis presented information
on the populations living within 10 km
of the facilities with estimated cancer
risks greater than or equal to 1-in-1
PO 00000
Frm 00052
Fmt 4701
Sfmt 4700
million (table 23), greater than or equal
to 50-in-1 million (table 24), and greater
than 100-in-1 million (table 25) after
implementation of standards that we are
finalizing under CAA sections 112(d)(2),
(3), and (5). The results of our analysis
of risk-based demographics considering
standards under CAA sections 112(d)(2),
(3), and (5) are shown in the last column
of tables 23, 24, and 25 titled ‘‘Baseline
and CAA Section 112(d)(2), (3), and
(5).’’ In this analysis we evaluated how
the final CAA sections 112(d)(2), (3),
and (5) emission reductions in this final
regulatory action affect the distribution
of risks identified in the baseline. This
enables us to characterize the postcontrol risks and to illustrate for the
public’s understanding whether this
part of the final action affects, creates or
mitigates potential EJ concerns as
compared to the baseline.
The risk analysis indicated that the
emissions from the source category,
after implementation of the standards
(resulting in emissions reductions) that
we are finalizing under CAA sections
112(d)(2), (3), and (5), reduces the
number of people living within 10 km
of a facility and with a cancer risk
greater than or equal to 1-in-1 million
from 5.3 million people around 75
facilities to 3.2 million people around
70 facilities, reduces the number of
people living within 10 km of a facility
and with a cancer risk greater than or
equal to 50-in-1 million from 124,000
people around 38 facilities to 23,000
people around 23 facilities, and reduces
the number of people living within 10
km of a facility and with a cancer risk
greater than 100-in-1 million from
19,000 people around 16 facilities to
3,900 people around 13 facilities.
The demographics of the population
with estimated cancer risks greater than
or equal to 1-in-1 million considering
the standards we are finalizing under
CAA sections 112(d)(2), (3), and (5) are
very similar to both the total population
within 10 km and to the baseline
population with risks greater than or
equal to 1-in-1 million. Specifically, the
percent of the population that is
Hispanic or Latino is twice the national
average (38 percent versus 19 percent),
the percent below the poverty level is
above national average (16 percent
versus 13 percent), the percent over 25
without a high school diploma is above
the national average (18 percent versus
12 percent), and the percent linguistic
isolation is two times the national
average (11 percent versus 5 percent).
After implementation of the standards
that we are finalizing under CAA
sections 112(d)(2), (3), and (5), the
percentage and number of African
Americans at cancer risks greater than
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
or equal to 50-in-1 million and greater
than 100-in-1 million is significantly
reduced. For example, African
Americans exposed to risks greater than
100-in-1 million went from 31 percent
or 5,900 people in the baseline to 6
percent or 220 people after
implementation of the final CAA section
112(d)(2), 112(d)(3), and 112(d)(5)
emissions reductions. It should be noted
that while the number of Hispanic or
Latino people with risks greater than
100-in-1 million was reduced from
4,900 to 2,600 people, the percentage of
the remaining population at >100-in-1
million risk that is Hispanic or Latino
went up from 26 percent in the baseline
to 68 percent after the final CAA section
112(d)(2), 112(d)(3), and 112(d)(5)
emissions reductions. However,.
Similarly, the number of people below
the poverty level or linguistically
isolated with a cancer risk >100-in-1
million decreased significantly;
however, the percentage of the
remaining population at risk postemission controls that are in these
demographics went up from the
baseline. For example, the proportion of
the population with risks greater than
100-in-1 million that were below the
poverty level was much higher than the
baseline (38 percent versus 25 percent),
but the number of people was reduced
from 4,700 people to 560 people.
In summary, implementation of the
final CAA sections 112(d)(2), (3), and (5)
standards would significantly reduce
24141
the number of people in all
demographic groups that are exposed to
risks greater than or equal to 1-in-1
million, greater than and equal to 50-in1 million, and greater than 100-in-1
million. Specifically, the percent of the
population that is African American
who are at a cancer risk greater than or
equal to 50-in-1 million and greater than
100-in-1 million was reduced from 43
percent in the baseline to about 13
percent after the CAA section 112(d)(2),
112(d)(3), and 112(d)(5) controls. The
percentage of Hispanic or Latino people
increased as the higher risk facilities in
Puerto Rico make-up an increasing
portion of the remaining populations
with higher cancer risks.
TABLE 23—COMPARISON AT BASELINE AND CAA SECTION 112(d)(2), (3), AND (5) POST-CONTROL OF DEMOGRAPHICS OF
POPULATIONS WITH CANCER RISK GREATER THAN OR EQUAL TO 1-IN-1 MILLION LIVING WITHIN 10 KM OF FACILITIES
THAT WERE ASSESSED
Demographic group
Nationwide
Total Population ...............................................................................................
Number of Facilities .........................................................................................
Total
population
living
within 10 km
of EtO
facilities
328M
........................
Cancer risk ≥ 1-in-1 million
Baseline
Post-control
17.3M
88
5.3M
75
3.2M
70
40 percent
[6.9M]
13 percent
[2.3M]
0.3 percent
[51K]
36 percent
[6.2M]
11 percent
[1.9M]
40 percent
[2.1M]
15 percent
[770K]
0.3 percent
[17K]
39 percent
[2.1M]
7 percent
[350K]
40 percent
[1.3M]
16 percent
[520K]
0.3 percent
[9K]
38 percent
[1.2M]
6 percent
[190K]
15 percent
[2.5M]
85 percent
[14.8M]
16 percent
[840K]
84 percent
[4.5M]
16 percent
[520K]
84 percent
[2.7M]
16 percent
[2.7M]
84percent
[14.6M]
18 percent
[960K]
82 percent
[4.3M]
18 percent
[590K]
82 percent
[2.7M]
11 percent
[570K]
11 percent
[360K]
Race and Ethnicity by Percent [Number of People]
White ................................................................................................................
African American .............................................................................................
Native American ..............................................................................................
Hispanic or Latino (includes white and nonwhite) ...........................................
Other and Multiracial .......................................................................................
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
19 percent
[62M]
8 percent
[27M]
Income by Percent [Number of People]
Below Poverty Level ........................................................................................
Above Poverty Level ........................................................................................
13 percent
[44M]
87 percent
[284M]
Education by Percent [Number of People]
Over 25 and without a High School Diploma ..................................................
Over 25 and with a High School Diploma .......................................................
12 percent
[40M]
88 percent
[288M]
Linguistically Isolated by Percent [Number of People]
khammond on DSKJM1Z7X2PROD with RULES2
Linguistically Isolated .......................................................................................
5 percent
[18M]
10 percent
[1.8M]
Notes:
• Nationwide population and demographic percentages are based on the Census Bureau’s (Census) 2015–2019 American Community Survey
(ACS) 5-year block group averages. Total population count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00053
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24142
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE 24—COMPARISON AT BASELINE AND CAA SECTION 112(d)(2), (3), AND (5) POST-CONTROL OF DEMOGRAPHICS OF
POPULATIONS WITH CANCER RISK GREATER THAN OR EQUAL TO 50-IN-1 MILLION LIVING WITHIN 10 KM OF FACILITIES THAT WERE ASSESSED
Demographic group
Nationwide
Total Population ...............................................................................................
Number of Facilities .........................................................................................
Total
population
living within
10 km of EtO
facilities
328M
........................
Cancer risk ≥ 50-in-1 million
Baseline
Post-control
17.3M
88
124,000
38
23,000
23
40 percent
[6.9M]
13 percent
[2.3M]
0.3 percent
[51K]
36 percent
[6.2M]
11 percent
[1.9M]
31 percent
[39K]
43 percent
[54K]
0.1 percent
[190]
22 percent
[27K]
3 percent
[3.9K]
30 percent
[7K]
13 percent
[2.9K]
0.1 percent
[<100]
56 percent
[13K]
2 percent
[400]
15 percent
[2.5M]
85 percent
[14.8M]
22 percent
[28K]
78 percent
[96K]
29 percent
[6.6K]
71 percent
[17K]
16 percent
[2.7M]
84 percent
[14.6M]
17 percent
[21K]
83 percent
[103K]
21 percent
[5K]
79 percent
[18K]
9 percent
[11K]
30 percent
[6.9K]
Race and Ethnicity by Percent [Number of People]
White ................................................................................................................
African American .............................................................................................
Native American ..............................................................................................
Hispanic or Latino (includes white and nonwhite) ...........................................
Other and Multiracial .......................................................................................
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
19 percent
[62M]
8 percent
[27M]
Income by Percent [Number of People]
Below Poverty Level ........................................................................................
13 percent
[44M]
87 percent
[284M]
Above Poverty Level ........................................................................................
Education by Percent [Number of People]
Over 25 and without a High School Diploma ..................................................
12 percent
[40M]
88 percent
[288M]
Over 25 and with a High School Diploma .......................................................
Linguistically Isolated by Percent [Number of People]
Linguistically Isolated .......................................................................................
5 percent
[18M]
10 percent
[1.8M]
Notes:
• Nationwide population and demographic percentages are based on Census’ 2015–2019 ACS 5-year block group averages. Total population
count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
• To account for the uncertainty of demographics estimates in smaller populations, any population values of 100 persons or less have been
shown simply as ‘‘<100.’’
TABLE 25—COMPARISON AT BASELINE AND CAA SECTION 112(d)(2), (3), AND (5) POST-CONTROL OF DEMOGRAPHICS OF
POPULATIONS WITH CANCER RISK GREATER THAN 100-IN-1 MILLION LIVING WITHIN 10 KM OF FACILITIES THAT
WERE ASSESSED
Demographic group
Nationwide
khammond on DSKJM1Z7X2PROD with RULES2
Total Population ...............................................................................................
Number of Facilities .........................................................................................
Total
population
living within
10 km of EtO
facilities
328M
........................
Cancer risk > 100-in-1 million
Baseline
Post-control
17.3M
88
19,000
16
3,900
13
40 percent
[6.9M]
13 percent
[3M]
0.3 percent
[51K]
40 percent
[7.7K]
31 percent
[5.9K]
0.1 percent
[<100]
25 percent
[1K]
6 percent
[200]
0 percent
[0]
Race and Ethnicity by Percent [Number of People]
White ................................................................................................................
African American .............................................................................................
Native American ..............................................................................................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00054
Fmt 4701
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
24143
TABLE 25—COMPARISON AT BASELINE AND CAA SECTION 112(d)(2), (3), AND (5) POST-CONTROL OF DEMOGRAPHICS OF
POPULATIONS WITH CANCER RISK GREATER THAN 100-IN-1 MILLION LIVING WITHIN 10 KM OF FACILITIES THAT
WERE ASSESSED—Continued
Demographic group
Nationwide
Hispanic or Latino (includes white and nonwhite) ...........................................
Other and Multiracial .......................................................................................
19 percent
[62M]
8 percent
[27M]
Total
population
living within
10 km of EtO
facilities
Cancer risk > 100-in-1 million
Baseline
Post-control
36 percent
[6.2M]
11 percent
[1.9M]
26 percent
[4.9K]
3 percent
[500]
68 percent
[2.6K]
1 percent
[<100]
15 percent
[2.5M]
85 percent
[14.8M]
25 percent
[4.7K]
75 percent
[14K]
38 percent
[1.4K]
62 percent
[2.4K]
16 percent
[2.7M]
84 percent
[14.6M]
18 percent
[3.5K]
82 percent
[16K]
22 percent
[900]
78 percent
[3K]
16 percent
[3K]
44 percent
[1.7K]
Income by Percent [Number of People]
Below Poverty Level ........................................................................................
Above Poverty Level ........................................................................................
13 percent
[44M]
87 percent
[284M]
Education by Percent [Number of People]
Over 25 and without a High School Diploma ..................................................
Over 25 and with a High School Diploma .......................................................
12 percent
[40M]
88 percent
[288M]
Linguistically Isolated by Percent [Number of People]
Linguistically Isolated .......................................................................................
5 percent
[18M]
10 percent
[1.8M]
khammond on DSKJM1Z7X2PROD with RULES2
Notes:
• Nationwide population and demographic percentages are based on Census’ 2015–2019 ACS 5-year block group averages. Total population
count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
• To account for the uncertainty of demographics estimates in smaller populations, any population values of 100 persons or less have been
shown simply as ‘‘<100.’’
4. Demographics of Affected
Populations Anticipated After
Implementation of Residual Risk
Standards (Post-Control)
This analysis presented information
on the populations living within 10 km
of the facilities with estimated cancer
risks greater than or equal to 1-in-1
million (table 26), greater than or equal
to 50-in-1 million (table 27), and greater
than 100-in-1 million (table 28) after
implementation of the standards being
finalized under CAA section 112(f)(2) as
described in section IV.C of this
preamble. The demographic results for
the risks after implementation of the
residual risk-based controls are in the
column titled ‘‘Residual Risk
Standards.’’ These standards will be
implemented in addition to the CAA
section 112(d)(2), (3), and (5) standards
and are anticipated to result in
additional post-control emissions
reductions. Therefore, in this analysis,
we evaluated how all of the final
standards and emission reductions
described in this action affect the
reduction and distribution of risks. This
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
enables us to characterize the postcontrol risks and to understand whether
the final action affects, creates or
mitigates potential EJ concerns as
compared to the baseline.
The risk analysis indicated that the
number of people exposed to risks
greater than or equal to 1-in-1 million
within 10 km of a facility (table 26) is
reduced from 3.2 million people after
implementation of the CAA section
112(d)(2), (3), and (5) controls to
approximately 700,000 people after
implementation of the residual risk
standards. This represents a significant
reduction (about 80 percent reduction)
in the size of the population facing this
level of risk after implementation of the
residual risk standards being finalized,
when compared to the population facing
this level of risk after implementation of
just the CAA section 112(d)(2), (3), and
(5) controls. The people with a cancer
risk greater than or equal to 1-in-1
million are located around 67 facilities
after implementation of the residual risk
standard-based controls.
PO 00000
Frm 00055
Fmt 4701
Sfmt 4700
The demographics of the post-control
population living within 10 km of a
facility and with an estimated cancer
risks greater than or equal to 1-in-1
million after implementation of the
residual risk standards and resulting
controls (table 26) are very similar to the
CAA section 112(d)(2), (3), and (5) postcontrol population with risks greater
than or equal to 1-in-1 million.
Specifically, the percent of the
population that is Hispanic or Latino is
nearly twice the national average (34
percent versus 19 percent), the percent
below poverty is above national average
(15 percent versus 13 percent), the
percent over 25 without a high school
diploma is above the national average
(15 percent versus 12 percent), and the
percent linguistic isolation is almost
two times the national average (11
percent versus 5 percent).
The risk analysis indicated that the
number of people living within 10 km
of a facility and exposed to risks greater
than or equal to 50-in-1 million (table
27) is reduced from 23,000 people after
implementation of the CAA section
E:\FR\FM\05APR2.SGM
05APR2
24144
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
112(d)(2), (3), and (5)-based controls to
170 people after implementation of the
residual risk-based controls. This
represents a 99 percent reduction in the
size of the populations at risk. The
people living within 10 km of a facility
and with a cancer risk greater than or
equal to 50-in-1 million after
implementation of the final rule are
located around 11 facilities.
The demographic breakdown of the
much smaller post-control population
living within 10 km of a facility and
with estimated cancer risks greater than
or equal to 50-in-1 million for the
residual risk controls (table 27) is
significantly different from the
population after implementation of the
CAA section 112(d)(2), (3), and (5)
controls. Specifically for the 170
individuals still at greater than or equal
to 50-in-1 million risk, the percent of
the population that is Hispanic or
Latino is significantly higher at 76
percent for the residual risk controls.
This higher percentage is driven by two
facilities in Puerto Rico, for which the
population is over 99 percent Hispanic
or Latino. However, the number of
Hispanic or Latino people with risks
greater than or equal to 50-in-1 million
was reduced by about 99 percent from
13,000 people to 130 people after
anticipated implementation of the
residual risk standard-based controls.
Similarly, the percentage of the
population that is below the poverty
level or linguistically isolated went up
from the CAA section 112(d)(2), (3), and
(5) post-control population, but the
number of people in each demographic
decreased significantly.
The risk analysis indicated that the
number of people living within 10 km
of a facility and exposed to risks greater
than 100-in-1 million (table 28) is
reduced from 3,900 people after
implementation of the CAA section
112(d)(2), (3), and (5)-based controls to
zero people for residual risk-based
controls. After implementation of the
residual risk standards, there are no
facilities or people with risks greater
than 100-in-1 million. Therefore, there
are no greater than 100-in-1 million risk
populations or demographics to discuss.
In summary, as shown in the residual
risk post-control risk-based
demographic analysis, the standards
being finalized will reduce the number
of people and facilities expected to have
cancer risks greater than or equal to 1in-1 million, greater than or equal to 50in-1 million, and greater than 100-in-1
million significantly. Under residual
risk-based controls, the number of
Hispanic or Latino people that are
exposed to risks greater than or equal to
1-in-1 million is reduced by 80 percent,
the number of Hispanic or Latino people
that are exposed to risks greater than or
equal to 50-in-1 million is reduced by
99 percent, and the number of Hispanic
or Latino people that are exposed to
risks greater than 100-in-1 million is
reduced by 100 percent. We note that,
primarily driven by the higher risk
facilities in Puerto Rico, the percentage
of population that is Hispanic or Latino,
below the poverty level, over 25 without
a high school diploma, or in linguistic
isolation increases as the cancer risk
increases from greater than or equal to
1-in-1 million to greater than 50-in-1
million. Under residual risk-based
controls, there are no facilities or people
with risks greater than 100-in-1 million.
TABLE 26—COMPARISON OF DEMOGRAPHICS FOR POPULATIONS WITH CANCER RISK GREATER THAN OR EQUAL TO 1-IN-1
MILLION LIVING WITHIN 10 KM OF STERILIZER FACILITIES AFTER IMPLEMENTATION OF VARIOUS COMPONENTS OF THE
FINAL STANDARDS
Cancer risk ≥1-in-1 million
Demographic group
Nationwide
Total Population ...........................................................................................................................
Number of Facilities with Pop. Above Cancer Level ...................................................................
328M
........................
Post-control
CAA section
112(d)(2), (3),
and (5) standards
Residual risk
standards
(CAA section
112(f)(2))
3.2M
70
700K
67
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
19 percent
[62M]
8 percent
[27M]
40 percent
[1.3M]
16 percent
[520K]
0.3 percent
[9K]
38 percent
[1.2M]
6 percent
[190K]
40 percent
[280K]
18 percent
[130K]
0.2 percent
[2.2K]
34 percent
[240K]
8 percent
[53K]
13 percent
[44M]
87 percent
[284M]
16 percent
[520K]
84 percent
[7M]
15 percent
[100K]
85 percent
[600K]
12 percent
[40M]
88 percent
[288M]
18 percent
[590K]
82 percent
[2.7M]
15 percent
[110K]
85 percent
[590K]
Race and Ethnicity by Percent [Number of People]
White ............................................................................................................................................
African American .........................................................................................................................
Native American ..........................................................................................................................
Hispanic or Latino (includes white and nonwhite) .......................................................................
Other and Multiracial ...................................................................................................................
Income by Percent [Number of People]
Below Poverty Level ....................................................................................................................
khammond on DSKJM1Z7X2PROD with RULES2
Above Poverty Level ....................................................................................................................
Education by Percent [Number of People]
> 25 w/o a HS Diploma ...............................................................................................................
> 25 w/HS Diploma ......................................................................................................................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00056
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
24145
TABLE 26—COMPARISON OF DEMOGRAPHICS FOR POPULATIONS WITH CANCER RISK GREATER THAN OR EQUAL TO 1-IN-1
MILLION LIVING WITHIN 10 KM OF STERILIZER FACILITIES AFTER IMPLEMENTATION OF VARIOUS COMPONENTS OF THE
FINAL STANDARDS—Continued
Cancer risk ≥1-in-1 million
Demographic group
Nationwide
Post-control
CAA section
112(d)(2), (3),
and (5) standards
Residual risk
standards
(CAA section
112(f)(2))
Linguistically Isolated by Percent [Number of People]
Linguistically Isolated ...................................................................................................................
5 percent
[18M]
11 percent
[360K]
11 percent
[80K]
Notes:
• Nationwide population and demographic percentages are based on Census’ 2015–2019 ACS 5-year block group averages. Total population
count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
TABLE 27—COMPARISON OF DEMOGRAPHICS FOR POPULATIONS WITH CANCER RISK GREATER THAN OR EQUAL TO 50-IN1 MILLION LIVING WITHIN 10 KM OF STERILIZER FACILITIES AFTER IMPLEMENTATION OF VARIOUS COMPONENTS OF
THE FINAL RULE
Cancer risk ≥50-in-1 million
post-control
Demographic group
Nationwide
Total Population ...........................................................................................................................
Number of Facilities with Pop. Above Cancer Level ...................................................................
328M
........................
CAA section
112(d)(2), (3),
and (5)
standards
Residual risk
standards
(112(f)(2))
23,000
23
170
11
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
19 percent
[62M]
8 percent
[27M]
30 percent
[7K]
13 percent
[2.9K]
0.1 percent
[190]
56 percent
[13K]
2 percent
[400]
12 percent
[<100]
11 percent
[<100]
0.3 percent
[<100]
76 percent
[130]
0.4 percent
[<100]
13 percent
[44M]
87 percent
[284M]
29 percent
[6.6K]
71 percent
[17K]
30 percent
[<100]
70 percent
[120]
12 percent
[40M]
88 percent
[288M]
21 percent
[5K]
79 percent
[18K]
31 percent
[<100]
69 percent
[120]
30 percent
[6.9K]
47 percent
[<100]
Race and Ethnicity by Percent [Number of People]
White ............................................................................................................................................
African American .........................................................................................................................
Native American ..........................................................................................................................
Hispanic or Latino (includes white and nonwhite) .......................................................................
Other and Multiracial ...................................................................................................................
Income by Percent [Number of People]
Below Poverty Level ....................................................................................................................
Above Poverty Level ....................................................................................................................
Education by Percent [Number of People]
>25 w/o a HS Diploma ................................................................................................................
khammond on DSKJM1Z7X2PROD with RULES2
>25 w/HS Diploma .......................................................................................................................
Linguistically Isolated by Percent [Number of People]
Linguistically Isolated ...................................................................................................................
5 percent
[18M]
Notes:
• Nationwide population and demographic percentages are based on Census’ 2015–2019 ACS 5-year block group averages. Total population
count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00057
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24146
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
• To account for the uncertainty of demographics estimates in smaller populations, any population values of 100 persons or less have been
shown simply as ‘‘<100’’.
TABLE 28—COMPARISON OF DEMOGRAPHICS FOR POPULATIONS WITH CANCER RISK GREATER THAN 100-IN-1 MILLION
LIVING WITHIN 10 KM OF STERILIZER FACILITIES AFTER IMPLEMENTATION OF VARIOUS COMPONENTS OF THE FINAL RULE
Cancer risk >100-in-1 million
Demographic group
Nationwide
Total Population ...........................................................................................................................
Number of Facilities with Pop. Above Cancer Level ...................................................................
328M
........................
CAA section
112(d)(2), (3),
and (5) postcontrol
Residual risk
controls
3,900
13
0
0
60 percent
[197M]
12 percent
[40M]
0.7 percent
[2M]
19 percent
[62M]
8 percent
[27M]
25 percent
[1K]
6 percent
[200]
0 percent
[0]
68 percent
[2.6K]
1 percent
[<100]
........................
13 percent
[44M]
87 percent
[284M]
38 percent
[1.4K]
62 percent
[2.4K]
........................
12 percent
[40M]
88 percent
[288M]
22 percent
[900]
78 percent
[3K]
........................
44 percent
[1.7K]
........................
Race and Ethnicity by Percent [Number of People]
White ............................................................................................................................................
African American .........................................................................................................................
Native American ..........................................................................................................................
Hispanic or Latino (includes white and nonwhite) .......................................................................
Other and Multiracial ...................................................................................................................
........................
........................
........................
........................
Income by Percent [Number of People]
Below Poverty Level ....................................................................................................................
Above Poverty Level ....................................................................................................................
........................
Education by Percent [Number of People]
>25 w/o a HS Diploma ................................................................................................................
>25 w/HS Diploma .......................................................................................................................
........................
Linguistically Isolated by Percent [Number of People]
Linguistically Isolated ...................................................................................................................
5 percent
[18M]
Notes:
• Nationwide population and demographic percentages are based on Census’ 2015–2019 ACS 5-year block group averages. Total population
count within 10 km is based on 2010 Decennial Census block population.
• To avoid double counting, the ‘‘Hispanic or Latino’’ category is treated as a distinct demographic category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
• The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR was located at a user assigned receptor
at an individual residence and not at a census block centroid, we were unable to estimate population and demographics for that facility.
• The sum of individual populations with a demographic category may not add up to total due to rounding.
• To account for the uncertainty of demographics estimates in smaller populations, any population values of 100 persons or less have been
shown simply as ‘‘<100’’.
khammond on DSKJM1Z7X2PROD with RULES2
VI. Statutory and Executive Order
Reviews
A. Executive Orders 12866: Regulatory
Planning and Review and Executive
Order 13563: Improving Regulation and
Regulatory Review
This action is a ‘‘significant regulatory
action’’, as defined under section 3(f)(1)
of Executive Order 12866, as amended
by Executive Order 14094. Accordingly,
the EPA submitted this action to the
Office of Management and Budget
(OMB) for Executive Order 12866
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
review. Documentation of any changes
made in response to the Executive Order
12866 review is available in the docket.
The EPA prepared an analysis of the
potential costs and benefits associated
with this action. This analysis,
Regulatory Impact Analysis for the Final
National Emission Standards for
Hazardous Air Pollutants: Ethylene
Oxide Commercial Sterilization and
Fumigation Operations, is also available
in the docket.
PO 00000
Frm 00058
Fmt 4701
Sfmt 4700
B. Paperwork Reduction Act (PRA)
The information collection activities
in this rule have been submitted for
approval to the Office of Management
and Budget (OMB) under the PRA. The
Information Collection Request (ICR)
document that the EPA prepared has
been assigned EPA ICR number 1666.12.
You can find a copy of the ICR in the
docket for this rulemaking, and it is
briefly summarized here.
We are amending the reporting and
recordkeeping requirements for several
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
emission sources at commercial
sterilization facilities (e.g., SCV, ARV,
CEV, and room air emissions). The
amendments also require electronic
reporting, removes the SSM exemption,
and imposes other revisions that affect
reporting and recordkeeping. This
information was be collected to assure
compliance with 40 CFR part 63,
subpart O.
Respondents/affected entities:
Owners or operators of commercial
sterilization facilities.
Respondent’s obligation to respond:
Mandatory (40 CFR part 63, subpart O).
Estimated number of respondents: 88
facilities.
Frequency of response: Quarterly,
semiannual, or annual. Responses
include notification of compliance
status reports and semiannual
compliance reports.
Total estimated burden: 34,351 hours
(per year) for the responding facilities
and 9,174 hours (per year) for the
Agency. Burden is defined at 5 CFR
1320.3(b).
Total estimated cost: $5,140,563 (per
year), which includes $2,549,368
annualized capital and operation and
maintenance costs for the responding
facilities.
An Agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number. The OMB control
numbers for the EPA’s regulations in 40
CFR are listed in 40 CFR part 9. When
OMB approves this ICR, the Agency will
announce that approval in the Federal
Register and publish a technical
amendment to 40 CFR part 9 to display
the OMB control number for the
approved information collection
activities contained in this final rule.
khammond on DSKJM1Z7X2PROD with RULES2
C. Regulatory Flexibility Act (RFA)
Pursuant to section 603 of the RFA,
the EPA prepared a final regulatory
flexibility analysis (FRFA) that
examines the impact of the rule on
small entities along with regulatory
alternatives that could minimize the
impact. The complete FRFA is available
for review in the docket and is
summarized here.
1. Statement of Need and Rule
Objectives
This industry is regulated by the EPA
because pollutants emitted from EtO
sterilization and fumigation facilities are
considered to cause or contribute
significantly to air pollution that may
reasonably be anticipated to endanger
public health. This action is being
finalized to comply with CAA section
112 requirements, which direct the EPA
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
to complete periodic reviews of
NESHAPs following initial
promulgation. The requirements are
being finalized to address unacceptable
health risks linked to emissions from
subpart O facilities and to provide an
ample margin of safety to protect public
health.
The EPA is required under CAA
section 112(d) to establish emission
standards for each category or
subcategory of major and area sources of
HAPs listed for regulation in section
112(b). These standards are applicable
to new or existing sources of HAPs and
require the maximum degree of
emission reduction. The EPA is required
to review these standards set under
CAA section 112 every eight years
following their promulgation and revise
them as necessary, taking into account
any ‘‘developments in practices,
processes, or control technologies.’’ This
review is known as the technology
review. It has been over 25 years since
the initial NESHAP for this source
category was promulgated in 1994 and
roughly 15 years since the last
technology review. As such, this final
rule is overdue. This rule also
establishes standards for currently
unregulated sources of EtO emissions at
subpart O facilities under CAA section
112(d), such as room air emissions. The
decision in Louisiana Environmental
Action Network v. EPA, 955 F.3d 1088
(D.C. Cir. 2020) concluded that the EPA
is required to address regulatory gaps
(i.e., ‘‘gap-filling’’) when conducting
NESHAP reviews. Finally, the EPA
determined that a risk review was
warranted (despite not being required)
due to the updated unit risk estimate
associated with EtO, which is
significantly higher than it was during
the last review of this NESHAP in 2006.
Therefore, the EPA is finalizing
requirements under CAA section 112(f)
to address unacceptable health risk
attributed to emissions from subpart O
facilities and to provide an ample
margin of safety to protect public health.
2. Significant Issues Raised by the
Public Comments in Response to the
Initial Regulatory Flexibility Analysis
(IRFA) and EPA Response
While the EPA did not receive any
comments specifically in response to
the IRFA, we did receive comments
from the Office of Advocacy within the
Small Business Administration (SBA),
and a summary of the major comments
and our responses is provided in the
next section. The issues raised by SBA
were also reflected in comments from
small businesses and organizations with
small business interests.
PO 00000
Frm 00059
Fmt 4701
Sfmt 4700
24147
3. SBA Office of Advocacy Comments
and EPA Response
The SBA’s Office of Advocacy
(hereafter referred to as ‘‘Advocacy’’)
provided substantive comments on the
April 2023 Proposal. Those comments
made the following claims: (1) the
proposed compliance period for existing
sources (18 months) would
disadvantage small business; (2) the
proposed requirement for area source
commercial sterilization facilities to
obtain a title V permit would impose
significant costs and uncertainty for
small businesses; and (3) EPA should
adopt the BMP alternatives for GACT at
area source facilities. Based on those
claims, Advocacy insisted that EPA
reconsider these policies to reduce the
impact on small entities and reduce the
likelihood they will leave the market.
In response to Advocacy’s comments,
EPA agrees that the proposed
compliance timeframe is too short and
that more time is needed to comply with
the rule. Therefore, as part of the final
rulemaking, EPA is providing the
maximum amount of time that is
allowed under the CAA to comply with
the emission standards, which is three
years for standards that are promulgated
pursuant to CAA section 112(d) and two
years for standards that are promulgated
pursuant to CAA section 112(f)(2). With
respect to title V permitting, because of
the lack of other Federal requirements
under the CAA that commercial
sterilization facilities are subject to, as
well as the robust monitoring and
reporting requirements of the final rule,
the EPA is not finalizing a requirement
for area source facilities to obtain a title
V permit. In addition, with respect to
GACT, emission standards were
evaluated against the BMP on a sourceby-source basis. In general, we are
finalizing the emission standards for
each source pursuant to CAA section
112(d)(5), with the exception of existing
Group 2 room air emissions at areas
source facilities, because they achieve
higher emission reductions than the
BMP. Further discussion is available in
section IV.B.3.
More detailed responses to
Advocacy’s comments can be found in
the document, Summary of Public
Comments and Responses for the Risk
and Technology Review for Commercial
Sterilization Facilities, available in the
docket for this rulemaking.
4. Estimate of the Number of Small
Entities to Which the Final Rule Applies
For purposes of assessing the impacts
of this rule on small entities, a small
entity is defined as a small business in
the commercial EtO sterilization
E:\FR\FM\05APR2.SGM
05APR2
24148
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
industry whose parent company has
revenues or numbers of employees
below the SBA Size Standards for the
relevant NAICS code. We have
identified 20 different NAICS codes
within this source category. A complete
list of those NAICS codes and SBA Size
Standards is available in section 5.2 of
the RIA. The rule contains provisions
that will affect 22 small entities. These
small entities are involved in sterilizing
various types of medical devices and
spices. In addition, at least 12 of these
small entities are involved in sterilizing
the types of medical devices discussed
in section I.A.1 of this preamble.
5. Projected Reporting, Recordkeeping
and Other Compliance Requirements of
the Final Rule
Under the rule requirements, small
entities will be required to comply with
various emission standards, which may
require the use of one or more new
control devices. Small entities will also
need to demonstrate compliance with
the emission standards through the use
of an EtO CEMS or through periodic
performance testing and parametric
monitoring. This rule includes
reporting, recordkeeping, and other
administrative requirements. Under the
rule, the EPA estimates that
approximately 13 small entities (60
percent of small entities) could incur
total annual costs associated with the
proposal that are at least three percent
of their annual revenues. Considering
the level of total annual costs relative to
annual sales for these small entities, the
EPA determined that there is potential
for the requirements to have a
‘Significant Impact on a Substantial
Number of Small Entities’. See section
5.2 of the RIA for more information on
the characterization of the impacts
under the rule.
6. Steps Taken To Minimize Economic
Impact to Small Entities
khammond on DSKJM1Z7X2PROD with RULES2
a. Small Business Advocacy Review
Panel
As required by section 609(b) of the
RFA, the EPA also convened a Small
Business Advocacy Review (SBAR)
Panel to obtain advice and
recommendations from small entity
representatives (SERs) that potentially
would be subject to the rule’s
requirements. On November 25, 2020,
the EPA’s Small Business Advocacy
Chairperson convened the Panel, which
consisted of the Chairperson, the
Director of the Sector Policies and
Programs Division within the EPA’s
Office of Air Quality Planning and
Standards, the Administrator of the
Office of Information and Regulatory
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Affairs within OMB, and the Chief
Counsel for Advocacy of the SBA.
Prior to convening the Panel, the EPA
conducted outreach and solicited
comments from the SERs. After the
Panel was convened, the Panel provided
additional information to the SERs and
requested their input. In light of the
SERs’ comments, the Panel considered
the regulatory flexibility issues and
elements of the IRFA specified by RFA/
Small Business Regulatory Enforcement
and Fairness Act and developed the
findings and discussion summarized in
the SBAR report. The report was
finalized on April 26, 2021, and
transmitted to the EPA Administrator
for consideration. A copy of the full
SBAR Panel Report is available in the
rulemaking docket.
b. Alternatives Considered
The SBAR Panel recommended
several flexibilities relating to the format
of the standards, room air emissions
requirements, subcategorization, the
compliance timeframe, the
consideration of GACT standards,
incentivizing lower EtO use, a
compliance alternative for combined
emission streams, proximity
requirements, and the consideration of
interactions with OSHA standards. The
EPA is including some of these
flexibilities as a part of the rule
requirements.
As discussed in section VI.C.3, the
EPA is providing the maximum amount
of time that is allowed under the CAA
to comply with the emission standards.
In addition, as discussed in section
IV.B.3.b, the EPA is not any finalizing
any mass rate emission standards and is
finalizing percent emission reduction
standards in their place. Finally, as
discussed in section IV.F.3, the EPA is
finalizing compliance flexibilities for
combined emission streams, as well as
the option to demonstrate compliance
with a site-wide emission limit, as
opposed to having to demonstrate
compliance with each individual or
combined emission stream.
In addition, the EPA is preparing a
Small Entity Compliance Guide to help
small entities comply with this rule.
The Small Entity Compliance Guide
will be available on the same date as the
date of publication of the final rule or
as soon as possible after that date and
will be available on the rule web page
at: https://www.epa.gov/stationarysources-air-pollution/ethylene-oxideemissions-standards-sterilizationfacilities.
PO 00000
Frm 00060
Fmt 4701
Sfmt 4700
D. Unfunded Mandates Reform Act
(UMRA)
This action does not contain an
unfunded mandate of $100 million or
more as described in UMRA, 2 U.S.C.
1531–1538, and does not significantly or
uniquely affect small governments. The
action imposes no enforceable duty on
any State, local, or Tribal governments.
E. Executive Order 13132: Federalism
This action does not have federalism
implications. It will not have substantial
direct effects on the States, on the
relationship between the National
Government and the States, or on the
distribution of power and
responsibilities among the various
levels of government.
F. Executive Order 13175: Consultation
and Coordination With Indian Tribal
Governments
This action does not have Tribal
implications as specified in Executive
Order 13175. None of the commercial
sterilization facilities that have been
identified as being affected by this final
action are owned or operated by Tribal
governments or located within Tribal
lands within a 10-mile radius. Thus,
Executive Order 13175 does not apply
to this action. We conducted an impact
analysis using the latitude and
longitude coordinates from the risk
modeling input file to identify Tribal
lands within a 10- and 50-mile radius of
commercial sterilization facilities to
determine potential air quality impacts
on Tribes. Consistent with the EPA
Policy on Consultation and
Coordination with Indian Tribes,
although there were no Tribal lands
located within a 10-mile radius of
commercial sterilization facilities, the
EPA offered consultation with all Tribes
that were identified within a 50-mile
radius of an affected facility, however,
only one Tribal official requested
consultation. Additional details
regarding the consultation letter and
distribution list can be found in the
memorandum, Commercial Sterilization
Facilities RTR Consultation Letter,
which is available in the docket for this
rulemaking. The EPA also participated
on a phone call with the National Tribal
Air Association on May 25, 2023, and
presented an overview of the
rulemaking.
G. Executive Order 13045: Protection of
Children From Environmental Health
Risks and Safety Risks
Executive Order 13045 (62 FR 19885,
April 23, 1997) directs Federal agencies
to include an evaluation of the health
and safety effects of the planned
regulation on children in Federal health
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
and safety standards and explain why
the regulation is preferable to
potentially effective and reasonable
feasible alternatives. This action is
subject to Executive Order 13045
because it is a 3(f)(1) significant
regulatory action as defined by
Executive Order 12866, and the EPA
believes that the environmental health
or safety risk addressed by this action
has a disproportionate effect on
children. The EPA’s Policy on
Children’s Health also applies to this
action. Accordingly, we have evaluated
the environmental health or safety
effects of EtO emissions and exposures
on children. The protection offered by
these standards may be especially
important for children.
Because EtO is mutagenic (i.e., it can
damage DNA), children are expected to
be more susceptible to its harmful
effects. To take this into account, as part
of the risk assessment in support of this
rulemaking, the EPA followed its
guidelines and applied age-dependent
adjustment factors (ADAFs) for early
lifestage exposures (from birth up to 16
years of age). With the ADAF applied to
account for greater susceptibility of
children, the adjusted EtO inhalation
URE is 5 × 10¥3 per mg/m3. It should
be noted that, because EtO is mutagenic,
emission reductions in this preamble
will be particularly beneficial to
children. In addition, children are at
increased risk if they live, play, or
attend school in close proximity to a
commercial sterilization facility, of
which there are many cases noted by the
public to be the case. For these reasons,
there is both increased susceptibility
and increased exposure for early
lifestages as a result of EtO emissions
from commercial sterilization facilities.
A total of 3.97 million children ages
0–17 live within 10km of commercial
sterilization facilities. Due to baseline
emissions from commercial sterilization
facilities (prior to application of controls
in this action), there are approximately
1.25 million children (0–17 years) with
increased lifetime cancer risks of greater
than or equal to 1-in-1 million, 30,000
with increased lifetime cancer risks
greater than or equal to 50-in-1 million,
and 4,300 with increased lifetime cancer
risks greater than 100-in-1 million. After
application of the controls in this
action, lifetime cancer risks to children
from commercial sterilization facility
emissions decrease significantly to
approximately 162,300 children with
increased lifetime cancer risks of greater
than or equal to 1-in-1 million, less than
100 with increased lifetime cancer risks
of greater than or equal to 50-in-1
million, and none with increased
lifetime cancer risks greater than 100-in-
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
1 million. The methodology and
detailed results of the demographic
analysis are presented in a technical
report, Analysis of Demographic Factors
for Populations Living Near Ethylene
Oxide Commercial Sterilization and
Fumigation Operations, available in the
docket for this action.
More detailed information on the
evaluation of the scientific evidence and
policy considerations pertaining to
children, including an explanation for
why the Administrator judges the
standards to be requisite to protect
public health, including the health of
children, with an adequate margin of
safety, in addition to the summaries of
this action’s health and risk assessments
are contained in sections II.A and IV.C
of this preamble and further
documented in the risk report, Residual
Risk Assessment for the Commercial
Sterilization Facilities Source Category
in Support of the 2024 Risk and
Technology Review Final Rule, which is
available in Docket ID No. EPA–HQ–
OAR–2019–0178.
H. Executive Order 13211: Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use
This action is not a ‘‘significant
energy action’’ because it is not likely to
have a significant adverse effect on the
supply, distribution, or use of energy.
The overall energy impact of this rule
should be minimal for commercial
sterilization facilities and their parent
companies. EPA was unable to quantify
the degree to which manufacturers will
need to switch sites, so we cannot
estimate potential energy impacts
related to transportation. The EPA
solicited comment on any potential
impacts the proposed standards may
have in relation to energy use for
transportation but did not receive any
comments that would help to quantify
such impacts.
I. National Technology Transfer and
Advancement Act (NTTAA) and 1 CFR
Part 51
This rulemaking involves technical
standards. The EPA conducted searches
for the standards through the Enhanced
National Standards Systems Network
Database managed by the American
National Standards Institute (ANSI). We
also contacted voluntary consensus
standards (VCS) organizations and
accessed and searched their databases.
We conducted searches for EPA
Methods 1, 1A, 2, 2A, 2C, 3A, 3B, and
4 of 40 CFR part 60, Appendix A, EPA
Method 204 of 40 CFR part 51,
Appendix M, and EPA Methods 301 and
320 in 40 CFR part 63, Appendix A.
PO 00000
Frm 00061
Fmt 4701
Sfmt 4700
24149
During the EPA’s VCS search, if the title
or abstract (if provided) of the VCS
described technical sampling and
analytical procedures that are similar to
the EPA’s reference method, the EPA
reviewed it as a potential equivalent
method.
The EPA incorporates by reference
VCS ANSI/ASME PTC 19.10–1981 Part
10, ‘‘Flue and Exhaust Gas Analyses,’’ a
method for quantitatively determining
the gaseous constituents of exhausts
resulting from stationary combustion
and includes a description of the
apparatus, and calculations used which
are used in conjunction with
Performance Test Codes to determine
quantitatively, as an acceptable
alternative to EPA Method 3B of
appendix A to 40 CFR part 60 for the
manual procedures only and not the
instrumental procedures. The ANSI/
ASME PTC 19.10–1981 Part 10 method
incorporates both manual and
instrumental methodologies for the
determination of oxygen content. The
manual method segment of the oxygen
determination is performed through the
absorption of oxygen. This method is
available at the American National
Standards Institute (ANSI), 1899 L
Street NW, 11th floor, Washington, DC
20036 and the American Society of
Mechanical Engineers (ASME), Three
Park Avenue, New York, NY 10016–
5990. See https://www.ansi.org and
https://www.asme.org.
The EPA incorporates by reference
VCS ASTM D6348–12 (Reapproved
2020), ‘‘Determination of Gaseous
Compounds by Extractive Direct
Interface Fourier Transform (FTIR)
Spectroscopy,’’ as an acceptable
alternative to EPA Method 320 of
appendix A to 40 CFR part 63 with
caveats requiring inclusion of selected
annexes to the standard as mandatory.
The ASTM D6348–12 (R2020) method is
an extractive FTIR spectroscopy-based
field test method and is used to quantify
gas phase concentrations of multiple
target compounds in emission streams
from stationary sources. This Éeld test
method provides near real time analysis
of extracted gas samples. In the
September 22, 2008, NTTAA summary,
ASTM D6348–03(2010) was determined
equivalent to EPA Method 320 with
caveats. ASTM D6348–12 (R2020) is a
revised version of ASTM D6348–
03(2010) and includes a new section on
accepting the results from direct
measurement of a certified spike gas
cylinder, but still lacks the caveats we
placed on the D6348–03(2010) version.
We are finalizing that the test plan
preparation and implementation in the
Annexes to ASTM D 6348–12 (R2020),
Sections Al through A8 are mandatory;
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
and in ASTM D6348–12 (R2020) Annex
A5 (Analyte Spiking Technique), the
percent (%) R must be determined for
each target analyte (equation A5.5). We
are finalizing that, in order for the test
data to be acceptable for a compound,
%R must be 70% ≤ R ≤ 130%. If the %R
value does not meet this criterion for a
target compound, the test data is not
acceptable for that compound and the
test must be repeated for that analyte
(i.e., the sampling and/or analytical
procedure should be adjusted before a
retest). The %R value for each
compound must be reported in the test
report, and all field measurements must
be corrected with the calculated %R
value for that compound by using the
following equation:
Reported Results= st ack Concentration
%R
The ASTM D6348–12 (R2020) method
is available at ASTM International, 1850
M Street NW, Suite 1030, Washington,
DC 20036. See https://www.astm.org/.
ASTM D3695–88 is already approved
for the locations in which it appears in
the amendatory text.
While the EPA identified 12 other
VCS as being potentially applicable, the
Agency decided not to use them because
these methods are impractical as
alternatives due to lack of equivalency,
documentation, validation data, and
other important technical and policy
considerations. The search and review
results have been documented and are
in the memorandum, Voluntary
Consensus Standard Results for
National Emission Standards for
Hazardous Air Pollutants: Ethylene
Oxide Emissions Standards for
Sterilization Facilities Residual Risk
and Technology Review, which is
available in the docket for this
rulemaking.
Under 40 CFR 63.7(f) and 40 CFR
63.8(f), subpart A—General Provisions,
a source may apply to the EPA for
permission to use alternative test
methods or alternative monitoring
requirements in place of any required
testing methods, performance
specifications, or procedures in the final
rule or any amendments.
khammond on DSKJM1Z7X2PROD with RULES2
J. Executive Order 12898: Federal
Actions To Address Environmental
Justice in Minority Populations and
Low-Income Populations and Executive
Order 14096: Revitalizing Our Nation’s
Commitment to Environmental Justice
for All
The EPA believes that the human
health or environmental conditions that
exist prior to this action result in or
have the potential to result in
disproportionate and adverse human
health or environmental effects on
communities with EJ concerns. A total
of 17.3 million people live within 10 km
of the 88 facilities that were assessed.
The percent of the population that is
Hispanic or Latino is substantially
higher than the national average (36
percent versus 19 percent), driven by
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
the seven facilities in Puerto Rico,
where an average of 99 percent of the
658,000 people living within 10 km of
the facilities are Hispanic or Latino. The
proportion of other demographic groups
living within 10 km of commercial
sterilizers is similar to the national
average. The EPA also conducted a risk
assessment of possible cancer risks and
other adverse health effects, and found
that prior to the implementation of this
regulation, cancer risks are unacceptable
for several communities. See section
VI.F for an analysis that characterizes
communities living in proximity to
facilities and risks prior to
implementation of the final regulation.
The EPA believes that this action is
likely to reduce existing
disproportionate and adverse effects on
communities with EJ concerns. This
action establishes standards for SCVs
and ARVs at facilities where EtO use is
less than 1 tpy, ARVs at facilities where
EtO use is at least 1 tpy but less than
10 tpy, CEVs, and room air emissions.
In addition, it tightens standards for
SCVs at facilities where EtO use is at
least 1 tpy, as well as ARVs at facilities
where EtO use is at least 10 tpy. This
action also finalizes amendments to
correct and clarify regulatory provisions
related to emissions during periods of
SSM, including removing general
exemptions for periods of SSM and
adding work practice standards for
periods of SSM where appropriate. As a
result of these changes, we expect zero
people to be exposed to cancer risk
levels above 100-in-1 million. See
section IV for more information about
the control requirements of the
regulation and the resulting reduction in
cancer risks.
The EPA additionally identified and
addressed environmental justice
concerns by engaging in outreach
activities to communities we expect to
be impacted most by the rulemaking
The EPA is also requiring owners and
operators of commercial sterilization
facilities to submit electronic copies of
required compliance reports,
performance test reports, and
performance evaluation reports, which
PO 00000
Frm 00062
Fmt 4701
Sfmt 4700
= 100
will increase transparency and will
provide greater access to information for
the public, including impacted
communities.
The information supporting this
Executive order review is contained in
section VI.F of this preamble, as well as
in a technical report, Analysis of
Demographic Factors for Populations
Living Near Ethylene Oxide Commercial
Sterilization and Fumigation
Operations, available in the docket for
this action.
K. Congressional Review Act (CRA)
This action is subject to the CRA, and
the EPA will submit a rule report to
each House of the Congress and to the
Comptroller General of the United
States. This action is not a ‘‘major rule’’
as defined by 5 U.S.C. 804(2).
List of Subjects
40 CFR Part 60
Environmental protection,
Administrative practice and procedures,
Hazardous substances, Reporting and
recordkeeping requirements.
40 CFR Part 63
Environmental protection,
Administrative practice and procedures,
Air pollution control, Hazardous
substances, Incorporation by reference,
Intergovernmental relations, Reporting
and recordkeeping requirements.
Michael S. Regan,
Administrator.
For the reasons set forth in the
preamble, the EPA amends 40 CFR parts
60 and 63 as follows:
PART 60—STANDARDS OF
PERFORMANCE FOR NEW
STATIONARY SOURCES
1. The authority citation for part 60
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.001
24150
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Appendix B to Part 60—Performance
Specifications
2. Appendix B to part 60 is amended
by adding Performance Specification 19
to read as follows:
■
Appendix B to Part 60—Performance
Specifications
*
*
*
*
*
khammond on DSKJM1Z7X2PROD with RULES2
Performance Specification 19-Performance
Specifications and Test Procedures for
Ethylene Oxide (ETO) Continuous Emission
Monitoring Systems
1.0 Scope and Application
1.1 Analyte. This performance
specification (PS) is applicable for measuring
gaseous concentrations of Ethylene Oxide
(EtO), CAS: 775–21–8, on a continuous basis
in the units of the applicable standard or in
units that can be converted to units of the
applicable standard(s) (e.g., lbs/hr,). This
performance specification may be approved
for the measurement of other pollutants and/
or in other sectors by the Administrator on
a case-by-case basis if not otherwise allowed
or denied in an applicable subpart of the
regulations.
1.2 Applicability.
1.2.1 This specification is used to
evaluate the acceptability of EtO continuous
emission monitoring systems (CEMS) at the
time of installation or soon after and
whenever specified in the regulations. The
specification includes requirements for
initial acceptance including instrument
accuracy and stability assessments and use of
audit samples if they are available.
1.2.2 The Administrator may require the
operator, under section 114 of the Clean Air
Act, to conduct CEMS performance
evaluations at other times besides the initial
test to evaluate the CEMS performance. See
40 CFR part 60, § 60.13(c) and § 63.8(e)(1).
1.2.3 A source that demonstrates their
CEMS meets the criteria of this PS may use
the system to continuously monitor gaseous
EtO under any regulation or permit that
requires compliance with this PS. If your
CEMS reports the EtO concentration in the
units of the applicable standard, no
additional CEMS components are necessary.
If your CEMS does not report concentrations
in the units of the existing standard, then
other CEMS (i.e., oxygen) or CEMS
components (e.g., temperature, stack gas
flow, moisture, and pressure) may be
necessary to convert the units reported by
your CEMS to the units of the standard.
1.2.4 These specification test results are
intended to be valid for the life of the system.
As a result, the EtO measurement system
must be tested and operated in a
configuration consistent with the
configuration that will be used for ongoing
continuous emissions monitoring.
1.2.5 Substantive changes to the system
configuration require retesting according to
this PS. Examples of such conditions include
but are not limited to: major changes in
dilution ratio (for dilution-based systems);
changes in sample conditioning and
transport, if used, such as filtering device
design or materials; changes in probe design
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
or configuration and changes in materials of
construction. Changes consistent with
instrument manufacturer upgrade that fall
under manufacturer’s certification do not
require additional field verification.
Manufacturer’s upgrades (e.g., changes to the
quantification algorithm) require
recertification by the manufacturer for those
requirements allowed by this PS, including
interference, and level of detection (LOD).
1.2.6 This specification is not designed to
evaluate the ongoing CEMS performance, nor
does it identify specific calibration
techniques and auxiliary procedures to assess
CEMS performance over an extended period
of time. The requirements in Procedure 7 to
Appendix F of this part are designed to
provide a way to assess CEMS and CEMS
components (if applicable) performance over
an extended period of time. The source
owner or operator is responsible to calibrate,
maintain, and operate the CEMS properly.
2.0 Summary of Performance Specification
2.1 This specification covers the
procedures that each EtO CEMS must meet
during the performance evaluation test.
Installation and measurement location
specifications, data reduction procedures,
and performance criteria are included.
2.2 The technology used to measure EtO
must provide a distinct response and address
any appropriate interference correction(s). It
must accurately measure EtO in a
representative sample of stack effluent.
2.3 The relative accuracy (RA) must be
established against a reference method (RM)
(i.e., Method 320, or other alternative
approved as a RM by the Administrator) on
a case-by-case basis if not otherwise allowed
or denied in an applicable subpart of the
regulations.
2.4 A standard addition (SA) procedure
using a reference standard is included in
appendix A to this performance specification
for use in verifying LOD. For extractive
CEMS, where the SA is done by dynamic
spiking (DS), the appendix A procedure is
allowed as an option for assessing calibration
drift and is also referenced by Procedure 7 of
appendix F to this part for ongoing quality
control tests.
3.0 Definitions
3.1 Calibration drift (CD) means the
absolute value of the difference between the
CEMS output response and an upscale
reference gas or a zero-level gas, expressed as
a percentage of the span value, when the
CEMS is challenged after a stated period of
operation during which no unscheduled
adjustments, maintenance or repairs took
place. For other parameters that are
selectively measured by the CEMS (e.g.,
temperature, velocity, pressure, flow rate) to
measure in the units of the applicable
standard, use two analogous values (e.g.,
Low: 0–20% of full scale, High: 50–100% of
full scale). 3.2 Calibration Span means the
calibrated portion of the measurement range
as specified in the applicable regulation or
another requirement. If the span is not
specified in the applicable regulation or other
requirement, then it must be a value
approximately equivalent to three times the
applicable emission standard. When the
PO 00000
Frm 00063
Fmt 4701
Sfmt 4700
24151
emission standard is expressed as mass
emissions, use the average flow rate in the
duct to calculate the concentration
equivalent of the emission standard.
3.3 Centroidal area means a central area
that is geometrically similar to the stack or
duct cross section and is no greater than 10
percent of the stack or duct cross-sectional
area.
3.4 Continuous Emission Monitoring
System (CEMS) means the total equipment
required to measure the pollutant
concentration or emission rate continuously.
The system generally consists of the
following three major subsystems:
3.4.1 Sample interface means that portion
of the CEMS used for one or more of the
following: Sample acquisition, sample
transport, sample conditioning, and
protection of the monitor from the effects of
the stack effluent.
3.4.2 EtO analyzer means that portion of
the EtO CEMS that measures the total vapor
phase EtO concentration and generates a
proportional output.
3.4.3 Data recorder means that portion of
the CEMS that provides a permanent
electronic record of the analyzer output. The
data recorder may record other pertinent data
such as effluent flow rates, various
instrument temperatures or abnormal CEMS
operation. The data recorder may also
include automatic data reduction capabilities
and CEMS control capabilities.
3.5 Diluent gas means a major gaseous
constituent in a gaseous pollutant mixture.
For combustion sources, either carbon
dioxide (CO2) or oxygen (O2) or a
combination of these two gases are the major
gaseous diluents of interest.
3.6 Dynamic spiking (DS) means the
procedure where a known concentration of
EtO gas is injected into the probe sample gas
stream for extractive CEMS at a known flow
rate to assess the performance of the
measurement system in the presence of
potential interference from the flue gas
sample matrix.
3.7 Flow Rate Sensor means that portion
of the CEMS that senses the volumetric flow
rate and generates an output proportional to
that flow rate. The flow rate sensor shall have
provisions to check the CD for each flow rate
parameter that it measures individually (e.g.,
velocity, pressure).
3.8 Independent measurement(s) means
the series of CEMS data values taken during
sample gas analysis separated by two times
the procedure specific response time (RT) of
the CEMS.
3.9 Interference means a compound or
material in the sample matrix other than EtO
whose characteristics may bias the CEMS
measurement (positively or negatively). The
interference may not prevent the sample
measurement but could increase the
analytical uncertainty in the measured EtO
concentration through reaction with EtO or
by changing the electronic signal generated
during EtO measurement.
3.10 Interference test means the test to
detect CEMS responses to interferences that
are not adequately accounted for in the
calibration procedure and may cause
measurement bias.
3.11 Level of detection (LOD) means the
lowest level of pollutant that the CEMS can
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24152
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
detect in the presence of the source gas
matrix interferents with 99 percent
confidence.
3.12 Measurement error (ME) is the mean
difference between the concentration
measured by the CEMS and the known
concentration of a reference gas standard,
divided by the span, when the entire CEMS,
including the sampling interface, is
challenged.
3.13 Reference gas standard means the
gas mixture containing EtO at a known
concentration and produced and certified in
accordance with ‘‘EPA Traceability Protocol
for Assay and Certification of Gaseous
Calibration Standards,’’ September 1997, as
amended August 25, 1999, EPA–600/R–97/
121 or more recent updates. The tests for
analyzer measurement error, calibration drift,
and system bias require the use of calibration
gas prepared according to this protocol. If a
zero gas is used for the low-level gas, it must
meet the requirements under the definition
for ‘‘zero air’’ in 40 CFR 72.2. Alternatively,
if the ‘‘protocol’’ gas is not commercially
available, you must use a reference gas that
has been prepared according to the
procedures in appendix B of this PS.
3.14 Relative accuracy (RA) means the
absolute mean difference between the gas
concentration, or the emission rate
determined by the CEMS, and the value
determined by the RM, plus the confidence
coefficient of a series of nine test runs,
divided by the average of the RM or the
applicable emission standard.
3.15 Response time (RT) means the time
it takes for the measurement system, while
operating normally at its target sample flow
rate, dilution ratio, or data collection rate to
respond to a known step change in gas
concentration, either from a low- or zerolevel to a high-level gas concentration or
from a high-level to a low or zero-level gas
concentration, and to read 95 percent of the
change to the stable instrument response.
There may be several RTs for an instrument
related to different functions or procedures
(e.g., DS, LOD, and ME).
3.16 Span value means an EtO
concentration approximately equal to two
times the concentration equivalent to the
emission standard unless otherwise specified
in the applicable regulation, permit or
another requirement. Unless otherwise
specified, the span may be rounded up to the
nearest multiple of 5.
3.17 Stable value means the measure of
two or more values that are statistically the
same and the absence of measurement system
drift.
3.18 Standard addition means the
addition of known amounts of EtO gas (either
statically or dynamically) measured sample
gas stream.
3.19 Zero gas means a gas with an EtO
concentration that is below the LOD of the
measurement system.
4.0 Interferences
Sample gas interferences will vary
depending on the instrument or technology
used to make the measurement. Interferences
must be evaluated through the interference
test in this PS. Several compounds including
carbon dioxide (CO2), carbon monoxide (CO),
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
methane (CH4), and water (H2O) are potential
optical interferences with certain types of
EtO monitoring technology.
Note: Interferences may be mitigated
though the use of dilution systems, however
this approach could also affect the sensitivity
of the measurement.
5.0 Safety
The procedures required under this PS
may involve hazardous materials, operations,
and equipment. This PS may not address all
the safety issues associated with these
procedures. It is the responsibility of the user
to establish appropriate safety and health
practices and determine the applicable
regulatory limitations prior to performing
these procedures. The CEMS user’s manual
and as well as cautions within and materials
recommended by the RM should be
consulted for specific precautions to be taken
in regard to the relative accuracy testing.
6.0 Equipment and Supplies
The equipment and supplies are the same
as in section 6 of PS 18, except replace HCl
for EtO where appropriate. The following
definitions are added and/or revised:
6.1 Moisture Measurement System. If
correction of the measured EtO emissions for
moisture is required, you must install,
operate, maintain, and quality assure a
continuous moisture monitoring system for
measuring and recording the moisture
content of the flue gases. The following
continuous moisture monitoring systems are
acceptable: Any optical measurement system
validated according to Method 301 or section
13.0 of Method 320 in appendix A to part 63
of this chapter; a continuous moisture sensor;
an oxygen analyzer (or analyzers) capable of
measuring O2 both on a wet basis and on a
dry basis; or other continuous moisture
measurement methods approved by the
Administrator.
7.0 Reagents and Standards
7.1 Reference Gases means the gas
mixture containing EtO at a known
concentration and produced and certified in
accordance with ‘‘EPA Traceability Protocol
for Assay and Certification of Gaseous
Standards, May 2012 (EPA 600/R–12/531) or
more recent updates. The tests for analyzer
measurement error, calibration drift, and
system bias require the use of calibration gas
prepared according to this protocol. If a zero
gas is used for the low-level gas, it must meet
the requirements under the definition for
‘‘zero air’’ in 40 CFR 72.2. Alternatively, if
the ‘‘protocol’’ gas is not commercially
available, you must use a reference gas that
has been prepared according to the
procedures in appendix B of this PS and
meeting the requirements in section 12.2 of
appendix B of this PS, if applicable.
7.2 Cylinder gas may be diluted for use in
this specification, including measurement
error testing. You must document the
quantitative introduction of EtO standards
into the system using Method 205, found in
40 CFR part 51, appendix M, or other
procedure approved by the Administrator.
The laboratory/field evaluations in Method
205 must be conducted at least quarterly and
prior to any audit test (e.g., CGA, RAA)
required in QA Procedure 7 (40 CFR part 60,
PO 00000
Frm 00064
Fmt 4701
Sfmt 4700
appendix F). Calibration must be conducted
on an annual basis or whenever significant
changes are made to the dilution system. In
addition to the requirements in Method 205,
when in use, you must document gas flow
rates through each of the channels; if the
dilution system records these values
electronically, this is considered the
documentation. For the purpose of this PS,
cylinder gas should not be diluted beyond a
dilution ratio of 500:1 using Method 205.
8.0 CEMS Measurement Location
Specifications and Pretest Preparation
8.1 Prior to the start of your initial PS
tests, you must ensure that the CEMS is
installed according to the manufacturer’s
specifications and the requirements in this
section.
8.2 CEMS Installation. Install the CEMS
at an accessible location where the pollutant
concentration or emission rate measurements
are directly representative of the EtO
emissions. If the units of the emission
standard are expressed as a mass (e.g., lb/hr),
then the CEMS probe must also be located
within 0.5 equivalent diameters of the flow
sensor and the CEMS must be located (1) at
least two equivalent diameters downstream
from the nearest control device, the point of
pollutant generation, or other point at which
a change in the pollutant concentration or
emission rate may occur and (2) at least a half
equivalent diameter upstream from the
effluent exhaust or control device. If the
CEMS are to utilize time-sharing, the
distance between each measurement point
and the CEMS should be approximately the
same. The CEMS need not be installed at the
same location as the relative accuracy test
location. If you fail the RA requirements in
this specification due to the CEMS
measurement location and a satisfactory
correction technique cannot be established,
the Administrator may require the CEMS to
be relocated.
8.2.1 Single point sample gas extraction
should be (1) no less than 1.0 m (3.3 ft.) from
the stack or duct wall or (2) within the
centroidal area of the stack or duct cross
section.
8.2.2 CEMS and Data Recorder Scale
Check. After CEMS installation, record and
document the measurement range of the EtO
CEMS. The CEMS operating range and the
range of the data recording device must
encompass all potential and expected EtO
concentrations, including the concentration
equivalent to the applicable emission limit
and the span value.
9.0
Quality Control—Reserved
10.0 Calibration and Standardization—
Reserved
11.0 Performance Specification Test
Procedure
After completing the CEMS installation,
setup, and calibration, you must complete
the PS test procedures in this section. You
must perform the following procedures and
meet the performance requirements for the
initial demonstration of your CEMS:
a. Interference Test;
b. Level of Detection Determination;
c. Response Time Test;
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
d. Measurement Error Test;
e. Calibration Drift Test; and
f. Relative Accuracy Test.
g. If CEMS is to be time-shared, determine
the response time to each measurement
point, the sampling time at each
measurement point, and the cycle time at
each measurement point. The sampling time
at each measurement point shall be at least
3 times as long as the system response time
(RT), and the maximum number of
measurement points shall not exceed the
quotient, rounded down to the next whole
number, of 15 minutes divided by the longest
cycle time of the measurement point.
11.1 Interference Test
11.1.1 Prior to its initial use in the field,
you must demonstrate that your monitoring
system meets the performance requirements
of the interference test in section 13.5 of this
PS to verify that the candidate system
measures EtO accurately in the presence of
common interferences in emission matrices
from commercial sterilizers. In the event this
performance specification is applied in other
emission sources, the interference test must
evaluate any other predominant gases is the
emission matrices of those sources.
11.1.2 Your interference test must be
conducted in a controlled environment. The
equipment you test for interference must
include the combination of the analyzer,
related analysis software, and any sample
conditioning equipment (e.g., dilution
module, moisture removal equipment or
other interferent scrubber) used to control
interferents.
11.1.3 If you own multiple measurement
systems with components of the same make
and model numbers, you need only perform
this interference test on one analyzer and
associated interference conditioning
equipment combination. You may also rely
on an interference test conducted by the
manufacturer or a continuous measurement
system integrator on a system having
components of the same make(s) and
model(s) of the system that you use.
11.1.4 Perform the interference check
using an EtO reference gas concentration of
approximately ten times the LOD or at 50
parts per billion, whichever is greater.
11.1.5 Introduce the interference test
gases listed in table 1 in section 17.0 of this
PS to the analyzer/conditioning system
separately or in any combination. The
interference test gases need not be of
reference gas quality.
11.1.6 The interference test must be
performed by combining an EtO reference gas
with each interference test gas (or gas
mixture). You must measure the baseline EtO
response, followed by the response after
adding the interference test gas(es) while
maintaining a constant EtO concentration.
You must perform each interference gas
injection and evaluation in triplicate.
Note: The baseline EtO gas may include
interference gases at concentrations typical of
ambient air (e.g., 21 percent O2, 400 parts per
million (ppm) CO2, 2 percent H2O), but these
concentrations must be brought to the
concentrations listed in table 1 of this PS
when their interference effects are being
evaluated.
11.1.7 You should document the gas
volume/rate, temperature, and pressure used
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
to conduct the interference test. A gas
blending system or manifold may be used.
11.1.8 Ensure the duration of each
interference test is sufficient to condition the
EtO measurement system surfaces before a
stable measurement is obtained.
11.1.9 Measure the EtO response of the
analyzer/sample conditioning system
combination to the test gases in ppbv. Record
the responses and determine the overall
interference response using table 2 in section
17.0 of this PS.
11.1.10 For each interference gas (or
mixture), calculate the mean difference
(DMCavg) between the measurement system
responses with and without the interference
test gas(es) using equation 1 in section 12.2
of this PS. Summarize the results following
the format contained in table 2 in section 17.
11.1.11 Calculate the percent interference
(I) for the gas runs using equation 2 in section
12.2 of this PS.
11.1.12 The total interference response
(i.e., the sum of the interference responses of
all tested gaseous components) must not
exceed the criteria set forth in section 13.5
of this PS.
11.2 Level of Detection Determination
11.2.1 You must determine the minimum
amount of EtO that can be detected above the
background in a representative gas matrix.
11.2.2 You must perform the LOD
determination in a controlled environment
such as a laboratory or manufacturer’s
facility.
11.2.3 You must add interference gases
listed in table 1 of this PS to a constant
concentration of EtO reference gas.
11.2.3.1 You may not use an effective
reference EtO gas concentration greater than
ten times the estimated instrument LOD.
11.2.3.2 Inject the EtO and interferents
described in section 11.1.5 of this PS directly
into the inlet to the analyzer, allow time for
the value to stabilize and then collect
measurement data for 15 minutes and
average those results. Repeat this procedure
to obtain a total of seven or more of these
runs, purging the measurement system with
ambient air between each run, to determine
the LOD.
11.2.4 Calculate the standard deviation of
the measured values and define the LOD as
three times the standard deviation of these
measurements.
11.2.5 You must verify the controlled
environment LOD of section 11.2.2 of this PS
for your CEMS during initial setup and field
certification testing using the SA procedure
in appendix A of this PS with the following
exceptions:
11.2.5.1 You must make three
independent SA measurements spiking the
native source concentration by no more than
five times the controlled environment LOD
concentration determined in section 11.2.4.
11.2.5.2 You must perform the SA as a
dynamic spike by passing the spiked source
gas sample through all filters, scrubbers,
conditioners, and other monitoring system
components used during normal sampling,
and as much of the sampling probe as
practical.
11.2.5.3 The amount detected, or
standard addition response (SAR), is based
on the average difference of the native EtO
PO 00000
Frm 00065
Fmt 4701
Sfmt 4700
24153
concentration in the stack or duct relative to
the native stack concentration plus the SA.
You must be able to detect the effective spike
addition (ESA) above the native EtO present
in the stack gas matrix. The ESA is calculated
using equation A7 in appendix A of this PS.
11.2.5.4 If the field verification of your
system LOD does not demonstrate a SAR
greater than or equal to your initial
controlled environment LOD, you must
increase the SA concentration incrementally
and repeat the field verification procedure
until the SAR is equal to or greater than LOD.
The site-specific standard addition detection
level (SADL) is equal to the standard
addition needed to achieve the acceptable
SAR, and the SADL replaces the controlled
environment LOD. The SADL is calculated as
the ESA using equation A7 in appendix A of
this PS. As described in section 13.1 of this
PS, the controlled environment LOD or the
SADL that replaces a controlled environment
LOD must be less than 20 percent of the
applicable emission limit.
11.3 Response Time Determination. You
must determine ME– and SA–RT.
11.3.1 For ME–RT, start the upscale RT
determination by injecting zero gas into the
measurement system as required by the
procedures in section 11.4 of this PS. For the
SA–RT start the upscale RT determination at
native stack concentration of EtO. Allow the
value to stabilize, which for the purpose of
this PS is a change no change greater than 1.0
percent of span or 10 ppbv (whichever is
greater) for 30 seconds.
11.3.2 When the CEMS output has
stabilized, record the response in ppbv,
record the time (hh:mm:ss), and immediately
introduce an upscale (high level) or spike
reference gas as required by the relevant
(ME–RT or SA–RT) procedure. Record the
time (hh:mm:ss) required for the
measurement system to reach 95 percent of
the change to the final stable value, the
difference in these times is the upscale RT.
11.3.3 Reintroduce the zero gas for the
ME–RT or stop the upscale gas flow for the
SA–RT and immediately record the time
(hh:mm:ss). Record the time (hh:mm:ss)
required to reach within 95 percent of the
previous stable response in 11.3.1 or 10 ppbv
(whichever is greater); the difference in these
times is the downscale RT.
Note: For CEMS that perform a series of
operations (purge, blow back, sample
integration, analyze, etc.), you must start
adding reference or zero gas immediately
after these procedures are complete.)
11.3.4 Repeat the entire procedure until
you have three sets of data, then determine
the mean upscale and mean downscale RTs
for each relevant procedure (from each
measurement point if the CEMS is timesharing). Report the greater of the average
upscale or average downscale RTs as the RT
for the system.
11.4 Measurement Error (ME) Test
11.4.1 The measurement error test must
be performed at the same time as the
calibration drift test when the system is being
placed in service. The measurement error test
must be performed any time a substantive
change (see section 1.2.5) has been made to
the measurement system.
11.4.1.1 Introduce reference gases to the
CEMS probe, prior to the sample
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24154
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
conditioning and filtration system. You may
use a gas dilution system meeting the
requirement in section 7.2 of this PS.
11.4.1.2 Challenge the measurement
system with a zero gas and at the three
upscale EtO reference gas concentrations in
the range shown in table 3 of this PS. You
may introduce different reference gas
concentrations in any order, but you must
not introduce the same gas concentration
twice in succession.
11.4.1.3 Introduce the calibration gas into
the sampling probe with sufficient flow rate
to replace the entire source gas sample and
continue the gas flow until the response is
stable, as evidenced when the difference
between two consecutive measurements is
within 1.0 percent of span or 5 ppbv
(whichever is less). Record this value and
inject the next calibration gas.
11.4.1.4 Make triplicate measurements for
each reference gas for a total of twelve
measurements.
11.4.1.5 At each reference gas
concentration, determine the average of the
three CEMS responses (MCl). Calculate the
ME using equation 3A in section 12.3.
11.4.1.6 For non-dilution systems, you
may adjust the system to maintain the correct
flow rate at the analyzer during the test, but
you may not make adjustments for any other
purpose. For dilution systems, you must
operate the measurement system at the
appropriate dilution ratio during all system
ME checks, and you may make only the
adjustments necessary to maintain the proper
ratio.
11.4.2 You may use table 5 in section
17.0 to record and report your ME test
results.
11.4.3 If the ME specification in section
13.3 is not met for all four reference gas
concentrations, take corrective action, and
repeat the test until an acceptable 4-level ME
test is achieved.
11.5 Seven-Day Calibration Drift (CD)
Test
11.5.1 The CD Test Period. Prior to the
start of the RA tests, you must perform a
seven-day CD test. The purpose of the sevenday CD test is to verify the ability of the
CEMS to maintain calibration for each of
seven consecutive unit operating days as
specified in section 11.5.5 of this PS.
11.5.2 The CD tests must be performed
using the zero gas and high-level reference
gas standards as defined in table 3 of this PS.
11.5.3 Conduct the CD test on each day
during continuous operation of the CEMS
and normal facility operations following the
procedures in section 11.7 of this PS, except
that the zero gas and high-level gas need only
be introduced to the measurement system
once each for the seven days.
11.5.4 If periodic automatic or manual
adjustments are made to the CEMS zero and
upscale response factor settings, conduct the
CD test immediately before these
adjustments.
Note: Automatic signal or mathematical
processing of all measurement data to
determine emission results may be performed
throughout the entire CD process.
11.5.5 Determine the magnitude of the CD
at approximately 24-hour intervals, for 7
consecutive unit operating days. The 7
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
consecutive unit operating days need not be
7 consecutive calendar days.
11.5.6 Record the CEMS response for
single measurements of zero gas and highlevel reference gas. You may use table 6 in
section 17 of this PS to record and report the
results of your 7-day CD test. Calculate the
CD using equation 3B in section 12.3. Report
the absolute value of the differences as a
percentage of the span value.
11.5.7 The zero-level and high-level CD
for each day must be less than 5.0 percent of
the span value or an absolute difference of 10
ppbv, as specified in section 13.2 of this PS.
You must meet this criterion for 7
consecutive operating days.
11.5.8 Dynamic Spiking Option for
Seven-Day CD Test. You have the option to
conduct a high-level dynamic spiking
procedure for each of the 7 days in lieu of
the high-level reference gas injection
described in sections 11.5.2 and 11.5.3. If this
option is selected, the daily zero CD check
is still required.
11.5.8.1 To conduct each of the seven
daily mid-level dynamic spikes, you must
use the DS procedure described in appendix
A of this PS using a single spike chosen to
yield the range as indicated in table 3.
11.5.8.2 You must perform the dynamic
spike procedure by passing the spiked source
gas sample through all filters, scrubbers,
conditioners, and other monitoring system
components used during normal sampling,
and as much of the sampling probe as
practical.
11.5.8.3 Calculate the high-level CD as a
percent of span using equation A6 of
appendix A to this PS and calculate the zerodrift using equation 3B in section 12.3.
Record and report the results as described in
sections 11.5.6 and 11.5.7.
11.6 Relative Accuracy Test
11.6.1 Unless otherwise specified in an
applicable regulation, use Method 320 as the
RM for EtO measurement. Conduct the RM
tests in such a way that they will yield
results representative of the emissions from
the source that can be compared to the CEMS
data. You must collect gas samples that are
at stack conditions (hot and wet), and you
must traverse the stack or duct as required in
section 11.6.3.
11.6.2 Conduct the diluent (if applicable),
moisture (if needed), and pollutant
measurements simultaneously. If the
emission standard is expressed in a mass unit
(i.e., lb/hr) you must also determine the
flowrate simultaneously with each test using
Method 2, 2A, 2B, 2C or 2D in appendix A–
1 to this part, as applicable.
11.6.3 Reference Method Measurement
Location and Traverse Point(s) Selection.
11.6.3.1 Measurement Location. Select, as
appropriate, an accessible RM measurement
location at least two equivalent diameters
downstream from the nearest control device,
point of pollutant generation, or other point
at which a change in the pollutant
concentration or emission rate may occur,
and at least one-half equivalent diameter
upstream from the effluent exhaust or a
control device. When pollutant concentration
changes are due solely to diluent leakage
(e.g., air heater leakages) and pollutants and
diluents are simultaneously measured at the
PO 00000
Frm 00066
Fmt 4701
Sfmt 4700
same location, a half diameter may be used
in lieu of two equivalent diameters. The
equivalent duct diameter is calculated
according to Method 1 in appendix A–1 to
this part. The CEMS and RM sampling
locations need not be the same.
11.6.3.2 Traverse Point Selection. Select
traverse points that assure acquisition of
representative RM samples over the stack or
duct cross section according to one of the
following options: (a) sample at twelve
traverse points located according to section
11.3 of Method 1 in appendix A–1 to this
part or (b) sample at the three traverse points
at 16.7, 50.0, and 83.3 percent of the
measurement line. Alternatively, you may
conduct a stratification test following the
procedures in sections 11.6.3.2.1 through
11.6.3.2.4 to justify sampling at a single
point. Stratification testing must be
conducted at the sampling location to be
used for the RM measurements during the RA
test and must be made during normal facility
operating conditions. You must evaluate the
stratification by measuring the gas on the
same moisture basis as the EtO CEMS (wet
or dry). Stratification testing must be
repeated for each RA test program to justify
single point.
11.6.3.2.1 Use a probe of appropriate
length to measure the EtO concentration, as
described in this section, using 12 traverse
points located according to section 11.3 of
Method 1 in appendix A–1 to this part for a
circular stack or nine points at the centroids
of similarly shaped, equal area divisions of
the cross section of a rectangular stack.
11.6.3.2.2 Calculate the mean measured
concentration for all sampling points
(MNavg).
11.6.3.2.3 Calculate the percent
stratification (St) of each traverse point using
equation 5 in section 12.5.
11.6.3.2.4 The gas stream is considered to
be unstratified and you may perform the RA
testing at a single point that most closely
matches the mean if the concentration at
each traverse point differs from the mean
measured concentration for all traverse
points by no more than 5.0 percent of the
mean concentration of EtO or 10 ppbv,
whichever is less restrictive.
11.6.4 In order to correlate the CEMS and
RM data properly, record the beginning and
end of each RM run (including the time of
day in hours, minutes, and seconds) using a
clock synchronized with the CEMS clock
used to create a permanent time record with
the CEMS output.
11.6.5 You must conduct the RA test
during representative process and control
operating conditions or as specified in an
applicable regulation, permit or subpart.
11.6.6 Conduct a minimum of nine RM
test runs.
Note: More than nine RM test runs may be
performed. If this option is chosen, up to
three test run results may be excluded so
long as the total number of test run results
used to determine the CEMS RA is greater
than or equal to nine. However, all data must
be reported including the excluded test runs.
11.6.7 Analyze the results from the RM
test runs using equations 9 through14 in
section 12.6. Calculate the RA between the
CEMS results and the RM results.
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
11.7 Record Keeping and Reporting
11.7.1 Record the results of the CD test,
the RT test, the ME test, and the RA test. Also
keep records of the RM and CEMS field data,
calculations, and reference gas certifications
necessary to confirm that the performance of
the CEMS met the performance
specifications.
11.7.2 For systems that use Method 205
to prepare EtO reference gas standards,
record results of Method 205 performance
test field evaluation, reference gas
certifications, and gas dilution system
calibration.
11.7.3 Record the LOD and field verified
SADL for the CEMS in ppbv.
11.7.4 Record the results of the
interference test.
11.7.5 Report the results of all
certification tests to the appropriate
regulatory agency (or agencies), in hardcopy
and/or electronic format, as required by the
applicable regulation or permit.
12.0
Calculations and Data Analysis
12.1
Nomenclature.
Ci = Zero or EtO reference gas
concentration used for test i (ppbv);
CC = Confidence coefficient (ppbv);
CD = Calibration drift (percent);
davg = Mean difference between CEMS
response and the reference gas (ppbv);
di = Difference of CEMS response and the
RM value (ppbv or units of emission
standard, as applicable);
I = Total interference from major matrix
stack gases (percent);
DMCavg = Average of the 3 absolute values
of the difference between the measured EtO
calibration gas concentrations with and
without interference from selected stack
gases (ppbv);
MCi = Measured EtO (or zero) reference gas
concentration i (ppbv);
MCi = Average of the measured EtO (or
zero) reference gas concentration i (ppbv);
MCint = Measured EtO concentration of the
EtO reference gas plus the individual or
combined interference gases (ppbv);
ME = Measurement error for CEMS
(percent);
MNavg = Average concentration at all
sampling points (ppbv);
24155
MNbi = Measured native concentration
bracketing each calibration check
measurement (ppbv);
MNi = Measured native concentration for
test or run I (ppbv);
n = Number of measurements in an average
value;
RA = Relative accuracy of CEMS compared
to a RM (percent);
RMavg = Mean measured RM value (ppbv)
or units of the emission standard);
RMi = RM concentration for test run i
(ppbv or units of the emission standard);
S = Span value (ppmv);
Sd = Standard deviation of the differences
(ppmv);
Sti = Stratification at traverse point i
(percent);
SADL = Standard addition detection level
(ppmv);
t0.975 = One-sided t-value at the 97.5th
percentile obtained from table 4 in section
17.0 for n-1 measurements;
12.2 Calculate the difference between the
measured EtO concentration with and
without interferents for each interference gas
(or mixture) for your CEMS as:
Eq.1
Calculate the total percent interference as:
n
Eq.2
1=L~x100
i:1
12.3 Calculate the ME or CD at
Concentration i as:
ICt-MCil
s
ME=--
Eq.3A
IQ-MC1I
Eq.3B
12.4 Calculate the average native
concentration before and after each
calibration check measurement as:
ER05AP24.004
Eq.5
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00067
Fmt 4701
Sfmt 4725
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.003
12.5 Calculate the Percent Stratification
at Each Traverse Point as:
ER05AP24.002
khammond on DSKJM1Z7X2PROD with RULES2
Eq.4
ER05AP24.005
ER05AP24.006
s
CD=
24156
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
12.6 Calculate the RA Using RM and
CEMS Data
12.6.1 Determine the CEMS final
integrated average pollutant concentration or
emission rate for each RM test period.
Consider system RT, if important, and
confirm that the results have been corrected
to the same moisture, temperature, and
diluent concentration basis, as applicable. If
the emission standard is based on a mass
emission (i.e., lbs/hr), confirm the results
have been calculated correctly.
12.6.3 Make a direct comparison of the
average RM results and CEMS average value
for identical test periods.
12.6.4 For each test run, calculate the
arithmetic difference of the RM and CEMS
results using equation 6.
Eq.6
12.6.5 Calculate the standard deviation of
the differences (Sd) of the CEMS measured
results and RM results using equation 7.
t (di - 2014
17:02 Apr 04, 2024
Jkt 262001
absolute difference of 10.0 ppbv for 7
consecutive operating days.
13.3 Measurement Error. The ME must be
less than or equal to 5.0 percent of the span
or an absolute difference of 10.0 ppbv value
at the low-, mid-, and high-level reference gas
concentrations.
13.4 Relative Accuracy. Unless otherwise
specified in an applicable regulation or
permit, the RA of the CEMS, whether
calculated in units of EtO concentration or in
units of the emission standard, must be less
PO 00000
Frm 00068
Fmt 4701
Sfmt 4700
than or equal to 20.0 percent of the RM when
RMavg is used in the denominator of equation
11.
13.4.1 In cases where the RA is calculated
on a concentration (ppmv) basis, if the
average RM emission level for the test is less
than 50 percent of the EtO concentration
equivalent to the emission standard, you may
substitute the EtO concentration equivalent
to the standard in the denominator of
equation 14 in place of RMavg.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.011
ER05AP24.010
13.0 Method Performance
13.1 Level of Detection. You may not use
a CEMS whose LOD or SADL is greater than
20 percent of the applicable regulatory limit
or other action level for the intended use of
the data. If the regulatory limit is not based
on a concentration, document the calculated
concentration equivalent as required in
section 11.7.
13.2 Calibration Drift. The zero- and highlevel calibration drift for the CEMS must not
exceed 5.0 percent of the span value or an
ER05AP24.009
khammond on DSKJM1Z7X2PROD with RULES2
Eq.11
ER05AP24.008
12.6.9 Calculate RA of the CEMS using
equation 11.
ER05AP24.007
Eq.10
ER05AP24.012
12.6.8 Calculate the average RM value
using equation 10.
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
13.4.2 Similarly, if the RA is calculated in
units of the emission standard and the EtO
emission level measured by the RMs is less
than 50 percent of the emission standard, you
may substitute the emission standard in the
denominator of equation 14 in place of
RMavg.
13.4.3 The alternative calculated RA in
paragraph 13.4.1 or 13.4.2 must be less than
or equal to 15.0 percent.
13.5 Interference Test.
13.5.1 The sum of the interference
response(s) from equation 2 must not be
greater than 2.5 percent of the calibration
span or ±3.0 percent of the equivalent EtO
concentration used for the interference test,
whichever is less restrictive. The results are
also acceptable if the sum of the interference
response(s) does not exceed ten times the
LOD or 30 ppbv.
14.0
Pollution Prevention—[Reserved]
15.0
Waste Management—[Reserved]
16.0
Bibliography
24157
Various Waste Media,’’ 40 CFR part 63,
appendix A.
2. EPA Traceability Protocol for Assay and
Certification of Gaseous Calibration
Standards, U.S. Environmental Protection
Agency office of Research and Development,
EPA/600/R–12/531, May 2012.
17.0 Tables, Diagrams, Flowcharts, and
Validation Data
1. ‘‘Method 301—Field Validation of
Pollutant Measurement Methods from
TABLE 1—INTERFERENCE TEST GAS CONCENTRATIONS
Approximate concentration
(balance N2)
Potential interferent gas 1
CO2 ...........................................................................................................
CH4 ...........................................................................................................
H2O ...........................................................................................................
N2 ..............................................................................................................
1% ± 0.2% CO2.
20 ± 5 ppm.
5% ± 1% H2O.1
Balance.1
1 Any of these specific gases can be tested at a lower level if the manufacturer has provided reliableness for limiting or scrubbing that gas to a
specified level in CEMS field installations.
TABLE 2—EXAMPLE INTERFERENCE TEST DATA SHEET
Date of Test
Analyzer type
Model Number
Serial Number
Span
Test Organization
Test Personnel
EtO
concentration
(ppbv)
khammond on DSKJM1Z7X2PROD with RULES2
Interference gas or combination
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00069
Fmt 4701
Sfmt 4700
EtO
concentration
w/interference
(ppbv)
E:\FR\FM\05APR2.SGM
Absolute
difference
(ppbv)
05APR2
Average absolute
difference
(ppbv)
24158
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
EtO
concentration
w/interference
(ppbv)
EtO
concentration
(ppbv)
Interference gas or combination
Absolute
difference
(ppbv)
Average absolute
difference
(ppbv)
TABLE 3—PERFORMANCE SPECIFICATION TEST ZERO AND REFERENCE GAS RANGES
Test
EtO zero and reference gas concentrations
in terms of percent of span a
Units
Zero
Calibration Drift ..........................................
Measurement Error ....................................
a Reference
b High-level
% Of Span .................................................
% Of Span .................................................
Low level
2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00070
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Difference—
low
(ppbv)
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
24159
TABLE 5—MEASUREMENT ERROR TEST DATA—Continued
Source:
Date:
CEMS:
Location:
Serial Number:
Span:
Reference
gas value
(ppbv)
Run number
CEMS
response
(ppbv)
Difference—
low
(ppbv)
Difference—
low
(ppbv)
Difference—
low
(ppbv)
Difference
(ppbv)
Percent
of span
9
Mean Difference—ppbv
Measurement Error—%
TABLE 6—CALIBRATION DRIFT TEST DATA
Source/Location:
CEMS:
Instrument Serial Number:
Instrument Span:
Day
Date
Reference
gas value
(ppbv)
Time
CEMS
response
(ppbv)
Zero Gas
1
0
2
0
3
0
4
0
5
0
6
0
7
0
High-Level Gas
1
2
3
4
5
6
7
PS–19 Appendix A Standard Addition
Procedures
khammond on DSKJM1Z7X2PROD with RULES2
1.0
Scope and Application
1.1 This appendix A (appendix PS–19A)
to Performance Specification 19 (PS–19)
describes the procedure and performance
requirements for standard addition (SA) as a
quality check for ethylene oxide (EtO)
continuous emission monitoring systems
(CEMS).
1.2 This procedure must be used, as a
level of detection (LOD) verification of all
field-installed CEMS. Additionally, it is
allowed by Procedure 7 in appendix F to this
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
part as an alternative to upscale calibration
drift (CD) tests, cylinder gas audits and
relative accuracy audits (RAAs), and may be
used for quality assurance purposes under
other applicable regulations or permits that
require EtO monitoring.
2.0 Summary of the Appendix for Standard
Addition
As used here, SA is a gas phase method of
standard additions (either static or dynamic)
used to verify the accuracy of CEMS
measurements in the presence of the sample
matrix. For extractive CEMS, it consists of
spiking a known quantity of EtO dynamically
PO 00000
Frm 00071
Fmt 4701
Sfmt 4700
into the measurement system as an addition
to the native EtO and the native source gas
matrix.
3.0 Definitions
(See PS–19 and Procedure 7 of appendix F
to this part for the Definitions Used in this
appendix.)
4.0 Interferences
Interferences are discussed in PS–19,
section 4.0.
5.0 Safety
The procedures required under this
appendix may involve hazardous materials,
E:\FR\FM\05APR2.SGM
05APR2
24160
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
operations, and equipment. This procedure
may not address all of the safety problems
associated with these procedures. You as the
facility or operator must establish
appropriate safety and health practices and
determine the applicable regulatory
limitations prior to performing these
procedures. As the CEMS user, you should
consult instrument operation manuals,
material safety data sheets, compressed gas
safety requirements, and other Occupational
Safety and Health Administration regulations
for specific precautions to be taken.
6.0 Equipment and Supplies
An example of equipment and supplies is
described in section 6 of PS–18.
khammond on DSKJM1Z7X2PROD with RULES2
7.0 Reagents and Standards
SA materials must meet the requirements
defined for reference gases in section 7 of
PS–19 to perform this procedure.
8.0 Standard Addition and Dynamic
Spiking Procedure
The standard addition procedure consists
of measuring the native source gas
concentration, addition of reference gas, and
measurement of the resulting SA elevated
source gas concentration. EtO is spiked
dynamically and thus, one must account for
the dilution of sample gas from the addition
of the EtO reference gas.
8.1 SA Concentration and Measurement
Replicates.
8.1.1 You must inject EtO gas to create a
measured concentration based on the
requirements of the particular performance
test (e.g., LOD verification, CD).
8.1.2 Each dynamic spike (DS) or
standard addition (SA) replicate consists of a
measurement of the source emissions
concentration of EtO (native stack
concentration) with and without the addition
of EtO. With a single CEMS, you must
alternate the measurement of the native and
SA-elevated source gas so that each
measurement of SA-elevated source gas is
immediately preceded and followed by a
measurement of native stack gas. Introduce
the SA gases in such a manner that the entire
CEMS is challenged. Alternatively, you may
use an independent continuous EtO monitor
to measure the native source concentration
before and after each standard addition as
described in section 8.1.4.
8.1.3 Unless specified otherwise by an
applicable rule, your SA-elevated
concentration may not exceed 100 percent of
span when the SA and native EtO
concentration are combined.
8.1.4 As an alternative to making
background measurements pre- and post-SA,
you may use an independent continuous EtO
monitor as a temporary unit to measure
native stack EtO concentration while
simultaneously using the CEMS to measure
the SA-elevated source concentration. If you
use an independent continuous EtO monitor
you must make one concurrent background
or native EtO measurement using both the
installed CEMS and the independent
continuous EtO monitor, immediately before
the SA procedure in section 8.2 or 8.3 begins,
to confirm that the independent monitoring
system measures the same background
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
concentration as the CEMS being qualified
with this PS.
8.2 Dynamic Spiking Procedure.
8.2.1 Your EtO spike addition must not
alter the total volumetric sample system flow
rate or basic dilution ratio of your CEMS (if
applicable).
8.2.2 Your spike gas flow rate must not
contribute more than 10 percent of the total
volumetric flow rate through the CEMS.
8.2.3 You must determine a dilution
factor (DF) or relative concentration of EtO
for each dynamic spike. Calibrated, NISTtraceable flow meters accurate to within 2.0
percent or highly accurate tracer gas
measurements are required to make the
necessary DF determinations at the accuracy
required for this PS. Calibrated, NISTtraceable flow meters (e.g., venturi, orifice)
accurate to within 2.0 percent should be
recertified against an NIST-traceable flow
meter annually. Note: Since the spiking mass
balance calculation is directly dependent on
the accuracy of the DF determination, the
accuracy of measurements required to
determine the total volumetric gas flow rate,
spike gas flow rate, or tracer gas standard
addition concentration is critical to your
ability to accurately perform the DS
procedure and calculate the results.
8.2.4 You must monitor and record the
total sampling system flow rate and sample
dilution factor (DF) for the spiking and stack
gas sampling systems to ensure they are
known and do not change during the spiking
procedure. Record all data on a data sheet
similar to table A1 in section 13 of this
appendix.
8.2.4.1 You may either measure the spike
gas flow and the total flow with calibrated
flow meters capable of NIST traceable
accuracy to ±2.0 percent or calculate the flow
using a stable tracer gas included in your
spike gas standard.
8.2.4.2 If you use flow measurements to
determine the spike dilution, then use
equation A1 in section 11.2.1 of this
appendix PS–19A to calculate the DF.
Determination of the spike dilution requires
measurement of EtO spike flow (Qspike) and
total flow through the CEM sampling system
(Qprobe).
8.2.4.3 If your CEMS is capable of
measuring an independent stable tracer gas,
you may use a spike gas that includes the
tracer to determine the DF using equation A2
or A3 (sections 11.2.2 and 11.2.3 of this
appendix PS–19A) depending on whether the
tracer gas is also present in the native source
emissions.
8.2.4.4 For extractive CEMS, you must
correct the background measurements of EtO
for the dilution caused by the addition of the
spike gas standard. For spiking systems that
alternate between addition of EtO and zero
gas at a constant DF, the background
measurements between spikes will not be
equal to the native source concentration.
8.2.5 Begin by collecting unspiked
sample measurements of EtO. You must use
the average of two unspiked sample
measurements as your pre-spike background.
Note: Measurements should agree within
5.0 percent or three times the level of
detection to avoid biasing the spike results.
8.2.5.1 Introduce the EtO gas spike into
the permanent CEMS probe, upstream of the
PO 00000
Frm 00072
Fmt 4701
Sfmt 4700
particulate filter or sample conditioning
system and as close to the sampling inlet as
practical.
8.2.5.2 Maintain the EtO gas spike for at
least twice the DS response time of your
CEMS or until the consecutive measurements
agree within 5.0 percent. Collect two
independent measurements of the native plus
spiked EtO concentration.
8.2.5.3 Stop the flow of spike gas for at
least twice the DS response time of your
CEMS or until the consecutive measurements
agree within 5.0 percent. Collect two
independent measurements of the native EtO
concentration.
8.2.6 Repeat the collection of sample
measurements in section 8.2.5 until you have
data for each spike concentration including
a final set of unspiked sample measurements
according to section 8.2.5.3.
8.2.7 Verify that the CEMS responded as
expected for each spike gas injection, and
that the data quality is not impacted by large
shifts in the native source concentration.
Discard and repeat any spike injections as
necessary to generate a complete set of the
required replicate spike measurements.
8.2.8 Calculate the standard addition
response (SAR) for extractive CEMS, using
equation A4 in section 11.2, of this appendix
PS–19A.
8.2.9 If the DS results do not meet the
specifications for the appropriate
performance test in PS–19 or Procedure 7 of
appendix F of this part, you must take
corrective action and repeat the DS
procedure.
9.0
Quality Control—Reserved
10.0 Calibration and Standardization—
Reserved
11.0 Calculations and Data Analysis
Calculate the SA response for each
measurement and its associated native EtO
measurement(s), using equations in this
section. (Note: For cases where the emission
standard is expressed in units of lb/hr or
corrected to a specified O2 or CO2
concentration, an absolute accuracy
specification based on a span at stack
conditions may be calculated using the
average concentration and applicable
conversion factors. The appropriate
procedures for use in cases where a percent
removal standard is more restrictive than the
emission standard is the same as in PS–2,
sections 12 and 13, in this appendix.)
11.1 Nomenclature.
Cspike = Actual EtO reference gas
concentration spiked (e.g., bottle or reference
gas concentration) ppmv;
Ctracer spiked = Tracer gas concentration
injected with spike gas (‘‘reference
concentration’’) ppmv;
DF = Spiked gas dilution factor;
DSCD = Calibration drift determined using
DS procedure (percent);
DSE = Dynamic spike error (ppmv);
ESA = Effective spike addition (ppmv);
MCSA = Measured SA-elevated source gas
concentration (ppmv);
MCspiked = Measured EtO reference gas
concentration i (ppmv);
MCnative = Average measured concentration
of the native EtO (ppmv);
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Mnative tracer = Measured tracer gas
concentration present in native effluent gas
(ppmv);
Mspiked tracer = Measured diluted tracer gas
concentration in a spiked sample (ppmv);
Qspike = Flow rate of the dynamic spike gas
(Lpm);
Qprobe = Average total stack sample flow
through the system (Lpm);
S = Span (ppmv);
SAR = Standard addition response (ppmv)
24161
11.2 Calculating Dynamic Spike
Response and Error.
11.2.1 If you determine your spike DF
using spike gas and stack sample flow
measurements, calculate the DF using
equation A1:
Eq.Al
11.2.2 If you determine your spike DF
using an independent stable tracer gas that is
not present in the native source emissions,
calculate the DF for DS using equation A2:
DF_M.,iw.,.
Eq.A2
C1raccroiW
11.2.3 If you determine your spike
dilution factor using an independent stable
tracer that is present in the native source
emissions, calculate the dilution factor for
dynamic spiking using equation A3:
~---Mmtiv.--DF
:.-------
Eq.A3
C..,.roiW-Ma.....,.
11.2.4 Calculate the SA response using
equation A4:
Eq.A4
SARrMCJpiW-(1- DF)xMG.tiw
11.2.7 The effective spike addition (ESA)
is the expected increase in the measured
concentration as a result of injecting a spike.
Calculate ESA using equation A7:
12.0
Reserved
13.0
Tables and Figures
ER05AP24.015
khammond on DSKJM1Z7X2PROD with RULES2
Eq.A7
TABLE A13—1—SPIKE DATA SHEET
Facility Name:
Date:
Unit(s) Tested:
Personnel:
I Time:
Analyzer Make and Mode
VerDate Sep<11>2014
17:02 Apr 04, 2024
I
Jkt 262001
PO 00000
Frm 00073
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
ER05AP24.018
Eq.A6
s
05APR2
ER05AP24.014
DCSD=IDSEI
ER05AP24.017
level CD, calculate the CD as a percent of
span using equation A6:
ER05AP24.013
11.2.6 Calculating CD using DS. When
using the DS option for determining mid-
ER05AP24.016
Eq.AS
DSE=MC.w-MC..,...DFx(c...,.MC....)
ER05AP24.019
11.2.5 Calculate the DS error using
equation A5.
24162
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
TABLE A13—1—SPIKE DATA SHEET—Continued
Serial Number
Calibration Span
Qprobe
(lpm)
Actual value (ppb)
MCnative
Qspike
(lpm)
DF 1
Pre
Post
Cspike 2
Avg.
MCspike 3
DSE
(ppbv)
Average
SD
1 DF
must be less than or equal to 10%.
2C
spike = Actual EtO concentration of the spike gas, ppbv.
3 MC
spike = Measured EtO concentration of the spiked sample at the target level, ppbv.
PS–19 Appendix B Preparation and
Certification of Ethylene Oxide Gas
Standards
khammond on DSKJM1Z7X2PROD with RULES2
1.0 Scope and Application
1.1 This appendix (appendix PS–19B) to
Performance Specification 19 (PS–19)
describes the procedure and performance
criteria for the preparation and certification
of EtO Gas Manufacturer Primary Standards
(GMPS) and Gas Manufacturer Alternative
Certified Standards (GMACS). These
procedures are not specific to ethylene oxide
and could be transferable to the preparation
of gas standards for other pollutants
regulated under 40 CFR parts 59, 60, 61, 63,
and 65.
2.0 Summary of the Appendix
EPA requires the use of EPA Protocol gas
standards for emissions monitoring. These
gases are established following the EPA
Traceability Protocol for Assay and
Certification of Gaseous Standards, May 2012
(EPA 600/R–12/531) otherwise referred in
this appendix PS–19B as the EPA
Traceability Protocol. The EPA Traceability
Protocol requires the use of certified
reference gas standards directly traceable to
National Institute of Standards and
Technology (NIST) or other recognized
national metrology institute (NMI) reference
gas standards. A NIST certified value is a
value for which NIST has the highest
confidence in that all known or suspected
sources of bias and imprecision have been
accounted for. Without NIST or other NMI
reference gas standards, the necessary EPA
Protocol gas standards cannot be prepared.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
An alternative approach is needed to
establish a gas standard functionally
equivalent to the EPA Protocol gas standard
when NIST or NMI reference gas standard are
not available. This appendix PS–19B is
intended to provide procedures and
performance criteria for the establishment of
Gas Manufacturer Alternative Certified
Standards (GMACS), the functional
equivalent of EPA Protocol gas standards.
GMACS and Gas Manufacturer Primary
Standards (GMPS), the functional equivalent
of the NIST or NMI reference gas standards.
The GMPS are the reference gases used to
establish the certified concentrations of the
GMACs. The GMPS are established using a
dual certification approach where the
gravimetrically prepared reference value is
confirmed using an independent
measurement approach traceable to the
International System of Units (SI) and
references materials or devices.
2.1 This appendix PS–19B is intended to
be performance-based and allow specialty gas
manufacturers (SGM) flexibility in the
preparation and certification of GMPS and
GMACS.
2.2 This appendix PS–19B is not
intended to be a replacement for the EPA
Protocol gases established according to the
EPA Traceability Protocol when calibration
gases that meet EPA Traceability Protocol
requirements are available. When NIST or
other recognized NMI reference gas standards
are manufactured and readily available, those
gases must be used.
2.3 This appendix PS–19B is reliant on
the procedures included the EPA Traceability
Protocol for Assay and Certification of
PO 00000
Frm 00074
Fmt 4701
Sfmt 4700
Gaseous Standards, May 2012 (EPA 600/R–
12/531). Users of this appendix PS–19B for
the preparation of GMPS and GMACS must
be proficient with the preparation protocol
cylinders using this standard.
Note: This appendix PS–19B does not
require the user to participate in any protocol
gas verification program.
2.4 Any alternatives to the procedures in
this appendix PS–19B are subject to
Administrator review under the alternative
test method the authority to approve
alternatives or changes to test methods
specified in the General Provisions to 40 CFR
parts 60, 61, and 63 (§§ 60.8(b)(2),
61.13(h)(1)(ii), and 63.7(e)(2)(ii)). Requests
for alternative to the procedures must be
submitted to the agency according to
Guideline Document 22 (https://
www.epa.gov/system/files/documents/202209/gd-022r5.pdf).
3.0 Definitions
3.1 Certification means a set of
procedures and performance criteria used by
a SGM to prepare and certify a GMPS and/
or GMACS for commercial sale.
3.2 Certified Reference Material or CRM
means a material that has been certified or
verified by either NIST or other NMI (e.g.,
VSL, NPL) and may be used for traceability
purposes.
3.3 Dual Method Certification means a
process in which the gravimetric value is
independently confirmed by a measured
value.
3.4 EPA Protocol Gas means a calibration
or reference gas required for emissions
monitoring directly traceable to NIST or
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
other accepted NMI reference gas standards,
prepared following the EPA Traceability
Protocol
3.5 EPA Traceable Protocol for Assay
and Calibration Gas Standards or commonly
referred to as the ‘‘EPA Traceability
Protocol’’ means the document The protocol
allows producers of these standards, users of
gaseous standards, and other analytical
laboratories to establish traceability of EPA
Protocol Gases to gaseous reference standards
produced by the National Institute of
Standards and Technology (NIST).
3.6 Gas Calibration Cylinder means a
refillable cylinder that meets the applicable
DOT/TC specifications for high pressure
cylinders. The cylinders shall be
permanently stamped with a unique value.
3.7 Gas Manufacturer Alternative
Certified Standards or GMACS means a gas
that has been prepared according to this
procedure and serves as a functional
substitute for an EPA Protocol Gas where
EPA Protocol gases are not available.
3.8 Gas Manufacturer Intermediate
Standard means a gas reference standard
made by a gas supplier and certified
according to the U.S. EPA protocol rules for
GMISs. For the purpose of this Appendix,
GMISs may be assayed against a GMPS.
3.9 Gas Manufacturer Primary Standards
or GMPS means a reference gas standard
prepared and certified by the SGM that
serves as a functional substitute for the
reference gas standards established by, but
not yet available from NIST or other accepted
NMI and required by the EPA Traceability
Protocol to produce EPA Protocol gases.
3.10 Gravimetry means the quantitative
measurement of an analyte by weight.
3.11 NIST means the National Institute
of Standards and Technology, located in
Gaithersburg, Maryland.
3.12 NIST Traceable Reference Material
or NTRM means is a reference material
produced by a commercial supplier with a
well-defined traceability linkage to NIST and
named by NIST procedures, on a batch rather
than individual basis. This linkage is
established via criteria and protocols defined
by NIST that are tailored to meet the needs
of the metrological community to be served.
3.13 Primary Reference Materials or PRM
means a mixture composition is verified
against VSL’s own primary standard gas
mixtures to confirm the assigned value.
3.14 Protocol Gas means a calibration or
reference gas required for emissions
monitoring traceable to NIST or other
accepted NMI, prepared following the EPA
Traceability Protocol.
3.15 Research Gas Mixture or RGMs
means a reference material produced by a
commercial supplier certified by NIST on an
individual basis, often using non routine
procedures, are called Research Gas Mixtures
(RGMs), and may be used for traceability
purposes.
3.16 Specialty Gas Manufacturer or SGM
means an organization that prepares and
certified gas calibration gas mixtures.
3.17 International System of Units or SI
means the standards for international
measurement and are comprised of length
(meter), time (second), amount of substance
(mole), electric current (ampere), temperature
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(kelvin), luminous intensity (candela), and
mass (kilogram).
3.18 Standard Reference Material or SRM
means a material or substance issued by
NIST that meets NIST-specific certification
criteria and is issues with that with a
certificate or certificate of analysis that
reports the results of its characterizations and
provides information regarding the
appropriate use(s) of the material.
3.19 Uncertainty means the expression of
the statistical dispersion of the values
attributed to a measured quantity. For the
purpose of this appendix, uncertainty is
calculated using the root sum square of all
uncertainty budget items associated with
each procedure at k=2 (i.e., approximately 95
confidence).
3.20 VSL means Van Swinden National
Lab, located in Delft, Netherlands.
4.0
Interferences—Reserved
5.0 Safety
The procedures required under this
appendix may involve hazardous materials,
operations, and equipment. This procedure
may not address all of the safety problems
associated with these procedures. You as the
facility or operator must establish
appropriate safety and health practices and
determine the applicable regulatory
limitations prior to performing these
procedures. You should consult instrument
operation manuals, material safety data
sheets, compressed gas safety requirements,
and other Occupational Safety and Health
Administration regulations for specific
precautions to be taken.
6.0 Equipment and Supplies
This procedure is not prescriptive on the
type of equipment or the supplies necessary
for the preparation of GMPS and GMACS
gaseous cylinder standards, however SGM
must use the appropriate equipment and
supplies necessary to meet the uncertainty
requirements in this appendix.
7.0
Reagents and Standards—Reserved
8.0 Procedures.
The exact procedures used will depend on
the gas manufacturer and the physical
characteristics of the compound being
prepared as a gaseous calibration standard.
Any procedure is deemed appropriate so long
as the criteria in section 8.1 for GMPS and
section 8.2 for GMACS are met.
8.1 Preparation and Certification of the
GMPS.
The GMPS certified value is established
using the dual certification approach. A
candidate GMPS cylinder is prepared
gravimetrically, and its established reference
value is confirmed by an independent
measurement traceable to SI units as well as
other appropriate reference materials. The
level of agreement between the gravimetric
reference value and the SI-based independent
measurements along with the average value
and associated, combined, expanded
uncertainties serve to establish the certified
reference value. If high purity reference
material is not readily available for a
gravimetric preparation, a user may petition
the Administrator for an alternative method
for preparation of a GMPS.
PO 00000
Frm 00075
Fmt 4701
Sfmt 4700
24163
The procedures for the gravimetric
preparation, stability evaluation, and
independent verification of GMPS must meet
the criteria in this section following the
procedures in 8.1(a) through (g).
(a) Raw Materials
(b) GMPS Cylinder Preparation/Creation
(c) GMPS Cylinder Independent
Verification
(d) GMPS Cylinder Certification
(e) GMPS Cylinder Stability
(f) GMPS Cylinder Expiration Period
(g) GMPS Documentation
8.1.1 Raw Materials. Raw materials used
in the production of GMPS must be of high
quality (e.g., 99+% purity recommended).
Additionally, because raw material purity is
the largest component of uncertainty in gas
gravimetry, SGMs must substantiate the
purity of the raw material prior to use, either
via (1) a validated certificate of analysis for
the actual lot number purchased provided by
the raw material vendor, or (2) a purity assay
conducted by the SGM on the actual raw
material to be used. The uncertainty of the
raw material (Ur) assay must be included as
one of the components of the total combined
uncertainty for the mixture.
8.1.2 GMPS Gravimetric Cylinder
Preparation/Creation. The GMPS standards
shall be based on a gravimetric preparation.
The gravimetric preparation shall yield an
expected concentration for the target
component, and with the required statistical
controls in place to calculate the uncertainty
of that concentration.
8.1.2.1 The scale used to generate the
gravimetric reference standard must be
independently calibrated over the range of
target masses with ASTM E617–13 Class-1
weights on no less than a yearly basis. For
such certifications, a high accuracy mass
comparator (electronic or pendulum-type
scale) is employed as the ‘‘scale.’’ The
resolution of the scale should be sufficient to
be able to calculate the overall uncertainty of
any concentration derived from these steps.
8.1.2.1.1 The scale used for the
gravimetric operation must be independently
calibrated and traceable to NIST standards
with a defined uncertainty (ut).
8.1.2.1.2 The scale calibration must be
checked before the start of each new
weighing operation (i.e., the day of) with a
weight in the appropriate range that also
meets ASTM E617–13 Class-1 requirements.
8.1.2.1.3 All material and equipment
associated with the gravimetric analysis shall
have or apply a procedure to estimate the
uncertainty of the measurement, including
but not limited to the balance(s) used (uca)
standard weight (uw).
8.1.2.1.4 The assay purity and associated
material uncertainty (ur) of the assay for each
component raw material and the balance gas
must be known. This purity deviation is
factored into the uncertainty of the mass of
each material blended into the mixture.
8.1.2.1.5 The procedures below are
minimum requirements and do not speak to
all of the details an SRM would do to ensure
the preparation of a high-accuracy
gravimetric candidate GMPS, (e.g., controls
for external factors that would influence
scale reading accuracy buoyancy effects,
moisture/dust adsorption on the cylinder
E:\FR\FM\05APR2.SGM
05APR2
24164
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
surface, and errors caused by the location of
the cylinder on the scale). The SGM should
develop and follow and internal standard
operation procedures (SOP) for the
preparation of the candidate GMPS.
8.1.2.1.6 Record the Target cylinder
identification number, blend date, and
balance gas on the appropriate form (see
figure B–1). Additionally, record the
intended component(s) to be used in the
preparation for this candidate GMPS,
identifying the standard type, material name
(e.g., Ethylene Oxide), MW (g/mol), and
purity (wt%).
8.1.2.1.7 Add the components to the
candidate GMPS, recording the weight of
each component added.
8.1.2.1.8 GMPS Gravimetric Uncertainty.
Calculate and document the gravimetric
concentration (GMPS–Cg) for each
component of the candidate GMPS. You must
also document the combined uncertainty,
expressed as the root sum of the uncertainty
budget items identified, for the candidate
GMPS value (GMPS–Cgu). Gravimetric
preparation uncertainty budget items
include:
(a) The purity of the raw material and the
balance gas;
(b) The measured accuracy of the
(electronic) balance including consideration
the uncertainty of the calibration weights, the
calibration uncertainty, and its linearity;
(c) The repeatability of the balance
readings including errors caused by the
location of the cylinder on the balance;
(d) Balance Buoyancy effects;
(e) Effects of moisture adsorption and dust
on the outer surface of the cylinder;
(f) Cylinder dilutions, if any, used to
prepare target concentrations, including
propagated uncertainties.
8.1.3 GMPS Independent Verification.
The certification of the candidate GMPS is
based on independent measurements
verifying the reference concentration of the
gravimetrically prepared GMPS candidate.
The independent verification must be based
on a measurement approach traceable to the
SI and may include the use of intrinsic NIST
or accepted NMI reference materials to
establish said traceability. Candidate
independent verification measurement
approaches include classical chemistry,
spectroscopic approaches, as well as other
instrumental approaches as long as adequate
and appropriate SI traceability can be
incorporated. The approach must be
performed using NIST (or equivalent)
traceable calibrations materials and using
procedures that would allow the user to
determine the overall uncertainty of the
measurement. In some instances, a
component may not be suitable to analysis
using a classical approach, in those instances
alternative approaches may be used do long
as they (1) yield a concentration for the target
com, (2) have a calculated uncertainty, (3)
have traceability to the SI, and (4)
documented conformity to the general
metrological principles for primary methods
outlined above.
8.1.3.1 GMPS Independent Verification
Measurement Uncertainty. The cumulative
uncertainty of the GMPS independent
verification measurement approach is
integral to the ability to assess the overall
quality of the independent verification
measurement. You must also document the
combined uncertainty, expressed as the root
sum of the uncertainty budget items
identified. Ensure that all known or
suspected sources of bias and imprecision
have been accounted for. The following
elements are examples of sources of
measurement error that must be included in
the overall uncertainty calculation for the
GMPS independent verification
measurement:
(a) The uncertainty of the certified
reference solution (the traceability source);
(b) Any propagated uncertainties through
serial dilutions;
(c) The errors in volumetric sampling of
the candidate GMPS mixture;
(d) The uncertainty of the instrument
calibration curve (least squares fit and
residual);
(e) The bias or error associated with any
measurement interferences;
(f) The repeatability of replicate aliquot
injections from the same sample;
(g) The repeatability of replicate samples of
the mixture;
(h) Any external factors influencing
sampling or instrument accuracy;
(i) The uncertainty of measured volumetric
gas flows;
(j) The bias or uncertainty associated with
quantitative gas flow delivery;
(k) The error associated with instrumental
measurement analyzers;
(l) Replicate measurement instrument error
and precision.
8.1.4 GMPS Certification. The candidate
GMPS certified value is based on three
factors:
(a) The relative agreement between the
gravimetric reference value and the
independent, measured value of the
gravimetrically-prepared GMPS candidate;
(b) The combined, expanded uncertainty
(k=2) of the gravimetric value and
independently measured concentrations
values;
(c) The average of the independently
measured concentrations values.
8.1.4.1 GMPS Relative Agreement.
Calculate the relative agreement according to
equation B–1, expressed as Relative Percent
Difference (RPD) between the gravimetric
concentration (GMPS–Cg) the independently
measured concentrations (GMPS–Ca). The
results of these two analyses must agree
within 4.0 percent (%).
Eq.Bl
≤5.0 percent (%). If these objectives are not
met, the candidate GMPS is not acceptable,
and must not be used.
khammond on DSKJM1Z7X2PROD with RULES2
GMPS-C.a or GMPS-C. =Jut+ u~ + ... + u~
8.1.4.3 GMPS Certified Concentration
Value. If the GMPS meets the Relative
Agreement criteria in section 8.1.5.3 and the
combined, expanded uncertainty criteria in
section 8.1.5.4, the GMPS is valid. The GMPS
certified value (GMPS–CC) is based on the
independently measurement concentration
(GMPS–Ca). The certification date is the date
of the last confirmatory measurement.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
8.1.4.4 An SGMs may propose to
Administrator an alternative acceptance
values for section 8.1.5.1 or 8.1.5.2 for those
components that are unable to meet the
documented criteria. These proposals must
include sufficient documentation that the
objectives are unreasonable for a given
component and concentrations.
8.1.5 GMPS Stability Testing. The SGM
must test and document mixture stability of
PO 00000
Frm 00076
Fmt 4701
Sfmt 4700
Eq.B2
the GMPS to assure that the mixture stays
within claimed accuracy bounds for the
entire claimed expiration period.
Alternatively, once a preparation process has
been developed, the SGM can perform a
stability study consisting not less than three
cylinders prepared using the defined process
and at the concentration(s) defined by the
process. Once the stability study cylinders
have demonstrated acceptable stability for
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.021
Cua) according to equation B–2. Establish the
GMPS combined, expanded uncertainty
(GMPS–Cuc) as the root sum of the two
individual uncertainties with a coverage
factor k=2. The combined uncertainty must
ER05AP24.020
8.1.4.2 GMPS Combined, Expanded
Uncertainty. Determine the individual
uncertainties for the gravimetric approach
(GMPS–Cug) and the independent
measurement verification approach (GMPS–
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
the minimum expiration period (6-months),
additional GMPS cylinders can be prepared
under identical process conditions.
8.1.5.1 The SGM may select the sampling
frequency based on the targeted expiration
period, the gas consumed in the analysis and
expected component behavior. Stability
testing data must consist of at least:
(a) Five discrete samplings of the retained
mixture for an expiration period of 6-months
to 1-year;
(b) Ten discrete samplings for an
expiration period of 1–3 years; and
(c) Twenty for any period greater than 3
years.
8.1.5.2 Stability testing must be
conducted for each cylinder size/type and at
a similar concentration as the candidate
GMPS. Stability analyses must be performed
using methods that assure consistent results
can be achieved. If instrumental analysis
using a gas standard is employed, use of a
GMPS standard is highly recommended. In
the absence of a certified GMPS, stability
testing must be conducted using the same
independent verification measurement
procedures and methodology used in section
8.1.4, or using another known-to-be-stable
gas standard containing the target component
in a similar concentration range.
8.1.5.3 Stability testing data must not
show any upward or downward trends that
would cause the mixture to become out of
specification prior to the claimed expiration
period.
8.1.6 GMPS Expiration Period. The
expiration period for the GMPS mixture
based must be based on the empirical
stability test data. The expiration periods for
reactive gases must not exceed the length of
the stability test, however for non-reactive
gases you may forecast an expiration period
not to exceed two times the actual stability
testing duration. The maximum expiration
period for a GMPS is time span from the date
of preparation to the date of the last/most
recent stability study may not be less than 6months. Provided that acceptable stability is
observed, the maximum expiration period
may be extended by retaining the stability
study cylinders and performing additional
analyses.
8.1.7 GMPS Documentation. You must
document the preparation of the GMPS
through the appropriate record keeping and
document the certification of a GMPS. The
information is section 8.1.8.1 and 8.1.8.2
must be maintained as a record by the SGM
for the purpose of maintaining traceability
and to verify the preparation. The
information in section 8.1.8.3 must be
documented and maintained by the SGM.
This documentation and the records of the
preparation and certification must be made
available upon request by the appropriate
delegated authority.
8.1.7.1 The following information for the
gravimetric preparation information of the
GMPS must be documented and maintained
as a record. This record should include but
is not limited to the: blend date, gravimetric
concentration, gravimetric concentration
uncertainties as a percentage and absolute,
reference material information and purity,
scale ID, scale accuracy, and calculated
gravimetric uncertainties associated with
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
material, balance, and environmental effects.
You must include sufficient information that
will allow a 3rd party to recalculate the
prepared concentration and expanded
uncertainties.
8.1.7.2 The following information for the
analytical verification of the GMPS must be
recorded and maintained as a record. This
record should include the confirming
methodology and any associated SOPs,
confirming concentration(s), instrumentation
used, calibration standards used and
associated COAs, calibration curve data,
replicate analysis calculated, and expanded
uncertainties.
8.1.7.3 The following information must
be documented for inclusion on the COA for
the GMACS.
(a) Manufacturer’s company name and
address of the producing location
(b) Manufacturer’s part number for the
GMPS, lot number, and/or production record.
(c) Cylinder number, cylinder type,
cylinder preparation ID, moisture dew point
and cylinder pressure.
(d) Certification date and claimed
expiration date.
(e) GMPS component(s) name, final
certified concentration(s) (GMPS–Cc), and
balance gas.
(f) Gravimetric value and uncertainty
(g)Verification value and uncertainty
(h) GMPS final certified value and
uncertainty absolute as a percentage (GMPS–
Cu)
8.2 Preparation and Certification of the
GMACS. The preparation and certification of
the candidate GMACS is also based on the
independent verification of the
gravimetrically prepared reference value.
However, the independent verification
utilizes the GMPS to perform the
independent verification. This is
accomplished by following the procedures in
section 2.1 and 2.2 of the EPA Traceability
Protocol, using the GMPS as the certified
reference material. The measured value of the
independent verification following the EPA
Traceability Protocol procedures also
establishes the certified reference value,
providing the relative agreement performance
criteria are met.
8.2.1 GMACS Gravimetric Cylinder
Preparation/Creation. The gravimetric
preparation of the GMACS is identical to the
procedures used to gravimetrically prepare
the GMPS. You must maintain the same
information required for the gravimetric
preparation of GMPS, as found in section
8.1.8.1 for GMACS, as a record.
8.2.2 GMACS Independent Verification
and Certification. The candidate GMACS
independent verification of the
gravimetrically prepared reference value is
contingent on the SGM following the
procedures in sections 2.1 and 2.2 of the EPA
Traceability Protocol. In addition, the EtO
candidate GMACS certified reference value
and associated expanded uncertainty is based
on the EPA Traceability Protocol measured
value. This is contingent upon the
gravimetric and measured values meeting the
relative agreement performance criteria
established in section 8.1.5.3 and the
uncertainty criteria established in section
8.1.5.4. Gas Manufacturers Intermediate
PO 00000
Frm 00077
Fmt 4701
Sfmt 4700
24165
Standards (GMIS) can be prepared by direct
comparison to a GMPS that has been
prepared and certified according to section
2.1.3.1 and 2.2 of the EPA Traceability
Protocol. The tagged value of the GMACS
must be based on the EPA Traceability
Protocol measured value as long as the
performance criteria in sections 12.1 and 12.2
are met.
8.2.3 GMACS Stability Testing. The SGM
must test and document the stability of the
GMACS to assure that the mixture stays
within claimed certified bounds for the entire
claimed expiration period. Use the
procedures in section 8.1.6 to assess stability.
The GMACS must also meet the requirements
in section 2.1.5.2 of the EPA Traceability
Protocol.
8.2.4 GMACS Expiration Date. The
certification period of the GMACS shall be
based on the documented stability tests of the
GMPS in section 8.1.6. The expiration date
shall be based on the certification date, plus
the certification period plus one day. There
is not a maximum period of expiration;
however, expiration periods must not be less
than six months.
8.2.5 GMACS Documentation You must
document and maintain the same
information required for the analytical
verification of the GMPS, as found in section
8.1.8 for GMACS, as a record. The records of
the preparation and certification must be
made available upon request by the
appropriate delegated authority.
8.2.6 GMACS Certificate of Analysis
(COA). You must provide comprehensive
documentation of the GMPS and GMACS
development process in the form of a
GMACS Certificate of Analysis (COA) that
accompanies each commercially distributed
GMACS. As a minimum, the COA must
contain the following information:
(a) Identification of the gas as a Gas
Manufacturer Alternative Certified Standard;
(b) The cylinder number;
(c) The certified concentration of the
GMACS;
(d) The combined expanded uncertainty
(k=2) of the GMACS reference value (both
absolute and relative);
(e) The expiration date;
(f) The reference materials or standards
used (i.e., GMPS and GMIS);
(g) The same information (cylinder
number, certified concentration,
uncertainties, expiration dates, etc. for these
cylinders);
(h) The gravimetric and independent
measured verification reference
concentration values and associated
uncertainties for each GMPS used;
(i) Associated measurement principles and
uncertainties;
(j) Any additional information stipulated
by the EPA Traceability Protocol;
(k) Any comments/special instructions.
The SGM GMACS provider is encouraged
to include additional relevant information to
the COA, as appropriate. An example
GMACS COA can be found in section 14 of
this appendix.
9.0
Quality Control—Reserved
10.0 Calibration and Standardization
There is a myriad of instrumental and
mechanical techniques used in the
E:\FR\FM\05APR2.SGM
05APR2
24166
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
performance of this Appendix B. When
reference methods are used, you must follow
the calibration requirements of those
methods and as defined in this appendix. For
all other approaches, it is recommended to
develop internal SOPs and develop.
12.2 GMACS/GMPS Uncertainty. Final
certification of the GMPS and GMACS
reference concentrations must meet the
combined expanded uncertainty (k=2) of ≤5.0
percent (%).
13.0
Pollution Prevention—Reserved
11.0 Calculations and Data Analysis—
Reserved
14.0
Waste Management—Reserved
15.0
Bibliography
12.0
Method Performance
12.1 GMPS/GMACS Relative Agreement.
As part of the certification/verification
procedures for the candidate GMPS and
GMACS, the relative agreement between the
gravimetrically prepared reference value and
the independently measured verification
value must agree within 4.0 percent (%).
1. EPA Traceability Protocol for Assay and
Certification of Gaseous Calibration
Standards, Office of Research and
Development, National Risk Management
Research Laboratory, May 2012, EPA 600/R–
12/531. https://www.epa.gov/air-research/
epa-traceability-protocol-assay-andcertification-gaseous-calibration-standards.
2. EPA Alternative Method 114, Approval
of Alternative Method for preparation of HCl
Gas Standards for PS–18 and Procedure 6,
February 22, 2016, https://www.epa.gov/
sites/default/files/2020-08/documents/
alt114.pdf.
3. Evaluation of Measurement Data—Guide
to the Expression of Uncertainty in
Measurement, JCGM 100:2008, https://
www.bipm.org/documents/20126/2071204/
JCGM_100_2008_E.pdf/cb0ef43f-baa5-11cf3f85-4dcd86f77bd6.
16.0
Tables and Figures
Figure B–1 Example Gravimetric
Preparation Sheet for GMPS and GMACS
BILLING CODE 6560–50–P
General Information
I :z.tbnber
~-
Component Parameters
Compon•tt
Compon•tt
CompoMnt
Compon•tt
Component
1
2
3
4
5
Sfmt 4725
E:\FR\FM\05APR2.SGM
~malecular--"t:IWmnll
Dlludon Standard or Pin Cylinder
tbnber
lottbnber
DlludonStandlrdWelptCc.w...wmadoin
or Punt Weitdlt 5
: .. - ••
Dlludon Standard WelptAmnc:J,
relati!Nlor+/-wallltlt.9'
• iwt96)
DlludonStandlrd or Pin w__....,.1
Mechlnical Eflilcts- u.. (I!}
Scale c.nadtv Selection {I!}
Scafe Calibralion I
Scale"-~ •U.llrJ
Weitdlt Standard - u.. r.1
~WeitdltAddedW
....,.,
~
Total
Additional
..
·-·
Dilution standard or cross Contaminant Additions
•
•
•
WaillhtAdd,edfirl
..
-
{aJ
WelptAdded {a)
firJ
I
khammond on DSKJM1Z7X2PROD with RULES2
~=:rfram•hdcldom{I)
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
I
Frm 00078
Fmt 4701
05APR2
ER05AP24.022
Totals calculations
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Figure B–2
GMACs
24167
Apparatus for the assay of the
GIISFlow
loVent
Refal'ence
Standanl
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00079
Fmt 4701
Sfmt 4725
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.023
khammond on DSKJM1Z7X2PROD with RULES2
%elo
Gas
24168
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Figure B–3
Examples COA
Example Certificate of Analysis (COA)
Ethylene Oxide Gas Manufacturer Alternative Certified standard
Assay Laboratory
QaSP!Dff 1oformatioQ
Lot Number
COmpany Name
eompany Address
Qty. state. Zip Code
QlentName
Client Address
Qty, state, Zip Code
ProductJnformation
Uprtainty (absolute)
Composition
Ethylene Oxide
Q!rtified Cone,
XJ00C ppm
Nltro&en
Balance
Cylinder Number:
Cylinder Type:
Cylinder Pressure
Mixture Dew Point
XXlOOOOCXX
xxxxxx
Certification Date:
x-xxx-xxxx
Prior Certification Date: X·XXX·XXXX
xxxx
xxxx
Expiration Date:
VDamJntv (a:ltUYel
XJOCppm
X.XX9'
Part Number:
x-xxx-xxxx
xxxxxxxxxxxx
O!rtifiqtion Data
Gravimetric: Analysis
Composition
Metsvmd Cone,
Vocerta!ntv (absolute)
Uncert,lnty keJative)
Ethylene Oxide
X.XXXppm
XJOCppm
X.XX9'
Mgsuntd Cone,
XJOOCppm
VDamJotv (absolute)
UnamJnty kelltlvel
XJOCppm
XJOC9'
UngmJnty (absolute}
Ung!rtainty (reJative)
X.XX'6
confirmIn, Analysis
Composition
Ethylene Oxide
Instrument Modef/Anafytical PrincJPle
Reference standard XXXXXXXXXXX
Composition
Mnsvmd Cone,
XJOOCppm
Ethylene Oxide
BILLING CODE 6560–50–C
3. Appendix F to part 60 is amended
by adding Procedure 7 to read as
follows:
■
Appendix F to Part 60—Quality
Assurance Procedures
*
*
*
*
*
khammond on DSKJM1Z7X2PROD with RULES2
Procedure 7. Quality Assurance
Requirements for Gaseous Ethylene Exide
(ETO) Continuous Emission Monitoring
Systems Used for Compliance Determination
1.0 Applicability and Principle
1.1 Applicability. Procedure 7 is used to
evaluate the effectiveness of quality control
(QC) and quality assurance (QA) procedures
and to evaluate the quality of data produced
by any ethylene oxide (EtO) gas, CAS: 75–21–
8, continuous emission monitoring system
(CEMS) that is used for determining
compliance with emission standards for EtO
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
X.XXppm
on a continuous basis as specified in an
applicable permit or regulation.
1.1.1 This procedure specifies the
minimum QA requirements necessary for the
control and assessment of the quality of
CEMS data submitted to the Environmental
Protection Agency (EPA) or a delegated
authority. If you are responsible for one or
more CEMS used for EtO compliance
monitoring you must meet these minimum
requirements and you are encouraged to
develop and implement a more extensive QA
program or to continue such programs where
they already exist.
1.1.2 Data collected as a result of QA and
quality control (QC) measures required in
this procedure are to be submitted to the EPA
or the delegated authority in accordance with
the applicable regulation or permit. These
data are to be used by both the delegated
authority and you, as the CEMS operator, in
assessing the effectiveness of the CEMS QC
and QA procedures in the maintenance of
PO 00000
Frm 00080
Fmt 4701
Sfmt 4700
acceptable CEMS operation and valid
emission data.
1.2 Principle
1.2.1 The QA procedures consist of two
distinct and equally important functions.
One function is the assessment of the quality
of the CEMS data by estimating accuracy.
The other function is the control and
improvement of the quality of the CEMS data
by implementing QC policies and corrective
actions. These two functions form an
iterative control loop. When the assessment
function indicates that the data quality is
inadequate, the control effort must be
increased until the data quality is acceptable.
In order to provide uniformity in the
assessment and reporting of data quality, this
procedure specifies the assessment
procedures to evaluate response drift and
accuracy. The procedures specified are based
on Performance Specification 19 (PS–19) in
appendix B to this part.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.024
X>0000000CJ)OOO
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Note 1 to section 1.0: Because the control
and corrective action function encompasses a
variety of policies, specifications, standards
and corrective measures, this procedure
treats QC requirements in general terms to
allow you, as source owner or operator to
develop the most effective and efficient QC
system for your circumstances.
2.0
Definitions
See PS–19 in appendix B to this part for
the primary definitions used in this
Procedure.
3.0
QC Requirements
3.1 You, as a source owner or operator,
must develop and implement a QC program.
At a minimum, each QC program must
include written procedures and/or
manufacturer’s information which should
describe in detail, complete, step-by-step
procedures and operations for each of the
following activities:
(a) Calibration Drift (CD) checks of CEMS;
(b) CD determination and adjustment of
CEMS;
(c) Routine and preventative maintenance
of CEMS (including spare parts inventory);
(d) Data recording, calculations, and
reporting;
(e) Accuracy audit procedures for CEMS
including reference method(s); and
(f) Program of corrective action for
malfunctioning CEMS.
3.2 These written procedures must be
kept on site and available for inspection by
the delegated authority. As described in
section 5.4, whenever excessive inaccuracies
occur for two consecutive quarters, you must
revise the current written procedures, or
modify or replace the CEMS to correct the
deficiency causing the excessive
inaccuracies.
4.0 Daily Data Quality Requirements and
Measurement Standardization Procedures
4.1 CD Assessment. An upscale gas, used
to meet a requirement in this section must be
a gas meeting the requirements in section 7.1
of PS–19 of appendix B to this part.
4.1.1 CD Requirement. Consistent with
§ 60.13(d) and with § 63.8(c) of this chapter,
you, as source owners or operators of CEMS
must check, record, and quantify the CD at
two levels, using a zero gas and high-level
gas at least once daily (approximately every
24 hours). Perform the CD check in
accordance with the procedure in the
applicable performance specification (e.g.,
section 11.3 of PS–19 in appendix B to this
part). The daily zero- and high-level CD must
not exceed two times the drift limits
specified in the applicable performance
specification (e.g., section 13.2 of PS–19 in
appendix B to this part.)
4.1.2 Recording Requirement for CD
Corrective action. Corrective actions taken to
bring a CEMS back in control after exceeding
a CD limit must be recorded and reported
with the associated CEMS data. Reporting of
a corrective action must include the
unadjusted concentration measured prior to
resetting the calibration and the adjusted
value after resetting the calibration to bring
the CEMS back into control.
4.1.3 Dynamic Spiking Option for highlevel CD. You have the option to conduct a
daily dynamic spiking procedure found in
section 11.5.8 of PS–19 of appendix B to this
part in lieu of the daily high-level CD check.
If this option is selected, the daily zero CD
check is still required.
4.1.4 Out of Control Criteria for Excessive
CD. Consistent with § 63.8(c)(7)(i)(A) of this
chapter, an EtO CEMS is out of control if the
zero or high-level CD exceeds two times the
applicable CD specification in the applicable
performance specification or in the relevant
standard. When a CEMS is out of control, you
as owner or operator of the affected source
must take the necessary corrective actions
and repeat the tests that caused the system
to go out of control (in this case, the failed
CD check) until the applicable performance
requirements are met.
4.1.5 Additional Quality Assurance for
Data Above Span. This procedure must be
used when required by an applicable
regulation and may be used when significant
data above span are being collected.
Furthermore, the terms of this procedure do
24169
not apply to the extent that alternate terms
are otherwise specified in an applicable rule
or permit.
4.1.5.1 Any time the average measured
concentration of EtO exceeds 200 percent of
the span value for two consecutive one-hour
averages, conduct the following ’above span’
CEMS response check.
4.1.5.1.1 Within a period of 24 hours
(before or after) of the ’above span’ period,
introduce a higher, ’above span’ EtO
reference gas standard to the CEMS. Use
’above span’ reference gas that meets the
requirements of section 7.0 of PS–19 in
appendix B to this part and target a
concentration level between 75 and 125
percent of the highest hourly concentration
measured during the period of measurements
above span or 5 ppmv whichever is greater.
4.1.5.1.2 Introduce the reference gas at
the probe for extractive CEMS.
4.1.5.1.3 At no time may the ’above span’
concentration exceed the analyzer full-scale
range.
4.1.5.2 Record and report the results of
this procedure as you would for a daily
calibration. The ’above span’ response check
is successful if the value measured by the
CEMS is within 20 percent of the certified
value of the reference gas.
4.1.5.3 If the ’above span’ response check
is conducted during the period when
measured emissions are above span and there
is a failure to collect at least one data point
in an hour due to the response check
duration, then determine the emissions
average for that missed hour as the average
of hourly averages for the hour preceding the
missed hour and the hour following the
missed hour.
4.1.5.4 In the event that the ’above span’
response check is not successful (i.e., the
CEMS measured value is not within 20
percent of the certified value of the reference
gas), then you must normalize the one-hour
average stack gas values measured above the
span during the 24-hour period preceding or
following the ’above span’ response check for
reporting based on the CEMS response to the
reference gas as shown in Eq. 7–1:
Eq. 7-1
Certtfted reference gas11alue
z Measuredsta.ckgasresult
d ,-L-- f ,,:
Measure 11CIARf o n 1 erence gas
4.2 Out of Control Period Duration for
Daily Assessments. The beginning of the outof-control period is the hour in which the
owner or operator conducts a daily
performance check (e.g., calibration drift)
that indicates an exceedance of the
performance requirements established under
this procedure. The end of the out-of-control
period is the completion of daily assessment
of the same type following corrective actions,
which shows that the applicable performance
requirements have been met.
4.3 CEMS Data Status During Out-ofControl Period. During the period the CEMS
is out-of- control, the CEMS data may not be
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
used in calculating compliance with an
emissions limit nor be counted towards
meeting minimum data availability as
required and described in the applicable
regulation or permit.
5.0
Data Accuracy Assessment
You must audit your CEMS for the
accuracy of EtO measurement on a regular
basis at the frequency described in this
section, unless otherwise specified in an
applicable regulation or permit. Quarterly
audits are performed at least once each
calendar quarter. Successive quarterly audits,
to the extent practicable, shall occur no
PO 00000
Frm 00081
Fmt 4701
Sfmt 4700
closer than 2 months apart. Annual audits are
performed at least once every four
consecutive calendar quarters.
5.1 Concentration Accuracy Auditing
Requirements. Unless otherwise specified in
an applicable regulation or permit, you must
audit the EtO measurement accuracy of each
CEMS at least once each calendar quarter,
except in the case where the affected facility
is off-line (does not operate). In that case, the
audit must be performed as soon as is
practicable in the quarter in which the unit
recommences operation. Successive quarterly
audits must, to the extent practicable, be
performed no less than 2 months apart. The
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.025
khammond on DSKJM1Z7X2PROD with RULES2
.
Nom,alindstackgasresult=
24170
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Audit point
Audit range
khammond on DSKJM1Z7X2PROD with RULES2
1 (Mid-Level) ...........
2 (High-Level) ..........
50 to 60% of span value.
80 to 100% of span value.
5.1.3.1 Inject each of the three audit gases
(zero and two upscale) three times each for
a total of nine injections. Inject the gases so
that the entire measurement system is
challenged. Do not inject the same gas
concentration twice in succession.
5.1.3.2 Use EtO audit gases that meet the
requirements of section 7 of PS–19 in
appendix B to this part.
5.2.3.3 Calculate results as described in
section 6.3.
5.1.4 Dynamic Spiking Audit. A quarterly
DSA may be conducted as an option to
conducting a RATA in three of four calendar
quarters, but in no more than three quarters
in succession.
5.1.4.1 To conduct a DSA, you must
challenge the entire EtO CEMS with a zero
gas in accordance with the procedure in
section 11.8 of PS–19 in appendix B of this
part. You must also conduct the DS
procedure as described in appendix A to PS–
19 of appendix B to this part. You must
conduct three spike injections with each of
two upscale level audit gases. The upscale
level gases must meet the requirements of
section 7 of PS–19 in appendix B to this part
and must be chosen to yield concentrations
at the analyzer of 50 to 60 percent of span
and 80 to 100 percent of span. Do not inject
the same spike gas concentration twice in
succession.
5.1.4.2 Calculate results as described in
section 6.4. To determine CEMS accuracy,
you must calculate the dynamic spiking error
(DSE) for each of the two upscale audit gases
using equation A5 in appendix A to PS–19
and equation 7–3 in section 6.4 of this
Procedure.
5.1.5 Other Alternative Quarterly Audits.
Other alternative audit procedures, as
approved by the Administrator, may be used
for three of four calendar quarters.
5.2 Out of Control Criteria for Excessive
Audit Inaccuracy. If the results of the RATA,
RAA, CGA, or DSA do not meet the
applicable performance criteria in section
5.2.4, the CEMS is out-of-control. If the
CEMS is out-of-control, take necessary
corrective action to eliminate the problem.
Following corrective action, the CEMS must
pass a test of the same type that resulted in
the out-of-control period to determine if the
CEMS is operating within the specifications
(e.g., a RATA must always follow an out-ofcontrol period resulting from a RATA).
5.2.1 If the audit results show the CEMS
to be out-of-control, you must report both the
results of the audit showing the CEMS to be
out-of-control and the results of the audit
following corrective action showing the
CEMS to be operating within specifications.
5.2.2 Out-Of-Control Period Duration for
Excessive Audit Inaccuracy. The beginning of
the out-of-control period is the time
corresponding to the completion of the
sampling for the failed RATA, RAA, CGA or
DSA. The end of the out-of-control period is
the time corresponding to the completion of
the sampling of the subsequent successful
audit.
5.2.3 CEMS Data Status During Out-OfControl Period. During the period the CEMS
is out-of- control, the CEMS data may not be
used in calculating emission compliance nor
be counted towards meeting minimum data
availability as required and described in the
applicable regulation or permit.
5.2.4 Criteria for Excessive Quarterly and
Yearly Audit Inaccuracy. Unless specified
otherwise in the applicable regulation or
permit, the criteria for excessive inaccuracy
are:
5.2.4.1 For the RATA, the CEMS must
meet the RA specifications in section 13.4 of
PS–19 in appendix B to this part.
5.2.4.2 For the CGA, the accuracy must
not exceed 10.0 percent of the span value at
the zero gas and the mid- and high-level
reference gas concentrations.
5.2.4.3 For the RAA, the RA must not
exceed 20.0 percent of the RMavg as
calculated using equation 7–2 in section 6.2
of this procedure whether calculated in units
of EtO concentration or in units of the
emission standard. In cases where the RA is
calculated on a concentration (ppbv) basis, if
the average EtO concentration measured by
the RM during the test is less than 75 percent
of the EtO concentration equivalent to the
applicable standard, you may substitute the
equivalent emission standard value (in
ppbw) in the denominator of equation 7–2 in
the place of RMavg and the result of this
alternative calculation of RA must not exceed
15.0 percent.
5.2.4.4 For DSA, the accuracy must not
exceed 5.0 percent of the span value at the
zero gas and the mid- and high-level
reference gas concentrations or 20.0 percent
of the applicable emission standard,
whichever is greater.
5.3 Criteria for Acceptable QC
Procedures. Repeated excessive inaccuracies
(i.e., out-of-control conditions resulting from
the quarterly or yearly audits) indicate that
the QC procedures are inadequate or that the
CEMS is incapable of providing quality data.
Therefore, whenever excessive inaccuracies
occur for two consecutive quarters, you must
revise the QC procedures (see section 3.0) or
modify or replace the CEMS.
5.4 Criteria for Optional QA Test
Frequency. If all the quality criteria are met
in sections 4 and 5 of this procedure, the
CEMS is in-control.
5.5.1 Unless otherwise specified in an
applicable rule or permit, if the CEMS is incontrol and if your source emits ≤75 percent
of the EtO emission limit for each averaging
period as specified in the relevant standard
for eight consecutive quarters that include a
minimum of two RATAs, you may revise
your auditing procedures to use CGA, RAA
or DSA each quarter for seven subsequent
quarters following a RATA.
5.5.2 You must perform at least one
RATA that meets the acceptance criteria
every 2 years.
5.5.3 If you fail a RATA, RAA, CGA, or
DSA, then the audit schedule in section 5.2
must be followed until the audit results meet
the criteria in section 5.3.4 to start
requalifying for the optional QA test
frequency in section 5.5.
6.0 Calculations for CEMS Data Accuracy
6.1 RATA RA Calculation. Follow
equations 9 through 14 in section 12 of PS–
19 in appendix B to this part to calculate the
RA for the RATA. The RATA must be
calculated either in units of the applicable
emission standard or in concentration units
(ppbv).
6.2 RAA Accuracy Calculation. Use
equation 7–2 to calculate the accuracy for the
RAA. The RA may be calculated in
concentration units (ppmv) or in the units of
the applicable emission standard.
_MNavs-R.Ma.x100
RA-
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Eq. 7-2
RM.v.
PO 00000
Frm 00082
Fmt 4701
Sfmt 4725
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.026
accuracy audits shall be conducted as
follows:
5.1.1 Relative Accuracy Test Audit
(RATA). A RATA must be conducted at least
once every four calendar quarters, except as
otherwise noted in sections 5.1.5 or 5.5 of
this procedure. Perform the RATA as
described in section 11.6 of PS–19 in
appendix B to this part. If the EtO
concentration measured by the RM during a
RATA (in ppmv or other units of the
standard) is less than or equal to 20 percent
of the concentration equivalent to the
applicable emission standard, you must
perform a Cylinder Gas Audit (CGA) or a
Dynamic Spike Audit (DSA) for at least one
subsequent (one of the following three)
quarterly accuracy audits.
5.1.2 Quarterly Relative Accuracy Audit
(RAA). A quarterly RAA may be conducted
as an option to conducting a RATA in three
of four calendar quarters, but in no more than
three quarters in succession. To conduct an
RAA, follow the test procedures in section
11.6 of PS–19 in appendix B to this part,
except that only three test runs are required.
The difference between the mean of the RM
values and the mean of the CEMS responses
relative to the mean of the values (or
alternatively the emission standard) is used
to assess the accuracy of the CEMS. Calculate
the RAA results as described in section 6.2.
As an alternative to an RAA, a cylinder gas
audit or a dynamic spiking audit may be
conducted.
5.1.3 Cylinder Gas Audit. A quarterly
CGA may be conducted as an option to
conducting a RATA in three of four calendar
quarters, but in no more than three
consecutive quarters. To perform a CGA,
challenge the CEMS with a zero-level and
two upscale level audit gases of known
concentrations within the following ranges:
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Where:
RA = Accuracy of the CEMS (percent)
MNavg = Average measured CEMS response
during the audit in units of applicable
standard or appropriate concentration.
RMavg = Average reference method value in
units of applicable standard or
appropriate concentration.
6.3 CGA Accuracy Calculation. For each
gas concentration, determine the average of
the three CEMS responses and subtract the
average response from the audit gas value.
For extractive CEMS, calculate the ME at
each gas level using equation 3A in section
12.3 of PS–19 of appendix B to this part.
6.4 DSA Accuracy Calculation. DSA
accuracy is calculated as a percent of span.
24171
To calculate the DSA accuracy for each
upscale spike concentration, first calculate
the DSE using equation A5 in appendix A of
PS–19 in appendix B to this part. Then use
equation 7–3 to calculate the average DSA
accuracy for each upscale spike
concentration. To calculate DSA accuracy at
the zero level, use equation 3A in section
12.3 of PS–19 in appendix B to this part.
If('D~Btl]
khammond on DSKJM1Z7X2PROD with RULES2
7.0
Reporting Requirements
At the reporting interval specified in the
applicable regulation or permit, report for
each CEMS the quarterly and annual
accuracy audit results from section 6 and the
daily assessment results from section 4.
Unless otherwise specified in the applicable
regulation or permit, include all data sheets,
calculations, CEMS data records (i.e., charts,
records of CEMS responses), reference gas
certifications and reference method results
necessary to confirm that the performance of
the CEMS met the performance
specifications.
7.1 Unless otherwise specified in the
applicable regulations or permit, report the
daily assessments (CD and beam intensity)
and accuracy audit information at the
interval for emissions reporting required
under the applicable regulations or permits.
7.1.1 At a minimum, the daily
assessments and accuracy audit information
reporting must contain the following
information:
a. Company name and address.
b. Identification and location of monitors
in the CEMS.
c. Manufacturer and model number of each
monitor in the CEMS.
d. Assessment of CEMS data accuracy and
date of assessment as determined by a RATA,
RAA, CGA or DSA described in section 5
including:
i. The RA for the RATA;
ii. The accuracy for the CGA, RAA, or DSA;
iii. The RM results, the reference gas
certified values;
iv. The CEMS responses;
v. The calculation results as defined in
section 6; and
vi. Results from the performance audit
samples described in section 5 and the
applicable RMs.
e. Summary of all out-of-control periods
including corrective actions taken when
CEMS was determined out-of-control, as
described in sections 4 and 5. 7.1.2 If the
accuracy audit results show the CEMS to be
out-of-control, you must report both the audit
results showing the CEMS to be out-ofcontrol and the results of the audit following
corrective action showing the CEMS to be
operating within specifications.
7.1.2 If the accuracy audit results show
the CEMS to be out-of-control, you must
report both the audit results showing the
CEMS to be out-of-control and the results of
the audit following corrective action showing
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
3
Eq. 7-3
x:100
the CEMS to be operating within
specifications.
8.0 Bibliography
1. EPA Traceability Protocol for Assay and
Certification of Gaseous Calibration
Standards, U.S. Environmental
Protection Agency office of Research and
Development, EPA/600/R–12/531, May
2012.
2. Method 205, ‘‘Verification of Gas Dilution
Systems for Field Instrument
Calibrations,’’ 40 CFR part 51, appendix
M.
9.0 [Reserved]
PART 63—NATIONAL EMISSION
STANDARDS FOR HAZARDOUS AIR
POLLUTANTS FOR SOURCE
CATEGORIES
4. The authority citation for part 63
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
Subpart A—General Provisions
5. Section 63.14 is amended by:
a. Revising paragraphs (a) and (f) and
paragraph (i) introductory text;
■ b. Redesignating paragraphs (i)(88)
through (119) as paragraphs (i)(89)
through (120), and;
■ c. Adding new paragraph (i)(88) and
note 2 to paragraph (i).
The revisions and additions read as
follows:
■
■
§ 63.14
Incorporations by reference.
(a) Certain material is incorporated by
reference into this part with the
approval of the Director of the Federal
Register under 5 U.S.C. 552(a) and 1
CFR part 51. To enforce any edition
other than that specified in this section,
the EPA must publish a document in the
Federal Register and the material must
be available to the public. All approved
incorporation by reference (IBR)
material is available for inspection at
the EPA and at the National Archives
and Records Administration (NARA).
Contact the EPA at: EPA Docket Center,
Public Reading Room, EPA WJC West,
Room 3334, 1301 Constitution Ave. NW,
PO 00000
Frm 00083
Fmt 4701
Sfmt 4700
Washington, DC, telephone: 202–566–
1744. For information on the availability
of this material at NARA, visit
www.archives.gov/federal-register/cfr/
ibr-locations or email fr.inspection@
nara.gov. The material may be obtained
from the sources in the following
paragraphs of this section.
*
*
*
*
*
(f) American Society of Mechanical
Engineers (ASME), Two Park Avenue,
New York, NY 10016–5990; phone:
(800) 843–2763; email: CustomerCare@
asme.org; website: www.asme.org.
(1) ANSI/ASME PTC 19.10–1981,
Flue and Exhaust Gas Analyses [Part 10,
Instruments and Apparatus], issued
August 31, 1981; IBR approved for
§§ 63.309(k); 63.365(b); 63.457(k);
63.772(e) and (h); 63.865(b); 63.997(e);
63.1282(d) and (g); 63.1625(b); table 5 to
subpart EEEE; §§ 63.3166(a); 63.3360(e);
63.3545(a); 63.3555(a); 63.4166(a);
63.4362(a); 63.4766(a); 63.4965(a);
63.5160(d); table 4 to subpart UUUU;
table 3 to subpart YYYY; §§ 63.7822(b);
63.7824(e); 63.7825(b); 63.8000(d);
63.9307(c); 63.9323(a); 63.9621(b) and
(c); 63.11148(e); 63.11155(e);
63.11162(f); 63.11163(g); 63.11410(j);
63.11551(a); 63.11646(a); 63.11945;
table 4 to subpart AAAAA; table 5 to
subpart DDDDD; table 4 to subpart JJJJJ;
table 4 to subpart KKKKK; table 4 to
subpart SSSSS; tables 4 and 5 of subpart
UUUUU; table 1 to subpart ZZZZZ; and
table 4 to subpart JJJJJJ.
(2) [Reserved]
*
*
*
*
*
(i) ASTM International, 100 Barr
Harbor Drive, P.O. Box CB700, West
Conshohocken, Pennsylvania 19428–
2959; phone: (800) 262–1373; website:
www.astm.org.
*
*
*
*
*
(88) ASTM D6348–12 (Reapproved
2020), Standard Test Method for
Determination of Gaseous Compounds
by Extractive Direct Interface Fourier
Transform (FTIR) Spectroscopy,
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.027
DSA Accuracy=
24172
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Approved December 1, 2020; IBR
approved for § 63.365(b).
*
*
*
*
*
Note 2 to paragraph (i): Standards listed in
this paragraph (i) may also be available from
standards resellers including the Standards
Store, https://global.ihs.com.
*
*
*
*
*
6. Subpart O is revised and
republished to read as follows:
■
Subpart O—Ethylene Oxide Emissions
Standards for Sterilization Facilities
Sec.
63.360 Applicability.
63.361 Definitions.
63.362 Standards.
63.363 Compliance and performance
provisions.
63.364 Monitoring requirements.
63.365 Test methods and procedures.
63.366 Reporting requirements.
63.367 Recordkeeping requirements.
63.368 Implementation and enforcement.
Table 1 to Subpart O of Part 63 Standards for
SCVs
Table 2 to Subpart O of Part 63 Standards for
ARVs
Table 3 to Subpart O of Part 63 Standards for
CEVs
Table 4 to Subpart O of Part 63 Standards for
Group 1 Room Air Emissions
Table 5 to Subpart O of Part 63 Standards for
Group 2 Room Air Emissions
Table 6 to Subpart O of Part 63 Applicability
of General Provisions to Subpart O
Appendix A to Subpart O of Part 63—
Monitoring Provisions for EtO CEMS
Subpart O—Ethylene Oxide Emissions
Standards for Sterilization Facilities
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.360
Applicability.
(a) You are subject to the
requirements of this subpart if you own
or operate a sterilization facility that has
an affected source specified in
paragraph (b) of this section. Table 6 to
this subpart shows which parts of the
General Provisions in §§ 63.1 through
63.15 apply to you.
(b) The affected sources subject to this
subpart are:
(1) Each SCV at any sterilization
facility;
(2) Each ARV at any sterilization
facility;
(3) Each CEV at any sterilization
facility;
(4) The collection of all Group 1 room
air emissions at any sterilization facility;
and
(5) The collection of all Group 2 room
air emissions at any sterilization facility.
(c) An existing affected source is one
the construction or reconstruction of
which was commenced on or before
April 13, 2023.
(d) A new affected source is one the
construction or reconstruction of which
is commenced after April 13, 2023.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(e) An SCV, ARV, or CEV is
reconstructed if you meet the
reconstruction criteria as defined in
§ 63.2, and if you commence
reconstruction after April 13, 2023.
(f) This subpart does not apply to
beehive fumigators.
(g) This subpart does not apply to
research or laboratory facilities as
defined in section 112(c)(7) of title III of
the Clean Air Act Amendment of 1990.
(h) This subpart does not apply to EtO
sterilization operations at stationary
sources such as hospitals, doctor’s
offices, clinics, or other facilities whose
primary purpose is to provide medical
or dental services to humans or animals.
(i) If you are an owner or operator of
an area source subject to this subpart,
you are exempt from the obligation to
obtain a permit under 40 CFR part 70 or
71, provided you are not required to
obtain a permit under 40 CFR 70.3(a) or
71.3(a) for a reason other than your
status as an area source under this
subpart. Notwithstanding the previous
sentence, you must continue to comply
with the provisions of this subpart
applicable to area sources.
(j) You must comply with the
provisions of this subpart no later than
the dates specified in paragraphs (j)(1)
through (17) of this section:
(1) If you own or operate an existing
affected source, you must comply with
the applicable provisions of this subpart
no later than the dates specified in
tables 1 through 5 to this subpart, as
applicable.
(2) If you own or operate a new
affected source, and the initial startup of
your affected source is on or before
April 5, 2024, you must comply with
the provisions of this subpart no later
than April 5, 2024.
(3) If you own or operate a new
affected source, and the initial startup is
after April 5, 2024, you must comply
with the provisions of this subpart upon
startup of your affected source.
(4) If existing SCV, ARV, or CEV or
parts of an existing collection of Group
1 or Group 2 room air emissions are
replaced such that the replacement
meets the definition of reconstruction in
§ 63.2 and the reconstruction
commenced after April 13, 2023, then
the existing affected source becomes a
new affected source. The reconstructed
source must comply with the
requirements for a new affected source
upon initial startup of the reconstructed
source or by April 5, 2024, whichever is
later.
(5) All existing SCVs at facilities that
meet or exceed 1 tpy of EtO use within
any consecutive 12-month period after
April 7, 2025, that increase their EtO
use after April 6, 2026, such that the
PO 00000
Frm 00084
Fmt 4701
Sfmt 4700
SCV becomes subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
(6) All existing SCVs at facilities that
do not exceed 1 tpy of EtO use within
any consecutive 12-month period after
April 6, 2026, that increase their EtO
use thereafter, such that the SCV
becomes subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
(7) All new SCVs at facilities that
increase their EtO use over a year after
startup such that the SCV becomes
subject to a more stringent emission
standard, immediately upon becoming
subject to the more stringent emission
standard.
(8) All existing ARVs at facilities that
meet or exceed 10 tpy of EtO use within
any consecutive 12-month period after
April 7, 2025, that increase their EtO
use after April 6, 2026, such that the
ARV becomes subject to a more
stringent emission standard,
immediately upon becoming subject to
the more stringent emission standard.
(9) All existing ARVs at facilities that
do not exceed 10 tpy of EtO use within
any consecutive 12-month period after
April 6, 2026, that increase their EtO
use after thereafter, such that the ARV
becomes subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
(10) All new ARVs at facilities that
increase their EtO use over a year after
startup such that the ARV becomes
subject to a more stringent emission
standard, immediately upon becoming
subject to the more stringent emission
standard.
(11) All existing CEVs at facilities that
do not exceed 60 tpy of EtO use within
any consecutive 12-month period after
April 6, 2026, that increase their EtO
use thereafter, such that the CEV
becomes subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
(12) All new CEVs at facilities that
increase their EtO use over a year after
startup such that the CEV becomes
subject to a more stringent emission
standard, immediately upon becoming
subject to the more stringent emission
standard.
(13) All existing collections of Group
1 room air emissions at facilities that do
not exceed 40 tpy of EtO use within any
consecutive 12-month period after April
6, 2026, that increase their EtO use
thereafter, such that the collection of
Group 1 room air emissions becomes
subject to a more stringent emission
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
standard, immediately upon becoming
subject to the more stringent emission
standard.
(14) All new Group 1 room air
emissions at facilities that increase their
EtO use over a year after startup such
that the Group 1 room air emissions
become subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
(15) All existing collections of Group
2 room air emissions at facilities that
meet or exceed 4 tpy of EtO use within
any consecutive 12-month period after
April 7, 2025, that increase their EtO
use after April 6, 2026, such that the
collection of Group 2 room air
emissions becomes subject to a more
stringent emission standard,
immediately upon becoming subject to
the more stringent emission standard.
(16) All existing collections of Group
2 room air emissions at facilities that do
not exceed 4 tpy of EtO use within any
consecutive 12-month period after April
6, 2026, that increase their EtO use
thereafter, such that the collection of
Group 2 room air emissions becomes
subject to a more stringent emission
standard, immediately upon becoming
subject to the more stringent emission
standard.
(17) All new Group 2 room air
emissions at facilities that increase their
EtO use over a year after startup such
that the Group 2 room air emissions
become subject to a more stringent
emission standard, immediately upon
becoming subject to the more stringent
emission standard.
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.361
Definitions.
Terms and nomenclature used in this
subpart are defined in the Clean Air Act
(the Act) as amended in 1990, §§ 63.2
and 63.3, or in this section. For the
purposes of this subpart, if the same
term is defined in subpart A of this part
and in this section, it shall have the
meaning given in this section.
Acid-water scrubber means an add-on
air pollution control device that uses an
aqueous or alkaline scrubbing liquor to
absorb and neutralize acid gases.
Aeration means, for the purposes of
this rule, exposing sterilized material at
elevated temperatures to drive EtO out
of the material.
Aeration room means any vessel or
room that is used to facilitate off-gassing
of EtO at a sterilization facility. If a
facility uses only combination
sterilization units, for the purposes of
this rule, there are no aeration rooms at
the facility.
Aeration room vent (ARV) means the
point(s) through which the evacuation
of EtO-laden air from an aeration room
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
occurs. For combination sterilization
units, there is no ARV.
Catalytic oxidizer means a
combustion device that uses a solidphase catalyst to lower the temperature
required to promote the oxidization and
achieve adequate reduction of volatile
organic compounds, as well as volatile
hazardous air pollutants.
Chamber exhaust vent (CEV) means
the point(s) through which EtO-laden
air is removed from the sterilization
chamber during chamber unloading
following the completion of sterilization
and associated air washes. This may
also be referred to as a ‘‘backvent’’ (or
‘‘back vent’’). For combination
sterilization units, there is no CEV.
Combination sterilization unit means
any enclosed vessel in which both
sterilization and aeration of the same
product occur within the same vessel,
i.e., the vessel is filled with ethylene
oxide gas or an ethylene oxide/inert gas
mixture for the purpose of sterilizing
and is followed by aeration of ethylene
oxide.
Combined emission stream means
when the emissions from more than one
emission source are routed together
using common ductwork prior to the
control system.
Continuous monitoring system (CMS)
means, for the purposes of this rule, the
equipment necessary to continuously
samples the regulated parameter
specified in § 63.364 or § 63.365 of this
subpart without interruption, evaluates
the detector response at least once every
15 seconds, and computes and records
the average value at least every 60
seconds, except during allowable
periods of calibration and except as
defined otherwise by the continuous
emission monitoring system (CEMS)
performance specifications (PS) in
appendix B to part 60 of this chapter.
Control System Residence Time
means the time elapsed from entrance of
flow into the control system until
gaseous materials exit the control
system. For control systems with
multiple exhaust streams whereby the
residence time may vary for the streams,
the residence time for purposes of
complying with this subpart means the
longest residence time for any exhaust
stream in use. If a peak shaver is used,
it is part of the control system, and its
residence time must be considered.
Deviation means any instance in
which an owner or operator of an
affected source, subject to this subpart:
(1) Fails to meet any requirement or
obligation established by this subpart
including, but not limited to, any
emission limitation, parameter value, or
best management practice; or
PO 00000
Frm 00085
Fmt 4701
Sfmt 4700
24173
(2) Fails to meet any term or condition
that is adopted to implement an
applicable requirement in this subpart
or that is included in the operating
permit for any facility required to obtain
such a permit.
EtO dispensing means charging a
sterilization chamber or chambers with
EtO from non-cartridge storage media
(e.g., drums, cylinders) via the use of
piping, lines, and other equipment. This
includes injection rooms and postinjection handling of containers.
Gas/solid reactor means an add-on air
pollution control device that uses a dry,
solid-phase system to chemically
convert EtO so that it becomes bound to
the solid packing. This may also be
referred to as a ‘‘dry bed reactor’’ or a
‘‘dry bed scrubber.’’
Group 1 room air emissions mean
emissions from indoor EtO storage, EtO
dispensing, vacuum pump operations,
and pre-aeration handling of sterilized
material.
Group 2 room air emissions mean
emissions from post-aeration handling
of sterilized material.
Indoor EtO storage means the storage
of EtO within non-cartridge media (e.g.,
drums, cylinders) inside a sterilization
building.
Initial startup means the moment
when an affected source subject to an
emissions standard in § 63.362 first
begins operation.
Injection room means any room where
EtO is injected into containers (e.g.,
bags, pouches) that are filled with
product to be sterilized.
Maximum ethylene glycol
concentration means the concentration
of ethylene glycol in the scrubber liquor
of an acid-water scrubber control device
established during a performance test
when the scrubber achieves the
appropriate control of EtO emissions.
Maximum gas/solid reactor pressure
drop means the pressure drop of the
gas/solid reactor established during a
performance test when the gas/solid
reactor achieves the appropriate control
of EtO emissions.
Maximum liquor tank level means the
level of scrubber liquor in the acidwater scrubber liquor recirculation tank
established during a performance test
when the scrubber achieves the
appropriate control of EtO emissions.
Maximum scrubber liquor pH means
the pH of the acid-water scrubber liquor
established during a performance test
when the scrubber achieves the
appropriate control of EtO emissions.
Minimum stack volumetric flow rate
means the stack volumetric flow rate
corrected established during a
compliance demonstration when
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24174
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
permanent total enclosure (PTE)
requirements are met.
Minimum temperature at the inlet to
the catalyst bed means the temperature
at the inlet to the catalyst bed
established during a performance test
when the catalytic oxidizer achieves the
appropriate control of EtO emissions.
Minimum temperature difference
across the catalyst bed means the
temperature difference across the
catalyst bed established during a
performance test when the catalytic
oxidizer achieves the appropriate
control of EtO emissions.
Minimum temperature in or
immediately downstream of the firebox
means the temperature in or
immediately downstream of the firebox
established during a performance test
when the thermal oxidizer achieves the
appropriate control of EtO emissions.
Natural draft opening (NDO) means
any permanent opening in the enclosure
that remains open during operation of
the facility and is not connected to a
duct in which a fan is installed.
Operating day means any day that a
facility is engaged in a sterilization
operation.
Peak shaver means a device that is
used to reduce high EtO concentrations
within an exhaust stream such that the
downstream control device is not
overwhelmed.
Permanent total enclosure (PTE)
means a permanently installed
enclosure that meets the criteria of
Method 204 of appendix M, 40 CFR part
51 for a PTE. A PTE completely
surrounds a source of emissions such
that all EtO emissions are captured,
contained, and directed to a control
system or to an outlet(s).
Post-aeration handling of sterilized
material means the storage and
transportation of material that has been
removed from aeration but has not been
placed in a vehicle for the sole purpose
of distribution to another facility. Postaeration handling of sterilized material
ends when that vehicle is closed for the
final time before leaving the facility.
This definition does not include
handling of material that has been both
previously sterilized and not removed
from aeration following re-sterilization.
Post-injection handling of containers
means the storage and transportation of
containers (e.g., bags, pouches) that
have been injected with EtO but have
not been placed in a sterilization
chamber.
Pre-aeration handling of sterilized
material means the storage and
transportation of material that has been
removed from a sterilization chamber
but has not been placed in an aeration
room. If only combination sterilization
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
units are used, and if material is not
moved out of the vessel between
sterilization and aeration, then
emissions from this source do not exist.
This does not include post-injection
handling of containers.
Rolling sum means the weighted sum
of all data, meeting QA/QC
requirements or otherwise normalized,
collected during the applicable rolling
time period. The period of a rolling sum
stipulates the frequency of data
collection, summing, and reporting. As
an example, to demonstrate compliance
with a rolling 30-operating day sum
emission reduction standard determined
from hourly data, you must (1)
determine the total mass of ethylene
oxide prior to control and following
control for each operating day; (2) then
sum the current daily total mass prior to
control with the previous 29 operating
day total mass values and repeat the
same process for the current daily total
mass following control; and (3) then
divide the 30-operating day total mass
emissions following control by the 30operating day total mass prior to control
and subtract the resulting value from
one to obtain the 30-operating day
emission reduction achieved.
Single-item sterilization means a
process in which one or more items are
placed in a pouch, EtO is injected into
the pouch, and the sealed pouch is
placed in a vessel to allow sterilization
to occur.
Sterilization chamber means any
enclosed vessel or room that is filled
with EtO gas, or an EtO/inert gas
mixture, for the purpose of sterilizing
and/or fumigating at a sterilization
facility. This does not include injection
rooms.
Sterilization chamber vent (SCV)
means the point (prior to the vacuum
pump) through which the evacuation of
EtO from the sterilization chamber
occurs following sterilization or
fumigation, including any subsequent
air washes.
Sterilization facility means any
stationary source where EtO is used in
the sterilization or fumigation of
materials, including but not limited to
facilities that engage in single-item
sterilization.
Sterilization operation means any
time when EtO is removed from the
sterilization chamber through the SCV
or the chamber exhaust vent, when EtO
is removed from the aeration room
through the aeration room vent, when
EtO is stored within the building, when
EtO is dispensed from a container to a
chamber, when material is moved from
sterilization to aeration, or when
materials are handled post-aeration.
PO 00000
Frm 00086
Fmt 4701
Sfmt 4700
Thermal oxidizer means all
combustion devices except flares.
Vacuum pump operation means the
operation of vacuum pumps, excluding
dry seal vacuum pumps, for the purpose
of removing EtO from a sterilization
chamber.
§ 63.362
Standards.
(a) Compliance date. If you own or
operate an affected source, you must
comply with the applicable requirement
by the compliance date specified in
§ 63.360(j). The standards of this section
are summarized in tables 1 through 5 to
this subpart.
(b) Applicability of standards. The
standards in paragraphs (c) through (k)
of this section apply at all times. If using
EtO CEMS to determine compliance
with an applicable standard, this
compliance demonstration is based on
the previous 30-operating days of data.
If using EtO CEMS to determine
compliance with an applicable emission
reduction standard in paragraphs (c)
through (g) and (i) of this section for
each operating day, you must determine
the total inlet mass to and outlet mass
from the control system using the
procedures laid out in § 63.364(f) and
appendix A to this subpart, and you
must maintain the emission limit based
on the inlet mass and the applicable
emission reduction standard. If using
EtO CEMS to determine compliance
with an applicable emission reduction
standard in paragraph (j) of this section,
you must continuously comply with the
requirements of that paragraph.
(c) SCV. You must comply with each
applicable standard in table 1 to this
subpart, and you must meet each
applicable requirement specified in
§ 63.363. If a SCV is combined with a
stream from another emission source,
you must comply with the appropriate
emission standard as prescribed in
paragraph (i) of this section.
(d) ARV. You must comply with each
applicable standard in table 2 to this
subpart, and you must meet each
applicable requirement specified in
§ 63.363. If an ARV is combined with a
stream from another emission source,
you must comply with the appropriate
emission standard as prescribed in
paragraph (i) of this section.
(e) CEV. You must comply with each
applicable standard in table 3 to this
subpart, and you must meet each
applicable requirement specified in
§ 63.363. If a CEV is combined with a
stream from another emission source,
you must comply with the appropriate
emission standard as prescribed in
paragraph (i) of this section.
(f) Group 1 room air emissions. You
must comply with the applicable
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
standard in table 4 to this subpart, and
you must meet each applicable
requirement specified in § 63.363. If
Group 1 room air emissions are
combined with a stream from another
emission source, you must comply with
the appropriate emission standard as
prescribed in paragraph (i) of this
section.
(g) Group 2 room air emissions. You
must comply with the applicable
standard in table 5 to this subpart, and
you must meet each applicable
requirement specified in § 63.363. If
Group 2 room air emissions are
combined with a stream from another
emission source, you must comply with
the appropriate emission standard as
prescribed in paragraph (i) of this
section. If you are required to limit the
sterilization chamber concentration of
EtO to 1 ppmv prior to opening the
sterilization chamber door, you must
meet the monitoring requirements
specified in § 63.364(h).
(h) Capture systems. Room air
emissions for which numerical limits
are prescribed must be captured and
routed under negative pressure to a
control system. You may assume the
capture system efficiency is 100 percent
if both conditions in paragraphs (h)(1)
and (2) of this section are met:
(1) The capture system meets the
criteria in Method 204 of appendix M to
40 CFR part 51 for a PTE and directs all
the exhaust gases from the enclosure to
an add-on control system.
(2) All sterilization operations
creating exhaust gases for which the
compliance demonstration is applicable
are contained within the capture
system.
(i) Requirements for combined
emission streams. When streams from
two or more emission sources are
combined, you must demonstrate
compliance by either the approach
specified in paragraph (i)(1) of this
section or the approach specified in
paragraph (i)(2) of this section in lieu of
the applicable standards in paragraphs
(c) through (g) of this section for the
affected source. The combined emission
stream limit is based on as 30-operating
day rolling sum. In order to elect to
comply with a combined emission
streams limit, you must use a CEMS on
each exhaust stack at the facility to
determine compliance.
(1) Monitoring after emission streams
are combined. You must follow
24175
requirements of paragraphs (i)(1)(i)
through (iii) of this section to determine
the applicable combined emission
streams limitation and demonstrate
compliance. Under this approach, you
must first determine the 30-operating
day rolling sum of mass inlet to the
control system. Then, the emission
limitation is determined by applying the
most stringent emission reduction
standard to the 30-operating day rolling
sum of the inlet mass. You must
maintain actual emissions at or below
that rate. For example, suppose a facility
controls all of its ARVs and CEVs with
one control system and that the
emission reduction standards that apply
to the ARVs and CEVs are 99.9% and
99%, respectively. Further suppose that
the mass of uncontrolled EtO emissions
from the combined stream is 5 lb during
the 30-operating day period. Under this
approach, the facility would need to
apply an emission reduction of 99.9% to
the combined stream, resulting in an
emission limit of 0.005 lb for the 30operating day period.
(i) The combined emission streams
limit for each 30-operating day period is
determined daily by using equation 1 to
this paragraph.
Equation 1 to paragraph (i) (2)(i)
= Maodoy * (1- Max(BR))
khammond on DSKJM1Z7X2PROD with RULES2
Where:
CESCombined = The combined emission stream
limit based upon monitoring after the
emission streams are combined, in
pounds.
M30day = The 30-operating day total mass sent
to controls for the combined emission
stream (i.e., monitoring data at the inlet
of the control system), as calculated
using equation A–3 and determined in
accordance with appendix A to this
subpart. The term ‘‘M30day’’ as used in
this equation is equivalent to the term
‘‘E30day’’ as designated in equation A–3.
Max(ER) = The most stringent emission
reduction standard specified in tables 1
through 5 of this subpart applicable to
any of the constituent streams, in
decimal format.
the combined emission stream is split
between two or more control systems,
further sum the 30-operating day rolling
sum of emissions from each control
system to obtain ECombined.
(iii) Compliance with the combined
emission streams limitation shall be
determined by demonstrating that
ECombined, as calculated in accordance
with paragraph (i)(1)(ii) of this section,
for each 30-operating day period is at or
below CESCombined, as calculated in
paragraph (i)(1)(i) of this section.
(2) Monitoring before emission
streams are combined. You must follow
requirements of paragraphs (i)(2)(i)
through (iii) of this section to determine
the applicable combined emission
streams limitation and demonstrate
(ii) The 30-operating day rolling sum
of emissions for the combined emission compliance. Under this approach, you
stream (i.e., monitoring data at the outlet must first determine 30-operating day
of the control system) is calculated daily rolling sum of inlet mass to the control
system for each component stream.
using equation A–3 and determined in
Then, the emission limitation is
accordance with appendix A to this
determined by applying the applicable
subpart. For purposes of this section,
emission reduction standards to the 30this value is designated as ECombined. If
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00087
Fmt 4701
Sfmt 4700
(Eq. 1)
operating day rolling sum of each
component stream and summing across
the components. You must maintain
actual emissions at or below that rate.
For example, suppose a facility controls
all of its ARVs and CEVs with one
control system and that the emission
reduction standards that apply to the
ARVs and CEVs are 99.9% and 99%,
respectively. Further suppose that
during a 30-operating day period the
mass of uncontrolled EtO emissions
from the ARVs is 4 lb and the mass of
uncontrolled EtO emissions from the
CEVs is 1 lb. Under this approach, the
facility would need to apply an
emission reduction of 99.9% to the ARV
stream and an emission reduction of
99% to the CEV stream, resulting in an
emission limit of 0.014 lb for the 30operating day period.
(i) The combined emission streams
limit for each 30-operating day period is
determined daily by using equation 2 to
this paragraph.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.028
CBScom11ind
24176
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Equation 2 to paragraph (i) (2)(i)
Where:
CESStreams = The combined emission stream
limit based upon monitoring before the
emission streams are combined, in
pounds.
Mc,i = The 30-operating day total mass sent
to controls for each non-SCV constituent
emission stream (i.e., monitoring data at
the inlet of the control system), as
calculated using equation A–3 and
determined in accordance with appendix
A to this subpart. The term ‘‘Mc,i’’ as
used in this equation is equivalent to the
term ‘‘E30day’’ as designated in equation
A–3.
ERi = The applicable emission reduction
standard from tables 2 through 5 of this
subpart to each non-SCV constituent
emission stream i.
i = Non-SCV constituent emission stream
index.
n = Total number of non-SCV constituent
emission streams.
Mc,j = The 30-operating day total mass sent
to controls for each SCV emission
stream, as determined in accordance
with equation 10 of
§ 63.364(f)(1)(i)(C)(1).
ERj = The applicable SCV emission reduction
standard in table 1 to this subpart, in
decimal format.
j = SCV emission stream index.
m = Total number of SCV emission streams.
using equation A–3 and determined in
accordance with appendix A to this
subpart. For purposes of this section,
this value is designated as ECombined. If
the combined emission stream is split
between two or more control systems,
then further sum the 30-operating day
rolling sum emissions from each control
system to obtain ECombined.
(iii) Compliance with the combined
emission streams limitation shall be
determined by demonstrating that
ECombined, as calculated in accordance
with paragraph (i)(2)(ii) of this section,
for each 30-operating day period is at or
below CESStreams, as calculated
paragraph (i)(2)(i) of this section.
(3) If room air emissions are both
subject to an emission standard and
split between two or more control
systems, then these control systems
must be treated as part of the same
control system.
(j) Site-wide emission limitation. You
may choose to comply with a site-wide
emission limitation (SWEL) specified in
this paragraph (j) in lieu of the
applicable standards in paragraphs (c)
through (g) of this section for the
facility. The SWEL, which is calculated
daily, is based on the previous 30
(ii) The 30-operating day rolling sum
operating days of data. In order to elect
emissions for the combined emission
to comply with a SWEL, you must
stream (i.e., monitoring data at the outlet utilize an EtO CEMS on each exhaust
of the control system) is calculated daily stack at the facility to determine
compliance. The owner or operator may
demonstrate compliance via one of the
two SWEL approaches in lieu of the
applicable standard(s) in paragraphs (c)
through (g) of this section for the
facility. If electing to comply with a
SWEL, you must comply with paragraph
(j)(3) of this section.
(1) SWEL based upon facility EtO use.
If you elect to comply with a SWEL
based upon facility EtO use, you must
follow requirements of paragraphs
(j)(1)(i) through (iii) of this section to
determine the applicable SWEL and
demonstrate compliance. Under this
approach, you first determine the 30operating day rolling sum of EtO use.
The SWEL is determined by multiplying
by 0.99 and then applying the required
SCV percent emission reduction
standard in table 1 to this subpart to the
30-operating day rolling sum of EtO
usage. Then, for each CEMS at the outlet
of the control systems at the facility,
determine the 30-operating day rolling
sum of emissions. Finally, determine
the facility actual emissions by
summing the 30-operating day rolling
sums for each CEMS at the facility. You
must maintain actual emissions at or
below the SWEL.
(i) The SWEL for each 30-operating
day period is determined daily by using
equation 3 to this paragraph.
Equation 3 to paragraph O)(l)(i)
BRscv)
ERSCV = The applicable SCV emission
reduction standard in table 1 to this
subpart, in decimal format.
(ii) The 30-operating day rolling sum
of emissions are determined daily using
equation 4 to this paragraph.
khammond on DSKJM1Z7X2PROD with RULES2
Equation 4 to paragraph (j)(l)(ii)
(Eq. 4)
Where:
EFac = The total emissions from the facility
over the previous 30-operating days, in
pounds.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Eo,i = The 30-operating day rolling sum of
emissions calculated at each exhaust
stack, i, monitored by an EtO CEMS, as
calculated using equation A–3 of
appendix A to this subpart.
PO 00000
Frm 00088
Fmt 4701
Sfmt 4700
i = Exhaust stack index
n = Total number of exhaust stacks
(iii) Compliance with the SWEL based
upon facility EtO usage shall be
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.031
in accordance with equation 11 of
§ 63.364(i)(2).
0.99 = Adjustment factor for EtO residual in
sterilized product.
(Eq. 3)
ER05AP24.030
Where:
SWELFac = SWEL based upon facility EtO
use, in pounds.
MFac = Facility EtO use over the previous 30
operating days, in pounds, as determined
= M,ac * 0.99 * (1-
ER05AP24.029
SWBL,ac
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
determined by demonstrating that EFac,
as calculated in accordance with
paragraph (j)(1)(ii) of this section, for
each 30-operating day period is at or
below the SWEL, as calculated
paragraph (j)(1)(i) of this section.
(2) SWEL based upon emissions
streams. If you elect to comply with a
SWEL based upon emissions streams,
you must follow requirements of
paragraphs (j)(2)(i) through (iii) of this
section to determine the applicable
SWEL and demonstrate compliance.
Under this approach, for each non-SCV
affected source, you must determine the
mass of EtO sent to controls and apply
the applicable emission reduction
standard. For each SCV affected source,
you must determine the mass of EtO
sent to controls as specified in
§ 63.364(f)(1)(i)(C)(1) and apply the
applicable emission reduction standard.
The SWEL is determined by summing
across the result of this calculation for
each affected source (both non-SCV and
SCV). Then, for each CEMS at the outlet
24177
of the control system(s) at the facility,
determine the 30-operating day rolling
sum of emissions. Finally, determine
the facility actual emissions by
summing the 30-operating day rolling
sums for each CEMS at the facility. You
must maintain actual emissions at or
below the SWEL.
(i) The SWEL for each 30-operating
day period is determined daily by using
equation 5 to this paragraph.
Equation 5 to paragraph (j) (2)(i)
khammond on DSKJM1Z7X2PROD with RULES2
Where:
SWELStreams = SWEL based upon individual
emissions streams, in pounds.
Mc,i = The 30-operating day total mass sent
to controls (i.e., monitoring data at the
inlet of the control system) for each nonSCV emission stream, as calculated using
equation A–3 and determined in
accordance with appendix A to this
subpart. The term ‘‘Mc,i’’ as used in this
equation is equivalent to the term
‘‘E30day’’ as designated in equation A–3.
ERi = The applicable emission reduction
standard to each non-SCV emission
stream, i, specified in tables 1 through 5
of this subpart, in decimal format.
i = Non-SCV emission streams index.
n = Total number of non-SCV emission
streams.
Mc,j = The 30-operating day total mass sent
to controls for each SCV emission
stream, as determined in accordance
with equation 10 in
§ 63.364(f)(1)(i)(C)(1).
ERj = The applicable SCV emission reduction
standard in table 1 to this subpart, in
decimal format.
j = SCV emission stream index.
m = Total number of SCV emission streams.
(ii) The 30-operating day rolling sum
of emissions are determined daily using
equation 4 to this section.
(iii) Compliance with the SWEL based
upon emission streams shall be
determined by demonstrating that EFac,
as calculated in accordance with
paragraph (j)(2)(ii) of this section, for
each 30-operating day period is at or
below SWELStreams, as calculated in
paragraph (j)(2)(i) of this section.
(3) Boundary. The boundary for this
approach includes all affected sources at
the facility.
(k) General duty. At all times, you
must operate and maintain any affected
source, including associated air
pollution control equipment and
monitoring equipment, in a manner
consistent with safety and good air
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
pollution control practices for
minimizing emissions. The general duty
to minimize emissions does not require
the owner or operator to make any
further efforts to reduce emissions if
levels required by the applicable
standard have been achieved.
Determination of whether a source is
operating in compliance with operation
and maintenance requirements will be
based on information available to the
Administrator which may include, but
is not limited to, monitoring results,
review of operation and maintenance
procedures, review of operation and
maintenance records, and inspection of
the source.
§ 63.363 Compliance and performance
provisions.
(a) Continuous compliance. You must
demonstrate continuous compliance
with the applicable emission standard(s)
using an EtO CEMS, including a shared
EtO CEMS, installed and operated in
accordance with the requirements of
Performance Specification 19 in
appendix B and Procedure 7 in
appendix F to part 60 of this chapter.
Alternatively, if you own or operate a
facility where EtO use is less than 100
pounds/yr, you may demonstrate
continuous compliance by conducting
annual performance tests using the
performance testing requirements in
§ 63.7, according to the applicability in
table 6 to this subpart, the procedures
listed in this section, and the test
methods listed in § 63.365. If you elect
to demonstrate compliance through
periodic performance testing, you must
also demonstrate continuous
compliance with each operating limit
required under this section according to
the methods specified in § 63.364. If you
own or operate an area source facility
PO 00000
Frm 00089
Fmt 4701
Sfmt 4700
where EtO use is less than 100 pounds/
yr where an existing collection of Group
2 room air emission is operated in
accordance with the PTE requirements
of EPA Method 204 of appendix M to
part 51 of this chapter, you may instead
conduct these performance tests once
every three years.
(b) Initial compliance for Facilities
that use EtO CEMS. To demonstrate
initial compliance with an emission
standard using a CEMS that measures
HAP concentrations directly (i.e., an
EtO CEMS), the initial performance test
must consist of the first 30 operating
days after the certification of the CEMS
according to Performance Specification
19 in Appendix B to part 40 of this
chapter. The initial compliance
demonstration period must be
completed on or before the date that
compliance must be demonstrated (i.e.,
180 days after the applicable
compliance date). You must follow the
procedures in appendix A to this
subpart.
(1) The CEMS performance test must
demonstrate compliance with the
applicable EtO standards in tables 1
through 5 to this subpart. Alternatively,
the CEMS performance test may
demonstrate compliance with
§ 63.362(i) or (j).
(i) You may time-share your CEMS
among different measurement points
provided that:
(A) The measurement points are
approximately equidistant from the
CEMS;
(B) The sampling time at each
measurement point is at least 3 times as
long as the CEMS response time;
(C) The CEMS completes at least one
complete cycle of operation for each
shared measurement point within a 15minute period; and
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.032
(Eq. 5)
khammond on DSKJM1Z7X2PROD with RULES2
24178
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(D) The CEMS meets the other
requirements of PS 19.
(2) You must collect hourly data from
auxiliary monitoring systems during the
performance test period, to convert the
pollutant concentrations to pounds per
hour.
(c) Initial compliance demonstration
where facility EtO use is less than 100
pounds per year. If you own or operate
an affected source that is both subject to
an emission standard in § 63.362 and
located within a facility where EtO use
is less than 100 pounds per year, you
may comply with paragraphs (c)(1) and
(2) of this section:
(1) Conduct an initial compliance
demonstration using the procedures
listed in § 63.7 of this part according to
the applicability in table 6 to this
subpart, the procedures listed in this
section, and the test methods listed in
§ 63.365;
(2) Complete the initial compliance
demonstration within 180 days after the
compliance date for the affected source
as determined in § 63.360(j).
(d) Operating limits for facility where
EtO use is less than 100 lb/yr. If annual
EtO use at the facility is less than 100
lb, the procedures in paragraphs (d)(1)
through (5) of this section may be used
to determine compliance with the
standard(s) under § 63.362(c) through (g)
and to establish operating limits for
each of the control devices, as
applicable:
(1) You must determine the percent
emission reduction of the control
system used to comply with § 63.362(c)
through (g) using the test methods and
procedures in § 63.365(d)(1).
(2) If an acid-water scrubber(s) is used
to comply with a standard, then you
must establish as an operating limit:
(i) The maximum ethylene glycol
concentration using the procedures
described in § 63.365(e)(1)(i);
(ii) The maximum liquor tank level
using the procedures described in
§ 63.365(e)(1)(ii); or
(iii) The maximum scrubber liquor pH
using the procedures described in
§ 63.365(e)(1)(iii).
(3) If a thermal oxidizer(s) is used to
comply with a standard, you must
establish as an operating limit the
minimum temperature in or
immediately downstream of the firebox
using the procedures described in
§ 63.365(e)(2).
(4) If a catalytic oxidizer(s) is used to
comply with the standard, you must
establish as operating limits both:
(i) The minimum temperature at the
inlet to the catalyst bed using the
procedures described in § 63.365(e)(3);
and
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(ii) The minimum temperature
difference across the catalyst bed using
the procedures described in
§ 63.365(e)(3).
(5) If a gas/solid reactor(s) is used to
comply with the standard, you must
establish as an operating limit the
pressure drop across the media beds and
conduct weekly sampling and analysis
of the media. Determine the maximum
gas/solid reactor pressure drop using the
procedures described in § 63.365(e)(4).
(e) Other control technology for
facility where EtO use is less than 100
lb/yr. If you are conducting a
performance test using a control
technology other than an acid-water
scrubber, catalytic oxidizer, thermal
oxidizer, or gas/solid reactor, you must
provide to the Administrator
information describing the design and
operation of the air pollution control
system, including recommendations for
the parameters to be monitored that will
demonstrate continuous compliance.
Based on this information, the
Administrator will determine the
parameter(s) to be measured during the
performance test. During the
performance test required in paragraph
(a) of this section, using the methods
approved in § 63.365(e)(5), you must
determine the site-specific operating
limit(s) for the operating parameters
approved by the Administrator. You
must submit the information at least
sixty days before the performance test is
scheduled to begin. The information on
the control technology must include the
five items listed in paragraphs (1)
through (5) of this section:
(1) Identification of the specific
parameters you propose to use as
additional operating limits;
(2) A discussion of the relationship
between these parameters and emissions
of regulated pollutants, identifying how
emissions of regulated pollutants
change with changes in these
parameters and how limits on these
parameters will serve to limit emissions
of regulated pollutants;
(3) A discussion of how you will
establish the upper and/or lower values
which will establish the operating limits
for these parameters;
(4) A discussion identifying the
methods you will use to measure and
the instruments you will use to monitor
these parameters, as well as the relative
accuracy and precision of these methods
and instruments; and
(5) A discussion identifying the
frequency and methods for recalibrating
the instruments you will use for
monitoring these parameters.
(f) Other emission streams. If the
emission stream does not consist only of
an SCV(s), the procedures in paragraphs
PO 00000
Frm 00090
Fmt 4701
Sfmt 4700
(f)(1) through (3) of this section shall be
used to determine initial compliance
with the emission limits under
§ 63.362(d) through (g), as applicable:
(1) You must comply with paragraph
(c) of this section, as applicable.
(2) If you are complying with a
percent emission reduction standard as
specified in tables 1 through 5 to this
subpart, you must determine
compliance with § 63.362(c) through (g),
as applicable, using the test methods
and procedures in § 63.365(d)(1).
(3) If you are required to operate any
portion of the facility under PTE, you
must initially demonstrate that the PTE
meets the requirements of Method 204
of 40 CFR part 51, appendix M, and that
all exhaust gases from the enclosure are
delivered to a control system or stack(s).
You must also meet the requirements in
§ 63.363(f)(3)(i) and either
§ 63.363(f)(3)(ii) or (iii):
(i) Maintain direction of the airflow
into the enclosure at all times, verifying
daily using the procedures described in
§ 63.364(f)(5) and meet either of the
requirements.
(ii) Establish as an operating limit the
minimum volumetric flow rate through
the affected stack(s) using the
procedures described in § 63.365(f)(1);
or
(iii) Install, operate, calibrate, and
maintain a continuous pressure
differential monitoring system using the
procedures described in § 63.364(f)(4).
§ 63.364
Monitoring requirements.
(a) General requirements. (1) If you
own or operate an affected source
subject to an emission standard in
§ 63.362, you must comply with the
monitoring requirements in § 63.8,
according to the applicability in table 6
to this subpart, and in this section.
(2) If you own or operate an affected
source at a facility where EtO use is less
than 100 lb/yr that is subject to an
emission standard in § 63.362, you may
monitor the parameters specified in
paragraphs (b), (c), (d), (e), (g), and (i) of
this section. All monitoring equipment
shall be installed such that
representative measurements of
emissions or process parameters from
the source are obtained. For monitoring
equipment purchased from a vendor,
verification of the operational status of
the monitoring equipment shall include
completion of the manufacturer’s
written specifications or
recommendations for installation,
operation, and calibration of the system.
(3) If you own or operate an affected
source that is subject to an emission
standard in § 63.362 and that is required
to monitor using EtO CEMS, you must
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
comply with paragraphs (f), (g), and (i)
of this section.
(4) If you comply with the
management practice for Group 2 room
air emissions at area sources, you must
comply with paragraph (h) of this
section.
(5) You must keep the written
procedures required by § 63.8(d)(2) on
record for the life of the affected source
or until the affected source is no longer
subject to the provisions of this part, to
be made available for inspection, upon
request, by the Administrator. If the
performance evaluation plan is revised,
you must keep previous (i.e.,
superseded) versions of the performance
evaluation plan on record to be made
available for inspection, upon request,
by the Administrator, for a period of 5
years after each revision to the plan. The
program of corrective action should be
included in the plan required under
§ 63.8(d)(2).
(b) Acid-water scrubbers. If you are
demonstrating continuous compliance
through periodic performance testing on
an acid-water scrubber(s), you must:
(1) Ethylene glycol concentration.
Sample the scrubber liquor from the
acid-water scrubber(s) and analyze and
record at least once per week the
ethylene glycol concentration of the
scrubber liquor using the test methods
and procedures in § 63.365(e)(1).
Monitoring is required during a week
only if the scrubber unit has been
operated. You must maintain the weekly
ethylene glycol concentration below the
operating limit established during the
most recent performance test;
(2) Scrubber liquor tank level.
Measure and record at least once per
day the level of the scrubber liquor in
the recirculation tank(s). You must
install, maintain, and use a liquid level
indicator to measure the scrubber liquor
tank level (i.e., a marker on the tank
wall, a dipstick, a magnetic indicator,
etc.). Monitoring is required during a
day only if the scrubber unit has been
operated. You must maintain the daily
scrubber liquor height in each
recirculation tank below the applicable
operating limit established during the
most recent performance test; or
(3) pH. Monitor and record at least
every 15 minutes the scrubber liquor
pH. Monitoring is required when the
scrubber is operating. A data acquisition
system for the pH monitor shall
compute and record each 3-hour average
scrubber liquor pH value, rolled hourly.
This must be done by first averaging the
scrubber liquor pH readings obtained
over a clock hour, i.e., beginning and
ending on the hour. All data collected
during the operating hour must be used,
even if the scrubber unit is not operating
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
for a complete hour. Then, the average
of the previous 3 operating hours must
be calculated to determine the 3-hour
rolling average scrubber liquor pH. You
must maintain the 3-hour rolling
average scrubber liquor pH below the
applicable operating limit established
during the most recent performance test.
You must ensure the pH monitoring
system meets the following
requirements:
(i) The pH sensor must be installed in
a position that provides a representative
measurement of scrubber liquor pH;
(ii) The sample must be properly
mixed and representative of the fluid to
be measured; and
(iii) A performance evaluation
(including a two-point calibration with
one of the two buffer solutions having
a pH within 1 of the pH of the operating
limit) of the pH monitoring system must
be conducted in accordance with your
monitoring plan at the time of each
performance test but no less frequently
than quarterly.
(c) Oxidizers. If you are demonstrating
continuous compliance through
periodic performance testing on a
catalytic oxidizer or thermal oxidizer,
the requirements in paragraphs (c)(1)
and (2) of this section apply:
(1) For thermal oxidizers, you must
monitor and record at least every 15
minutes the temperature in or
immediately downstream of the firebox
using the temperature monitor
described in paragraph (c)(4) of this
section. Monitoring is required when
the thermal oxidizer is operating. A data
acquisition system for the temperature
monitor shall compute and record each
3-hour average temperature value, rolled
hourly. This must be done by first
averaging the temperature readings over
a clock hour, i.e., beginning and ending
on the hour. All data collected during
the operating hour must be used, even
if the thermal oxidizer is not operating
for a complete hour. Then, the average
of the previous 3 operating hours must
be calculated to determine the 3-hour
rolling average temperature in or
immediately downstream of the firebox.
You must maintain the 3-hour rolling
average temperature above the operating
limit established during the most recent
performance test.
(2) For catalytic oxidizers, you must
monitor and record at least every 15
minutes the temperature at the inlet to
the catalyst bed using the temperature
monitor described in paragraph (c)(4) of
this section. Monitoring is required
when the catalytic oxidizer is operating.
A data acquisition system for the
temperature monitor shall compute and
record each 3-hour average temperature,
rolled hourly. This must be done by first
PO 00000
Frm 00091
Fmt 4701
Sfmt 4700
24179
averaging the temperature readings over
a clock hour, i.e., beginning and ending
on the hour. All data collected during
the operating hour must be used, even
if the catalytic oxidizer is not operating
for a complete hour. Then, the average
of the previous 3 operating hours must
be calculated to determine the 3-hour
rolling average temperature at the inlet
to the catalyst bed. You must maintain
the 3-hour rolling average temperature
above the operating limit established
during the most recent performance test.
(3) For catalytic oxidizers, you must
monitor and record at least every 15
minutes the temperature increase across
the catalyst bed, immediately
downstream of the catalytic bed, using
the temperature monitor described in
paragraph (c)(4) of this section.
Monitoring is required when the
catalytic oxidizer is operating. A data
acquisition system for the temperature
monitor shall compute and record each
3-hour average temperature increase,
rolled hourly. This must be done by first
computing the difference in outlet
temperature minus inlet temperature
(monitored under paragraph (c)(2)), and
second averaging the temperature
difference values over a clock hour, i.e.,
beginning and ending on the hour. All
data collected during the operating hour
must be used, even if the catalytic
oxidizer is not operating for a complete
hour. Then, the average of the previous
3 operating hours must be calculated to
determine the 3-hour rolling average
temperature increase across the catalyst
bed. You must maintain the 3-hour
average temperature increase above the
operating limit established during the
most recent performance test.
(4) You must install, calibrate,
operate, and maintain a temperature
monitor with a minimum accuracy of ±1
percent over the normal range of the
temperature measured, expressed in
degrees Celsius, or 2.8 degrees Celsius,
whichever is greater. You must verify
the accuracy of the temperature monitor
twice each calendar year at least five
months apart with a reference
temperature monitor (traceable to
National Institute of Standards and
Technology (NIST) standards or an
independent temperature measurement
device dedicated for this purpose).
During accuracy checking, the probe of
the reference device shall be at the same
location as that of the temperature
monitor being tested. As an alternative,
the accuracy of the temperature monitor
may be verified in a calibrated oven
(traceable to NIST standards).
(5) For catalytic oxidizers, if the
monitor indicates that the temperature
is below the operating limit, within 7
calendar days you must:
E:\FR\FM\05APR2.SGM
05APR2
24180
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(i) Correct the temperature or
temperature increase so that it falls
within the established operating range;
or
(ii) Replace the catalyst bed.
Following replacement of the catalyst
bed, you must conduct a new
performance test within 180 days and
re-establish the operating limits.
(d) Gas-solid reactors. If you are
demonstrating continuous compliance
through periodic performance testing on
a gas/solid reactor(s), you must:
(1) Media analysis. Sample the media
from the gas/solid reactor(s) and have
the manufacturer analyze at least once
per week. Monitoring is required during
a week only if the gas/solid reactor unit
has been operated; and
(2) Pressure drop. Monitor and record
at least every 15 minutes the pressure
drop. Monitoring is required when the
gas/solid reactor is operating. A data
acquisition system for the pressure drop
monitor shall compute and record each
3-hour average gas/solid reactor
pressure drop value, rolled hourly. This
must be done by first averaging the gas/
solid reactor pressure drop readings
obtained over a clock hour, i.e.,
beginning and ending on the hour. All
data collected during the operating hour
must be used, even if the gas/solid
reactor unit is not operating for a
complete hour. Then, the average of the
previous 3 operating hours must be
calculated to determine the 3-hour
rolling average gas/solid reactor
pressure drop. You must maintain the 3hour rolling average gas/solid reactor
pressure drop below the applicable
operating limit established during the
most recent performance test.
(e) Performance testing, other control
technology. If you are complying with
§ 63.363(d) or (e) using periodic
performance testing and the use of a
control device other than acid-water
scrubbers, catalytic or thermal oxidizers,
or gas/solid reactors, you must monitor
the parameters as approved by the
Administrator using the methods and
procedures in § 63.365(e).
(f) EtO CEMS configurations. If you
are using EtO CEMS to demonstrate
compliance with an emission standard,
you must install and operate an EtO
CEMS on each outlet for the control
system in accordance with the
requirements of Appendix A to subpart
O of this part. You must also conduct
monitoring for each inlet to the control
system that is used to demonstrate
compliance with the emission reduction
standard in accordance with the
requirements of appendix A to this
subpart, with the exception for SCV
emission streams to the control system.
(1) EtO CEMS inlet configuration. The
following caveats apply:
(i) SCVs. If you do not own or operate
a single-item sterilizer, to demonstrate
compliance with the percent emission
reduction standards for emissions
streams that are comprised only of
SCVs, you may use the following
procedures as an alternative to
monitoring the inlet emission stream to
determine the mass emissions of EtO
being emitted via sterilization
chamber(s) vents prior to the controls.
(A) Determine the mass (MSCV,n) of
EtO used for each charge and at each
sterilization chamber used during the
previous 30 days using the procedures
in either paragraph (f)(1)(i)(A)(1) or (2)
of this section.
(1) Weigh the EtO gas cylinder(s) used
to charge the sterilizer(s) before and
after charging. Record these weights to
the nearest 45 g (0.1 lb) and calculate
the theoretical mass (Mc) vented to the
controls using equation 1 to this
paragraph.
Equation 1 to paragraph (f)(l)(i)(A)(l)
(Eq. 1)
Where:
MSCV,n = Theoretical total mass of EtO vented
to controls per charge, g (lb)
Mcharge = total mass of sterilizer gas charge,
g (lb)
%EOw = weight percent of EtO
(2) Install a calibrated rate meter at
the sterilizer inlet(s) and continuously
measure the flow rate (Qm) and duration
of each sterilizer charge. Calculate the
theoretical mass (MSCV,n) vented to the
controls using equation 2 to this
paragraph.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
n = number of EtO charges
MW = molecular weight of EtO, 44.05 grams
per gram-mole (g/g-mole) (44.05 pounds
per pound-mole (lb/lb-mole))
SV = standard volume, 24.05 liters per grammole (L/g-mole) at 20 °C and 101.325 kPa
(385.1 scf per pound-mole (scf/lb-mole)
at 68 °F and 1 atm).
(B) Determine the adjustment factor (f)
using equation 8 to this paragraph.
PO 00000
Frm 00092
Fmt 4701
Sfmt 4700
Determine the mass of EtO sent to
controls from all non-SCV affected
sources, I, using equation 4 to this
paragraph. For facilities where EtO use
is less than 4 tpy, if not all Group 2
room air emissions are routed to a
control device, do not include Group 2
room air emissions in I, and subtract
0.002 from this factor.
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.034
Where:
MSCV,n = theoretical total mass of EtO sent to
controls per charge
Qm = volumetric flow rate, liters per minute
(L/min) corrected to 20 °C and 101.325
kilopascals (kPa) (scf per minute (scfm)
corrected to 68 °F and 1 atmosphere of
pressure (atm))
Tn = time duration of each charge, min
%EOv = volume fraction percent of EtO
ER05AP24.033
khammond on DSKJM1Z7X2PROD with RULES2
Equation 2 to paragraph (f)(l)(i)(A)(2)
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
24181
Equations 3 and 4 to paragraph (f)(l)(i)(B)
f
Where:
f = Adjustment factor.
I
= 0.99 -M,aa
-
(Eq. 3)
I = Mass of non-SCV EtO routed to control
devices over the previous 30 operating
days
I
= L,,,=1
~n Mt:J.
Where:
I = Mass of non-SCV EtO routed to control
devices over the previous 30 operating
days
Mc,i = The 30-operating day total mass sent
to controls (i.e., monitoring data at the
MFac = Facility EtO use over the previous 30operating days, in pounds, as determined
in accordance with equation 11 of
§ 63.364(i)(2)
(Eq. 4)
inlet of the control system) for each nonSCV emission stream, as calculated using
equation A–3 and determined in
accordance with appendix A to this
subpart. The term ‘‘Mc,i’’ as used in this
equation is equivalent to the term
‘‘E30day’’ as designated in equation A–3.
i = Non-SCV emission stream index.
n = Total number of non-SCV emission
streams.
(C)(1) Determine the mass rate of EtO
sent to controls during the previous 30
days using equation 5 to this paragraph.
Equation 5 to paragraph (f)(l)(i)(C)(l)
n
Mscv = fx
L
(Eq. 5)
Mscv.-
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00093
Fmt 4701
Sfmt 4700
stack and attribute all of the emissions
measured at the common stack to the
emission source(s).
(B) If you choose the common stack
monitoring option:
(1) For each hour in which valid data
are obtained for all parameters, you
must calculate the pollutant emission
rate; and
(2) You must assign the calculated
pollutant emission rate to each of the
units subject to the rule that share the
common stack.
(iv) Unit with multiple parallel
control devices with multiple stacks. If
the exhaust gases from an emission
source, which is configured such that
emissions are controlled with multiple
parallel control devices or multiple
series of control devices are discharged
to the atmosphere through more than
one stack, you shall install the required
CEMS described in each of the multiple
stacks. You shall calculate hourly, flowweighted, average pollutant emission
rates for the unit as follows:
(A) Calculate the pollutant emission
rate at each stack or duct for each hour
in which valid data are obtained for all
parameters;
(B) Multiply each calculated hourly
pollutant emission rate at each stack or
duct by the corresponding hourly gas
flow rate at that stack or duct;
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.036
(2) If both this approach is chosen and
the SCV is (or SCVs are) combined with
another emission stream, then the
owner or operator cannot monitor the
point after the combination occurs.
(ii) Room air emissions. If room air
emissions are both subject to an
emission standard and split between
two or more control systems, then
monitoring must be conducted for room
air emissions before they are combined
with other streams.
(2) EtO CEMS on exhaust
configurations. Exhaust gases from the
emission sources under this subpart
exhaust to the atmosphere through a
variety of different configurations,
including but not limited to individual
stacks, a common stack configuration, or
a main stack plus a bypass stack. For the
CEMS used to provide data under this
subpart, the continuous monitoring
system installation requirements for
these exhaust configurations are as
follows:
(i) Single unit-single stack
configurations. For an emission source
that exhausts to the atmosphere through
a single, dedicated stack, you shall
either install the required CEMS in the
stack or at a location in the ductwork
downstream of all emissions control
devices, where the pollutant and
diluents concentrations are
representative of the emissions that exit
to the atmosphere.
(ii) Unit utilizing common stack with
other emission source(s). When an
emission source utilizes a common
stack with one or more other emission
sources, but no emission sources not
subject to this rule, you shall either:
(A) Install the required CEMS in the
duct from each emission source, leading
to the common stack; or
(B) Install the required CEMS in the
common stack.
(iii) Unit(s) utilizing common stack
with non-commercial sterilization
emission source(s). (A) When one or
more emission sources shares a common
stack with one or more emission sources
not subject to this rule, you shall either:
(1) Install the required CEMS in the
ducts from each emission source that is
subject to this rule, leading to the
common stack; or
(2) Install the required CEMS
described in this section in the common
ER05AP24.035
khammond on DSKJM1Z7X2PROD with RULES2
Where:
MSCV = Total mass of EtO sent to controls
over the previous 30 operating days, g/
hr (lb/hr)
f = Adjustment factor
MSCV,n = Theoretical mass of EtO sent to
controls per charge per chamber, g (lb)
n = Total number of charges during the
previous 30 operating days
ER05AP24.037
1=1
khammond on DSKJM1Z7X2PROD with RULES2
24182
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(C) Sum the products determined
under paragraph (f)(2)(iv)(B) of this
section; and
(D) Divide the result obtained in
paragraph (f)(2)(I(C) of this section by
the total hourly gas flow rate for the
unit, summed across all of the stacks or
ducts.
(g) PTE monitoring. If you are
required to operate all or a portion of
your sterilization facility under PTE
conditions, you must:
(1) Initial compliance. Demonstrate
initial procedures in § 63.365(g)(1) and
continued compliance with the
provisions in this section. You must
follow the requirements of either
paragraphs (g)(2) and (3) of this section
or paragraph (g)(4) of this section.
(2) Continuous compliance. If you
choose to demonstrate continuous
compliance through volumetric flow
rate monitoring, you must monitor and
record at least every 15 minutes the
volumetric flow rate from each outlet
where air from the PTE is sent using a
flow rate monitoring system described
in paragraph (g)(3) of this section.
Monitoring is required when the portion
of the facility covered by PTE is
operated. A data acquisition system for
the flow rate monitoring system shall
compute and record each 3-hour average
flow rate value, rolled hourly. This must
be done by first averaging the flow rate
readings over a clock hour, i.e.,
beginning and ending on the hour. All
data collected during the operating hour
must be used, even the portion of the
facility covered by PTE is not operated
for a complete hour. Then, the average
of the previous 3 operating hours must
be calculated to determine the 3-hour
rolling average flow rate. You must
maintain the 3-hour rolling average flow
rate above the applicable operating
limits established during the most
recent compliance demonstration.
(3) Continuous flow rate monitoring
system for PTE. You must install,
operate, calibrate, and maintain
instruments, according to the
requirements in paragraphs (g)(3)(i)
through (ix) of this section, for
continuously measuring and recording
the stack gas flow rate to allow
determination of compliance with the
minimum volumetric flow rate through
the affected stack operating limit(s).
(i) You must install each sensor of the
flow rate monitoring system in a
location that provides representative
measurement of the exhaust gas flow
rate. The flow rate sensor is that portion
of the system that senses the volumetric
flow rate and generates an output
proportional to that flow rate.
(ii) The flow rate monitoring system
must be designed to measure the
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
exhaust flow rate over a range that
extends from a value of at least 20
percent less than the lowest expected
exhaust flow rate to a value of at least
20 percent greater than the highest
expected exhaust flow rate.
(iii) The flow rate monitoring system
must be equipped with a data
acquisition and recording system that is
capable of recording values over the
entire range specified in paragraph
(g)(3)(ii) of this section.
(iv) The signal conditioner, wiring,
power supply, and data acquisition and
recording system for the flow rate
monitoring system must be compatible
with the output signal of the flow rate
sensors used in the monitoring system.
(v) The flow rate monitoring system
must be designed to complete a
minimum of one cycle of operation for
each successive 15-minute period.
(vi) The flow rate sensor must have
provisions to determine the daily zero
and upscale calibration drift (CD) (see
sections 3.1 and 8.3 of Performance
Specification 2 in appendix B to Part 60
of this chapter for a discussion of CD).
(A) Conduct the CD tests at two
reference signal levels, zero (e.g., 0 to 20
percent of span) and upscale (e.g., 50 to
70 percent of span).
(B) The absolute value of the
difference between the flow monitor
response and the reference signal must
be equal to or less than 3 percent of the
flow monitor span.
(vii) You must perform an initial
relative accuracy test of the flow rate
monitoring system according to section
8.2 of Performance Specification 6 of
appendix B to part 60 of the chapter
with the exceptions in paragraphs
(g)(3)(vii)(A) and (B) of this section.
(A) The relative accuracy test is to
evaluate the flow rate monitoring
system alone rather than a continuous
emission rate monitoring system.
(B) The relative accuracy of the flow
rate monitoring system shall be no
greater than 10 percent of the mean
value of the reference method data.
(viii) You must verify the accuracy of
the flow rate monitoring system at least
once per year by repeating the relative
accuracy test specified in paragraph
(g)(3)(vii) of this section.
(ix) You must operate the flow rate
monitoring system and record data
during all periods of operation of the
affected facility including periods of
startup, shutdown, and malfunction.
(4) Pressure differential monitor. You
must instead install, operate, calibrate,
and maintain a continuous pressure
differential monitoring system, as
follows, to verify the presence of PTE.
You must operate this system whenever
the facility is in operation. You must
PO 00000
Frm 00094
Fmt 4701
Sfmt 4700
also maintain the pressure differential at
or above 0.007 inches of water over a
three-hour rolling average.
(i) This monitoring system must
measure the pressure differential
between the interior and exterior of the
PTE, with at least one monitoring device
located in each room that borders the
PTE. These monitoring devices shall be
designed to provide measurements of
pressure differential to at least the
nearest 0.001 inches of water and
having a complete cycle time no greater
than 5 minutes.
(ii) A data acquisition system for the
monitoring system shall compute and
record each 3-hour average pressure
differential value, rolled hourly. This
must be done by first averaging the
pressure differential readings over a
clock hour, i.e., beginning and ending
on the hour. All data collected during
the operating hour must be used, even
in portions of the facility covered by
PTE that are not operated for a complete
hour. Then, the average of the previous
3 operating hours must be calculated to
determine the 3-hour rolling average
pressure differential. If data are not
recorded from an alternative monitoring
device, during any malfunction of the
principal monitoring device(s) or the
automatic recorder, you must manually
record the measured data at least
hourly.
(h) Sterilization chamber end-cycle
EtO concentration. As part of your
monitoring plan, you must document
your approach for determining the EtO
sterilization chamber concentration. If
you choose a parametric approach you
must meet the requirements in
paragraph (h)(1) of this section and if
you choose a direct measurement
approach you must meet the
requirements in paragraph (h)(2) of this
section. Alternatively, you may petition
the administrator for an alternative
monitoring approach under § 63.8(f).
(1) If you choose a parametric
approach for determining chamber EtO
concentrations you must document
parameter(s) used in the calculation to
determine of EtO concentrations and the
calculation(s) used to determine the
chamber concentration. Any
instrumentation used for parametric
monitoring must also be identified in
the monitoring plan and at a minimum
this plan should include the following
for each instrument:
(i) Parameter measured and
measurement principle of the monitor.
(ii) Instrument name, model number,
serial number, and range.
(iii) Manufacturer recommended
operation practices, including daily
operational check.
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(iv) Procedures for calibration, the
frequency of calibration, and accuracy
requirements of the calibration.
(v) Description for how the
information from the parameter monitor
is being collected and stored.
(2) If you choose a direct
measurement approach for determining
chamber EtO calibrations you must
document the procedures used for the
operation of the instruments. Any
instrument used for direct measurement
of EtO must be identified in the
monitoring plan and at a minimum this
plan must include the following
information:
(i) Instrument name, model number,
serial number, and range.
(ii) Description of the measurement
principle and any potential
interferences.
(iii) If applicable, the description of
the sampling condition system.
(iv) Procedures for calibration, the
frequency of calibration, and accuracy
requirements of the calibration.
(v) Description for how the
information from the parameter monitor
is being collected and stored.
(i) EtO usage. If you own or operate
a sterilization facility subject to the
requirements of this subpart you must
24183
monitor and record on a daily basis the
daily and 30-operating day EtO usage
according to the requirements of this
paragraph. Additionally, you must
record EtO usage for each calendar
month.
(1) Monitor and record on a daily
basis, the daily total mass of ethylene
oxide, in pounds, used at the facility.
The daily total mass must be
determined using the methodology
specified in § 63.365(c)(1)(i) and (ii).
(2) Determine and record daily the 30operating day rolling ethylene oxide
usage rate using equation 6 to this
paragraph.
Equation 6 to paragraph (i)(2)
Where:
MFac = Facility EtO use over the previous 30
operating days, in pounds.
mFac,i = Daily EtO use for operating day i, in
pounds, as determined in accordance
with paragraph (i)(1) of this section
i = Operating day index.
(3) Determine and record the total
mass of EtO used in each calendar
month.
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.365
Test methods and procedures.
(a) General—(1) Performance testing
for facility where EtO use is less than
100 pounds per year. If you own or
operate an affected source at a facility
where EtO use is less than 100 lb/yr that
is subject to an emission standard in
§ 63.362, you must comply with the
performance testing requirements in
§ 63.7, according to the applicability in
table 6 to this subpart, using the
methods in paragraph (b) or (c) of this
section, following the applicable
procedures for initial compliance and
continuous compliance in paragraphs
(d), (e), and (f) of this section.
(2) Facilities subject to capture
efficiency. If you are subject to capture
efficiency requirements in § 63.362, you
must follow the applicable procedures
for initial and continuous compliance in
paragraph (f) of this section.
(b) Test methods for facility where
EtO use is less than 100 pounds per
year. You must use the following test
methods to determine the average mass
emissions of EtO in lb/hr at the inlet of
a control system (MAPCD, i) and/or outlet
of a control system or stack (EAPCD, o).
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(1) Select the location of the sampling
ports and the number of traverse points
according to Method 1 of appendix A–
1 to part 60 of this chapter.
Alternatively, for ducts less than 0.3
meter (12 in.) in diameter, you may
choose to locate sample ports according
to Method 1A of appendix A–1 to part
60 of this chapter.
(2) Determine the flow rate through
the control system exhaust(s)
continuously during the test period
according to either Methods 2, 2A, or 2C
of appendix A–1 to part 60 of this
chapter, as appropriate. If using Method
2, 2A, or 2C, you must complete
velocity traverses immediately before
and subsequently after each test run. If
your test run is greater than 1 hour, you
must also complete a velocity traverse at
least every hour. Average the velocity
collected during a test run and calculate
volumetric flow as outlined in the
appropriate method.
(3) Determine the oxygen and carbon
dioxide concentration of the effluent
according to Method 3A or 3B of
appendix A–2 to part 60 of this chapter.
The manual procedures (but not
instrumental procedures) of voluntary
consensus standard ANSI/ASME PTC
19.10–1981 (incorporated by reference,
see § 63.14) may be used as an
alternative to EPA Method 3B.
(4) Determine the moisture content of
the stack gas according to Method 4 of
appendix A–3 to part 60 of this chapter.
Alternatively, you may use an on-line
technique that has been validated using
Method 301 of appendix A to this part.
PO 00000
Frm 00095
Fmt 4701
Sfmt 4700
(5) Determine the EtO concentration
according to either paragraph (b)(5)(i) or
(ii) of this section.
(i) Follow Method 320 of appendix A
to this part and the following
paragraphs (5)(i)(A) through (D).
(A) The instrumentation used for
measurement must have the
measurement range to properly quantify
the EtO in the gas stream. Additionally,
for outlet emission streams, the
instrumentation must have a method
detection limit an order of magnitude
below concentration equivalent of the
emission limit.
(B) Instrumentation used must be
continuous in nature with an averaging
time of one minute or less.
(C) Calibration Spectra and all other
analyte spiking required in the method
must use EtO gaseous cylinder
standard(s) which meet the criteria
found in Performance Specification 19
of appendix B to part 60 if this chapter.
(D) Other methods and materials may
be used; however, these alternative test
methods are subject to Administrator
approval.
(ii) Alternatively, ASTM D6348–12
(Reapproved 2020), (incorporated by
reference, see § 63.14) may be used with
the following conditions:
(A) The test plan preparation and
implementation in the Annexes to
ASTM D 6348–12 (R2020), Sections A1
through A8 are mandatory; and
(B) In ASTM D6348–12 (R2020)
Annex A5 (Analyte Spiking Technique),
the percent (%) R must be determined
for each target analyte (equation A5.5).
In order for the test data to be acceptable
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.038
(Eq. 6)
24184
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
for a compound, %R must be 70% ≥ R
≤ 130%. If the %R value does not meet
this criterion for a target compound, the
test data is not acceptable for that
compound and the test must be repeated
for that analyte (i.e., the sampling and/
or analytical procedure should be
adjusted before a retest). The %R value
for each compound must be reported in
the test report, and all field
measurements must be corrected with
the calculated %R value for that
compound by using equation 1 to this
paragraph:
Equation 1 to paragraph (b)(5)(ii)
Reported Results= ((Measured Concentration in Stack))/(¾R) x 100.]
(6) Calculate the mass emission of EtO
by using equations 2 and 3 to this
paragraph:
Equations 2 and 3 to paragraph (b)(6)
MacD.m
Baco.o
=
=
Where:
MAPCD, i = average inlet mass rate of EtO per
hour, lb/hr
CEtO,i = inlet EtO concentration, ppmdv.
Qi = average inlet volumetric flow per hour
at standard conditions, dscf/hr
44.05 = molecular weight (MW) of EtO, lb/
lb-mole
MW/385.1 × 106 = conversion factor, from
ppmv at standard conditions to lb/cf
EAPCD, o = average outlet mass rate of EtO per
hour, lb/hr
CEtO,o = outlet EtO concentration, ppbdv.
Qo = average outlet volumetric flow per hour
at standard conditions, dscf/hr
CBto.£ X Qt X 44.0S
(Eq. 2)
385.1 X 106
CBtOp X Qo X 44.05
385.1 x 109
(Eq. 3)
MW/385.1 × 109 = conversion factor, from
ppbv at standard conditions to lb/cf
(c) Alternative approach for SCVs for
facility where EtO use is less than 100
pounds per year. If you do not own or
operate a single-item sterilizer, to
demonstrate compliance with the
percent emission reduction standards
for emissions streams that are
comprised only of SCVs, you may use
the following procedures as an
alternative to paragraph (b) of this
section to determine the mass emissions
of EtO being emitted via sterilization
chamber(s) vents prior to the controls.
(1) Determine the mass (MSCV,n) of
EtO used for each charge and at each
sterilization chamber used during the
performance tests using the procedures
in either paragraph (c)(1)(i) or (ii) of this
section.
(i) Weigh the EtO gas cylinder(s) used
to charge the sterilizer(s) before and
after charging. Record these weights to
the nearest 45 g (0.1 lb) and calculate
the theoretical mass (MSCV,n) vented to
the controls using equation 4 to this
paragraph.
Equation 4 to paragraph (c)(l)(i)
= Mm.r.x 96BOw
khammond on DSKJM1Z7X2PROD with RULES2
Equation 5 to paragraph (c)(l)(ii)
(Eq. 5)
Where:
VerDate Sep<11>2014
MSCV,n = Total mass of EtO sent to
controls per charge
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00096
Fmt 4701
Sfmt 4700
Qm = volumetric flow rate, liters per
minute (L/min) corrected to 20 °C and
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.042
(ii) Install a calibrated rate meter at
the sterilizer inlet(s) and continuously
measure the flow rate (Qm) and duration
of each sterilizer charge. Calculate the
theoretical mass (MSCV,n) vented to the
controls using equation 5 to this
paragraph.
ER05AP24.041
%E.O.w = weight percent of EtO
ER05AP24.040
Where:
MSCV,n = Theoretical total mass of EtO
vented to controls per charge, g (lb)
Mcharge = total mass of sterilizer gas
charge, g (lb)
(Eq. 4)
ER05AP24.039
Mscv.n
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
MW = molecular weight of EtO, 44.05
grams per gram-mole (g/g-mole) (44.05
pounds per pound-mole (lb/lb-mole))
SV = standard volume, 24.05 liters per
gram-mole (L/g-mole) at 20 °C and
101.325 kilopascals (kPa) (scf per minute
(scfm) corrected to 68 °F and 1
atmosphere of pressure (atm))
Tn = time duration of each charge, min
n = number of EtO charges
%E.O.v = volume fraction percent of EtO
24185
101.325 kPa (385.1 scf per pound-mole
(scf/lb-mole) at 68 °F and 1 atm).
(2) Determine the mass rate of EtO
sent to controls during the performance
test using equation 6 to this paragraph.
Equation 6 to paragraph (c)(2)
(Eq. 6)
Where:
MSCV = Total mass of EtO sent to
controls per hour, g/hr (lb/hr)
MSCV,n = Total mass of EtO sent to
controls per charge per chamber, g (lb)
Tt = Total time of the performance test,
hour
n = Total number of charges during
testing period
f = Portion of EtO use that is assumed to
be routed to the control system (0.93 if
aeration is conducted in separate vessel;
0.98 otherwise)
(d) Compliance determination for
facility where EtO use is less than 100
pounds per year. Each compliance
demonstration shall consist of three
separate runs using the applicable
methods in paragraph (b) or (c) of this
section. To determine compliance with
the relevant standard, arithmetic mean
of the three runs must be used. These
procedures may be performed over a run
duration of 1-hour (for a total of three
1-hour runs), except for the SCV testing
from this category, where each run shall
consist of the entirety of the sterilizer
chamber evacuation and subsequent
washes. The owner or operator may not
conduct performance tests during
periods of malfunction. The owner or
operator must record the process
information that is necessary to
document operating conditions during
the test and include in such record an
explanation to support that such
conditions represent the entire range of
normal operation, including operational
conditions for maximum emissions if
such emissions are not expected during
maximum production. The owner or
operator must also account for the
control system residence time when
conducting the performance test. Upon
request, the owner or operator shall
make available to the Administrator
such records as may be necessary to
determine the conditions of
performance tests. The following
procedures shall be used to demonstrate
compliance with a removal efficiency
standard. In addition to these
procedures, the procedures in paragraph
(e) of this section must be followed to
establish the operating parameter limits
for each applicable emission control(s).
(1) You may determine the mass rate
emissions of the stream prior to the
control system and at the outlet of the
control system using the test methods in
paragraph (b) of this section. If the vent
stream is comprised only of one or more
SCVs, then you may use the procedures
in paragraph (c) of this section for the
mass rate emissions at the inlet.
(2) Calculate the total mass of EtO per
hour that is routed to the control system
by summing the mass of EtO per hour
from each vent.
(3) Determine percent emission
reduction (%ER) using the equation 7 to
this paragraph:
Equation 7 to paragraph (d) (3)
(4) Repeat these procedures two
additional times. The arithmetic average
percent efficiency of the three runs shall
determine the overall efficiency of the
control system.
(e) Determination of operating limits
for control device(s). If you are using
performance testing to demonstrate
compliance with removal efficiency
standards, and if you are not
demonstrating continual compliance
with the applicable standard(s) using an
EtO CEMS, you must also determine the
operating limit(s) for each control
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
device and then monitor the
parameter(s) for each control device.
The procedures in the following
paragraphs shall be used to establish the
parameter operating limits to be
continually monitored in § 63.364.
(1) Acid-water scrubbers. The
procedures in paragraph (e)(1) of this
section shall be used to determine the
operating limits for acid-water
scrubbers.
(i) Ethylene glycol concentration. For
determining the ethylene glycol
concentration operating limit, you must
establish the maximum ethylene glycol
concentration as the ethylene glycol
concentration averaged over three test
runs; use the sampling and analysis
procedures in ASTM D3695–88
(incorporated by reference, see § 63.14)
PO 00000
Frm 00097
Fmt 4701
Sfmt 4700
to determine the ethylene glycol
concentration.
(ii) Scrubber liquor tank level. During
the performance test, you must monitor
and record the scrubber liquor tank
level to the nearest 1⁄4 inch at the end
of each of the three test runs. Use the
data collected during the most recent
performance test to calculate the average
scrubber liquor tank level. This scrubber
liquor tank level is the maximum
operating limit for your scrubber liquor
tank. Repeat this procedure for every
scrubber liquor tank that is included in
the performance test.
(iii) Scrubber liquor pH. During the
performance test, you must monitor and
record the scrubber liquor pH at least
once every 15 minutes during each of
the three test runs. You must use pH
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.043
khammond on DSKJM1Z7X2PROD with RULES2
Where:
% ER = percent emission reduction
MAPCD,i = total mass of EtO per hour to
the control device
EAPCD,o = total mass of EtO per hour from
the control device
ER05AP24.044
(Eq. 7)
khammond on DSKJM1Z7X2PROD with RULES2
24186
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
monitors as described in § 63.364(b)(3).
Use the data collected during the most
recent performance test to calculate the
average scrubber pH measured. This
scrubber liquor pH is the maximum
operating limit for your acid-water
scrubber. Repeat this procedure for
every scrubber liquor tank that is
included in the performance test.
(2) Thermal oxidizers. The procedures
in this paragraph shall be used to
determine the operating limits for
thermal oxidizers.
(i) During the performance test, you
must monitor and record the
temperature at least once every 15
minutes during each of the three test
runs. You must monitor the temperature
in the firebox of the thermal oxidizer or
immediately downstream of the firebox.
You must use temperature monitors as
described in § 63.364(c)(4).
(ii) Use the data collected during the
performance test to calculate and record
the average temperature for each test
run maintained during the performance
test. The average temperature of the test
runs is the minimum operating limit for
your thermal oxidizer, unless it exceeds
the recommended maximum oxidation
temperature provided by the oxidation
unit manufacturer. If this occurs, the
minimum operating limit for your
thermal oxidizer consists of the
recommended maximum oxidation
temperature provided by the oxidation
unit manufacturer.
(iii) Paragraphs (e)(2)(i) and (ii) of this
section must be completed for each
thermal oxidizer that is involved in the
performance test.
(3) Catalytic oxidizers. The
procedures in this paragraph shall be
used to determine the operating limits
for catalytic oxidizers.
(i) Prior to the start of the performance
test, you must check the catalyst bed for
channeling, abrasion, and settling. If
problems are found during the
inspection, you must replace the
catalyst bed or take other correction
action consistent with the
manufacturer’s recommendations.
(ii) During the performance test, you
must monitor and record the
temperature at the inlet to the catalyst
bed and the temperature difference
across the catalyst bed at least once
every 15 minutes during each of the
three test runs. You must use
temperature monitors as described in
§ 63.364(c)(4).
(iii) Use the data collected during the
performance test to calculate and record
the average temperature at the inlet to
the catalyst bed and the average
temperature difference across the
catalyst bed maintained for each test
run, and then calculate the arithmetic
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
averages of the test runs. These
arithmetic averages of the test runs are
the minimum operating limits for your
catalytic oxidizer, unless it exceeds the
recommended maximum oxidation
temperature provided by the oxidation
unit manufacturer. If this occurs, the
minimum operating limit for your
catalytic oxidizer consists of the
recommended maximum oxidation
temperature provided by the oxidation
unit manufacturer.
(iv) Paragraphs (e)(3)(i) through (iii) of
this section must be completed for each
catalytic oxidizer that is involved in the
performance test.
(4) Gas/solid reactors. During the
performance test, you must monitor and
record the gas/solid reactor pressure
drop at least once every 15 minutes
during each of the three test runs. Use
the data collected during the most
recent performance test to calculate the
gas/solid reactor pressure measured.
This gas/solid reactor pressure is the
maximum operating limit for your gas/
solid. Repeat this procedure for every
gas/solid reactor that is included in the
performance test.
(5) Other control system for facility
where EtO use is less than 100 pounds
per year. If you seek to demonstrate
compliance with a standard found at
§ 63.362 with a control device other
than an acid-water scrubber, catalytic
oxidizer, thermal oxidizer, or gas/solid
reactor, you must provide to the
Administrator the information requested
under § 63.363(e). You must submit a
monitoring plan that contains the
following items: a description of the
device; test results collected in
accordance with § 63.363(e) verifying
the performance of the device for
controlling EtO emissions to the
atmosphere to the levels required by the
applicable standards; the appropriate
operating parameters that will be
monitored, identifying the ongoing QA
procedures and performance
specifications that will be conducted on
the instruments; the frequency of
conducting QA and performance
checks; and the frequency of measuring
and recording to establish continuous
compliance with the standards. Your
monitoring plan is subject to the
Administrator’s approval. Upon
approval by the Administrator you must
install, calibrate, operate, and maintain
the monitor(s) approved by the
Administrator based on the information
submitted in your monitoring plan. You
must include in your monitoring plan
proposed performance specifications
and quality assurance procedures for
your monitors. The Administrator may
request further information and shall
PO 00000
Frm 00098
Fmt 4701
Sfmt 4700
approve appropriate test methods and
procedures.
(f) Determination of compliance with
PTE requirement. If you are required to
operate any portion of your facility with
PTE, you must demonstrate initial
compliance with the requirements of
this subpart by following the procedures
of paragraphs (f)(1) through (3) of this
section, as applicable, during the initial
compliance demonstration or during the
initial certification of the CEMS tests.
(1) Determine the capture efficiency
by verifying the capture system meets
the criteria in section 6 of Method 204
of appendix M to part 51 of this chapter
and directs all the exhaust gases from
the enclosure to an add-on control
device.
(2) Ensure that the air passing through
all NDOs flows into the enclosure
continuously. If the facial velocities
(FVs) are less than or equal to 9,000
meters per hour (492 feet per minute),
the continuous inward flow of air shall
be verified by continuous observation
using smoke tubes, streamers, tracer
gases, or other means approved by the
Administrator over the period that the
volumetric flow rate tests required to
determine FVs are carried out. If the FVs
are greater than 9,000 meters per hour
(492 feet per minute), the direction of
airflow through the NDOs shall be
presumed to be inward at all times
without verification.
(3) If you are demonstrating
continuous compliance through
monitoring the volumetric flow rate,
you must monitor and record the
volumetric flow rate (in cubic feet per
second) from the PTE through the
stack(s) at least once every 15 minutes
during each of the three test runs. Use
the data collected during the most
recent compliance demonstration to
calculate the average volumetric flow
rate measured during the compliance
demonstration. This volumetric flow
rate is the minimum operating limit for
the stack. Repeat this procedure for
every stack that is included in the
compliance demonstration.
§ 63.366
Reporting requirements.
(a) General requirements. The owner
or operator of an affected source subject
to the emissions standards in § 63.362
must fulfill all reporting requirements in
§ 63.10(a), (d), (e), and (f), according to
the applicability in table 6 to this
subpart. These reports will be made to
the Administrator at the appropriate
address identified in § 63.13 or
submitted electronically.
(b) Initial compliance report
submission. You must submit an initial
compliance report that provides
summary, monitoring system
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
performance, and deviation information
to the Administrator on April 5, 2027,
or once the report template for this
subpart has been available on the
Compliance and Emissions Data
Reporting Interface (CEDRI) website for
one year, whichever date is later, to the
EPA via CEDRI, which can be accessed
through the EPA’s Central Data
Exchange (CDX) (https://cdx.epa.gov/).
The EPA will make all the information
submitted through CEDRI available to
the public without further notice to you.
Do not use CEDRI to submit information
you claim as confidential business
information (CBI). Anything submitted
using CEDRI cannot later be claimed
CBI. You must use the appropriate
electronic report template on the CEDRI
website (https://www.epa.gov/
electronic-reporting-air-emissions/cedri)
for this subpart. The date report
templates become available will be
listed on the CEDRI website. The report
must be submitted by the deadline
specified in this subpart, regardless of
the method in which the report is
submitted. Although we do not expect
persons to assert a claim of CBI, if you
wish to assert a CBI claim, submit a
complete report, including information
claimed to be CBI, to the EPA. The CBI
report must be generated using the
appropriate form on the CEDRI website
or an alternate electronic file consistent
with the extensible markup language
(XML) schema listed on the CEDRI
website. Submit the CBI file on a
compact disc, flash drive, or other
commonly used electronic storage
medium and clearly mark the medium
as CBI. Mail the electronic medium to
U.S. EPA/OAQPS/CORE CBI Office,
Attention: Commercial Sterilization
Facilities Sector Lead, MD C404–02,
4930 Old Page Rd., Durham, NC 27703.
The same file with the CBI omitted must
be submitted to the EPA via the EPA’s
CDX as described earlier in this
paragraph. All CBI claims must be
asserted at the time of submission.
Furthermore, under CAA section 114(c),
emissions data is not entitled to
confidential treatment, and the EPA is
required to make emissions data
available to the public. Thus, emissions
data will not be protected as CBI and
will be made publicly available. Reports
of deviations from an operating limit
shall include all information required in
§ 63.10(c)(5) through (13), as applicable
in table 6 to this subpart, along with
information from any calibration tests in
which the monitoring equipment is not
in compliance with Performance
Specification 19 in appendix B and
Procedure 7 in appendix F to part 60 of
this chapter or the method used for
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
parameter monitoring device
calibration. Reports shall also include
the name, title, and signature of the
responsible official who is certifying the
accuracy of the report. If your report is
submitted via CEDRI, the certifier’s
electronic signature during the
submission process replaces this
requirement. When no deviations have
occurred or monitoring equipment has
not been inoperative, repaired, or
adjusted, such information shall be
stated in the report. In addition, the
summary report shall include:
(1) The following information:
(i) Date that facility commenced
construction or reconstruction;
(ii) Hours of commercial sterilization
operation over the previous 12 months;
and
(iii) Monthly EtO use, in tons, over
the previous 36 months.
(iv) If you are electing to determine
the mass of EtO sent to the control
device from the SCV(s) via the
procedure in § 63.364(f)(1)(i), you must
report the daily EtO use from each
applicable chamber for the previous 7
months.
(v) An indication if you are required
to comply with one or more combined
emission stream limitations. If so,
indicate the affected sources that are
included in each combined emission
stream limitation.
(vi) An indication if you are electing
to comply with a site-wide emission
limit. If you are electing to comply with
a site-wide emission limit, report the
daily EtO use over the previous 7
months.
(2) If your sterilization facility is
demonstrating continuous compliance
through periodic performance testing,
you must report the following:
(i) Control system ID;
(ii) Control device ID;
(iii) Control device type; and
(iv) Recirculation tank ID if an acidwater scrubber is used to meet the
emission standard and you elect to
comply with the maximum scrubber
liquor height limit;
(3) You must report the following for
each sterilization chamber at your
facility:
(i) The sterilization chamber ID;
(ii) The ID of the control system that
the SCV was routed to, if applicable;
(iii) The portion of SCV exhaust that
was routed to the control system, if
applicable;
(iv) The ID of the EtO CEMS that was
used to monitor SCV emissions, if
applicable;
(v) The portion of SCV exhaust that
was monitored with the EtO CEMS, if
applicable;
(vi) The ID of the control system that
the CEV was routed to, if applicable;
PO 00000
Frm 00099
Fmt 4701
Sfmt 4700
24187
(vii) The portion of CEV exhaust that
was routed to the control system, if
applicable;
(viii) The ID of the EtO CEMS that
was used to monitor CEV emissions, if
applicable;
(ix) The portion of CEV exhaust that
was monitored with the EtO CEMS, if
applicable;
(4) If emissions from any room in your
facility are subject to an emission
standard, you must report the following
for each room where there is the
potential for EtO emissions:
(i) Room ID;
(ii) Documentation of emissions
occurring within the room, including
aeration, EtO storage, EtO dispensing,
pre-aeration handling of sterilized
material, and post-aeration handling of
sterilized material;
(iii) The ID of the control system that
the room air was routed to, if applicable;
(iv) The portion of room air that was
routed to the control system, if
applicable;
(v) The ID of the EtO CEMS that was
used to monitor room air emissions, if
applicable;
(vi) The portion of room air that was
monitored with the EtO CEMS, if
applicable;
(5) If an EtO CEMS was used to
demonstrate continuous compliance
with an emission standard for more than
30-operating days, you must report the
following:
(i) The information specified in
section 11 of appendix A to this subpart.
(ii) The affected sources that are
included in each inlet that is being
monitored with EtO CEMS;
(iii) The IDs of each inlet(s) to and
outlet(s) from each control system.
(iv) The daily sum of EtO for each
inlet, along with 30-operating day
rolling sums.
(v) The daily sum of EtO emissions
from each outlet of the control system,
along with 30-operating day rolling
sums.
(vi) For each day, calculate and report
the daily mass emission limit that the
control system must achieve based on
the previous 30 days of data. For control
systems with multiple emission streams,
and complying with a combined
emission stream limitation in § 63.362(i)
or a SWEL in § 63.362(j), report the
daily 30-operating day mass emission
limit as determined in accordance with
CES in § 63.362(i)(1)(i) and (i)(2)(i) or
with § 63.362(j)(1)(i) and (j)(2)(i), as
applicable.
(vii) For each day, the mass of EtO
emitted from the control system over the
previous 30 operating days.
(6) If any portion of your facility is
required to be operated with PTE, you
must report the following:
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24188
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(i) If you are choosing to demonstrate
continuous compliance through the use
of volumetric flow rate monitoring, you
must report the 3-hr rolling average,
rolled hourly volumetric flow from each
outlet where air from the PTE is sent, in
cubic feet per second.
(ii) If you are choosing to demonstrate
continuous compliance through use of
differential pressure monitoring, you
must report the 3-hr rolling average,
rolled hourly pressure differential
reading, in inches water.
(7) If you are complying with the
requirement to follow the best
management practice to limit
sterilization chamber concentration of
EtO to 1 ppmv prior to opening the
sterilization chamber door, you must
provide a certification from your
responsible official that this approach is
being followed and you are meeting the
monitoring requirements at § 63.362(h).
(8) If you own or operate an existing
collection of Group 2 room air
emissions at an area source facility and
facility EtO use is less than 4 tpy, you
must report the following for each room
where there are Group 2 room air
emissions:
(i) Room ID;
(ii) Number of room air changes per
hour;
(iii) Room temperature, in degrees
Celsius; and
(iv) EtO concentration, in ppmv dry
basis (ppbvd).
(9) If you own or operate an existing
collection of Group 2 room air
emissions at an area source facility and
EtO use is less than 4 tpy, you are not
required to report the information in
paragraph (b)(8) of this section if you
meet the following requirements:
(i) You are complying with the best
management practice to limit
sterilization chamber concentration of
EtO to 1 ppmv prior to opening the
sterilization chamber door; and
(ii) The requirements of § 63.363 are
met.
(10) Report the number of deviations
to meet an applicable standard. For each
instance, report the date, time, the cause
and duration of each deviation. For each
deviation the report must include a list
of the affected sources or equipment, an
estimate of the quantity of each
regulated pollutant emitted over any
emission limit, and a description of the
method used to determine the
emissions.
(c) Quarterly compliance report
submission. You must submit
compliance reports that provide
summary, monitoring system
performance, and deviation information
to the Administrator within 30 days
following the end of each calendar
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
quarter. Beginning on April 5, 2027, or
once the report template for this subpart
has been available on the Compliance
and Emissions Data Reporting Interface
(CEDRI) website for 1 year, whichever
date is later, submit all subsequent
reports to the EPA via CEDRI, which can
be accessed through the EPA’s CDX
(https://cdx.epa.gov/). The EPA will
make all the information submitted
through CEDRI available to the public
without further notice to you. Do not
use CEDRI to submit information you
claim as CBI. Anything submitted using
CEDRI cannot later be claimed CBI. You
must use the appropriate electronic
report template on the CEDRI website
(https://www.epa.gov/electronicreporting-air-emissions/cedri) for this
subpart. The date report templates
become available will be listed on the
CEDRI website. The report must be
submitted by the deadline specified in
this subpart, regardless of the method in
which the report is submitted. Although
we do not expect persons to assert a
claim of CBI, if you wish to assert a CBI
claim, submit a complete report,
including information claimed to be
CBI, to the EPA. The CBI report must be
generated using the appropriate form on
the CEDRI website or an alternate
electronic file consistent with the XML
schema listed on the CEDRI website.
Submit the CBI file on a compact disc,
flash drive, or other commonly used
electronic storage medium and clearly
mark the medium as CBI. Mail the
electronic medium to U.S. EPA/OAQPS/
CORE CBI Office, Attention:
Commercial Sterilization Facilities
Sector Lead, MD C404–02, 4930 Old
Page Rd., Durham, NC 27703. The same
file with the CBI omitted must be
submitted to the EPA via the EPA’s CDX
as described earlier in this paragraph.
All CBI claims must be asserted at the
time of submission. Furthermore, under
CAA section 114(c), emissions data is
not entitled to confidential treatment,
and the EPA is required to make
emissions data available to the public.
Reports of deviations from an operating
limit shall include all information
required in § 63.10(c)(5) through (13), as
applicable in table 6 to this subpart, and
information from any calibration tests in
which the monitoring equipment is not
in compliance with Performance
Specification 19 in appendix B and
Procedure 7 in appendix F to part 60 of
this chapter or the method used for
parameter monitoring device
calibration. Reports shall also include
the name, title, and signature of the
responsible official who is certifying the
accuracy of the report. If your report is
submitted via CEDRI, the certifier’s
PO 00000
Frm 00100
Fmt 4701
Sfmt 4700
electronic signature during the
submission process replaces this
requirement. When no deviations have
occurred or monitoring equipment has
not been inoperative, repaired, or
adjusted, such information shall be
stated in the report. In addition, the
summary report shall include:
(1) The information listed in
paragraphs (b)(1)(i) through (vi) of this
section, with the exception that monthly
EtO use, in tons, only needs reported for
the previous 12 months;
(2) If your sterilization facility is
demonstrating continuous compliance
through periodic performance testing,
you must report the ID for any control
system that has not operated since the
end of the period covered by the
previous compliance report. If a control
system has commenced operation since
end of the period covered by the
previous compliance report, or if any of
the information in paragraphs (b)(2)(i)
through (iv) of this section has changed
for a control system that was included
in the previous compliance report, you
must report the information in
paragraphs (b)(2)(i) through (iv) of this
section for those control systems;
(3) You must report the ID for any
sterilization chamber that has not
operated since then end of the period
covered by the previous compliance
report. If a sterilization chamber has
commenced operation since the end of
the period covered by the previous
compliance report, or if any of the
information in paragraphs (b)(3)(i)
through (ix) of this section has changed
for a sterilization chamber that was
included in the previous compliance
report, you must report the information
in paragraphs (b)(3)(i) through (ix) of
this section for those sterilization
chambers;
(4) If emissions from any room in your
facility are subject to an emission
standard, you must report the ID for any
room where there has not been the
potential for EtO emissions since the
end of the period covered by the
previous compliance report. If a room
has had the potential for EtO emissions
since the end of the period covered by
the previous compliance report, or if
any of the information in paragraphs
(b)(4)(i) through (vi) of this section has
changed for a room where there is the
potential for EtO emissions that was
included in the previous compliance
report, you must report the information
in paragraphs (b)(4)(i) through (vi) of
this section for those rooms;
(5) If an EtO CEMS was used to
demonstrate continuous compliance,
you must report the information
specified in paragraphs (b)(5)(i) through
(vi) of this section.
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(6) If any portion of your facility is
required to be operated with PTE, you
must report the information listed in
paragraph (b)(6) of this section.
(7) If you are complying with the
requirement to follow the best
management practice to limit
sterilization chamber concentration of
EtO to 1 ppmv prior to opening the
sterilization chamber door, you must
provide a certification from your
responsible official that this approach is
being followed and you are meeting the
monitoring requirements at § 63.362(h).
(8) If you own or operate an existing
collection of Group 2 room air
emissions at an area source facility and
facility EtO use is less than 4 tpy, you
must report the ID for any room where
Group 2 room air emissions have ceased
since end of the period covered by the
previous compliance report. If a room
has had Group 2 room air emissions
since the end of the period covered by
the previous compliance report, or if
any of the information in paragraphs
(b)(8)(i) through (iv) of this section has
changed for a room where there are
Group 2 room air emissions that were
included in the previous compliance
report, you must report the information
in paragraphs (b)(8)(i) through (iv) of
this section for each room where there
are Group 2 room air emissions.
(9) If you own or operate an existing
collection of Group 2 room air
emissions at an area source facility and
facility EtO use is less than 4 tpy, you
are not required to report the
information in paragraph (c)(8) of this
section if you meet the requirements in
paragraph (b)(9) of this section.
(10) Report the number of deviations
to meet an applicable standard. For each
instance, report the date, time, the
cause, and duration of each deviation.
For each deviation, the report must
include a list of the affected sources or
equipment, the quantity of each
regulated pollutant emitted over any
emission limit, and a description of the
method used to determine the
emissions.
(d) Construction and reconstruction
application. You must fulfill all
requirements for construction or
reconstruction of a facility in § 63.5,
according to the applicability in table 6
to this subpart, and in this paragraph.
(1) Applicability. (i) This paragraph
(d) and § 63.5 implement the
preconstruction review requirements of
section 112(i)(1) for facilities subject to
these emissions standards. In addition,
this paragraph (d) and § 63.5 include
other requirements for constructed and
reconstructed facilities that are or
become subject to these emissions
standards.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
(ii) After April 5, 2024, the
requirements in this section and in
§ 63.5 apply to owners or operators who
construct a new facility or reconstruct a
facility subject to these emissions
standards after April 5, 2024. New or
reconstructed facilities subject to these
emissions standards with an initial
startup date before the effective date are
not subject to the preconstruction
review requirements specified in
paragraphs (b)(2) and (3) of this section
and § 63.5(d)(3) and (4) and (e).
(2) Advance approval. After April 5,
2024, whether or not an approved
permit program is effective in the
jurisdictional authority in which a
facility is (or would be) located, no
person may construct a new facility or
reconstruct a facility subject to these
emissions standards, or reconstruct a
facility such that the facility becomes a
facility subject to these emissions
standards, without obtaining advance
written approval from the Administrator
in accordance with the procedures
specified in paragraph (b)(3) of this
section and § 63.5(d)(3) and (4) and (e).
(3) Application for approval of
construction or reconstruction. The
provisions of paragraph (b)(3) of this
section and § 63.5(d)(3) and (4)
implement section 112(i)(1) of the Act.
(i) General application requirements.
(A) An owner or operator who is subject
to the requirements of paragraph (b)(2)
of this section shall submit to the
Administrator an application for
approval of the construction of a new
facility subject to these emissions
standards, the reconstruction of a
facility subject to these emissions
standards, or the reconstruction of a
facility such that the facility becomes a
facility subject to these emissions
standards. The application shall be
submitted as soon as practicable before
the construction or reconstruction is
planned to commence (but not sooner
than the effective date) if the
construction or reconstruction
commences after the effective date. The
application shall be submitted as soon
as practicable before the initial startup
date but no later than 60 days after the
effective date if the construction or
reconstruction had commenced and the
initial startup date had not occurred
before the effective date. The
application for approval of construction
or reconstruction may be used to fulfill
the initial notification requirements of
paragraph (e)(1)(iii) of this section. The
owner or operator may submit the
application for approval well in advance
of the date construction or
reconstruction is planned to commence
in order to ensure a timely review by the
Administrator and that the planned
PO 00000
Frm 00101
Fmt 4701
Sfmt 4700
24189
commencement date will not be
delayed.
(B) A separate application shall be
submitted for each construction or
reconstruction. Each application for
approval of construction or
reconstruction shall include at a
minimum:
(1) The applicant’s name and address.
(2) A notification of intention to
construct a new facility subject to these
emissions standards or make any
physical or operational change to a
facility subject to these emissions
standards that may meet or has been
determined to meet the criteria for a
reconstruction, as defined in § 63.2.
(3) The address (i.e., physical
location) or proposed address of the
facility.
(4) An identification of the relevant
standard that is the basis of the
application.
(5) The expected commencement date
of the construction or reconstruction.
(6) The expected completion date of
the construction or reconstruction.
(7) The anticipated date of (initial)
startup of the facility.
(8) The type and quantity of
hazardous air pollutants emitted by the
facility, reported in units and averaging
times and in accordance with the test
methods specified in the standard, or if
actual emissions data are not yet
available, an estimate of the type and
quantity of hazardous air pollutants
expected to be emitted by the facility
reported in units and averaging times
specified. The owner or operator may
submit percent reduction information, if
the standard is established in terms of
percent reduction. However, operating
parameters, such as flow rate, shall be
included in the submission to the extent
that they demonstrate performance and
compliance.
(9) Other information as specified in
paragraph (b)(3)(ii) of this section and
§ 63.5(d)(3).
(C) An owner or operator who submits
estimates or preliminary information in
place of the actual emissions data and
analysis required in paragraphs
(b)(3)(i)(B)(8) and (b)(3)(ii) of this
section shall submit the actual,
measured emissions data and other
correct information as soon as available
but no later than with the notification of
compliance status required in paragraph
(c)(2) of this section.
(ii) Application for approval of
construction. Each application for
approval of construction shall include,
in addition to the information required
in paragraph (b)(3)(i)(B) of this section,
technical information describing the
proposed nature, size, design, operating
design capacity, and method of
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24190
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
operation of the facility subject to these
emissions standards, including an
identification of each point of emission
for each hazardous air pollutant that is
emitted (or could be emitted) and a
description of the planned air pollution
control system (equipment or method)
for each emission point. The description
of the equipment to be used for the
control of emissions shall include each
control device for each hazardous air
pollutant and the estimated control
efficiency (percent) for each control
device. The description of the method to
be used for the control of emissions
shall include an estimated control
efficiency (percent) for that method.
Such technical information shall
include calculations of emission
estimates in sufficient detail to permit
assessment of the validity of the
calculations. An owner or operator who
submits approximations of control
efficiencies under paragraph (b)(3) of
this section shall submit the actual
control efficiencies as specified in
paragraph (b)(3)(i)(C) of this section.
(4) Approval of construction or
reconstruction based on prior
jurisdictional authority preconstruction
review. (i) The Administrator may
approve an application for construction
or reconstruction specified in
paragraphs (b)(2) and (3) of this section
and § 63.5(d)(3) and (4) if the owner or
operator of a new or reconstructed
facility who is subject to such
requirement demonstrates to the
Administrator’s satisfaction that the
following conditions have been (or will
be) met:
(A) The owner or operator of the new
or reconstructed facility subject to these
emissions standards has undergone a
preconstruction review and approval
process in the jurisdictional authority in
which the facility is (or would be)
located before the effective date and has
received a federally enforceable
construction permit that contains a
finding that the facility will meet these
emissions standards as proposed, if the
facility is properly built and operated;
(B) In making its finding, the
jurisdictional authority has considered
factors substantially equivalent to those
specified in § 63.5(e)(1).
(ii) The owner or operator shall
submit to the Administrator the request
for approval of construction or
reconstruction no later than the
application deadline specified in
paragraph (b)(3)(i) of this section. The
owner or operator shall include in the
request information sufficient for the
Administrator’s determination. The
Administrator will evaluate the owner
or operator’s request in accordance with
the procedures specified in § 63.5. The
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Administrator may request additional
relevant information after the submittal
of a request for approval of construction
or reconstruction.
(e) Notification requirements. The
owner or operator of an affected source
subject to an emissions standard in
§ 63.362 shall fulfill all notification
requirements in § 63.9, according to the
applicability in table 6 to this subpart,
and in this paragraph (e).
(1) Initial notifications. (i) If you own
or operate an affected source subject to
an emissions standard in § 63.362, you
may use the application for approval of
construction or reconstruction under
paragraph (d)(3)(ii) of this section and
§ 63.5(d)(3), respectively, if relevant to
fulfill the initial notification
requirements.
(ii) The owner or operator of a new or
reconstructed facility subject to these
emissions standards that has an initial
startup date after the effective date and
for which an application for approval of
construction or reconstruction is
required under paragraph (d)(3) of this
section and § 63.5(d)(3) and (4) shall
provide the following information in
writing to the Administrator:
(A) A notification of intention to
construct a new facility subject to these
emissions standards, reconstruct a
facility subject to these emissions
standards, or reconstruct a facility such
that the facility becomes a facility
subject to these emissions standards
with the application for approval of
construction or reconstruction as
specified in paragraph (d)(3)(i)(A) of this
section;
(B) A notification of the date when
construction or reconstruction was
commenced, submitted simultaneously
with the application for approval of
construction or reconstruction, if
construction or reconstruction was
commenced before the effective date of
these standards;
(C) A notification of the date when
construction or reconstruction was
commenced, delivered or postmarked
no later than 30 days after such date, if
construction or reconstruction was
commenced after the effective date of
these standards;
(D) A notification of the anticipated
date of startup of the facility, delivered
or postmarked not more than 60 days
nor less than 30 days before such date;
and
(E) A notification of the actual date of
initial startup of the facility, delivered
or postmarked within 15 calendar days
after that date.
(iii) After the effective date, whether
or not an approved permit program is
effective in the jurisdictional authority
in which a facility subject to these
PO 00000
Frm 00102
Fmt 4701
Sfmt 4700
emissions standards is (or would be)
located, an owner or operator who
intends to construct a new facility
subject to these emissions standards or
reconstruct a facility subject to these
emissions standards, or reconstruct a
facility such that it becomes a facility
subject to these emissions standards,
shall notify the Administrator in writing
of the intended construction or
reconstruction. The notification shall be
submitted as soon as practicable before
the construction or reconstruction is
planned to commence (but no sooner
than the effective date of these
standards) if the construction or
reconstruction commences after the
effective date of the standard. The
notification shall be submitted as soon
as practicable before the initial startup
date but no later than 60 days after the
effective date of this standard if the
construction or reconstruction had
commenced and the initial startup date
has not occurred before the standard’s
effective date. The notification shall
include all the information required for
an application for approval of
construction or reconstruction as
specified in paragraph (d)(3) of this
section and § 63.5(d)(3) and (4). For
facilities subject to these emissions
standards, the application for approval
of construction or reconstruction may be
used to fulfill the initial notification
requirements of § 63.9.
(2) If an owner or operator of a facility
subject to these emissions standards
submits estimates or preliminary
information in the application for
approval of construction or
reconstruction required in paragraph
(d)(3)(ii) of this section and § 63.5(d)(3),
respectively, in place of the actual
emissions data or control efficiencies
required in paragraphs (d)(3)(i)(B)(8)
and (b)(3)(ii) of this section, the owner
or operator shall submit the actual
emissions data and other correct
information as soon as available but no
later than with the initial notification of
compliance status.
(3) If you own or operate an affected
source subject to an emissions standard
in § 63.362, you must also include the
amount of EtO used at the facility
during the previous consecutive 12month period in the initial notification
report required by § 63.9(b)(2) and (3).
For new sterilization facilities subject to
this subpart, the amount of EtO used at
the facility shall be an estimate of
expected use during the first
consecutive 12-month period of
operation.
(4) Beginning October 7, 2024, you
must submit all subsequent Notification
of Compliance Status reports in PDF
formatto the EPA following the
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
procedure specified in § 63.9(k), except
any medium submitted through mail
must be sent to the attention of the
Commercial Sterilization Sector Lead.
(f) Performance test submission.
Beginning on June 4, 2024, within 60
days after the date of completing each
performance test required by this
subpart, you must submit the results of
the performance test following the
procedures specified in paragraphs (f)(1)
through (3) of this section.
(1) Data collected using test methods
supported by the EPA’s Electronic
Reporting Tool (ERT) as listed on the
EPA’s ERT website (https://
www.epa.gov/electronic-reporting-airemissions/electronic-reporting-tool-ert)
at the time of the test. Submit the results
of the performance test to the EPA via
the CEDRI, which can be accessed
through the EPA’s CDX (https://
cdx.epa.gov/). The data must be
submitted in a file format generated
using the EPA’s ERT. Alternatively, you
may submit an electronic file consistent
with the XML schema listed on the
EPA’s ERT website.
(2) Data collected using test methods
that are not supported by the EPA’s ERT
as listed on the EPA’s ERT website at
the time of the test. The results of the
performance test must be included as an
attachment in the ERT or an alternate
electronic file consistent with the XML
schema listed on the EPA’s ERT
website. Submit the ERT generated
package or alternative file to the EPA via
CEDRI.
(3) CBI. Do not use CEDRI to submit
information you claim as CBI. Anything
submitted using CEDRI cannot later be
claimed CBI. Although we do not expect
persons to assert a claim of CBI, if you
wish to assert a CBI claim for some of
the information submitted under
paragraph (f)(1)(i) or (ii) of this section,
you must submit a complete file,
including information claimed to be
CBI, to the EPA. The file must be
generated using the EPA’s ERT or an
alternate electronic file consistent with
the XML schema listed on the EPA’s
ERT website. Submit the file on a
compact disc, flash drive, or other
commonly used electronic storage
medium and clearly mark the medium
as CBI. Mail the electronic medium to
U.S. EPA/OAQPS/CORE CBI Office,
Attention: Group Leader, Measurement
Policy Group, MD C404–02, 4930 Old
Page Rd., Durham, NC 27703. The same
file with the CBI omitted must be
submitted to the EPA via the EPA’s CDX
as described in paragraphs (f)(1)(i) and
(ii) of this section. All CBI claims must
be asserted at the time of submission.
Furthermore, under CAA section 114(c),
emissions data is not entitled to
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
confidential treatment, and the EPA is
required to make emissions data
available to the public. Thus, emissions
data will not be protected as CBI and
will be made publicly available.
(g) Performance evaluation
submission. Beginning on June 4, 2024,
within 60 days after the date of
completing each CEMS performance
evaluation (as defined in § 63.2), you
must submit the results of the
performance evaluation following the
procedures specified in paragraphs
(g)(1) through (3) of this section.
(1) Performance evaluations of CEMS
measuring relative accuracy test audit
(RATA) pollutants that are supported by
the EPA’s ERT as listed on the EPA’s
ERT website at the time of the
evaluation. Submit the results of the
performance evaluation to the EPA via
CEDRI, which can be accessed through
the EPA’s CDX. The data must be
submitted in a file format generated
using the EPA’s ERT. Alternatively, you
may submit an electronic file consistent
with the XML schema listed on the
EPA’s ERT website.
(2) Performance evaluations of CEMS
measuring RATA pollutants that are not
supported by the EPA’s ERT as listed on
the EPA’s ERT website at the time of the
evaluation. The results of the
performance evaluation must be
included as an attachment in the ERT or
an alternate electronic file consistent
with the XML schema listed on the
EPA’s ERT website. Submit the ERT
generated package or alternative file to
the EPA via CEDRI.
(3) CBI. Do not use CEDRI to submit
information you claim as CBI. Anything
submitted using CEDRI cannot later be
claimed CBI. Although we do not expect
persons to assert a claim of CBI, if you
wish to assert a CBI claim for some of
the information submitted under
paragraph (g)(1)(i) or (ii) of this section,
you must submit a complete file,
including information claimed to be
CBI, to the EPA. The CBI file must be
generated using the EPA’s ERT or an
alternate electronic file consistent with
the XML schema listed on the EPA’s
ERT website. Submit the CBI file on a
compact disc, flash drive, or other
commonly used electronic storage
medium and clearly mark the medium
as CBI. Mail the electronic medium to
U.S. EPA/OAQPS/CORE CBI Office,
Attention: Group Leader, Measurement
Policy Group, MD C404–02, 4930 Old
Page Rd., Durham, NC 27703. The same
file with the CBI omitted must be
submitted to the EPA via the EPA’s CDX
as described in paragraphs (g)(1)(i) and
(ii) of this section. All CBI claims must
be asserted at the time of submission.
Furthermore, under CAA section 114(c),
PO 00000
Frm 00103
Fmt 4701
Sfmt 4700
24191
emissions data is not entitled to
confidential treatment, and the EPA is
required to make emissions data
available to the public. Thus, emissions
data will not be protected as CBI and
will be made publicly available.
(h) Extensions for CDX/CEDRI
outages. If you are required to
electronically submit a report through
CEDRI in the EPA’s CDX, you may
assert a claim of EPA system outage for
failure to timely comply with that
reporting requirement. To assert a claim
of EPA system outage, you must meet
the requirements outlined in paragraphs
(h)(1) through (7) of this section.
(1) You must have been or will be
precluded from accessing CEDRI and
submitting a required report within the
time prescribed due to an outage of
either the EPA’s CEDRI or CDX systems.
(2) The outage must have occurred
within the period of time beginning five
business days prior to the date that the
submission is due.
(3) The outage may be planned or
unplanned.
(4) You must submit notification to
the Administrator in writing as soon as
possible following the date you first
knew, or through due diligence should
have known, that the event may cause
or has caused a delay in reporting.
(5) You must provide to the
Administrator a written description
identifying:
(i) The date(s) and time(s) when CDX
or CEDRI was accessed and the system
was unavailable;
(ii) A rationale for attributing the
delay in reporting beyond the regulatory
deadline to EPA system outage;
(iii) A description of measures taken
or to be taken to minimize the delay in
reporting; and
(iv) The date by which you propose to
report, or if you have already met the
reporting requirement at the time of the
notification, the date you reported.
(6) The decision to accept the claim
of EPA system outage and allow an
extension to the reporting deadline is
solely within the discretion of the
Administrator.
(7) In any circumstance, the report
must be submitted electronically as
soon as possible after the outage is
resolved.
(i) Extensions for force majeure
events. If you are required to
electronically submit a report through
CEDRI in the EPA’s CDX, you may
assert a claim of force majeure for
failure to timely comply with that
reporting requirement. To assert a claim
of force majeure, you must meet the
requirements outlined in paragraphs
(i)(1) through (5) of this section.
E:\FR\FM\05APR2.SGM
05APR2
24192
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
(1) You may submit a claim if a force
majeure event is about to occur, occurs,
or has occurred or there are lingering
effects from such an event within the
period of time beginning five business
days prior to the date the submission is
due. For the purposes of this section, a
force majeure event is defined as an
event that will be or has been caused by
circumstances beyond the control of the
affected facility, its contractors, or any
entity controlled by the affected facility
that prevents you from complying with
the requirement to submit a report
electronically within the time period
prescribed. Examples of such events are
acts of nature (e.g., hurricanes,
earthquakes, or floods), acts of war or
terrorism, or equipment failure or safety
hazard beyond the control of the
affected facility (e.g., large scale power
outage).
(2) You must submit notification to
the Administrator in writing as soon as
possible following the date you first
knew, or through due diligence should
have known, that the event may cause
or has caused a delay in reporting.
(3) You must provide to the
Administrator:
(i) A written description of the force
majeure event;
(ii) A rationale for attributing the
delay in reporting beyond the regulatory
deadline to the force majeure event;
(iii) A description of measures taken
or to be taken to minimize the delay in
reporting; and
(iv) The date by which you propose to
report, or if you have already met the
reporting requirement at the time of the
notification, the date you reported.
(4) The decision to accept the claim
of force majeure and allow an extension
to the reporting deadline is solely
within the discretion of the
Administrator.
(5) In any circumstance, the reporting
must occur as soon as possible after the
force majeure event occurs.
§ 63.367
Recordkeeping requirements.
(a) If you own or operate an affected
source subject to § 63.362, you must
comply with the recordkeeping
requirements in § 63.10(a) through (c),
according to the applicability in table 6
to this subpart, and in this section. All
records required to be maintained by
this subpart or a subpart referenced by
this subpart shall be maintained in such
a manner that they can be readily
accessed and are suitable for inspection.
(b) You must maintain the previous
five years of records specified in
§ 63.366(b) and (c), as applicable.
(c) You must maintain the previous
five years of records for compliance
tests and associated data analysis, as
applicable.
(d) Any records required to be
maintained by this subpart that are
submitted electronically via the EPA’s
CEDRI may be maintained in electronic
format. This ability to maintain
electronic copies does not affect the
requirement for facilities to make
records, data, and reports available
upon request to a delegated air agency
or the EPA as part of an on-site
compliance evaluation.
(e) If you are using an EtO CEMS to
demonstrate continuous compliance,
you must maintain the previous five
years of records for all required
certification and QA tests.
(f) For each deviation from an
emission limit, operating limit, or best
management practice, you must keep a
record of the information specified in
paragraph (g)(1) through (4) of this
section. The records shall be maintained
as specified in § 63.10(b)(1).
(1) The occurrence and duration of
each startup, shutdown, or malfunction
of process, air pollution control, and
monitoring equipment.
(2) In the event that an affected unit
does not meet an applicable standard,
record the number of deviations. For
each deviation, record the date, time,
cause, and duration of each deviation.
(3) For each failure to meet an
applicable standard, record and retain a
list of the affected sources or equipment,
an estimate of the quantity of each
regulated pollutant emitted over any
emission limit and a description of the
method used to estimate the emissions.
(4) Record actions taken to minimize
emissions in accordance with
§ 63.368
Implementation and enforcement.
(a) This subpart can be implemented
and enforced by the U.S. EPA or a
delegated authority such as the
applicable State, local, or Tribal agency.
If the U.S. EPA Administrator has
delegated authority to a State, local, or
Tribal agency, then that agency, in
addition to the U.S. EPA, has the
authority to implement and enforce this
subpart. Contact the applicable U.S.
EPA Regional Office to find out whether
implementation and enforcement of this
subpart are delegated to a State, local, or
Tribal agency.
(b) In delegating implementation and
enforcement authority of this subpart to
a State, local, or Tribal agency under
subpart E of this part, the authorities
contained in paragraph (c) of this
section are retained by the
Administrator of U.S. EPA and cannot
be transferred to the State, local, or
Tribal agency.
(c) The authorities that cannot be
delegated to State, local, or Tribal
agencies are as specified in paragraphs
(c)(1) through (5) of this section.
(1) Approval of alternatives to the
requirements in §§ 63.360 and 63.362.
(2) Approval of major alternatives to
test methods under § 63.7(e)(2)(ii) and
(f), as defined in § 63.90, and as required
in this subpart.
(3) Approval of major alternatives to
monitoring under § 63.8(f), as defined in
§ 63.90, and as required in this subpart.
(4) Approval of major alternatives to
recordkeeping and reporting under
§ 63.10(f), as defined in § 63.90, and as
required in this subpart.
(5) Approval of an alternative to any
electronic reporting to the EPA required
by this subpart.
Table 1 to Subpart O of Part 63—
Standards for SCVs
As required in § 63.362(c), for each
SCV, you must meet the applicable
standard in the following table:
For each . . .
For which . . .
You must . . .
You must comply with
the standard . . .
1. Existing SCV ..............
a. Facility EtO use is at least 10 tpy .......................................
i. Continuously reduce EtO emissions by 99 percent 1.
i. Continuously reduce EtO emissions by 99 percent 1.
ii. Continuously reduce EtO emissions by 99.8
percent 2 3.
i. Continuously reduce EtO emissions by 99.99
percent 2 3.
i. Continuously reduce EtO emissions by 99.9
percent 2 3.
i. Continuously reduce EtO emissions by 99 percent 2 4.
Until April 6, 2026.
b. Facility EtO use is at least 1 tpy but less than 10 tpy ........
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.362(k) and any corrective actions
taken to return the affected unit to its
normal or usual manner of operation.
c. Facility EtO use is at least 30 tpy .......................................
d. Facility EtO use is at least 10 tpy but less than 30 tpy ......
e. Facility EtO use is less than 1 tpy ......................................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00104
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Until April 6, 2026.
No later
2026.
No later
2026.
No later
2026.
No later
2027.
than April 6,
than April 6,
than April 6,
than April 5,
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
For each . . .
For which . . .
You must . . .
2. New SCV ...................
a. Initial startup is on or before April 5, 2024, and facility EtO
use is at least 30 tpy.
b. Initial startup is on or before April 5, 2024, and facility EtO
use is at least 10 tpy but less than 30 tpy.
c. Initial startup is on or before April 5, 2024, and facility EtO
use is at least 1 tpy but less than 10 tpy.
d. Initial startup is on or before April 5, 2024, and facility EtO
use is less than 1 tpy.
e. Initial startup is after April 5, 2024, and facility EtO use is
at least 30 tpy.
f. Initial startup is after April 5, 2024, and facility EtO use is
at least 10 tpy but less than 30 tpy.
g. Initial startup is after April 5, 2024, and facility EtO use is
at least 1 tpy but less than 10 tpy.
h. Initial startup is after April 5, 2024, and facility EtO use is
less than 1 tpy.
i. Continuously
percent 2 5.
i. Continuously
percent 2 5.
i. Continuously
percent 2 5.
i. Continuously
cent 2 6.
i. Continuously
percent 2 5.
i. Continuously
percent 2 5.
i. Continuously
percent 2 5.
i. Continuously
cent 2 6.
24193
You must comply with
the standard . . .
reduce EtO emissions by 99.99
reduce EtO emissions by 99.9
reduce EtO emissions by 99.8
reduce EtO emissions by 99 perreduce EtO emissions by 99.99
reduce EtO emissions by 99.9
reduce EtO emissions by 99.8
reduce EtO emissions by 99 per-
No later than April 5,
2024.
No later than April 5,
2024.
No later than April 5,
2024.
No later than April 5,
2024.
Upon startup of the
source.
Upon startup of the
source.
Upon startup of the
source.
Upon startup of the
source.
1 The
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after December 6, 1996.
using EtO CEMS to determine compliance, this standard is based on the previous 30 operating days of data.
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after April 7, 2025.
4 The standard applies if the facility has used less than 1 tpy of EtO within all consecutive 12-month periods after April 6, 2026.
5 The standard applies if the facility is expected to meet or exceed the specified EtO use within one year after startup. Afterwards, the standard applies if the facility
has met or exceeded the specified EtO use within any consecutive 12-month period after startup.
6 The standard applies if the facility is not expected to meet or exceed 1 tpy of EtO use within one year after startup. Afterwards, the standard applies if the facility
has used less than 1 tpy of EtO within all consecutive 12-month periods after startup.
2 If
3 The
Table 2 to Subpart O of Part 63—
Standards for ARVs
As required in § 63.362(d), for each
ARV, you must meet the applicable
standard in the following table:
For each . . .
For which . . .
You must . . .
1. Existing ARV ..............
a. Facility EtO use is at least 10 tpy .......................................
i. Continuously
cent 1.
i. Continuously
percent 2 3.
i. Continuously
percent 2 3.
i. Continuously
cent 2 4.
i. Continuously
percent 2 5.
i. Continuously
cent 2 6.
i. Continuously
percent 2 5.
i. Continuously
cent 2 6.
b. Facility EtO use is at least 30 tpy .......................................
c. Facility EtO use is at least 10 tpy but less than 30 tpy ......
d. Facility EtO use is less than 10 tpy ....................................
2. New ARV ...................
a. Initial startup is on or before April 5, 2024, and facility EtO
use is at least 10 tpy.
b. Initial startup is on or before April 5, 2024, and facility EtO
use is less than 10 tpy.
c. Initial startup is after April 5, 2024, and facility EtO use is
at least 10 tpy.
d. Initial startup is after April 5, 2024, and facility EtO use is
less than 10 tpy.
You must comply with
the standard . . .
reduce EtO emissions by 99 per-
Until April 6, 2026.
reduce EtO emissions by 99.9
No later than April 6,
2026.
No later than April 6,
2026.
No later than April 5,
2027.
No later than April 5,
2024.
No later than April 5,
2024.
Upon startup of the
source.
Upon startup of the
source.
reduce EtO emissions by 99.6
reduce EtO emissions by 99 perreduce EtO emissions by 99.9
reduce EtO emissions by 99 perreduce EtO emissions by 99.9
reduce EtO emissions by 99 per-
1 The
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after December 6, 1996.
using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after April 7, 2025.
4 The standard applies if the facility has used less than 10 tpy of EtO within all consecutive 12-month periods after April 6, 2026.
5 The standard applies if the facility is expected to meet or exceed the specified EtO use within one year after startup. Afterwards, the standard applies if the facility
has met or exceeded the specified EtO use within any consecutive 12-month period after startup.
6 The standard applies if the facility is not expected to meet or exceed 10 tpy of EtO use within one year after startup. Afterwards, the standard applies if the facility
has used less than 10 tpy of EtO within all consecutive 12-month periods after startup.
2 If
3 The
khammond on DSKJM1Z7X2PROD with RULES2
Table 3 to Subpart O of Part 63—
Standards for CEVs
As required in § 63.362(e), for each
CEV, you must meet the applicable
standard in the following table:
For each . . .
For which . . .
You must . . .
1. Existing CEV at a
major source facility.
2. Existing CEV at an
area source facility.
a. Not applicable .....................................................................
i. Continuously
percent 1.
i. Continuously
percent 1 2.
i. Continuously
cent 1 3.
i. Continuously
percent 1.
a. Facility EtO use is at least 60 tpy .......................................
b. Facility EtO use is less than 60 tpy ....................................
3. New CEV at a major
source facility.
VerDate Sep<11>2014
a. Initial startup is on or before April 5, 2024 .........................
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00105
Fmt 4701
Sfmt 4700
You must comply with
the standard . . .
reduce EtO emissions by 99.94
reduce EtO emissions by 99.9
reduce EtO emissions by 99 perreduce EtO emissions by 99.94
E:\FR\FM\05APR2.SGM
05APR2
No later
2027.
No later
2026.
No later
2027.
No later
2024.
than April 5,
than April 6,
than April 5,
than April 5,
24194
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
For each . . .
4. New CEV at an area
source facility.
For which . . .
You must . . .
b. Initial startup is after April 5, 2024 ......................................
i. Continuously
percent 1.
i. Continuously
percent 1 4.
i. Continuously
cent 1 5.
i. Continuously
percent 1 4.
i. Continuously
cent 1 5.
a. Initial startup is on or before April 5, 2024, and facility EtO
use is at least 60 tpy.
b. Initial startup is on or before April 5, 2024, facility EtO use
is less than 60 tpy.
c. Initial startup is after April 5, 2024, and facility EtO use is
at least 60 tpy.
d. Initial startup is after April 5, 2024, facility EtO use is less
than 60 tpy.
You must comply with
the standard . . .
reduce EtO emissions by 99.94
reduce EtO emissions by 99.9
reduce EtO emissions by 99 perreduce EtO emissions by 99.9
reduce EtO emissions by 99 per-
Upon startup of the
source.
No later than April 5,
2024.
No later than April 5,
2024.
Upon startup of the
source.
Upon startup of the
source.
1 If
using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after April 7, 2025.
standard applies if the facility has used less than 60 tpy of EtO within all consecutive 12-month periods after April 6, 2026.
4 The standard applies if the facility is expected to meet or exceed the specified EtO use within one year after startup. Afterwards, the standard applies if the facility
has met or exceeded the specified EtO use within any consecutive 12-month period after startup.
5 The standard applies if the facility is not expected to meet or exceed 60 tpy of EtO use within one year after startup. Afterwards, the standard applies if the facility
has used less than 60 tpy of EtO within all consecutive 12-month periods after startup.
2 The
3 The
Table 4 to Subpart O of Part 63—
Standards for Group 1 Room Air
Emissions
emissions at each facility, you must
meet the applicable standard in the
following table:
As required in § 63.362(f), for your
collection of Group 1 room air
For which . . .
You must . . .
1. Existing collection of Group 1 room air emissions at a
major source facility.
a. Not applicable .........
2. Existing collection of Group 1 room air emissions at an
area source facility.
a. Facility EtO use is
at least 40 tpy.
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.
Also,
ii. Continuously reduce EtO emissions by 97 percent 1 .....
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.2 Also,
ii. Continuously reduce EtO emissions by 98 percent 1 2 ...
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.
Also,
ii. Continuously reduce EtO emissions by 80 percent 1 3 ...
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.
Also,
ii. Continuously reduce EtO emissions by 97 percent 1 .....
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.
Also,
ii. Continuously reduce EtO emissions by 97 percent 1 .....
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.4 Also,
ii. Continuously reduce EtO emissions by 98 percent 1 4 ...
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.5 Also,
ii. Continuously reduce EtO emissions by 80 percent 1 5 ...
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.4 Also,
ii. Continuously reduce EtO emissions by 98 percent 1 4 ...
i. Operate all areas of the facility that contain Group 1
room air emissions with PTE, with all exhaust gas
streams being captured and routed to a control system.5 Also,
ii. Continuously reduce EtO emissions by 80 percent 1 5 ...
b. Facility EtO use is
less than 40 tpy.
3. New collection of Group 1 room air emissions at a
major source facility.
a. Initial startup is on
or before April 5,
2024.
b. Initial startup is after
April 5, 2024.
4. New collection of Group 1 room air emissions at an
area source facility.
khammond on DSKJM1Z7X2PROD with RULES2
You must comply
with the requirement(s) . . .
For each . . .
a. Initial startup is on
or before April 5,
2024, and facility
EtO use is at least
40 tpy.
b. Initial startup is on
or before April 5,
2024, and facility
EtO use is less than
40 tpy.
c. Initial startup is after
April 5, 2024, and
facility EtO use is at
least 40 tpy.
d. Initial startup is after
April 5, 2024, and
facility EtO use is
less than 40 tpy.
1 If using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
2 The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period
3 The standard applies if the facility has used less than 40 tpy of EtO within all consecutive 12-month periods after April
No later than April
5, 2027.
No later than April
6, 2026.
No later than April
5, 2027.
No later than April
5, 2024.
Upon startup of the
source.
No later than April
5, 2024.
No later than April
5, 2024.
Upon startup of the
source.
Upon startup of the
source.
after April 7, 2025.
6, 2026.
standard applies if the facility is expected to meet or exceed the specified EtO use within one year after startup. Afterwards, the standard applies if the facility
has met or exceeded the specified EtO use within any consecutive 12-month period after startup.
5 The standard applies if the facility is not expected to meet or exceed 40 tpy of EtO use within one year after startup. Afterwards, the standard applies if the facility
has used less than 40 tpy of EtO within all consecutive 12-month periods after startup.
4 The
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00106
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Table 5 to Subpart O of Part 63—
Standards for Group 2 Room Air
Emissions
24195
emissions, you must meet the applicable
standard in the following table:
As required in § 63.362(g), for your
collection of Group 2 room air
For each . . .
For which . . .
You must . . .
You must comply with
the requirement(s) . . .
1. Existing collection of Group
2 room air emissions at a
major source facility.
a. Not applicable ...................
No later than April 5,
2027.
2. Existing collection of Group
2 room air emissions at an
area source facility.
a. Facility EtO use is at least
20 tpy.
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system. Also,
ii. Continuously reduce EtO emissions by 86 percent 1
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.2 Also,.
ii. Continuously reduce EtO emissions by 98 percent 1 2
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.2 Also,
ii. Continuously reduce EtO emissions by 80 percent 1 2
Lower the EtO concentration within each sterilization chamber to 1 ppm
before the chamber can be opened 3.
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system. Also,
ii. Continuously reduce EtO emissions by 86 percent 1
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system. Also,
ii. Continuously reduce EtO emissions by 86 percent 1
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.5 Also,
ii. Continuously reduce EtO emissions by 98 percent 1 5
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.6 Also,
ii. Continuously reduce EtO emissions by 80 percent 1 6
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.5 Also,
ii. Continuously reduce EtO emissions by 98 percent 1 5
i. Operate all areas of the facility that contain Group 2 room air emissions
with PTE, with all exhaust gas streams being captured and routed to a
control system.6 Also,
ii. Continuously reduce EtO emissions by 80 percent 1 6
b. Facility EtO use is at least
4 tpy but less than 20 tpy.
3. New collection of Group 2
room air emissions at a
major source facility.
c. Facility EtO use is less
than 4 tpy.
a. Initial startup is on or before April 5, 2024.
b. Initial startup is after April
5, 2024.
4. New collection of Group 2
room air emissions at an
area source facility.
a. Initial startup is on or before April 5, 2024, and facility EtO use is at least 20
tpy.
b. Initial startup is on or before April 5, 2024, and facility EtO use is less than
20 tpy.
c. Initial startup is after April
5, 2024, and facility EtO
use is at least 20 tpy.
d. Initial startup is after April
5, 2024, and facility EtO
use is less than 20 tpy.
No later than April 6,
2026.
No later than April 6,
2026.
No later than April 5,
2027.
No later than April 5,
2024.
Upon startup of the
source.
No later than April 5,
2024.
No later than April 5,
2024.
Upon startup of the
source.
Upon startup of the
source.
1 This
standard is based on a rolling 30-operating day average.
standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-month period after April 7, 2025.
standard applies if the facility has used less than 4 tpy of EtO within all consecutive 12-month periods after April 6, 2026.
4 The standard applies if the facility is expected to meet or exceed the specified EtO use within one year after startup. Afterwards, the standard applies if the facility
has met or exceeded the specified EtO use within any consecutive 12-month period after startup.
5 The standard applies if the facility is not expected to meet or exceed 20 tpy of EtO use within one year after startup. Afterwards, the standard applies if the facility
has used less than 20 tpy of EtO within all consecutive 12-month periods after startup.
2 The
3 The
khammond on DSKJM1Z7X2PROD with RULES2
Table 6 to Subpart O of Part 63—
Applicability of General Provisions to
This Subpart
As specified in § 63.360, the parts of
the General Provisions that apply to you
are shown in the following table:
Citation
Subject
Applies to subpart O
§ 63.1(a)(1) ................................
Applicability ...............................
§ 63.1(a)(2)–(3) ..........................
§ 63.1(a)(4) ................................
...................................................
...................................................
§ 63.1(a)(5) ................................
§ 63.1(a)(6)–(8) ..........................
§ 63.1(a)(9) ................................
§ 63.1(a)(10)–(14) ......................
§ 63.1(b)(1)–(2) ..........................
§ 63.1(b)(3) ................................
§ 63.1(c)(1) ................................
[Reserved] ................................
...................................................
[Reserved].
...................................................
...................................................
...................................................
...................................................
Yes, additional terms defined in § 63.361; when overlap between subparts A
and O occurs, subpart O takes precedence.
Yes.
Yes. Subpart O clarifies the applicability of each paragraph in subpart A to
facilities subject to subpart O.
No.
Yes.
§ 63.1(c)(2) ................................
...................................................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00107
Yes.
Yes.
No.
No. Subpart O clarifies the applicability of each paragraph in subpart A to
facilities subject to subpart O in this table.
Yes.
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24196
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Citation
Subject
Applies to subpart O
§ 63.1(c)(3) ................................
§ 63.1(c)(4) ................................
§ 63.1(c)(5) ................................
§ 63.1(c)(6) ................................
§ 63.1(d) .....................................
§ 63.1(e) .....................................
§ 63.2 .........................................
[Reserved] ................................
...................................................
...................................................
...................................................
[Reserved] ................................
...................................................
Definitions .................................
§ 63.3 .........................................
§ 63.4(a)(1)–(3) ..........................
§ 63.5(a) .....................................
Units and abbreviations ............
Prohibited activities ...................
Construction/Reconstruction .....
§ 63.5(b)(1) ................................
§ 63.5(b)(2) ................................
§ 63.5(b)(3) ................................
§ 63.5(b)(4)–(6) ..........................
§ 63.5(c) .....................................
§ 63.5(d)(1)–(2) ..........................
§ 63.5(d)(3)–(4) ..........................
§ 63.5(e) .....................................
§ 63.5(f)(1)–(2) ...........................
§ 63.6(a) .....................................
§ 63.6(b)–(c) ..............................
§ 63.6(d) .....................................
§ 63.6(e)(1)(i) .............................
§ 63.6(e)(1)(ii) ............................
...................................................
[Reserved].
...................................................
...................................................
[Reserved].
...................................................
...................................................
...................................................
...................................................
Applicability ...............................
...................................................
[Reserved].
...................................................
Requirement to correct malfunctions ASAP.
...................................................
[Reserved] ................................
SSM Plan Requirements ..........
SSM exemption ........................
Methods for Determining Compliance.
...................................................
...................................................
...................................................
...................................................
Alternative Standard .................
Compliance with opacity and
visible emission standards.
Compliance Extension ..............
Presidential Compliance Exemption.
Applicability and Performance
Test Dates.
Notification of Performance
Test.
Quality Assurance/Test Plan ....
Testing Facilities .......................
SSM exemption ........................
Conduct of Performance Tests
No.
Yes.
No. § 63.360 specifies applicability.
Yes.
No.
Yes.
Yes, additional terms defined in § 63.361; when overlap between subparts A
and O occurs, subpart O takes precedence.
Yes, other units used in subpart O are defined in the text of subpart O.
Yes.
No. § 63.366(b)(1) contains applicability requirements for constructed or reconstructed facilities.
Yes.
§ 63.6(e)(1)(iii) ...........................
§ 63.6(e)(2) ................................
§ 63.6(e)(3) ................................
§ 63.6(f)(1) .................................
§ 63.6(f)(2)(i) ..............................
§ 63.6(f)(2)(ii) .............................
§ 63.6(f)(2)(iii)–(iv) .....................
§ 63.6(f)(2)(v) .............................
§ 63.6(f)(3) .................................
§ 63.6(g) .....................................
§ 63.6(h) .....................................
§ 63.6(i)(1)–(14), and (16) .........
§ 63.6(j) ......................................
§ 63.7(a) .....................................
§ 63.7(b) .....................................
§ 63.7(c) .....................................
§ 63.7(d) .....................................
§ 63.7(e)(1) ................................
§ 63.7(e)(2)–(4) ..........................
§ 63.7(f) ......................................
§ 63.7(g) .....................................
§ 63.7(h) .....................................
§ 63.8(a)(1) ................................
§ 63.8(a)(2) ................................
§ 63.8(a)(3) ................................
§ 63.8(a)(4) ................................
§ 63.8(b)(1) ................................
§ 63.8(b)(2)–(3) ..........................
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.8(c)(1)(i) .............................
§ 63.8(c)(1)(ii) ............................
§ 63.8(c)(1)(iii) ............................
Alternative Test Method ...........
Performance Test Data Analysis.
Waiver of Tests ........................
Applicability of Monitoring Requirements.
Performance Specifications ......
[Reserved] ................................
Monitoring with Flares ..............
Monitoring .................................
Multiple Effluents and Multiple
Monitoring Systems.
General duty to minimize emissions and CMS operation.
...................................................
§ 63.8(c)(2)–(3) ..........................
§ 63.8(c)(4)–(5) ..........................
Requirement to develop SSM
Plan for CMS.
...................................................
...................................................
§ 63.8(c)(6) ................................
...................................................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00108
No. See § 63.366(b)(2).
Yes.
No. See § 63.366(b)(3).
Yes.
Yes.
No. See § 63.366(b)(4).
Yes.
No. § 63.360(j) specifies compliance dates for facilities.
No.
No.
Yes.
No.
No.
No.
Yes.
No. § 63.363 specifies parameters for determining compliance.
Yes.
No.
Yes.
Yes.
No. Subpart O does not contain any opacity or visible emission standards.
Yes.
Yes.
Yes.
Yes.
Yes.
Yes.
No.
Yes. § 63.365 also contains test methods specific to facilities subject to the
emissions standards.
Yes.
Yes, except this subpart specifies how and when the performance test and
performance evaluation results are reported.
Yes.
Yes.
Yes.
No.
Yes.
Yes.
Yes.
No.
No. A startup, shutdown, and malfunction plan is not required for these
standards.
No.
Yes.
No. Frequency of monitoring measurements is provided in § 63.364; opacity
monitors are not required for these standards.
No. Performance specifications are contained in § 63.365.
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Citation
Subject
§ 63.8(c)(7)(i)(A)–(B) ..................
§ 63.8(c)(7)(i)(C) ........................
§ 63.8(c)(7)(ii) ............................
§ 63.8(c)(8) ................................
§ 63.8(d)(1)–(2) ..........................
§ 63.8(d)(3) ................................
§ 63.8(e)(1) ................................
...................................................
...................................................
...................................................
...................................................
...................................................
Written procedures for CMS .....
CMS Performance Evaluation ..
§ 63.8(e)(2) ................................
§ 63.8(e)(3) ................................
§ 63.8(e)(4) ................................
§ 63.8(e)(5)(i) .............................
§ 63.8(e)(5)(ii) ............................
§ 63.8(f)(1)–(5) ...........................
§ 63.8(f)(6) .................................
§ 63.8(g)(1) ................................
§ 63.8(g)(2) ................................
§ 63.8(g)(3)–(5) ..........................
§ 63.9(a) .....................................
§ 63.9(b)(1)–(i) ...........................
§ 63.9(b)(1)(ii)–(iii) .....................
...................................................
...................................................
...................................................
...................................................
...................................................
...................................................
...................................................
...................................................
...................................................
...................................................
Notification requirements ..........
...................................................
Initial Notifications .....................
§ 63.9(b)(2)–(3) ..........................
Initial Notifications .....................
§ 63.9(b)(4)–(5) ..........................
Initial Notifications .....................
§ 63.9(c) .....................................
Request for Compliance Extension.
Notification of Special Compliance Requirements for New
Sources.
Notification of Performance
Test.
Notification of VE/Opacity Test
Additional Notifications When
Using CMS.
Additional Notifications When
Using CMS.
Notification of Compliance Status.
Adjustment of Submittal Deadlines.
Change in previous information
Electronic reporting procedures
Recordkeeping/Reporting .........
Recordkeeping/Reporting .........
Recordkeeping for startup and
shutdown.
Recordkeeping for SSM and
failures to meet standards.
Records related to maintenance of air pollution control
equipment.
Actions taken to minimize emissions during SSM.
CMS Records ...........................
Records ....................................
CMS Records ...........................
Records ....................................
Records ....................................
Records ....................................
Records ....................................
Records ....................................
Use of SSM Plan ......................
General Reporting Requirements.
Report of Performance Test
Results.
Reporting Opacity or VE Observations.
Progress Reports ......................
SSM Reports ............................
Additional CEMS Reports .........
§ 63.9(d) .....................................
§ 63.9(e) .....................................
§ 63.9(f) ......................................
§ 63.9(g)(1) ................................
§ 63.9(g)(2)–(3) ..........................
§ 63.9(h)(1)–(3) ..........................
§ 63.9(i) ......................................
§ 63.9(j) ......................................
§ 63.9(k) .....................................
§ 63.10(a) ...................................
§ 63.10(b)(1) ..............................
§ 63.10(b)(2)(i) ...........................
§ 63.10(b)(2)(ii) ..........................
§ 63.10(b)(2)(iii) .........................
khammond on DSKJM1Z7X2PROD with RULES2
§ 63.10(b)(2)(iv)–(v) ...................
§ 63.10(b)(2)(vi) .........................
§ 63.10(b)(2)(vii)–(ix) .................
§ 63.10(b)(2)(x)–(xi) ...................
§ 63.10(b)(2)(xii) ........................
§ 63.10(b)(2)(xiii) ........................
§ 63.10(b)(2)(xiv) .......................
§ 63.10(b)(3) ..............................
§ 63.10(c)(1)–(14) ......................
§ 63.10(c)(15) ............................
§ 63.10(d)(1) ..............................
§ 63.10(d)(2) ..............................
§ 63.10(d)(3) ..............................
§ 63.10(d)(4) ..............................
§ 63.10(d)(5) ..............................
§ 63.10(e)(1) ..............................
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00109
24197
Applies to subpart O
No. Performance specifications are contained in § 63.365.
No. Opacity monitors are not required for these standards.
No. Performance specifications are contained in § 63.365.
No.
Yes.
No.
Yes, but only applies for CEMS, except this subpart specifies how and
when the performance evaluation results are reported.
Yes.
Yes.
Yes.
Yes.
No. Opacity monitors are not required for these standards.
Yes.
No.
Yes.
No.
Yes.
Yes.
Yes.
No. § 63.366(c)(1)(i) contains language for facilities that increase usage
such that the source becomes subject to the emissions standards.
Yes. § 63.366(c)(3) contains additional information to be included in the initial report for existing and new facilities.
No. § 63.366(c)(1)(ii) and (iii) contains requirements for new or reconstructed facilities subject to the emissions standards.
Yes.
No.
Yes.
No. Opacity monitors are not required for these standards.
Yes.
No. Opacity monitors and relative accuracy testing are not required for
these standards.
Yes, except § 63.9(h)(5) does not apply because § 63.366(c)(2) instructs facilities to submit actual data.
Yes.
Yes.
Yes, as specified in § 63.9(j).
Yes.
Yes.
No. See 63.367(f) for recordkeeping requirements.
No. See 63.367(f) for recordkeeping requirements.
Yes.
No.
Yes.
Yes.
Yes.
Yes.
Yes.
Yes.
Yes.
Yes.
No.
Yes.
No. This subpart specifies how and when the performance test results are
reported.
No. Subpart O does not contain opacity or visible emissions standards.
Yes.
No. See § 63.366 for malfunction reporting requirements.
Yes.
Fmt 4701
Sfmt 4700
E:\FR\FM\05APR2.SGM
05APR2
24198
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
Citation
Subject
§ 63.10(e)(2)(i) ...........................
Additional CMS Reports ...........
§ 63.10(e)(2)(ii) ..........................
§ 63.10(e)(3)(i)–(iv) ....................
§ 63.10(e)(3)(v) ..........................
Additional COMS Reports ........
Reports .....................................
Excess Emissions Reports .......
§ 63.10(e)(3)(vi)–(viii) .................
Excess Emissions Report and
Summary Report.
Reporting COMS data ..............
Waiver for Recordkeeping/Reporting.
Control device requirements for
flares and work practice requirements for equipment
leaks.
Delegation .................................
Addresses .................................
Incorporation by Reference ......
Availability of Information .........
§ 63.10(e)(4) ..............................
§ 63.10(f) ....................................
§ 63.11 .......................................
§ 63.12
§ 63.13
§ 63.14
§ 63.15
.......................................
.......................................
.......................................
.......................................
Appendix A to Subpart O of Part 63—
Monitoring Provisions for EtO CEMS
khammond on DSKJM1Z7X2PROD with RULES2
1. Applicability
These monitoring provisions apply to the
measurement of EtO emissions from
commercial sterilization facilities, using
CEMS. The CEMS must be capable of
measuring EtO in lb/hr.
2. Monitoring of EtO Emissions
2.1 Monitoring System Installation
Requirements. Install EtO CEMS and any
additional monitoring systems needed to
convert pollutant concentrations to lb/hr in
accordance with § 63.365 and Performance
Specification 19 (PS 19) of appendix B to part
60 of this chapter.
2.2 Primary and Backup Monitoring
Systems. In the electronic monitoring plan
described in section 10.1.1.2.1 of this
appendix, you must designate a primary EtO
CEMS. The primary EtO CEMS must be used
to report hourly EtO concentration values
when the system is able to provide qualityassured data, i.e., when the system is ‘‘in
control’’. However, to increase data
availability in the event of a primary
monitoring system outage, you may install,
operate, maintain, and calibrate backup
monitoring systems, as follows:
2.2.1 Redundant Backup Systems. A
redundant backup monitoring system is a
separate EtO CEMS with its own probe,
sample interface, and analyzer. A redundant
backup system is one that is permanently
installed at the unit or stack location and is
kept on ‘‘hot standby’’ in case the primary
monitoring system is unable to provide
quality-assured data. A redundant backup
system must be represented as a unique
monitoring system in the electronic
monitoring plan. Each redundant backup
monitoring system must be certified
according to the applicable provisions in
section 3 of this appendix and must meet the
applicable on-going QA requirements in
section 5 of this appendix.
2.2.2 Non-redundant Backup Monitoring
Systems. A non-redundant backup
monitoring system is a separate EtO CEMS
that has been certified at a particular unit or
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
Applies to subpart O
Yes, except this subpart specifies how and when the performance evaluation results are reported.
No. Opacity monitors are not required for these standards.
Yes.
No. § 63.366(b) and (c) specify contents and submittal dates for excess
emissions and monitoring system performance reports.
Yes.
No. Opacity monitors are not required for these standards.
Yes.
Yes.
Yes.
Yes.
Yes.
Yes.
stack location but is not permanently
installed at that location. Rather, the system
is kept on ‘‘cold standby’’ and may be
reinstalled in the event of a primary
monitoring system outage. A nonredundant
backup monitoring system must be
represented as a unique monitoring system in
the electronic monitoring plan. Nonredundant backup EtO CEMS must complete
the same certification tests as the primary
monitoring system, with one exception. The
7-day calibration error test is not required for
a non-redundant backup EtO CEMS. Except
as otherwise provided in section 2.2.4.4 of
this appendix, a non-redundant backup
monitoring system may only be used for 720
hours per year at a particular unit or stack
location.
2.2.3 Temporary Like-kind Replacement
Analyzers. When a primary EtO analyzer
needs repair or maintenance, you may
temporarily install a like-kind replacement
analyzer, to minimize data loss. Except as
otherwise provided in section 2.2.4.4 of this
appendix, a temporary like-kind replacement
analyzer may only be used for 720 hours per
year at a particular unit or stack location. The
analyzer must be represented as a component
of the primary EtO CEMS and must be
assigned a 3-character component ID number,
beginning with the prefix ‘‘LK’’.
2.2.4 Quality Assurance Requirements for
Non-redundant Backup Monitoring Systems
and Temporary Like-kind Replacement
Analyzers. To quality-assure the data from
non-redundant backup EtO monitoring
systems and temporary like-kind replacement
EtO analyzers, the following provisions
apply:
2.2.4.1 When a certified non-redundant
backup EtO CEMS or a temporary like-kind
replacement EtO analyzer is brought into
service, a calibration error test and a linearity
check must be performed and passed. A
single point system integrity check is also
required.
2.2.4.2 Each non-redundant backup EtO
CEMS or temporary like-kind replacement
EtO analyzer shall comply with all required
daily, weekly, and quarterly qualityassurance test requirements in section 5 of
this appendix, for as long as the system or
analyzer remains in service.
PO 00000
Frm 00110
Fmt 4701
Sfmt 4700
2.2.4.3 For the routine, on-going qualityassurance of a non-redundant backup EtO
monitoring system, a relative accuracy test
audit (RATA) must be performed and passed
at least once every 8 calendar quarters at the
unit or stack location(s) where the system
will be used.
2.2.4.4 To use a non-redundant backup
EtO monitoring system or a temporary likekind replacement analyzer for more than 720
hours per year at a particular unit or stack
location, a RATA must first be performed and
passed at that location.
2.3 Monitoring System Equipment,
Supplies, Definitions, and General
Operation.
The following provisions apply:
2.3.1 PS 19, Sections 3.0, 6.0, and 11.0 of
appendix B to part 60 of this chapter.
3. Initial Certification Procedures
The initial certification procedures for the
EtO CEMS used to provide data under this
subpart are as follows:
3.1 Your EtO CEMS must be certified
according to PS 19, section(s) 13.
3.2 Any additional stack gas flow rate
monitoring system(s) needed to express
pollutant concentrations in lb/hr must be
certified according to part 75 of this chapter.
4. Recertification Procedures
Whenever the owner or operator makes a
replacement, modification, or change to a
certified CEMS that may significantly affect
the ability of the system to accurately
measure or record pollutant gas
concentrations or stack gas flow rates, the
owner or operator shall recertify the
monitoring system. Furthermore, whenever
the owner or operator makes a replacement,
modification, or change to the flue gas
handling system or the unit operation that
may significantly change the concentration or
flow profile, the owner or operator shall
recertify the monitoring system. The same
tests performed for the initial certification of
the monitoring system shall be repeated for
recertification, unless otherwise specified by
the Administrator. Examples of changes that
require recertification include: Replacement
of a gas analyzer; complete monitoring
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
system replacement, and changing the
location or orientation of the sampling probe.
5. On-Going Quality Assurance
Requirements
On-going QA test requirements for EtO
CEMS must be implemented as follows:
5.1 The quality assurance/quality control
procedures in Procedure 7 of appendix F to
part 60 of this chapter shall apply.
5.2 Stack gas flow rate, diluent gas, and
moisture monitoring systems must meet the
applicable ongoing QA test requirements of
part 75 of this chapter.
5.2.1 Out-of-Control Periods. A EtO
CEMS that is used to provide data under this
appendix is considered to be out-of-control,
and data from the CEMS may not be reported
as quality-assured, when any acceptance
criteria for a required QA test is not met. The
EtO CEMS is also considered to be out-ofcontrol when a required QA test is not
performed on schedule or within an allotted
grace period. To end an out-of-control period,
the QA test that was either failed or not done
on time must be performed and passed. Outof-control periods are counted as hours of
monitoring system downtime.
5.2.2 Grace Periods. For the purposes of
this appendix, a ‘‘grace period’’ is defined as
a specified number of unit or stack operating
hours after the deadline for a required
quality-assurance test of a continuous
monitor has passed, in which the test may be
performed and passed without loss of data.
5.2.2.1 For the flow rate monitoring
systems described in section 5.1 of this
appendix, a 168 unit or stack operating hour
grace period is available for quarterly
linearity checks, and a 720 unit or stack
operating hour grace period is available for
RATAs, as provided, respectively, in sections
2.2.4 and 2.3.3 of appendix B to part 75 of
this chapter.
5.2.2.2 For the purposes of this appendix,
if the deadline for a required gas audit or
RATA of a EtO CEMS cannot be met due to
circumstances beyond the control of the
owner or operator:
5.2.2.2.1 A 168 unit or stack operating
hour grace period is available in which to
perform the gas audit; or
5.2.2.2.2 A 720 unit or stack operating
hour grace period is available in which to
perform the RATA.
5.2.2.3 If a required QA test is performed
during a grace period, the deadline for the
next test shall be determined as follows:
5.2.2.3.1 For the gas audit of an EtO
CEMS, the grace period test only satisfies the
audit requirement for the calendar quarter in
which the test was originally due. If the
calendar quarter in which the grace period
audit is performed is a QA operating quarter,
an additional gas audit is required for that
quarter.
5.2.2.3.2 For the RATA of an EtO CEMS,
the next RATA is due within three QA
operating quarters after the calendar quarter
in which the grace period test is performed.
5.2.3 Conditional Data Validation. For
recertification and diagnostic testing of the
monitoring systems that are used to provide
data under this appendix, and for the
required QA tests when nonredundant
backup monitoring systems or temporary
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
like-kind replacement analyzers are brought
into service, the conditional data validation
provisions in §§ 75.20(b)(3)(ii) through
(b)(3)(ix) of this chapter may be used to avoid
or minimize data loss. The allotted window
of time to complete calibration tests and
RATAs shall be as specified in
§ 75.20(b)(3)(iv) of this chapter; the allotted
window of time to complete a gas audit shall
be the same as for a linearity check (i.e., 168
unit or stack operating hours).
5.3 Data Validation.
5.3.1 Out-of-Control Periods. An EtO
CEMS that is used to provide data under this
appendix is considered to be out-of-control,
and data from the CEMS may not be reported
as quality-assured, when any acceptance
criteria for a required QA test is not met. The
EtO CEMS is also considered to be out-ofcontrol when a required QA test is not
performed on schedule or within an allotted
grace period. To end an out-of-control period,
the QA test that was either failed or not done
on time must be performed and passed. Outof-control periods are counted as hours of
monitoring system downtime.
5.3.2 Grace Periods. For the purposes of
this appendix, a ‘‘grace period’’ is defined as
a specified number of unit or stack operating
hours after the deadline for a required
quality-assurance test of a continuous
monitor has passed, in which the test may be
performed and passed without loss of data.
5.3.2.1 For the monitoring systems
described in section 5.1 of this appendix, a
168 unit or stack operating hour grace period
is available for quarterly linearity checks, and
a 720 unit or stack operating hour grace
period is available for RATAs, as provided,
respectively, in sections 2.2.4 and 2.3.3 of
appendix B to part 75 of this chapter.
5.3.2.2 For the purposes of this appendix,
if the deadline for a required gas audit/data
accuracy assessment or RATA of an EtO
CEMS cannot be met due to circumstances
beyond the control of the owner or operator:
5.3.2.2.1 A 168 unit or stack operating
hour grace period is available in which to
perform the gas audit or other quarterly data
accuracy assessment; or
5.3.2.2.2 A 720 unit or stack operating
hour grace period is available in which to
perform the RATA.
5.3.2.3 If a required QA test is performed
during a grace period, the deadline for the
next test shall be determined as follows:
5.3.2.3.1 For a gas audit or RATA of the
monitoring systems described in sections 5.1
and 5.2 of this appendix, determine the
deadline for the next gas audit or RATA (as
applicable) in accordance with section
2.2.4(b) or 2.3.3(d) of appendix B to part 75
of this chapter; treat a gas audit in the same
manner as a linearity check.
5.3.2.3.2 For the gas audit or other
quarterly data accuracy assessment of an EtO
CEMS, the grace period test only satisfies the
audit requirement for the calendar quarter in
which the test was originally due. If the
calendar quarter in which the grace period
audit is performed is a QA operating quarter,
an additional gas audit/data accuracy
assessment is required for that quarter.
5.3.2.3.3 For the RATA of an EtO CEMS,
the next RATA is due within three QA
operating quarters after the calendar quarter
in which the grace period test is performed.
PO 00000
Frm 00111
Fmt 4701
Sfmt 4700
24199
5.3.3 Conditional Data Validation. For
recertification and diagnostic testing of the
monitoring systems that are used to provide
data under this appendix, the conditional
data validation provisions in § 75.20(b)(3)(ii)
through (ix) of this chapter may be used to
avoid or minimize data loss. The allotted
window of time to complete calibration tests
and RATAs shall be as specified in
§ 75.20(b)(3)(iv) of this chapter; the allotted
window of time to complete a quarterly gas
audit or data accuracy assessment shall be
the same as for a linearity check (i.e., 168
unit or stack operating hours).
6. Missing Data Requirements
For the purposes of this appendix, the
owner or operator of an affected unit shall
not substitute for missing data from EtO
CEMS. Any process operating hour for which
quality-assured EtO concentration data are
not obtained is counted as an hour of
monitoring system downtime.
7. Bias Adjustment
Bias adjustment of hourly emissions data
from an EtO CEMS is not required.
8. QA/QC Program Requirements
The owner or operator shall develop and
implement a quality assurance/quality
control (QA/QC) program for the EtO CEMS
that are used to provide data under this
subpart. At a minimum, the program shall
include a written plan that describes in detail
(or that refers to separate documents
containing) complete, step-by-step
procedures and operations for the most
important QA/QC activities. Electronic
storage of the QA/QC plan is permissible,
provided that the information can be made
available in hard copy to auditors and
inspectors. The QA/QC program
requirements for the other monitoring
systems described in section 5.2 of this
appendix are specified in section 1 of
appendix B to part 75 of this chapter.
8.1 General Requirements for EtO CEMS.
8.1.1 Preventive Maintenance. Keep a
written record of procedures needed to
maintain the EtO CEMS in proper operating
condition and a schedule for those
procedures. This shall, at a minimum,
include procedures specified by the
manufacturers of the equipment and, if
applicable, additional or alternate procedures
developed for the equipment.
8.1.2 Recordkeeping and Reporting. Keep
a written record describing procedures that
will be used to implement the recordkeeping
and reporting requirements of this appendix.
8.1.3 Maintenance Records. Keep a
record of all testing, maintenance, or repair
activities performed on any EtO CEMS in a
location and format suitable for inspection. A
maintenance log may be used for this
purpose. The following records should be
maintained: Date, time, and description of
any testing, adjustment, repair, replacement,
or preventive maintenance action performed
on any monitoring system and records of any
corrective actions associated with a monitor
outage period. Additionally, any adjustment
that may significantly affect a system’s ability
to accurately measure emissions data must be
recorded and a written explanation of the
E:\FR\FM\05APR2.SGM
05APR2
24200
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
procedures used to make the adjustment(s)
shall be kept.
8.2 Specific Requirements for EtO CEMS.
The following requirements are specific to
EtO CEMS:
8.2.1 Keep a written record of the
procedures used for each type of QA test
required for each EtO CEMS. Explain how
the results of each type of QA test are
calculated and evaluated.
8.2.2 Explain how each component of the
EtO CEMS will be adjusted to provide correct
responses to calibration gases after routine
maintenance, repairs, or corrective actions.
9. Data Reduction and Calculations
9.1 Design and operate the EtO CEMS to
complete a minimum of one cycle of
operation (sampling, analyzing, and data
recording) for each successive 15-minute
period.
9.2 Reduce the EtO concentration data to
hourly averages in accordance with
§ 60.13(h)(2) of this chapter.
9.3 Convert each hourly average EtO
concentration to an EtO mass emission rate
(lb/hr) using an equation that has the general
form of equation A–1 of this appendix:
(Eq. A-1)
Where:
Eho = EtO mass emission rate for the hour, lb/
hr
K = Units conversion constant, 1.144E–10 lb/
scf-ppbv,
Ch = Hourly average EtO concentration,
ppbv,
any affected source exhausting to the
emission stream (e.g., if the emission stream
includes contributions from an SCV and ARV
subject to 99.99% and 99.9% emission
reduction standards, respectively, report to
four significant figures), expressed in
scientific notation.
Qh = Stack gas volumetric flow rate for the
hour, scfh.
(Note: Use unadjusted flow rate values;
bias adjustment is not required.)
9.4 Use equation A–2 of this appendix to
calculate the daily total EtO emissions.
Report each daily total to the same precision
as the most stringent standard that applies to
Equation A-2
Where:
Eday = Total daily EtO emissions, lb.
Eho = Hourly EtO emission rate for unit or
stack sampling hour ‘‘h’’ in the averaging
period, from equation A–1 of this appendix,
lb/hr.
9.5 Use equation A–3 of this appendix to
calculate the 30-operating day rolling total
EtO emissions. Report each 30-operating day
rolling total to the same precision as the most
stringent standard that applies to any affected
source exhausting to the emission stream
(e.g., if the emission stream includes
contributions from an SCV and ARV subject
to 99.99% and 99.9% emission reduction
standards, respectively, report to four
significant figures), expressed in scientific
notation.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
PO 00000
Frm 00112
Fmt 4701
Sfmt 4700
and component ID numbers; the make,
model, and serial number of the monitoring
equipment; the sample acquisition method;
formulas used to calculate emissions;
monitor span and range information (if
applicable).
10.1.1.2.2 Hard Copy. Keep records of the
following: schematics and/or blueprints
showing the location of the monitoring
system(s) and test ports; data flow diagrams;
test protocols; monitor span and range
calculations (if applicable); miscellaneous
technical justifications.
10.1.2 EtO Emissions Records. For EtO
CEMS, the owner or operator must record the
following information for each unit or stack
operating hour:
10.1.2.1 The date and hour;
10.1.2.2 Monitoring system and
component identification codes, as provided
in the electronic monitoring plan, for each
hour in which the CEMS provides a qualityassured value of EtO concentration (as
applicable);
10.1.2.3 The pollutant concentration, for
each hour in which a quality-assured value
is obtained. Record the data in parts per
billion by volume (ppbv), with one leading
non-zero digit and one decimal place,
expressed in scientific notation. Use the
following rounding convention: If the digit
immediately following the first decimal place
E:\FR\FM\05APR2.SGM
05APR2
ER05AP24.046
10. Recordkeeping Requirements
10.1 For each EtO CEMS installed at an
affected source, and for any other monitoring
system(s) needed to convert pollutant
concentrations to units of the applicable
emissions limit, the owner or operator must
maintain a file of all measurements, data,
reports, and other information required by
this appendix in a form suitable for
inspection, for 5 years from the date of each
record, in accordance with § 63.367. The file
shall contain the information in paragraphs
10.1.1 through 10.1.8 of this section.
10.1.1 Monitoring Plan Records. For each
affected source or group of sources monitored
at a common stack, the owner or operator
shall prepare and maintain a monitoring plan
for the EtO CEMS and any other monitoring
system(s) (i.e., flow rate, diluent gas, or
moisture systems) needed to convert
pollutant concentrations to units of the
applicable emission standard. The
monitoring plan shall contain essential
information on the continuous monitoring
systems and shall explain how the data
derived from these systems ensure that all
EtO emissions from the unit or stack are
monitored and reported.
10.1.1.1 Updates. Whenever the owner or
operator makes a replacement, modification,
or change in a certified continuous EtO
monitoring system that is used to provide
data under this subpart (including a change
in the automated data acquisition and
handling system or the flue gas handling
system) which affects information reported in
the monitoring plan (e.g., a change to a serial
number for a component of a monitoring
system), the owner or operator shall update
the monitoring plan.
10.1.1.2 Contents of the Monitoring Plan.
For EtO CEMS, the monitoring plan shall
contain the applicable electronic and hard
copy information in sections 10.1.1.2.1 and
10.1.1.2.2 of this appendix. For stack gas flow
rate, diluent gas, and moisture monitoring
systems, the monitoring plan shall include
the electronic and hard copy information
required for those systems under § 75.53(g) of
this chapter. The electronic monitoring plan
shall be evaluated using CEDRI.
10.1.1.2.1 Electronic. Record the unit or
stack ID number(s); monitoring location(s);
the EtO monitoring methodology used (i.e.,
CEMS); EtO monitoring system information,
including, but not limited to: unique system
ER05AP24.045
khammond on DSKJM1Z7X2PROD with RULES2
Where:
E30day = Total EtO emissions during the 30operating day, lb.
Eday,i = Total daily EtO emissions, in lbs,
for each operating day i from equation A–2
of this appendix, lb.
i = Operating day index.
ER05AP24.047
Equation A-3
khammond on DSKJM1Z7X2PROD with RULES2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
is 5 or greater, round the first decimal place
upward (increase it by one); if the digit
immediately following the first decimal place
is 4 or less, leave the first decimal place
unchanged.
10.1.2.4 A special code, indicating
whether or not a quality-assured EtO
concentration value is obtained for the hour.
This code may be entered manually when a
temporary like-kind replacement EtO
analyzer is used for reporting; and
10.1.2.5 Monitor data availability, as a
percentage of unit or stack operating hours,
calculated according to § 75.32 of this
chapter.
10.1.3 Stack Gas Volumetric Flow Rate
Records.
10.1.3.1 Hourly measurements of stack
gas volumetric flow rate during unit
operation are required to demonstrate
compliance with EtO emission standards.
10.1.3.2 Use a flow rate monitor that
meets the requirements of part 75 of this
chapter to record the required data. You must
keep hourly flow rate records, as specified in
§ 75.57(c)(2) of this chapter.
10.1.4 EtO Emission Rate Records.
Record the following information for each
affected unit or common stack:
10.1.4.1 The date and hour;
10.1.4.2 The hourly EtO emissions rate
(lb/hr), for each hour in which valid values
of EtO concentration and stack gas
volumetric flow rate are obtained for the
hour. Report each emission rate to the same
precision as the most stringent standard that
applies to any affected source exhausting to
the emission stream (e.g., if the emission
stream includes contributions from an SCV
and ARV subject to 99.99% and 99.9%
emission reduction standards, respectively,
report to four significant figures), expressed
in scientific notation. Use the following
rounding convention: If the digit
immediately following the first decimal place
is 5 or greater, round the first decimal place
upward (increase it by one); if the digit
immediately following the first decimal place
is 4 or less, leave the first decimal place
unchanged;
10.1.4.4 A code indicating that the EtO
emission rate was not calculated for the hour,
if valid data for EtO concentration and/or any
of the other necessary parameters are not
obtained for the hour. For the purposes of
this appendix, the substitute data values
required under part 75 of this chapter for
stack gas flow rate are not considered to be
valid data.
10.1.5 Certification and Quality
Assurance Test Records. For the EtO CEMS
used to provide data under this subpart at
each affected unit (or group of units
monitored at a common stack), record the
following information for all required
certification, recertification, diagnostic, and
quality-assurance tests:
10.1.5.1 EtO CEMS.
10.1.5.1.1 For each required 7-day and
daily calibration drift (CD) test or daily
calibration error test (including daily
calibration transfer standard tests) of the EtO
CEMS, record the test date(s) and time(s),
reference gas value(s), monitor response(s),
and calculated calibration drift or calibration
error value(s). If you use the dynamic spiking
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
option for the mid-level calibration drift
check under PS 19, you must also record the
measured concentration of the native EtO in
the flue gas before and after the spike and the
spiked gas dilution factor.
10.1.5.1.2 or each required RATA of an
EtO CEMS, record the beginning and ending
date and time of each test run, the reference
method(s) used, and the reference method
and EtO CEMS run values. Keep records of
stratification tests performed (if any), all of
the raw field data, relevant process operating
data, and all of the calculations used to
determine the relative accuracy.
10.1.5.1.3 For each required measurement
error (ME) test of an EtO monitor, record the
date and time of each gas injection, the
reference gas concentration (low, mid, or
high) and the monitor response for each of
the three injections at each of the three
levels. Also record the average monitor
response and the ME at each gas level and
the related calculations.
10.1.5.1.4 For each required level of
detection (LOD) test of an EtO monitor
performed in a controlled environment,
record the test date, the concentrations of the
reference gas and interference gases, the
results of the seven (or more) consecutive
measurements of EtO, the standard deviation,
and the LOD value. For each required LOD
test performed in the field, record the test
date, the three measurements of the native
source EtO concentration, the results of the
three independent standard addition (SA)
measurements known as standard addition
response (SAR), the effective spike addition
gas concentration, the resulting standard
addition detection level (SADL) value and all
related calculations. For extractive CEMS
performing the SA using dynamic spiking,
you must record the spiked gas dilution
factor.
10.1.5.1.5 For each required ME/level of
detection response time test of an EtO
monitor, record the test date, the native EtO
concentration of the flue gas, the reference
gas value, the stable reference gas readings,
the upscale/downscale start and end times,
and the results of the upscale and downscale
stages of the test.
10.1.5.1.6 For each required interference
test of an EtO monitor, record (or obtain from
the analyzer manufacturer records of): The
date of the test; the gas volume/rate,
temperature, and pressure used to conduct
the test; the EtO concentration of the
reference gas used; the concentrations of the
interference test gases; the baseline EtO
responses for each interferent combination
spiked; and the total percent interference as
a function of span or EtO concentration.
10.1.5.1.7 For each quarterly relative
accuracy audit (RAA) of an EtO monitor,
record the beginning and ending date and
time of each test run, the reference method
used, the EtO concentrations measured by
the reference method and CEMS for each test
run, the average concentrations measured by
the reference method and the CEMS, and the
calculated relative accuracy. Keep records of
the raw field data, relevant process operating
data, and the calculations used to determine
the relative accuracy.
10.1.5.1.8 For each quarterly cylinder gas
audit (CGA) of an EtO monitor, record the
PO 00000
Frm 00113
Fmt 4701
Sfmt 4700
24201
date and time of each injection, and the
reference gas concentration (zero, mid, or
high) and the monitor response for each
injection. Also record the average monitor
response and the calculated ME at each gas
level.
10.1.5.1.9 For each quarterly dynamic
spiking audit (DSA) of an EtO monitor,
record the date and time of the zero gas
injection and each spike injection, the results
of the zero gas injection, the gas
concentrations (mid and high) and the
dilution factors and the monitor response for
each of the six upscale injections as well as
the corresponding native EtO concentrations
measured before and after each injection.
Also record the average dynamic spiking
error for each of the upscale gases, the
calculated average DSA Accuracy at each
upscale gas concentration, and all
calculations leading to the DSA Accuracy.
10.1.5.2 Additional Monitoring Systems.
For the stack gas flow rate monitoring
systems described in section 3.2 of this
appendix, you must keep records of all
certification, recertification, diagnostic, and
on-going quality-assurance tests of these
systems, as specified in § 75.59(a) of this
chapter.
11. Reporting Requirements
11.1 General Reporting Provisions. The
owner or operator shall comply with the
following requirements for reporting EtO
emissions from each affected unit (or group
of units monitored at a common stack):
11.1.1 Notifications, in accordance with
paragraph 11.2 of this section;
11.1.2 Monitoring plan reporting, in
accordance with paragraph 11.3 of this
section;
11.1.3 Certification, recertification, and
QA test submittals, in accordance with
paragraph 11.4 of this section; and
11.1.4 Electronic quarterly report
submittals, in accordance with paragraph
11.5 of this section.
11.2 Notifications. The owner or operator
shall provide notifications for each affected
unit (or group of units monitored at a
common stack) in accordance with § 63.366.
11.3 Monitoring Plan Reporting. For each
affected unit (or group of units monitored at
a common stack) using EtO CEMS, the owner
or operator shall make electronic and hard
copy monitoring plan submittals as follows:
11.3.1 For a sterilization facility that
begins reporting hourly EtO concentrations
with a previously certified CEMS, submit the
monitoring plan information in section
10.1.1.2 of this appendix prior to or
concurrent with the first required quarterly
emissions report. For a new sterilization
facility, submit the information in section
10.1.1.2 of this appendix at least 21 days
prior to the start of initial certification testing
of the CEMS. Also submit the monitoring
plan information in § 75.53(g) of this chapter
pertaining to any required flow rate
monitoring systems within the applicable
timeframe specified in this section, if the
required records are not already in place.
11.3.2 Update the monitoring plan when
required, as provided in paragraph 10.1.1.1 of
this appendix. An electronic monitoring plan
information update must be submitted either
E:\FR\FM\05APR2.SGM
05APR2
khammond on DSKJM1Z7X2PROD with RULES2
24202
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
prior to or concurrent with the quarterly
report for the calendar quarter in which the
update is required.
11.3.3 All electronic monitoring plan
submittals and updates shall be made to the
Administrator using CEDRI. Hard copy
portions of the monitoring plan shall be kept
on record according to section 10.1 of this
appendix.
11.4 Certification, Recertification, and
Quality-Assurance Test Reporting
Requirements. Use CEDRI to submit the
results of all required certification,
recertification, quality-assurance, and
diagnostic tests of the monitoring systems
required under this appendix electronically.
Submit the test results concurrent with the
quarterly electronic emissions report.
However, for RATAs of the EtO monitor, if
this is not possible, you have up to 60 days
after the test completion date to submit the
test results; in this case, you may claim
provisional status for the emissions data
affected by the test, starting from the date and
hour in which the test was completed and
continuing until the date and hour in which
the test results are submitted. If the test is
successful, the status of the data in that time
period changes from provisional to qualityassured, and no further action is required.
However, if the test is unsuccessful, the
provisional data must be invalidated and
resubmission of the affected emission
report(s) is required.
11.4.1 For each daily CD (or calibration
error) assessment (including daily calibration
transfer standard tests), and for each sevenday calibration drift (CD) test of an EtO
monitor, report:
11.4.1.1 Facility ID information;
11.4.1.2 The monitoring component ID;
11.4.1.3 The instrument span and span
scale;
11.4.1.4 For each gas injection, the date
and time, the calibration gas level (zero or
high-level), the reference gas value (ppbv),
and the monitor response (ppbv);
11.4.1.5 A flag to indicate whether
dynamic spiking was used for the high-level
value;
11.4.1.6 Calibration drift (percent of span
or reference gas, as applicable);
11.4.1.7 When using the dynamic spiking
option, the measured concentration of native
EtO before and after each mid-level spike and
the spiked gas dilution factor; and
11.4.1.8 Reason for test.
11.4.2 For each RATA of an EtO CEMS,
report:
11.4.2.1 Facility ID information;
11.4.2.2 Monitoring system ID number;
11.4.2.3 Type of test (i.e., initial or annual
RATA);
11.4.2.4 Reason for test;
11.4.2.5 The reference method used;
11.4.2.6 Starting and ending date and
time for each test run;
11.4.2.7 Units of measure;
11.4.2.8 The measured reference method
and CEMS values for each test run, on a
consistent moisture basis, in appropriate
units of measure;
11.4.2.9 Flags to indicate which test runs
were used in the calculations;
11.4.2.10 Arithmetic mean of the CEMS
values, of the reference method values, and
of their differences;
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
11.4.2.11 Standard deviation, using
equation 7 in section 12.6 of PS 19 in
appendix B to part 60 of this chapter;
11.4.2.12 Confidence coefficient, using
equation 8 in section 12.6 of PS 19 in
appendix B to part 60 of this chapter;
11.4.2.13 t-value; and
11.4.2.14 Relative accuracy calculated
using equation 11 in section 12.6 of PS 19 in
appendix B to part 60 of this chapter.
11.4.3 For each measurement error (ME)
test of an EtO monitor, report:
11.4.3.1 Facility ID information;
11.4.3.2 Monitoring component ID;
11.4.3.3 Instrument span and span scale;
11.4.3.4 For each gas injection, the date
and time, the calibration gas level (zero, low,
mid, or high), the reference gas value in ppbv
and the monitor response.
11.4.3.5 For extractive CEMS, the mean
reference value and mean of measured values
at each reference gas level (ppbv).
11.4.3.6 ME at each reference gas level;
and
11.4.3.7 Reason for test.
11.4.4 For each interference test of an EtO
monitoring system, report:
11.4.4.1 Facility ID information;
11.4.4.2 Date of test;
11.4.4.3 Monitoring system ID;
11.4.4.4 Results of the test (pass or fail);
11.4.4.5 Reason for test; and
11.4.4.6 A flag to indicate whether the
test was performed: On this particular
monitoring system; on one of multiple
systems of the same type; or by the
manufacturer on a system with components
of the same make and model(s) as this
system.
11.4.5 For each LOD test of an EtO
monitor, report:
11.4.5.1 Facility ID information;
11.4.5.2 Date of test;
11.4.5.3 Reason for test;
11.4.5.4 Monitoring system ID;
11.4.5.5 A code to indicate whether the
test was done in a controlled environment or
in the field;
11.4.5.6 EtO reference gas concentration;
11.4.5.7 EtO responses with interference
gas (seven repetitions);
11.4.5.8 Standard deviation of EtO
responses;
11.4.5.9 Effective spike addition gas
concentrations;
11.4.5.10 EtO concentration measured
without spike;
11.4.5.11 EtO concentration measured
with spike;
11.4.5.12 Dilution factor for spike;
11.4.5.13 The controlled environment
LOD value (ppbv or ppbv-meters);
11.4.5.14 The field determined standard
addition detection level (SADL in ppbv or
ppbv-meters); and
11.4.5.15 Result of LOD/SADL test (pass/
fail).
11.4.6 For each ME or LOD response time
test of an EtO monitor, report:
11.4.6.1 Facility ID information;
11.4.6.2 Date of test;
11.4.6.3 Monitoring component ID;
11.4.6.4 The higher of the upscale or
downscale tests, in minutes; and
11.4.6.5 Reason for test.
11.4.7 For each quarterly RAA of an EtO
monitor, report:
PO 00000
Frm 00114
Fmt 4701
Sfmt 4700
11.4.7.1 Facility ID information;
11.4.7.2 Monitoring system ID;
11.4.7.3 Begin and end time of each test
run;
11.4.7.4 The reference method used;
11.4.7.5 The reference method and CEMS
values for each test run, including the units
of measure;
11.4.7.6 The mean reference method and
CEMS values for the three test runs;
11.4.7.7 The calculated relative accuracy,
percent; and
11.4.7.8 Reason for test.
11.4.8 For each quarterly cylinder gas
audit of an EtO monitor, report:
11.4.8.1 Facility ID information;
11.4.8.2 Monitoring component ID;
11.4.8.3 Instrument span and span scale;
11.4.8.4 For each gas injection, the date
and time, the reference gas level (zero, mid,
or high), the reference gas value in ppbv, and
the monitor response.
11.4.8.5 For extractive CEMS, the mean
reference gas value and mean monitor
response at each reference gas level (ppbv).
11.4.8.6 ME at each reference gas level;
and
11.4.8.7 Reason for test.
11.4.9 For each quarterly DSA of an EtO
monitor, report:
11.4.9.1 Facility ID information;
11.4.9.2 Monitoring component ID;
11.4.9.3 Instrument span and span scale;
11.4.9.4 For the zero gas injection, the
date and time, and the monitor response
(Note: The zero gas injection from a
calibration drift check performed on the same
day as the upscale spikes may be used for
this purpose.);
11.4.9.5 Zero spike error;
11.4.9.6 For the upscale gas spiking, the
date and time of each spike, the reference gas
level (mid- or high-), the reference gas value
(ppbv), the dilution factor, the native EtO
concentrations before and after each spike,
and the monitor response for each gas spike;
11.4.9.7 Upscale spike error;
11.4.9.8 DSA at the zero level and at each
upscale gas level; and
11.4.9.9 Reason for test.
11.4.10 Reporting Requirements for
Diluent Gas, Flow Rate, and Moisture
Monitoring Systems. For the certification,
recertification, diagnostic, and QA tests of
stack gas flow rate, moisture, and diluent gas
monitoring systems that are certified and
quality-assured according to part 75 of this
chapter, report the information in section
10.1.8.2 of this appendix.
11.5 Quarterly Reports.
11.5.1 The owner or operator of any
affected unit shall use CEDRI to submit
electronic quarterly reports to the
Administrator in an XML format specified by
the Administrator, for each affected unit (or
group of units monitored at a common stack).
If the certified EtO CEMS is used for the
initial compliance demonstration, EtO
emissions reporting shall begin with the first
operating hour of the 30-operating day
compliance demonstration period.
Otherwise, EtO emissions reporting shall
begin with the first operating hour after
successfully completing all required
certification tests of the CEMS.
11.5.2 The electronic reports must be
submitted within 30 days following the end
E:\FR\FM\05APR2.SGM
05APR2
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES2
of each calendar quarter, except for units that
have been placed in long-term cold storage.
11.5.3 Each electronic quarterly report
shall include the following information:
11.5.3.1 The date of report generation;
11.5.3.2 Facility identification
information;
11.5.3.3 The information in sections
10.1.2 through 10.1.4 of this appendix, as
applicable to the type(s) of monitoring
system(s) used to measure the pollutant
concentrations and other necessary
parameters.
VerDate Sep<11>2014
17:02 Apr 04, 2024
Jkt 262001
11.5.3.4 The results of all daily
calibrations (including calibration transfer
standard tests) of the EtO monitor as
described in section 10.1.8.1.1 of this
appendix; and
11.5.3.5 If applicable, the results of all
daily flow monitor interference checks, in
accordance with section 10.1.8.2 of this
appendix.
11.5.4 Compliance Certification. Based
on reasonable inquiry of those persons with
primary responsibility for ensuring that all
EtO emissions from the affected unit(s) have
PO 00000
Frm 00115
Fmt 4701
Sfmt 9990
24203
been correctly and fully monitored, the
owner or operator shall submit a compliance
certification in support of each electronic
quarterly emissions monitoring report. The
compliance certification shall include a
statement by a responsible official with that
official’s name, title, and signature, certifying
that, to the best of his or her knowledge, the
report is true, accurate, and complete.
[FR Doc. 2024–05905 Filed 4–4–24; 8:45 am]
BILLING CODE 6560–50–P
E:\FR\FM\05APR2.SGM
05APR2
Agencies
[Federal Register Volume 89, Number 67 (Friday, April 5, 2024)]
[Rules and Regulations]
[Pages 24090-24203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05905]
[[Page 24089]]
Vol. 89
Friday,
No. 67
April 5, 2024
Part II
Environmental Protection Agency
-----------------------------------------------------------------------
40 CFR Parts 60 and 63
National Emission Standards for Hazardous Air Pollutants: Ethylene
Oxide Emissions Standards for Sterilization Facilities Residual Risk
and Technology Review; Final Rule
Federal Register / Vol. 89 , No. 67 / Friday, April 5, 2024 / Rules
and Regulations
[[Page 24090]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Parts 60 and 63
[EPA-HQ-OAR-2019-0178; FRL-7055-02-OAR]
RIN 2060-AU37
National Emission Standards for Hazardous Air Pollutants:
Ethylene Oxide Emissions Standards for Sterilization Facilities
Residual Risk and Technology Review
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This action finalizes the residual risk and technology review
(RTR) conducted for the Commercial Sterilization Facilities source
category regulated under national emission standards for hazardous air
pollutants (NESHAP) under the Clean Air Act. The EPA is finalizing
decisions concerning the RTR, including definitions for affected
sources, emission standards for previously unregulated sources,
amendments pursuant to the risk review to address ethylene oxide (EtO)
emissions from certain sterilization chamber vents (SCVs), aeration
room vents (ARVs), chamber exhaust vents (CEVs), and room air
emissions, and amendments pursuant to the technology review for certain
SCVs and ARVs. In addition, we are taking final action to correct and
clarify regulatory provisions related to emissions during periods of
startup, shutdown, and malfunction (SSM), including removing exemptions
for periods of SSM. We are also taking final action to require owners
and operators to demonstrate compliance through the use of EtO
continuous emissions monitoring systems (CEMS), with exceptions for
very small users of EtO; add provisions for electronic reporting of
performance test results and other reports; and include other technical
revisions to improve consistency and clarity. We estimate that these
final amendments will reduce EtO emissions from this source category by
approximately 21 tons per year (tpy).
DATES: This final rule is effective on April 5, 2024. The incorporation
by reference (IBR) of certain material listed in the rule is approved
by the Director of the Federal Register April 5, 2024. The
incorporation by reference (IBR) of certain other material listed in
the rule was approved by the Director of the Federal Register before
February 27, 2021.
ADDRESSES: The U.S. Environmental Protection Agency (EPA) has
established a docket for this action under Docket ID No. EPA-HQ-OAR-
2019-0178. All documents in the docket are listed on the https://www.regulations.gov/ website. Although listed, some information is not
publicly available, e.g., Confidential Business Information or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, is not placed on the internet
and will be publicly available only in hard copy form. Publicly
available docket materials are available either electronically through
https://www.regulations.gov/, or in hard copy at the EPA Docket Center,
WJC West Building, Room Number 3334, 1301 Constitution Ave. NW,
Washington, DC. The Public Reading Room hours of operation are 8:30
a.m. to 4:30 p.m. Eastern Standard Time (EST), Monday through Friday.
The telephone number for the Public Reading Room is (202) 566-1744, and
the telephone number for the EPA Docket Center is (202) 566-1742.
FOR FURTHER INFORMATION CONTACT: For questions about this final action,
contact U.S. EPA, Attn: Jonathan Witt, Mail Drop: E143-05, 109 T.W.
Alexander Drive, P.O. Box 12055, RTP, North Carolina 27711; telephone
number: (919) 541-5645; and email address: [email protected]. For
specific information regarding the risk modeling methodology, contact
U.S. EPA, Attn: Matthew Woody, Mail Drop: C539-02, 109 T.W. Alexander
Drive, P.O. Box 12055, RTP, North Carolina 27711; telephone number:
(919) 541-1535; and email address: [email protected].
SUPPLEMENTARY INFORMATION:
Preamble acronyms and abbreviations. We use multiple acronyms and
terms in this preamble. While this list may not be exhaustive, to ease
the reading of this preamble and for reference purposes, the EPA
defines the following terms and acronyms here:
ADAF age-dependent adjustment factor
AEGL acute exposure guideline level
APCD air pollution control device
ARV aeration room vent
ASME American Society of Mechanical Engineers
BTF Beyond-the-Floor
BMP best management practice
CAA Clean Air Act
CDX Central Data Exchange
CEDRI Compliance and Emissions Data Reporting Interface
CEMS continuous emission monitoring system
CEV chamber exhaust vent
CFR Code of Federal Regulations
cfs cubic feet per second
dscfm dry standard cubic feet per minute
EJ environmental justice
EPA Environmental Protection Agency
ERT Electronic Reporting Tool
EtO ethylene oxide
FDA Food and Drug Administration
FIFRA Federal Insecticide, Fungicide, and Rodenticide Act
FR Federal Register
FRFA final regulatory flexibility analysis
FTIR Fourier Transform Infrared Spectroscopy
GACT generally available control technology
HAP hazardous air pollutants(s)
HEM Human Exposure Model
HQ hazard quotient
ICR Information Collection Request
ID Interim Decision
IFU instructions for use
IRFA initial regulatory flexibility analysis
IRIS Integrated Risk Information System
ISO International Organization for Standardization
km kilometer
lb pound
lb/h pounds per hour
LEL lower explosive limit
LPL lower prediction limit
MACT maximum achievable control technology
MIR maximum individual risk
mg/L milligrams per liter
NAICS North American Industry Classification System
NDO natural draft opening
NESHAP national emission standards for hazardous air pollutants
OMB Office of Management and Budget
OPP Office of Pesticide Programs
OSHA Occupational Safety and Health Administration
PID Proposed Interim Decision
ppbv parts per billion by volume
ppm parts per million
ppmv parts per million by volume
PTE permanent total enclosure
REL reference exposure level
RDL Representative detection level
RFA Regulatory Flexibility Act
RIA regulatory impact assessment
RTR risk and technology review
SAB Science Advisory Board
SBA Small Business Administration
SBAR Small Business Advocacy Review
SCV sterilization chamber vent
SER small entity representative
SSM startup, shutdown, and malfunction
TOSHI target organ-specific hazard index
tpy tons per year
UPL upper prediction limit
[micro]g/m\3\ micrograms per cubic meter
UMRA Unfunded Mandates Reform Act
URE unit risk estimate
VCS voluntary consensus standards
Background information. On April 13, 2023, the EPA proposed
revisions to the Commercial Sterilization Facilities NESHAP based on
our RTR. In this action, we are finalizing decisions and revisions for
the rule. We summarize some of the more significant comments we timely
received regarding the proposed rule and provide our responses in this
preamble. A summary of all other public comments on the proposal and
the EPA's responses to
[[Page 24091]]
those comments is available in Summary of Public Comments and Responses
for the Risk and Technology Review for Commercial Sterilization
Facilities, Docket ID No. EPA-HQ-OAR-2019-0178. A ``track changes''
version of the regulatory language that incorporates the changes in
this action is available in the docket.
Organization of this document. The information in this preamble is
organized as follows:
I. General Information
A. Executive Summary
B. Does this action apply to me?
C. Where can I get a copy of this document and other related
information?
D. Judicial Review and Administrative Reconsideration
II. Background
A. What is the statutory authority for this action?
B. What is the Commercial Sterilization Facilities source
category and how does the NESHAP regulate HAP emissions from the
source category?
C. What changes did we propose for the Commercial Sterilization
Facilities source category in our April 13, 2023, RTR proposal?
III. What is included in this final rule?
A. What are the final rule amendments addressing the affected
source definitions?
B. What are the final rule amendments pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) for the Commercial Sterilization
Facilities source category?
C. What are the final rule amendments based on the risk review
for the Commercial Sterilization Facilities source category?
D. What are the final rule amendments based on the technology
review for the Commercial Sterilization Facilities source category?
E. What are the final rule amendments addressing emissions
during periods of startup, shutdown, and malfunction?
F. What other changes have been made to the NESHAP?
G. What are the effective and compliance dates of the standards?
IV. What is the rationale for our final decisions and amendments for
the Commercial Sterilization Facilities source category?
A. Amendments Addressing the Affected Source Definitions
B. Amendments Pursuant to CAA sections 112(d)(2), 112(d)(3), and
112(d)(5) for the Commercial Sterilization Facilities Source
Category
C. Residual Risk Review for the Commercial Sterilization
Facilities Source Category
D. Technology Review for the Commercial Sterilization Facilities
Source Category
E. Amendments Addressing Emissions During Periods of SSM
F. Other Amendments to the Standards
V. Summary of Cost, Environmental, and Economic Impacts and
Additional Analyses Conducted
A. What are the affected facilities?
B. What are the air quality impacts?
C. What are the cost impacts?
D. What are the economic impacts?
E. What are the benefits?
F. What analysis of environmental justice did we conduct?
VI. Statutory and Executive Order Reviews
A. Executive Orders 12866: Regulatory Planning and Review and
Executive Order 13563: Improving Regulation and Regulatory Review
B. Paperwork Reduction Act (PRA)
C. Regulatory Flexibility Act (RFA)
D. Unfunded Mandates Reform Act (UMRA)
E. Executive Order 13132: Federalism
F. Executive Order 13175: Consultation and Coordination With
Indian Tribal Governments
G. Executive Order 13045: Protection of Children From
Environmental Health Risks and Safety Risks
H. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use
I. National Technology Transfer and Advancement Act (NTTAA) and
1 CFR Part 51
J. Executive Order 12898: Federal Actions To Address
Environmental Justice in Minority Populations and Low-Income
Populations and Executive Order 14096: Revitalizing Our Nation's
Commitment to Environmental Justice for All
K. Congressional Review Act (CRA)
I. General Information
A. Executive Summary
1. Purpose of the Regulatory Action
Exercising authority under multiple provisions of section 112 of
the Clean Air Act (CAA), we are finalizing revisions to the NESHAP for
Commercial Sterilization Facilities (40 CFR part 63, subpart O) by both
amending the current standards and establishing standards for
previously unregulated emissions within this source category. First, we
are finalizing emission standards under CAA sections 112(d)(2)-(3) and
(d)(5) for previously unregulated emission sources of EtO. Second, we
are finalizing risk-based standards under CAA section 112(f)(2) to
protect public health with an ample margin of safety. Third, we are
finalizing emission standards under CAA section 112(d)(6) based on our
review of developments in practices, processes, and control
technologies for this source category.
This final rulemaking reflects the EtO toxicological assessment
that EPA's Integrated Risk Information System (IRIS) Program completed
in December 2016,\1\ which indicated that EtO is a far more potent
carcinogen than we had understood when the RTR for this source category
was conducted in 2006. There are 88 commercial sterilization facilities
in this source category, many of which are located near residences,
schools, and other public facilities. Many of these facilities are also
located in communities with environmental justice (EJ) concerns. We
have determined that approximately 23 of these facilities pose high
lifetime cancer risks to the surrounding communities, and some
facilities pose exceptionally high risks that are among some of the
highest for a CAA section 112(f)(2) risk assessment. Throughout this
rulemaking process, we have engaged in outreach activities to these
communities, along with their State and local governments, to discuss
their concerns, along with the need and potential solutions for
reducing emissions and increasing transparency on exposure and
potential impacts to communities, which this final rule will achieve.
---------------------------------------------------------------------------
\1\ Evaluation of the Inhalation Carcinogenicity of Ethylene
Oxide, December 2016, EPA/635/R-16/350Fc.
---------------------------------------------------------------------------
This important action will reduce EtO emissions and lifetime cancer
risks in multiple communities across the country, including communities
with EJ concerns, and it updates our standards using proven and cost-
effective control technologies that are already in use at some
facilities in this source category. The protections offered by these
standards will be especially important for children. In addition, this
rule will advance the President's Cancer Moonshot,\2\ by preventing
cancer before it starts. Recognizing that we now have additional
information about the health risks of EtO that was not available at the
time of the 2006 RTR, and in order to ensure that our standards for
this source category adequately protect public health, we have
conducted a second residual risk review under CAA section 112(f)(2), as
discussed in section I.A.3 of this preamble.
---------------------------------------------------------------------------
\2\ https://www.whitehouse.gov/briefing-room/statements-releases/2023/09/13/fact-sheet-as-part-of-president-bidens-unity-agenda-white-house-cancer-moonshot-announces-new-actions-and-commitments-to-end-cancer-as-we-know-it/.
---------------------------------------------------------------------------
In deciding to conduct this second residual risk review, we
considered the health effects of EtO exposure, the impacts to
surrounding communities, the advantages of EtO reductions, and the
distribution of those reductions consistent with the clear goal of CAA
section 112(f)(2) to protect the most exposed and susceptible
populations. While commercial sterilizers provide a critical benefit
for the health of all, protecting people who live near commercial
sterilization facilities from the disproportionate risk of being
significantly harmed by toxic air
[[Page 24092]]
pollution is also a core responsibility for the EPA under the CAA.
At the same time, we recognize that commercial sterilization
facilities play a vital role in maintaining an adequate supply of
sterilized medical devices for public health needs in the U.S.
According to the U.S. Food and Drug Administration (FDA), ``Literature
shows that about fifty percent of all sterile medical devices in the
U.S. are sterilized with ethylene oxide.'' FDA also notes that, ``For
many medical devices, sterilization with ethylene oxide may be the only
method that effectively sterilizes and does not damage the device
during the sterilization process.'' \3\ In developing this final rule,
therefore, we carefully considered the important function these
facilities serve, drawing from extensive engagement with industry
stakeholders as well as Federal agencies with expertise in and
responsibility for the medical device supply chain.
---------------------------------------------------------------------------
\3\ https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/sterilization-medical-devices.
---------------------------------------------------------------------------
To ensure our actions with respect to this source category are
based on the most accurate and complete information possible, we have
had many interactions with the EtO commercial sterilization industry in
recent years, including meetings, requests for information, and
outreach specific to this final rulemaking. This has enabled us to work
from the best possible information when conducting the analyses to
support this final rulemaking, including the current configuration of
facilities and the performance of control technologies that are
currently used.
We have engaged with the U.S. Department of Health and Human
Services, particularly FDA, regarding the potential impacts of this
final rule on commercial facilities that sterilize medical devices.
These discussions have focused on identifying and discussing any
concerns regarding the potential impact on the availability of certain
medical devices that are sterilized with EtO, in cases where
alternative sterilization methods are not readily available, in
particular, devices that are (1) experiencing or at risk of
experiencing a shortage, (2) intended to provide life-supporting, life-
sustaining care or that is intended for use in emergency medical care
or during surgery, (3) used in pediatric services, and/or (4)
sterilized exclusively at a particular facility.
Mindful of the vital role that commercial sterilizers play in
supplying the nation with sterile medical devices, and the core
objective of protecting public health under CAA section 112, the EPA
has carefully evaluated the feasibility and cost of compliance with
this rule, and potential implications for the medical device supply
chain.\4\ The EPA notes that a number of the facilities covered by this
final rule have already implemented one or more of the controls that
will be needed for compliance. Moreover, the EPA's own experience
working with facility owners, as well as State and local agencies that
have regulated EtO emissions from these facilities, confirms that it is
feasible for individual facilities to install the required controls
well within the deadlines provided in this rule, and for multiple
facilities to do so simultaneously.
---------------------------------------------------------------------------
\4\ For more information, see the document Regulatory Impact
Analysis for the Final National Emission Standards for Hazardous Air
Pollutants: Ethylene Oxide Commercial Sterilization and Fumigation
Operations, available in the docket for this rulemaking.
---------------------------------------------------------------------------
In addition, as a result of the comments received, as well as the
EPA's consultation with FDA and other Federal partners, the final rule
incorporates several key changes from the proposed rule, including
modifications to the format of certain standards and compliance
flexibilities. We are also providing sufficient compliance time to
enable these facilities to continue sterilizing products while
installing and testing new control systems and associated equipment
that will afford ample protection for nearby communities. These
modifications to the proposed rule are intended to facilitate cost-
effective compliance, and to avoid any impacts to the integrity of the
medical device supply chain, while ensuring that these standards reduce
cancer risks for communities exposed to EtO emissions.
Given that key industry players are already planning for
compliance, and in light of the significant changes made between the
proposal and this final rule, the EPA does not anticipate that the
implementation of these standards will have any adverse impacts on the
medical supply chain. However, as the Agency proceeds to implement this
final rule, we intend to continue to work closely with FDA, the
relevant trade associations, and facility owners to monitor the process
of planning for compliance, to proactively identify any anticipated
changes in facility operations that might implicate the medical supply
chain, and to take appropriate steps to address any such impacts. In
addition, in order to increase the resilience of the medical supply
chain, we support the development and implementation of viable, safe,
and cost-effective alternatives to EtO sterilization.
On April 13, 2023, the Office of Pesticide Programs (OPP) published
a notice announcing the availability of a proposed interim decision
(PID) as part of its periodic review of the registration of EtO under
the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) (88 FR
22447). The PID contained a number of measures aimed at protecting
workers from excessive EtO exposure. Since the issuance of the PID, OPP
has been actively collaborating with the Office of Air and Radiation to
ensure that the requirements of the FIFRA Interim Decision (ID) do not
interfere with the requirements of this rule, and vice versa. The ID
will contain the final requirements to mitigate worker exposure to EtO,
considering the comments received on the PID. Furthermore, OPP has been
consulting regularly with other Federal agencies and with industry
trade groups, to discuss how best to harmonize the requirements of the
FIFRA ID with the requirements of this rule, and to ensure that the
operative standards, once finalized, will protect both workers and
neighboring communities from the risks of EtO exposure while mitigating
and managing any risk to the supply chain for sterile medical devices.
2. Summary of the Major Provisions of the Regulatory Action in Question
We are finalizing numeric emission limits, operating limits, and
management practices under CAA sections 112(d)(2)-(3), (d)(5), and
(d)(6) for EtO emissions from certain emission sources, and also
finalizing standards under CAA section 112(f)(2) for certain emission
sources in order to ensure that the standards provide an ample margin
of safety to protect public health.\5\
---------------------------------------------------------------------------
\5\ In 1992, pursuant to CAA section 112(c)(1), we published a
list of major and area sources for regulation under CAA section 112,
including major and area sources at commercial sterilization
facilities. 57 FR 31576, 31586 (July 16, 1992). Area sources at
commercial sterilization facilities were listed for regulation under
CAA section 112(c)(3) based on our finding that they present a
threat of adverse effects to human health or the environment (by
such sources individually or in the aggregate) warranting regulation
under that section. Id. at 31586.
---------------------------------------------------------------------------
For the following, previously unregulated emission sources at
commercial sterilization facilities, we are setting standards under CAA
sections 112(d)(2)-(3) or (d)(5): SCVs and ARVs at facilities where EtO
use is less than 1 tpy,\6\ ARVs at facilities where
[[Page 24093]]
EtO use is at least 1 tpy but less than 10 tpy,\7\ CEVs,\8\ and room
air emissions.\9\
---------------------------------------------------------------------------
\6\ In developing the original rule, EPA considered potential
standards for SCV and ARV at area source facilities where EtO use is
less than 1 tpy but the Agency understood these sources at the time
to have low emission contributions (e.g., a facility with EtO use of
1,999 lb/yr would have roughly less than 167 lb/month of usage and
emissions, and less than 41 lb/week usage and emissions.) At the
time, EPA considered costs for monitoring, recordkeeping, and
reporting under the rule. Threshold cutoffs for area sources are at
the discretion of the Agency.
\7\ EPA considered standards for ARV and CEV at area source
facilities where EtO use is at least 1 tpy and less than 10 tpy. As
noted, the Agency understood at the time that the largest emission
source of EtO occurred from the SCV, and therefore finalized
emission reduction standards for all SCV at facilities where EtO use
is at least 1 tpy. At the time ARV sources were understood to have
low emission contributions. As noted, threshold cutoffs for area
sources are at the discretion of the Agency.
\8\ The standards for CEVs were originally promulgated on
December 6, 1994. Following promulgation of the rule, we suspended
certain compliance deadlines and ultimately removed the standards
for CEVs due to safety concerns. In the late 1990s, there were
multiple explosions at EtO commercial sterilization facilities using
oxidizers to control emissions from the CEV. For CEVs, it was
determined that the primary contributing issue leading to the
explosions was that EtO concentrations were above a safe level
(i.e., above the lower explosive limit (LEL)) within the CEV gas
streams. We could not conclude at the time that the CEVs could be
safely controlled, so the standards for CEVs were removed on
November 2, 2001 (66 FR 55583). However, as discussed in section
III.B.5 of the proposal preamble (88 FR 22790), facilities with
controlled CEVs have revised their operating procedures to address
the explosion issue by not exceeding 10 to 25 percent of the LEL. We
have, therefore, determined that CEVs can be safely controlled.
\9\ As discussed in section III.A, room air emissions include
emissions resulting from indoor EtO storage, EtO dispensing, vacuum
pump operation, pre-aeration handling of sterilized material, and
post-aeration handling of sterilized material.
---------------------------------------------------------------------------
Next, based on our assessment of the residual risk after
considering the emission reductions from the previous standards in
subpart O, as well as the standards under CAA sections 112(d)(2)-(3) or
(d)(5) for the previously unregulated sources, we are finalizing more
stringent standards under CAA section 112(f)(2) to address risk at the
following types of sources:
SCVs at facilities where EtO use is at least 30 tpy
SCVs at facilities where EtO use is at least 10 tpy but less
than 30 tpy
SCVs at facilities where EtO use is at least 1 tpy but less
than 10 tpy
ARVs at facilities where EtO use is at least 30 tpy
CEVs at area source facilities \10\ where EtO use is at least
400 tpy
---------------------------------------------------------------------------
\10\ As discussed in section III.B of the proposal preamble (88
FR 22790, April 13, 2023), CAA section 112(a) defines a major source
as ``any stationary source or group of stationary sources located
within a contiguous area and under common control that emits or has
the potential to emit considering controls, in the aggregate, 10 tpy
or more of any HAP or 25 tpy or more of any combination of HAPs. .
.''. It further defines an area source as ``any stationary source of
HAPs that is not a major source''. A synthetic area source facility
is one that otherwise has the potential to emit HAPs in amounts that
are at or above those for major sources of HAP, but that has taken a
restriction so that its potential to emit is less than the threshold
amounts for major sources. Most of the EtO used at these facilities
is released through SCVs and ARVs, and subpart O contains emission
standards for these sources at facilities where EtO use is at least
10 tpy. Some State and local governments also regulate EtO emissions
from these facilities. Based on these facts, as well as our review
of the permits for these facilities, it is our understanding that
all facilities that use more than 10 tpy are synthetic area sources.
---------------------------------------------------------------------------
CEVs at area source facilities where EtO use is at least 60
but less than 400 tpy
Group 1 room air emissions \11\ at area source facilities
where EtO use is at least 40 tpy
---------------------------------------------------------------------------
\11\ As discussed in section III.A, Group 1 room air emissions
cover indoor EtO storage, EtO dispensing, vacuum pump operation, and
pre-aeration handling of sterilized material.
---------------------------------------------------------------------------
Group 2 room air emissions \12\ at area source facilities
where EtO use is at least 20 tpy
---------------------------------------------------------------------------
\12\ As discussed in section III.A, Group 2 room air emissions
cover post-aeration handling of sterilized material.
---------------------------------------------------------------------------
Group 2 room air emissions at area source facilities where EtO
use is at least 4 tpy but less than 20 tpy
Finally, under CAA section 112(d)(6), we are revising current
standards for the following sources that were regulated in the previous
40 CFR part 63, subpart O:
SCVs at facilities where EtO use is at least 10 tpy
SCVs at facilities where EtO use is at least 1 tpy but less
than 10 tpy
ARVs at facilities where EtO use is at least 10 tpy
Table 1 summarizes the final CAA section 112(d) and 112(f)(2)
standards.
Table 1--Summary of Standards After Taking Actions Pursuant to CAA Sections 112(d)(2), 112(d)(3), 112(d)(5),
112(f)(2), and 112(d)(6)
----------------------------------------------------------------------------------------------------------------
Emission source Existing or new? EtO use Standards CAA section
----------------------------------------------------------------------------------------------------------------
SCV............................. Existing and new.. At least 30 tpy... 99.99 percent 112(f)(2).
emission
reduction.
At least 10 tpy 99.9 percent 112(f)(2).
but less than 30 emission
tpy. reduction.
At least 10 tpy... 99.9 percent 112(d)(6).
emission
reduction.
At least 1 but 99.8 percent 112(f)(2) and
less than 10 tpy. emission 112(d)(6).
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
ARV............................. Existing.......... At least 30 tpy... 99.9 percent 112(f)(2).
emission
reduction.
At least 10 tpy 99.6 percent 112(f)(2).
but less than 30 emission
tpy. reduction.
At least 10 tpy... 99.6 percent 112(d)(6).
emission
reduction.
At least 1 but 99 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
New............... At least 30 tpy... 99.9 percent 112(f)(2).
emission
reduction.
At least 10 tpy... 99.9 percent 112(d)(6).
emission
reduction.
At least 1 but 99 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
CEVs at major source facilities. Existing and new.. N/A............... 99.94 percent 112(d)(2) and
emission 112(d)(3).
reduction \1\.
CEVs at area source facilities.. Existing and new.. At least 400 tpy.. 99.9 percent 112(f)(2).
emission
reduction.
At least 60 but 99.9 percent 112(f)(2).
less than 400 tpy. emission
reduction.
Less than 60 tpy.. 99 percent 112(d)(5).
emission
reduction.
Group 1 room air emissions at Existing and new.. N/A............... 97 percent 112(d)(2) and
major sources. emission 112(d)(3).
reduction 2 3.
Group 1 room air emissions at Existing and new.. At least 40 tpy... 98 percent 112(f)(2).
area sources. emission
reduction \3\.
Less than 40 tpy.. 80 percent 112(d)(5).
emission
reduction \3\.
[[Page 24094]]
Group 2 room air emissions at Existing and new.. N/A............... 86 percent 112(d)(2) and
major sources. emission 112(d)(3).
reduction 1 3.
Group 2 room air emissions at Existing.......... At least 20 tpy... 98 percent 112(f)(2).
area sources. emission
reduction \3\.
At least 4 but 80 percent 112(f)(2).
less than 20 tpy. emission
reduction \3\.
Less than 4 tpy... Lower the EtO 112(d)(5).
concentration
within each
sterilization
chamber to 1 ppm
before the
chamber can be
opened \4\.
New............... At least 20 tpy... 98 percent 112(f)(2).
emission
reduction \3\.
At least 4 but 80 percent 112(f)(2).
less than 20 tpy. emission
reduction \3\.
Less than 4 tpy... 80 percent 112(d)(5).
emission
reduction \3\.
----------------------------------------------------------------------------------------------------------------
\1\ MACT floor.
\2\ Beyond-the-Floor (BTF) standard.
\3\ To assure compliance with the emission limit, we are requiring each facility to operate area sources with
these emissions in accordance with the PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
\4\ Owners and operators may also apply for an alternative means of emission limitation under CAA section
112(h)(3).
To demonstrate compliance with the emission limits, we are
finalizing capture requirements. We are also finalizing a requirement
for facilities to monitor with an EtO continuous emissions monitoring
system (CEMS), with exceptions for small users.
3. EPA Authority
We note that the EPA completed a residual risk and technology
review under CAA sections 112(f)(2) and 112(d)(6), respectively, for
this source category in 2006 (71 FR 17712). While CAA section 112(f)(2)
requires only a one-time risk review, which is to be conducted within
eight years of the date the initial standards are promulgated, it does
not limit our discretion or authority to conduct another risk review
should we consider that such review is warranted. As discussed in more
detail in section IV.C of this preamble, as our understanding of the
health effects of EtO developed, we conducted a second residual risk
review under CAA section 112(f)(2) for commercial sterilization
facilities using EtO in order to ensure that the standards provide an
ample margin of safety to protect public health.
As discussed in further detail in section IV.C, this second
residual risk review also encompasses certain area sources for which we
did not evaluate residual risk in our 2006 rulemaking. Although CAA
section 112(f)(5) states that a risk review is not required for
categories of area sources subject to generally available control
technology (GACT) standards, it does not prohibit such review. In 2006,
we undertook a CAA section 112(f)(2) analysis only for area source
emissions standards that were issued as maximum achievable control
technology (MACT) standards and exercised our discretion under CAA
section 112(f)(5) not to do a CAA section 112(f)(2) analysis for those
emission points for which GACT standards were established (67 FR
17715). However, as we made clear in that prior risk assessment, ``[w]e
have the authority to revisit (and revise, if necessary) any rulemaking
if . . . significant improvements to science [suggest that] the public
is exposed to significant increases in risk as compared to the [2006
risk assessment].'' Id. In light of the updated IRIS cancer unit risk
estimate (URE) for EtO, which is approximately 60 times greater than
the value we used in our previous risk assessment, we are now
exercising our discretionary authority to conduct another CAA section
112(f)(2) analysis and to include in this analysis area source
commercial sterilizers using EtO for which we have promulgated, or have
considered, GACT standards.
Section 112(d)(6) of the CAA requires EPA to review and revise, as
necessary, standards promulgated under CAA section 112 at least every
eight years, taking into account developments in practices, processes,
and control technologies. We last completed this required technology
review for the Ethylene Oxide Commercial Sterilization NESHAP (40 CFR
63, subpart O) in 2006. Accordingly, in this final action, we are also
conducting a CAA section 112(d)(6) review of the current standards in
this source category.
4. Costs and Benefits
Table 2 of this preamble summarizes the costs of this final action
for 40 CFR part 63, subpart O (Ethylene Oxide Commercial Sterilization
NESHAP).
Table 2--Total Capital Investment and Total Annual Cost
[2021$]
----------------------------------------------------------------------------------------------------------------
Number of
facilities w/costs Total capital Total annual
Requirement associated with investment costs
new requirements
----------------------------------------------------------------------------------------------------------------
Permanent total enclosure................................... 28 $77,500,000 $8,280,000
Additional control devices.................................. 83 187,000,000 43,000,000
Monitoring and testing...................................... 89 48,100,000 19,400,000
Recordkeeping and reporting................................. \1\ 90 .............. \2\ 2,600,000
---------------------------------------------------
Total................................................... \1\ 90 313,000,000 74,000,000
----------------------------------------------------------------------------------------------------------------
\1\ This includes the 88 facilities that are currently operating, as well as two planned facilities that are
expected to start operating within the next few years.
\2\ This includes $763,000 of one-time annual costs for reading the rule and developing record systems.
[[Page 24095]]
The capital costs for permanent total enclosure (PTE) and
additional gas/solid reactors were annualized to 20 years. We estimate
that these amendments will reduce EtO emissions from this source
category by 21 tpy. Table 3 of this preamble summarizes the cancer risk
reductions that will result from the final amendments, which are
updated based on revisions made in the final rule and described in more
detail in section IV.C.2.
Table 3--Summary of Cancer Risk Reductions
----------------------------------------------------------------------------------------------------------------
Cancer risks after
Current cancer risks-- Current cancer risks-- implementation of final
actual emissions allowable emissions amendments
----------------------------------------------------------------------------------------------------------------
Maximum Individual Risk (MIR) \1\.... 6,000-in-1 million..... 8,000-in-1 million \3\. 100-in-1 million.
Number of People with Cancer Risks 19,000................. 260,000................ 0.
>100-in-1 million.
Number of People with Cancer Risks 8.5 million............ 62 million............. 700,000 to 1.4
>=1-in-1 million. million.\2\
Estimated Annual Cancer Incidence 0.9.................... 8...................... 0.1 to 0.2.\2\
(cases per year).
----------------------------------------------------------------------------------------------------------------
\1\ The MIR or maximum individual lifetime cancer risk is defined as the increase in estimated cancer risk
associated with a 70-year lifetime of continuous exposure at the highest concentration of HAP where people are
likely to live.
\2\ Ranges in values account for if all facilities were performing at the level of the standards (high end) to
considering facilities that are currently performing better than the standards (low end).
As indicated in table 3, we project that the standards in the final
rule will significantly reduce incremental lifetime cancer risks
associated with emissions of EtO from this source category. We estimate
that the current maximum increase in lifetime cancer risk associated
with any facility in this source category is 6,000-in-1 million based
on estimated actual emissions (or 8,000-in-1 million based on allowable
emissions) under the existing standards, and that approximately 19,000
people are exposed to EtO from this source category at levels that
would correspond to a lifetime cancer risk of greater than 100-in-1
million (which is our presumptive upper bound threshold for acceptable
health risks), based on actual emissions. When considering allowable
emissions, this number increases to 260,000. Under the final rule, no
individual will be exposed to EtO at levels that correspond to a
lifetime cancer risk of greater than 100-in-1 million, and the number
of people with a potential risk of greater than or equal to 1-in-1
million will be reduced by approximately 92 percent.
See section V of this preamble for further discussion of the costs
and a discussion of the benefits of the final standards. See section
IV.F of this preamble for discussion of the revisions to monitoring,
recordkeeping, reporting, and testing requirements. See section IV.C
for a discussion of the risk assessment results.
B. Does this action apply to me?
Regulated entities. Categories and entities potentially regulated
by this action are shown in table 4 of this preamble.
Table 4--NESHAP and Industrial Source Categories Affected by This Final
Action
------------------------------------------------------------------------
Industrial category NESHAP NAICS \1\ code
------------------------------------------------------------------------
Surgical and Medical Instrument 40 CFR part 63, 339112
Manufacturing. subpart O.
Surgical Appliance and Supplies 40 CFR part 63, 339113
Manufacturing. subpart O.
Pharmaceutical Preparation 40 CFR part 63, 325412
Manufacturing. subpart O.
Spice and Extract Manufacturing... 40 CFR part 63, 311942
subpart O.
Dried and Dehydrated Food 40 CFR part 63, 311423
Manufacturing. subpart O.
Packaging and Labeling Services... 40 CFR part 63, 561910
subpart O.
------------------------------------------------------------------------
\1\ North American Industry Classification System.
Table 4 of this preamble is not intended to be exhaustive, but
rather to provide a guide for readers regarding entities likely to be
affected by the final action for the source category listed. To
determine whether your facility is affected, you should examine the
applicability criteria in the appropriate NESHAP. If you have any
questions regarding the applicability of any aspect of this NESHAP,
please contact the appropriate person listed in the preceding FOR
FURTHER INFORMATION CONTACT section of this preamble.
C. Where can I get a copy of this document and other related
information?
In addition to being available in the docket, an electronic copy of
this final action will also be available on the internet. Following
signature by the EPA Administrator, the EPA will post a copy of this
final action at: https://www.epa.gov/stationary-sources-air-pollution/ethylene-oxide-emissions-standards-sterilization-facilities. Following
publication in the Federal Register, the EPA will post the Federal
Register version and key technical documents at this same website.
Additional information is available on the RTR website at https://www.epa.gov/stationary-sources-air-pollution/risk-and-technology-review-national-emissions-standards-hazardous. This information
includes an overview of the RTR program and links to project websites
for the RTR source categories.
D. Judicial Review and Administrative Reconsideration
Under Clean Air Act (CAA) section 307(b)(1), judicial review of
this final action is available only by filing a petition for review in
the United States Court of Appeals for the District of Columbia Circuit
(the Court) by June 4, 2024. Under CAA section 307(b)(2), the
requirements established by this final rule may not be challenged
separately in any civil or criminal proceedings brought by the EPA to
enforce the requirements.
Section 307(d)(7)(B) of the CAA further provides that only an
objection to a rule or procedure which was raised with reasonable
specificity during the period for public comment (including any public
hearing) may be raised
[[Page 24096]]
during judicial review. This section also provides a mechanism for the
EPA to reconsider the rule if the person raising an objection can
demonstrate to the Administrator that it was impracticable to raise
such objection within the period for public comment or if the grounds
for such objection arose after the period for public comment (but
within the time specified for judicial review) and if such objection is
of central relevance to the outcome of the rule. Any person seeking to
make such a demonstration should submit a Petition for Reconsideration
to the Office of the Administrator, U.S. EPA, Room 3000, WJC South
Building, 1200 Pennsylvania Ave. NW, Washington, DC 20460, with a copy
to both the person(s) listed in the preceding FOR FURTHER INFORMATION
CONTACT section, and the Associate General Counsel for the Air and
Radiation Law Office, Office of General Counsel (Mail Code 2344A), U.S.
EPA, 1200 Pennsylvania Ave. NW, Washington, DC 20460.
II. Background
A. What is the statutory authority for this action?
The statutory authority for this action is provided by sections 112
and 301 of the Clean Air Act (CAA), as amended (42 U.S.C. 7401 et
seq.). The discussion that follows identifies the relevant statutory
sections and briefly explains the contours of the methodology used to
implement these statutory requirements. A more comprehensive discussion
appears in the document titled CAA Section 112 Risk and Technology
Reviews: Statutory Authority and Methodology, in the docket for this
rulemaking. Section 112 of the CAA establishes a two-stage regulatory
process to address emissions of hazardous air pollutants (HAP) from
stationary sources. In the first stage, we must identify categories of
sources emitting one or more of the HAP listed in CAA section 112(b)
and then promulgate technology-based NESHAP for those sources. Sources
of HAP emissions are either major sources or area sources, and CAA
section 112 establishes different requirements for major source
standards and area source standards. ``Major sources'' are those that
emit, or have the potential to emit, any single HAP at a rate of 10
tons per year (tpy) or more, or 25 tpy or more of any combination of
HAP. All other sources are ``area sources.'' For major sources, these
standards are commonly referred to as maximum achievable control
technology (MACT) standards and must reflect the maximum degree of
emission reductions of HAP achievable (after considering cost, energy
requirements, and non-air quality health and environmental impacts). In
developing MACT standards, CAA section 112(d)(2) directs the EPA to
consider the application of measures, processes, methods, systems, or
techniques, including, but not limited to, those that reduce the volume
of or eliminate HAP emissions through process changes, substitution of
materials, or other modifications; enclose systems or processes to
eliminate emissions; collect, capture, or treat HAP when released from
a process, stack, storage, or fugitive emissions point; are design,
equipment, work practice, or operational standards; or any combination
of the above.
For these MACT standards, the statute specifies certain minimum
stringency requirements, which are referred to as MACT floor
requirements, and which may not be based on cost considerations. See
CAA section 112(d)(3). For new sources, the MACT floor cannot be less
stringent than the emission control achieved in practice by the best-
controlled similar source. The MACT standards for existing sources can
be less stringent than floors for new sources, but they cannot be less
stringent than the average emission limitation achieved by the best-
performing 12 percent of existing sources in the category or
subcategory (or the best-performing five sources for categories or
subcategories with fewer than 30 sources). In developing MACT
standards, we must also consider control options that are more
stringent than the floor under CAA section 112(d)(2). We may establish
standards more stringent than the floor, based on the consideration of
the cost of achieving the emissions reductions, any non-air quality
health and environmental impacts, and energy requirements. For area
sources, CAA section 112(d)(5) allows the EPA to set standards based on
GACT in lieu of MACT standards. For categories of major sources and any
area source categories subject to MACT standards, the second stage in
standard-setting focuses on identifying and addressing any remaining
(i.e., ``residual'') risk pursuant to CAA section 112(f). Section
112(f) specifically states that the EPA ``shall not be required'' to
conduct risk review under this subsection for categories of area
sources subject to GACT standards but does not limit the EPA's
authority or discretion from conducting such review. As discussed in
more detail in section III.C of this preamble, in light of the updated
URE regarding EtO, the EPA is choosing to exercise that discretion.
In the second stage of the regulatory process, the CAA requires the
EPA to undertake two different analyses, which we refer to as the
technology review and the residual risk review. Under the technology
review, we must review the technology-based standards and revise them
``as necessary (taking into account developments in practices,
processes, and control technologies)'' no less frequently than every 8
years, pursuant to CAA section 112(d)(6). In conducting this review,
the EPA is not required to recalculate the MACT floors that were
established in earlier rulemakings. Natural Resources Defense Council
(NRDC) v. EPA, 529 F.3d 1077, 1084 (D.C. Cir. 2008). Association of
Battery Recyclers, Inc. v. EPA, 716 F.3d 667 (D.C. Cir. 2013). The EPA
may consider cost in deciding whether to revise the standards pursuant
to CAA section 112(d)(6). The EPA is required to address regulatory
gaps, such as missing standards for listed air toxics known to be
emitted from the source category, and any new MACT standards must be
established under CAA sections 112(d)(2) and (3), or, in specific
circumstances, CAA sections 112(d)(4) or (h). Louisiana Environmental
Action Network (LEAN) v. EPA, 955 F.3d 1088 (D.C. Cir. 2020).
The residual risk review in the second stage of the regulatory
process focuses on identifying and addressing any remaining (i.e.,
``residual'') risk pursuant to CAA section 112(f). For source
categories subject to MACT standards, section 112(f)(2) of the CAA
requires the EPA to determine whether promulgation of additional
standards is needed to provide an ample margin of safety to protect
public health or to prevent an adverse environmental effect. Section
112(d)(5) of the CAA provides that this residual risk review is not
required for categories of area sources subject to GACT standards.
Section 112(f)(2)(B) of the CAA further expressly preserves the EPA's
use of the two-step approach for developing standards to address any
residual risk and the Agency's interpretation of ``ample margin of
safety'' developed in the National Emissions Standards for Hazardous
Air Pollutants: Benzene Emissions from Maleic Anhydride Plants,
Ethylbenzene/Styrene Plants, Benzene Storage Vessels, Benzene Equipment
Leaks, and Coke By-Product Recovery Plants (Benzene NESHAP) (54 FR
38044, September 14, 1989). The EPA notified Congress in the Residual
Risk Report that the Agency intended to use the Benzene NESHAP approach
in making CAA section 112(f) residual risk
[[Page 24097]]
determinations (EPA-453/R-99-001, p. ES-11). The EPA subsequently
adopted this approach in its residual risk determinations, and the
United States Court of Appeals for the District of Columbia Circuit
upheld the EPA's interpretation that CAA section 112(f)(2) incorporates
the approach established in the Benzene NESHAP. See NRDC v. EPA, 529
F.3d 1077, 1083 (D.C. Cir. 2008).
The approach incorporated into the CAA and used by the EPA to
evaluate residual risk and to develop standards under CAA section
112(f)(2) is a two-step approach. In the first step, the EPA determines
whether risks are acceptable. This determination ``considers all health
information, including risk estimation uncertainty, and includes a
presumptive limit on maximum individual lifetime [cancer] risk (MIR)
\13\ of approximately 1-in-10 thousand.'' (54 FR 38045). If risks are
unacceptable, the EPA must determine the emissions standards necessary
to reduce risk to an acceptable level without considering costs. In the
second step of the approach, the EPA considers whether the emissions
standards provide an ample margin of safety to protect public health
``in consideration of all health information, including the number of
persons at risk levels higher than approximately 1-in-1 million, as
well as other relevant factors, including costs and economic impacts,
technological feasibility, and other factors relevant to each
particular decision.'' Id. The EPA must promulgate emission standards
necessary to provide an ample margin of safety to protect public health
or determine that the standards being reviewed provide an ample margin
of safety without any revisions. After conducting the ample margin of
safety analysis, we consider whether a more stringent standard is
necessary to prevent an adverse environmental effect, taking into
consideration costs, energy, safety, and other relevant factors. For
more information on the statutory authority for this rule, see 88 FR
22790, April 13, 2023.
---------------------------------------------------------------------------
\13\ Although defined as ``maximum individual risk,'' MIR refers
only to cancer risk and reflects the estimated risk if an individual
were exposed to the maximum level of a pollutant for a 70-year
lifetime.
---------------------------------------------------------------------------
B. What is the Commercial Sterilization Facilities source category and
how does the NESHAP regulate HAP emissions from the source category?
The EPA promulgated the EtO Commercial Sterilization Facilities
NESHAP on December 6, 1994 (59 FR 62585). The standards are codified at
40 CFR part 63, subpart O. The EtO commercial sterilization industry
consists of facilities operating a sterilizer process that uses EtO to
sterilize or fumigate materials (e.g., medical equipment and supplies,
spices, and other miscellaneous products and items). The source
category covered by this MACT standard currently includes 88
facilities.
The original 1994 rulemaking for this source category set standards
for EtO emissions originating from three emission points: sterilization
chamber vents (SCV), aeration room vents (ARV), and chamber exhaust
vents (CEV). The SCV evacuates EtO from the sterilization chamber
following sterilization, fumigation, and any subsequent gas washes
before the chamber door is opened. The ARV evacuates EtO-laden air from
the aeration room or chamber that is used to facilitate off-gassing of
the sterile product and packaging. The CEV evacuates EtO-laden air from
the sterilization chamber after the chamber door is opened for product
unloading following the completion of sterilization and associated gas
washes. Other sources of emissions within this source category are room
air emissions from equipment used to charge EtO into sterilization
chambers, as well as EtO residuals desorbing from sterilized products
within the facility, but the current EtO Commercial Sterilization
NESHAP does not include standards for room air emissions.
In the chamber EtO sterilization process, items to be sterilized
are placed in a chamber and exposed to EtO gas at a predetermined
concentration, temperature, humidity, and pressure for a period of time
known as the dwell period. Following the dwell period, the EtO gas is
evacuated from the chamber, and the sterilized materials are then
aerated to remove EtO residuals from the product. After the aeration
step, sterilized materials are typically moved to a shipping/warehouse
area for storage until they are ready to be distributed to the
customer. Sterilizer process equipment and emission control
configurations vary across facilities. The most common sterilizer
process equipment configuration includes a separate sterilizer chamber,
separate aeration room, and chamber exhaust on the sterilizer chamber
(also referred to as a back-vent). Another common configuration
includes a combination sterilizer where the sterilization and aeration
steps of the process occur within the same chamber.
Another EtO sterilization process is single-item sterilization
where small individual items are sterilized in sealed pouches. EtO gas
is introduced into the sealed pouch, either by injection or use of an
EtO ampule, and the sealed pouch is then placed in a chamber where the
sterilization step and aeration step occur.
In 2006, we finalized a residual risk review and a technology
review under CAA section 112(f)(2) and CAA section 112(d)(6),
respectively (71 FR 17712, April 7, 2006). No changes were made to the
EtO Commercial Sterilization NESHAP in that action.
The current emission standards for commercial sterilization
facilities in 40 CFR part 63, subpart O are shown in table 5:
Table 5--Current EtO Standards for Commercial Sterilizers
----------------------------------------------------------------------------------------------------------------
Existing and new sources subcategory
(in any consecutive 12-month period) Sterilization chamber Aeration room vent Chamber exhaust vent
\1\ vent (SCV) (ARV) (CEV) \2\
----------------------------------------------------------------------------------------------------------------
Sources using 10 tons or more of EtO. 99 percent emission 1 part per million No control.
reduction (see 40 CFR (ppm) maximum outlet
63.362(c)). concentration or 99
percent emission
reduction (see 40 CFR
63.362(d)).
Sources using 1 ton or more of EtO 99 percent emission No control............. No control.
but less than 10 tons of EtO. reduction (see 40 CFR
63.362(c)).
Sources using less than 1 ton of EtO. No control required; No control required; No control required;
minimal recordkeeping minimal recordkeeping minimal recordkeeping
requirements apply requirements apply requirements apply
(see 40 CFR (see 40 CFR (see 40 CFR
63.367(c)).). 63.367(c)).). 63.367(c)).).
----------------------------------------------------------------------------------------------------------------
\1\ Determined on a rolling 12-month basis.
\2\ The CEV emission source was included in the original standard but was later eliminated from the 40 CFR part
63, subpart O regulation in 2001.
[[Page 24098]]
For more information on the commercial sterilization industry and
the current standards under 40 CFR part 63, subpart O, see 88 FR 22790,
April 13, 2023.
We note that hospital sterilizers are regulated under a different
NESHAP (40 CFR part 63, subpart WWWWW), which is not addressed in this
rulemaking.\14\ We are aware of the potential risk posed by EtO
emissions from this source category and will address hospital
sterilizers in a future rulemaking.
---------------------------------------------------------------------------
\14\ Hospitals are defined at 40 CFR 63.10448 to mean facilities
that provide medical care and treatment for patients who are acutely
ill or chronically ill on an inpatient basis under supervision of
licensed physicians and under nursing care offered 24 hours per day.
Hospitals include diagnostic and major surgery facilities but
exclude doctor's offices, clinics, or other facilities whose primary
purpose is to provide medical services to humans or animals on an
outpatient basis.
---------------------------------------------------------------------------
C. What changes did we propose for the Commercial Sterilization
Facilities source category in our April 13, 2023, RTR proposal?
On April 13, 2023, the EPA published a proposed rule in the Federal
Register for the EtO Commercial Sterilization NESHAP, 40 CFR part 63,
subpart O, that took into consideration the RTR analyses. In the
proposed rule, we proposed emission standards under CAA sections
112(d)(2)-(3) or (d)(5) for a number of unregulated emission sources of
EtO. We then proposed tightening certain of these proposed standards
and existing standards with risk-based standards under CAA section
112(f)(2) in order to protect public health with an ample margin of
safety. Finally, we proposed revisions to certain existing standards
under CAA section 112(d)(6) based on our review of developments in
practices, processes, and control technologies for this source
category.
For the following emission sources that were unregulated, we
proposed to set standards under CAA sections 112(d)(2)-(3) or (d)(5):
SCVs, ARVs, and CEVs at facilities where EtO use is less
than 1 tpy,
ARVs and CEVs at facilities where EtO use is at least 1
tpy but less than 10 tpy,
CEVs at facilities where EtO use is at least 10 tpy, and
Room air emissions.
Next, based on our assessment of the residual risk after
considering the emission reductions from the standards in subpart O, as
well as the proposed standards for the unregulated sources, we proposed
more stringent standards under CAA section 112(f)(2) to address risk
for the following types of sources:
SCVs at facilities where EtO use is at least 40 tpy,
SCVs at facilities where EtO use is at least 10 tpy but
less than 40 tpy,
SCVs at facilities where EtO use is at least 1 tpy but
less than 10 tpy, and
Group 2 room air emissions at area source facilities where
EtO use is at least 20 tpy.
Finally, under CAA section 112(d)(6), we proposed to revise
standards for the following sources that were regulated in the previous
40 CFR part 63, subpart O:
SCVs at facilities where EtO use is at least 10 tpy,
SCVs at facilities where EtO use is at least 1 tpy but
less than 10 tpy, and
ARVs at facilities where EtO use is at least 10 tpy.
Table 6 summarizes the proposed section CAA section 112(d) and
112(f)(2) standards.
Table 6--Summary of Standards After Proposed Actions Pursuant to CAA Sections 112(d)(2), 112(d)(3), 112(d)(5),
112(f)(2), and 112(d)(6)
----------------------------------------------------------------------------------------------------------------
Emission source Existing or new? EtO use Standards CAA section
----------------------------------------------------------------------------------------------------------------
SCV............................. Existing and new.. At least 40 tpy... 99.94 percent 112(f)(2).
emission
reduction.
At least 10 tpy 99.94 percent 112(f)(2).
but less than 40 emission
tpy. reduction.
At least 10 tpy... 99.94 percent 112(d)(6).
emission
reduction.
At least 1 but 99.8 percent 112(f)(2) and
less than 10 tpy. emission 112(d)(6).
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
ARV............................. Existing.......... At least 10 tpy... 99.6 percent 112(d)(6).
emission
reduction.
At least 1 but 99 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
New............... At least 10 tpy... 99.9 percent 112(d)(6).
emission
reduction.
At least 1 but 99 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
CEV............................. Existing and new.. At least 10 tpy... 3.2E-4 lb/h....... 112(d)(2) and (3).
At least 1 but 99.9 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
Group 1 room air emissions...... Existing and new.. N/A............... 1.3E-3 lb/h \1\... 112(d)(2) and
112(d)(3).
Group 1 room air emissions at Existing and new.. N/A............... 1.3E-3 lb/h \1\... 112(d)(5).
area sources.
Group 2 room air emissions at Existing and new.. N/A............... 2.8E-3 lb/h \1\... 112(d)(2) and
major sources. 112(d)(3).
Group 2 room air emissions at Existing.......... At least 20 tpy... 2.8E-3 lb/h \1\... 112(f)(2).
area sources. Less than 20 tpy.. Follow either the 112(d)(5).
Cycle Calculation
Approach or the
Bioburden/
Biological
Indicator
Approach to
achieve sterility
assurance in
accordance with
ISO 11135:2014
(July 15, 2014)
and ISO 11138-
1:2017 (March
2017).
[[Page 24099]]
New............... N/A............... 2.8E-3 lb/h \1\... 112(d)(5).
----------------------------------------------------------------------------------------------------------------
\1\ To assure compliance with the emission limit, we proposed requiring each facility to operate areas with
these emissions in accordance with the PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
To demonstrate compliance with the emission limits, we proposed
capture requirements. We also proposed that facilities either monitor
with an EtO CEMS or conduct initial and annual performance tests with
continuous parameter monitoring.
We also proposed the following amendments:
Corrections and clarifications to regulatory provisions
related to emissions during periods of SSM, including removing general
exemptions for periods of SSM and adding work practice standards for
periods of SSM where appropriate.
Revisions to monitoring and performance testing
requirements and addition of provisions for electronic reporting of
performance test results and reports, performance evaluation reports,
and compliance reports.
Requiring all area source facilities to obtain a title V
operating permit, and
Compliance requirements for facilities using combined
emission streams.
III. What is included in this final rule?
This action finalizes the EPA's determinations pursuant to the RTR
provisions of CAA section 112 for the Commercial Sterilization
Facilities source category and amends the EtO Commercial Sterilization
NESHAP based on those determinations. This action also finalizes other
changes to the NESHAP, including adding requirements and clarifications
for periods of SSM; requiring the use of CEMS to demonstrate compliance
for facilities where EtO use is at least 100 pounds (lb)/year; adding
provisions for electronic reporting of performance test results and
reports, performance evaluation reports, and compliance reports; and
other minor editorial and technical changes. This action also reflects
several changes to the April 2023 proposal in consideration of comments
received during the public comment period described in section IV of
this preamble.
A. What are the final rule amendments addressing the affected source
definitions?
The previous subpart O did not contain definitions for affected
sources, which meant that the definition of an ``affected source'' at
40 CFR 63.2 applied.\15\ We did not believe that this was appropriate
because a facility may not route all emissions from a particular type
of point source to the same control system, thus making compliance
demonstration with the standards difficult. For SCVs, ARVs, and CEVs,
we are finalizing, as proposed, the affected source definition as the
individual vent. For Group 1 and Group 2 room air emissions, we are
finalizing, as proposed, the affected source definition as the
collection of all room air emissions for each group at any
sterilization facility. Group 1 room air emissions are defined as
emissions from indoor EtO storage, EtO dispensing, vacuum pump
operations, and pre-aeration handling of sterilized material. Group 2
room air emissions are defined as emissions from post-aeration handling
of sterilized material.
---------------------------------------------------------------------------
\15\ 40 CFR 63.2 defines an affected source as ``the collection
of equipment, activities, or both within a single contiguous area
and under common control that is included in a section 112(c) source
category or subcategory for which a section 112(d) standard or other
relevant standard is established pursuant to section 112 of the
Act.''
---------------------------------------------------------------------------
Section IV.A.3 of this preamble provides a summary of key comments
we received on the affected source definitions and our responses.
B. What are the final rule amendments pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) for the Commercial Sterilization
Facilities source category?
We are finalizing EtO emissions standards pursuant to CAA sections
112(d)(2)-(3) and 112(d)(5) for major and area sources that were
previously unregulated. Please note that the final standards for some
of these sources are further tightened pursuant to CAA section
112(f)(2), as shown in table 1 in section I.A above and discussed in
more detail below in sections III.C and IV.\16\
---------------------------------------------------------------------------
\16\ These sources include CEVs at area source facilities where
EtO use is at least 60 tpy, Group 1 room air emissions at area
source facilities where EtO use is at least 40 tpy, and Group 2 room
air emissions at area source facilities where EtO use is at least 4
tpy.
---------------------------------------------------------------------------
Pursuant to CAA section 112(d)(2)-(3) or 112(d)(5), we are
establishing in this final rule the following emission standards for
the previously unregulated sources:
99 percent reduction for new and existing SCVs at
facilities where EtO use is less than 1 tpy,
99 percent reduction for new and existing ARVs facilities
where EtO use is at least 1 tpy less than 10 tpy,
99 percent reduction for new and existing ARVs at
facilities where EtO use is less than 1 tpy,
99.94 percent reduction for new and existing CEVs at major
source facilities,
99 percent emission reduction for new and existing CEVs at
area source facilities,
97 percent reduction for new and existing Group 1 room air
emissions at major source facilities,
80 percent emission reduction for new and existing Group 1
room air emissions at area source facilities,
86 percent reduction for new and existing Group 2 room air
emissions at major source facilities, and
80 percent emission reduction for new Group 2 room air
emissions at area source facilities.
As discussed in more detail below in section IV.C.3 of this notice,
we are not finalizing any of the alternative emission limits for
percent reduction standards on which we had solicited comment as part
of the proposed rulemaking. Further, based on comments received on the
proposed rulemaking, we are finalizing a revised best management
practice (BMP) as the GACT standard under CAA section 112(d)(5) for
existing Group 2 room air emissions at area sources. The BMP requires
the in-chamber EtO concentration to be lowered to 1 part per million
(ppm) before the chamber can be opened, as opposed to the proposed
measure that would have required these facilities to follow either the
Cycle Calculation Approach or the Bioburden/Biological Indicator
Approach to achieve sterility assurance in accordance with
International Organization for Standardization (ISO) 11135:2014 and ISO
11138-1:2017. In addition, we are finalizing, as proposed, a
requirement that facilities operate all areas with room air emissions
subject to an emission standard in accordance with the PTE requirements
of EPA
[[Page 24100]]
Method 204, irrespective of which CAA section 112 authority is invoked.
Lastly, we are finalizing the removal of the 1 ppm alternative for ARVs
at facilities where EtO use is at least 10 tpy. Section IV.B of this
preamble provides in more detail the standards we are finalizing
pursuant to CAA section 112(d)(2), 112(d)(3), and 112(d)(5), our
rationales for the final standards and for changes since proposal, and
a summary of key comments we received on the proposed standards and our
responses.
C. What are the final rule amendments based on the risk review for the
Commercial Sterilization Facilities source category?
This section introduces the final amendments to the Commercial
Sterilization Facilities NESHAP being promulgated pursuant to CAA
section 112(f). As in the proposal, we determined that the risks for
this source category were unacceptable under the previous provisions,
and we are making a final determination of unacceptability as part of
this final action, warranting necessary emission reductions as directed
under the provisions we are finalizing pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) in this rulemaking. When risks are
unacceptable after considering the emission reductions from the
standards in subpart O, we must determine the emissions standards
necessary to reduce risk to an acceptable level. As such, we are
promulgating final amendments to the Commercial Sterilization
Facilities NESHAP pursuant to CAA section 112(f)(2) that will reduce
risk to an acceptable level and will also provide an ample margin of
safety to protect public health (see section IV.C of the preamble for
further discussion). Based on comments received during the proposed
rulemaking, we are finalizing the following EtO emissions standards
under CAA section 112(f)(2):
99.99 percent reduction for SCVs at facilities where EtO
use is at least 30 tpy,
99.9 percent reduction for SCVs at facilities where EtO
use is at least 10 tpy but less than 30 tpy,
99.8 percent reduction for SCVs at facilities where EtO
use is at least 1 tpy but less than 10 tpy,
99.9 percent reduction for ARVs at facilities where EtO
use is at least 30 tpy,
99.9 percent reduction for CEVs at area source facilities
where EtO use is at least 60 tpy,
98 percent reduction for Group 1 room air emissions at
area sources facilities where EtO use is at least 40 tpy,
98 percent reduction for Group 2 room air emissions at
area sources facilities where EtO use is at least 20 tpy, and
80 percent reduction for Group 2 room air emissions at
area source facilities where EtO use is at least 4 tpy but less than 20
tpy.
We are not finalizing alternative emission limits for percent
reduction standards for the same reasons discussed in section III.B of
this preamble. Further, based on comments received during the proposed
rulemaking, we are not finalizing any of the work practice standards
that were proposed for facilities where the MIR remained greater than
100-in-1 million after the imposition of requirements under ``Control
Option 1''.\17\ These standards would have required facilities to limit
their Group 2 room air emissions to a maximum volumetric flow rate of
2,900 dry standard cubic feet per minute (dscfm) and a maximum EtO
concentration of 30 parts-per-billion by volume (ppbv).
---------------------------------------------------------------------------
\17\ Refer to section III.D.1.b of the proposal preamble (88 FR
22790, April 13, 2023) for further discussion of Control Option 1.
---------------------------------------------------------------------------
Section IV.C.3 of this preamble provides a summary of key comments
we received regarding the risk review and our responses.
D. What are the final rule amendments based on the technology review
for the Commercial Sterilization Facilities source category?
We determined that there are developments in practices, processes,
and control technologies that warrant revisions to the previous
standards for this source category. Therefore, to satisfy the
requirements of CAA section 112(d)(6), we are revising the standards to
include, as in the proposed rule:
99.8 percent reduction for SCVs at facilities where EtO
use is at least 1 tpy but less than 10 tpy,
99.6 percent reduction for existing ARVs at facilities
where EtO use is at least 10 tpy, and
99.9 percent reduction for new ARVs at facilities where
EtO use is at least 10 tpy.
Based on comments received during the proposed rulemaking, we are
finalizing a 99.9 percent emission reduction standard for SCVs at
facilities where EtO use is at least 10 tpy, which is different from
the 99.94 percent emission reduction standard that was proposed (see
section IV.D.3.a of this document for further discussion). We are not
finalizing any of the alternative emission limits for percent reduction
standards that we had solicited comment on as part of the proposed
rulemaking. As part of the technology review, we also identified
regulatory gaps (previously unregulated processes or pollutants) and
are establishing new standards to fill those gaps as described in
section III.B of this preamble. Section IV.D.3 of this preamble
provides a summary of key comments we received regarding the technology
review and our responses.
E. What are the final rule amendments addressing emissions during
periods of startup, shutdown, and malfunction?
In its 2008 decision in Sierra Club v. EPA, 551 F.3d 1019 (D.C.
Cir. 2008), the United States Court of Appeals for the District of
Columbia Circuit vacated portions of two provisions in our CAA section
112 regulations governing the emissions of HAP during periods of SSM.
Specifically, the court vacated the SSM exemption contained in 40 CFR
63.6(f)(1) and 40 CFR 63.6(h)(1), holding that under section 302(k) of
the CAA, emissions standards or limitations must be continuous in
nature and that the SSM exemption violates the CAA's requirement that
some section 112 standards apply continuously. We have eliminated the
SSM exemption in this rule. Consistent with Sierra Club v. EPA, the EPA
has established standards in this rule that apply at all times. We have
also revised table 6 in subpart O (the General Provisions Applicability
Table) in several respects as is explained in section III.G.1 of the
proposal preamble (88 FR 22790). For example, we have eliminated and
revised certain recordkeeping that is related to the SSM exemption as
described in detail in the proposed rule and summarized again in
section IV.E.1 of this preamble.
In establishing standards in this rule, we have considered startup
and shutdown periods and, for the reasons explained in section III.G.1
of the proposal preamble and section IV.E of this preamble, have not
established alternate standards for those periods.
The EPA is also finalizing provisions related to malfunctions as
proposed. Periods of startup, normal operations, and shutdown are all
predictable and routine aspects of a source's operations. Malfunctions,
in contrast, are neither predictable nor routine. Instead, they are, by
definition, sudden, infrequent, and not reasonably preventable failures
of emissions control, process, or monitoring equipment. (40 CFR 63.2)
(Definition of malfunction). The EPA interprets CAA section 112 as not
requiring emissions that occur during periods of malfunction to be
factored into development of CAA section 112
[[Page 24101]]
standards. This reading has been upheld as reasonable by the D.C.
Circuit in U.S. Sugar Corp. v. EPA, 830 F.3d 579, 606-610 (2016).
Section IV.E.3 of this preamble provides a summary of key comments
we received on the SSM provisions and our responses.
F. What other changes have been made to the NESHAP?
This rule also finalizes, as proposed, revisions to several other
requirements in the Commercial Sterilization Facilities NESHAP. We
describe these revisions in this section as well as other proposed
provisions that have changed since proposal.
1. Demonstrating Compliance
In the majority of instances, parametric monitoring is used to good
effect as an ongoing means of ensuring that these devices continue to
get necessary emission reductions.\18\ However, given the nature of
EtO, in which small amounts can have large risk impacts, parametric
monitoring alone will not be sensitive enough to detect very small
fluctuations in EtO concentration. Based on comments received during
the proposed rulemaking, the EPA is finalizing a requirement to use EtO
CEMS for demonstrating compliance. However, facilities where EtO use is
less than 100 lb/year will have the option to use EtO CEMS or
performance testing and parametric monitoring to demonstrate
compliance. Based on comments received during the proposed rulemaking,
we are promulgating the following requirements:
---------------------------------------------------------------------------
\18\ Parametric monitoring is an approach that measures one or
more key indicators of process operation or emission control device
operation, typically on a continuous basis. The parameters are known
to affect emission levels associated with the process or the control
efficiency of the source's air pollution control device.
---------------------------------------------------------------------------
Quarterly reporting of EtO CEMS data,
Minimum data availability of 90 percent for EtO CEMS, and
Use of either outlet volumetric flow rate monitors or
differential pressure monitors to demonstrate continuous compliance
with EPA Method 204.
Based on comments received during the proposed rulemaking, we are
not finalizing a requirement for the mass of EtO being routed to a
control device from an SCV to be determined through inlet testing.
Based on comments received during the proposed rulemaking, we are
finalizing revisions to parametric monitoring requirements, and we are
finalizing technical edits to Performance Specification 19 and QA
Procedure 7.
2. Electronic Reporting
To increase the ease and efficiency of data submittal and data
accessibility, we are finalizing, as proposed, a requirement that
owners or operators of commercial sterilization facilities submit
compliance reports (being finalized at 40 CFR 63.366(b) and (c)),
performance test reports (being finalized at 40 CFR 63.366(f)), and
performance evaluation reports (being finalized at 40 CFR 63.366(g))
electronically through the EPA's Central Data Exchange (CDX) using the
Compliance and Emissions Data Reporting Interface (CEDRI). The final
rule requires that performance test results collected using test
methods that are supported by the EPA's Electronic Reporting Tool (ERT)
as listed on the ERT website \19\ at the time of the test be submitted
in the format generated through the use of the ERT and that other
performance test results be submitted in portable document format (PDF)
using the attachment module of the ERT. Similarly, performance
evaluation results of CEMS measuring relative accuracy test audit
pollutants that are supported by the ERT at the time of the test must
be submitted in the format generated through the use of the ERT and
other performance evaluation results be submitted in PDF using the
attachment module of the ERT. For compliance reports, the final rule
requires that owners or operators use the appropriate spreadsheet
template to submit information to CEDRI. The final version of the
template for these reports is in the docket and will be located on the
CEDRI website.\20\ Furthermore, we are finalizing as proposed
provisions that allow facility operators the ability to seek extensions
for submitting electronic reports for circumstances beyond the control
of the facility, i.e., for a possible outage in the CDX or CEDRI or for
a force majeure event in the time just prior to a report's due date, as
well as the process to seek such an extension.
---------------------------------------------------------------------------
\19\ https://www.epa.gov/electronic-reporting-air-emissions/electronic-reporting-tool-ert.
\20\ https://www.epa.gov/electronic-reporting-air-emissions/cedri.
---------------------------------------------------------------------------
For a more detailed discussion of these final amendments to the
Commercial Sterilization Facilities NESHAP, see section IV.G.2.g of the
proposal preamble (88 FR 22790, April 13, 2023), as well as section
VI.B below on compliance with the Paperwork Reduction Act. For a more
thorough discussion of electronic reporting, see the memorandum,
Electronic Reporting Requirements for New Source Performance Standards
(NSPS) and National Emission Standards for Hazardous Air Pollutants
(NESHAP) Rules, which is available in the docket for this rulemaking
(see Docket Item No. EPA-HQ-OAR-2019-0178-0398).
3. Title V Permitting
Because of the lack of other Federal requirements under the CAA
that commercial sterilization facilities are subject to, as well as the
robust monitoring and reporting requirements of the final rule, we are
not finalizing a requirement for area source facilities subject to
subpart O to obtain a title V permit from the delegated authority in
which the source is located.
4. Combined Emission Streams
To increase the ease and efficiency of complying with the revised
NESHAP, we are finalizing, based on comments received during the
proposed rulemaking, alternative compliance approaches for combined
emission streams. For these streams, facilities will now be allowed to
demonstrate compliance with a mass emission limit that is determined
based on the emission standards to which the component streams are
subject, as well as characteristics specific to those facilities. In
addition, we are finalizing an option for owners and operators to
demonstrate compliance with a site-wide emission limitation, as opposed
to demonstrating compliance for each individual and combined emission
stream.
5. Minor Clarifications and Corrections
We are including several additional minor clarifying edits in the
final rule based on comments received during the public comment period.
The comments and our specific responses to these items can be found in
the document, Summary of Public Comments and Responses for the 2024
Risk and Technology Review for Commercial Sterilization Facilities,
available in the docket for this rulemaking.
G. What are the effective and compliance dates of the standards?
The revisions to the standards being promulgated in this action are
effective on April 5, 2024. The compliance date for the standards
promulgated pursuant to CAA section 112(f)(2) for the following
existing sources is April 6, 2026:
SCVs at facilities where EtO use is at least 1 tpy,
ARVs at facilities where EtO use is at least 30 tpy,
[[Page 24102]]
CEVs at area source facilities where EtO use is at least
60 tpy,
Group 1 room air emissions at area source facilities where
EtO use is at least 40 tpy, and
Group 2 room air emissions at area source facilities where
EtO use is at least 4 tpy.
The compliance date for the standards promulgated pursuant to CAA
section 112(d)(2)-(3), 112(d)(5) or 112(d)(6) for the following
existing sources is April 5, 2027:
SCVs at facilities where EtO use is less than 1 tpy,
ARVs at facilities where EtO use is less than 30 tpy,
CEVs at major source facilities,
CEVs at area source facilities where EtO use is less than
60 tpy,
Room air emissions at major source facilities,
Group 1 room air emissions at area source facilities where
EtO use is less than 40 tpy, and
Group 2 room air emissions at area source facilities where
EtO use is less than 4 tpy.
As required by CAA section 112(i)(1), new sources must comply with
each applicable standard immediately upon its effective date, which is
April 5, 2024, or upon startup, whichever is later.
The compliance schedules for existing sources have changed since
proposal. We had proposed an 18-months compliance deadline for all of
the proposed standards for existing sources. Based on the comments
received, we have determined that 18 months is not a sufficient period
for sources to comply with the CAA section 112(d)(2)-(3), 112(d)(5) and
112(d)(6) standards for existing sources, for the following reasons:
Most commercial sterilization facilities were not
initially designed to be compliant with the PTE requirements of EPA
Method 204. We have learned from the comments received that for these
facilities, the capture requirements associated with the emission
reduction standards for Group 1 and Group 2 room air emissions in the
final rule will likely require a redesign of a portion if not all of
the facility. Many facilities will also need to purchase additional
equipment (e.g., fans, transformers, variable frequency drives, etc.)
to meet the capture requirements. Moreover, compliance with the final
emission standards will likely require the installation of additional
control devices. We have reviewed the time that it has taken for
previous projects of this nature to be completed, from submission of
the initial State or local permit application to installation of the
continuous compliance mechanisms. Based on this analysis, we find that
the process of bringing a facility into compliance with the PTE
requirements of EPA Method 204, as well as installing and verifying
additional emission controls, can take approximately a year from permit
submission to project completion. However, this estimate does not
account for the time needed to design and plan before the initial
permit application is submitted, nor for the time needed to avoid
impacts on medical device supply chains, to procure control devices
from a limited number of vendors, and to account for the other
complexities identified below.
The process of redesigning a facility or installing
additional controls will require some reduction in sterilization
capacity. Moreover, the process of coming into compliance with the
standards may require multiple facilities to reduce their sterilization
capacity simultaneously. Based on comments received during the proposed
rulemaking, the average reduction in capacity during the re-design and
installation period can range from 10 percent \21\ to 20 percent.\22\
In addition, there is already strain on the medical device supply
chain, and it is difficult for most facilities to absorb any additional
demand for sterilized product. Three years is needed to ensure that
owners and operators can come into compliance with the emissions
standards while at the same time minimizing any potential impacts to
the medical device supply chain, for which reliability is important to
protect public health.
---------------------------------------------------------------------------
\21\ Commenter provided the following statement: ``For example,
a 10% reduction in capacity across the 83 commercial sterilizers in
the U.S. implies that an additional 8 sterilization facilities will
be required to maintain existing throughput'' (see Docket Item No.
EPA-HQ-OAR-2019-0178-0618).
\22\ Commenter provided the following statement: ``During . . .
upgrades, EtO sterilization capacity was reduced by more than 20
percent as emissions control equipment was installed and tested.''
(see Docket Item No. EPA-HQ-OAR-2019-0178-0566).
---------------------------------------------------------------------------
There are a limited number of vendors that specialize in
the redesign of facilities to be compliant with the PTE requirements of
EPA Method 204. In addition, there are a limited number of control
technology vendors that supply the types of advanced control systems
that the EPA expects will be necessary for facilities to comply with
the final standards. Three years is needed to ensure that all owners
and operators can receive the necessary services and have the proper
equipment in place by the compliance date.
For the same reasons explained above, existing sources will need
more than the proposed 18 months to comply with the standards
promulgated under CAA section 112(f)(2). As with standards promulgated
under section 112(d)(2)-(3), 112(d)(5) and 112(d)(6), in most instances
compliance with the section 112(f)(2) standards will require sources to
plan, purchase, and install equipment for EtO control. For example, for
SCVs at facilities where EtO use is at least 30 tpy, if an existing
affected source currently does not achieve 99.99 percent control of EtO
emissions and a new control system is needed to meet that limit, the
facility will need time to properly engineer the project, obtain
capital authorization and funding, procure the equipment, construct the
equipment, start up the equipment, set up new software, develop
operating procedures, and train operators on the new equipment. The
additional factors identified above, such as avoiding impacts to
medical device supply chains and securing control devices from a
limited number of vendors, apply similarly to section 112(f)(2)
standards as to standards promulgated under section 112(d)(2)-(3),
112(d)(5) and 112(d)(6).
If facilities commence work on these emissions reduction efforts
immediately after this rule becomes effective, we believe that sources
will be able to comply with the standards in this final rule within the
two year compliance window set by Sec. 112(f)(4), without substantial
interruption in operations.
Specifically, we offer the following timeline as a general guide to
completing the necessary upgrades in a timely manner:
Step 1: Secure vendors for facility retrofits, control
devices, EtO CEMS, and any other equipment and services that will be
needed in order to comply with the NESHAP.
Step 2: Work with vendors on (1) any new facility designs
that will be required in order to meet the PTE requirements of EPA
Method 204, (2) any new control system designs that will be required in
order to meet the emission standards, (3) a schedule to ensure timely
compliance with the NESHAP, and (4) purchase of the equipment that will
be required in order to meet items (1) and (2), along with EtO CEMS.
Step 3: Submit a permit application to the relevant
permitting authority.
Step 4: Complete the necessary facility retrofits, control
device installations, and EtO CEMS installations.
Step 5: Test the control systems and facility air handling
systems in order to ensure that the NESHAP is being met.
We recognize that this is a significant undertaking for the
industry, and we encourage facilities to engage in these
[[Page 24103]]
steps as early as practicable, as opposed to delaying action until
closer to the end of the compliance period.
Although we believe sources that follow this timeline will be able
to comply with these standards within two years, to minimize any
potential impact to the medical device supply chain, we are allowing up
to three years for existing sources to comply with section 112(d)(2)-
(3), 112(d)(5) and 112(d)(6) standards, the maximum timeframe
authorized under CAA section 112(i)(3)(A). Further, CAA section
112(i)(3)(B) and EPA's regulation at 40 CFR 63.6(i)(4)(i)(A) authorize
States with delegated authority to implement and enforce this NESHAP to
grant an existing source an additional year to comply with section
112(d) standards, if such additional period is necessary for the
installation of controls.\23\ In addition, for each standard, owners
and operators will have 180 days after the end of the relevant
compliance period to begin demonstrating compliance with that standard.
See 40 CFR 63.7(a)(2).
---------------------------------------------------------------------------
\23\ This flexibility has been available since the NESHAP was
first promulgated (59 FR 62585, December 6, 1994) and continues to
be available in the current NESHAP.
---------------------------------------------------------------------------
Lastly, if more time is needed to comply with any standard in this
final rule, CAA section 112(i)(4) provides that ``The President may
exempt any stationary source from compliance with any standard or
limitation under this section for a period of not more than 2 years if
the President determines that the technology to implement such standard
is not available and that it is in the national security interests of
the United States to do so. An exemption under this paragraph may be
extended for 1 or more additional periods, each period not to exceed 2
years. The President shall report to Congress with respect to each
exemption (or extension thereof) made under this paragraph.''
IV. What is the rationale for our final decisions and amendments for
the Commercial Sterilization Facilities source category?
For each issue, this section provides a description of what we
proposed and what we are finalizing for the issue, the EPA's rationale
for the final decisions and amendments, and a summary of key comments
and responses. For all comments not discussed in this preamble, comment
summaries and the EPA's responses can be found in the comment summary
and response document available in the docket.
A. Amendments Addressing the Affected Source Definitions
1. What amendments did we propose to address the affected source
definitions?
For SCVs, ARVs, and CEVs, we proposed to define the affected source
as the individual vent. For Group 1 and Group 2 room air emissions we
proposed to define the affected source as the collection of all room
air emissions for each group at any sterilization facility. More
information concerning the affected source definitions is in section
III.A. of the proposal preamble (88 FR 22790, April 13, 2023).
2. How did the affected source definitions change since proposal?
We are finalizing the affected source definitions as proposed (88
FR 22790, April 13, 2023).
3. What key comments did we receive on the affected source definitions
and what are our responses?
Comment: Two commenters suggested that the definition of an
affected source should be based on control system outlets, stating that
when emission streams are combined, the limit must be based on the
actual achievable rate of control with further consideration for the
modeled risk of the facility. One commenter suggested that the affected
source should be defined as the sterilization facility as a whole, and
another commenter stated the affected source definition(s) should
consider destruction efficiency. Additionally, commenters expressed
concerns that the affected source definitions for point sources (i.e.,
SCVs, ARVs, and CEVs) would disproportionately favor facilities with
smaller capacity and facilities with multiple individual vents
regardless of size. Specifically, one commenter stated that a facility
with multiple individual vents would have a higher ``emission rate
ceiling'' with respect to mass rate (i.e., lb/h) emission limits.
Response: We disagree with the commenters' suggestion that the
definition of an affected source should be based on control system
outlets or the sterilization facility as a whole. There are many
different ways in which emission sources can be combined and controlled
at commercial sterilization facilities. If affected source definitions
were based on control system outlets, it is not clear which outlets
(and, by extension, emission source combinations) would be selected and
what the criteria for selecting those outlets would be. It is not
feasible to set an emission standard for every conceivable combination
of emission sources. Furthermore, the commenters do not provide any
suggestions on which control system outlets should be considered when
defining affected sources. The most straightforward approach is to
define the affected source as the emission source itself and to have
owners and operators decide how best to combine and control emissions
from affected sources at their facilities. With respect to defining the
affected source as the sterilization facility as a whole, there is very
limited data available where a performance test has been conducted for
an entire facility. Furthermore, defining the affected source as the
sterilization facility would require a compliance mechanism that some
facilities may find unnecessarily complicated, given that compliance
demonstration has typically been conducted on a source-by-source basis.
It is not clear and the commenter does not provide any explanation on
how to base an affected source definition on destruction efficiency.
Lastly, regarding the comment that the definition of affected
sources for point sources is disproportionally favorable to facilities
with smaller capacity or with multiple individual vents, this is not an
issue in the final rule. All of the emission standards in this final
rule are in a percent reduction format, which is the same regardless of
facility size or how many vents are in place. Therefore, concerns
regarding ``emission rate ceilings'' are no longer relevant.
Comment: One commenter stated that there is unnecessary complexity
to the proposed definitions of Group 1 and Group 2 room air emissions
due to the variability in size and facility configuration, particularly
as they apply to the proposed format of the emission standards for
these sources (i.e., lb/h). The commenter also stated that the
definitions favor facilities which have smaller capacity and noted that
individual facility characteristics must be considered for Group 1 and
Group 2 emissions. Specifically, the commenter stated that emission
rates should be based on technological feasibility to control
emissions, including feasibility limitations regarding low inlet
concentrations.
Response: We disagree with one commenter's assertion that there is
unnecessary complexity to the proposed definitions of Group 1 and Group
2 room air emissions due to the variability in size and facility
configuration. All sterilization facilities, regardless of size or
configuration, follow the same basic procedure: sterilization and its
associated activities (e.g., EtO storage and dispensing, vacuum pump
[[Page 24104]]
operation, handling of pre-aeration sterilized product), aeration, and
shipping. Group 1 room air emissions simply cover all activities that
occur prior to aeration, and Group 2 room air emissions cover all
activities that occur after aeration. Combining room air emissions
based on whether they occur before or after aeration is a clear way to
defining room air emissions affected sources. It also reflects the most
common controlled room air configuration that we have observed. With
respect to considering individual facility characteristics The simplest
breakdown of controlled room air emissions that we have observed
involves capturing and routing all emissions from post-aeration
handling of sterilization material to one control system, and then
capturing and routing all other room air emission sources (i.e., Group
1 room air emissions) to another control system. It is important to
define the affected sources for room air emissions in this manner so
that owners and operators can have flexibility in how they chose to
control their emissions,\24\ and so that facilities who have already
chosen to control their emissions in this manner can continue to do so
while minimizing any potential compliance issues. With respect to the
comment that the definition of affected sources for room air emissions
is disproportionally favorable to facilities with smaller capacity, the
comment appears to pertain more to the setting of the emission
standards themselves, rather than the affected source definition. As
discussed in section IV.B.3.b of this preamble, we are no longer
finalizing mass rate emission standards, and we are accounting for
technical feasibility (e.g., manufacturer guarantees, emission
reductions achieved in performance tests) when finalizing emission
standards. The emission standards in this final rule for room air
emissions are in a percent reduction format, which is the same
regardless of facility size.
---------------------------------------------------------------------------
\24\ The EPA has not observed any instance where a facility is
routing a portion of its Group 1 room air emissions to one control
system, and the other portion to a different control system.
---------------------------------------------------------------------------
4. What is the rationale for our final approach and final decisions to
address the affected source definitions?
We evaluated the comments on our proposed affected source
definitions. For the reasons explained in the proposed rule (88 FR
22790, April 13, 2023), we determined that these amendments are
necessary because the definition of an ``affected source'' at 40 CFR
63.2 is not appropriate for this source category. More information
concerning the amendments we are finalizing for affected source
definitions is in the preamble to the proposed rule and in the comments
and our specific responses to the comments in the document, Summary of
Public Comments and Responses for the Risk and Technology Review for
Commercial Sterilization Facilities, available in the docket for this
rulemaking. Therefore, we are finalizing the affected source
definitions as proposed.
B. Amendments Pursuant to CAA Sections 112(d)(2), 112(d)(3), and
112(d)(5) for the Commercial Sterilization Facilities Source Category
1. What did we propose pursuant to CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5) for the Commercial Sterilization Facilities source
category?
We proposed to establish standards under CAA sections 112(d)(2)-(3)
and 112(d)(5) for the following emission sources that were unregulated:
SCVs, ARVs, and CEVs at facilities where EtO use is less than 1 tpy,
ARVs and CEVs at facilities where EtO use is at least 1 tpy but less
than 10 tpy, CEVs at facilities where EtO use is at least 10 tpy, and
room air emissions. We also proposed a technical correction to the
emission standard for ARVs at facilities where EtO use is at least 10
tpy. We proposed the following emission standards pursuant to CAA
section 112(d)(2)-(3):
3.2E-4 lb/h for new and existing CEVs at facilities where
EtO use is at least 10 tpy,
1.3E-3 lb/h for new and existing Group 1 room air
emissions at major source facilities, and
2.8E-3 lb/h for new and existing Group 2 room air
emissions at major source facilities.
For more information, see section III.B of the proposal preamble
(88 FR 22790, April 13, 2023). We proposed the following emission
standards pursuant to CAA section 112(d)(5):
99 percent emission reduction for new and existing SCVs at
facilities where EtO use is less than 1 tpy,
99 percent emission reduction for new and existing ARVs at
facilities where EtO use is at least 1 tpy but less than 10 tpy,
99 percent emission reduction for new and existing ARVs at
facilities where EtO use is less than 1 tpy,
99 percent emission reduction for new and existing CEVs at
facilities where EtO use is at least 1 tpy but less than 10 tpy,
99 percent emission reduction for new and existing CEVs at
facilities where EtO use less than 1 tpy.
1.3E-3 lb/h emission limit for new and existing Group 1
room air emissions at area source facilities, and
2.8E-3 lb/h emission limit for new Group 2 room air
emissions at area source facilities.
These are emissions standards that reflect the use of generally
available control technologies. For more information, see section III.B
of the proposal preamble (88 FR 22790, April 13, 2023).
For existing Group 2 room air emissions at area source facilities,
pursuant to CAA section 112(d)(5), we proposed a requirement for
facilities to follow either the Cycle Calculation Approach or the
Bioburden/Biological Indicator Approach to achieve sterility assurance
in accordance with ISO 11135:2014 and ISO 11138-1:2017. This is a BMP
that would reduce EtO use per sterilization cycle (i.e., pollution
prevention). For more information, see section III.B.8.g of the
proposal preamble (88 FR 22790, April 13, 2023). In order to ensure
complete capture of EtO emissions and, in turn, compliance with the
proposed standards, we proposed to require each facility to operate
areas with room air emissions subject to an emission standard in
accordance with the PTE requirements of EPA Method 204 of appendix M to
40 CFR part 51. For more information, see section III.B of the proposal
preamble (88 FR 22790, April 13, 2023).
We addressed a necessary correction to the emission standards for
these sources in 40 CFR 63.362(d) that allow facilities to either
achieve 99 percent emission reduction or limit the outlet concentration
to a maximum of 1 part per million by volume (ppmv), ``whichever is
less stringent, from each aeration room vent.'' We proposed removing
the less stringent 1 ppmv concentration alternative for these sources
because it is not equivalent and therefore not an appropriate
alternative to 99 percent emission reduction standard. For more
information, see section III.B.2 of the proposal preamble (88 FR 22790,
April 13, 2023).
2. How did the revisions pursuant to CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5) change since proposal for the Commercial Sterilization
Facilities source category?
We are finalizing as proposed the following standards under CAA
section 112(d)(5):
99 percent emission reduction for new and existing SCVs at
facilities where EtO use is less than 1 tpy,
99 percent emission reduction for new and existing ARVs at
facilities
[[Page 24105]]
where EtO use is at least 1 tpy but less than 10 tpy, and
99 percent emission reduction for new and existing ARVs at
facilities where EtO use is less than 1 tpy.
In addition, we are finalizing a requirement for each facility to
operate areas with room air emissions subject to an emission standard
in accordance with the PTE requirements of EPA Method 204 of appendix M
to 40 CFR part 51. We are also finalizing the removal of the 1 ppm
alternative for ARVs at facilities where EtO use is at least 10 tpy, as
proposed.
Based on comments received during the proposed rulemaking, we have
revised the proposed standards for the following affected sources. The
final emission standards pursuant to CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5) are as follows:
99.94 percent emission reduction for new and existing CEVs
at major source facilities,
99 percent emission reduction for new and existing CEVs at
area source facilities,
97 percent emission reduction for new and existing Group 1
room air emissions at major source facilities,
80 percent emission reduction for new and existing Group 1
room air emissions at area source facilities,
86 percent emission reduction for new and existing Group 2
room air emissions at major source facilities,
For existing Group 2 room air emissions at area source
facilities, lower the EtO concentration within each sterilization
chamber to 1 ppm before the chamber can be opened, and
80 percent emission reduction for new Group 2 room air
emissions at area source facilities.
For new and existing CEVs at major source facilities, as well as
new and existing room air emissions at major source facilities, based
on comments received during the proposed rulemaking, we have re-
calculated the MACT floor based on percent emission reduction, as
opposed to mass rate emissions. The primary reason for finalizing this
change is that there is a serious concern that mass rate emission
standards could result in operational reductions that could adversely
impact the medical supply chain. The revised MACT floor for new and
existing CEVs at major source facilities is 99.94 percent emission
reduction. Because we were unable to identify more stringent (i.e.,
beyond the floor or ``BTF'') options that are cost-effective, we are
finalizing 99.94 percent emission reduction as the MACT standard under
CAA section 112(d)(2)-(3) for new and existing CEVs at major source
facilities. The revised MACT floor for new and existing Group 1 room
air emissions at major source facilities is 90 percent emission
reduction. We were able to identify a more stringent (i.e., 97 percent
control) and cost-effective BTF option and, therefore, we are
finalizing a 97 percent emission reduction standard as the MACT
standard under CAA section 112(d)(2)-(3) for new and existing Group 1
room air emissions at major source facilities. The revised MACT floor
for new and existing Group 2 room air emissions at major source
facilities is 86 percent emission reduction. Because the concentration
that corresponds to this emission reduction is three times the
representative detection level (RDL) for EtO, there are no BTF options
to consider due to the potential difficulty of demonstrating compliance
with limits lower than the MACT floor. Therefore, we are finalizing 86
percent emission reduction as the MACT standards for new and existing
Group 2 room air emissions at major source facilities. For more
information, see section IV.B.3.b of this preamble.
For both new and existing Group 1 room air emissions at area source
facilities, as well as new Group 2 room air emissions at area source
facilities, based on comments received during the proposed rulemaking,
we are finalizing an 80 percent emission reduction standard, consistent
with the manufacturer guarantee for the control technology on which the
standard is based. The primary reason for the change from mass rate to
percent reduction is that there is a serious concern that mass rate
emission standards could result in operational reductions in order to
meet the standards while still ensuring work health and safety, but
that could adversely impact the medical supply chain. In addition,
while some sources have demonstrated emission reductions higher than 80
percent, those reductions are limited to facilities with higher EtO
usage rates, and we cannot determine whether smaller users of EtO can
meet those emission reductions. For more information, see section
IV.B.3.b of this preamble.
For existing Group 2 room air emissions at area source facilities,
based on comments received during the proposed rulemaking, we are
finalizing a revised BMP due to concerns that the BMP that we proposed
(as well as alternatives for which we solicited comment in the
proposal), would adversely impact the medical supply chain due to
inefficiencies that would arise, as well as having to lengthen cycle
dwell times in order to ensure sterility. The final requirement reduces
existing Group 2 room air emissions at area source facilities by 20
percent, does not interfere with sterility assurance, and is expected
to impact only 20 percent of facilities. We do not anticipate any
severe negative impacts to the medical supply chain as a result of
finalizing this requirement. For more information, see section IV.B.3.a
of this preamble.
3. What key comments did we receive on the proposal revisions pursuant
to CAA section 112(d)(2), 112(d)(3), and 112(d)(5), and what are our
responses?
This section provides comment and responses for the key comments
received regarding BMPs, mass rate emission standards, PTE, and
warehouses. Other comment summaries and our responses for additional
issues raised regarding these activities, as well as issues raised
regarding our proposed emission standards for SCVs and ARVs at
facilities where EtO use is less than 1 tpy, ARVs at facilities where
EtO use is a least 1 tpy but less than 10 tpy, room air emissions at
major source facilities, and our proposed technical correction to the
emission standard for ARVs at facilities where EtO use is at least 10
tpy can be found in the document, Summary of Public Comments and
Responses for the Risk and Technology Review for Commercial
Sterilization Facilities, available in the docket for this rulemaking.
a. BMP
Comment: Several commenters contended that we should not require
facilities to follow either the Cycle Calculation Approach or the
Bioburden/Biological Indicator Approach to achieve sterility assurance
in accordance with ISO 11135:2014 and ISO 11138-1:2017. They stated
that owners and operators should have the flexibility to optimize
cycles using a variety of ISO/AAMI 11135 methods and that we should not
limit or restrict the validation method that may be used.
One commenter stated that requiring facilities to follow the Cycle
Calculation or Bioburden/Biological Indicator Approach would result in
more dedicated product loads, more cycles needed to sterilize different
project mixes, and most chambers not being filled to capacity. The
commenter stated that de-consolidation of existing cycles to implement
an appropriate Cycle Calculation or Bioburden/Biological Indicator
approach would require (1) creation and validation of new product
families, new process challenge devices, and biological indicators, (2)
cycle development, and (3) maintenance through requalification and
annual reporting. The commenter noted that the
[[Page 24106]]
extra burden associated with maintaining more cycles would create more
work and require more chamber time, resulting in less sterilization
capacity. Two commenters stated that requiring either the Cycle
Calculation or Bioburden/Biological Indicator approach could limit
research for product innovation as available development time in EtO
sterilization chambers would be taken up for optimizing existing
products.
Two commenters stated the ISO standards were intended for the
process of EtO sterilization and not emission reduction or controls.
One commenter further contended it is a faulty approach to base
emission standards on international standards, as these standards are
revised periodically and may continue to evolve. Another commenter
noted that ISO/AAMI standards are currently being revised to be more
flexible to achieve optimized cycles, while minimizing impact on
sterilization capacity. The commenter contended that cycle validation
must focus on achieving sterility required for patient safety and
assuring product performance and reliability, and that reducing EtO use
cannot take priority over patient safety.
One commenter stated that conducting Cycle Calculation studies for
every product type or category would not be feasible with the current
capacity. The commenter stated this would require effort to redesign
sterilization cycles, evaluate product and packaging performance, and
validate the redesigned cycles. The commenter also stated that the new
validation work will impact sterilization capacity as sterilizer
equipment is not available for production use during study times (i.e.,
production capacity is diverted to cycle validation). The commenter
further stated that sites that use more than one vendor would have to
redesign sterilization cycles at each vendor and that, given the
limited resources and expertise, this would not be possible to achieve
on this scale. Another commenter stated they have not been able to
ensure product sterility using Cycle Calculation approach.
Finally, one commenter stated that the Bioburden/Biological
Indicator methods limit the number of products that can be validated in
a single cycle. The commenter stated that the Bioburden/Biological
Indicator approach may be limited to a range of products with similar
attributes and drive up the number of required cycles. The commenter
also stated that each validated cycle will require requalification
every few years, and the additional testing at sterilizers and testing
laboratories will decrease available sterilization capacity. The
commenter stated that the inability to fill a sterilization chamber
fully with product and waiting until full can lead to inefficient use
of sterilization chambers and supply issues. Another commenter stated
the Bioburden/Biological Indicator approach results in additional cost
and delays, as it requires that the product bioburden levels be
enumerated and characterized, and that consistency in the bioburden
population and the bioburden's resistance to the sterilization process
remain relatively stable over a multi-year period. The commenter also
stated that it may take many years to establish the range in numbers
and types of bioburden to properly perform a validation using this
proposed Bioburden/Biological Indicator approach. Another commenter
stated that the Bioburden approach would require upgrades to supplier
facilities, manufacturing facility, and microbiological control
practices.
Response: We agree with the commenters' concerns regarding
potential inefficiencies in the sterilization process that may arise
from requiring facilities to follow either the Cycle Calculation
Approach or the Bioburden/Biological Indicator Approach to achieve
sterility assurance in accordance with ISO 11135:2014 and ISO 11138-
1:2017, along with the potentially adverse impacts to the medical
supply chain that could result from the proposed approach. These
inefficiencies include reduced cycle optimization (i.e., not being able
to sterilize as much product per load or chamber), having to run more
cycles overall in order to meet the demand for sterile medical devices,
and diverting already strained resources away from normal operations to
developing new cycle validations. We also agree with the commenters'
concerns that requiring facilities to follow this requirement would
limit research for product innovation. Given the current strain on
resources, some companies may not be able to invest in additional
chambers to conduct research. In addition, we agree with the
commenters' concerns that because this requirement is based on
international standards, which are revised periodically, this could
result in potential future complications. Therefore, we are not
including this requirement in the final rule.
Comment: As mentioned above, the EPA solicited comments on several
other BMPs, including limiting EtO concentration limit and limiting
packaging and pallet material. Two commenters stated that it is not
technically feasible for facilities and products to meet a 290
milligrams per liter (mg/L) EtO concentration limit. One commenter
stated that many industry guidelines and studies show that 400 mg/L is
the minimum recommended concentration, and many products use higher
concentrations to meet sterility assurance and product quality
requirements as set forth by FDA. Another commenter stated that process
efficiency is reduced with concentrations below 400 mg/L and that
efficiency is constant at concentrations greater than 500 mg/L. One
commenter indicated that an EtO concentration range of 400 to 650 mg/L
is common practice because it achieves microbiological lethality for
most products within a reasonable exposure time. Another commenter
stated that product design, stability post-sterilization, and lethality
are the drivers behind the choice of EtO concentration. The commenter
also stated that research and development with biological indicators is
routinely conducted using 600 mg/L cycles and that enforcing a lower
limit may have an unintended negative consequence on the availability
of biological indicators required for sterilization process validation
and routine monitoring. One commenter stated we should not propose to
limit the EtO concentration to 290 mg/L for small facilities and that
we should, instead, allow performance-based standards. In addition,
several commenters stated that an upper-bound limit on EtO
concentration may lead to longer cycle times and dwell times and that
longer dwell times would impact sterilization capacity and would lead
to offshoring, as well as the construction of additional facilities.
One commenter stated limiting packaging and pallet material will
interrupt trade, reduce innovation, increase the cost of medical
devices, and disrupt the medical device manufacturing industry without
a quantifiable reduction in EtO emissions. Two commenters stated that
packaging and pallet material selection will drive the design of
medical products. Two commenters noted that packaging requirements are
in place to ensure a sterile barrier until use and to prevent product
damage. One commenter stated packaging must pass rigorous test
requirements, according to industry standards. Another commenter
indicated that facilities use barcode instructions for use (IFUs) in
place of paper IFUs when possible. However, paper IFUs are regulated by
FDA. Two commenters noted that paper IFUs have not been documented to
be a source of residual emissions. Another commenter
[[Page 24107]]
stated that there is no evidence that barcode materials would have less
EtO retention than paper, and that labeling decisions have practical
and legal considerations. One commenter noted that a minimal amount of
plastic wrap is used to ensure the structural integrity of pallets
during shipping and that excessive plastic is not in the interest of
sterilization facilities, as it slows EtO penetration. The commenter
also stated that kits are transported in cardboard to protect from
punctures, and it is not possible to eliminate cardboard. A puncture to
a kit means the kit needs to be re-sterilized, requiring use of
additional EtO. One commenter stated that changes to pallet material
could have supply chain issues given interoperability and weight
requirements. Finally, another commenter stated that pallet materials
impact the strength and design of pallet, and any issues would have
implications for the entre medical device supply chain.
Response: We agree with the commenters' concerns regarding the
issues with prescribing an upper-bound limit on in-chamber EtO
concentration, as well as the negative impacts to the medical supply
chain that could result from increasing the dwell time to maintain
sterility as an outcome of such a requirement. Therefore, we are not
including this requirement in the final rule. We also agree with the
commenters' concerns regarding the need to ensure a sterile barrier
through sufficient packaging, as well as the potential supply chain
impacts from placing limits on the types of pallets that may be used.
Therefore, we are not requiring limits on packaging or transport
materials as part of this rulemaking.
Comment: One commenter recommended an end of sterilization cycle
chamber limit of less than 1 ppm (with a zero mg/L reading) in the
sterilization chamber (EtO remaining calculated measurement) as a BMP.
The commenter stated that removing EtO from the sterilization chamber
is the most efficient stage for EtO removal. The commenter further
stated that longer EtO dwell times, as well as the potential for the
elimination of nitrogen gas washes to keep total cycle time equivalent,
could result in more EtO residual at aeration and the greater potential
for room air emissions after aeration.
Response: We agree with the commenter's suggestion of a requirement
to limit the in-chamber EtO concentration to 1 ppm. It does not
interfere with sterility assurance, and, based on responses to the
December 2019 questionnaire and September 2021 Information Collection
Request (ICR), 80 percent of all commercial sterilization facilities,
regardless of annual EtO use, are already meeting this limit. Those who
are not meeting the limit currently are close to the limit,\25\ so we
do not anticipate any severe negative impacts to the medical device
supply chain as a result of finalizing this requirement. We estimate
that the emission reductions from applying this requirement to the
source category would be 20 percent. In addition, since 80 percent of
facilities are already meeting this limit, this would result in an 80
percent reduction in costs. We have evaluated the changes in cost,
emissions, and cost-effectiveness for this BMP, and it is more cost-
effective than the other options we considered. Therefore, for Group 2
room air emissions we are finalizing the BMP such that the in-chamber
EtO concentration is to be lowered to 1 ppm before the chamber can be
opened. We note that, even though this BMP is expected to result in
fewer emission reductions than the BMP we proposed, this rule will
still reduce EtO emissions (and, therefore, lifetime cancer risks) in
multiple communities across the country. As discussed in section
IV.C.2.a.iii, this BMP will ultimately apply only to facilities where
EtO use is less than 4 tpy. We are finalizing the requirement that area
source facilities whose EtO usage is at least 4 tpy but less than 20
tpy and area source facilities whose EtO usage is at least 20 tpy are
required to reduce Group 2 room air emissions by 80 percent and 98
percent, respectively (see section IV.C.2.a.iii for more information).
For SCVs and ARVs at facilities where EtO use is less than 1 tpy, as
well as ARVs at facilities where EtO use is less than 10 tpy, our
general rationale for proposing emission standards over the BMP was
that emission standards would both achieve greater emission reduction
and incur fewer annual costs than the BMP. However, even considering
lower annual costs for the BMP, the emission standards would still
achieve greater emission reduction. Therefore, for SCVs and ARVs at
facilities where EtO use is less than 1 tpy, as well as ARVs at
facilities where EtO use is less than 10 tpy, we are finalizing the
emission standards as proposed pursuant to CAA section 112(d)(5). For
CEVs at area source facilities, as well as room air emissions at area
source facilities, we are also evaluating percent emission reduction
standards, as opposed to mass rate emission standards. The revised GACT
analyses for those emission sources are presented in section IV.B.3.b
of this preamble.
---------------------------------------------------------------------------
\25\ The highest concentration that was reported prior to
opening the chamber door was 20 ppm. While this may seem high, this
is reduced from starting EtO concentrations of several thousand ppm
(see section IV.F.3 of this preamble for further discussion).
---------------------------------------------------------------------------
Comment: Several commenters stated that we do not have the
legislative authority or expertise to regulate sterilization cycles and
that FDA is the Federal agency that has authority to regulate medical
device sterilization. They stated that Congress gave FDA the authority
to ensure the availability of safe and effective medical products and
that we must not finalize any regulatory requirements that are under
FDA purview.
Response: The EPA proposed the BMP (i.e., require facilities to
follow either the Cycle Calculation Approach or the Bioburden/
Biological Indicator Approach) pursuant to CAA section 112(d)(5), which
authorizes the EPA to set standards for area sources that provide for
the use of generally available control technologies or management
practices to reduce emissions. In addition, CAA section 112(h)(1)
authorizes the EPA to promulgate a design, equipment, work practice or
operational standard, or a combination thereof, if the EPA does not
think it can prescribe an emission standard. We have identified
modification of the post-sterilization process (e.g., reducing the EtO
concentration within the sterilization chamber prior to opening the
chamber) as a BMP that can reduce EtO emissions from certain affected
sources at commercial sterilization area source facilities. Neither CAA
section 112(d)(5) nor section 112(h)(1) limits the scope of management
or work practices that the EPA may consider in setting standards to
control HAP, nor did the commenter identify any such legal limitation
in the CAA or other applicable legal authorities. As discussed above,
we are not finalizing the proposed BMP; in response to comment, we are
finalizing a requirement for area source facilities with existing Group
2 room air emissions to lower the in-chamber EtO concentration to 1 ppm
before the chamber is opened.\26\ As discussed in
[[Page 24108]]
section IV.C.2.a.iii of this preamble, this requirement will ultimately
apply only to existing Group 2 room air emissions at facilities where
EtO use is less than 4 tpy. Based on responses to the December 2019
questionnaire and the September 2021 ICR, we have not identified any
facilities where EtO use is less than 4 tpy that are not currently
meeting this requirement. Therefore, in general, we do not anticipate
that any facilities will need to go through a new cycle validation as a
result of this requirement. Based on our conversations with FDA, this
requirement is not anticipated to have an adverse impact on the medical
device supply chain.
---------------------------------------------------------------------------
\26\ We have previously regulated the in-chamber EtO
concentration when we established standards for CEVs at facilities
where EtO use is at least 1 tpy but less than 10 tpy (59 FR 62586,
December 6, 1994). These requirements were removed initially due to
safety concerns regarding the regulation of emissions from CEVs, not
related to any limitations on our authority. See discussion in
section III.B.5 of the proposal preamble (88 FR 22790, April 13,
2023) for more information regarding why safety is not a concern
regarding the requirements finalized in this action.
---------------------------------------------------------------------------
b. Mass Rate Emission Standards
Comment: Several commenters were opposed to mass rate emission
standards, stating that they do not account for the substantial
variability among volumetric flow rates in sterilization operations.
The commenters expressed concerns with potential operational reductions
needed in order to meet the standards while still ensuring worker
health and safety, as well as compliance with EPA Method 204. The
commenters suggested that we finalize emission reduction and outlet
concentration standards instead. In addition, these commenters
recommended that these standards be based on control device
manufacturer guarantees. One commenter stated that, based on their
discussions with control device manufacturers, they believe that the
best and most advanced technologies will be guaranteed to meet a 99
percent emission reduction standard for CEVs and an 80 percent emission
reduction standard for room air emissions.
Response: We agree with the commenters' concerns regarding the
potential impacts of mass rate emission standards. Given the low outlet
EtO concentration of these streams, along with current EtO detection
levels, a mass rate emission standard essentially functions as an
upper-bound limit on volumetric flow rate. It may not be appropriate to
limit volumetric flow rate in this fashion, as additional flow may be
needed in order to demonstrate compliance with EPA Method 204 or to
ensure worker health and safety. If volumetric flow rate is limited, a
facility may be forced to reduce its sterilization capacity in order to
meet the mass rate emission standards. However, we disagree with the
commenters' suggestion that outlet concentration standards be
considered. We are concerned that some owners and operators may choose
to dilute the air flow of the emissions stream rather than control
emissions, in order to meet an outlet concentration standard, which
would not result in emission reductions. In order to ensure emission
reductions from an outlet concentration standard, an upper-bound limit
on the volumetric flow rate would be necessary. As we have discussed
before, this may be inappropriate for the source category. Therefore,
although we proposed mass emission rate standards, we are finalizing
percentage emission reduction standards in their place, and those
specific standards are discussed later in this section.
We re-calculated the MACT floor for existing CEVs at major source
facilities. We ranked the percent reduction performance of the CEVs
``for which the EPA has emissions information'' and found the best
performing 12 percent of CEVs consists of one CEV that is being
controlled by a gas/solid reactor.\27\ Because the variability and
uncertainty associated using available, short-term data would tend to
reduce the minimum percent reduction, we then used the lower, not
upper, prediction limit approach to develop the MACT floor for existing
sources.\28\ The LPL approach predicts the level of emissions that the
sources upon which the floor is based are expected to meet over time,
considering both the average emissions level achieved as well as
emissions variability and the uncertainty that exists in the
determination of emissions variability given the available, short-term
data. For LPLs, our practice is to use the first percentile, or LPL 1,
as that is the level of emission reductions that we are 99 percent
confident is achieved by the average source represented in a dataset
over a long-term period based on its previous, measured performance
history as reflected in short term stack test data. The LPL 1 value of
the existing source MACT floor is 99.94 percent emission reduction. The
LPL 1 EtO concentration that corresponds to this emission reduction
rate is 49 ppbv. Based on our review of available EtO measurement
instruments and our demonstration program, we find the in-stack
detection level for EtO, given the current technology, and potential
makeup of emission streams, is approximately 10 ppbv. Some EtO CEMS
manufacturers claim instrument detection levels much lower than 10
ppbv. However, we believe at the current time, 10 ppbv is the lowest
level that can be consistently demonstrated and replicated across a
wide range of emission profiles. We expect that EtO CEMS manufacturers,
measurement companies, and laboratories will continue to improve EtO
detection levels (making them lower). In the meantime, consistent with
our practice regarding reducing relative measurement imprecision by
applying a multiplication factor of three to the RDL, the average
detection level of the best performers, or, in this case, the better
performing instruments, so that measurements at or above this level
have a measurement accuracy within 10 to 20 percent--similar to that
contained in the American Society of Mechanical Engineers (ASME) ReMAP
study,\29\ we apply a multiplication factor of three to the RDL of 10
ppbv, which yields a workable-in-practice lower measurable value of 30
ppbv. For reference, below is the equation that relates the percent
emission reduction, inlet EtO concentration, and outlet EtO
concentration:
---------------------------------------------------------------------------
\27\ See CAA section 112(d)(3). See also, National Ass'n of
Clean Water Agencies v. EPA, 734 F.3d 1115, 1131 (2013) (citing
Sierra Club v. EPA, 167 F.3d 658, 661 and 662) (``We accorded
Chevron deference to EPA's . . . estimate of the MACT floor, noting
that the requirement that the existing unit floors `not be less
stringent than the average emissions limitation achieved by the best
performing 12 percent of units' does not, on its own, dictate `how
the performance of the best units is to be calculated, . . . [and]
recognizing that `EPA typically has wide latitude in determining the
extent of data gathering necessary to solve a problem.' ''
\28\ The variability for a DRE format limit requires use of a
lower prediction limit (LPL), the UPL template was therefore
modified for use to determine the LPL; rather than use of the 99th
percentile that captures the ``right tail'' of the data
distribution, the LPL template uses the 1st percentile, i.e.,
captures the ``left tail'' of the data distribution (the t-statistic
is 0.01). The LPL differs from the more commonly used UPL in that
variability and uncertainty associated with percent reduction limits
tend to make the predicted limits smaller than their averages; for
UPL applications, variability and uncertainty associated with
emission limits tend to make those predicted limits larger than
their averages. Both approaches--UPL and LPL--rely on the same set
of equations developed for the UPL; they only differ in the selected
percentile. In other words, the LPL relies on calculations
associated with the first percentile (LPL 1) of the data
distribution, which is below the fiftieth percentile (LPL 50), or
average for data with a normal distribution, while the UPL relies on
calculations associated with the ninety-ninth percentile (UPL 99) of
the data distribution, which is above the fiftieth percentile (UPL
50), or average for data with a normal distribution. Also note that
for data in a normal distribution, LPL 50 = UPL 50.
\29\ See the discussion in the MATS rule preamble at 77 FR 9370,
February 16, 2012.
[GRAPHIC] [TIFF OMITTED] TR05AP24.000
Where, ER is the percent emission reduction, EtOIM is
the inlet EtO mass, and EtOOM is the outlet EtO mass. Since
[[Page 24109]]
the outlet EtO concentration that corresponds to the MACT floor of
99.94 percent emission reduction is above 3xRDL, there are more
stringent (i.e., BTF) options to consider.\30\ We considered two BTF
options for reducing EtO emissions from this source: the first option
is 99.95 percent emission reduction, and the second option reflects the
most stringent emission reduction for which compliance can be
demonstrated. With respect to the second option, the most stringent
emission reduction for which compliance can be demonstrated is that
which corresponds to an outlet concentration of 30 ppbv (i.e., 3xRDL).
This emission reduction is 99.96 percent, which is lower than all of
the reported emission reductions in the test runs that were used to
calculate the MACT floor. The impacts of these options are presented in
table 7. Because we have not identified any major source facilities
with existing CEVs, the impacts are based on a model plant for existing
CEVs at a synthetic area source facility with the following assumptions
reflecting the average of each of the parameters at synthetic area
source facilities:
---------------------------------------------------------------------------
\30\ As Judge Williams explained in his concurring opinion in
Sierra Club v. EPA, CAA ``Section 112(d)(2) calls for emissions
standards that are the most stringent that the EPA finds to be
`achievable,' taking into account a variety of factors including
cost. . . . The ``achievable'' standards have come to be known as
the ``beyond-the-floor'' standards, . . . meaning, obviously, ones
more stringent than the ``floors'' established under Sec.
112(d)(3).'' 479 F.3d 875, 884 (D.C. Cir. 2007).
---------------------------------------------------------------------------
Annual EtO use: 200 tpy.
Annual operating hours: 8,000.
Portion of EtO going to CEVs: 1 percent.
CEV flow rate: 278 cubic feet per second (cfs).
Table 7--Nationwide Emissions Reduction and Cost Impacts of BTF Options Considered Under CAA Sections 112(d)(2) and 112(d)(3) for CEVs at Major Source
Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual EtO emission reductions Cost effectiveness ($/
Option Proposed standard investment ($) costs ($/yr) (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
MACT Floor........................... 99.94 percent emission $830,000 $176,000 2.4E-2 [480 lb/yr]...... $735,000 [$370/lb].
reduction.
1.................................... 99.95 percent emission 184,000 65,500 2.0E-4 [0.4 lb/year].... 328,000,000 [$164,000/
reduction. lb].
2.................................... 99.96 percent emission 184,000 66,200 2.0E-4 [0.4 lb/year].... 331,000,000 [$166,000/
reduction. lb].
--------------------------------------------------------------------------------------------------------------------------------------------------------
While we acknowledge that EtO is a highly toxic HAP, the cost
estimates above are far outside the range of the cost-effectiveness
values that we have determined to be cost-effective for highly toxic
HAPs (e.g., we finalized a requirement with a cost-effectiveness of
$15,000/lb ($30,000,000/ton) for existing small hard chromium
electroplating to provide an ample margin of safety (taking into
account cost among other factors) (77 FR 58227-8, 58239). Based on the
estimates above, we find neither option to be cost effective.
Therefore, the final MACT standard for existing CEVs at major source
facilities is 99.94 percent emission reduction.
For new sources, CAA section 112(d)(3) requires that the standard
shall not be less stringent than the emission control that is achieved
in practice by the best controlled similar source. In this case, the
best controlled similar source is also the CEV that is being controlled
by a gas/solid reactor and the data of which is used to determine the
MACT floor for existing sources. Therefore, the new source MACT floor
is equivalent to the existing source MACT floor, which is 99.94 percent
emission reduction. As explained above, because this emission reduction
limit is above the lowest level at which compliance can be
demonstrated, the EPA considered more stringent (i.e., BTF) options. We
considered the same BTF options as those evaluated for existing CEVs at
major source facilities, for the same reasons explained above. The
first BTF option would require achieving 99.95 percent emission
reduction, and the second BTF option would require achieving 99.96
percent emission reduction. The impacts of these options are presented
in table 7 of this preamble. Because we have not identified any major
source facilities with existing CEVs, the impacts are based on a model
plant for existing CEVs at a synthetic area source facility. Based on
the estimates above and for the reason explained above, we find neither
option to be cost effective. Therefore, the final MACT standard for new
CEVs at major source facilities is 99.94 percent emission reduction.
For the reasons explained above, our final MACT standards under CAA
sections 112(d)(2) and (3) for both new and existing CEVs at major
source facilities require these facilities to reduce the EtO emissions
from new and existing CEVs by 99.94 percent.
For existing CEVs at area source facilities, we considered two
potential GACT options for reducing EtO emissions from this group: the
first option reflects the use of emission controls on the CEVs, and the
second option reflects applying a BMP to lower the in-chamber EtO
concentration to 1 ppm before the chamber is opened (i.e., pollution
prevention). With respect to the first option, because 34 out of 40
area source facilities with CEVs already using controls to reduce CEV
emissions, and we have no reason to believe that the other six cannot
do the same, we consider emission controls to be generally available
for existing CEVs at these facilities. Evaluating the available
information on controls, including the documented control efficiency
for 12 facilities in the category, we determined that a control
efficiency of 99 percent is generally available for existing CEVs at
area source facilities. The second potential GACT option we considered
was the same management practice discussed in section IV.B.3.a of this
preamble, which would require facilities to lower the in-chamber EtO
concentration to 1 ppm before the chamber is opened. The impacts of
these two options are presented in table 8.
[[Page 24110]]
Table 8--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for Existing CEVs at Area Source Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual costs ($/ EtO emission Cost effectiveness ($/
Option Proposed standard investment ($) yr) reductions (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................. 99 percent emission $1,750,000 $740,000.............. 3.84 [7,680 lb/year].. 193,000 [$96/lb]
reduction.
2.................................. BMP (estimated 20 percent 0 $3,560,000 (one-time 0.796 [1,590 lb/year]. $4,470,000 [$2,240/lb]
emission reduction). annual cost) \1\.
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as preparing and submitting the necessary paperwork to FDA for approval. It is expected that facilities will only incur
this cost once and it is assumed to be incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating
total annual costs (i.e., annualized capital costs plus annual costs) in the analysis.
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness numbers of these options are
within the range of the values that we have determined to be cost-
effective for highly toxic HAPs. Such values include hexavalent
chromium, where we finalized a requirement with a cost-effectiveness of
$15,000/lb ($30,000,000/ton) for existing small hard chromium
electroplating to provide an ample margin of safety (taking into
account cost among other factors) (77 FR 58227-8, 58239). We are
finalizing Option 1 for the following reasons. First, while both
options are considered generally available under CAA section 112(d)(5),
Option 1 would achieve much greater emission reduction than Option 2.
Second, Option 1 would incur fewer annual costs than Option 2.
Therefore, pursuant to CAA section 112(d)(5), we are finalizing Option
1 for existing CEVs at area source facilities. Specifically, we are
finalizing a requirement for these facilities to continuously reduce
emissions from existing CEVs by 99 percent.
For new CEVs at area source facilities, we considered two potential
GACT options similar to those evaluated for existing CEVs at area
source facilities. The first potential GACT option would require
achieving 99 percent emission reduction. The second potential GACT
option we considered is a BMP described in section IV.B.3.a, which
would require facilities to lower the in-chamber EtO concentration to 1
ppm before the chamber is opened. The impacts of these options, which
are presented in table 9 of this preamble, are based on a model plant
for new CEVs at a new area source facility with the following
assumptions reflecting the average of each of the parameters at
existing area source facilities:
Annual EtO use: 100 tpy.
Annual operating hours: 8,000.
Portion of EtO going to CEVs: 1 percent.
CEV flow rate: 200 cubic feet per second (cfs).
Number of unique cycles: nine.
Table 9--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for New CEVs at Area Source Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual costs ($/ EtO emission Cost effectiveness ($/
Option Proposed standard investment ($) yr) reductions (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................. 99 percent emission $553,000 $142,000.............. 0.99 [1,980 lb/year].. $144,000 [$72/lb]
reduction.
2.................................. BMP (estimated 20 percent 0 $80,000 (one-time 0.20 [400 lb/year].... $400,000 [$200/lb]
emission reduction). annual cost) \1\.
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be
incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized
capital costs plus annual costs) in the analysis.
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness number of Option 2 is within
the range of the values that we have determined to be cost-effective
for highly toxic HAPs. While both options are considered generally
available under CAA section 112(d)(5), Option 1 would achieve greater
emission reductions than Option 2, and it is more cost-effective.
Therefore, we are finalizing Option 1 as the standard for new CEVs at
area source facilities under CAA section 112(d)(5). The standard
requires these facilities to continuously reduce emissions from new
CEVs by 99 percent.
We have re-calculated the MACT floor for existing Group 1 room air
emissions at major source facilities. We ranked the performance of the
facilities with Group 1 room air emissions for which data are available
based on percent emission reduction. There are only three performance
tests that are currently available, only one of which contains three
test runs. Therefore, the best performing 12 percent of facilities for
which data are available consists of one facility with three test runs
that is controlling its Group 1 room air emissions with a gas/solid
reactor. That facility reported an emission reduction of 98 percent. We
then used the LPL approach, as mentioned previously, to develop the
MACT floor for existing sources. The LPL 1 value of the existing source
MACT floor is 90 percent emission reduction. The outlet EtO
concentration (UPL 99 value) that corresponds to this emission
reduction is 93 ppbv. Since this is above 3xRDL, there are more
stringent (i.e., BTF) options to consider. We considered two BTF
options for reducing EtO emissions from this source: the first option
we considered was 95 percent emission reduction. The first option
reflects the lowest emission reduction that we have observed in
performance tests, and The second option reflects the most stringent
emission reduction for which compliance can be demonstrated. With
respect to the second option, the most stringent emission reduction for
which compliance can be demonstrated is that which corresponds to an
outlet concentration of 30 ppbv (i.e., 3xRDL). This emission reduction
is 97 percent, which is lower than two of the three reported values in
the test runs that were used to calculate the MACT floor. The impacts
of these options are presented in table 10 (along with the MACT floor
impacts). Because we have
[[Page 24111]]
not identified any major source facilities with existing Group 1 room
air emissions, the impacts are based on a model plant for existing
Group 1 room air emissions at a synthetic area source facility with the
following assumptions reflecting the average of each of the parameters
at synthetic area source facilities:
Annual EtO use: 140 tpy.
Annual operating hours: 8,000.
Portion of EtO going to Group 1 RAE: 0.4 percent.
Group 1 room air emission flow rate: 400 cubic feet per
second (cfs).
Table 10--Nationwide Emissions Reduction and Cost Impacts of BTF Options Considered Under CAA Sections 112(d)(2) and 112(d)(3) for Group 1 Room Air
Emissions at Major Source Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual EtO emission reductions Cost effectiveness ($/
Option Proposed standard investment ($) costs ($/yr) (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
MACT floor........................... 90 percent emission reduction $830,000 $176,000 0.168 [336 lb/year]..... $1,050,000 [$525/lb].
1.................................... 95 percent emission reduction 553,000 129,000 2.80E-2 [56.0 lb/year].. $4,610,000 [$2,300/lb].
2.................................... 97 percent emission reduction 461,000 113,000 1.12E-2 [22.4 lb/year].. $10,100,000 [$5,040/lb].
--------------------------------------------------------------------------------------------------------------------------------------------------------
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness numbers are within the range
of the values that we have determined to be cost-effective for highly
toxic HAPs. While both options are considered BTF under CAA sections
112(d)(2), Option 2 would achieve greater emission reductions than
Option 1. Therefore, the final MACT standard under CAA sections
112(d)(2) and (3) for existing Group 1 room air emissions at major
source facilities is 97 percent emission reduction.
For new sources, CAA section 112(d)(3) requires that the standard
shall not be less stringent than the emission control that is achieved
in practice by the best controlled similar source. In this case, the
best controlled similar source is also the Group 1 room air emissions
that are being controlled by a gas/solid reactor and the data of which
is used to determine the MACT floor for existing sources. Therefore,
the new source MACT floor is equivalent to the existing source MACT
floor, which is 90 percent emission reduction. We considered the same
BTF options as those evaluated for existing Group 1 room air emissions
at major source facilities for the same reasons explained above. The
first BTF option would require achieving 95 percent emission reduction,
and the second BTF option would require achieving 97 percent emission
reduction. The impacts of these options are presented in table 10 of
this preamble. Because we have not identified any major source
facilities with existing Group 1 room air emissions, the impacts are
based on a model plant for new Group 1 room air emissions at a
synthetic area source facility. Based on the estimates above, and
considering EtO is a highly potent carcinogen, the cost-effectiveness
numbers are within the range of the values that we have determined to
be cost-effective for highly toxic HAPs. While both options are
considered BTF under CAA sections 112(d)(2), Option 2 would achieve
greater emission reductions than Option 1. Therefore, the final
standard for new Group 2 room air emissions at major source facilities
is 97 percent emission reduction. We also considered non-air quality
health and environmental impacts and energy requirements when
evaluating the BTF options. Further discussion of these considerations
is presented in the document MACT Floor Analysis for Ethylene Oxide
Commercial Sterilization--Chamber Exhaust Vents and Room Air Emission
Sources--Promulgation Rule Review for the Ethylene Oxide Commercial
Sterilization Source Category, available in the docket for this
rulemaking.
For existing Group 1 room air emissions at area source facilities,
we considered two potential GACT options for reducing EtO emissions
from this group: the first option reflects the use of emission controls
on Group 1 room air emissions, and the second option is the same BMP
discussed above (lowering the in-chamber EtO concentration to 1 ppm
before the chamber is opened). With respect to the first option, 32 out
of 74 area source facilities with Group 1 room air emissions are
already using controls to reduce those emissions.\31\ We considered a
standard of 80 percent emission reduction, which is the manufacturer
guarantee for room air emissions controls provided by one of the
commenters. We find this standard to be reasonable for existing Group 1
room air emissions at area source facilities because it is the
manufacturer guarantee, which means that it is a level of emission
reduction that all sources can achieve. While some sources have
demonstrated emission reductions higher than 80 percent, those
reductions are limited to facilities with higher EtO usage rates, and
we cannot determine whether smaller users of EtO can meet those
emission reductions. The second potential GACT option we considered was
the same management practice discussed in section IV.B.3.a, which would
require facilities to lower the in-chamber EtO concentration to 1 ppm
before the chamber is opened. During the sterilization process, EtO
becomes trapped within the material and continues to off-gas after the
sterilization process is complete. Therefore, if more EtO is driven out
of the product prior to opening the chamber, this can lead to a
reduction in post-sterilization EtO emissions, including those from
pre-aeration handling of sterilized material. The impacts of these
options are presented in table 11.
---------------------------------------------------------------------------
\31\ The Group 1 room air emission reduction at these facilities
ranges from 52 percent to 99.8 percent. It should be noted that the
facility with the emission reduction at the upper bound of this
range uses 135 tpy of EtO.
[[Page 24112]]
Table 11--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for Existing Group 1 Room Air Emissions at
Area Source Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual costs ($/ EtO emission Cost effectiveness ($/
Option Proposed standard investment ($) yr) reductions (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................. 80 percent emission $91,000,000 $12,900,000........... 3.66 [7,320 lb/year].. $3,530,000 [$1,770/
reduction. lb].
2.................................. BMP (estimated 20 percent $0 $5,040,000 (one-time 1.13 [2,260 lb/year].. $4,460,000 [$2,230/
emission reduction). annual cost) \1\. lb].
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be
incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized
capital costs plus annual costs) in the analysis.
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness numbers of these options are
within the range of the values that we have determined to be cost
effective for highly toxic HAPs. We are finalizing Option 1 because
while both options are considered generally available under CAA section
112(d)(5), Option 1 would achieve greater emission reduction than
Option 2. Therefore, pursuant to CAA section 112(d)(5), we are
finalizing Option 1 for existing Group 1 room air emissions at area
source facilities. Specifically, we are finalizing a requirement for
these facilities to continuously reduce emissions from existing Group 1
room air emissions by 80 percent.
For new Group 1 room air emissions at area source facilities, we
considered the same two potential GACT options as those evaluated for
existing Group 1 room air emissions at area source facilities for the
same reasons explained above. The first potential GACT option (Option
1) would require achieving an emission reduction of 80 percent. The
second potential GACT option we considered (Option 2) is a BMP that
would require facilities to lower the in-chamber EtO concentration to 1
ppm before the chamber is opened. The impacts of these options, which
are presented in table 12 of this preamble, are based on a model plant
for new Group 1 room air emissions at an area source facility with the
assumptions reflecting the average of each of the parameters at area
source facilities with new Group 1 room air emissions as described in
section III.B.8.c of the proposal preamble.
Table 12--Model Plant Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for New Group 1 Room Air Emissions at Area
Source Facilities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual costs ($/ EtO emission Cost effectiveness ($/
Option Proposed standard investment ($) yr) reductions (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................. 80 percent emission $922,000 $192,000.............. 0.288 [576 lb/year]... $666,000 [$333/lb].
reduction.
2.................................. BMP........................ 0 $80,000 (one-time 7.20E-2 [144 lb/year]. $1,110,000 [$556/lb].
(estimated 20 percent annual cost) \1\.
emission reduction).
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber EtO concentration to 1 ppm before the
chamber is opened, as well as re-submitting to FDA for approval. It is expected that facilities will only incur this cost once and it is assumed to be
incurred in the first year of compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e., annualized
capital costs plus annual costs) in the analysis.
Based on the estimates above, we find both options to be cost
effective. While both options are considered generally available under
CAA section 112(d)(5), Option 1 would achieve greater emission
reductions than Option 2. Therefore, pursuant to CAA section 112(d)(5),
we are finalizing standards for new Group 1 room air emissions at area
source facilities. Specifically, we are finalizing a requirement for
these facilities to continuously reduce emissions from new Group 1 room
air emissions by 80 percent.
We re-calculated the MACT floor for existing Group 2 room air
emissions at major source facilities. We ranked the performance of the
facilities with Group 2 room air emissions for which data are available
based on percent emission reduction. There are only three performance
tests that are currently available, only one of which contains three
test runs. Therefore, the best performing 12 percent of facilities for
which data are available consists of one facility with three test runs
that is controlling its Group 2 room air emissions with a gas/solid
reactor. That facility reported an emission reduction of 96 percent. As
mentioned previously, we then used the LPL approach to develop the MACT
floor for existing sources. The LPL 1 value of the existing source MACT
floor is 94 percent emission reduction. The outlet EtO concentration
(LPL 1 value) that corresponds to this emission reduction is 10 ppbv.
Since this is below 3xRDL, we adjusted the MACT floor by determining
the emission reduction using 30 ppbv and the LPL 1 value of the inlet
EtO concentration of the Group 2 room air emissions stream at the
facility, which is 0.12 ppmv. This results in an adjusted MACT floor of
86 percent emission reduction. Since this represents 3xRDL, there are
no more stringent (i.e., BTF) options to consider, as there would be
difficulty demonstrating compliance at any such lower limit. Therefore,
the final MACT standard under CAA sections 112(d)(2) and (3) for
existing Group 2 room air emissions at major source facilities is 86
percent emission reduction.
For new sources, CAA section 112(d)(3) requires that the standard
shall not be less stringent than the emission control that is achieved
in practice by the best controlled similar source. In this case, the
best controlled similar source is also the Group 2 room air emissions
that are being controlled by a gas/solid reactor and the data of which
is used to determine the MACT
[[Page 24113]]
floor for existing sources. Therefore, the new source MACT floor is
equivalent to the existing source MACT floor, which is 86 percent
emission reduction. As explained above, because this emission limit
represents the lowest level at which compliance can be demonstrated,
the EPA did not consider more stringent (i.e., BTF) options. Therefore,
the proposed standard for new Group 2 room air emissions at major
source facilities is 86 percent emission reduction.
For existing Group 2 room air emissions at area source facilities,
we considered two potential GACT options for reducing EtO emissions
from this group: the first option reflects the use of emission controls
on Group 2 room air emissions, and the second option is the same BMP
discussed above (lowering the in-chamber EtO concentration to 1 ppm
before the chamber is opened). With respect to the first option, 30 out
of 80 area source facilities with Group 2 room air emissions are
already using controls to reduce those emissions.\32\ We considered a
standard of 80 percent emission reduction, which is the manufacturer
guarantee for room air emissions controls provided by one of the
commenters. We find this standard to be reasonable for existing Group 2
room air emissions at area source facilities because it is the
manufacturer guarantee, which means that it is a level of emission
reduction that all sources can achieve. While some sources have
demonstrated emission reductions higher than 80 percent, those
reductions are limited to facilities with higher EtO usage rates, and
we cannot determine whether smaller users of EtO can meet those
emission reductions. The second potential GACT option we considered was
the same management practice discussed in section IV.B.3.a, which would
require facilities to lower the in-chamber EtO concentration to 1 ppm
before the chamber is opened. During the sterilization process, EtO
becomes trapped within the material and continues to off-gas after the
sterilization process is complete. Therefore, if more EtO is driven out
of the product prior to opening the chamber, this can lead to a
reduction in post-sterilization EtO emissions, including those from
post-aeration handling of sterilized material. The impacts of these
options are presented in table 13.
---------------------------------------------------------------------------
\32\ The Group 2 room air emission reduction at these facilities
ranges from 30 percent to 99.97 percent. It should be noted that the
facility with the emission reduction at the upper bound of this
range uses 135 tpy of EtO.
Table 13--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for
Existing Group 2 Room Air Emissions at Area Source Facilities
----------------------------------------------------------------------------------------------------------------
EtO emission Cost
Option Proposed Total capital Total annual reductions effectiveness
standard investment ($) costs ($/yr) (tpy) ($/ton EtO)
----------------------------------------------------------------------------------------------------------------
1........................... 80 percent $236,000,000 $32,700,000.... 1.10 [2,200 lb/ $29,700,000
emission year]. [$14,900/lb].
reduction.
2........................... BMP (estimated 0 $5,440,000 (one- 0.311 [622 lb/ $17,500,000
20 percent time annual year]. [$8,750/lb].
emission cost) \1\.
reduction).
----------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber
EtO concentration to 1 ppm before the chamber is opened, as well as re-submitting to FDA for approval. It is
expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of
compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e.,
annualized capital costs plus annual costs) in the analysis.
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness numbers of these options are
within the range of the values that we have determined to be cost-
effective for highly toxic HAPs. Further, as discussed in section
III.B.8.g of the proposal preamble (88 FR 28790, April 13, 2023), there
are multiple factors we consider in assessing the cost of the emission
reductions. See NRDC v. EPA, 749 F.3d 1055, 1060 (D.C. Cir. April 18,
2014) (``Section 112 does not command the EPA to use a particular form
of cost analysis.''). These factors include, but are not limited to,
total capital costs, total annual costs, cost-effectiveness, and annual
costs compared to total revenue (i.e., costs to sales ratios). Our
established methodology for assessing economic impacts of regulations
indicates that the potential for adverse economic impacts begins when
the cost to sales ratio exceeds three percent. According to our
estimates, the annual cost of the emission control option for most of
the affected sources discussed above is well below three percent.\33\
However, reducing existing Group 2 room air emissions at area source
facilities using emission control devices (Option 1), would
significantly impact several companies operating a total of nine area
source facilities with Group 2 room air emissions. We estimate that the
annual cost of controls at the level under Option 1 would exceed three
percent of revenue for these companies.\34\ Based on the available
economic information, assuming market conditions remain approximately
the same, we are concerned that these companies would not be able to
sustain the costs associated with Option 1. In addition, according to
FDA, six of these facilities could impact the availability of the
medical devices described in section I.A.1 of this preamble. Therefore,
pursuant to CAA section 112(d)(5), we are finalizing Option 2 as the
GACT standard for existing Group 2 room air emissions at area source
facilities. Specifically, this GACT standard requires facilities to
lower the in-chamber EtO concentration to 1 ppm before the chamber is
opened.\35\
---------------------------------------------------------------------------
\33\ See memorandum, Technical Support Document for Proposed
Rule--Industry Profile, Review of Unregulated Emissions, CAA Section
112(d)(6) Technology Review, and CAA Section 112(f) Risk Assessment
for the Ethylene Oxide Emissions Standards for Sterilization
Facilities NESHAP, located at Docket ID No. EPA-HQ-OAR-2019-0178.
\34\ The issue of high cost-to-sales ratios is present only for
this option and, thus, is not discussed for other options.
\35\ As discussed in section IV.C.2.a.iii of this preamble, this
GACT standard will ultimately apply only to facilities where EtO use
is less than 4 tpy. Facilities where EtO use is at least 4 tpy will
be required to meet an emission standard established under CAA
section 112(f)(2).
---------------------------------------------------------------------------
For new Group 2 room air emissions at area sources facilities, we
considered the same two potential GACT options as those evaluated for
existing Group 1 room air emissions at area source facilities for the
same reasons explained above. The first potential GACT option (Option
1) would require achieving an emission reduction of 80 percent. The
second potential GACT option we considered (Option 2) is a BMP that
would require facilities to lower the in-chamber EtO concentration to 1
ppm before the chamber is opened. The impacts of these options, which
are presented in table 14 of this preamble, are based on a model plant
for new Group 2 room air emissions at an area source facility with the
assumptions reflecting the average of each of the parameters at area
source facilities with
[[Page 24114]]
new Group 1 room air emissions as described in section III.B.8.h of the
proposal preamble.
Table 14--Model Plant Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(5) for
New Group 2 Room Air Emissions at Area Source Facilities
----------------------------------------------------------------------------------------------------------------
EtO emission Cost
Option Proposed Total capital Total annual reductions effectiveness
standard investment ($) costs ($/yr) (tpy) ($/ton EtO)
----------------------------------------------------------------------------------------------------------------
1........................... 80 percent $1,840,000 $332,000....... 3.6E-2 [72 lb/ $9,170,000
emission year]. [$4,560/lb].
reduction.
2........................... BMP (estimated 0 $40,000 (one- 9.1E-3 [18 lb/ $4,375,000
20 percent time annual year]. [$2,190/lb].
emission cost)\1\.
reduction).
----------------------------------------------------------------------------------------------------------------
\1\ This includes the cost for testing to verify that the new sterilization process will lower the in-chamber
EtO concentration to 1 ppm before the chamber is opened, as well as re-submitting to FDA for approval. It is
expected that facilities will only incur this cost once and it is assumed to be incurred in the first year of
compliance, but it is treated as an annual cost for the purposes of estimating total annual costs (i.e.,
annualized capital costs plus annual costs) in the analysis.
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness numbers of these options are
within the range of the values that we have determined to be cost-
effective for highly toxic HAPs. As discussed earlier in this section,
this includes hexavalent chromium, where we finalized a requirement
with a cost-effectiveness of $15,000/lb ($30,000,000/ton) for existing
small hard chromium electroplating to provide an ample margin of safety
(taking into account cost among other factors) (77 FR 58227-8, 58239).
Although both options are considered generally available under CAA
section 112(d)(5), Option 1 would achieve four times the emission
reductions of Option 2. Therefore, pursuant to CAA section 112(d)(5),
we are finalizing standards for new Group 2 room air emissions at area
source facilities. Specifically, we are finalizing a requirement for
these facilities to continuously reduce emissions from new Group 2 room
air emissions by 80 percent.
c. PTE
Comment: We received extensive comment on our proposal to require
that each facility must operate areas with room air emissions subject
to an emission standard under the PTE requirements of EPA Method 204.
Some commenters were supportive of this requirement, stating that other
regulatory bodies have already required this and that this is the
correct protocol for ensuring that emissions are captured and routed to
a control system. Other commenters were opposed to this requirement,
stating that EPA Method 204 was established for smaller point source
operations (e.g., paint booths, spray coating), as opposed to larger
sterilization facilities. Several commenters cited other technical
concerns, including the fact that not every facility is currently
configured to meet the PTE requirements of EPA Method 204. The
commenters suggested broad alternatives, including a simple requirement
to operate areas with room air emissions subject to an emission
standard under negative pressure.
Response: We strongly disagree with the commenters that EPA Method
204 is not appropriate to apply to this source category. The design
requirements of EPA Method 204 are agnostic to the industry it is
applied. It has been applied widely to any industrial processes that
needs to control VOC emissions, including several existing commercial
sterilizers that have already been complying with EPA Method 204. In
order to meet the emission standards, it is necessary to ensure that
all emissions are captured and routed to a control system. Our
established protocol in numerous new source performance standards,
NESHAPs, and federally enforceable State and local programs (e.g.,
title V permits, State implementation plans) for ensuring complete
capture of room air emissions is EPA Method 204. We recognize that many
commercial sterilizers will need to retrofit their facilities to meet
the PTE requirements of EPA Method 204, similar to facilities that have
already done so. We have accounted for the cost to retrofit facilities
by scaling the cost from a large facility that conducted a retrofit.
Furthermore, based on our knowledge regarding the application of EPA
Method 204 in general, retrofitting to meet this method can be
complicated, depending on the size of the facility. However, commercial
sterilization facilities tend to be simple buildings (in some cases,
re-purposed warehouses) with a relatively small footprint, which helps
the retrofitting process. The emission standards for room air emissions
that we evaluated assume 100 percent capture of EtO emissions,\36\ and
the costs of complying with the PTE requirements of EPA Method 204 were
included in our BTF and GACT evaluations. We found each emission
standard that we evaluated to be cost-effective (see section IV.B.3.b
of this preamble for more information). In addition, the term
``negative pressure'' is vague and can imply any capture efficiency
between zero and 100 percent. The commenters did not provide specific
suggestions for alternative capture efficiencies, nor did they provide
the criteria that would be used to demonstrate that those efficiencies
are being met, and we are unable to evaluate alternative negative
pressure requirements as a result. Therefore, EPA Method 204 is
appropriate to apply to this source category in order to ensure
complete capture of room air emissions.
---------------------------------------------------------------------------
\36\ Section 2 of EPA Method 204 states, in part, ``If the
criteria are met and if all the exhaust gases from the enclosure are
ducted to a control device, then the volatile organic compounds
(VOC) capture efficiency (CE) is assumed to be 100 percent, and CE
need not be measured.''
---------------------------------------------------------------------------
Comment: Several commenters requested various flexibilities and
clarifications with respect to the PTE requirements of EPA Method 204.
Several commenters expressed concern with Criterion 5.1 of EPA Method
204, stating that it would not be possible to always ensure that doors
are ``at least four equivalent opening diameters'' from all EtO storage
media or post-aeration sterilized product, particularly during loading
and unloading operations. Two commenters recommended that we revise the
standards to permit implementation of cascading air systems to capture
room air emissions.\37\ One commenter stated that these systems would
provide greater flexibility to accommodate sterilization operations
that could not implement a PTE, would offer EtO capture and control
efficiency that was as effective as a PTE, and would have fewer
manufacturing implications and potential adverse impacts. Finally, two
[[Page 24115]]
commenters expressed concern with Criteria 5.2, 5.3, and 5.5 of EPA
Method 204.
---------------------------------------------------------------------------
\37\ These are systems that move air from ambient pressure,
through warehouse ventilation, secondary aeration, primary aeration,
the sterilizer chamber, and ultimately to an air pollution control
device to capture and control EtO emissions. This is opposed to
other systems where air from one source is captured and then
directly sent to a control system.
---------------------------------------------------------------------------
Response: Criterion 5.1 of EPA Method 204 states that ``Any natural
draft opening (NDO) shall be at least four equivalent opening diameters
from each VOC emitting point unless otherwise specified by the
Administrator.'' \38\ We disagree with the commenters' concerns that
Criterion 5.1 of EPA Method 204 will not be possible to meet for doors
where either EtO storage media is moved into a PTE or post-aeration
sterilized material is moved out of a PTE. There may be certain
facility designs where such an exemption is either necessary or
unnecessary in order to ensure complete capture of room air emissions.
However, the EPA does not have enough information to make that
determination for all facilities within the source category as part of
this rulemaking. Criterion 5.1 of EPA Method 204 allows delegated
authorities to exempt any NDO from this requirement, as needed.
Therefore, we are not exempting Criterion 5.1 of EPA Method 204 for
doors where either EtO storage media is moved into a PTE or post-
aeration sterilized material is moved out of a PTE as part of this
final rule. Instead, we are relying on the delegated authorities to
make that determination for their commercial sterilization facilities,
as provided in Criterion 5.1., as they are in a better place to
determine whether there are sufficient measures in place to capture any
emission points within four equivalent opening diameters of an NDO.
With respect to cascading air systems, we disagree with the commenters'
suggestion that they be permitted in place of the PTE requirements of
EPA Method 204, as they are insufficient on their own to ensure
complete capture of room air emissions. However, it is not our intent
to discourage or prohibit the use of these systems altogether.
Cascading air systems may be used to capture and route room air
emissions to a control device. However, in order to ensure complete
capture of room air emissions, if such a system contains one or more
areas that are subject to the PTE requirements of EPA Method 204, then
the entire system must be treated as a single enclosure that is subject
to those requirements.
---------------------------------------------------------------------------
\38\ Per 40 CFR 51.100(s), EtO is a VOC.
---------------------------------------------------------------------------
For all other flexibilities suggested by the commenters, we provide
the following responses:
Criterion 5.2 of EPA Method 204 states that ``Any exhaust
point from the enclosure shall be at least four equivalent duct or hood
diameters from each NDO.'' One commenter stated that Criterion 5.2 may
not be possible for all facilities due to preexisting layouts. This
criterion only applies to temporary total enclosures, as opposed to
PTEs, and is not required in the final rule.
Criterion 5.3 of EPA Method 204 states that ``The total
area of all NDO's shall not exceed 5 percent of the surface area of the
enclosure's four walls, floor, and ceiling.'' One commenter stated that
the presence of garage doors could exceed the requirement that NDOs not
exceed five percent of the PTE total floor space. However, we note that
facilities can be, and have been, re-designed in order to meet the PTE
requirements of EPA Method 204, including Criterion 5.3. Therefore, we
are not finalizing any exceptions for this criterion.
Criterion 5.5 of EPA Method 204 states that ``All access
doors and windows whose areas are not included in section 5.3 and are
not included in the calculation in section 5.4 shall be closed during
routine operation of the process''. Two commenters expressed concern
with Criterion 5.4 of EPA Method 204. However, the commenters did not
provide any explanation as to why exceptions for Criterion 5.5 of EPA
Method 204 should be made. Therefore, we are not finalizing any
exceptions for this criterion.
d. Warehouses
Comment: We received extensive comments on the regulation of
warehouses, particularly stand-alone (i.e., off-site) warehouses. Most
commenters were supportive of regulating emissions from all warehouses,
stating that sterilized materials can continue to off-gas significant
quantities of EtO after being moved to a warehouse. Several commenters
pointed to a stand-alone warehouse in Georgia, where the State
estimated that potential pre-control EtO emissions were approximately
5,000 lb/year. One commenter was opposed to including standards for
stand-alone warehouses as part of this final rule, stating that we
could, instead, identify potentially applicable facilities, collect
data from these facilities, and then determine if further regulation is
necessary.
Response: It is our understanding that there are three types of
warehouses within this industry: attached warehouses, co-located
warehouses, and stand-alone warehouses. Attached warehouses are those
that are part of an EtO sterilization building. Co-located warehouses
are those that are detached from but ``contiguous'' (including
adjacent) to and ``under common control'' with the EtO sterilization
building, including leased properties.\39\ Stand-alone warehouses are
those that are not attached to or co-located with an EtO sterilization
building. According to our record at the time of category listing,
``the Commercial Sterilization Facilities source category includes
``facilities which use ethylene oxide in any equipment which destroys
bacteria, viruses, fungi, insects, or other unwanted microorganisms or
materials when such facilities are engaged in the growth, manufacture,
construction, transportation, retail or wholesale trade, or storage of
commercial products, or when such facilities are engaged in the
operation of museums, art galleries, arboreta, or botanical or
zoological gardens or exhibits. Not included in this category are
hospitals, doctor offices, veterinary offices, clinics, and other
facilities where medical services are rendered'' (emphasis added).\40\
Under this definition, warehouses that are part of facilities which use
EtO, including attached and co-located warehouses, are part of the
source category and, therefore, subject to the standards for Group 2
room air emissions. However, because stand-alone warehouses do not use
EtO, they are not included in the source category definition.
Furthermore, we do not have sufficient information to understand where
these warehouses are located, who owns them, how they are operated, or
what level of emissions potential they may have. While several
commenters note that emissions information is available for at least
one stand-alone warehouse, it is unknown whether the emissions
information for this facility is representative of all stand-alone
warehouses. Thus, standards for these facilities are not included as
part of this final rule. However, as suggested by one commenter, we are
planning to gather information from stand-alone warehouses as soon as
possible to
[[Page 24116]]
understand what the source category looks like and its emission
potential and, if necessary, develop a regulatory action that both
lists a new source category and proposes standards for stand-alone
warehouses handling EtO sterilized medical devices. This information
gathering effort may include engaging with State and local agencies and
non-governmental organizations, as well as conducting an ICR(s)
pursuant to CAA section 114.
---------------------------------------------------------------------------
\39\ This final rule establishes standards under CAA section 112
for both major and area sources of commercial sterilization
facilities. As the EPA explained in its final rule promulgating the
General Provisions for NESHAP pursuant to section 112, ``[f]or the
purposes of implementing section 112, the major/area source
determination is made on a plant-wide basis; that is, HAP emissions
from all sources located within a contiguous area and under common
control are considered in the determination.'' 59 FR 12408, 12411
(March 16, 1994). The EPA noted that ``the common dictionary term
``contiguous'' consists, in part, of ``nearby, neighboring,
adjacent,'' and that ``the EPA has historically interpreted
`contiguous property' to mean the same as `contiguous or adjacent
property' in the development of numerous regulations to implement
the Act.'' Id. at 12412.
\40\ Documentation for Developing the Initial Source Category
List, Final Report, page A-83 (see EPA-450/3-91-030, July 1992).
---------------------------------------------------------------------------
The remaining comments and our specific responses can be found in
the document, Summary of Public Comments and Responses for the Risk and
Technology Review for Commercial Sterilization Facilities, available in
the docket for this rulemaking.
4. What is the rationale for our final approach and final decisions for
the revisions pursuant to CAA section 112(d)(2), 112(d)(3), and
112(d)(5)?
We evaluated the comments on our proposed standards for SCVs, ARVs,
and CEVs at facilities where EtO use is less than 1 tpy, ARVs and CEVs
at facilities where EtO use is at least 1 tpy but less than 10 tpy,
CEVs at facilities where EtO use is at least 10 tpy, and room air
emissions, as well as our proposed technical correction to the emission
standard for ARVs at facilities where EtO use is at least 10 tpy. As
explained above in section IV.B.3 and in Chapter 4 of the document,
Summary of Public Comments and Responses for the Risk and Technology
Review for Commercial Sterilization Facilities, we made changes in the
final rule based on comments received during the proposed rulemaking.
More information and rationale concerning all the amendments we are
finalizing pursuant to CAA sections 112(d)(2), 112(d)(3), and 112(d)(5)
is in the preamble to the proposed rule (88 FR 22790, April 13, 2023),
in section IV.B.3 of this preamble, and in the comments and our
specific responses to the comments in the document, Summary of Public
Comments and Responses for the Risk and Technology Review for
Commercial Sterilization Facilities, which is available in the docket
for this rulemaking. Therefore, we are finalizing the proposed
standards for SCVs and ARVs at facilities where EtO use is less than 1
tpy, finalizing the proposed standards for ARVs at facilities where EtO
use is at least 1 tpy but less than 10 tpy, finalizing standards for
CEVs, finalizing the proposed emission standards for room air emissions
at major sources facilities, finalizing emission standards for room air
emissions at area source facilities, and finalizing the proposed
revisions for ARVs at facilities where EtO use is at least 10 tpy.
C. Residual Risk Review for the Commercial Sterilization Facilities
Source Category
1. What did we propose pursuant to CAA section 112(f) for the
Commercial Sterilization Facilities source category?
Pursuant to CAA section 112(f), we conducted a residual risk review
and presented the results of this review, along with our proposed
decisions regarding risk acceptability and ample margin of safety, in
the April 13, 2023, proposed rule for 40 CFR part 63, subpart O (88 FR
22790). The results of the risk assessment for the proposal are
presented briefly in table 15 of this preamble. As discussed in section
III.A of the proposed rule, all baseline risk results were developed
using the best estimates of actual emissions, and we did not conduct a
separate assessment of allowables at proposal. More detail is in the
residual risk technical support document, Residual Risk Assessment for
the Commercial Sterilization Facilities Source Category in Support of
the 2023 Risk and Technology Review Proposed Rule, which is available
in the docket for this rulemaking (see Docket Item No. EPA-HQ-OAR-2019-
0178-0482).
Table 15--Commercial Sterilization Facilities Source Category Baseline Risk Assessment Results in the Proposal
--------------------------------------------------------------------------------------------------------------------------------------------------------
Estimated population at Estimated
Maximum increased risk of cancer annual cancer Maximum screening acute
Number of facilities \1\ individual ---------------------------------- incidence Maximum chronic noncancer hazard quotient
cancer risk (in >100-in-1 [gteqt]1-in-1 (cases per noncancer TOSHI (HQ)
1 million) \2\ million million year)
--------------------------------------------------------------------------------------------------------------------------------------------------------
97 \3\................................. 6,000 18,000 8,300,000 0.9 0.04 0.002 (REL).
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Number of facilities evaluated in the risk analysis.
\2\ Maximum individual excess lifetime cancer risk due to HAP emissions from the source category.
\3\ As part of the risk assessment for the proposed rulemaking, there were 86 facilities in the Commercial Sterilization Facilities source category in
operation and 11 research and development facilities, for a total of 97 facilities. To exercise caution with respect to this source category, we
included research facilities in our assessment because there was a lack of certainty over whether these were true research facilities, for which CAA
section 112(c)(7) requires that a separate category be established. However, EtO use at these facilities tends to be very low (less than 1 tpy), and
these facilities had low risk.
The results of the proposed chronic baseline inhalation cancer risk
assessment at proposal indicated that, based on estimates of current
actual emissions, the MIR posed by the source category was 6,000-in-1
million. At proposal, the total estimated cancer incidence from this
source category was estimated to be 0.9 excess cancer cases per year,
or one case in every 1.1 years. Approximately 8.3 million people were
estimated to have cancer risks at or above 1-in-1 million from HAP
emitted from the facilities in this source category. At proposal, the
estimated maximum chronic noncancer target organ-specific hazard index
(TOSHI) for the source category was 0.04, indicating low likelihood of
adverse noncancer effects from long-term inhalation exposures.
As shown in table 15 of this preamble, the acute risk screening
assessment of reasonable worst-case inhalation impacts indicates a
maximum acute HQ of 0.002 for propylene oxide based on the reference
exposure level (REL) acute health reference value.\41\ For EtO, the
maximum HQ is 0.0005 based on the acute exposure guideline level
(AEGL)-2 acute health reference value.\42\
---------------------------------------------------------------------------
\41\ Not to be confused with the ``recommended exposure limit'',
which is used by the National Institute for Occupational Safety and
Health.
\42\ Acute RELs, ERPG-1, and AEGL-1 acute health reference
values are not available for ethylene oxide.
---------------------------------------------------------------------------
At proposal, the maximum lifetime individual cancer risk posed by
the 97 modeled facilities, based on whole facility emissions, was
6,000-in-1 million, with EtO emissions from SCVs and Group 2 room air
emissions from the Commercial Sterilization Facilities source category
driving the risk. Regarding the noncancer risk
[[Page 24117]]
assessment, the maximum chronic noncancer TOSHI posed by whole facility
emissions was estimated to be 0.04 (for the neurological system as the
target organ), driven by emissions of EtO from source category sources.
We weighed all health risk factors, including those shown in table
15 of this preamble, in our risk acceptability determination and
proposed that the risks posed by this source category under the current
provisions are unacceptable. At proposal, we identified several options
to control EtO emissions from SCVs and Group 2 room air emissions.
To reduce risks, we considered two additional control options after
implementation of controls under CAA sections 112(d)(2), 112(d)(3), and
112(d)(5). Control Option 1 would have required a 99.94 percent
emission reduction standard for SCVs at facilities where EtO use is at
least 40 tpy, as well as a 2.8 E-3 lb/h standard for existing Group 2
room air emissions at area source facilities where EtO use is at least
20 tpy. We determined that this would have resulted in a source
category MIR of 400-in-1 million. Control Option 2 would have imposed
the same requirements as Control Option 1, but it would also have
required facilities where the MIR is greater than 100-in-1 million
after Control Option 1 is imposed to limit their existing Group 2 room
air emissions to a maximum volumetric flow rate of 2,900 dscfm and a
maximum EtO concentration of 30 ppbv. This would have resulted in a
source category MIR of 100-in-1 million. We proposed Control Option 2
and solicited comment on Control Option 1.
We proposed that, after implementation of the proposed controls for
SCVs and Group 2 room air emissions at commercial sterilization
facilities, the resulting risks would be acceptable for this source
category. In our proposal, we presented the risk impacts using health
risk measures and information, including the MIR, cancer incidence, and
associated uncertainty in emissions estimates after application of the
proposed options to control EtO emissions from Group 2 room air
emissions (88 FR 22790, April 13, 2023). At proposal, we determined
application of the controls for SCVs and Group 2 room air emissions
would reduce the estimated MIR from 6,000-in-1 million to 100-in-1
million.
We then considered whether the standards provide an ample margin of
safety to protect public health and whether, taking into consideration
costs, energy, safety, and other relevant factors, additional standards
are required to prevent an adverse environmental effect. To determine
whether the rule provides an ample margin of safety, we considered the
requirements that we proposed to achieve acceptable risks. In addition,
we considered more stringent controls for SCVs, as well as expanding
the emission standard and work practice standards for existing Group 2
room air emissions to all facilities in the source category. In
considering whether the standards should be tightened to provide an
ample margin of safety to protect public health, we considered the same
risk factors that we considered for our acceptability determination and
also examined the costs, technological feasibility, and other relevant
factors related to emissions control options that might reduce risk
associated with emissions from the source category. Based on these
considerations, we proposed that the standards that we proposed to
achieve acceptable risks, along with a 99.94 percent emission reduction
standard for SCVs at facilities where EtO use is at least 10 tpy but
less than 40 tpy and a 99.8 percent emission reduction standard for
SCVs at facilities where EtO use is at least 1 tpy but less than 10
tpy, would provide an ample margin of safety to protect public health
(section III.D.2 of the proposal preamble, 88 FR 22790, April 13,
2023). We also solicited comment on which of the available control
options should be applied in order to provide an ample margin of safety
to protect public health.
2. How did the risk review change for the Commercial Sterilization
Facilities source category?
a. Commercial Sterilization Facilities Source Category Risk Assessment
and Determination of Risk Acceptability (Step 1)
As part of the final risk assessment, the EPA reanalyzed risks to
include allowable emissions (which we did not include at the proposal
stage), changes since proposal to certain emission standards being
finalized for previously unregulated sources, and three additional
facilities identified by commenters. Allowable emissions are the
maximum amount that facilities are allowed to emit under CAA section
112(d) standards. For previously unregulated sources, since there were
no CAA section 112(d) standards in place, the allowable emissions in
the baseline risk assessment are equal to the uncontrolled emissions
from these sources. In some instances, the actual emissions for these
sources are lower than the allowable emissions. This is because some
facilities are already controlling these sources as a result of local
requirements or through voluntary control measures.\43\ The revised
emissions used to reanalyze risks are available in the docket for this
rulemaking (see section IV.C.3 of this preamble and Appendix 1 of the
Residual Risk Assessment for the Commercial Sterilization Facilities
Source Category in Support of the 2024 Risk and Technology Review Final
Rule).
---------------------------------------------------------------------------
\43\ As discussed later in this section, for previously
unregulated sources, the allowable emissions in the risk assessment
that considers controls we are promulgating under CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) are equal to the controlled
emissions from these sources assuming that they are only controlled
to the degree that we are requiring pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5). In some instances, the actual
emissions for these sources may still be lower than the allowable
emissions. This is because some facilities are already controlling
these sources to a degree greater than what we are finalizing
pursuant to CAA sections 112(d)(2), 112(d)(3), and 112(d)(5) as a
result of local requirements or through voluntary control measures.
---------------------------------------------------------------------------
Based on the actual emission estimates, the results of the chronic
inhalation cancer risk from the risk assessment indicate that the
maximum lifetime individual cancer risk posed by the 88 facilities
could be as high as 6,000-in-1 million, with EtO as the major
contributor to the risk. The total estimated cancer incidence from the
revised risk assessment is 0.9 excess cancer cases per year, or one
excess case in every 1.1 years. Of the approximately 115 million people
that live within 50 kilometers (km) of the 88 facilities included in
the risk assessment, 8.5 million people were estimated to have cancer
risks greater than or equal to 1-in-1 million from HAP emitted from the
facilities in this source category, and approximately 19,000 are
estimated to have cancer risks greater than 100-in-1 million (table 16
of this preamble).
The estimated maximum chronic noncancer TOSHI for the source
category remained unchanged from the proposal at 0.04, indicating low
likelihood of adverse noncancer effects from long-term inhalation
exposures. Additionally, the worst-case acute HQ remained unchanged
from proposal (0.002 for propylene oxide based on the REL acute health
reference value).
The maximum lifetime individual cancer risk based on whole facility
emissions was 6,000-in-1 million driven by EtO emissions from the
Commercial Sterilization Facilities source category. The maximum
chronic noncancer TOSHI posed by whole facility emissions was estimated
to be 0.04 (for the neurological system as the target organ), driven by
emissions of EtO from source category sources.
[[Page 24118]]
Based on allowable emission estimates, the maximum lifetime
individual cancer risk could be as high as 8,000-in-1 million, with EtO
driving the risk. The total estimated cancer incidence is 8 excess
cancer cases per year, or 1 excess case in every 1.5 months.
Approximately 62 million people were estimated to have cancer risks
greater than or equal to 1-in-1 million from allowable emissions, and
approximately 260,000 are estimated to have cancer risks greater than
100-in-1 million (table 16 of this preamble).
Table 16--Commercial Sterilization Facilities Source Category Baseline Risk Assessment Results Based on Revised Emissions in Final Rule
--------------------------------------------------------------------------------------------------------------------------------------------------------
Maximum Estimated population at Estimated
individual increased risk of cancer annual cancer Maximum
Number of facilities \1\ cancer risk -------------------------------- incidence chronic Maximum screening acute
(in 1 million) >100-in-1 [gteqt]1-in-1 (cases per noncancer noncancer HQ
\2\ million million year) TOSHI
--------------------------------------------------------------------------------------------------------------------------------------------------------
Actual Emissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
88 \3\.................................... 6,000 19,000 8,500,000 0.9 0.04 0.002 (REL).
--------------------------------------------------------------------------------------------------------------------------------------------------------
Allowable Emissions
--------------------------------------------------------------------------------------------------------------------------------------------------------
88 \3\.................................... 8,000 260,000 62,000,000 8 0.05 ............................
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Number of facilities evaluated in the risk analysis.
\2\ Maximum individual excess lifetime cancer risk due to HAP emissions from the source category.
\3\ Two of the 90 facilities identified in the source category are planned or under construction and therefore were not included in the risk assessment.
Risks were then estimated after application of the controls
finalized in this rulemaking pursuant to CAA sections 112(d)(2),
112(d)(3), and 112(d)(5). A summary of those controls is presented in
table 17.
Table 17--Summary of Standards After Taking Actions Pursuant to CAA Sections 112(d)(2), 112(d)(3), and 112(d)(5)
----------------------------------------------------------------------------------------------------------------
Emission source Existing or new? EtO use Standards CAA section
----------------------------------------------------------------------------------------------------------------
SCV............................. Existing and new.. At least 10 tpy... 99 percent Current standard.
emission
reduction.
At least 1 but 99 percent Current standard.
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
ARV............................. Existing and new.. At least 10 tpy... 99 percent Current standard.
emission
reduction.
At least 1 but 99 percent 112(d)(5).
less than 10 tpy. emission
reduction.
Less than 1 tpy... 99 percent 112(d)(5).
emission
reduction.
CEV at major sources............ Existing and new.. N/A............... 99.94 percent 112(d)(2) and
emission 112(d)(3).
reduction \1\.
CEV at area sources............. Existing and new.. N/A............... 99 percent 112(d)(5).
emission
reduction \1\.
Group 1 room air emissions at Existing and new.. N/A............... 97 percent 112(d)(2) and
major sources. emission 112(d)(3).
reduction \1\ \2\.
Group 1 room air emissions at Existing and new.. N/A............... 80 percent 112(d)(5).
area sources. emission
reduction \1\ \2\.
Group 2 room air emissions at Existing and new.. N/A............... 86 percent 112(d)(2) and
major sources. emission 112(d)(3).
reduction \1\ \2\.
Group 2 room air emissions at Existing.......... N/A............... Lower the EtO 112(d)(5).
area sources. concentration
within each
sterilization
chamber to 1 ppm
before the
chamber can be
opened.\1\
New............... N/A............... 80 percent 112(d)(5).
emission
reduction \1\ \2\.
----------------------------------------------------------------------------------------------------------------
\1\ This standard is different from what was proposed.
\2\ To assure compliance with the emission limit, we are requiring each facility to operate areas with these
emissions in accordance with the PTE requirements of EPA Method 204 of appendix M to 40 CFR part 51.
Based on the risk assessment considering controls finalized under
CAA sections 112(d)(2), 112(d)(3), and 112(d)(5), the maximum lifetime
individual cancer risk could be as high as 6,000-in-1 million, with EtO
driving the risk. For previously unregulated sources, the allowable
emissions in this risk assessment are equal to the controlled emissions
from these sources assuming that they are only controlled to the degree
that we are requiring pursuant to CAA sections 112(d)(2), 112(d)(3),
and 112(d)(5). In some instances, the actual emissions for these
sources may still be lower than the allowable emissions. This is
because some facilities are already controlling these sources to a
degree greater than what we are finalizing pursuant to CAA sections
112(d)(2), 112(d)(3), and 112(d)(5) as a result of local requirements
or through voluntary control measures. The total estimated
[[Page 24119]]
cancer incidence could be as high as 4 excess cancer cases per year, or
1 excess case in every 3 months. As many as 38 million people are
estimated to have cancer risks greater than or equal to 1-in-1 million,
and approximately 85,000 people are estimated to have cancer risks
greater than 100-in-1 million (table 18 of this preamble).
However, as noted above, some facilities are currently performing
better than the controls finalized under CAA sections 112(d)(2),
112(d)(3), and 112(d)(5), and in that case we estimate the maximum
lifetime individual cancer risk as 5,000-in-1 million, with EtO driving
the risk. The total estimated cancer incidence is estimated to be 0.4
excess cancer cases per year, or 1 excess case in every 2.5 years.
Approximately 4.2 million people were estimated to have cancer risks
greater than or equal to 1-in-1 million, and approximately 3,900 are
estimated to have cancer risks greater than 100-in-1 million (table 18
of this preamble), based only on the application of the CAA section
112(d)(2), 112(d)(3), and 112(d)(5) actions being finalized.
Table 18--Commercial Sterilization Facilities Source Category Risk Assessment Results Based on Emissions After
Controls Promulgated Under CAA Sections 112(d)(2)-(3) and 112(d)(5)
----------------------------------------------------------------------------------------------------------------
Estimated population at Estimated
Maximum increased risk of cancer \2\ annual cancer
Number of facilities \1\ individual ---------------------------------- incidence
cancer risk (in >100-in-1 [gteqt]1-in-1 (cases per
1 million) \2\ million million year) \2\
----------------------------------------------------------------------------------------------------------------
88 \3\...................................... \4\ 5,000-6,000 \4\ 3,900- \4\ 4,200,000- \4\ 0.4-4
260,000 62,000,000
----------------------------------------------------------------------------------------------------------------
\1\ Number of facilities evaluated in the risk analysis.
\2\ Maximum individual excess lifetime cancer risk due to HAP emissions from the source category.
\3\ Two of the 90 facilities identified in the source category are planned or under construction and therefore
were not included in the risk assessment.
\4\ Ranges in values account for if all facilities were performing at the level of the standards (high end) to
considering facilities that are currently performing better than the standards (low end).
Based on the revised risk assessment results considering controls
finalized under CAA sections 112(d)(2), 112(d)(3), and 112(d)(5), we
continue to find that the risks are unacceptable, as we did during the
proposal due to emissions of EtO from SCVs, ARVs, Group 1 room air
emission, Group 2 room air emissions, and CEVs. Pursuant to CAA section
112(f)(2), the EPA must first determine the emission standards
necessary to reduce risks to an acceptable level, and then determine
whether further HAP emissions reductions are necessary to provide an
ample margin of safety to protect public health or to prevent, taking
into consideration costs, energy, safety, and other relevant factors,
an adverse environmental effect. Immediately below is a discussion of
the standards the EPA has evaluated for bringing risks to an acceptable
level (step 1).
i. SCV Emissions
There are 26 facilities within the source category where the
``revised allowable emissions'' from SCVs (i.e., allowable emissions
after implementing existing and newly promulgated 112(d) standards in
this final rule) contribute to the facilities' MIRs exceeding 100-in-1
million, and EtO usage at these facilities ranges from four tpy to 446
tpy. The previous subpart O required 99 percent emission reduction for
SCVs at facilities where EtO use is at least 1 tpy. An emission
reduction of 99 percent is also the final standard under CAA section
112(d)(5) for the previously unregulated SCVs, which were those at
facilities where EtO use is less than 1 tpy (see section IV.B.2).
Our data do not identify any add-on controls beyond those we have
already considered when promulgating or reviewing the SCV standards in
the previous subpart O or finalizing the standards for the previously
unregulated SCVs in section IV.B. However, our evaluation of the
performance test data and manufacturer guarantees shows that these
controls can achieve greater than 99 percent reduction. We therefore
considered more stringent SCV standards for facilities where EtO use is
at least 1 tpy, which would include all 26 facilities where the revised
allowable emissions from SCVs contribute to the facilities' MIRs
exceeding 100-in-1 million.
We evaluated 99.8 percent reduction of SCV emissions from
facilities using at least 1 tpy but less than 10 tpy of EtO.\44\ As
discussed in section III.D.2 of the proposal preamble (88 FR 22790,
April 13, 2023), 99.8 percent is the maximum emission reduction from
SCV with which compliance can be demonstrated at all facilities with
EtO usage within this range.\45\ A 99.8 percent reduction would
eliminate SCV emissions as a contributor to a facility's MIR exceeding
100-in-1 million for facilities using at least 1 tpy but less than 10
tpy of EtO.\46\ We have determined that a 99.8 percent emission
reduction standard is feasible because of one commenter's statement
that, based on their discussions with control device manufacturers, the
best and most advanced technologies will be guaranteed to meet a 99.9
percent emission reduction standard for SCVs.
---------------------------------------------------------------------------
\44\ The MIRs of facilities with EtO usage less than 1 tpy are
all below 100-in-a-million.
\45\ i.e., Based on facility characteristics, there is no
compliance demonstration issue because the required EtO
concentration to meet this limit would be at or above 30 ppbv (which
is 3 x RDL).
\46\ A facility with usage amount in this range may still have a
MIR exceeding 100-in-a-million due to other emissions.
---------------------------------------------------------------------------
For facilities using at least 10 tpy, further reduction would be
needed to eliminate SCV emissions as a contributor to a facility's MIR
exceeding 100-in-a-million. We evaluated 99.9 percent reduction, which
as mentioned above reflects the manufacturer guaranteed control level.
A 99.9 percent reduction would eliminate SCV emissions as a contributor
to facilities' MIRs exceeding 100-in-1 million for facilities using at
least 10 tpy but less than 30 tpy of EtO. As discussed in section
III.D.2 of the proposal preamble (88 FR 22790, April 13, 2023), we
evaluated a 99.94 percent emission reduction standard for these
facilities as part of Control Option A under the second step of the
residual risk review. However, as discussed in section IV.C.3 of this
preamble, several commenters stated that we do not have representative
performance tests for SCVs. While this is not true for the whole source
category, it is true for facilities where EtO use is at least 10 tpy
but less than 30 tpy. Therefore, as part of this final rule, we did not
evaluate an
[[Page 24120]]
emission reduction standard more stringent than the manufacturer
guarantee for SCVs at these facilities.
For facilities using at least 30 tpy, further reduction would be
needed to eliminate SCV emissions as a contributor to a facility's MIR
exceeding 100-in-1 million. We evaluated 99.99 percent reduction based
on a performance test showing this level of reduction from a facility
within this group. A 99.99 percent reduction would eliminate SCV
emissions as a contributor to a facility's MIR exceeding 100-in-a-
million for facilities using at least 30 tpy of EtO. We received
comment on the technical feasibility of emission standards that exceed
the manufacturer guarantee for SCVs (i.e., 99.9 percent emission
reduction), but we do not have any information suggesting that any
facility within this group cannot achieve 99.99 percent emission
reduction. See section IV.C.3 of this preamble for more information.
ii. ARV Emissions
There are three facilities where revised allowable ARV emissions
contribute to the facility's MIR exceeding 100-in-1 million, and EtO
use at these facilities currently ranges from 44 tpy to 446 tpy of EtO.
The previous subpart O required a 1 ppm maximum outlet concentration or
99 percent emission reduction for ARVs at facilities where EtO use is
at least 10 tpy. As discussed in section IV.B, we are removing the 1
ppm maximum outlet concentration alternative standard, and we are
finalizing 99 percent emission reduction standards under CAA section
112(d)(5) for previously unregulated ARVs, which were those at
facilities where EtO use is less than 10 tpy. As a result, the final
112(d) standard for ARV emissions at all facilities is 99 percent
reduction.
Our data do not identify any add-on controls beyond those we have
already considered when promulgating, or proposing revisions to the
previous ARV standards in subpart O or finalizing the standards for the
previously unregulated ARVs in section IV.B. However, as discussed in
section III.F.3 of the proposal preamble (88 FR 22790, April 13, 2023),
our evaluation of the performance test data shows that these controls
can achieve greater than 99 percent emission reduction.\47\ We
evaluated 99.9 percent reduction of ARV emissions from facilities using
at least 30 tpy of EtO,\48\ which is feasible because it is currently
achieved by one-third of these facilities. Of these 12 facilities that
are currently achieving this emission reduction, nine use catalytic
oxidizers, two use a catalytic oxidizer and gas/solid reactor in
series, one uses a thermal oxidizer, and one uses a gas/solid reactor.
Note that this does not sum to 12 because one facility uses two
different types of control systems to reduce its ARV emissions.\49\ A
99.9 percent emission reduction would eliminate ARV emissions as a
contributor to a facility's MIR to exceed 100-in-1 million for
facilities using at least 30 tpy of EtO.\50\
---------------------------------------------------------------------------
\47\ While the types of controls used for ARVs are the same as
those used for SCVs, the distribution of these controls is
different. For example, the use of catalytic oxidizers and gas/solid
reactors is more prominent when controlling ARV emissions, while the
use wet scrubbers is more prominent when controlling SCV emissions.
See memorandum, Technical Support Document for Proposed Rule--
Industry Profile, Review of Unregulated Emissions, CAA Section
112(d)(6) Technology Review, and CAA Section 112(f) Risk Assessment
for the Ethylene Oxide Emissions Standards for Sterilization
Facilities NESHAP, located at Docket ID No. EPA-HQ-OAR-2019-0178.
\48\ As discussed above, one of the facilities where allowable
ARV emissions contribute to the facility's MIR exceeding 100-in-1
million uses 44 tpy. Evaluating the emission reduction for
facilities where EtO use is at least 30 tpy provides a sufficient
buffer in case the EtO use at this facility drops to below 40 tpy.
\49\ As part of the proposed rulemaking, a similar analysis was
conducted for ARVs at facilities where EtO use is at least 10 tpy.
See section III.F.3.a of the proposal preamble for more details on
that analysis (88 FR 22790, April 13, 2023).
\50\ As part of the proposed rulemaking, we evaluated a 99.9
percent emission reduction standard for ARVs at facilities where EtO
use is at least 10 tpy as part of the technology review (see section
III.F.3 of the proposal preamble (88 FR 22790, April 13, 2023)). For
existing sources, this option was rejected in favor of a more cost-
effective option (i.e., 99.6 percent emission reduction). However,
we proposed a 99.9 percent emission reduction standard for new
sources pursuant to CAA section 112(d)(6).
---------------------------------------------------------------------------
iii. Group 2 Room Air Emissions
There are 13 facilities, all area sources, where revised allowable
Group 2 room air emissions contribute to the facilities' MIRs exceeding
100-in-1 million and the EtO usage at these facilities ranges from 4
tpy to 446 tpy.\51\ Because Group 2 room air emissions contribute to
unacceptable risks from existing area sources in this source category,
we evaluated available control options for reducing risks from Group 2
room air emissions.
---------------------------------------------------------------------------
\51\ As discussed earlier, the EPA has the authority to conduct
an (f)(2) review of GACT standards and is exercising that authority
in this action.
---------------------------------------------------------------------------
As discussed in section IV.B of this preamble, we are finalizing a
GACT standard for previously unregulated Group 2 room air emissions at
existing area source facilities. Specifically, we are finalizing under
CAA section 112(d)(5) that area source facilities lower the EtO
concentration within each sterilization chamber to 1 ppm before the
chamber can be opened.\52\ Because there is still unacceptable risk
from facilities where EtO usage is above 4 tpy, this requirement will
ultimately apply only to existing Group 2 room air emissions at
facilities where EtO use is less than 4 tpy.
---------------------------------------------------------------------------
\52\ As discussed in section IV.B of this preamble, we are
finalizing an 80 percent emission reduction standard for all new
Group 2 room air emissions at area source facilities, regardless of
EtO use, under CAA section 112(d)(5).
---------------------------------------------------------------------------
In evaluating the appropriate GACT standard for previously
unregulated existing Group 2 room air emissions at area source
facilities, we considered an emission reduction of 80 percent that
reflects the use of control devices (Option 1) but did not finalize
that option under CAA section 112(d)(5) for reasons stated in section
IV.B.3.b. However, having determined under CAA section 112(f)(2) that
the risk for the source category is unacceptable, we are determining
the emissions standards necessary to reduce risk to an acceptable level
without considering costs. We evaluated 80 percent emission reduction
of Group 2 room air emissions from area source facilities using at
least 4 tpy but less than 20 tpy of EtO. As discussed in section
IV.B.3.b of this preamble, 80 percent is the manufacturer guarantee for
room air emissions controls provided by one of the commenters. We do
not have any performance test data for Group 2 room air emissions at
these facilities, so it is unknown whether these sources can achieve
greater than 80 percent emission reduction. An 80 percent reduction
would eliminate Group 2 room air emissions as a contributor to a
facility's MIRs exceeding 100-in-1 million for area source facilities
using at least 4 tpy but less than 20 tpy.
For area source facilities using at least 20 tpy, further reduction
would be needed to eliminate Group 2 room air emissions as a
contributor to a facility's MIR exceeding 100-in-a-million. Our data do
not identify any add-on controls beyond those we have already
considered when finalizing the standards for the previously unregulated
Group 2 room air emission in section IV.B. However, our evaluation of
the performance data shows that these controls can achieve greater than
80 percent emission reduction at area source facilities where EtO use
is at least 20 tpy. We therefore considered a more stringent Group 2
room air emission standard for these facilities. We evaluated 98
percent reduction of Group 2 room air emissions from area source
facilities using at least 20 tpy, which is the emission reduction that
has been achieved in one-third of the
[[Page 24121]]
available performance test runs for these facilities.\53\ 98 percent
reduction would eliminate Group 2 room air emissions as a contributor
to a facility's MIR exceeding 100-in-a-million for area source
facilities where EtO use is at least 20 tpy.
---------------------------------------------------------------------------
\53\ All of these facilities use gas/solid reactors to control
their Group 2 room air emissions.
---------------------------------------------------------------------------
iv. CEV Emissions
There is one facility within the source category where revised
allowable emissions from CEVs contribute to the facility's MIR
exceeding 100-in-1 million, and this is an area source facility that
currently uses 446 tpy of EtO. The previous subpart O did not regulate
CEVs at area source facilities. As discussed in section IV.B of this
preamble, we are finalizing a GACT standard for these sources.
Specifically, pursuant to CAA section 112(d)(5), we are finalizing a 99
percent emission reduction standard for CEVs at area source facilities.
Our data do not identify any add-on controls beyond those we have
already considered when finalizing the standards for CEVs in section
IV.B. However, our evaluation of the performance test data shows that
these controls can achieve greater than 99 percent reduction. We
therefore considered a more stringent CEV emission standard for area
source facilities where EtO use is at least 400 tpy. We evaluated 99.9
percent reduction of CEV emissions from facilities where EtO use is at
least 400 tpy, which is the emission reduction that is currently
achieved by 75 percent of these facilities.\54\ A 99.9 percent
reduction would eliminate CEV emissions as a contributer to a
facility's MIR exceeding 100-in-1-million for facilities where EtO use
is at least 400 tpy.
---------------------------------------------------------------------------
\54\ There are three facilities that are currently achieving
this emission reduction. Of these three facilities, two use
catalytic oxidizers, and one uses a wet scrubber.
---------------------------------------------------------------------------
v. Group 1 Room Air Emissions
There are four area source facilities within the source category
where revised allowable Group 1 room air emissions contribute to the
facilities' MIRs exceeding 100-in-1 million, and the EtO usage at these
facilities ranges from 44 to 446 tpy. The previous subpart O did not
regulate Group 1 room air emissions at area source facilities. As
discussed in section IV.B of this preamble, we are finalizing a GACT
standard for these sources. Specifically, pursuant to CAA section
112(d)(5), we are finalizing an 80 percent emission reduction as the
GACT standard for Group 1 room air emissions at area source facilities.
Our data do not identify any add-on controls beyond those we have
already considered when finalizing the standards for Group 1 room air
emissions in section IV.B. However, our evaluation of the performance
test data shows that these controls can achieve greater than 80 percent
reduction. We therefore considered a more stringent Group 1 room air
emission standard for area source facilities where EtO use is at least
40 tpy. We evaluated 98 percent emission reduction of Group 1 room air
emissions from area source facilities using at least 40 tpy, which is
the emission reduction that has been achieved in all but one of the six
available performance test runs for these facilities.\55\ A 98 percent
reduction would eliminate Group 1 room air emissions as a contributor
to a facility's MIRs exceeding 100-in-1-million for area source
facilities where EtO use is at least 40 tpy.
---------------------------------------------------------------------------
\55\ All of these facilities use gas/solid reactors to control
their Group 1 room air emissions.
---------------------------------------------------------------------------
Considering all of the emission reductions that we evaluated above,
the source category MIR would be reduced to 100-in-1 million. This
means that all facilities would have an MIR at or below 100-in-1
million,\56\ and the population exposed to risk levels greater 100-in-1
million would be reduced to zero. In addition, the population exposed
to risk levels greater than or equal to 1-in-1 million living within 50
km of a facility would be reduced to between 710,000 (when considering
some facilities are currently performing better than the standards) and
1.41 million people (when considering all facilities perform at the
level of the standards). Finally, the cancer incidence would be reduced
from 0.9 to between 0.1 (when considering some facilities are currently
performing better than the standards) and 0.2 (when considering all
facilities perform at the level of the standards), or from 1 cancer
case every 1.1 years to 1 cancer case every 5 to 10 years. For these
reasons, we find that the preceding emission reductions that we
evaluated reduce risks to an acceptable level. These emission reduction
measures are:
---------------------------------------------------------------------------
\56\ Considering actual emissions, most facilities (i.e., 87 out
of 88) would have an MIR less than 100-in-1 million.
---------------------------------------------------------------------------
99.99 percent emission reduction for SCVs at facilities
where EtO use is at least 30 tpy,
99.9 percent emission reduction for SCVs at facilities
where EtO use is at least 10 tpy but less than 30 tpy,
99.8 percent emission reduction for SCVs at facilities
where EtO use is at least 1 tpy but less than 10 tpy,
99.9 percent emission reduction for ARVs at facilities
where EtO use is at least 30 tpy,
99.9 percent emission reduction for CEVs at facilities
where EtO use is at least 400 tpy,
98 percent emission reduction for Group 1 room air
emissions at area source facilities where EtO use is at least 40 tpy,
98 percent emission reduction for Group 2 room air
emissions at area source facilities where EtO use is at least 20 tpy,
and
80 percent emission reduction for Group 2 room air
emissions at area source facilities where EtO use is at least 4 tpy but
less than 20 tpy.
b. Ample Margin of Safety (Step 2)
At step 1 of our review of residual risks under CAA section
112(f)(2), we have identified a suite of standards and determined that
they are necessary to reduce risks to an acceptable level. These
include standards for SCVs at facilities with EtO usage of at least 1
tpy, ARVs at facilities with EtO usage of at least 30 tpy, CEVs at area
source facilities with EtO usage of at least 400 tpy, Group 1 room air
emissions at area source facilities with EtO usage of at least 40 tpy,
and Group 2 room air emissions at area source facilities with EtO usage
of at least four tpy. For step 2 of our review of residual risks, we
evaluate whether more stringent standards are necessary to provide an
ample margin of safety to protect public health. While we do not
consider costs in the step 1 analysis, costs are a factor we consider
in the step 2 analysis. For details on the assumptions and
methodologies used in the costs and impacts analyses, see the technical
memorandum titled Ample Margin of Safety Analysis for Ethylene Oxide
Commercial Sterilization--Promulgation Rule Review for the Ethylene
Oxide Commercial Sterilization Source Category, which is available in
the docket for this rulemaking.
As part of the proposed rulemaking, we considered six options
(which are identified in the proposal preamble table 22 (88 FR 22829)
and proposed Control Options A and C as part of the ample margin of
safety analysis. Control Option A would have required 99.94 percent
emission reduction for SCVs at facilities where EtO use is at least 10
tpy but less than 40 tpy. We are not finalizing Control Option A for
the following reasons. First, this option is less stringent than the
standard we have
[[Page 24122]]
already identified in Step 1 (99.99 percent emission reduction) for SCV
emissions at facilities where EtO use is at least 30 tpy.\57\ Second,
for facilities where EtO use is less than 30 tpy, we do not have any
performance tests showing that these facilities can perform better than
the manufacturer guarantee (i.e., 99.9 percent emission reduction for
SCVs). For these reasons, we are not finalizing Control Option A as
part of this rulemaking. Control Option C would have required 99.8
percent emission reduction for SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy. As discussed in section IV.C.2.a of
this preamble (step 1 of risk review), Control Option C is one of the
standards identified under the revised Step 1 analysis as necessary to
reduce risks to an acceptable level.
---------------------------------------------------------------------------
\57\ For facilities where use is less than 30 tpy, we do not
have performance test data indicating that 99.99 percent emission
reduction for SCVs is technical feasible.
---------------------------------------------------------------------------
In addition, we evaluated the following options but rejected them
for the reasons discussed below:
[cir] For ARVs at facilities where EtO use is at least 30 tpy, we
do not have data showing that it is technically feasible for all
facilities to achieve greater than 99.9 percent emission reduction
(which is the standard applicable to these sources that we have
determined under step 1 as necessary to reduce risks to an acceptable
level).
For ARVs at facilities where EtO use is less than 10 tpy,
we were unable to identify any cost-effective options that achieve
emission reduction greater than the current 99 percent emission
reduction standard (GACT). More information is presented in the
technical memorandum titled Ample Margin of Safety Analysis for
Ethylene Oxide Commercial Sterilization--Promulgation Rule Review for
the Ethylene Oxide Commercial Sterilization Source Category, which is
available in the docket for this rulemaking.
For Group 2 room air emissions at area source facilities
where EtO use is at least 20 tpy, we do not have data indicating that
it is technically feasible for all facilities to achieve greater than
98 percent emission reduction (which is the standard applicable to
these sources that we have determined under step 1 as necessary to
reduce risks to an acceptable level).
For Group 2 room air emissions at area source facilities
where EtO use is less than 20 tpy, we do not have any performance tests
showing that these facilities can perform better than the manufacturer
guarantee (i.e., 80 percent emission reduction for room air emissions,
which is the standard for facilities using at least 4 tpy but less than
20 tpy of EtO that we have determined under step 1 as necessary to
reduce risks to an acceptable level).
For Group 2 room air emissions at area source facilities
where EtO use is less than 4 tpy, 80 percent emission reduction is not
cost effective.\58\
---------------------------------------------------------------------------
\58\ As discussed in section IV.B.3.b of this preamble, we
analyzed this option as part of the GACT analysis and found it to be
cost-effective. However, this analysis included all facilities in
the source category (i.e., not just those where EtO use is less than
4 tpy).
---------------------------------------------------------------------------
For Group 1 room air emissions at area source facilities
where EtO use is at least 40 tpy, we do not have data indicating that
it is technically feasible for all facilities to achieve greater than
98 percent emission reduction (which is the standard for these affected
sources that we have identified in Step 1 as necessary to reduce risks
to an acceptable level).
For Group 1 room air emissions at area source facilities
where EtO use is less than 40 tpy, we do not have any performance tests
showing that these facilities can perform better than the manufacturer
guarantee (i.e., 80 percent emission reduction for room air emissions,
which we have established in this final rule as the GACT standard for
Group 1 room air emissions at these facilities).
However, there are two potential options. One potential option is
99.6 percent emission reduction for ARVs at facilities where EtO use is
at least 10 tpy but less than 30 tpy. This is cost effective and is
already being achieved by these facilities. The other potential option
is to further reduce CEV emissions at area source facilities.\59\ Under
this option, which would reduce CEV emissions by 99.9 percent at area
source facilities where EtO use is at least 60 tpy less than 400
tpy,\60\ costs were found to be a $6,820,000 total capital investment
and a $1,670,000 total annualized cost. The estimated EtO emissions
reductions are 1.9 tpy (i.e., 3,720 lb/year) with a cost effectiveness
of $895,000 per ton of EtO (i.e., $448 per lb of EtO). Considering EtO
is a highly potent carcinogen, the cost-effectiveness number of this
option is within the range of the values that we have determined to be
cost-effective for highly toxic HAPs. As explained in section IV.B.3.b
of this preamble, this includes hexavalent chromium, where we finalized
a requirement with a cost-effectiveness of $15,000/lb ($30,000,000/ton)
for existing small hard chromium electroplating to provide an ample
margin of safety (taking into account cost among other factors) (77 FR
58227-8, 58239). While we do not know what the full extent of risk
reductions would be, we estimate that, compared to the measures in step
1, this control option would further reduce the population exposed to
risk levels greater than or equal to 1-in-1 million by additional
10,000-30,000 people. For area sources where EtO use is less than 60
tpy, we do not have any performance test data showing that existing
controls can achieve greater than 99 percent reduction for CEVs (which
is the GACT standard we have established in this final rule for CEV at
area sources). In addition, for area source facilities where EtO use is
at least 400 tpy, we were unable to identify any cost-effective
options. Therefore, we did not consider a more stringent CEV standard
for facilities where EtO use at least 400 tpy.
---------------------------------------------------------------------------
\59\ As discussed in section IV.B.3.b of this preamble, pursuant
to CAA sections 112(d)(2) and 112(d)(3), we are finalizing a 99.94
percent emission reduction standard for CEVs at major source
facilities. We did not identify any cost-effective BTF options.
\60\ As discussed in step 1 analysis, pursuant to CAA section
112(f)(2), this standard for CEVs at area source facilities where
EtO usage is at least 400 tpy is necessary to reduce risks to an
acceptable level.
---------------------------------------------------------------------------
In the post control scenario (i.e., with the implementation of the
standards identified under step 1 and the two potential options
discussed immediately above in this step 2 analysis, we estimated that
the baseline cancer MIR of 6,000-in-1 million for actual emissions and
8,000-in-1 million for allowable emissions would be reduced to 100-in-1
million, with EtO driving the risk. While the MIR for the source
category will be 100-in-1 million, we estimate that most facilities
(i.e., 87 out of 88) will have an MIR less than 100-in-1 million. There
is an estimated reduction in cancer incidence to 0.2 excess cancer
cases per year (or one excess case every 5 years), down from 0.9 excess
cancer cases per year (or one excess cancer case every 1.1 years) for
baseline actual emissions and down from 8 excess cancer cases per year
(or one excess cancer case every 1.5 months) for baseline allowable
emissions. We estimate that, after full implementation of this final
rule, 0 people would have cancer risks greater than 100-in-1 million,
down from 19,000 people for actual emissions and 260,000 people for
allowable emissions. In addition, the number of people estimated to
have a cancer risk greater than or equal to 1-in-1 million would be
reduced to 1.38 million people, down from 8.5 million people for actual
emissions and 62 million people for
[[Page 24123]]
allowable emissions (table 19 of this preamble).
Again, we note that some facilities are currently performing better
than the controls finalized under CAA sections 112(f)(2), and in that
case we estimate the maximum lifetime individual cancer risk as 100-in-
1 million, with EtO driving the risk. The total estimated cancer
incidence is estimated to be 0.1 excess cancer cases per year, or 1
excess case in every 10 years, with approximately 700,000 people
estimated to have cancer risks greater than or equal to 1-in-1 million
and 0 people estimated to have cancer risks greater than 100-in-1
million (table 19 of this preamble).
Table 19--Baseline and Post-Control Risk (After Controls Promulgated Under CAA Sections 112(F)(2) Summary For
the Commercial Sterilization Facilities Source Category Based on Emissions in the Final Rule
----------------------------------------------------------------------------------------------------------------
Inhalation cancer risk Population cancer risk
---------------------------------------------------------------------------------
Maximum Cancer
individual incidence >100-in-1 [gteqt]1-in-1
risk (in 1 Risk driver (cases per million million
million) year)
----------------------------------------------------------------------------------------------------------------
Actual Emissions Baseline Risk 6,000 ethylene oxide.. 0.9 19,000 8,500,000
Allowable Emissions Baseline 8,000 ethylene oxide.. 8 260,000 62,000,000
Risk.
Post-control Risk............. 100 ethylene oxide.. \1\ 0.1-0.2 0 \1\ 700,000-
1,380,000
----------------------------------------------------------------------------------------------------------------
\1\ Ranges in values account for if all facilities were performing at the level of the standards (high end) to
considering facilities that are currently performing better than the standards (low end).
Additional details of the analyzed risks can be found in the
Residual Risk Assessment for the Commercial Sterilization Facilities
Source Category in Support of the 2024 Risk and Technology Review Final
Rule, available in the docket for this rulemaking.
Based on our ample margin of safety analysis, including all health
information and the associated cost and feasibility discussed above, we
find that requiring the standards that, based on our analysis, would
bring risks to an acceptable level, along with 99.6 percent emission
reduction for ARVs at facilities where EtO use is at least 10 tpy but
less than 30 tpy and 99.9 percent emission reduction for CEVs at area
source facilities where EtO use is at least 60 tpy but less than 400
tpy, would provide an ample margin of safety to protect public health.
c. Environmental Effects
As explained in our proposed rule, the emissions data indicate that
no environmental HAP are emitted by sources within this source
category. In addition, we are unaware of any adverse environmental
effects caused by HAP emitted by this source category. Therefore, we do
not expect there to be an adverse environmental effect as a result of
HAP emissions from this source category. For the reason stated above,
it is not necessary to set a more stringent standard to prevent, taking
into consideration costs, energy, safety, and other relevant factors,
an adverse environmental effect.
d. Rule Changes
Based on comments received on the proposed rulemaking, we are
finalizing the following emissions standards pursuant to CAA section
112(f)(2):
99.99 percent emission reduction for SCVs at facilities
where EtO use is at least 30 tpy,
99.9 percent emission reduction for SCVs at facilities
where EtO use is at least 10 tpy but less than 30 tpy,
99.8 percent emission reduction for SCVs at facilities
where EtO use is at least 1 tpy but less than 10 tpy,
99.9 percent emission reduction for ARVs at facilities
where EtO use is at least 30 tpy,
99.6 percent emission reduction for ARVs at facilities
where EtO use is at least 10 tpy but less than 30 tpy,
99.9 percent emission reduction for CEVs at area source
facilities where EtO use is at least 60 tpy,
98 percent emission reduction for Group 1 room air
emissions at area source facilities where EtO use is at least 40 tpy,
98 percent emission reduction for Group 2 room air
emissions at area source facilities where EtO use is at least 20 tpy,
and
80 percent emission reduction for Group 2 room air
emissions at area source facilities where EtO use is at least 4 tpy but
less than 20 tpy.
We are not finalizing the work practice standards that were
proposed for facilities where the MIR remained greater than 100-in-1
million after the imposition of requirements under ``Control Option
1'', which would have required facilities to limit their existing Group
2 room air emissions to a maximum volumetric flow rate of 2,900 dscfm
and a maximum EtO concentration of 30 ppbv. We had proposed these
standards based on the risk review we conducted during the proposal
stage, which has been substantially revised. As discussed above, based
on the revised risk review, we are finalizing a different suite of
standards pursuant to CAA section 112(f)(2) to reduce risks to an
acceptable level and provide an ample margin of safety to protect
public health.
3. What key comments did we receive on the risk review, and what are
our responses?
This section provides comment summaries and responses for the key
comments received regarding our exclusion of allowable emissions from
the risk assessment, the control requirements proposed for SCVs, and
the work practice standards that were proposed for facilities where the
MIR remained greater than 100-in-1 million after the imposition of
requirements under ``Control Option 1'' evaluated in the residual risk
assessment during the proposal stage, as well as the proposed GACT
standards that were incorporated into the residual risk assessment. We
received comments against the exclusion of allowable emissions from the
risk assessment, the control requirements proposed for SCVs, and the
work practice standards that were proposed for facilities where the MIR
remained greater than 100-in-1 million after the imposition of
requirements under ``Control Option 1.'' Other comments on these
issues, as well as on additional issues regarding the residual risk
review and our proposed changes based on the residual risk review, can
be found in the document, Summary of Public Comments and Responses for
the Risk and Technology Review for
[[Page 24124]]
Commercial Sterilization Facilities, available in the docket for this
rulemaking.
Comment: Two commenters contended that we should use allowable
emissions when conducting residual risk assessments. One commenter
stated that actual emissions only provide a snapshot in time and that
there is no legal requirement at the Federal level to maintain
emissions beyond the NESHAP requirements in any given year. The
commenter also referenced a 2010 Science Advisory Board (SAB) report
that recommended we use ``facility-specific allowable emissions
reflecting current regulatory limits.'' \61\
---------------------------------------------------------------------------
\61\ Commenter provided the following reference: EPA Science
Advisory Board, Review of EPA's draft entitled, ``Risk and
Technology Review (RTR) Risk Assessment Methodologies: For Review by
the EPA's Science Advisory Board with Case Studies--MACT I Petroleum
Refining Sources and Portland Cement Manufacturing'', at ii, (May 7,
2010), https://www.regulations.gov/document/EPA-HQ-OAR-2010-0682-0103.
---------------------------------------------------------------------------
Response: We agree with commenters that allowable emissions should
be considered as part of the residual risk assessment. As discussed in
section III.C of the proposed rulemaking (88 FR 22790), because
allowable emissions and risks were higher than actual emissions, and in
light of our finding that risks were unacceptable based on actual
emissions, we determined that a separate assessment of allowable
emissions was unnecessary. However, for the reasons stated by the
commenters, we have incorporated allowable emissions into our revised
risk assessment as part of this final rulemaking.
Comment: Two commenters expressed the following concerns with the
99.94 percent emission reduction standard for SCVs:
Our technical publications on reduction ranges for add-on
control equipment for HAPs do not show that a destruction and removal
efficiency of 99.94 percent is achievable under normal continuous
operation.
The proposed requirement does not require additional
controls based on new technology, but requires achieving greater
efficiency from existing controls. Specifically, one commenter stated
that nothing in the proposal preamble suggests that the control systems
installed in order to meet the current SCV standard need to be replaced
or their performance upgraded. The commenter further stated that our
cost estimates include nothing with respect to controls for SCVs.
Emission control device manufacturers do not guarantee a
destruction removal efficiency of 99.94 percent for SCVs.
Two commenters stated that emissions standards should be based on
achievable, manufacturer guaranteed destruction removal efficiency of
emission control equipment. One commenter stated that, based on their
discussions with control device manufacturers, they believe that the
best and most advanced technologies will be guaranteed to meet a 99.9
percent emission reduction standard for SCVs.
Response: We disagree with the commenters that our technical
publications on reduction ranges for add-on control equipment for HAPs
do not show that an emission reduction of 99.94 percent (and,
therefore, any greater emission reduction) is achievable under normal
continuous operation for SCVs. Such a performance test was conducted
for at least two systems that control SCV emissions, and the reported
emission reduction for both of these systems was 99.99 percent. Below
is a discussion on the relevant points for each performance test:
The first performance test was conducted on November 17,
1999.\62\ It is unknown what the EtO use at this facility was at the
time of the performance test, but it is expected that it was somewhere
between 10 tpy and 30 tpy. At the time of the performance test, the
facility used a wet scrubber to control its SCV emissions.\63\ Prior to
November 2, 2001, we required facilities to test the both the first and
last evacuations of the SCV. The SCV concentration decreases over time,
so any emission reductions between the first and last evacuations are
going to be at least as high as that of the last evacuation. For this
performance test, the average emission reduction at the first
evacuation was 99.9946 percent, and the average emission reduction at
the last evacuation was 99.99 percent. This means that the emission
reduction over all the SCV cycles exceeded 99.99 percent. While this
performance test data is almost 25 years old, emission control
technology has continued to improve over time, and emission reductions
today are likely higher.
---------------------------------------------------------------------------
\62\ https://www.regulations.gov/document/EPA-HQ-OAR-2019-0178-0297.
\63\ This facility continues to use a wet scrubber to control
its SCV emissions to this day.
---------------------------------------------------------------------------
The data from this performance test indicates that, for
facilities where EtO use is at least 30 tpy, any SCV control system
that is achieving higher than 99.9946 percent emission reduction on the
first evacuation is likely achieving at least 99.99 percent emission
reduction overall. Our current performance test data indicates that at
least 15 facilities where EtO use is at least 30 tpy are currently
achieving greater than 99.9946 percent emission reduction on the first
evacuation, and the highest emission reduction on the first evacuation
that we have observed is 99.99999982 percent. Of these 15 facilities
that are currently achieving this emission reduction, eight use wet
scrubbers, three use a wet scrubber and gas/solid reactor in series,
two use thermal oxidizers, one uses a catalytic oxidizer, and one uses
a wet scrubber and catalytic oxidizer in series.
The second performance test was conducted on March 10, 11,
and 12, 2020,\64\ and EtO use at this facility is 229.2 tpy. This
facility uses wet scrubbers and gas/solid reactors in series to control
its SCV emissions. Due to the configuration of the control system at
this facility, there is no mechanism to test the SCVs on their own.
Therefore, this performance test was conducted for all emission sources
at the facility. For lower concentration streams like ARVs, CEVs, and
room air emissions, emission reductions tend to be lower. Therefore, it
is likely that the SCV emission reduction at this facility exceeds
99.99 percent.
---------------------------------------------------------------------------
\64\ https://www.regulations.gov/document/EPA-HQ-OAR-2019-0178-0349.
---------------------------------------------------------------------------
As a general matter, it is not our policy to simply rely on
manufacturer guarantees when setting or revising emission standards.
Typically, we evaluate performance tests to see what the controls are
actually achieving in practice and then set or revise the standards
based on that evaluation. However, if representative performance test
data are not available, then manufacturer guarantees may be considered.
We also note that it is common within this industry to combine
different types of control devices in series when reducing emissions.
Since these control devices are often made by different manufacturers,
there is no manufacturer guarantee available for these systems. We do
not share the commenters' concerns that emission control device
manufacturers do not guarantee a destruction removal efficiency of
99.94 percent for SCVs, as representative performance test data is
available and indicates that these emission reductions (and, in fact,
higher emission reductions) are achievable for higher use facilities.
However, such performance test data are not available for smaller
users, and it is not known whether those facilities can meet the
emission reduction that the higher use facility is demonstrating.
Therefore, we agree with commenters that consideration of manufacturer
guarantees is warranted for lower use facilities, and the
[[Page 24125]]
standards that we are finalizing for SCVs at facilities where EtO use
is less than 30 tpy do not exceed the manufacturer guarantee.
In addition, we disagree with one commenter's assertion that there
is nothing in the proposal preamble to suggest that the control systems
installed in order to meet the current SCV standard need to be replaced
or their performance upgraded. Furthermore, the commenter's assertion
that our cost estimates include nothing with respect to controls for
SCVs is incorrect. As discussed in section II.A of this preamble, under
the first step of the residual risk assessment, if risks are
unacceptable, the EPA must determine the emissions standards necessary
to reduce risk to an acceptable level without considering costs. While
we did not conduct a cost analysis for the SCV standards that we are
finalizing pursuant to CAA section 112(f)(2) step 1 (risk acceptability
analysis), we assume that new controls would be needed in order to
achieve those standards, and the cost of those controls are included in
the total costs of the rule. However, we note that the final standard
is simply an emission reduction standard, and owners and operators may
choose to meet the standard however they see fit (e.g., either through
process changes, the replacement of a control system, or the use of
additional control devices to further reduce emissions from an existing
control system). In some cases, existing controls may already be
achieving the standard, and in that case, no changes are required.
Comment: Several commenters stated that reducing the volumetric
flow rate from Group 2 room air emissions to 2,900 dscfm would be
detrimental to sterilization operations and may make it impossible to
achieve the proposed PTE requirement.
Response: Based on comments received on the proposed rulemaking, we
revised the risk assessment, which resulted in different emission
reduction measures than what we proposed to bring the risk to the
acceptable level. The proposed work practice standards are no longer
necessary to bring the MIR of Group 2 room air emissions at area source
facilities to 100-in-1 million. Therefore, we are not including a work
practice standard that would require any facilities to reduce their
throughput as part of this final rule.
4. What is the rationale for our final approach and final decisions for
the risk review?
As noted in our proposal, we set standards under CAA section
112(f)(2) using ``a two-step standard-setting approach, with an
analytical first step to determine an `acceptable risk' that considers
all health information, including risk estimation uncertainty, and
includes a presumptive benchmark on MIR of approximately 1-in-10
thousand'' (88 FR 22790, April 13, 2023; see also 54 FR 38045,
September 9, 1989). We weigh all health risk factors in our risk
acceptability determination, including the cancer MIR, cancer
incidence, the maximum TOSHI, the maximum acute HQ, the extent and the
distribution of cancer and noncancer risks in the exposed population,
multipathway risks, and the risk estimation uncertainties. In the
second step of the approach, the EPA considers whether the emissions
standards provide an ample margin of safety to protect public health
``in consideration of all health information, including the number of
persons at risk levels higher than approximately 1-in-1 million, as
well as other relevant factors, including costs and economic impacts,
technological feasibility, and other factors relevant to each
particular decision.'' Id. The EPA must promulgate emission standards
necessary to provide an ample margin of safety to protect public health
or determine that the standards being reviewed provide an ample margin
of safety without any revisions. After conducting the ample margin of
safety analysis, we consider whether a more stringent standard is
necessary to prevent an adverse environmental effect, taking into
consideration costs, energy, safety, and other relevant factors.
Since proposal, our determinations regarding risk acceptability,
ample margin of safety, or adverse environmental effects have not
changed. The revised risk assessment (see document, Residual Risk
Assessment for the Commercial Sterilization Facilities Source Category
in Support of the 2024 Risk and Technology Review Final Rule, which is
available in the docket for this rulemaking) shows that, after
application of controls finalized in this rulemaking, the MIR for the
source category is 100-in-1 million. Therefore, after application of
the controls for SCVs at facilities where EtO use is at least 1 tpy,
ARVs at facilities where EtO use is at least 30 tpy, CEVs at area
source facilities where EtO use is at least 400 tpy, Group 1 room air
emissions at area source facilities where EtO use is at least 40 tpy,
and Group 2 room air emissions at area source facilities where EtO use
is at least four tpy, we find that the risks are acceptable and that
the final standards will achieve an ample margin of safety to protect
public health.
D. Technology Review for the Commercial Sterilization Facilities Source
Category
1. What did we propose pursuant to CAA section 112(d)(6) for the
Commercial Sterilization Facilities source category?
Based on our technology review for the Commercial Sterilization
Facilities source category, we proposed under CAA section 112(d)(6)
changes to the standards for SCVs where EtO use is at least 10 tpy,
SCVs where EtO use is at least 1 tpy but less than 10 tpy, and ARVs
where EtO use is at least 10 tpy. We provide a summary of our findings,
as proposed, in this section. In general, while the types of controls
have essentially remained the same since promulgation of subpart O,
available information show greater emission reduction since then for
some of these control options.
For SCVs, we proposed the following emission standards pursuant to
CAA section 112(d)(6):
99.94 percent reduction for new and existing SCVs at
facilities where EtO use is at least 10 tpy, and
99.8 percent reduction for new and existing SCVs at
facilities where EtO use is at least 1 tpy but less than 10 tpy.
These are the maximum SCV emission reductions with which compliance
can be demonstrated. We evaluated these standards against the maximum
SCV emission reductions that all facilities are currently meeting
within each subcategory. For more information, see sections III.F.1 and
III.F.2 of the proposal preamble (88 FR 22790, April 13, 2023).
For ARVs, we proposed the following emission standards pursuant to
CAA section 112(d)(6):
99.6 percent emission reduction for existing ARVs at
facilities where EtO use is at least 10 tpy, and
99.9 percent emission reduction for new ARVs at facilities
where EtO use is at least 10 tpy.
These are the emission reductions that have been demonstrated by 75
percent and 50 percent of all available performance tests,
respectively. We evaluated both emission reductions for new and
existing ARVs. For more information, see section III.F.3 of the
proposal preamble (88 FR 22790, April 13, 2023).
2. How did the technology review change for the Commercial
Sterilization Facilities source category?
We are finalizing the following emission standards as a result of
the
[[Page 24126]]
technology review for the Commercial Sterilization Facilities source
category, as proposed:
99.8 percent emission reduction for new and existing SCVs
at facilities where EtO use is at least 1 tpy but less than 10 tpy,
99.6 percent emission reduction for existing ARVs at
facilities where EtO use is at least 10 tpy, and
99.9 percent emission reduction for new ARVs at facilities
where EtO use is at least 10 tpy.
For new and existing SCVs at facilities where EtO use is at least
10 tpy, based on comments received on the proposal, we are finalizing a
99.9 percent emission reduction, which is the manufacturer guarantee.
There is a lack of representative performance test data for these SCVs,
and we are unable to determine whether all facilities can achieve an
emission reduction higher than the manufacturer guarantee. For more
information, see section IV.D.3.a of this preamble.
3. What key comments did we receive on the technology review, and what
are our responses?
This section provides comment and responses for the major comments
on our proposed CAA section 112(d)(6) standards. Other comment
summaries and our responses for additional issues raised regarding
these activities, as well as issues raised regarding our proposed
revisions, can be found in the document Summary of Public Comments and
Responses for the Risk and Technology Review for Commercial
Sterilization Facilities, available in the docket for this rulemaking.
a. SCVs at Facilities Where EtO Use Is at Least 10 tpy
Comment: Several commenters questioned whether the proposed
emission standards for SCVs at facilities where EtO use is at least 10
tpy could be achieved with existing technology and stated that we
should consider manufacturer guarantees when revising the standard,
along with a maximum concentration limit. The commenters stated that we
arrived at a 99.94 percent emission reduction standard based on
performance tests that used the previous testing procedures in Subpart
O. These consisted of one-hour test runs that occurred during the
initial vacuum event, when EtO loading to the control system (and,
therefore, emission reduction) is high. The commenters further stated
that we proposed extending the duration of each test run to 24 hours,
which would cover a variety of operating conditions, including periods
of low inlet concentration, which have not been required to be tested.
The commenters contended that the performance test results based on the
proposed testing procedures would be lower than those under the
previous testing procedures. One commenter stated that there are no
data confirming whether state-of-the-art control systems can meet a
99.94 percent emission reduction standard for SCVs where each
performance test run is 24 hours, and another commenter stated that we
must ensure that any required emission reduction standards that are
finalized for SCVs are proven and achievable as part of performance
tests consisting of 24-hour test runs. One commenter stated that, based
on their discussions with control device manufacturers, they believe
that the best and most advanced technologies will be guaranteed to meet
a 99.9 percent emission reduction standard for SCVs.
Response: We agree with the commenters that it is not appropriate
to use performance test data based on the previous testing procedures
in Subpart O to justify revisions to the emission standards for SCVs.
We disagree with one commenter's statement that there are no data
confirming whether state-of-the-art control systems can meet a 99.94
percent emission reduction standard for SCVs where each test run is 24
hours. As discussed in section IV.C.3, such data exist for at least one
system that controls SCV emissions. However, the EtO usage at this
facility is fairly high, and we are unable to determine whether smaller
users can meet this emission standard. With respect to the suggestion
by some commenters that we consider a manufacturer guarantee reduction
level, which one commenter stated is 99.9 percent emission reduction
for SCVs, we have no data disputing such level or reason to question
the manufacturer's guarantee. Further, as discussed in our response to
the next comment below, we find the cost of this option to be
reasonable. Therefore, pursuant to CAA section 112(d)(6), we are
finalizing a 99.9 percent emission reduction standard for SCVs at
facilities where EtO use is at least 10 tpy.\65\
---------------------------------------------------------------------------
\65\ We also note that, as discussed in section IV.F.3 of this
preamble, we are finalizing a requirement for owners and operators
to include a representative performance test period for SCVs, along
with a justification, in their stack test protocol, so that the
delegated authorities can review and approve or deny the protocol as
appropriate. This will ensure that performance tests provide a more
accurate representation of SCVs emission reductions.
---------------------------------------------------------------------------
We disagree with the commenter's suggestion that we should consider
a maximum concentration limit along with the percentage reduction
standard. As discussed in section IV.B.3.a, we are concerned that some
owners and operators may dilute the air flow of the emissions stream to
meet a concentration standard, which would not result in any actual
emission reductions. Furthermore, it is not appropriate to establish
upper-bound limitations on air flow within this source category, as
additional flow may be necessary in order to mitigate any potential
safety issues that may arise. Therefore, we are not finalizing any
concentration standards as part of this rulemaking.
Comment: One commenter stated that, for the SCV technology rule
under CAA section 112(d)(6), we merely referred back to, and repeated
the proposed standards of, the residual risk review. The commenter
further stated that we did not conduct the technology review as a
separate analysis, but rather, it was inseparably intertwined with the
residual risk review. Finally, the commenter stated there is no true
technology review in the record and that cost considerations of the
proposed CAA section 112(d)(6) emissions standard for existing SCVs at
facilities where EtO use is at least 40 tpy were never considered, even
though section 112(d)(6) requires considerations of cost.\66\
---------------------------------------------------------------------------
\66\ In support of its comment that control costs must be
considered under section 112(d)(6) review, the commenter cited to
Nat'l Ass'n for Surface Finishing, 795 F.3d at 5 (``in the
technology review, EPA periodically assess, no less often than every
eight years, whether standards should be tightened in view of
developments in technologies and practices since the standard's
promulgation or last revision, and, in particular, the cost and
feasibility of developments and corresponding emissions savings'').
---------------------------------------------------------------------------
Response: We disagree with the commenter's statement that a
``true'' technology review was never conducted. In the proposal
preamble (88 FR 22839-41), the EPA discussed control options that can
achieve further emission reductions compared to the existing subpart O
standards. While the types of controls have essentially remained the
same, available information shows improvement in emission reduction
potential for some of these control options, which we consider to be a
development in control technologies; we analyzed this development and
proposed revisions to the standards pursuant to CAA section 112(d)(6).
The commenter appears to take issue with the fact that these are the
same options as those we evaluated under CAA section 112(f)(2),
specifically under step 2 (ample margin of safety) analysis. However,
in evaluating whether we can achieve further emission reduction and
thus lower risks, we naturally would
[[Page 24127]]
consider controls that reflect the current developments in processes
and technology by this industry (i.e., well performing air pollution
control), which we are also required to evaluate under CAA section
112(d)(6). For the reason stated above, we find the comment that our
technology review was not a ``true'' review to be without merit.
We acknowledge that in proposing a 99.94 percent standard pursuant
to CAA section 112(d)(6) for SCV at facilities using at least 10 tpy
EtO, we inadvertently evaluated the control costs for facilities using
between 10 to 40 tpy only. However, as discussed in our comment
response above, we no longer consider the proposed 99.94 percent
emission reduction standard to be appropriate. As suggested by several
commenters, we evaluated a manufacturer guarantee. Based on one
commenter's discussions with control device manufacturers, the best and
most advanced technologies will be guaranteed to meet 99.9 percent
emission reduction for SCVs. The impacts of this option and the 99.6
percent reduction option that we considered during the proposal stage
are presented below in table 20 for existing sources:
Table 20--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(6) for Existing SCVs at Facilities Where EtO
Use Is at Least 10 Tpy
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual EtO emission reductions Cost effectiveness ($/
Option Standard evaluated investment ($) costs ($/yr) (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................... 99.9 percent emission $1,840,000 $752,000 1.14 [2,280 lb]......... $661,000 [$330/lb].
reduction.
2.................................... 99.6 percent emission 0 0 0....................... N/A.
reduction.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Based on the estimates above, and considering EtO is a highly
potent carcinogen, the cost-effectiveness number of this option is
within the range of the values that we have determined to be cost-
effective for highly toxic HAPs. As explained in section IV.B.3.b of
this preamble, this includes hexavalent chromium, where we finalized a
requirement with a cost-effectiveness of $15,000/lb ($30,000,000/ton)
for existing small hard chromium electroplating to provide an ample
margin of safety (taking into account cost among other factors) (77 FR
58227-8, 58239). As part of the proposed rulemaking, the highest cost-
effectiveness number that we found was $19,420,188/ton. We did not
receive adverse comment on our finding that this is cost-effective.
While Option 2 would prevent backsliding, it does not achieve
additional emission reduction. Therefore, pursuant to CAA section
112(d)(6), we are revising the standard to require facilities where EtO
use is at least 10 tpy to reduce their emissions from existing SCVs by
99.9 percent.
The impacts of these options for new sources, which are presented
in table 21 of this preamble, are based on a model plant for new SCVs
at a facility using at least 10 tpy of EtO with the following
assumptions reflecting the average of each of the parameters at
existing facilities using at least 10 tpy of EtO:
Annual EtO use: 120 tpy.
Annual operating hours: 8,000.
Portion of EtO going to SCVs: 94.41 percent.
SCV flow rate: 200 cfs.
Table 21--Nationwide Emissions Reduction and Cost Impacts of Options Considered Under CAA Section 112(d)(6) for New SCVs at Facilities Where EtO Use Is
at Least 10 Tpy
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total capital Total annual EtO emission reductions Cost effectiveness ($/
Option Standard evaluated investment ($) costs ($/yr) (tpy) ton EtO)
--------------------------------------------------------------------------------------------------------------------------------------------------------
1.................................... 99.9 percent emission $523,000 $136,000 1.02 [2,040 lb]......... $134,000 [$67/lb].
reduction.
2.................................... 99.6 percent emission 348,000 106,000 0.68 [1,360 lb]......... 158,000 [$79/lb].
reduction.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Based on the estimates above, we find both options to be cost
effective. Option 1 would achieve greater emission reductions than
Option 2, and Option 1 would be more cost-effective. Therefore,
pursuant to CAA section 112(d)(6), we are revising the standard to
require facilities where EtO use is at least 10 tpy to reduce their
emissions from new SCVs by 99.9 percent.
Comment: In response to the EPA's solicitation of comment on
whether to include a mass emission rate standard as an alternative to
the percent emission reduction standard, two commenters were opposed to
such an alternative. One commenter stated that mass emission rate
standards for individual vents do not account for variability between
facilities or variability within facilities. The commenter also stated
that any standard that fails to reflect individual facility dynamics
that materially affect the ability to comply is inappropriate and not
achievable.
Response: We agree with the commenters' concerns regarding the
alternative, equivalent mass rate emission standards. Therefore, they
are not included in this final rule.
b. SCVs at Facilities Where EtO Use Is at Least 1 Tpy but Less Than 10
Tpy
Comment: One commenter stated that they support emission reduction
standards based on manufacturer guarantees for control equipment, along
with a maximum concentration limit, to ensure that compliance can be
achieved and demonstrated. In addition, the commenter did not agree
with our method to calculate alternative, equivalent mass rate emission
standards. Another commenter stated that, based on their discussions
with control device manufacturers, they believe that the best and most
advanced technologies will be guaranteed to meet a 99.9 percent
emission reduction standard for SCVs.
Response: We agree with the commenter's suggestion that
manufacturer guarantees be considered when finalizing the standard.
Most of the performance tests that are currently available for SCVs are
based on the previous testing procedures, which are not reflective of
actual operating conditions. The one performance test we have that is
based on actual operating conditions is for a facility
[[Page 24128]]
where EtO use exceeds 30 tpy and thus not appropriate for the group of
facilities at issue here (i.e., those using at least 1 tpy but less
than 10 tpy of EtO). Therefore, a manufacturer guarantee is appropriate
to consider in this instance, and a 99.8 percent emission reduction
standard falls within the manufacturer guarantee range for SCV controls
as provided by one of the commenters (99.9 percent emission reduction).
However, this does not change our rationale for a 99.8 percent
reduction standard during the proposal stage, which was that this is
the maximum emission SCV reduction with which compliance can be
demonstrated at all facilities where EtO use is at least 1 tpy but less
than 10 tpy considering current emission profiles.
We disagree with the commenter's recommendation for a maximum
concentration limit. As discussed in section IV.B.3.a, we are concerned
that some owners and operators may dilute the air flow of the emissions
stream to meet a concentration standard, which would not result in any
actual emission reductions. Furthermore, it is not appropriate to
establish upper-bound limitations on air flow within this source
category, as additional flow may be necessary in order to mitigate any
potential safety issues that may arise. Finally, as discussed in
section IV.D.3.a, we are not including any alternative, equivalent mass
rate emission standards in the final rule. Therefore, the commenter's
concerns regarding the methodology used to calculate the limits are no
longer relevant.
c. ARVs at Facilities Where EtO Use Is at Least 10 Tpy
Comment: Several commenters objected to the proposed emission
reduction standards and stated that they are not achievable as written.
One commenter stated that we should require emission reduction
standards based on manufacturer guarantees, along with a maximum
concentration limit. Another commenter stated that sterilization is a
batch process and that the concentration from the aeration area is
subject to constant fluctuation due to differences in product, cycles,
facility design, and EtO decline curve, which makes a consistent
emission reduction challenging to determine. Finally, several
commenters expressed concerns with the use, and our development, of the
alternative, equivalent mass rate emission standards due to the wide
variations in ARV parameters across this group of facilities, as well
as the difficulty in demonstrating compliance with this standard for
larger facilities.
Response: We disagree with the commenters' position that the
proposed emission reduction standards are not achievable. As discussed
in section III.F.3.a of the proposal preamble (88 FR 22790, April 13,
2023), most existing sources (i.e., 75 percent) are already achieving
99.6 percent emission reduction. In addition, 99.9 percent emission
reduction has been demonstrated by 50 percent of existing sources. We
also disagree with one commenter's suggestion that manufacturer
guarantees be considered in this instance for two reasons. First, there
is no need to rely on manufacturer guaranteed emission levels because
there are available performance test data for ARVs that are
representative of actual operating conditions. Unlike SCVs, which go
through different active phases with wildly varying concentrations,
fluctuations in ARV concentrations are slight; an aeration room serves
one purpose, which is to hold product at an elevated temperature, and
the resulting ARV concentration is relatively constant. Therefore, a
one-hour test period for this source is appropriate, and the resulting
performance test data are representative of actual operating
conditions. To that end, we disagree with another commenter's statement
that fluctuations in the ARV make it difficult to comply with an
emission reduction standard. Second, performance test data for ARVs are
plentiful. As discussed in section III.F.3.a of the proposal preamble,
there are 47 facilities where EtO use is at least 10 tpy, 41 of which
have ARVs. Of these 41 facilities, 32 (78 percent) have performance
test data. Because the performance test data from ARVs at these
facilities are both plentiful and representative of actual operating
conditions, there is no need to rely on a manufacturer guaranteed
emission reduction level in this instance. We also disagree with the
commenters' recommendation for a maximum concentration standard. As
discussed in section IV.B.3.a, we are concerned that some owners and
operators may dilute the air flow of the emissions stream to meet a
concentration standard, which would not result in any actual emission
reductions. Furthermore, it is not appropriate to establish upper-bound
limitations on air flow within this source category, as additional flow
may be necessary in order to mitigate any potential safety issues that
may arise. Finally, with respect to the alternative equivalent mass
rate emission standards, we agree with the commenters' concerns, and we
are not including these standards in the final rule.
Comment: One commenter stated that if the lowest practicably
measured concentration is 30 ppbv (our presumed workable-in-practice
detection limit for CEMS), then a source with an inlet concentration
that is too low will be unable to show the required emission reduction,
even if the control system is providing that level of reduction,
because the monitoring approach will be unable to distinguish the true
outlet concentration from 30 ppbv. The commenter further stated that
existing sources would need to have pre-control aeration room
concentrations of at least 7.5 ppmv to make this demonstration. Two
commenters stated that the increased 99.6 percent (existing facilities)
or 99.9 percent (new facilities) ARV emission reduction standards
penalize facilities that have reduced EtO concentrations during the
sterilization cycle. Several commenters noted that facilities have
reduce EtO concentrations during the sterilization cycle (i.e., use of
vacuum and/or nitrogen wash cycles) prior to moving the sterilized load
to aeration to reduce inlet ARV concentrations, and that removals, on a
percent basis, are only achievable with elevated inlet concentrations.
Response: One commenter is correct that, given the lowest
practicable measured concentration (30 ppbv), the pre-control
concentration would need to be 7.5 ppmv in order to demonstrate
compliance with the proposed standard for existing sources. The
performance test data that are available for ARVs at these facilities
consist of 86 test runs. Of these 86 test runs, only five (six percent)
had a measured concentration less than 7.5 ppmv, which suggests low
likelihood that facilities will have difficulty demonstrating
compliance due to low pre-control concentration. based on the current
operating conditions Furthermore, regarding the comment that these
standards would penalize sources who have already worked to reduce
their EtO concentrations during sterilization and, by extension, their
inlet ARV concentrations, as discussed in section III.F.3 of the
proposal preamble, 75 percent of existing sources are already meeting
the proposed standard; it is unclear, and the commenter does not
explain, why a requirement that retains facilities' status quo is a
punishment to those facilities. Most of the industry is either (1)
currently meeting the proposed standard or (2) capable of meeting the
proposed standard based on current operating conditions. In addition,
if a facility with existing ARVs
[[Page 24129]]
wishes to further reduce their EtO concentrations during sterilization,
then operational changes can be made to the aeration room so that the
facility can continue to demonstrate compliance with the emission
reduction standard. Since new facilities are not currently in
operation, there has been no reduction in EtO concentrations during
sterilization and, therefore, no penalty has been incurred.
4. What is the rationale for our final approach for the technology
review?
Our technology review focused on the identification and evaluation
of developments in practices, processes, and control technologies that
have occurred since the standards for Commercial Sterilization
Facilities were originally promulgated on December 6, 1994 (59 FR
62585) and further amended on November 2, 2001 (66 FR 55577).
Specifically, we focused our technology review on all previous
standards for the various emission sources in the Commercial
Sterilization Facilities source category, including SCVs at facilities
where EtO use is at least 10 tpy, SCVs at facilities where EtO use is
at least 1 tpy but less than 10 tpy, and ARVs at facilities where EtO
use is at least 10 tpy. In the proposal, we identified developments for
all emission sources, and we proposed to revise the standards for these
emissions sources under the technology review. Further information
regarding the technology review can be found in the proposed rule (88
FR 22790, April 13, 2023) and in the supporting materials in the
rulemaking docket at Docket ID No. EPA-HQ-OAR-2019-0178.
During the public comment period, we received several comments on
our proposed determinations for the technology review. No information
presented by commenters has led us to change our proposed determination
under CAA section 112(d)(6) for SCVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy and ARVs at facilities where EtO use
is at least 10 tpy, and we are finalizing the changes to those
standards as proposed. For SCVs at facilities where EtO use is at least
10 tpy, based on comments received on the proposal, we are finalizing a
99.9 percent emission reduction standard, which is the manufacturer
guarantee. There is at least one representative performance test
available for SCVs, but it was conducted at a facility with a higher
EtO usage rate, and we are unable to determine whether smaller
facilities can achieve the emission reduction from that performance
test. The key comments and our specific responses can be found in
section IV.D.3 of this preamble and in the document, Summary of Public
Comments and Responses for the Risk and Technology Review for
Commercial Sterilization Facilities, available in the docket for this
rulemaking.
E. Amendments Addressing Emissions During Periods of SSM
1. What amendments did we propose to address emissions during periods
of SSM?
For all emission points in the Commercial Sterilization Facilities
source category, we proposed eliminating the SSM exemptions and to have
the standards apply at all times. More information concerning the
elimination of SSM provisions is in section III.G. of the proposal
preamble (88 FR 22790, April 13, 2023).
2. How did the SSM provisions change since proposal?
We are finalizing the SSM provisions as proposed (88 FR 22790,
April 13, 2023).
3. What key comments did we receive on the SSM revisions and what are
our responses?
This section provides comment summaries and responses for the key
comments received regarding our proposed revisions. Other comment
summaries and the EPA's responses for additional issues raised
regarding these activities as well as issues raised regarding our
proposed revisions can be found in the document, Summary of Public
Comments and Responses for the Risk and Technology Review for
Commercial Sterilization Facilities, available in the docket for this
rulemaking.
Comment: One commenter stated that the EPA should consider other
approaches to adequately account for SSM contingencies. The commenter
suggested that the EPA classify sources in SSM states as sub-sources
subject to different emissions limitations or work practice standards.
Another commenter stated that EtO sterilizers do not create emissions
during startup or shut down because, unlike other industrial processes
regulated under the NESHAP program, EtO is not emitted as a byproduct
of combustion or chemical reaction but is released intentionally in a
highly controlled manner. The commenter further stated that
sterilization never begins before control equipment is activated and
always ends before control equipment is deactivated. Similarly, another
commenter stated that the EPA inaccurately assumed that startup and
shutdown are no different than normal operation. The commenter further
stated that constructing and starting new abatement equipment includes
periods of troubleshooting and acceptance testing. The commenter also
stated that the proposal does not address the permit-to-construct
process and related requirements before transferring to an operating
permit. Finally, one commenter suggested that the malfunction exemption
should not be eliminated because, due to the nature of sterilization
operations and various stages of cycles, commercial sterilizers must be
able to address malfunctions that could result in a potential risk to
employees or the facility without the risk of being in noncompliance.
Response: As discussed in section III.G.1 of the proposal preamble
(88 FR 22790, April 13, 2023), it is common practice in this source
category to start an air pollution control device (APCD) prior to
startup of the emissions source it is controlling, so the APCD would be
operating before emissions are routed to it, which has been confirmed
by one of the commenters. In addition, based on responses to the
December 2019 questionnaire and the September 2021 ICR, many facilities
already have measures in place to ensure that the emission standards
are met during periods of SSM, including holding emissions within the
process unit or the APCD itself, or the use of onsite generators in the
event of a power outage.\67\ The comments provided do not support
establishing emission standards that apply only during periods of SSM.
With respect to classifying sources in SSM states as sub-sources
subject to different emissions limitations or work practice standards,
the commenter does not provide any rationale for why this should be
done or any suggestions for what those emission standards should be.
With respect to emission spikes from troubleshooting control devices,
as discussed in section IV.F.3 of this preamble, the EPA is finalizing
a requirement for emission limits to be based on 30-operating day
rolling sums of EtO entering the control system(s) for EtO CEMS, which
will help to mitigate these spikes over time. However, the commenter
does not provide any rationale for why the permitting process should be
considering when evaluating SSM. Finally, we cannot agree with the
commenter's recommendation to keep the malfunction exemption in
[[Page 24130]]
contradiction with Sierra Club v. EPA, 551 F.3d 1019 (D.C. Cir. 2008),
in which the court vacated two provisions that exempted sources from
the requirement to comply with otherwise applicable CAA section 112(d)
emission standards during periods of SSM. As discussed in section
III.G.1 of the proposal preamble, in its 2008 decision in Sierra Club
v. EPA, 551 F.3d 1019 (D.C. Cir. 2008), the court held that emissions
standards or limitations must be continuous in nature, which means that
there cannot be exemptions for periods of malfunction. Further, while
the EPA could consider establishing a different standard during
malfunction if warranted and still be consistent with the Sierra Club
decision, the commenter does not provide any specific information
regarding instances where compliance with the standards during
malfunction could result in potential risks to the employees or the
facility or suggestions for what emission standards the EPA should
consider to address the concern. Therefore, the EPA is not finalizing
any emission standards that apply only during periods of SSM.
---------------------------------------------------------------------------
\67\ See memorandum, Review of Startup, Shutdown, and
Malfunction of Process and APCD Equipment in the Ethylene Oxide
Commercial Sterilization Source Category Technology Review Project,
located at Docket ID No. EPA-HQ-OAR-2019-0178.
---------------------------------------------------------------------------
Comment: One commenter stated that a specific area of concern is
the ability to demonstrate compliance during startup and shutdown,
asserting that the proposed rule offered no means for a source to
remain in compliance during the inevitable and foreseeable, but not
predictable, failure of monitoring equipment. The commenter further
suggested that the EPA should consider specific reporting and
monitoring alternative requirements for these scenarios. The commenter
provided the example of a requirement specific to releases from
sterilizer pressure relief devices (PRDs) resulting from malfunctions
or required during shutdown events that the commenter suggested could
be modeled after recent PRD requirements in 40 CFR 63.648(j). Another
commenter recommended that facilities should only be required to report
malfunction events that result in unpermitted releases to the
atmosphere. The commenter stated that, in the example situation where
control equipment unexpectedly goes offline during operations but EtO
remains trapped within the facilities ducts under negative pressure,
there would be no need to create additional administrative compliance
requirements for the facility.
Response: With respect to accounting for the failure of monitoring
equipment when demonstrating compliance, as discussed in section IV.F.3
of this preamble, the EPA is finalizing a minimum data availability
requirement of 90 percent for EtO CEMS. With respect to specific
reporting and monitoring alternative requirements that apply during
periods of SSM, the commenter did not provide any recommendations for
what those requirements should be. In addition, we agree with one
commenter's suggestion that facilities should only be required to
report malfunction events that result in unpermitted releases to the
atmosphere. However, to be clear, we are finalizing reporting
requirements for malfunction events that occur with emissions or
parametric monitoring equipment.
Comment: One commenter suggested that the EPA should not include
the general duty clause in the final rule. The commenter stated that it
is not clear on what basis the EPA is claiming authority to impose a
general standard of behavior on regulated sources. The commenter
asserted that CAA section 112 grants the EPA authority to set emissions
limits and certain specific alternative standards but does not grant
authority to impose a ``vague and subjective code of conduct.'' The
commenter stated that the general duty clause is redundant to proposed
amendment to 40 CFR 63.632(b) that would require compliance ``at all
times.'' The commenter asserted that if compliance with the specific
requirements of the rule will satisfy the general duty, then there is
no need for the EPA to reserve the authority to evaluate a source's
good air pollution control practices. Furthermore, the commenter
asserted that the general duty provisions date back to a regulatory
period during which air quality control rules lacked the specificity of
monitoring, reporting, and recordkeeping that are included in the
proposed rule. The commenter suggested that either the EPA should not
finalize the proposed general duty clause at 40 CFR 63.632(j) or that
the general duty clause from the General Provisions should be
incorporated. The commenter stated that the General Provision contains
language that more clearly explains the EPA's exercise of enforcement
discretion during SSM periods.
Response: As part of the proposed rulemaking, we proposed to add
the following general duty clause to 40 CFR 63.362(j):
``At all times, you must operate and maintain any affected source,
including associated air pollution control equipment and monitoring
equipment, in a manner consistent with safety and good air pollution
control practices for minimizing emissions. The general duty to
minimize emissions does not require the owner or operator to make any
further efforts to reduce emissions if levels required by the
applicable standard have been achieved. Determination of whether a
source is operating in compliance with operation and maintenance
requirements will be based on information available to the
Administrator which may include, but is not limited to, monitoring
results, review of operation and maintenance procedures, review of
operation and maintenance records, and inspection of the source.''
We disagree with the commenter's suggestion to not finalize the
general duty clause. We do not consider this duty clause to be
redundant just because the emission standards apply at all times; the
provision imposes a general duty to operate and maintain any affected
source, including associated air pollution control equipment and
monitoring equipment, in a manner consistent with safety and good air
pollution control practices for minimizing emissions. Commenters did
not provide data supporting the suggestion that this general duty
clause is redundant. Even assuming it were redundant, which it is not,
the commenter does not explain why it must be removed. In addition, the
inclusion of a general duty clause like the one proposed is standard
practice for other NESHAPs. Furthermore, we disagree with the
commenter's suggestion to incorporate the general duty clause from
Subpart A. As discussed in earlier in this section, in its 2008
decision in Sierra Club v. EPA, 551 F.3d 1019 (D.C. Cir. 2008), the
court held that under section 302(k) of the CAA, emissions standards or
limitations must be continuous in nature, which means that there cannot
be exemptions for periods of SSM. The general duty clause in Subpart A
contains certain exemptions for periods of SSM. We are therefore
finalizing the general duty provision as proposed.
4. What is the rationale for our final approach and final decisions to
address emissions during periods of SSM?
We evaluated all of the comments on the EPA's proposed amendments
to the SSM provisions. As explained in section III.G of the proposed
rule (88 FR 22790, April 13, 2023), in its 2008 decision in Sierra Club
v. EPA, the court held that under CAA section 302(k), emissions
standards or limitations must be continuous in nature and that the SSM
exemption violates the CAA's requirement that some CAA section 112
standards apply continuously. In addition, as part of this rulemaking,
we have gathered information that indicates many facilities already
have measures in place to ensure that the emission standards are met
during periods of
[[Page 24131]]
SSM. Therefore, we determined that these amendments, which remove and
revise provisions related to SSM, are necessary to be consistent with
the requirement that the standards apply at all times. More information
concerning the amendments we are finalizing for SSM is in the preamble
to the proposed rule and in the comments and our specific responses to
the comments in the document, Summary of Public Comments and Responses
for the Risk and Technology Review for Commercial Sterilization
Facilities, available in the docket for this rulemaking. Therefore, we
are finalizing our approach for the SSM provisions as proposed.
F. Other Amendments to the Standards
1. What other amendments did we propose for the Commercial
Sterilization Facilities source category?
We proposed that owners and operators would be required to
demonstrate compliance via annual performance testing and parametric
monitoring of EtO through the use of CEMS. As discussed in section
III.G.2.c of the proposal preamble (88 FR 22790, April 13, 2023), we
did not propose to include requirements for fenceline or ambient air
monitoring as part of this rule for the following reasons:
Typically for this type of monitoring, we require the
fenceline monitor to be located at least 50 meters from the source of
emissions to allow for some dispersion.
In contrast to the large number of dispersed and
difficult-to-monitor emission points for other source categories for
which we have either finalized or proposed fenceline monitoring
requirements (e.g., refineries), current room air releases at
commercial sterilization facilities are typically at ground-level and
consist of uncontrolled building emissions through doorways, loading
points, and ventilation exhausts, all of which can be captured while
inside the building and routed through a vent to a control device.
The proposed PTE design criteria, room air emission
standards, and associated parametric monitoring would effectively and
continuously ensure these previously uncontrolled emissions are
captured and routed to exhaust points that are then subject to removal
or emission rate standards.
With respect to fenceline monitoring, we solicited comment on (1)
whether fenceline monitoring should be required regardless of the
proposed PTE design criteria, proposed room air emission standards, and
proposed continuous parametric monitoring; (2) the technical
feasibility of fenceline monitoring and available technology able to
measure at any potential action level; and (3) the potential cost of
continuous fenceline monitoring and associated work practices if
implemented.
With respect to ambient air monitoring, we solicited comment on how
this could be used to screen for elevated concentrations of EtO above
the ambient baseline and how this information could be used to trigger
a root cause analysis to identify potential source(s) of emission and
to perform corrective action, if a potential source of the emissions
was part of an affected source under the commercial sterilization
proposed rule. We also solicited comment on (1) the feasibility of
other types of air monitoring that could be applied to this sector for
compliance assurance and the costs associated with this type of
monitoring, (2) how frequently this monitoring should occur, (3) the
recordkeeping and reporting requirements for this type of monitoring,
and (4) how should any action-level be defined.
We proposed various changes to the performance testing requirements
to ensure that the results are as accurate as possible, including the
approved test methods, requirements for SCV inlet testing, and 24-hour
test runs for larger users. Furthermore, we proposed various changes to
the parametric monitoring requirements, as well as requirements for
demonstrating continuous compliance with the PTE requirements given in
EPA Method 204.
We also proposed that owners or operators submit electronic copies
of required compliance reports (at 40 CFR 63.366(b) and (c)),
performance test reports (at 40 CFR 63.366(f)), and performance
evaluation reports (at 40 CFR 63.366(g)) through the EPA's CDX using
CEDRI, and we proposed two narrow circumstances in which owners or
operators may, within five business days of the reporting deadline,
seek extensions of that deadline if they are prevented from reporting
by conditions outside of their control. We proposed at 40 CFR 63.366(h)
that an extension may be warranted due to outages of the EPA's CDX or
CEDRI that precludes an owner or operator from accessing the system and
submitting required reports. We also proposed at 40 CFR 63.366(i) that
an extension may be warranted due to a force majeure event, such as an
act of nature, act of war or terrorism, or equipment failure or safety
hazards beyond the control of the facility.
Finally, we proposed to reinstate title V permitting requirements
for all area source facilities, and we proposed compliance mechanisms
for owners and operators of combined emission streams. We also proposed
revisions to clarify text or correct typographical errors, grammatical
errors, and cross-reference errors.
2. How did the other amendments for the Commercial Sterilization
Facilities source category change since proposal?
We are finalizing a requirement for owners and operators to use EtO
CEMS to demonstrate compliance. In addition, for affected sources with
a percent emission reduction standard, we are finalizing a requirement
for source owners or operators to obtain and record hourly average
ppbvd of EtO concentration, dscfm of flow rate, and weight differential
in pounds of EtO used, to calculate and record each day of operation--
where any operation less values obtained during periods of SSM
constitute a day of operation--and the emission limit(s) based on the
30-operating day rolling sum of EtO entering the control system(s), as
determined using values from the current operating day and the previous
29 operating days. However, owners and operators of facilities where
EtO use is less than 100 lb/year will have the option to demonstrate
compliance through annual performance testing and parametric
monitoring. We are not including requirements for fenceline or ambient
air monitoring in this final rule. For EtO CEMS, based on comments
received during the proposed rulemaking, we are finalizing a
requirement for quarterly reporting, as well as a minimum data
availability of 90 percent. For performance testing, we are finalizing
the incorporation of additional test methods. Based on comments
received during the proposed rulemaking, we are also retaining
currently approved test methods that we proposed to remove, and we are
not finalizing a requirement to conduct SCV inlet testing. For
performance test duration, based on comments received during the
proposed rulemaking, we are not finalizing a requirement for 24-hour
test runs. Instead, owners and operators may continue to conduct 1-hour
test runs for ARVs, CEVs, room air emissions, or any combination
thereof. For emission streams that contain an SCV, we are finalizing a
requirement for owners and operators to include a representative test
period as part of their test protocol, which is subject to approval
from the delegated authority. Based on comments received during the
proposed rulemaking, we are finalizing numerous revisions to the
proposed requirements for parametric monitoring. Furthermore, based on
comments received during the proposed
[[Page 24132]]
rulemaking, we are not finalizing a requirement for owners and
operators that are required to comply with EPA Method 204 to conduct
daily inspections of all applicable NDOs. Instead, we a finalizing a
requirement for owners and operators to demonstrate continuous
compliance with EPA Method 204 through the use of either outlet
volumetric flow rate monitors or differential pressure monitors.
We are not finalizing a requirement for all area source facilities
to obtain a title V operating permit. In addition, based on comments
received during the proposed rulemaking, we are finalizing revised
compliance mechanisms for combined emission streams. We are also
finalizing an option for owners and operators to demonstrate compliance
with a site-wide emission limitation, as opposed to demonstrating
compliance for each individual and combined emission stream.
3. What key comments did we receive on the other amendments for the
Commercial Sterilization Facilities source category and what are our
responses?
Comment: We received extensive comment on our proposal to allow
either the use of EtO CEMS or annual performance testing with
parametric monitoring for demonstrating compliance with emission
standards. Some commenters stated that EtO CEMS should be the only
mechanism allowed for demonstrating compliance, as it will yield more
real-time data that will allow for potential issues to be identified
and resolved more quickly. Other commenters stated that EtO CEMS are a
relatively new technology and that the available supply, reliability in
industrial facilities, and maintenance support for EtO CEMS is
questionable. Commenters also expressed concerns with parametric
monitoring and pointed to our requirements for CEMS in other rules, as
well as the fact that EtO CEMS are used in a number of sterilization
facilities.
Response: In the majority of instances, parametric monitoring is
used to good effect as an ongoing means of ensuring that control
devices continue to get necessary emission reductions. However, given
the nature of EtO, in which small amounts can have large risk impacts,
parametric monitoring alone will not be sensitive enough to detect very
small fluctuations. In addition, many facilities in this source
category are controlling their EtO emissions using systems that contain
one or more control devices, each with their own parametric monitoring
requirements. While this has proven to be effective in reducing EtO
emissions, it can lead to multiple, simultaneous parameter collection
and processing, increasing system complexity and increasing the time
necessary for diagnosis and correction of control device or process
problems.
Therefore, the EPA is finalizing a requirement to only use CEMS for
demonstrating compliance. However, facilities where EtO use is less
than 100 lb/year will still have the option to use CEMS or performance
testing and parametric monitoring to demonstrate compliance. This is
because risk remains at acceptable levels for these facilities even
when considering uncontrolled emissions. In addition, these facilities
tend to have relatively simple control systems. Although EtO CEMS is a
relatively new technology in this industry, it has been proven as a
highly effective method for demonstrating compliance. While the use of
these CEMS systems for low-level measurements of EtO is relatively new,
they are in use in this sector; because of this, we find it technically
feasible to require their use more broadly. Additionally, the EtO
instruments used as part of these CEMS are readily available and
although the low-level detection levels are recent, they have been
demonstrated in the field.
Comment: We received extensive comments on our decision to not
include fenceline or ambient air monitoring as part of the proposed
rulemaking. Some commenters were supportive of this exclusion, stating
that this source category is comprised of enclosed facilities with
defined emission points (e.g., windows, doors, ventilation exhaust) and
that PTE is sufficient to ensure the containment of emissions. Other
commenters were opposed to this exclusion, stating that fenceline and
ambient air monitoring are necessary in order to ensure that commercial
sterilization facilities are complying with the rule requirements, as
well as to provide important information about emissions, exposure, and
the efficacy of control equipment to nearby communities, regulatory
agencies, and workers. The commenters pointed to other source
categories where we have either required fenceline monitoring (i.e.,
petroleum refineries) or proposed it (i.e., the Synthetic Organic
Chemical Manufacturing Industry and the Polymers and Resins industry).
Response: We acknowledge that many commenters expressed their
strong support for fenceline monitoring requirements as part of this
rule. As a general matter, fenceline monitoring is considered a
particularly useful compliance monitoring approach if it is infeasible
to enclose an emission source(s). This is the case for source
categories where we have either required or proposed fenceline
monitoring, such as refineries, because facilities within these source
categories cover a wide variety of emission sources where PTE is not
feasible. At such sources, it is frequently impossible to rapidly
detect and remedy a leak or other unauthorized release without the use
of fenceline monitoring.
By contrast, as discussed in section IV.B.3.c, PTE in accordance
with EPA Method 204 has been demonstrated to be feasible for commercial
sterilization facilities. As part of the PTE requirements the EPA is
finalizing in this rule, the EPA is also requiring monitoring of either
the volumetric flow rate from each outlet or differential pressure in
order to ensure that the PTE is operating effectively on a continuous
basis. Furthermore, as discussed above, we are requiring EtO CEMS at
facilities where EtO use is at least 100 lb/year, which includes most
facilities within the source category. The data from these CEMS will
help to ensure that commercial sterilization facilities are complying
with the rule requirements, and the data will be made available to the
public, providing important information about emissions, exposure, and
the efficacy of control equipment to nearby communities, regulatory
agencies, and workers. As noted above, the physical configuration of
commercial sterilizer facilities can also make the implementation of
fenceline monitoring challenging at these sources. For these reasons,
the EPA is not finalizing fenceline monitoring requirements as part of
this rule.
Comment: We received extensive comments on our proposed requirement
that EtO CEMS data be reported on a daily basis. Some commenters were
supportive, stating that daily reporting provides assurance to the
public that emission control devices are working as designed. Other
commenters were opposed, stating that facilities need sufficient time
to conduct QA/QC to verify the accuracy and reliability of the data and
that reporting inaccurate data due to insufficient QA/QC would
undermine public confidence of the CEMS monitoring and potentially
adversely impact the medical supply chain if there is undue public
concern. One commenter questioned whether there is a precedent for
daily reporting, and another was unaware of any other NESHAP that
requires daily reporting for CEMS. Several commenters stated that
quarterly or semi-annual reporting is sufficient and more consistent
with other NESHAPs.
[[Page 24133]]
Response: We agree with the commenters' concern that daily
reporting of CEMS data is not appropriate. Sufficient time is needed so
that the proper QA/QC procedures can be conducted to verify the
accuracy and reliability of the data. Therefore, we are finalizing a
requirement that CEMS data be reported quarterly, which is consistent
with other NESHAPs that regulate pollutants of significant concern, as
well as at least one sterilization facility that uses CEMS to
demonstrate compliance with local requirements.
Comment: One commenter stated we did not address CEMS downtime and
how downtime will be assessed or impact reporting. In addition, two
commenters stated that there should be allowances or an exemption from
sampling during periods of non-operation (e.g., power outages, plant
shutdowns).
Response: Our general policy is to require source owners and
operators to have working monitoring while the emissions-producing
process is operating and to identify those periods where monitoring is
not working while the emissions-producing process is operating, as well
as to quickly correct monitoring issues so that such periods are
minimized. Recognizing that EtO CEMS are a newer technology that may
pose challenges to users who may be unfamiliar with instrument
characteristics, the rule will provide a period of data unavailability
for up to ten percent of process operating time for EtO CEMS in
operation before requiring additional corrective activity by owners or
operators. Such an allowance, referred to as a minimum data
availability requirement, has been used to good effect for other types
of CEMS as they were introduced. As familiarity with those CEMS
increased, so did their minimum data availability requirements; the EPA
expects this pattern to continue for EtO CEMS such that in the future,
the minimum data availability requirement for EtO CEMS will be replaced
by the agency's general policy. Until then, the rule will have a
minimum data availability for EtO CEMS of ninety percent. This means
that EtO emissions data must be collected over at least ninety percent
of the process operating time in order to avoid non-compliance and
potential penalties. Data availability will be determined by assessment
of the ratio of periods of valid EtO CEMS values to process operation
periods, where valid EtO CEMS values occur when a minimum of 4 equally
spaced values occur over an hour of process operation. Periods
associated with normal quality assurance activities, such as daily
calibrations, do not count as periods of data unavailability, however,
periods of out-of-control monitor operation or when the EtO CEMS is
unable to provide quality-assured data, such as those periods
associated with monitor or data acquisition and handling system
failure, do count as periods of data unavailability. Note that source
owners or operators are to record EtO CEMS values during all periods of
operation, include SSM, to the extent that the values are available.
Source owners or operators will need to keep records of periods of
process operation, EtO CEMS availability, and EtO CEMS unavailability;
cause and duration of EtO CEMS unavailability; and of activity taken to
correct and prevent future periods of EtO CEMS unavailability.
Moreover, owners or operators will be required to provide immediate
notice of failure to meet the data availability of 90 percent, as well
as root cause analysis of periods of EtO CEMS monitor unavailability
and specific corrective actions--along with schedule and enumerated
expenditures--planned to address EtO CEMS unavailability.
Comment: Several commenters stated that the requirement to measure
SCV inlets can create significant safety hazards. Two commenters stated
that EtO concentrations in abatement system inlets coming from SCVs can
reach several hundred thousand ppm. The commenters noted that these
concentrations exceed the lower explosion limit of 30,000 ppm, thereby
posing a significant explosion risk. Commenters noted that this
situation could also expose workers to EtO levels above the Immediately
Dangerous to Life or Health limit set by the U.S. Occupational Safety
and Health Administration (OSHA), resulting in hazardous working
conditions. Several commenters stated that we should retain the option
to determine emission reduction using mass balance calculations and
pounds of EtO injected into the sterilization chamber to ensure safe
testing practices.
Response: We agree with the commenters' concerns regarding the
safety risks associated with testing the SCV inlet. Therefore, we are
removing this requirement for SCVs from the final rule. Owners and
operators must instead determine the mass of EtO emissions from the SCV
by measuring the daily change in weight of the EtO drums that are used
to charge the sterilization chamber.
Comment: Several commenters were opposed to our proposed
requirement for each performance test run to be conducted over a 24
hour period for facilities where EtO use is at least 10 tpy, stating
that this requirement is difficult, infeasible, and of limited value.
The commenters stated that there are a limited number of testing
companies with both the experience to conduct performance tests of this
length, as well as the personnel to remain at facilities during these
long performance test periods. The commenters stated that multiple
companies will be in demand for these limited services and that
scheduling these performance tests so that the medical supply chain is
not adversely impacted will be difficult. In general, the commenters
agreed that a performance test run longer than one hour is necessary
but were divided on what constitutes a representative period, with one
commenter stating that eight to 10 hours is representative, and another
stating that six to 12 hours is representative. Several commenters
stated the performance test duration should be determined by the
facility and accompanied with a justification of how normal operations
are captured over this duration. One commenter stated that ARV and room
air emissions are continuous in nature and that one-hour performance
test runs are sufficient for these sources. The commenter also stated
the CEV operations are started and completed within an hour and,
therefore, one-hour performance test runs are appropriate for these
sources as well. Finally, one commenter suggested that each performance
test run for facilities where EtO use is less than 10 tpy should be
longer than one hour.
Response: As discussed earlier, we are finalizing a requirement to
only use EtO CEMS for demonstrating compliance. In addition, owners or
operators of affected sources subject to a percent emission reduction
standard will obtain and record EtO concentration in ppbvd, flow rate
in dscfm, and daily EtO use in pounds; determine daily amounts of EtO
entering and exiting control systems; use those daily amounts to
calculate and record 30-operating day rolling sums; and calculate
emission limits and determine compliance based on those rolling sums.
However, facilities where EtO use is less than 100 lb/year will still
have the option to use CEMS or performance testing and parametric
monitoring to demonstrate compliance. Therefore, our proposal for each
performance test run to be conducted over a 24-hour period for
facilities where EtO use is at least 10 tpy is no longer applies and is
not included in the final rule. For facilities where EtO use is less
than 100 lb/year, we agree that a one-hour performance test period for
[[Page 24134]]
ARVs and room air emissions is appropriate, as these operations are
continuous in nature, with minimal variations in emissions. We also
agree that a one-hour performance test period is appropriate for CEVs,
as these operations are typically started and concluded in less than
one hour. For SCVs, the emissions profile can vary significantly
depending on the number of chambers at a facility and how the emissions
are staggered. Therefore, we are finalizing a requirement for owners
and operators to include a representative performance test period for
SCVs, along with a justification, in their stack test protocol, so that
the delegated authorities can review and approve or deny the protocol
as appropriate.
Comment: We received comments on continuous compliance requirements
for verifying EPA Method 204. Several commenters contended that
continuously verifying the direction of airflow through daily
inspections of each NDO presents significant safety risks and are
redundant or impractical. They noted that NDOs may be located at
ceiling levels (such as a makeup air unit) in processing areas or in
other hard to reach areas where EtO concentrations may require the use
of specialized protective equipment. One commenter stated that
streamers are not practical, may not be observable, and often get stuck
or wrapped around objects. Another commenter noted that smoke testing
in EtO facilities is discouraged due to safety concerns, as any
indication of fire in an EtO facility is highly problematic, and seeing
smoke within the facility should not be routine. Finally, two
commenters questioned the value of daily NDO inspections when other
relevant parameters are being continuously monitored.
One commenter recommended the use of differential pressure
monitoring to verify EPA Method 204, accompanied by a data recording
system to demonstrate continuous compliance. Other commenters were
opposed to any continuous compliance requirements for verifying EPA
Method 204, stating that they would be burdensome, expensive, and
difficult to maintain. Two commenters stated that we should change the
criteria for demonstrating continuous compliance with EPA Method 204
from ``maintained above 0.007 inches of water'' to ``at least 0.007
inches of water'' to align to the Method 204 definition of facial
velocity equivalence.
Response: We agree with the commenters' concerns regarding the
safety and practical aspects of daily NDO inspections. Therefore, we
are not including this requirement in the final rule. In order to
ensure that emissions are not leaving through uncontrolled spaces, it
is critical to demonstrate continuous compliance with EPA Method 204.
In the absence of daily NDO inspections, differential pressure
monitoring and outlet volumetric flow rate monitoring are viable
options for verifying the continuous flow of air into a control device,
and both of these options were included in the proposed rulemaking.
Therefore, we are finalizing a requirement for owners and operators to
demonstrate continuous compliance with EPA Method 204 either through
outlet volumetric flow rate monitoring or through differential pressure
monitoring. We also agree with commenters that, if differential
pressure monitoring is used, the pressure differential should be
maintained at or above 0.007 inch of water in order to demonstrate
continuous compliance, as this is what is required in EPA Method 204.
Comment: We received extensive comments on our proposed requirement
for all area source facilities within the source category to obtain a
title V operating permit. Several commenters were supportive, citing
the serious health concerns of EtO. The commenters stated that
facilities with title V operating permits tend to receive more
oversight and that this, along with increased community engagement,
will ensure that these facilities are complying with the rule
requirements. Other commenters were opposed, stating the current and
proposed NESHAP included substantial compliance, parametric monitoring,
recordkeeping, and reporting obligations. One commenter stated that
subjecting area source EtO commercial sterilizers to the title V
permitting program requires additional regulatory fees; burdensome
permitting, recordkeeping and reporting requirements; increased
administrative costs; as well as Clean Air Act citizen suits. Two
commenters suggested that the proposed requirements could be
incorporated into a State minor source permit without the additional
burden of title V permitting, and that title V permits should apply
only to major sources. Multiple commenters also indicated that the
four-factor balancing test still weighs in favor of continued exclusion
of area source facilities within this source category from title V
permitting requirements.
With respect to the first factor (i.e., whether title V would
result in significant improvements to the compliance requirements,
including monitoring, recordkeeping, and reporting that are proposed
for the area source category), several commenters stated that requiring
title V operating permits would not provide significant improvements to
compliance requirements. Two commenters agreed with our 2005 analysis
that the NESHAP requirements applicable to area sources already
subjected them to continuous monitoring and assessment, reporting, and
certification of compliance status on a semiannual basis, which was
similar to what was required by title V. Commenters stated that the
proposed rule addressed increased transparency and further strengthened
monitoring, recordkeeping, and reporting requirements, including
developing a new performance specification and associated QA procedures
for CEMS capable of detecting EtO at very low levels. One commenter
stated that we recognized that modern NESHAPs have sufficient
parametric monitoring. The commenter also stated that the only gain
that we identified that was not already satisfied was the public
comment period for title V permitting; however, the commenter noted
that many facilities may need construction permits to come into
compliance with the updated requirements, during which many States have
an option to hold a public comment period and a public meeting(s) for
changes that may be of interest to the community. The commenter noted
that, as part of this rulemaking process, the EPA held numerous public
meetings for local communities regarding specific facilities and
additional public outreach meetings for transparency. This commenter
stated these outreach efforts and the potential construction permitting
actions will eliminate the need to have the title V public comment
period. Three commenters stated that one of the primary purposes of the
title V program was to clarify in a single document the various and
complex regulations that applied to a facility in order to improve
compliance. Two commenters stated that we agreed that EtO sterilizers
were still subject only to a single NESHAP. Three commenters stated the
benefit of requiring a title V permit to house all applicable
regulations into a single document would not apply to those area
sources and was not needed, and one commenter added that area sources
should be exempt from title V on that basis alone. One commenter stated
that, in response to a comment on our 2005 proposed rule, we also
indicated that NESHAP provisions independently required schedules of
compliance, provided inspection and entry
[[Page 24135]]
authority, and established emissions limitations and standards that
were enforceable regardless of title V permitting. This commenter noted
the proposed rule asserted that the compliance benefits of title V were
greater today than in 2005 and so the benefits would be greater, but
the commenter argued that we made these statements without providing
supporting analysis.
With respect to the second factor (i.e., whether title V permitting
would impose significant burdens on the area source category and
whether the burdens would be aggravated by any difficulty in obtaining
assistance from permitting authorities), several commenters noted that
requiring area sources to obtain a title V permit would pose
significant burdens on sterilization facilities, with one commenter
stating that it would pose significant burden ``within the time frame
being proposed.'' \68\ Additionally, the commenter stated the State
permitting agencies may be overly burdened in issuing title V permits
at a facility with such low emissions. Several commenters stated that
the proposed title V permitting requirement for area sources would be a
significant burden for small businesses, as these permits required
businesses to prepare significant amounts of paperwork, negotiate
compliance with the permitting authority, and subject their operations
and permit application to public comment or petitions that would
potentially delay operations and create additional regulatory burdens
that, per OMB analysis, may be biased against small businesses. One
commenter noted that small businesses in this industry had no
experience with title V permitting and that obtaining these permits
would require additional resources. The commenter stated that we
ignored the significant cost of uncertainty that title V permitting
introduced to small business planning. The commenter explained that
rather than hiring an engineer to determine how a facility could meet
the requirements, a small business would have to engage in a process
with multiple partners, develop supporting material that may or may not
be sufficient in the eyes of the regulatory authority, and prepare a
public relations strategy in anticipation of community opposition to
their operations, and that this investment must be made without the
certainty of an outcome that will allow continued operation. One
commenter noted that many Small Business Environmental Assistance
Programs are precluded from assisting with title V permitees and, as
such, this rule could strip small businesses of the assistance mandated
under CAA section 507. One commenter stated that our justification
seemed premised on an expectation of noncompliance, although clarified
that we had not alleged that small commercial sterilizers have a
history of noncompliance. The commenter noted that recent controversies
around EtO facilities had centered around large facilities owned by
large businesses. The commenter indicated it was not clear how title V
permitting of area sources would create additional incentives for
compliance or give State enforcement authorities the resources and
expertise they would not otherwise have to enforce this NESHAP. One
commenter stated the addition of title V permitting for area sources
formalized community involvement in the authorization of area source
commercial sterilizers, and that this level of community review was
unnecessary and overly burdensome. Another commenter noted that the
public already had access to commercial sterilizer locations,
emissions, and current standards to which they were subject via our
website and regulations, as well as our community outreach to advise
the public of the hazards of EtO.
---------------------------------------------------------------------------
\68\ Commenter provided the following statement: ``Requiring
areas sources to obtain a title V permit would pose significant
burdens on sterilization facilities especially within the time frame
being proposed.'' (see Docket Item No. EPA-HQ-OAR-2019-0178-0632,
Attachment 2, page 20).
---------------------------------------------------------------------------
With respect to the third factor (i.e., whether the costs of title
V permitting for area sources would be justified taking into
consideration any potential gains in compliance likely to occur for
such sources), two commenters stated there would be no justification
for imposing the burden of title V permitting. One commenter stated
that we could have separated the cost estimate for the 86 area sources
in order to provide more accurate numbers. Additionally, the commenter
stated that the 2019 cost estimates were not accurate, as the new rules
would require facilities to change not only their equipment, but also
their calculation methods, monitoring, and testing. The commenter
stated that those costs needed to be considered in a title V cost
analysis. Three commenters stated that our cost estimate for obtaining
a title V permit underestimated the cost of this requirement and that
we should not add to the burdens for area sources. One commenter stated
that the time and cost of getting a title V permit did not correlate to
the potential gains and that we provided no supporting data for our
conclusion that the average costs associated with title V ($67,211 for
the first year, as calculated in 2019) will likely be less for area
sources. This commenter suggested that our cost determination did not
align with the proposed rule, which said ``the rule amendments proposed
provide for a greater degree of complexity and requirements to achieve
and demonstrate compliance for area sources.'' One commenter noted that
we stated that the burden was not insignificant, but justified the
costs because it represented a small portion of the anticipated costs
related to the amendments of the proposed rule. One commenter stated
that the analysis on title V applicability did not ask how the burden
compared to the cost of complying [with] some other measure, but that
the question was whether the potential compliance benefits outweighed
the steep costs, the answer to which we seemed to concede was ``no.''
With respect to the fourth factor (i.e., whether adequate oversight
by State and local permitting authorities could achieve high compliance
with the NESHAP requirements without relying on title V permitting),
one commenter stated that CAA sections 112, 113, and 114 required
implementation and enforcement programs to be conducted by the EPA or
delegated to the proper State authority and a small business assistance
program to assist area sources exempted from title V with compliance.
The commenter noted that States and the EPA routinely conducted
voluntary compliance assistance outreach and education programs. The
commenter noted that the EPA's review of State-provided empirical data
demonstrated that area sources were adequately compliant with their
requirements without title V permitting. The commenter stated that the
proposed rule is silent on whether permitting authorities could
effectively implement NESHAPs without title V, and that the EPA alluded
to its 2019 ICR, implying that the responses thereto supported the
EPA's title V decision, but the EPA never identified specific data or
explained how it would support any of EPA's cursory statements. The
commenter concluded that there was no more difficulty enforcing the
single NESHAP for area sources now versus in 2005, when EPA
unequivocally determined title V would provide no benefits to its
ability to enforce CAA regulations in tandem with its State and local
partners. The commenter stated that requiring title V now would only
make enforcement more difficult, as State agencies would be flooded
with
[[Page 24136]]
title V applications that would require time and State funds to
implement and could potentially shift attention away from major source
compliance in a way that would compromise (and not improve)
implementation of any final NESHAP program. Another commenter stated
there was already sufficient oversight by State and local permitting
authorities, as well as subpart O requirements. One commenter stated
that, as a State regulatory agency, they had the ability to adequately
ensure compliance with the proposed standard for facilities within
their jurisdiction regardless of whether the facility is subject to
title V permitting. Another commenter stated the proposed removal of
the title V permitting exemption for area sources meant a significant
number of small operations would be required to obtain title V permits
for the first time, and as many of these area sources were subject to a
limited set of applicable requirements and permits, there was little
apparent benefit from the consolidation of these requirements within a
title V permit. One commenter stated that the EPA failed to discuss
whether there was a history of noncompliance with the EtO Commercial
Sterilization NESHAP, which indicated that that there are few potential
gains from the increased burdens. Finally, one commenter stated that
State operating permits (e.g., Synthetic Minor or Federally Enforceable
State Operating Permits) are abundant and adequate to deal with these
GACT sources without the added expense, complication, and delays
associated with title V permitting.
Response: We agree with commenters that the four-factor balancing
test continues to weigh in favor of exempting area source facilities
from title V permitting. In particular, we agree with commenters that
one of the primary benefits of the title V program is to clarify, in a
single document, the various and complex regulations that apply to a
facility in order to improve compliance, and that this benefit is not
realized in this case because commercial sterilization facilities are
subject to only one NESHAP (Subpart O). In addition, we agree with
commenters that, in light of the robust monitoring, recordkeeping and
reporting requirements in the final rule, a title V permit would likely
not add any substantial monitoring, recordkeeping and reporting
requirements. We further note that, even in the absence of title V
permitting requirements, this final rule will ensure transparency
around the emissions from these facilities by requiring that EtO CEMS
data be reported on a quarterly basis, and this data will be made
available to the public.
In summary, the benefits of requiring title V permitting for area
source facilities are not outweighed by the concerns. For the reasons
stated above, we agree with commenters that the four-factor balancing
test continues to weigh in favor of exempting area source facilities
from title V permitting on the basis that title V is unnecessarily
burdensome. Therefore, we are not finalizing title V permitting
requirements for area source facilities.
Comment: One commenter suggested that we require only a single
combined performance test for the outlet point and that the most
stringent applicable standard (i.e., the control level required for the
SCV) should be applied. Two commenters stated that our affected source
proposal is unnecessarily complicated. One commenter stated that where
control equipment has a single inlet and outlet, the facility should
not be required to test individual source inlets or outlets. The
commenter also stated that it is logical that point sources routed to
the same emission control system should be defined as a single unit.
The commenter stated it is important to set emission limits that
reflect this reality and test methods that allow for combined system
testing at the outlet of the system. The commenter also stated that the
proposed language implies that the SCV, CEV, and ARV must be tested
separately, which is challenging given the complexity in design of
existing duct work and access to inlets. The commenter stated that
testing the combined inlet to the APCD would be the safest, most
accurate, and most cost-effective method for determining compliance for
facilities with combined emissions. Another commenter stated that
applying the most restrictive removal efficiency standard when
different sources are combined is impractical.
Response: The EPA is finalizing approaches that will provide
facilities with flexibility in terms of how they choose to demonstrate
compliance with the standards for instances where emission streams are
combined prior to entering a control system. Facilities can determine
compliance via one of two options:
Option 1: Determine the mass of EtO entering the control
device at a point after the emission streams are combined, and apply
the most stringent emission reduction standard that the component
streams are subject to.
Option 2: Determine the mass of EtO entering the control
device at points before the emission streams are combined, and apply
the emission reduction standards that the component streams are subject
to.
Option 1 is consistent with what was proposed, and Option 2 has
been added in order to provide more flexibility for facilities in terms
of how they chose to demonstrate compliance. As an example, suppose an
area source facility uses at least 30 tpy but less than 60 tpy, and the
facility chooses to control all of its ARVs and CEVs with one control
system. The emission reduction standards that apply to the ARVs and
CEVs are 99.9% and 99%, respectively. In this example, suppose the mass
of EtO emissions from the ARVs is 4 lb, and the mass of EtO emissions
from the CEVs is 1 lb, meaning that the mass of EtO emissions from the
combined stream is 5 lb. Under Option 1, the facility would need to
apply an emission reduction of 99.9% to the combined stream, resulting
in an emission limit of 0.005 lb. Under Option 2, the facility would
apply an emission reduction of 99.9% to the ARV stream and an emission
reduction of 99% to the CEV stream, resulting in an emission limit of
0.014 lb. When an affected source is subject to a relatively high
emission reduction standard, it can be difficult to demonstrate
compliance with that standard when the concentration of pollutants
going into the control device is low. By combining emission streams and
increasing the concentration of pollutants in the air stream, it is
easier to demonstrate compliance.
Comment: One commenter recommended the creation of the option for a
site-wide emission limitation. This limitation could take the form of
either overall removal efficiency, or a total mass rate per hour.
Another commenter suggested a site-wide emission limitation based upon
EtO usage and end-state emissions and identified as precedent an
Illinois construction permit containing monthly and annual mass
emissions caps. The commenter also suggested a compliance option by
emission reduction or emission rate standards and identified as
precedent Illinois legislation requiring 99.9 percent emission
reduction at each exhaust point or limitation of EtO emissions to 0.2
ppm.
Response: We agree with the creation of an option for a site-wide
emission limitation and have included this in the final rulemaking.
Specifically, we are finalizing two options for determining compliance
on a site-wide basis:
Option 1: Determine the mass of EtO being used at the
facility and apply the SCV emission reduction standard, which is the
most stringent emission
[[Page 24137]]
reduction standard that any emission stream at the facility is subject
to.
Option 2: Determine the mass of EtO being emitted from
each affected source, and apply the emission reduction standards that
each affected source is subject to. For SCVs, the mass of EtO may be
determined by measuring how much is used and then applying a facility-
specific factor that accounts for EtO entering the control systems from
other affected sources.
We disagree with the suggestion to set an emissions cap, as the
amount of EtO that a facility will use in a given month is unknown.
4. What is the rationale for our final approach and final decisions for
the other amendments for the Commercial Sterilization Facilities source
category?
We are not finalizing a requirement for all area sources facilities
to obtain a title V operating permit, and we are not including
requirements for fenceline or ambient air monitoring as part of this
final rule. Based on the comments received during the proposed
rulemaking, we are requiring EtO CEMS for facilities where EtO use is
at least 100 lb/year, and we are finalizing a requirement for EtO CEMS
data to be reported quarterly. We are not finalizing a requirement for
owners and operators to conduct SCV inlet testing, and we are not
finalizing a requirement for each performance test run to be conducted
over a 24-hour period. Lastly, we are finalizing revised compliance
mechanisms for combined emission streams, as well as the option for
facilities to demonstrate compliance with a site-wide emission limit,
as opposed to having to demonstrate compliance for each individual and
combined emission stream. See section IV.F.3 of this preamble for
further discussion.
In a few instances, we received comments that led to additional
minor editorial corrections and technical clarifications being made in
the final rule, and our rationale for these corrections and technical
clarifications can be found in the document, Summary of Public Comments
and Responses for the Risk and Technology Review for Commercial
Sterilization Facilities, available in the docket for this rulemaking.
V. Summary of Cost, Environmental, and Economic Impacts and Additional
Analyses Conducted
A. What are the affected facilities?
As part of the proposed rulemaking, we estimated that there were 86
existing commercial sterilization facilities and two planned
facilities. However, based on comments received on the proposed
rulemaking, we understand that one of the existing facilities has
closed. In addition, the commenters identified three existing
commercial sterilization facilities that were unknown during the
proposed rulemaking. However, it should be noted that EtO use at the
three facilities that were previously unknown is very small (i.e., less
than 1 tpy). A complete list of the known 88 Commercial Sterilization
Facilities that are affected by this rulemaking is available in
Appendix 1 of the document, Residual Risk Assessment for the Commercial
Sterilization Facilities Source Category in Support of the 2024 Risk
and Technology Review Final Rule, which is available in the docket for
this rulemaking.
B. What are the air quality impacts?
At the current level of control prior to the amendments being
finalized in this action, the EPA estimates that EtO emissions were
approximately 23 tpy (actuals) and 160 tpy (allowables) from commercial
sterilization facilities. At the level of control required by the
amendments being finalized in this action, which includes standards for
previously unregulated sources and amendments to all sources where
standards were already in place, we estimated EtO emissions reductions
of 21 tpy (actuals) and 150 tpy (allowables) for the source category.
C. What are the cost impacts?
The total capital investment cost of the final amendments and
standards is estimated to be approximately $313 million in 2021
dollars. We estimate total annual costs of the final amendments to be
approximately $74 million.
The present value (PV) of the estimated compliance costs over the
20-year timeframe from 2025 to 2044 for the final rule is $773 million
in 2021 dollars, discounted at a 7 percent rate. The equivalent
annualized value (EAV) of the costs is $88 million, using a 7 percent
discount rate. Using a 3 percent discount rate, the PV and EAV of the
costs from 2025 to 2044 are estimated to be $932 million and $63
million, respectively.
The nationwide costs of the different amendments being finalized in
this action are presented in table 2 of this preamble. As described in
this preamble, we are finalizing standards for previously unregulated
sources, as well as amendments for sources where standards were already
in place. Many of the emissions capture and control technologies that
are needed to comply with the final rule will impact multiple sources
at once, and those costs form the basis of our impact estimates. These
costs are presented in table 2 of this preamble. There are 90
facilities (including the 88 existing facilities and the two planned
facilities) affected by the amendments, and the number of facilities
associated with each of the specific costs is indicated in table 2. The
facility list was developed using methods described in section II.C of
the proposal preamble (88 FR 22790, April 13, 2023). A complete list of
known commercial sterilization facilities is available in Appendix 1 of
the document, Residual Risk Assessment for the Commercial Sterilization
Facilities Source Category in Support of the 2024 Risk and Technology
Review Final Rule, which is available in the docket for this
rulemaking.
D. What are the economic impacts?
The economic impact analysis is designed to inform decision makers
about the potential economic consequences of the compliance costs
outlined in section V.C of this preamble. The EPA performed a screening
analysis that compared compliance costs to revenues at the ultimate
parent company level (several companies own more than one affected
facility). This is known as the cost-to-revenue or cost-to-sales test,
or the ``sales test.'' The use of a sales test for estimating small
business impacts for a rulemaking is consistent with EPA guidance on
compliance with the Regulatory Flexibility Act (RFA) and is consistent
with guidance published by the U.S. Small Business Administration's
Office of Advocacy that suggests that cost as a percentage of total
revenues is a metric for evaluating cost increases on small entities in
relation to increases on large entities.
There are 88 existing commercial sterilization facilities and 2
planned commercial sterilization facilities, owned by 50 parent
companies, affected by the final amendments. Of the parent companies,
22 companies, or 44 percent, are small entities based on the U.S. Small
Business Administration's table of size standards. Next, we determined
the magnitude of the costs of the amendments being finalized in this
action for each entity and then calculated a cost-to-sales ratio for
each entity by comparing estimated costs to the annual revenues of each
parent company. We then assessed whether there would be potential for a
significant impact on small entities based on the cost-to-sales ratios.
For all entities, the average cost-to-sales ratio is approximately 8
percent; the median cost-to-sales ratio is 0.2 percent; and the
[[Page 24138]]
maximum cost-to-sales ratio is approximately 69 percent. For large
firms, the average cost-to-sales ratio is approximately 0.2 percent;
the median cost-to-sales ratio is 0.03 percent; and the maximum cost-
to-sales ratio is 1.3 percent. This rule has potentially significant
impacts on small entities. For small firms, the average cost-to-sales
ratio is approximately 18 percent, the median cost-to-sales ratio is
4.7 percent, and the maximum cost-to-sales ratio is 69 percent. There
are 13 small entities (59 percent of all affected small entities) with
estimated cost-to-sales ratios of 3 percent or greater. See the
Regulatory Impact Analysis for further detail on the cost estimates,
small entity impact analysis, and a discussion of potential market and
economic impacts.
The EtO sterilization industry is an integral part of the supply
chain for many medical devices and capacity constraints have been
reported. Based on the data we analyzed, we expect that the largest
impacts of this rule are limited to a handful of the companies that
play a key role in the availability of certain medical devices, and
several of them are already in the planning stage for additional
controls.
Some companies involved in medical device sterilization have
installed, or are already planning for installation of, additional
emissions controls. The controls necessary to meet the requirements of
this final rule include PTEs and gas/solid reactors, along with (in
some cases) alterations to facility design to ensure adequate capture
of EtO emissions. Such controls rely on existing technologies that are
commercially available from manufacturers and are already well
established in this industry. In addition, a few companies have
constructed, or are in the process of constructing, new facilities with
state-of-the-art design and control installations to ensure full
capture and control of EtO emissions. These early actions by industry
demonstrate the feasibility of implementing the requirements in this
final rule.
Over the last several years, the industry has demonstrated the
capability to install controls on multiple facilities simultaneously
without interfering with medical supply chains. For example, three
companies re-designed their Illinois and Georgia facilities to comply
with the PTE requirements of EPA Method 204, as well as installed
emission controls at these facilities during overlapping timeframes
from May 2019 through August 2020 without disruption to the medical
supply chain. As discussed in section III.G of this preamble, we have
reviewed the time that it has taken for these projects to be completed,
from submission of the initial permit application to installation of
the continuous compliance mechanisms. Based on this review, we found
that the process of bringing a facility into compliance with the PTE
requirements of EPA Method 204, as well as installing and verifying
additional emission controls, takes approximately a year from permit
submission to project completion.
The EPA has evaluated available information about the state of
control installations at existing commercial sterilization facilities.
Of the 88 existing facilities, seven appear have already met the
emission standards and will not need to install additional emission
controls. Another 55 facilities appear to only need additional
abatement devices. We expect that 28 facilities still need to meet the
PTE requirements of EPA Method 204 and install additional abatement
devices. Table 22 presents the apparent compliance status with the
final rule for each relevant emission source and facility EtO use
combination, based on controls that are currently in place.
Table 22--Apparent Compliance Status With Final Rule and Compliance Timeframes
----------------------------------------------------------------------------------------------------------------
Number of
Number of facilities
Emission source Facility EtO use facilities with appearing to Compliance
this affected achieve final timeframe
source standard \1\
----------------------------------------------------------------------------------------------------------------
SCV.............................. At least 30 tpy..... 38 19 Two years.
At least 10 but less 9 9 Two years.
than 30 tpy.
At least 1 but less 18 16 Two years.
than 10 tpy.
Less than 1 tpy..... 23 22 Three years.
ARV.............................. At least 30 tpy..... 36 12 Two years.
At least 10 but less 5 5 Three years.
than 30 tpy.
At least 1 but less 10 7 Three years.
than 10 tpy.
Less than 1 tpy..... 4 2 Three years.
CEVs at major source facilities.. N/A................. 0 N/A Three years.
CEVs at area source facilities... At least 60 tpy..... 25 12 Two years.
Less than 60 tpy.... 15 8 Three years.
Group 1 room air emissions at N/A................. 0 N/A Three years.
major sources.
Group 1 room air emissions at At least 40 tpy..... 36 16 Two years.
area sources.
Less than 40 tpy.... 38 7 Three years.
Group 2 room air emissions at N/A................. 1 0 Three years.
major sources.
Group 2 room air emissions at At least 20 tpy..... 44 17 Two years.
area sources.
At least 4 but less 13 1 Two years.
than 20 tpy.
Less than 4 tpy..... 27 27 Three years.
----------------------------------------------------------------------------------------------------------------
\1\ The phrase ``appearing to achieve'' is used (as opposed to ``achieving'') to account for uncertainties in
the data. A notable example is the SCVs where, for a given facility, the emission reduction on the first
evacuation may not high enough to ensure that the standard is being met across all evacuations. Another
uncertainty is the fraction of EtO going to each emission stream. In some instances, there is facility-
specific information available, and in others, there is no information available and default fractions are
applied as a result.
[[Page 24139]]
E. What are the benefits?
The EPA did not monetize the benefits from the estimated emission
reductions of HAP associated with this final action. The EPA currently
does not have sufficient methods to monetize benefits associated with
HAP, HAP reductions, and risk reductions for this rulemaking. However,
we estimate that the final rule amendments would reduce EtO emissions
by 21 tons per year and expect that these reductions will lower the
risk of adverse health effects, including cancer, for individuals in
communities near commercial sterilization facilities. For example, the
estimated cancer incidence due to emissions from the source category
would be reduced from 0.9 to between 0.1 to 0.2, or from 1 cancer case
every 1.1 years to 1 cancer case every 5 to 10 years.
F. What analysis of environmental justice did we conduct?
Consistent with applicable executive orders and EPA policy, the EPA
has carefully analyzed the environmental justice implications of the
benefits associated with the reductions in EtO emissions as a result of
this final rule. The EPA conducted this analysis for the purpose of
providing the public with as full as possible an understanding of the
potential impacts of this final action. The EPA believes that analyses
like this can inform the public's understanding, place EPA's action in
context, and help, identify and illustrate the extent of potential
burdens and protections.
As part of understanding the impacts of this source category and of
this final rule, we examined the potential for the 88 facilities that
were assessed to pose concerns to communities with EJ concerns both in
the baseline i.e., under the current standards) standards considered in
this final rule.
To examine the potential for EJ concerns in the pre-control
baseline, we conducted two baseline demographic analyses, a proximity
analysis and a risk-based analysis. The baseline proximity demographic
analysis is an assessment of individual demographic groups in the total
population living within 10 kilometers (km) and 50 km of the
facilities. In this preamble, we focus on the 10 km radius for the
health risk assessment and for the demographic analysis because it
encompasses all the facility MIR locations and captures 100 percent of
the population with risks greater than 100-in-1 million. The results of
the proximity analysis for populations living within 50 km are included
in the technical report included in the docket for this final rule for
the public's understanding.
The baseline risk-based demographic analysis is an assessment of
risks to individual demographic groups in the population living within
the 10 km and 50 km radii around the facilities prior to the
implementation of any controls finalized by this action (``baseline'').
Again, in this preamble, we present for the public's understanding the
results for populations living within 10 km of facilities. Results for
populations living within 50 km are included in the technical report
included in the docket for this final rule.
Overall, the results of the proximity demographic analysis (see
first three columns of table 23) indicate that the percent of the
population living within 10 km of the 88 facilities that is Hispanic or
Latino is substantially higher than the national average (36 percent
versus 19 percent), driven largely by the seven facilities in Puerto
Rico. The baseline proximity analysis indicates that the proportion of
other demographic groups living within 10 km of commercial sterilizers
is closer to the national average. The baseline risk-based demographic
analysis (see ``baseline'' column in tables 23 to 25), which presents
information for individuals that are expected to have higher cancer
risks (greater than or equal to 1-in-1 million, greater than or equal
to 50-in-1 million, and greater than 100-in-1 million), suggests that
the African American, Hispanic or Latino, below the poverty level, over
25 and without a high school diploma, and linguistically isolated
demographic groups are also disproportionally represented at the higher
risk levels.
The post-control risk-based demographic analysis presents
information on current health risks and how the standards considered in
this final regulatory action would affect the distribution of these
risks across the populations and communities identified in the
baseline. The CAA section 112(d)(2), (3), and (5) post-control scenario
is shown in tables 23 to 25 and the residual risk post-control options
are shown in tables 26 to 28. The post-control options show a
substantial reduction in the number of individuals at each risk level,
as well as a significant reduction in the proportion of African
Americans that experience higher risk levels from facilities in this
source category. We project that a majority of the individuals that
would remain at risk after implementation of the final standards are
Hispanic or Latino, driven largely by the facilities in Puerto Rico.
These three distinct but complementary analyses indicate the
potential for EJ concerns associated with this source category in the
baseline, as well as the substantial anticipated benefits these final
standards will have in reducing EtO emissions and associated health
risks for all of the affected public, including people living in
communities with EJ concerns. Those benefits include that no individual
is expected to be exposed to inhalation cancer risk levels above 100-
in-1 million due to emissions from this source category after
implementation of all the CAA standards finalized in this action.
The methodology and detailed results of the demographic analysis
are presented in a technical report, Analysis of Demographic Factors
for Populations Living Near Ethylene Oxide Commercial Sterilization and
Fumigation Operations, available in the docket for this action, but a
synopsis is provided below. We also received comments on the
demographic analysis. Those comments and our specific responses can be
found in the document, Summary of Public Comments and Responses for the
2024 Risk and Technology Review for Commercial Sterilization
Facilities, available in the docket for this rulemaking.
1. Demographics
The first three columns of tables 23, 24, and 25 of this document
show the total population, population percentages, and population count
for each demographic group for the nationwide population and the total
population living within 10 km of EtO sterilization facilities. A total
of 17.3 million people live within 10 km of the 88 facilities that were
assessed. The results of the proximity demographic analysis indicate
that the percent of the population that is Hispanic or Latino is
substantially higher than the national average (36 percent versus 19
percent), driven by the seven facilities in Puerto Rico, where an
average of 99 percent of the 658,000 people living within 10 km of the
facilities in PR are Hispanic or Latino. The percent of the population
that is ``Other and multiracial'' (11 percent) is higher than the
national average (8 percent). The percent of people living below the
poverty level (15 percent) and those over the age of 25 without a high
school diploma (16 percent) are higher than the national averages (13
percent and 12 percent, respectively). The percent of people living in
linguistic isolation \69\ is double
[[Page 24140]]
the national average (10 percent versus 5 percent). We note that this
estimate of linguistic isolation is largely driven by the facilities in
Puerto Rico, where an average of 67 percent of the population is in
linguistic isolation in comparison to the national average.
---------------------------------------------------------------------------
\69\ Linguistic Isolation is defined in the U.S. Census Bureau's
American Community Survey as ``a household in which all members age
14 years and over speak a non-English language and also speak
English less than ``very well'' (have difficulty with English).''
---------------------------------------------------------------------------
In summary, the baseline proximity analysis indicates that the
percent of Hispanic or Latino populations living near commercial
sterilizers (within 10 km) is higher than what would be expected based
on the national average distribution. This is largely driven by the
seven facilities located in Puerto Rico where, on average, the
population of 658,000 people living within 10 km of these seven
facilities is 99 percent Hispanic or Latino. In addition, the
population around the facilities in Puerto Rico has 67 percent living
in linguistic isolation, 45 percent living below the poverty level, and
24 percent over 25 without a high school diploma.
2. Baseline Risk-Based Demographics
The baseline risk-based demographic analysis results are shown in
the ``baseline'' column of tables 23, 24, and 25. This analysis
presented information on the populations living within 10 km of the
facilities with estimated actual cancer risks greater than or equal to
1-in-1 million (table 23), greater than or equal to 50-in-1 million
(table 24), and greater than 100-in-1 million (table 25). The risk
analysis indicated that emissions from the source category, prior to
the reductions we are finalizing, expose a total of 5.3 million people
to a cancer risk greater than or equal to 1-in-1 million around 75
facilities, 124,000 people to a cancer risk greater than or equal to
50-in-1 million around 38 facilities, and 19,000 people to a cancer
risk greater than 100-in-1 million around 16 facilities. The
demographics of the baseline population with estimated cancer risks
greater than or equal to 1-in-1 million are very similar to the total
population within 10 km. Specifically, the percent of the population
that is Hispanic or Latino is more than two times larger than the
national average (39 percent versus 19 percent), the percent below the
poverty level is above national average (16 percent versus 13 percent),
the percent over 25 without a high school diploma is above the national
average (18 percent versus 12 percent), and the percent linguistic
isolation is two times the national average (11 percent versus 5
percent).
In contrast, the smaller populations with baseline cancer risk
greater than or equal to 50-in-1 million (124,000 people), and greater
than 100-in-1 million (19,000 people) are predominantly made up of
African Americans (43 and 31 percent versus 12 percent nationally), and
have a higher percentage of the population below the poverty level (22
and 25 percent versus 13 percent nationally). For this same group, the
percent over 25 without a high school diploma is above the national
average (17 and 18 percent versus 12 percent), and linguistic isolation
is above the national average (9 and 16 percent versus 5 percent). This
shows that risks tend to be higher both where more African American
residents reside, and where poverty is higher than in the rest of the
area within 10 km. It should be noted that the higher percentage
African American population with baseline cancer risk greater than or
equal to 50-in-1 million is driven largely by seven facilities located
in or near communities that have African American populations that are
between two and eight times the national average. The higher percentage
African American population with baseline cancer risk greater than 100-
in-1 million is driven largely by three facilities that are located in
communities where the proportion of African American residents is
between 2.5 and 8 times the national average. The population with
higher baseline cancer risks living within 10 km of the facilities
consists of a substantially smaller percentage of Hispanic or Latino
(22 and 26 percent) than the total population living within 10 km (36
percent Hispanic or Latino) and is above the national average (19
percent).
In summary, the baseline risk-based demographic analysis, which
presents information on those specific locations that are expected to
have higher cancer risks, suggests that African Americans, those living
below poverty, and those living in linguistic isolation are
disproportionally represented where risk is highest. The population
with risks greater than 100-in-1 million living within 10 km of a
commercial sterilizer has a proportion of African Americans (31
percent), those living below poverty (25 percent) and those living in
linguistic isolation (16 percent) that is more than twice as large as
the respective national average.
3. Risks Across Demographics Anticipated After Standards Under CAA
Sections 112(d)(2), 112(d)(3), and 112(d)(5)
This analysis presented information on the populations living
within 10 km of the facilities with estimated cancer risks greater than
or equal to 1-in-1 million (table 23), greater than or equal to 50-in-1
million (table 24), and greater than 100-in-1 million (table 25) after
implementation of standards that we are finalizing under CAA sections
112(d)(2), (3), and (5). The results of our analysis of risk-based
demographics considering standards under CAA sections 112(d)(2), (3),
and (5) are shown in the last column of tables 23, 24, and 25 titled
``Baseline and CAA Section 112(d)(2), (3), and (5).'' In this analysis
we evaluated how the final CAA sections 112(d)(2), (3), and (5)
emission reductions in this final regulatory action affect the
distribution of risks identified in the baseline. This enables us to
characterize the post-control risks and to illustrate for the public's
understanding whether this part of the final action affects, creates or
mitigates potential EJ concerns as compared to the baseline.
The risk analysis indicated that the emissions from the source
category, after implementation of the standards (resulting in emissions
reductions) that we are finalizing under CAA sections 112(d)(2), (3),
and (5), reduces the number of people living within 10 km of a facility
and with a cancer risk greater than or equal to 1-in-1 million from 5.3
million people around 75 facilities to 3.2 million people around 70
facilities, reduces the number of people living within 10 km of a
facility and with a cancer risk greater than or equal to 50-in-1
million from 124,000 people around 38 facilities to 23,000 people
around 23 facilities, and reduces the number of people living within 10
km of a facility and with a cancer risk greater than 100-in-1 million
from 19,000 people around 16 facilities to 3,900 people around 13
facilities.
The demographics of the population with estimated cancer risks
greater than or equal to 1-in-1 million considering the standards we
are finalizing under CAA sections 112(d)(2), (3), and (5) are very
similar to both the total population within 10 km and to the baseline
population with risks greater than or equal to 1-in-1 million.
Specifically, the percent of the population that is Hispanic or Latino
is twice the national average (38 percent versus 19 percent), the
percent below the poverty level is above national average (16 percent
versus 13 percent), the percent over 25 without a high school diploma
is above the national average (18 percent versus 12 percent), and the
percent linguistic isolation is two times the national average (11
percent versus 5 percent).
After implementation of the standards that we are finalizing under
CAA sections 112(d)(2), (3), and (5), the percentage and number of
African Americans at cancer risks greater than
[[Page 24141]]
or equal to 50-in-1 million and greater than 100-in-1 million is
significantly reduced. For example, African Americans exposed to risks
greater than 100-in-1 million went from 31 percent or 5,900 people in
the baseline to 6 percent or 220 people after implementation of the
final CAA section 112(d)(2), 112(d)(3), and 112(d)(5) emissions
reductions. It should be noted that while the number of Hispanic or
Latino people with risks greater than 100-in-1 million was reduced from
4,900 to 2,600 people, the percentage of the remaining population at
>100-in-1 million risk that is Hispanic or Latino went up from 26
percent in the baseline to 68 percent after the final CAA section
112(d)(2), 112(d)(3), and 112(d)(5) emissions reductions. However,.
Similarly, the number of people below the poverty level or
linguistically isolated with a cancer risk >100-in-1 million decreased
significantly; however, the percentage of the remaining population at
risk post-emission controls that are in these demographics went up from
the baseline. For example, the proportion of the population with risks
greater than 100-in-1 million that were below the poverty level was
much higher than the baseline (38 percent versus 25 percent), but the
number of people was reduced from 4,700 people to 560 people.
In summary, implementation of the final CAA sections 112(d)(2),
(3), and (5) standards would significantly reduce the number of people
in all demographic groups that are exposed to risks greater than or
equal to 1-in-1 million, greater than and equal to 50-in-1 million, and
greater than 100-in-1 million. Specifically, the percent of the
population that is African American who are at a cancer risk greater
than or equal to 50-in-1 million and greater than 100-in-1 million was
reduced from 43 percent in the baseline to about 13 percent after the
CAA section 112(d)(2), 112(d)(3), and 112(d)(5) controls. The
percentage of Hispanic or Latino people increased as the higher risk
facilities in Puerto Rico make-up an increasing portion of the
remaining populations with higher cancer risks.
Table 23--Comparison at Baseline and CAA Section 112(d)(2), (3), and (5) Post-Control of Demographics of
Populations With Cancer Risk Greater Than or Equal to 1-in-1 Million Living Within 10 km of Facilities That Were
Assessed
----------------------------------------------------------------------------------------------------------------
Total Cancer risk >= 1-in-1 million
population -------------------------------
Demographic group Nationwide living within
10 km of EtO Baseline Post-control
facilities
----------------------------------------------------------------------------------------------------------------
Total Population................................ 328M 17.3M 5.3M 3.2M
Number of Facilities............................ .............. 88 75 70
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................... 60 percent 40 percent 40 percent 40 percent
[197M] [6.9M] [2.1M] [1.3M]
African American................................ 12 percent 13 percent 15 percent 16 percent
[40M] [2.3M] [770K] [520K]
Native American................................. 0.7 percent 0.3 percent 0.3 percent 0.3 percent
[2M] [51K] [17K] [9K]
Hispanic or Latino (includes white and nonwhite) 19 percent 36 percent 39 percent 38 percent
[62M] [6.2M] [2.1M] [1.2M]
Other and Multiracial........................... 8 percent 11 percent 7 percent 6 percent
[27M] [1.9M] [350K] [190K]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................. 13 percent 15 percent 16 percent 16 percent
[44M] [2.5M] [840K] [520K]
Above Poverty Level............................. 87 percent 85 percent 84 percent 84 percent
[284M] [14.8M] [4.5M] [2.7M]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Over 25 and without a High School Diploma....... 12 percent 16 percent 18 percent 18 percent
[40M] [2.7M] [960K] [590K]
Over 25 and with a High School Diploma.......... 88 percent 84percent 82 percent 82 percent
[288M] [14.6M] [4.3M] [2.7M]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................... 5 percent 10 percent 11 percent 11 percent
[18M] [1.8M] [570K] [360K]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on the Census Bureau's (Census) 2015-2019
American Community Survey (ACS) 5-year block group averages. Total population count within 10 km is based on
2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
[[Page 24142]]
Table 24--Comparison at Baseline and CAA Section 112(d)(2), (3), and (5) Post-Control of Demographics of
Populations With Cancer Risk Greater Than or Equal to 50-in-1 Million Living Within 10 km of Facilities That
Were Assessed
----------------------------------------------------------------------------------------------------------------
Total Cancer risk >= 50-in-1 million
population -------------------------------
Demographic group Nationwide living within
10 km of EtO Baseline Post-control
facilities
----------------------------------------------------------------------------------------------------------------
Total Population................................ 328M 17.3M 124,000 23,000
Number of Facilities............................ .............. 88 38 23
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................... 60 percent 40 percent 31 percent 30 percent
[197M] [6.9M] [39K] [7K]
African American................................ 12 percent 13 percent 43 percent 13 percent
[40M] [2.3M] [54K] [2.9K]
Native American................................. 0.7 percent 0.3 percent 0.1 percent 0.1 percent
[2M] [51K] [190] [<100]
Hispanic or Latino (includes white and nonwhite) 19 percent 36 percent 22 percent 56 percent
[62M] [6.2M] [27K] [13K]
Other and Multiracial........................... 8 percent 11 percent 3 percent 2 percent
[27M] [1.9M] [3.9K] [400]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................. 13 percent 15 percent 22 percent 29 percent
[44M] [2.5M] [28K] [6.6K]
Above Poverty Level............................. 87 percent 85 percent 78 percent 71 percent
[284M] [14.8M] [96K] [17K]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Over 25 and without a High School Diploma....... 12 percent 16 percent 17 percent 21 percent
[40M] [2.7M] [21K] [5K]
Over 25 and with a High School Diploma.......... 88 percent 84 percent 83 percent 79 percent
[288M] [14.6M] [103K] [18K]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................... 5 percent 10 percent 9 percent 30 percent
[18M] [1.8M] [11K] [6.9K]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on Census' 2015-2019 ACS 5-year block group
averages. Total population count within 10 km is based on 2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
To account for the uncertainty of demographics estimates in smaller populations, any population values
of 100 persons or less have been shown simply as ``<100.''
Table 25--Comparison at Baseline and CAA Section 112(d)(2), (3), and (5) Post-Control of Demographics of
Populations With Cancer Risk Greater Than 100-in-1 Million Living Within 10 km of Facilities That Were Assessed
----------------------------------------------------------------------------------------------------------------
Total Cancer risk > 100-in-1 million
population -------------------------------
Demographic group Nationwide living within
10 km of EtO Baseline Post-control
facilities
----------------------------------------------------------------------------------------------------------------
Total Population................................ 328M 17.3M 19,000 3,900
Number of Facilities............................ .............. 88 16 13
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................... 60 percent 40 percent 40 percent 25 percent
[197M] [6.9M] [7.7K] [1K]
African American................................ 12 percent 13 percent 31 percent 6 percent
[40M] [3M] [5.9K] [200]
Native American................................. 0.7 percent 0.3 percent 0.1 percent 0 percent
[2M] [51K] [<100] [0]
[[Page 24143]]
Hispanic or Latino (includes white and nonwhite) 19 percent 36 percent 26 percent 68 percent
[62M] [6.2M] [4.9K] [2.6K]
Other and Multiracial........................... 8 percent 11 percent 3 percent 1 percent
[27M] [1.9M] [500] [<100]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................. 13 percent 15 percent 25 percent 38 percent
[44M] [2.5M] [4.7K] [1.4K]
Above Poverty Level............................. 87 percent 85 percent 75 percent 62 percent
[284M] [14.8M] [14K] [2.4K]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Over 25 and without a High School Diploma....... 12 percent 16 percent 18 percent 22 percent
[40M] [2.7M] [3.5K] [900]
Over 25 and with a High School Diploma.......... 88 percent 84 percent 82 percent 78 percent
[288M] [14.6M] [16K] [3K]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................... 5 percent 10 percent 16 percent 44 percent
[18M] [1.8M] [3K] [1.7K]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on Census' 2015-2019 ACS 5-year block group
averages. Total population count within 10 km is based on 2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
To account for the uncertainty of demographics estimates in smaller populations, any population values
of 100 persons or less have been shown simply as ``<100.''
4. Demographics of Affected Populations Anticipated After
Implementation of Residual Risk Standards (Post-Control)
This analysis presented information on the populations living
within 10 km of the facilities with estimated cancer risks greater than
or equal to 1-in-1 million (table 26), greater than or equal to 50-in-1
million (table 27), and greater than 100-in-1 million (table 28) after
implementation of the standards being finalized under CAA section
112(f)(2) as described in section IV.C of this preamble. The
demographic results for the risks after implementation of the residual
risk-based controls are in the column titled ``Residual Risk
Standards.'' These standards will be implemented in addition to the CAA
section 112(d)(2), (3), and (5) standards and are anticipated to result
in additional post-control emissions reductions. Therefore, in this
analysis, we evaluated how all of the final standards and emission
reductions described in this action affect the reduction and
distribution of risks. This enables us to characterize the post-control
risks and to understand whether the final action affects, creates or
mitigates potential EJ concerns as compared to the baseline.
The risk analysis indicated that the number of people exposed to
risks greater than or equal to 1-in-1 million within 10 km of a
facility (table 26) is reduced from 3.2 million people after
implementation of the CAA section 112(d)(2), (3), and (5) controls to
approximately 700,000 people after implementation of the residual risk
standards. This represents a significant reduction (about 80 percent
reduction) in the size of the population facing this level of risk
after implementation of the residual risk standards being finalized,
when compared to the population facing this level of risk after
implementation of just the CAA section 112(d)(2), (3), and (5)
controls. The people with a cancer risk greater than or equal to 1-in-1
million are located around 67 facilities after implementation of the
residual risk standard-based controls.
The demographics of the post-control population living within 10 km
of a facility and with an estimated cancer risks greater than or equal
to 1-in-1 million after implementation of the residual risk standards
and resulting controls (table 26) are very similar to the CAA section
112(d)(2), (3), and (5) post-control population with risks greater than
or equal to 1-in-1 million. Specifically, the percent of the population
that is Hispanic or Latino is nearly twice the national average (34
percent versus 19 percent), the percent below poverty is above national
average (15 percent versus 13 percent), the percent over 25 without a
high school diploma is above the national average (15 percent versus 12
percent), and the percent linguistic isolation is almost two times the
national average (11 percent versus 5 percent).
The risk analysis indicated that the number of people living within
10 km of a facility and exposed to risks greater than or equal to 50-
in-1 million (table 27) is reduced from 23,000 people after
implementation of the CAA section
[[Page 24144]]
112(d)(2), (3), and (5)-based controls to 170 people after
implementation of the residual risk-based controls. This represents a
99 percent reduction in the size of the populations at risk. The people
living within 10 km of a facility and with a cancer risk greater than
or equal to 50-in-1 million after implementation of the final rule are
located around 11 facilities.
The demographic breakdown of the much smaller post-control
population living within 10 km of a facility and with estimated cancer
risks greater than or equal to 50-in-1 million for the residual risk
controls (table 27) is significantly different from the population
after implementation of the CAA section 112(d)(2), (3), and (5)
controls. Specifically for the 170 individuals still at greater than or
equal to 50-in-1 million risk, the percent of the population that is
Hispanic or Latino is significantly higher at 76 percent for the
residual risk controls. This higher percentage is driven by two
facilities in Puerto Rico, for which the population is over 99 percent
Hispanic or Latino. However, the number of Hispanic or Latino people
with risks greater than or equal to 50-in-1 million was reduced by
about 99 percent from 13,000 people to 130 people after anticipated
implementation of the residual risk standard-based controls. Similarly,
the percentage of the population that is below the poverty level or
linguistically isolated went up from the CAA section 112(d)(2), (3),
and (5) post-control population, but the number of people in each
demographic decreased significantly.
The risk analysis indicated that the number of people living within
10 km of a facility and exposed to risks greater than 100-in-1 million
(table 28) is reduced from 3,900 people after implementation of the CAA
section 112(d)(2), (3), and (5)-based controls to zero people for
residual risk-based controls. After implementation of the residual risk
standards, there are no facilities or people with risks greater than
100-in-1 million. Therefore, there are no greater than 100-in-1 million
risk populations or demographics to discuss.
In summary, as shown in the residual risk post-control risk-based
demographic analysis, the standards being finalized will reduce the
number of people and facilities expected to have cancer risks greater
than or equal to 1-in-1 million, greater than or equal to 50-in-1
million, and greater than 100-in-1 million significantly. Under
residual risk-based controls, the number of Hispanic or Latino people
that are exposed to risks greater than or equal to 1-in-1 million is
reduced by 80 percent, the number of Hispanic or Latino people that are
exposed to risks greater than or equal to 50-in-1 million is reduced by
99 percent, and the number of Hispanic or Latino people that are
exposed to risks greater than 100-in-1 million is reduced by 100
percent. We note that, primarily driven by the higher risk facilities
in Puerto Rico, the percentage of population that is Hispanic or
Latino, below the poverty level, over 25 without a high school diploma,
or in linguistic isolation increases as the cancer risk increases from
greater than or equal to 1-in-1 million to greater than 50-in-1
million. Under residual risk-based controls, there are no facilities or
people with risks greater than 100-in-1 million.
Table 26--Comparison of Demographics for Populations With Cancer Risk Greater Than or Equal to 1-in-1 Million
Living Within 10 km of Sterilizer Facilities After Implementation of Various Components of the Final Standards
----------------------------------------------------------------------------------------------------------------
Cancer risk >=1-in-1 million
-------------------------------
Post-control
Demographic group Nationwide CAA section Residual risk
112(d)(2), standards (CAA
(3), and (5) section
standards 112(f)(2))
----------------------------------------------------------------------------------------------------------------
Total Population................................................ 328M 3.2M 700K
Number of Facilities with Pop. Above Cancer Level............... .............. 70 67
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................................... 60 percent 40 percent 40 percent
[197M] [1.3M] [280K]
African American................................................ 12 percent 16 percent 18 percent
[40M] [520K] [130K]
Native American................................................. 0.7 percent 0.3 percent 0.2 percent
[2M] [9K] [2.2K]
Hispanic or Latino (includes white and nonwhite)................ 19 percent 38 percent 34 percent
[62M] [1.2M] [240K]
Other and Multiracial........................................... 8 percent 6 percent 8 percent
[27M] [190K] [53K]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................................. 13 percent 16 percent 15 percent
[44M] [520K] [100K]
Above Poverty Level............................................. 87 percent 84 percent 85 percent
[284M] [7M] [600K]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
> 25 w/o a HS Diploma........................................... 12 percent 18 percent 15 percent
[40M] [590K] [110K]
> 25 w/HS Diploma............................................... 88 percent 82 percent 85 percent
[288M] [2.7M] [590K]
----------------------------------------------------------------------------------------------------------------
[[Page 24145]]
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................................... 5 percent 11 percent 11 percent
[18M] [360K] [80K]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on Census' 2015-2019 ACS 5-year block group
averages. Total population count within 10 km is based on 2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
Table 27--Comparison of Demographics for Populations With Cancer Risk Greater Than or Equal to 50-in-1 Million
Living Within 10 km of Sterilizer Facilities After Implementation of Various Components of the Final Rule
----------------------------------------------------------------------------------------------------------------
Cancer risk >=50-in-1 million
post-control
-------------------------------
Demographic group Nationwide CAA section
112(d)(2), Residual risk
(3), and (5) standards
standards (112(f)(2))
----------------------------------------------------------------------------------------------------------------
Total Population................................................ 328M 23,000 170
Number of Facilities with Pop. Above Cancer Level............... .............. 23 11
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................................... 60 percent 30 percent 12 percent
[197M] [7K] [<100]
African American................................................ 12 percent 13 percent 11 percent
[40M] [2.9K] [<100]
Native American................................................. 0.7 percent 0.1 percent 0.3 percent
[2M] [190] [<100]
Hispanic or Latino (includes white and nonwhite)................ 19 percent 56 percent 76 percent
[62M] [13K] [130]
Other and Multiracial........................................... 8 percent 2 percent 0.4 percent
[27M] [400] [<100]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................................. 13 percent 29 percent 30 percent
[44M] [6.6K] [<100]
Above Poverty Level............................................. 87 percent 71 percent 70 percent
[284M] [17K] [120]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
>25 w/o a HS Diploma............................................ 12 percent 21 percent 31 percent
[40M] [5K] [<100]
>25 w/HS Diploma................................................ 88 percent 79 percent 69 percent
[288M] [18K] [120]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................................... 5 percent 30 percent 47 percent
[18M] [6.9K] [<100]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on Census' 2015-2019 ACS 5-year block group
averages. Total population count within 10 km is based on 2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
[[Page 24146]]
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
To account for the uncertainty of demographics estimates in smaller populations, any population values
of 100 persons or less have been shown simply as ``<100''.
Table 28--Comparison of Demographics for Populations With Cancer Risk Greater Than 100-in-1 Million Living
Within 10 km of Sterilizer Facilities After Implementation of Various Components of the Final Rule
----------------------------------------------------------------------------------------------------------------
Cancer risk >100-in-1 million
-------------------------------
CAA section
Demographic group Nationwide 112(d)(2), Residual risk
(3), and (5) controls
post-control
----------------------------------------------------------------------------------------------------------------
Total Population................................................ 328M 3,900 0
Number of Facilities with Pop. Above Cancer Level............... .............. 13 0
----------------------------------------------------------------------------------------------------------------
Race and Ethnicity by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
White........................................................... 60 percent 25 percent ..............
[197M] [1K]
African American................................................ 12 percent 6 percent ..............
[40M] [200]
Native American................................................. 0.7 percent 0 percent ..............
[2M] [0]
Hispanic or Latino (includes white and nonwhite)................ 19 percent 68 percent ..............
[62M] [2.6K]
Other and Multiracial........................................... 8 percent 1 percent ..............
[27M] [<100]
----------------------------------------------------------------------------------------------------------------
Income by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Below Poverty Level............................................. 13 percent 38 percent ..............
[44M] [1.4K]
Above Poverty Level............................................. 87 percent 62 percent ..............
[284M] [2.4K]
----------------------------------------------------------------------------------------------------------------
Education by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
>25 w/o a HS Diploma............................................ 12 percent 22 percent ..............
[40M] [900]
>25 w/HS Diploma................................................ 88 percent 78 percent ..............
[288M] [3K]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated by Percent [Number of People]
----------------------------------------------------------------------------------------------------------------
Linguistically Isolated......................................... 5 percent 44 percent ..............
[18M] [1.7K]
----------------------------------------------------------------------------------------------------------------
Notes:
Nationwide population and demographic percentages are based on Census' 2015-2019 ACS 5-year block group
averages. Total population count within 10 km is based on 2010 Decennial Census block population.
To avoid double counting, the ``Hispanic or Latino'' category is treated as a distinct demographic
category. A person who identifies as Hispanic or Latino is counted as Hispanic or Latino, regardless of race.
The number of facilities represents facilities with a cancer MIR above level indicated. When the MIR
was located at a user assigned receptor at an individual residence and not at a census block centroid, we were
unable to estimate population and demographics for that facility.
The sum of individual populations with a demographic category may not add up to total due to rounding.
To account for the uncertainty of demographics estimates in smaller populations, any population values
of 100 persons or less have been shown simply as ``<100''.
VI. Statutory and Executive Order Reviews
A. Executive Orders 12866: Regulatory Planning and Review and Executive
Order 13563: Improving Regulation and Regulatory Review
This action is a ``significant regulatory action'', as defined
under section 3(f)(1) of Executive Order 12866, as amended by Executive
Order 14094. Accordingly, the EPA submitted this action to the Office
of Management and Budget (OMB) for Executive Order 12866 review.
Documentation of any changes made in response to the Executive Order
12866 review is available in the docket. The EPA prepared an analysis
of the potential costs and benefits associated with this action. This
analysis, Regulatory Impact Analysis for the Final National Emission
Standards for Hazardous Air Pollutants: Ethylene Oxide Commercial
Sterilization and Fumigation Operations, is also available in the
docket.
B. Paperwork Reduction Act (PRA)
The information collection activities in this rule have been
submitted for approval to the Office of Management and Budget (OMB)
under the PRA. The Information Collection Request (ICR) document that
the EPA prepared has been assigned EPA ICR number 1666.12. You can find
a copy of the ICR in the docket for this rulemaking, and it is briefly
summarized here.
We are amending the reporting and recordkeeping requirements for
several
[[Page 24147]]
emission sources at commercial sterilization facilities (e.g., SCV,
ARV, CEV, and room air emissions). The amendments also require
electronic reporting, removes the SSM exemption, and imposes other
revisions that affect reporting and recordkeeping. This information was
be collected to assure compliance with 40 CFR part 63, subpart O.
Respondents/affected entities: Owners or operators of commercial
sterilization facilities.
Respondent's obligation to respond: Mandatory (40 CFR part 63,
subpart O).
Estimated number of respondents: 88 facilities.
Frequency of response: Quarterly, semiannual, or annual. Responses
include notification of compliance status reports and semiannual
compliance reports.
Total estimated burden: 34,351 hours (per year) for the responding
facilities and 9,174 hours (per year) for the Agency. Burden is defined
at 5 CFR 1320.3(b).
Total estimated cost: $5,140,563 (per year), which includes
$2,549,368 annualized capital and operation and maintenance costs for
the responding facilities.
An Agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number. The OMB control numbers for the
EPA's regulations in 40 CFR are listed in 40 CFR part 9. When OMB
approves this ICR, the Agency will announce that approval in the
Federal Register and publish a technical amendment to 40 CFR part 9 to
display the OMB control number for the approved information collection
activities contained in this final rule.
C. Regulatory Flexibility Act (RFA)
Pursuant to section 603 of the RFA, the EPA prepared a final
regulatory flexibility analysis (FRFA) that examines the impact of the
rule on small entities along with regulatory alternatives that could
minimize the impact. The complete FRFA is available for review in the
docket and is summarized here.
1. Statement of Need and Rule Objectives
This industry is regulated by the EPA because pollutants emitted
from EtO sterilization and fumigation facilities are considered to
cause or contribute significantly to air pollution that may reasonably
be anticipated to endanger public health. This action is being
finalized to comply with CAA section 112 requirements, which direct the
EPA to complete periodic reviews of NESHAPs following initial
promulgation. The requirements are being finalized to address
unacceptable health risks linked to emissions from subpart O facilities
and to provide an ample margin of safety to protect public health.
The EPA is required under CAA section 112(d) to establish emission
standards for each category or subcategory of major and area sources of
HAPs listed for regulation in section 112(b). These standards are
applicable to new or existing sources of HAPs and require the maximum
degree of emission reduction. The EPA is required to review these
standards set under CAA section 112 every eight years following their
promulgation and revise them as necessary, taking into account any
``developments in practices, processes, or control technologies.'' This
review is known as the technology review. It has been over 25 years
since the initial NESHAP for this source category was promulgated in
1994 and roughly 15 years since the last technology review. As such,
this final rule is overdue. This rule also establishes standards for
currently unregulated sources of EtO emissions at subpart O facilities
under CAA section 112(d), such as room air emissions. The decision in
Louisiana Environmental Action Network v. EPA, 955 F.3d 1088 (D.C. Cir.
2020) concluded that the EPA is required to address regulatory gaps
(i.e., ``gap-filling'') when conducting NESHAP reviews. Finally, the
EPA determined that a risk review was warranted (despite not being
required) due to the updated unit risk estimate associated with EtO,
which is significantly higher than it was during the last review of
this NESHAP in 2006. Therefore, the EPA is finalizing requirements
under CAA section 112(f) to address unacceptable health risk attributed
to emissions from subpart O facilities and to provide an ample margin
of safety to protect public health.
2. Significant Issues Raised by the Public Comments in Response to the
Initial Regulatory Flexibility Analysis (IRFA) and EPA Response
While the EPA did not receive any comments specifically in response
to the IRFA, we did receive comments from the Office of Advocacy within
the Small Business Administration (SBA), and a summary of the major
comments and our responses is provided in the next section. The issues
raised by SBA were also reflected in comments from small businesses and
organizations with small business interests.
3. SBA Office of Advocacy Comments and EPA Response
The SBA's Office of Advocacy (hereafter referred to as
``Advocacy'') provided substantive comments on the April 2023 Proposal.
Those comments made the following claims: (1) the proposed compliance
period for existing sources (18 months) would disadvantage small
business; (2) the proposed requirement for area source commercial
sterilization facilities to obtain a title V permit would impose
significant costs and uncertainty for small businesses; and (3) EPA
should adopt the BMP alternatives for GACT at area source facilities.
Based on those claims, Advocacy insisted that EPA reconsider these
policies to reduce the impact on small entities and reduce the
likelihood they will leave the market.
In response to Advocacy's comments, EPA agrees that the proposed
compliance timeframe is too short and that more time is needed to
comply with the rule. Therefore, as part of the final rulemaking, EPA
is providing the maximum amount of time that is allowed under the CAA
to comply with the emission standards, which is three years for
standards that are promulgated pursuant to CAA section 112(d) and two
years for standards that are promulgated pursuant to CAA section
112(f)(2). With respect to title V permitting, because of the lack of
other Federal requirements under the CAA that commercial sterilization
facilities are subject to, as well as the robust monitoring and
reporting requirements of the final rule, the EPA is not finalizing a
requirement for area source facilities to obtain a title V permit. In
addition, with respect to GACT, emission standards were evaluated
against the BMP on a source-by-source basis. In general, we are
finalizing the emission standards for each source pursuant to CAA
section 112(d)(5), with the exception of existing Group 2 room air
emissions at areas source facilities, because they achieve higher
emission reductions than the BMP. Further discussion is available in
section IV.B.3.
More detailed responses to Advocacy's comments can be found in the
document, Summary of Public Comments and Responses for the Risk and
Technology Review for Commercial Sterilization Facilities, available in
the docket for this rulemaking.
4. Estimate of the Number of Small Entities to Which the Final Rule
Applies
For purposes of assessing the impacts of this rule on small
entities, a small entity is defined as a small business in the
commercial EtO sterilization
[[Page 24148]]
industry whose parent company has revenues or numbers of employees
below the SBA Size Standards for the relevant NAICS code. We have
identified 20 different NAICS codes within this source category. A
complete list of those NAICS codes and SBA Size Standards is available
in section 5.2 of the RIA. The rule contains provisions that will
affect 22 small entities. These small entities are involved in
sterilizing various types of medical devices and spices. In addition,
at least 12 of these small entities are involved in sterilizing the
types of medical devices discussed in section I.A.1 of this preamble.
5. Projected Reporting, Recordkeeping and Other Compliance Requirements
of the Final Rule
Under the rule requirements, small entities will be required to
comply with various emission standards, which may require the use of
one or more new control devices. Small entities will also need to
demonstrate compliance with the emission standards through the use of
an EtO CEMS or through periodic performance testing and parametric
monitoring. This rule includes reporting, recordkeeping, and other
administrative requirements. Under the rule, the EPA estimates that
approximately 13 small entities (60 percent of small entities) could
incur total annual costs associated with the proposal that are at least
three percent of their annual revenues. Considering the level of total
annual costs relative to annual sales for these small entities, the EPA
determined that there is potential for the requirements to have a
`Significant Impact on a Substantial Number of Small Entities'. See
section 5.2 of the RIA for more information on the characterization of
the impacts under the rule.
6. Steps Taken To Minimize Economic Impact to Small Entities
a. Small Business Advocacy Review Panel
As required by section 609(b) of the RFA, the EPA also convened a
Small Business Advocacy Review (SBAR) Panel to obtain advice and
recommendations from small entity representatives (SERs) that
potentially would be subject to the rule's requirements. On November
25, 2020, the EPA's Small Business Advocacy Chairperson convened the
Panel, which consisted of the Chairperson, the Director of the Sector
Policies and Programs Division within the EPA's Office of Air Quality
Planning and Standards, the Administrator of the Office of Information
and Regulatory Affairs within OMB, and the Chief Counsel for Advocacy
of the SBA.
Prior to convening the Panel, the EPA conducted outreach and
solicited comments from the SERs. After the Panel was convened, the
Panel provided additional information to the SERs and requested their
input. In light of the SERs' comments, the Panel considered the
regulatory flexibility issues and elements of the IRFA specified by
RFA/Small Business Regulatory Enforcement and Fairness Act and
developed the findings and discussion summarized in the SBAR report.
The report was finalized on April 26, 2021, and transmitted to the EPA
Administrator for consideration. A copy of the full SBAR Panel Report
is available in the rulemaking docket.
b. Alternatives Considered
The SBAR Panel recommended several flexibilities relating to the
format of the standards, room air emissions requirements,
subcategorization, the compliance timeframe, the consideration of GACT
standards, incentivizing lower EtO use, a compliance alternative for
combined emission streams, proximity requirements, and the
consideration of interactions with OSHA standards. The EPA is including
some of these flexibilities as a part of the rule requirements.
As discussed in section VI.C.3, the EPA is providing the maximum
amount of time that is allowed under the CAA to comply with the
emission standards. In addition, as discussed in section IV.B.3.b, the
EPA is not any finalizing any mass rate emission standards and is
finalizing percent emission reduction standards in their place.
Finally, as discussed in section IV.F.3, the EPA is finalizing
compliance flexibilities for combined emission streams, as well as the
option to demonstrate compliance with a site-wide emission limit, as
opposed to having to demonstrate compliance with each individual or
combined emission stream.
In addition, the EPA is preparing a Small Entity Compliance Guide
to help small entities comply with this rule. The Small Entity
Compliance Guide will be available on the same date as the date of
publication of the final rule or as soon as possible after that date
and will be available on the rule web page at: https://www.epa.gov/stationary-sources-air-pollution/ethylene-oxide-emissions-standards-sterilization-facilities.
D. Unfunded Mandates Reform Act (UMRA)
This action does not contain an unfunded mandate of $100 million or
more as described in UMRA, 2 U.S.C. 1531-1538, and does not
significantly or uniquely affect small governments. The action imposes
no enforceable duty on any State, local, or Tribal governments.
E. Executive Order 13132: Federalism
This action does not have federalism implications. It will not have
substantial direct effects on the States, on the relationship between
the National Government and the States, or on the distribution of power
and responsibilities among the various levels of government.
F. Executive Order 13175: Consultation and Coordination With Indian
Tribal Governments
This action does not have Tribal implications as specified in
Executive Order 13175. None of the commercial sterilization facilities
that have been identified as being affected by this final action are
owned or operated by Tribal governments or located within Tribal lands
within a 10-mile radius. Thus, Executive Order 13175 does not apply to
this action. We conducted an impact analysis using the latitude and
longitude coordinates from the risk modeling input file to identify
Tribal lands within a 10- and 50-mile radius of commercial
sterilization facilities to determine potential air quality impacts on
Tribes. Consistent with the EPA Policy on Consultation and Coordination
with Indian Tribes, although there were no Tribal lands located within
a 10-mile radius of commercial sterilization facilities, the EPA
offered consultation with all Tribes that were identified within a 50-
mile radius of an affected facility, however, only one Tribal official
requested consultation. Additional details regarding the consultation
letter and distribution list can be found in the memorandum, Commercial
Sterilization Facilities RTR Consultation Letter, which is available in
the docket for this rulemaking. The EPA also participated on a phone
call with the National Tribal Air Association on May 25, 2023, and
presented an overview of the rulemaking.
G. Executive Order 13045: Protection of Children From Environmental
Health Risks and Safety Risks
Executive Order 13045 (62 FR 19885, April 23, 1997) directs Federal
agencies to include an evaluation of the health and safety effects of
the planned regulation on children in Federal health
[[Page 24149]]
and safety standards and explain why the regulation is preferable to
potentially effective and reasonable feasible alternatives. This action
is subject to Executive Order 13045 because it is a 3(f)(1) significant
regulatory action as defined by Executive Order 12866, and the EPA
believes that the environmental health or safety risk addressed by this
action has a disproportionate effect on children. The EPA's Policy on
Children's Health also applies to this action. Accordingly, we have
evaluated the environmental health or safety effects of EtO emissions
and exposures on children. The protection offered by these standards
may be especially important for children.
Because EtO is mutagenic (i.e., it can damage DNA), children are
expected to be more susceptible to its harmful effects. To take this
into account, as part of the risk assessment in support of this
rulemaking, the EPA followed its guidelines and applied age-dependent
adjustment factors (ADAFs) for early lifestage exposures (from birth up
to 16 years of age). With the ADAF applied to account for greater
susceptibility of children, the adjusted EtO inhalation URE is 5 x 10-3
per [micro]g/m\3\. It should be noted that, because EtO is mutagenic,
emission reductions in this preamble will be particularly beneficial to
children. In addition, children are at increased risk if they live,
play, or attend school in close proximity to a commercial sterilization
facility, of which there are many cases noted by the public to be the
case. For these reasons, there is both increased susceptibility and
increased exposure for early lifestages as a result of EtO emissions
from commercial sterilization facilities.
A total of 3.97 million children ages 0-17 live within 10km of
commercial sterilization facilities. Due to baseline emissions from
commercial sterilization facilities (prior to application of controls
in this action), there are approximately 1.25 million children (0-17
years) with increased lifetime cancer risks of greater than or equal to
1-in-1 million, 30,000 with increased lifetime cancer risks greater
than or equal to 50-in-1 million, and 4,300 with increased lifetime
cancer risks greater than 100-in-1 million. After application of the
controls in this action, lifetime cancer risks to children from
commercial sterilization facility emissions decrease significantly to
approximately 162,300 children with increased lifetime cancer risks of
greater than or equal to 1-in-1 million, less than 100 with increased
lifetime cancer risks of greater than or equal to 50-in-1 million, and
none with increased lifetime cancer risks greater than 100-in-1
million. The methodology and detailed results of the demographic
analysis are presented in a technical report, Analysis of Demographic
Factors for Populations Living Near Ethylene Oxide Commercial
Sterilization and Fumigation Operations, available in the docket for
this action.
More detailed information on the evaluation of the scientific
evidence and policy considerations pertaining to children, including an
explanation for why the Administrator judges the standards to be
requisite to protect public health, including the health of children,
with an adequate margin of safety, in addition to the summaries of this
action's health and risk assessments are contained in sections II.A and
IV.C of this preamble and further documented in the risk report,
Residual Risk Assessment for the Commercial Sterilization Facilities
Source Category in Support of the 2024 Risk and Technology Review Final
Rule, which is available in Docket ID No. EPA-HQ-OAR-2019-0178.
H. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use
This action is not a ``significant energy action'' because it is
not likely to have a significant adverse effect on the supply,
distribution, or use of energy. The overall energy impact of this rule
should be minimal for commercial sterilization facilities and their
parent companies. EPA was unable to quantify the degree to which
manufacturers will need to switch sites, so we cannot estimate
potential energy impacts related to transportation. The EPA solicited
comment on any potential impacts the proposed standards may have in
relation to energy use for transportation but did not receive any
comments that would help to quantify such impacts.
I. National Technology Transfer and Advancement Act (NTTAA) and 1 CFR
Part 51
This rulemaking involves technical standards. The EPA conducted
searches for the standards through the Enhanced National Standards
Systems Network Database managed by the American National Standards
Institute (ANSI). We also contacted voluntary consensus standards (VCS)
organizations and accessed and searched their databases. We conducted
searches for EPA Methods 1, 1A, 2, 2A, 2C, 3A, 3B, and 4 of 40 CFR part
60, Appendix A, EPA Method 204 of 40 CFR part 51, Appendix M, and EPA
Methods 301 and 320 in 40 CFR part 63, Appendix A. During the EPA's VCS
search, if the title or abstract (if provided) of the VCS described
technical sampling and analytical procedures that are similar to the
EPA's reference method, the EPA reviewed it as a potential equivalent
method.
The EPA incorporates by reference VCS ANSI/ASME PTC 19.10-1981 Part
10, ``Flue and Exhaust Gas Analyses,'' a method for quantitatively
determining the gaseous constituents of exhausts resulting from
stationary combustion and includes a description of the apparatus, and
calculations used which are used in conjunction with Performance Test
Codes to determine quantitatively, as an acceptable alternative to EPA
Method 3B of appendix A to 40 CFR part 60 for the manual procedures
only and not the instrumental procedures. The ANSI/ASME PTC 19.10-1981
Part 10 method incorporates both manual and instrumental methodologies
for the determination of oxygen content. The manual method segment of
the oxygen determination is performed through the absorption of oxygen.
This method is available at the American National Standards Institute
(ANSI), 1899 L Street NW, 11th floor, Washington, DC 20036 and the
American Society of Mechanical Engineers (ASME), Three Park Avenue, New
York, NY 10016-5990. See https://www.ansi.org and https://www.asme.org.
The EPA incorporates by reference VCS ASTM D6348-12 (Reapproved
2020), ``Determination of Gaseous Compounds by Extractive Direct
Interface Fourier Transform (FTIR) Spectroscopy,'' as an acceptable
alternative to EPA Method 320 of appendix A to 40 CFR part 63 with
caveats requiring inclusion of selected annexes to the standard as
mandatory. The ASTM D6348-12 (R2020) method is an extractive FTIR
spectroscopy-based field test method and is used to quantify gas phase
concentrations of multiple target compounds in emission streams from
stationary sources. This [filig]eld test method provides near real time
analysis of extracted gas samples. In the September 22, 2008, NTTAA
summary, ASTM D6348-03(2010) was determined equivalent to EPA Method
320 with caveats. ASTM D6348-12 (R2020) is a revised version of ASTM
D6348-03(2010) and includes a new section on accepting the results from
direct measurement of a certified spike gas cylinder, but still lacks
the caveats we placed on the D6348-03(2010) version. We are finalizing
that the test plan preparation and implementation in the Annexes to
ASTM D 6348-12 (R2020), Sections Al through A8 are mandatory;
[[Page 24150]]
and in ASTM D6348-12 (R2020) Annex A5 (Analyte Spiking Technique), the
percent (%) R must be determined for each target analyte (equation
A5.5). We are finalizing that, in order for the test data to be
acceptable for a compound, %R must be 70% > R <= 130%. If the %R value
does not meet this criterion for a target compound, the test data is
not acceptable for that compound and the test must be repeated for that
analyte (i.e., the sampling and/or analytical procedure should be
adjusted before a retest). The %R value for each compound must be
reported in the test report, and all field measurements must be
corrected with the calculated %R value for that compound by using the
following equation:
[GRAPHIC] [TIFF OMITTED] TR05AP24.001
The ASTM D6348-12 (R2020) method is available at ASTM
International, 1850 M Street NW, Suite 1030, Washington, DC 20036. See
https://www.astm.org/.
ASTM D3695-88 is already approved for the locations in which it
appears in the amendatory text.
While the EPA identified 12 other VCS as being potentially
applicable, the Agency decided not to use them because these methods
are impractical as alternatives due to lack of equivalency,
documentation, validation data, and other important technical and
policy considerations. The search and review results have been
documented and are in the memorandum, Voluntary Consensus Standard
Results for National Emission Standards for Hazardous Air Pollutants:
Ethylene Oxide Emissions Standards for Sterilization Facilities
Residual Risk and Technology Review, which is available in the docket
for this rulemaking.
Under 40 CFR 63.7(f) and 40 CFR 63.8(f), subpart A--General
Provisions, a source may apply to the EPA for permission to use
alternative test methods or alternative monitoring requirements in
place of any required testing methods, performance specifications, or
procedures in the final rule or any amendments.
J. Executive Order 12898: Federal Actions To Address Environmental
Justice in Minority Populations and Low-Income Populations and
Executive Order 14096: Revitalizing Our Nation's Commitment to
Environmental Justice for All
The EPA believes that the human health or environmental conditions
that exist prior to this action result in or have the potential to
result in disproportionate and adverse human health or environmental
effects on communities with EJ concerns. A total of 17.3 million people
live within 10 km of the 88 facilities that were assessed. The percent
of the population that is Hispanic or Latino is substantially higher
than the national average (36 percent versus 19 percent), driven by the
seven facilities in Puerto Rico, where an average of 99 percent of the
658,000 people living within 10 km of the facilities are Hispanic or
Latino. The proportion of other demographic groups living within 10 km
of commercial sterilizers is similar to the national average. The EPA
also conducted a risk assessment of possible cancer risks and other
adverse health effects, and found that prior to the implementation of
this regulation, cancer risks are unacceptable for several communities.
See section VI.F for an analysis that characterizes communities living
in proximity to facilities and risks prior to implementation of the
final regulation.
The EPA believes that this action is likely to reduce existing
disproportionate and adverse effects on communities with EJ concerns.
This action establishes standards for SCVs and ARVs at facilities where
EtO use is less than 1 tpy, ARVs at facilities where EtO use is at
least 1 tpy but less than 10 tpy, CEVs, and room air emissions. In
addition, it tightens standards for SCVs at facilities where EtO use is
at least 1 tpy, as well as ARVs at facilities where EtO use is at least
10 tpy. This action also finalizes amendments to correct and clarify
regulatory provisions related to emissions during periods of SSM,
including removing general exemptions for periods of SSM and adding
work practice standards for periods of SSM where appropriate. As a
result of these changes, we expect zero people to be exposed to cancer
risk levels above 100-in-1 million. See section IV for more information
about the control requirements of the regulation and the resulting
reduction in cancer risks.
The EPA additionally identified and addressed environmental justice
concerns by engaging in outreach activities to communities we expect to
be impacted most by the rulemaking The EPA is also requiring owners and
operators of commercial sterilization facilities to submit electronic
copies of required compliance reports, performance test reports, and
performance evaluation reports, which will increase transparency and
will provide greater access to information for the public, including
impacted communities.
The information supporting this Executive order review is contained
in section VI.F of this preamble, as well as in a technical report,
Analysis of Demographic Factors for Populations Living Near Ethylene
Oxide Commercial Sterilization and Fumigation Operations, available in
the docket for this action.
K. Congressional Review Act (CRA)
This action is subject to the CRA, and the EPA will submit a rule
report to each House of the Congress and to the Comptroller General of
the United States. This action is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects
40 CFR Part 60
Environmental protection, Administrative practice and procedures,
Hazardous substances, Reporting and recordkeeping requirements.
40 CFR Part 63
Environmental protection, Administrative practice and procedures,
Air pollution control, Hazardous substances, Incorporation by
reference, Intergovernmental relations, Reporting and recordkeeping
requirements.
Michael S. Regan,
Administrator.
For the reasons set forth in the preamble, the EPA amends 40 CFR
parts 60 and 63 as follows:
PART 60--STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES
0
1. The authority citation for part 60 continues to read as follows:
Authority: 42 U.S.C. 7401 et seq.
[[Page 24151]]
Appendix B to Part 60--Performance Specifications
0
2. Appendix B to part 60 is amended by adding Performance Specification
19 to read as follows:
Appendix B to Part 60--Performance Specifications
* * * * *
Performance Specification 19-Performance Specifications and Test
Procedures for Ethylene Oxide (ETO) Continuous Emission Monitoring
Systems
1.0 Scope and Application
1.1 Analyte. This performance specification (PS) is applicable
for measuring gaseous concentrations of Ethylene Oxide (EtO), CAS:
775-21-8, on a continuous basis in the units of the applicable
standard or in units that can be converted to units of the
applicable standard(s) (e.g., lbs/hr,). This performance
specification may be approved for the measurement of other
pollutants and/or in other sectors by the Administrator on a case-
by-case basis if not otherwise allowed or denied in an applicable
subpart of the regulations.
1.2 Applicability.
1.2.1 This specification is used to evaluate the acceptability
of EtO continuous emission monitoring systems (CEMS) at the time of
installation or soon after and whenever specified in the
regulations. The specification includes requirements for initial
acceptance including instrument accuracy and stability assessments
and use of audit samples if they are available.
1.2.2 The Administrator may require the operator, under section
114 of the Clean Air Act, to conduct CEMS performance evaluations at
other times besides the initial test to evaluate the CEMS
performance. See 40 CFR part 60, Sec. 60.13(c) and Sec.
63.8(e)(1).
1.2.3 A source that demonstrates their CEMS meets the criteria
of this PS may use the system to continuously monitor gaseous EtO
under any regulation or permit that requires compliance with this
PS. If your CEMS reports the EtO concentration in the units of the
applicable standard, no additional CEMS components are necessary. If
your CEMS does not report concentrations in the units of the
existing standard, then other CEMS (i.e., oxygen) or CEMS components
(e.g., temperature, stack gas flow, moisture, and pressure) may be
necessary to convert the units reported by your CEMS to the units of
the standard.
1.2.4 These specification test results are intended to be valid
for the life of the system. As a result, the EtO measurement system
must be tested and operated in a configuration consistent with the
configuration that will be used for ongoing continuous emissions
monitoring.
1.2.5 Substantive changes to the system configuration require
retesting according to this PS. Examples of such conditions include
but are not limited to: major changes in dilution ratio (for
dilution-based systems); changes in sample conditioning and
transport, if used, such as filtering device design or materials;
changes in probe design or configuration and changes in materials of
construction. Changes consistent with instrument manufacturer
upgrade that fall under manufacturer's certification do not require
additional field verification. Manufacturer's upgrades (e.g.,
changes to the quantification algorithm) require recertification by
the manufacturer for those requirements allowed by this PS,
including interference, and level of detection (LOD).
1.2.6 This specification is not designed to evaluate the ongoing
CEMS performance, nor does it identify specific calibration
techniques and auxiliary procedures to assess CEMS performance over
an extended period of time. The requirements in Procedure 7 to
Appendix F of this part are designed to provide a way to assess CEMS
and CEMS components (if applicable) performance over an extended
period of time. The source owner or operator is responsible to
calibrate, maintain, and operate the CEMS properly.
2.0 Summary of Performance Specification
2.1 This specification covers the procedures that each EtO CEMS
must meet during the performance evaluation test. Installation and
measurement location specifications, data reduction procedures, and
performance criteria are included.
2.2 The technology used to measure EtO must provide a distinct
response and address any appropriate interference correction(s). It
must accurately measure EtO in a representative sample of stack
effluent.
2.3 The relative accuracy (RA) must be established against a
reference method (RM) (i.e., Method 320, or other alternative
approved as a RM by the Administrator) on a case-by-case basis if
not otherwise allowed or denied in an applicable subpart of the
regulations.
2.4 A standard addition (SA) procedure using a reference
standard is included in appendix A to this performance specification
for use in verifying LOD. For extractive CEMS, where the SA is done
by dynamic spiking (DS), the appendix A procedure is allowed as an
option for assessing calibration drift and is also referenced by
Procedure 7 of appendix F to this part for ongoing quality control
tests.
3.0 Definitions
3.1 Calibration drift (CD) means the absolute value of the
difference between the CEMS output response and an upscale reference
gas or a zero-level gas, expressed as a percentage of the span
value, when the CEMS is challenged after a stated period of
operation during which no unscheduled adjustments, maintenance or
repairs took place. For other parameters that are selectively
measured by the CEMS (e.g., temperature, velocity, pressure, flow
rate) to measure in the units of the applicable standard, use two
analogous values (e.g., Low: 0-20% of full scale, High: 50-100% of
full scale). 3.2 Calibration Span means the calibrated portion of
the measurement range as specified in the applicable regulation or
another requirement. If the span is not specified in the applicable
regulation or other requirement, then it must be a value
approximately equivalent to three times the applicable emission
standard. When the emission standard is expressed as mass emissions,
use the average flow rate in the duct to calculate the concentration
equivalent of the emission standard.
3.3 Centroidal area means a central area that is geometrically
similar to the stack or duct cross section and is no greater than 10
percent of the stack or duct cross-sectional area.
3.4 Continuous Emission Monitoring System (CEMS) means the total
equipment required to measure the pollutant concentration or
emission rate continuously. The system generally consists of the
following three major subsystems:
3.4.1 Sample interface means that portion of the CEMS used for
one or more of the following: Sample acquisition, sample transport,
sample conditioning, and protection of the monitor from the effects
of the stack effluent.
3.4.2 EtO analyzer means that portion of the EtO CEMS that
measures the total vapor phase EtO concentration and generates a
proportional output.
3.4.3 Data recorder means that portion of the CEMS that provides
a permanent electronic record of the analyzer output. The data
recorder may record other pertinent data such as effluent flow
rates, various instrument temperatures or abnormal CEMS operation.
The data recorder may also include automatic data reduction
capabilities and CEMS control capabilities.
3.5 Diluent gas means a major gaseous constituent in a gaseous
pollutant mixture. For combustion sources, either carbon dioxide
(CO2) or oxygen (O2) or a combination of these
two gases are the major gaseous diluents of interest.
3.6 Dynamic spiking (DS) means the procedure where a known
concentration of EtO gas is injected into the probe sample gas
stream for extractive CEMS at a known flow rate to assess the
performance of the measurement system in the presence of potential
interference from the flue gas sample matrix.
3.7 Flow Rate Sensor means that portion of the CEMS that senses
the volumetric flow rate and generates an output proportional to
that flow rate. The flow rate sensor shall have provisions to check
the CD for each flow rate parameter that it measures individually
(e.g., velocity, pressure).
3.8 Independent measurement(s) means the series of CEMS data
values taken during sample gas analysis separated by two times the
procedure specific response time (RT) of the CEMS.
3.9 Interference means a compound or material in the sample
matrix other than EtO whose characteristics may bias the CEMS
measurement (positively or negatively). The interference may not
prevent the sample measurement but could increase the analytical
uncertainty in the measured EtO concentration through reaction with
EtO or by changing the electronic signal generated during EtO
measurement.
3.10 Interference test means the test to detect CEMS responses
to interferences that are not adequately accounted for in the
calibration procedure and may cause measurement bias.
3.11 Level of detection (LOD) means the lowest level of
pollutant that the CEMS can
[[Page 24152]]
detect in the presence of the source gas matrix interferents with 99
percent confidence.
3.12 Measurement error (ME) is the mean difference between the
concentration measured by the CEMS and the known concentration of a
reference gas standard, divided by the span, when the entire CEMS,
including the sampling interface, is challenged.
3.13 Reference gas standard means the gas mixture containing EtO
at a known concentration and produced and certified in accordance
with ``EPA Traceability Protocol for Assay and Certification of
Gaseous Calibration Standards,'' September 1997, as amended August
25, 1999, EPA-600/R-97/121 or more recent updates. The tests for
analyzer measurement error, calibration drift, and system bias
require the use of calibration gas prepared according to this
protocol. If a zero gas is used for the low-level gas, it must meet
the requirements under the definition for ``zero air'' in 40 CFR
72.2. Alternatively, if the ``protocol'' gas is not commercially
available, you must use a reference gas that has been prepared
according to the procedures in appendix B of this PS.
3.14 Relative accuracy (RA) means the absolute mean difference
between the gas concentration, or the emission rate determined by
the CEMS, and the value determined by the RM, plus the confidence
coefficient of a series of nine test runs, divided by the average of
the RM or the applicable emission standard.
3.15 Response time (RT) means the time it takes for the
measurement system, while operating normally at its target sample
flow rate, dilution ratio, or data collection rate to respond to a
known step change in gas concentration, either from a low- or zero-
level to a high-level gas concentration or from a high-level to a
low or zero-level gas concentration, and to read 95 percent of the
change to the stable instrument response. There may be several RTs
for an instrument related to different functions or procedures
(e.g., DS, LOD, and ME).
3.16 Span value means an EtO concentration approximately equal
to two times the concentration equivalent to the emission standard
unless otherwise specified in the applicable regulation, permit or
another requirement. Unless otherwise specified, the span may be
rounded up to the nearest multiple of 5.
3.17 Stable value means the measure of two or more values that
are statistically the same and the absence of measurement system
drift.
3.18 Standard addition means the addition of known amounts of
EtO gas (either statically or dynamically) measured sample gas
stream.
3.19 Zero gas means a gas with an EtO concentration that is
below the LOD of the measurement system.
4.0 Interferences
Sample gas interferences will vary depending on the instrument
or technology used to make the measurement. Interferences must be
evaluated through the interference test in this PS. Several
compounds including carbon dioxide (CO2), carbon monoxide
(CO), methane (CH4), and water (H2O) are
potential optical interferences with certain types of EtO monitoring
technology.
Note: Interferences may be mitigated though the use of dilution
systems, however this approach could also affect the sensitivity of
the measurement.
5.0 Safety
The procedures required under this PS may involve hazardous
materials, operations, and equipment. This PS may not address all
the safety issues associated with these procedures. It is the
responsibility of the user to establish appropriate safety and
health practices and determine the applicable regulatory limitations
prior to performing these procedures. The CEMS user's manual and as
well as cautions within and materials recommended by the RM should
be consulted for specific precautions to be taken in regard to the
relative accuracy testing.
6.0 Equipment and Supplies
The equipment and supplies are the same as in section 6 of PS
18, except replace HCl for EtO where appropriate. The following
definitions are added and/or revised:
6.1 Moisture Measurement System. If correction of the measured
EtO emissions for moisture is required, you must install, operate,
maintain, and quality assure a continuous moisture monitoring system
for measuring and recording the moisture content of the flue gases.
The following continuous moisture monitoring systems are acceptable:
Any optical measurement system validated according to Method 301 or
section 13.0 of Method 320 in appendix A to part 63 of this chapter;
a continuous moisture sensor; an oxygen analyzer (or analyzers)
capable of measuring O2 both on a wet basis and on a dry
basis; or other continuous moisture measurement methods approved by
the Administrator.
7.0 Reagents and Standards
7.1 Reference Gases means the gas mixture containing EtO at a
known concentration and produced and certified in accordance with
``EPA Traceability Protocol for Assay and Certification of Gaseous
Standards, May 2012 (EPA 600/R-12/531) or more recent updates. The
tests for analyzer measurement error, calibration drift, and system
bias require the use of calibration gas prepared according to this
protocol. If a zero gas is used for the low-level gas, it must meet
the requirements under the definition for ``zero air'' in 40 CFR
72.2. Alternatively, if the ``protocol'' gas is not commercially
available, you must use a reference gas that has been prepared
according to the procedures in appendix B of this PS and meeting the
requirements in section 12.2 of appendix B of this PS, if
applicable.
7.2 Cylinder gas may be diluted for use in this specification,
including measurement error testing. You must document the
quantitative introduction of EtO standards into the system using
Method 205, found in 40 CFR part 51, appendix M, or other procedure
approved by the Administrator. The laboratory/field evaluations in
Method 205 must be conducted at least quarterly and prior to any
audit test (e.g., CGA, RAA) required in QA Procedure 7 (40 CFR part
60, appendix F). Calibration must be conducted on an annual basis or
whenever significant changes are made to the dilution system. In
addition to the requirements in Method 205, when in use, you must
document gas flow rates through each of the channels; if the
dilution system records these values electronically, this is
considered the documentation. For the purpose of this PS, cylinder
gas should not be diluted beyond a dilution ratio of 500:1 using
Method 205.
8.0 CEMS Measurement Location Specifications and Pretest Preparation
8.1 Prior to the start of your initial PS tests, you must ensure
that the CEMS is installed according to the manufacturer's
specifications and the requirements in this section.
8.2 CEMS Installation. Install the CEMS at an accessible
location where the pollutant concentration or emission rate
measurements are directly representative of the EtO emissions. If
the units of the emission standard are expressed as a mass (e.g.,
lb/hr), then the CEMS probe must also be located within 0.5
equivalent diameters of the flow sensor and the CEMS must be located
(1) at least two equivalent diameters downstream from the nearest
control device, the point of pollutant generation, or other point at
which a change in the pollutant concentration or emission rate may
occur and (2) at least a half equivalent diameter upstream from the
effluent exhaust or control device. If the CEMS are to utilize time-
sharing, the distance between each measurement point and the CEMS
should be approximately the same. The CEMS need not be installed at
the same location as the relative accuracy test location. If you
fail the RA requirements in this specification due to the CEMS
measurement location and a satisfactory correction technique cannot
be established, the Administrator may require the CEMS to be
relocated.
8.2.1 Single point sample gas extraction should be (1) no less
than 1.0 m (3.3 ft.) from the stack or duct wall or (2) within the
centroidal area of the stack or duct cross section.
8.2.2 CEMS and Data Recorder Scale Check. After CEMS
installation, record and document the measurement range of the EtO
CEMS. The CEMS operating range and the range of the data recording
device must encompass all potential and expected EtO concentrations,
including the concentration equivalent to the applicable emission
limit and the span value.
9.0 Quality Control--Reserved
10.0 Calibration and Standardization--Reserved
11.0 Performance Specification Test Procedure
After completing the CEMS installation, setup, and calibration,
you must complete the PS test procedures in this section. You must
perform the following procedures and meet the performance
requirements for the initial demonstration of your CEMS:
a. Interference Test;
b. Level of Detection Determination;
c. Response Time Test;
[[Page 24153]]
d. Measurement Error Test;
e. Calibration Drift Test; and
f. Relative Accuracy Test.
g. If CEMS is to be time-shared, determine the response time to
each measurement point, the sampling time at each measurement point,
and the cycle time at each measurement point. The sampling time at
each measurement point shall be at least 3 times as long as the
system response time (RT), and the maximum number of measurement
points shall not exceed the quotient, rounded down to the next whole
number, of 15 minutes divided by the longest cycle time of the
measurement point.
11.1 Interference Test
11.1.1 Prior to its initial use in the field, you must
demonstrate that your monitoring system meets the performance
requirements of the interference test in section 13.5 of this PS to
verify that the candidate system measures EtO accurately in the
presence of common interferences in emission matrices from
commercial sterilizers. In the event this performance specification
is applied in other emission sources, the interference test must
evaluate any other predominant gases is the emission matrices of
those sources.
11.1.2 Your interference test must be conducted in a controlled
environment. The equipment you test for interference must include
the combination of the analyzer, related analysis software, and any
sample conditioning equipment (e.g., dilution module, moisture
removal equipment or other interferent scrubber) used to control
interferents.
11.1.3 If you own multiple measurement systems with components
of the same make and model numbers, you need only perform this
interference test on one analyzer and associated interference
conditioning equipment combination. You may also rely on an
interference test conducted by the manufacturer or a continuous
measurement system integrator on a system having components of the
same make(s) and model(s) of the system that you use.
11.1.4 Perform the interference check using an EtO reference gas
concentration of approximately ten times the LOD or at 50 parts per
billion, whichever is greater.
11.1.5 Introduce the interference test gases listed in table 1
in section 17.0 of this PS to the analyzer/conditioning system
separately or in any combination. The interference test gases need
not be of reference gas quality.
11.1.6 The interference test must be performed by combining an
EtO reference gas with each interference test gas (or gas mixture).
You must measure the baseline EtO response, followed by the response
after adding the interference test gas(es) while maintaining a
constant EtO concentration. You must perform each interference gas
injection and evaluation in triplicate.
Note: The baseline EtO gas may include interference gases at
concentrations typical of ambient air (e.g., 21 percent
O2, 400 parts per million (ppm) CO2, 2 percent
H2O), but these concentrations must be brought to the
concentrations listed in table 1 of this PS when their interference
effects are being evaluated.
11.1.7 You should document the gas volume/rate, temperature, and
pressure used to conduct the interference test. A gas blending
system or manifold may be used.
11.1.8 Ensure the duration of each interference test is
sufficient to condition the EtO measurement system surfaces before a
stable measurement is obtained.
11.1.9 Measure the EtO response of the analyzer/sample
conditioning system combination to the test gases in ppbv. Record
the responses and determine the overall interference response using
table 2 in section 17.0 of this PS.
11.1.10 For each interference gas (or mixture), calculate the
mean difference ([Delta]MCavg) between the measurement
system responses with and without the interference test gas(es)
using equation 1 in section 12.2 of this PS. Summarize the results
following the format contained in table 2 in section 17.
11.1.11 Calculate the percent interference (I) for the gas runs
using equation 2 in section 12.2 of this PS.
11.1.12 The total interference response (i.e., the sum of the
interference responses of all tested gaseous components) must not
exceed the criteria set forth in section 13.5 of this PS.
11.2 Level of Detection Determination
11.2.1 You must determine the minimum amount of EtO that can be
detected above the background in a representative gas matrix.
11.2.2 You must perform the LOD determination in a controlled
environment such as a laboratory or manufacturer's facility.
11.2.3 You must add interference gases listed in table 1 of this
PS to a constant concentration of EtO reference gas.
11.2.3.1 You may not use an effective reference EtO gas
concentration greater than ten times the estimated instrument LOD.
11.2.3.2 Inject the EtO and interferents described in section
11.1.5 of this PS directly into the inlet to the analyzer, allow
time for the value to stabilize and then collect measurement data
for 15 minutes and average those results. Repeat this procedure to
obtain a total of seven or more of these runs, purging the
measurement system with ambient air between each run, to determine
the LOD.
11.2.4 Calculate the standard deviation of the measured values
and define the LOD as three times the standard deviation of these
measurements.
11.2.5 You must verify the controlled environment LOD of section
11.2.2 of this PS for your CEMS during initial setup and field
certification testing using the SA procedure in appendix A of this
PS with the following exceptions:
11.2.5.1 You must make three independent SA measurements spiking
the native source concentration by no more than five times the
controlled environment LOD concentration determined in section
11.2.4.
11.2.5.2 You must perform the SA as a dynamic spike by passing
the spiked source gas sample through all filters, scrubbers,
conditioners, and other monitoring system components used during
normal sampling, and as much of the sampling probe as practical.
11.2.5.3 The amount detected, or standard addition response
(SAR), is based on the average difference of the native EtO
concentration in the stack or duct relative to the native stack
concentration plus the SA. You must be able to detect the effective
spike addition (ESA) above the native EtO present in the stack gas
matrix. The ESA is calculated using equation A7 in appendix A of
this PS.
11.2.5.4 If the field verification of your system LOD does not
demonstrate a SAR greater than or equal to your initial controlled
environment LOD, you must increase the SA concentration
incrementally and repeat the field verification procedure until the
SAR is equal to or greater than LOD. The site-specific standard
addition detection level (SADL) is equal to the standard addition
needed to achieve the acceptable SAR, and the SADL replaces the
controlled environment LOD. The SADL is calculated as the ESA using
equation A7 in appendix A of this PS. As described in section 13.1
of this PS, the controlled environment LOD or the SADL that replaces
a controlled environment LOD must be less than 20 percent of the
applicable emission limit.
11.3 Response Time Determination. You must determine ME- and SA-
RT.
11.3.1 For ME-RT, start the upscale RT determination by
injecting zero gas into the measurement system as required by the
procedures in section 11.4 of this PS. For the SA-RT start the
upscale RT determination at native stack concentration of EtO. Allow
the value to stabilize, which for the purpose of this PS is a change
no change greater than 1.0 percent of span or 10 ppbv (whichever is
greater) for 30 seconds.
11.3.2 When the CEMS output has stabilized, record the response
in ppbv, record the time (hh:mm:ss), and immediately introduce an
upscale (high level) or spike reference gas as required by the
relevant (ME-RT or SA-RT) procedure. Record the time (hh:mm:ss)
required for the measurement system to reach 95 percent of the
change to the final stable value, the difference in these times is
the upscale RT.
11.3.3 Reintroduce the zero gas for the ME-RT or stop the
upscale gas flow for the SA-RT and immediately record the time
(hh:mm:ss). Record the time (hh:mm:ss) required to reach within 95
percent of the previous stable response in 11.3.1 or 10 ppbv
(whichever is greater); the difference in these times is the
downscale RT.
Note: For CEMS that perform a series of operations (purge, blow
back, sample integration, analyze, etc.), you must start adding
reference or zero gas immediately after these procedures are
complete.)
11.3.4 Repeat the entire procedure until you have three sets of
data, then determine the mean upscale and mean downscale RTs for
each relevant procedure (from each measurement point if the CEMS is
time-sharing). Report the greater of the average upscale or average
downscale RTs as the RT for the system.
11.4 Measurement Error (ME) Test
11.4.1 The measurement error test must be performed at the same
time as the calibration drift test when the system is being placed
in service. The measurement error test must be performed any time a
substantive change (see section 1.2.5) has been made to the
measurement system.
11.4.1.1 Introduce reference gases to the CEMS probe, prior to
the sample
[[Page 24154]]
conditioning and filtration system. You may use a gas dilution
system meeting the requirement in section 7.2 of this PS.
11.4.1.2 Challenge the measurement system with a zero gas and at
the three upscale EtO reference gas concentrations in the range
shown in table 3 of this PS. You may introduce different reference
gas concentrations in any order, but you must not introduce the same
gas concentration twice in succession.
11.4.1.3 Introduce the calibration gas into the sampling probe
with sufficient flow rate to replace the entire source gas sample
and continue the gas flow until the response is stable, as evidenced
when the difference between two consecutive measurements is within
1.0 percent of span or 5 ppbv (whichever is less). Record this value
and inject the next calibration gas.
11.4.1.4 Make triplicate measurements for each reference gas for
a total of twelve measurements.
11.4.1.5 At each reference gas concentration, determine the
average of the three CEMS responses (MCl). Calculate the ME using
equation 3A in section 12.3.
11.4.1.6 For non-dilution systems, you may adjust the system to
maintain the correct flow rate at the analyzer during the test, but
you may not make adjustments for any other purpose. For dilution
systems, you must operate the measurement system at the appropriate
dilution ratio during all system ME checks, and you may make only
the adjustments necessary to maintain the proper ratio.
11.4.2 You may use table 5 in section 17.0 to record and report
your ME test results.
11.4.3 If the ME specification in section 13.3 is not met for
all four reference gas concentrations, take corrective action, and
repeat the test until an acceptable 4-level ME test is achieved.
11.5 Seven-Day Calibration Drift (CD) Test
11.5.1 The CD Test Period. Prior to the start of the RA tests,
you must perform a seven-day CD test. The purpose of the seven-day
CD test is to verify the ability of the CEMS to maintain calibration
for each of seven consecutive unit operating days as specified in
section 11.5.5 of this PS.
11.5.2 The CD tests must be performed using the zero gas and
high-level reference gas standards as defined in table 3 of this PS.
11.5.3 Conduct the CD test on each day during continuous
operation of the CEMS and normal facility operations following the
procedures in section 11.7 of this PS, except that the zero gas and
high-level gas need only be introduced to the measurement system
once each for the seven days.
11.5.4 If periodic automatic or manual adjustments are made to
the CEMS zero and upscale response factor settings, conduct the CD
test immediately before these adjustments.
Note: Automatic signal or mathematical processing of all
measurement data to determine emission results may be performed
throughout the entire CD process.
11.5.5 Determine the magnitude of the CD at approximately 24-
hour intervals, for 7 consecutive unit operating days. The 7
consecutive unit operating days need not be 7 consecutive calendar
days.
11.5.6 Record the CEMS response for single measurements of zero
gas and high-level reference gas. You may use table 6 in section 17
of this PS to record and report the results of your 7-day CD test.
Calculate the CD using equation 3B in section 12.3. Report the
absolute value of the differences as a percentage of the span value.
11.5.7 The zero-level and high-level CD for each day must be
less than 5.0 percent of the span value or an absolute difference of
10 ppbv, as specified in section 13.2 of this PS. You must meet this
criterion for 7 consecutive operating days.
11.5.8 Dynamic Spiking Option for Seven-Day CD Test. You have
the option to conduct a high-level dynamic spiking procedure for
each of the 7 days in lieu of the high-level reference gas injection
described in sections 11.5.2 and 11.5.3. If this option is selected,
the daily zero CD check is still required.
11.5.8.1 To conduct each of the seven daily mid-level dynamic
spikes, you must use the DS procedure described in appendix A of
this PS using a single spike chosen to yield the range as indicated
in table 3.
11.5.8.2 You must perform the dynamic spike procedure by passing
the spiked source gas sample through all filters, scrubbers,
conditioners, and other monitoring system components used during
normal sampling, and as much of the sampling probe as practical.
11.5.8.3 Calculate the high-level CD as a percent of span using
equation A6 of appendix A to this PS and calculate the zero-drift
using equation 3B in section 12.3. Record and report the results as
described in sections 11.5.6 and 11.5.7.
11.6 Relative Accuracy Test
11.6.1 Unless otherwise specified in an applicable regulation,
use Method 320 as the RM for EtO measurement. Conduct the RM tests
in such a way that they will yield results representative of the
emissions from the source that can be compared to the CEMS data. You
must collect gas samples that are at stack conditions (hot and wet),
and you must traverse the stack or duct as required in section
11.6.3.
11.6.2 Conduct the diluent (if applicable), moisture (if
needed), and pollutant measurements simultaneously. If the emission
standard is expressed in a mass unit (i.e., lb/hr) you must also
determine the flowrate simultaneously with each test using Method 2,
2A, 2B, 2C or 2D in appendix A-1 to this part, as applicable.
11.6.3 Reference Method Measurement Location and Traverse
Point(s) Selection.
11.6.3.1 Measurement Location. Select, as appropriate, an
accessible RM measurement location at least two equivalent diameters
downstream from the nearest control device, point of pollutant
generation, or other point at which a change in the pollutant
concentration or emission rate may occur, and at least one-half
equivalent diameter upstream from the effluent exhaust or a control
device. When pollutant concentration changes are due solely to
diluent leakage (e.g., air heater leakages) and pollutants and
diluents are simultaneously measured at the same location, a half
diameter may be used in lieu of two equivalent diameters. The
equivalent duct diameter is calculated according to Method 1 in
appendix A-1 to this part. The CEMS and RM sampling locations need
not be the same.
11.6.3.2 Traverse Point Selection. Select traverse points that
assure acquisition of representative RM samples over the stack or
duct cross section according to one of the following options: (a)
sample at twelve traverse points located according to section 11.3
of Method 1 in appendix A-1 to this part or (b) sample at the three
traverse points at 16.7, 50.0, and 83.3 percent of the measurement
line. Alternatively, you may conduct a stratification test following
the procedures in sections 11.6.3.2.1 through 11.6.3.2.4 to justify
sampling at a single point. Stratification testing must be conducted
at the sampling location to be used for the RM measurements during
the RA test and must be made during normal facility operating
conditions. You must evaluate the stratification by measuring the
gas on the same moisture basis as the EtO CEMS (wet or dry).
Stratification testing must be repeated for each RA test program to
justify single point.
11.6.3.2.1 Use a probe of appropriate length to measure the EtO
concentration, as described in this section, using 12 traverse
points located according to section 11.3 of Method 1 in appendix A-1
to this part for a circular stack or nine points at the centroids of
similarly shaped, equal area divisions of the cross section of a
rectangular stack.
11.6.3.2.2 Calculate the mean measured concentration for all
sampling points (MNavg).
11.6.3.2.3 Calculate the percent stratification (St)
of each traverse point using equation 5 in section 12.5.
11.6.3.2.4 The gas stream is considered to be unstratified and
you may perform the RA testing at a single point that most closely
matches the mean if the concentration at each traverse point differs
from the mean measured concentration for all traverse points by no
more than 5.0 percent of the mean concentration of EtO or 10 ppbv,
whichever is less restrictive.
11.6.4 In order to correlate the CEMS and RM data properly,
record the beginning and end of each RM run (including the time of
day in hours, minutes, and seconds) using a clock synchronized with
the CEMS clock used to create a permanent time record with the CEMS
output.
11.6.5 You must conduct the RA test during representative
process and control operating conditions or as specified in an
applicable regulation, permit or subpart.
11.6.6 Conduct a minimum of nine RM test runs.
Note: More than nine RM test runs may be performed. If this
option is chosen, up to three test run results may be excluded so
long as the total number of test run results used to determine the
CEMS RA is greater than or equal to nine. However, all data must be
reported including the excluded test runs.
11.6.7 Analyze the results from the RM test runs using equations
9 through14 in section 12.6. Calculate the RA between the CEMS
results and the RM results.
[[Page 24155]]
11.7 Record Keeping and Reporting
11.7.1 Record the results of the CD test, the RT test, the ME
test, and the RA test. Also keep records of the RM and CEMS field
data, calculations, and reference gas certifications necessary to
confirm that the performance of the CEMS met the performance
specifications.
11.7.2 For systems that use Method 205 to prepare EtO reference
gas standards, record results of Method 205 performance test field
evaluation, reference gas certifications, and gas dilution system
calibration.
11.7.3 Record the LOD and field verified SADL for the CEMS in
ppbv.
11.7.4 Record the results of the interference test.
11.7.5 Report the results of all certification tests to the
appropriate regulatory agency (or agencies), in hardcopy and/or
electronic format, as required by the applicable regulation or
permit.
12.0 Calculations and Data Analysis
12.1 Nomenclature.
Ci = Zero or EtO reference gas concentration used for
test i (ppbv);
CC = Confidence coefficient (ppbv);
CD = Calibration drift (percent);
davg = Mean difference between CEMS response and the
reference gas (ppbv);
di = Difference of CEMS response and the RM value
(ppbv or units of emission standard, as applicable);
I = Total interference from major matrix stack gases (percent);
[Delta]MCavg = Average of the 3 absolute values of
the difference between the measured EtO calibration gas
concentrations with and without interference from selected stack
gases (ppbv);
MCi = Measured EtO (or zero) reference gas
concentration i (ppbv);
MCi = Average of the measured EtO (or zero) reference
gas concentration i (ppbv);
MCint = Measured EtO concentration of the EtO
reference gas plus the individual or combined interference gases
(ppbv);
ME = Measurement error for CEMS (percent);
MNavg = Average concentration at all sampling points
(ppbv);
MNbi = Measured native concentration bracketing each
calibration check measurement (ppbv);
MNi = Measured native concentration for test or run I
(ppbv);
n = Number of measurements in an average value;
RA = Relative accuracy of CEMS compared to a RM (percent);
RMavg = Mean measured RM value (ppbv) or units of the
emission standard);
RMi = RM concentration for test run i (ppbv or units
of the emission standard);
S = Span value (ppmv);
Sd = Standard deviation of the differences (ppmv);
Sti = Stratification at traverse point i (percent);
SADL = Standard addition detection level (ppmv);
t0.975 = One-sided t-value at the 97.5th percentile
obtained from table 4 in section 17.0 for n-1 measurements;
12.2 Calculate the difference between the measured EtO
concentration with and without interferents for each interference
gas (or mixture) for your CEMS as:
[GRAPHIC] [TIFF OMITTED] TR05AP24.002
Calculate the total percent interference as:
[GRAPHIC] [TIFF OMITTED] TR05AP24.003
12.3 Calculate the ME or CD at Concentration i as:
[GRAPHIC] [TIFF OMITTED] TR05AP24.004
12.4 Calculate the average native concentration before and after
each calibration check measurement as:
[GRAPHIC] [TIFF OMITTED] TR05AP24.005
12.5 Calculate the Percent Stratification at Each Traverse Point
as:
[GRAPHIC] [TIFF OMITTED] TR05AP24.006
[[Page 24156]]
12.6 Calculate the RA Using RM and CEMS Data
12.6.1 Determine the CEMS final integrated average pollutant
concentration or emission rate for each RM test period. Consider
system RT, if important, and confirm that the results have been
corrected to the same moisture, temperature, and diluent
concentration basis, as applicable. If the emission standard is
based on a mass emission (i.e., lbs/hr), confirm the results have
been calculated correctly.
12.6.3 Make a direct comparison of the average RM results and
CEMS average value for identical test periods.
12.6.4 For each test run, calculate the arithmetic difference of
the RM and CEMS results using equation 6.
[GRAPHIC] [TIFF OMITTED] TR05AP24.007
12.6.5 Calculate the standard deviation of the differences (Sd)
of the CEMS measured results and RM results using equation 7.
[GRAPHIC] [TIFF OMITTED] TR05AP24.008
12.6.6 Calculate the confidence coefficient (CC) for the RA test
using equation 8.
[GRAPHIC] [TIFF OMITTED] TR05AP24.009
12.6.7 Calculate the mean difference (davg) between the RM and
CEMS values in the units of ppbv or of the emission standard using
equation 9.
[GRAPHIC] [TIFF OMITTED] TR05AP24.010
12.6.8 Calculate the average RM value using equation 10.
[GRAPHIC] [TIFF OMITTED] TR05AP24.011
12.6.9 Calculate RA of the CEMS using equation 11.
[GRAPHIC] [TIFF OMITTED] TR05AP24.012
13.0 Method Performance
13.1 Level of Detection. You may not use a CEMS whose LOD or
SADL is greater than 20 percent of the applicable regulatory limit
or other action level for the intended use of the data. If the
regulatory limit is not based on a concentration, document the
calculated concentration equivalent as required in section 11.7.
13.2 Calibration Drift. The zero- and high-level calibration
drift for the CEMS must not exceed 5.0 percent of the span value or
an absolute difference of 10.0 ppbv for 7 consecutive operating
days.
13.3 Measurement Error. The ME must be less than or equal to 5.0
percent of the span or an absolute difference of 10.0 ppbv value at
the low-, mid-, and high-level reference gas concentrations.
13.4 Relative Accuracy. Unless otherwise specified in an
applicable regulation or permit, the RA of the CEMS, whether
calculated in units of EtO concentration or in units of the emission
standard, must be less than or equal to 20.0 percent of the RM when
RMavg is used in the denominator of equation 11.
13.4.1 In cases where the RA is calculated on a concentration
(ppmv) basis, if the average RM emission level for the test is less
than 50 percent of the EtO concentration equivalent to the emission
standard, you may substitute the EtO concentration equivalent to the
standard in the denominator of equation 14 in place of RMavg.
[[Page 24157]]
13.4.2 Similarly, if the RA is calculated in units of the
emission standard and the EtO emission level measured by the RMs is
less than 50 percent of the emission standard, you may substitute
the emission standard in the denominator of equation 14 in place of
RMavg.
13.4.3 The alternative calculated RA in paragraph 13.4.1 or
13.4.2 must be less than or equal to 15.0 percent.
13.5 Interference Test.
13.5.1 The sum of the interference response(s) from equation 2
must not be greater than 2.5 percent of the calibration span or
3.0 percent of the equivalent EtO concentration used for
the interference test, whichever is less restrictive. The results
are also acceptable if the sum of the interference response(s) does
not exceed ten times the LOD or 30 ppbv.
14.0 Pollution Prevention--[Reserved]
15.0 Waste Management--[Reserved]
16.0 Bibliography
1. ``Method 301--Field Validation of Pollutant Measurement
Methods from Various Waste Media,'' 40 CFR part 63, appendix A.
2. EPA Traceability Protocol for Assay and Certification of
Gaseous Calibration Standards, U.S. Environmental Protection Agency
office of Research and Development, EPA/600/R-12/531, May 2012.
17.0 Tables, Diagrams, Flowcharts, and Validation Data
Table 1--Interference Test Gas Concentrations
------------------------------------------------------------------------
Approximate concentration
Potential interferent gas \1\ (balance N2)
------------------------------------------------------------------------
CO2.................................... 1% 0.2% CO2.
CH4.................................... 20 5 ppm.
H2O.................................... 5% 1% H2O.\1\
N2..................................... Balance.\1\
------------------------------------------------------------------------
\1\ Any of these specific gases can be tested at a lower level if the
manufacturer has provided reliableness for limiting or scrubbing that
gas to a specified level in CEMS field installations.
Table 2--Example Interference Test Data Sheet
------------------------------------------------------------------------
------------------------------------------------------------------------
Date of Test
------------------------------------------------------------------------
Analyzer type
------------------------------------------------------------------------
Model Number
------------------------------------------------------------------------
Serial Number
------------------------------------------------------------------------
Span
------------------------------------------------------------------------
Test Organization
------------------------------------------------------------------------
Test Personnel
------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
EtO EtO concentration Absolute
Interference gas or combination concentration w/interference difference Average absolute
(ppbv) (ppbv) (ppbv) difference (ppbv)
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
[[Page 24158]]
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
------------------------------------------------------
------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
Table 3--Performance Specification Test Zero and Reference Gas Ranges
--------------------------------------------------------------------------------------------------------------------------------------------------------
EtO zero and reference gas concentrations in terms of percent of
span \a\
Test Units ---------------------------------------------------------------------- Section
Zero Low level Mid-level High level
--------------------------------------------------------------------------------------------------------------------------------------------------------
Calibration Drift....................... % Of Span.................. 2.0 percent or calculate the flow using a stable
tracer gas included in your spike gas standard.
8.2.4.2 If you use flow measurements to determine the spike
dilution, then use equation A1 in section 11.2.1 of this appendix
PS-19A to calculate the DF. Determination of the spike dilution
requires measurement of EtO spike flow (Qspike) and total
flow through the CEM sampling system (Qprobe).
8.2.4.3 If your CEMS is capable of measuring an independent
stable tracer gas, you may use a spike gas that includes the tracer
to determine the DF using equation A2 or A3 (sections 11.2.2 and
11.2.3 of this appendix PS-19A) depending on whether the tracer gas
is also present in the native source emissions.
8.2.4.4 For extractive CEMS, you must correct the background
measurements of EtO for the dilution caused by the addition of the
spike gas standard. For spiking systems that alternate between
addition of EtO and zero gas at a constant DF, the background
measurements between spikes will not be equal to the native source
concentration.
8.2.5 Begin by collecting unspiked sample measurements of EtO.
You must use the average of two unspiked sample measurements as your
pre-spike background.
Note: Measurements should agree within 5.0 percent or three
times the level of detection to avoid biasing the spike results.
8.2.5.1 Introduce the EtO gas spike into the permanent CEMS
probe, upstream of the particulate filter or sample conditioning
system and as close to the sampling inlet as practical.
8.2.5.2 Maintain the EtO gas spike for at least twice the DS
response time of your CEMS or until the consecutive measurements
agree within 5.0 percent. Collect two independent measurements of
the native plus spiked EtO concentration.
8.2.5.3 Stop the flow of spike gas for at least twice the DS
response time of your CEMS or until the consecutive measurements
agree within 5.0 percent. Collect two independent measurements of
the native EtO concentration.
8.2.6 Repeat the collection of sample measurements in section
8.2.5 until you have data for each spike concentration including a
final set of unspiked sample measurements according to section
8.2.5.3.
8.2.7 Verify that the CEMS responded as expected for each spike
gas injection, and that the data quality is not impacted by large
shifts in the native source concentration. Discard and repeat any
spike injections as necessary to generate a complete set of the
required replicate spike measurements.
8.2.8 Calculate the standard addition response (SAR) for
extractive CEMS, using equation A4 in section 11.2, of this appendix
PS-19A.
8.2.9 If the DS results do not meet the specifications for the
appropriate performance test in PS-19 or Procedure 7 of appendix F
of this part, you must take corrective action and repeat the DS
procedure.
9.0 Quality Control--Reserved
10.0 Calibration and Standardization--Reserved
11.0 Calculations and Data Analysis
Calculate the SA response for each measurement and its
associated native EtO measurement(s), using equations in this
section. (Note: For cases where the emission standard is expressed
in units of lb/hr or corrected to a specified O2 or
CO2 concentration, an absolute accuracy specification
based on a span at stack conditions may be calculated using the
average concentration and applicable conversion factors. The
appropriate procedures for use in cases where a percent removal
standard is more restrictive than the emission standard is the same
as in PS-2, sections 12 and 13, in this appendix.)
11.1 Nomenclature.
Cspike = Actual EtO reference gas concentration
spiked (e.g., bottle or reference gas concentration) ppmv;
Ctracer spiked = Tracer gas concentration injected
with spike gas (``reference concentration'') ppmv;
DF = Spiked gas dilution factor;
DSCD = Calibration drift determined using DS procedure
(percent);
DSE = Dynamic spike error (ppmv);
ESA = Effective spike addition (ppmv);
MCSA = Measured SA-elevated source gas concentration
(ppmv);
MCspiked = Measured EtO reference gas concentration i
(ppmv);
MCnative = Average measured concentration of the
native EtO (ppmv);
[[Page 24161]]
Mnative tracer = Measured tracer gas concentration
present in native effluent gas (ppmv);
Mspiked tracer = Measured diluted tracer gas
concentration in a spiked sample (ppmv);
Qspike = Flow rate of the dynamic spike gas (Lpm);
Qprobe = Average total stack sample flow through the
system (Lpm);
S = Span (ppmv);
SAR = Standard addition response (ppmv)
11.2 Calculating Dynamic Spike Response and Error.
11.2.1 If you determine your spike DF using spike gas and stack
sample flow measurements, calculate the DF using equation A1:
[GRAPHIC] [TIFF OMITTED] TR05AP24.013
11.2.2 If you determine your spike DF using an independent
stable tracer gas that is not present in the native source
emissions, calculate the DF for DS using equation A2:
[GRAPHIC] [TIFF OMITTED] TR05AP24.014
11.2.3 If you determine your spike dilution factor using an
independent stable tracer that is present in the native source
emissions, calculate the dilution factor for dynamic spiking using
equation A3:
[GRAPHIC] [TIFF OMITTED] TR05AP24.015
11.2.4 Calculate the SA response using equation A4:
[GRAPHIC] [TIFF OMITTED] TR05AP24.016
11.2.5 Calculate the DS error using equation A5.
[GRAPHIC] [TIFF OMITTED] TR05AP24.017
11.2.6 Calculating CD using DS. When using the DS option for
determining mid-level CD, calculate the CD as a percent of span
using equation A6:
[GRAPHIC] [TIFF OMITTED] TR05AP24.018
11.2.7 The effective spike addition (ESA) is the expected
increase in the measured concentration as a result of injecting a
spike. Calculate ESA using equation A7:
[GRAPHIC] [TIFF OMITTED] TR05AP24.019
12.0 Reserved
13.0 Tables and Figures
Table A13--1--Spike Data Sheet
------------------------------------------------------------------------
------------------------------------------------------------------------
Facility Name: Date: Time:
------------------------------------------------------------------------
Unit(s) Tested: Personnel:
------------------------------------------------------------------------
Analyzer Make and Mode
------------------------------------------------------------------------
[[Page 24162]]
Serial Number
------------------------------------------------------------------------
Calibration Span
------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
MCnative Actual value (ppb)
Qspike -----------------------------------------------------------------------------
Qprobe (lpm) (lpm) DF \1\ Cspike \2\ DSE (ppbv)
Pre Post Avg. MCspike \3\
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
--------------------------------------------------------------------------------------------------------------------------------------------------------
SD
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ DF must be less than or equal to 10%.
\2\ Cspike = Actual EtO concentration of the spike gas, ppbv.
\3\ MCspike = Measured EtO concentration of the spiked sample at the target level, ppbv.
PS-19 Appendix B Preparation and Certification of Ethylene Oxide Gas
Standards
1.0 Scope and Application
1.1 This appendix (appendix PS-19B) to Performance Specification
19 (PS-19) describes the procedure and performance criteria for the
preparation and certification of EtO Gas Manufacturer Primary
Standards (GMPS) and Gas Manufacturer Alternative Certified
Standards (GMACS). These procedures are not specific to ethylene
oxide and could be transferable to the preparation of gas standards
for other pollutants regulated under 40 CFR parts 59, 60, 61, 63,
and 65.
2.0 Summary of the Appendix
EPA requires the use of EPA Protocol gas standards for emissions
monitoring. These gases are established following the EPA
Traceability Protocol for Assay and Certification of Gaseous
Standards, May 2012 (EPA 600/R-12/531) otherwise referred in this
appendix PS-19B as the EPA Traceability Protocol. The EPA
Traceability Protocol requires the use of certified reference gas
standards directly traceable to National Institute of Standards and
Technology (NIST) or other recognized national metrology institute
(NMI) reference gas standards. A NIST certified value is a value for
which NIST has the highest confidence in that all known or suspected
sources of bias and imprecision have been accounted for. Without
NIST or other NMI reference gas standards, the necessary EPA
Protocol gas standards cannot be prepared. An alternative approach
is needed to establish a gas standard functionally equivalent to the
EPA Protocol gas standard when NIST or NMI reference gas standard
are not available. This appendix PS-19B is intended to provide
procedures and performance criteria for the establishment of Gas
Manufacturer Alternative Certified Standards (GMACS), the functional
equivalent of EPA Protocol gas standards. GMACS and Gas Manufacturer
Primary Standards (GMPS), the functional equivalent of the NIST or
NMI reference gas standards. The GMPS are the reference gases used
to establish the certified concentrations of the GMACs. The GMPS are
established using a dual certification approach where the
gravimetrically prepared reference value is confirmed using an
independent measurement approach traceable to the International
System of Units (SI) and references materials or devices.
2.1 This appendix PS-19B is intended to be performance-based and
allow specialty gas manufacturers (SGM) flexibility in the
preparation and certification of GMPS and GMACS.
2.2 This appendix PS-19B is not intended to be a replacement for
the EPA Protocol gases established according to the EPA Traceability
Protocol when calibration gases that meet EPA Traceability Protocol
requirements are available. When NIST or other recognized NMI
reference gas standards are manufactured and readily available,
those gases must be used.
2.3 This appendix PS-19B is reliant on the procedures included
the EPA Traceability Protocol for Assay and Certification of Gaseous
Standards, May 2012 (EPA 600/R-12/531). Users of this appendix PS-
19B for the preparation of GMPS and GMACS must be proficient with
the preparation protocol cylinders using this standard.
Note: This appendix PS-19B does not require the user to
participate in any protocol gas verification program.
2.4 Any alternatives to the procedures in this appendix PS-19B
are subject to Administrator review under the alternative test
method the authority to approve alternatives or changes to test
methods specified in the General Provisions to 40 CFR parts 60, 61,
and 63 (Sec. Sec. 60.8(b)(2), 61.13(h)(1)(ii), and 63.7(e)(2)(ii)).
Requests for alternative to the procedures must be submitted to the
agency according to Guideline Document 22 (https://www.epa.gov/system/files/documents/2022-09/gd-022r5.pdf).
3.0 Definitions
3.1 Certification means a set of procedures and performance
criteria used by a SGM to prepare and certify a GMPS and/or GMACS
for commercial sale.
3.2 Certified Reference Material or CRM means a material that
has been certified or verified by either NIST or other NMI (e.g.,
VSL, NPL) and may be used for traceability purposes.
3.3 Dual Method Certification means a process in which the
gravimetric value is independently confirmed by a measured value.
3.4 EPA Protocol Gas means a calibration or reference gas
required for emissions monitoring directly traceable to NIST or
[[Page 24163]]
other accepted NMI reference gas standards, prepared following the
EPA Traceability Protocol
3.5 EPA Traceable Protocol for Assay and Calibration Gas
Standards or commonly referred to as the ``EPA Traceability
Protocol'' means the document The protocol allows producers of these
standards, users of gaseous standards, and other analytical
laboratories to establish traceability of EPA Protocol Gases to
gaseous reference standards produced by the National Institute of
Standards and Technology (NIST).
3.6 Gas Calibration Cylinder means a refillable cylinder that
meets the applicable DOT/TC specifications for high pressure
cylinders. The cylinders shall be permanently stamped with a unique
value.
3.7 Gas Manufacturer Alternative Certified Standards or GMACS
means a gas that has been prepared according to this procedure and
serves as a functional substitute for an EPA Protocol Gas where EPA
Protocol gases are not available.
3.8 Gas Manufacturer Intermediate Standard means a gas reference
standard made by a gas supplier and certified according to the U.S.
EPA protocol rules for GMISs. For the purpose of this Appendix,
GMISs may be assayed against a GMPS.
3.9 Gas Manufacturer Primary Standards or GMPS means a
reference gas standard prepared and certified by the SGM that serves
as a functional substitute for the reference gas standards
established by, but not yet available from NIST or other accepted
NMI and required by the EPA Traceability Protocol to produce EPA
Protocol gases.
3.10 Gravimetry means the quantitative measurement of an
analyte by weight.
3.11 NIST means the National Institute of Standards and
Technology, located in Gaithersburg, Maryland.
3.12 NIST Traceable Reference Material or NTRM means is a
reference material produced by a commercial supplier with a well-
defined traceability linkage to NIST and named by NIST procedures,
on a batch rather than individual basis. This linkage is established
via criteria and protocols defined by NIST that are tailored to meet
the needs of the metrological community to be served.
3.13 Primary Reference Materials or PRM means a mixture
composition is verified against VSL's own primary standard gas
mixtures to confirm the assigned value.
3.14 Protocol Gas means a calibration or reference gas required
for emissions monitoring traceable to NIST or other accepted NMI,
prepared following the EPA Traceability Protocol.
3.15 Research Gas Mixture or RGMs means a reference material
produced by a commercial supplier certified by NIST on an individual
basis, often using non routine procedures, are called Research Gas
Mixtures (RGMs), and may be used for traceability purposes.
3.16 Specialty Gas Manufacturer or SGM means an organization
that prepares and certified gas calibration gas mixtures.
3.17 International System of Units or SI means the standards for
international measurement and are comprised of length (meter), time
(second), amount of substance (mole), electric current (ampere),
temperature (kelvin), luminous intensity (candela), and mass
(kilogram).
3.18 Standard Reference Material or SRM means a material or
substance issued by NIST that meets NIST-specific certification
criteria and is issues with that with a certificate or certificate
of analysis that reports the results of its characterizations and
provides information regarding the appropriate use(s) of the
material.
3.19 Uncertainty means the expression of the statistical
dispersion of the values attributed to a measured quantity. For the
purpose of this appendix, uncertainty is calculated using the root
sum square of all uncertainty budget items associated with each
procedure at k=2 (i.e., approximately 95 confidence).
3.20 VSL means Van Swinden National Lab, located in Delft,
Netherlands.
4.0 Interferences--Reserved
5.0 Safety
The procedures required under this appendix may involve
hazardous materials, operations, and equipment. This procedure may
not address all of the safety problems associated with these
procedures. You as the facility or operator must establish
appropriate safety and health practices and determine the applicable
regulatory limitations prior to performing these procedures. You
should consult instrument operation manuals, material safety data
sheets, compressed gas safety requirements, and other Occupational
Safety and Health Administration regulations for specific
precautions to be taken.
6.0 Equipment and Supplies
This procedure is not prescriptive on the type of equipment or
the supplies necessary for the preparation of GMPS and GMACS gaseous
cylinder standards, however SGM must use the appropriate equipment
and supplies necessary to meet the uncertainty requirements in this
appendix.
7.0 Reagents and Standards--Reserved
8.0 Procedures.
The exact procedures used will depend on the gas manufacturer
and the physical characteristics of the compound being prepared as a
gaseous calibration standard. Any procedure is deemed appropriate so
long as the criteria in section 8.1 for GMPS and section 8.2 for
GMACS are met.
8.1 Preparation and Certification of the GMPS.
The GMPS certified value is established using the dual
certification approach. A candidate GMPS cylinder is prepared
gravimetrically, and its established reference value is confirmed by
an independent measurement traceable to SI units as well as other
appropriate reference materials. The level of agreement between the
gravimetric reference value and the SI-based independent
measurements along with the average value and associated, combined,
expanded uncertainties serve to establish the certified reference
value. If high purity reference material is not readily available
for a gravimetric preparation, a user may petition the Administrator
for an alternative method for preparation of a GMPS.
The procedures for the gravimetric preparation, stability
evaluation, and independent verification of GMPS must meet the
criteria in this section following the procedures in 8.1(a) through
(g).
(a) Raw Materials
(b) GMPS Cylinder Preparation/Creation
(c) GMPS Cylinder Independent Verification
(d) GMPS Cylinder Certification
(e) GMPS Cylinder Stability
(f) GMPS Cylinder Expiration Period
(g) GMPS Documentation
8.1.1 Raw Materials. Raw materials used in the production of
GMPS must be of high quality (e.g., 99+% purity recommended).
Additionally, because raw material purity is the largest component
of uncertainty in gas gravimetry, SGMs must substantiate the purity
of the raw material prior to use, either via (1) a validated
certificate of analysis for the actual lot number purchased provided
by the raw material vendor, or (2) a purity assay conducted by the
SGM on the actual raw material to be used. The uncertainty of the
raw material (Ur) assay must be included as one of the
components of the total combined uncertainty for the mixture.
8.1.2 GMPS Gravimetric Cylinder Preparation/Creation. The GMPS
standards shall be based on a gravimetric preparation. The
gravimetric preparation shall yield an expected concentration for
the target component, and with the required statistical controls in
place to calculate the uncertainty of that concentration.
8.1.2.1 The scale used to generate the gravimetric reference
standard must be independently calibrated over the range of target
masses with ASTM E617-13 Class-1 weights on no less than a yearly
basis. For such certifications, a high accuracy mass comparator
(electronic or pendulum-type scale) is employed as the ``scale.''
The resolution of the scale should be sufficient to be able to
calculate the overall uncertainty of any concentration derived from
these steps.
8.1.2.1.1 The scale used for the gravimetric operation must be
independently calibrated and traceable to NIST standards with a
defined uncertainty (ut).
8.1.2.1.2 The scale calibration must be checked before the start
of each new weighing operation (i.e., the day of) with a weight in
the appropriate range that also meets ASTM E617-13 Class-1
requirements.
8.1.2.1.3 All material and equipment associated with the
gravimetric analysis shall have or apply a procedure to estimate the
uncertainty of the measurement, including but not limited to the
balance(s) used (uca) standard weight (uw).
8.1.2.1.4 The assay purity and associated material uncertainty
(ur) of the assay for each component raw material and the
balance gas must be known. This purity deviation is factored into
the uncertainty of the mass of each material blended into the
mixture.
8.1.2.1.5 The procedures below are minimum requirements and do
not speak to all of the details an SRM would do to ensure the
preparation of a high-accuracy gravimetric candidate GMPS, (e.g.,
controls for external factors that would influence scale reading
accuracy buoyancy effects, moisture/dust adsorption on the cylinder
[[Page 24164]]
surface, and errors caused by the location of the cylinder on the
scale). The SGM should develop and follow and internal standard
operation procedures (SOP) for the preparation of the candidate
GMPS.
8.1.2.1.6 Record the Target cylinder identification number,
blend date, and balance gas on the appropriate form (see figure B-
1). Additionally, record the intended component(s) to be used in the
preparation for this candidate GMPS, identifying the standard type,
material name (e.g., Ethylene Oxide), MW (g/mol), and purity (wt%).
8.1.2.1.7 Add the components to the candidate GMPS, recording
the weight of each component added.
8.1.2.1.8 GMPS Gravimetric Uncertainty. Calculate and document
the gravimetric concentration (GMPS-Cg) for each
component of the candidate GMPS. You must also document the combined
uncertainty, expressed as the root sum of the uncertainty budget
items identified, for the candidate GMPS value (GMPS-
Cgu). Gravimetric preparation uncertainty budget items
include:
(a) The purity of the raw material and the balance gas;
(b) The measured accuracy of the (electronic) balance including
consideration the uncertainty of the calibration weights, the
calibration uncertainty, and its linearity;
(c) The repeatability of the balance readings including errors
caused by the location of the cylinder on the balance;
(d) Balance Buoyancy effects;
(e) Effects of moisture adsorption and dust on the outer surface
of the cylinder;
(f) Cylinder dilutions, if any, used to prepare target
concentrations, including propagated uncertainties.
8.1.3 GMPS Independent Verification. The certification of the
candidate GMPS is based on independent measurements verifying the
reference concentration of the gravimetrically prepared GMPS
candidate. The independent verification must be based on a
measurement approach traceable to the SI and may include the use of
intrinsic NIST or accepted NMI reference materials to establish said
traceability. Candidate independent verification measurement
approaches include classical chemistry, spectroscopic approaches, as
well as other instrumental approaches as long as adequate and
appropriate SI traceability can be incorporated. The approach must
be performed using NIST (or equivalent) traceable calibrations
materials and using procedures that would allow the user to
determine the overall uncertainty of the measurement. In some
instances, a component may not be suitable to analysis using a
classical approach, in those instances alternative approaches may be
used do long as they (1) yield a concentration for the target com,
(2) have a calculated uncertainty, (3) have traceability to the SI,
and (4) documented conformity to the general metrological principles
for primary methods outlined above.
8.1.3.1 GMPS Independent Verification Measurement Uncertainty.
The cumulative uncertainty of the GMPS independent verification
measurement approach is integral to the ability to assess the
overall quality of the independent verification measurement. You
must also document the combined uncertainty, expressed as the root
sum of the uncertainty budget items identified. Ensure that all
known or suspected sources of bias and imprecision have been
accounted for. The following elements are examples of sources of
measurement error that must be included in the overall uncertainty
calculation for the GMPS independent verification measurement:
(a) The uncertainty of the certified reference solution (the
traceability source);
(b) Any propagated uncertainties through serial dilutions;
(c) The errors in volumetric sampling of the candidate GMPS
mixture;
(d) The uncertainty of the instrument calibration curve (least
squares fit and residual);
(e) The bias or error associated with any measurement
interferences;
(f) The repeatability of replicate aliquot injections from the
same sample;
(g) The repeatability of replicate samples of the mixture;
(h) Any external factors influencing sampling or instrument
accuracy;
(i) The uncertainty of measured volumetric gas flows;
(j) The bias or uncertainty associated with quantitative gas
flow delivery;
(k) The error associated with instrumental measurement
analyzers;
(l) Replicate measurement instrument error and precision.
8.1.4 GMPS Certification. The candidate GMPS certified value is
based on three factors:
(a) The relative agreement between the gravimetric reference
value and the independent, measured value of the gravimetrically-
prepared GMPS candidate;
(b) The combined, expanded uncertainty (k=2) of the gravimetric
value and independently measured concentrations values;
(c) The average of the independently measured concentrations
values.
8.1.4.1 GMPS Relative Agreement. Calculate the relative
agreement according to equation B-1, expressed as Relative Percent
Difference (RPD) between the gravimetric concentration (GMPS-
Cg) the independently measured concentrations (GMPS-
Ca). The results of these two analyses must agree within
4.0 percent (%).
[GRAPHIC] [TIFF OMITTED] TR05AP24.020
8.1.4.2 GMPS Combined, Expanded Uncertainty. Determine the
individual uncertainties for the gravimetric approach (GMPS-
Cug) and the independent measurement verification
approach (GMPS-Cua) according to equation B-2. Establish
the GMPS combined, expanded uncertainty (GMPS-Cuc) as the
root sum of the two individual uncertainties with a coverage factor
k=2. The combined uncertainty must <=5.0 percent (%). If these
objectives are not met, the candidate GMPS is not acceptable, and
must not be used.
[GRAPHIC] [TIFF OMITTED] TR05AP24.021
8.1.4.3 GMPS Certified Concentration Value. If the GMPS meets
the Relative Agreement criteria in section 8.1.5.3 and the combined,
expanded uncertainty criteria in section 8.1.5.4, the GMPS is valid.
The GMPS certified value (GMPS-CC) is based on the
independently measurement concentration (GMPS-Ca). The
certification date is the date of the last confirmatory measurement.
8.1.4.4 An SGMs may propose to Administrator an alternative
acceptance values for section 8.1.5.1 or 8.1.5.2 for those
components that are unable to meet the documented criteria. These
proposals must include sufficient documentation that the objectives
are unreasonable for a given component and concentrations.
8.1.5 GMPS Stability Testing. The SGM must test and document
mixture stability of the GMPS to assure that the mixture stays
within claimed accuracy bounds for the entire claimed expiration
period. Alternatively, once a preparation process has been
developed, the SGM can perform a stability study consisting not less
than three cylinders prepared using the defined process and at the
concentration(s) defined by the process. Once the stability study
cylinders have demonstrated acceptable stability for
[[Page 24165]]
the minimum expiration period (6-months), additional GMPS cylinders
can be prepared under identical process conditions.
8.1.5.1 The SGM may select the sampling frequency based on the
targeted expiration period, the gas consumed in the analysis and
expected component behavior. Stability testing data must consist of
at least:
(a) Five discrete samplings of the retained mixture for an
expiration period of 6-months to 1-year;
(b) Ten discrete samplings for an expiration period of 1-3
years; and
(c) Twenty for any period greater than 3 years.
8.1.5.2 Stability testing must be conducted for each cylinder
size/type and at a similar concentration as the candidate GMPS.
Stability analyses must be performed using methods that assure
consistent results can be achieved. If instrumental analysis using a
gas standard is employed, use of a GMPS standard is highly
recommended. In the absence of a certified GMPS, stability testing
must be conducted using the same independent verification
measurement procedures and methodology used in section 8.1.4, or
using another known-to-be-stable gas standard containing the target
component in a similar concentration range.
8.1.5.3 Stability testing data must not show any upward or
downward trends that would cause the mixture to become out of
specification prior to the claimed expiration period.
8.1.6 GMPS Expiration Period. The expiration period for the GMPS
mixture based must be based on the empirical stability test data.
The expiration periods for reactive gases must not exceed the length
of the stability test, however for non-reactive gases you may
forecast an expiration period not to exceed two times the actual
stability testing duration. The maximum expiration period for a GMPS
is time span from the date of preparation to the date of the last/
most recent stability study may not be less than 6-months. Provided
that acceptable stability is observed, the maximum expiration period
may be extended by retaining the stability study cylinders and
performing additional analyses.
8.1.7 GMPS Documentation. You must document the preparation of
the GMPS through the appropriate record keeping and document the
certification of a GMPS. The information is section 8.1.8.1 and
8.1.8.2 must be maintained as a record by the SGM for the purpose of
maintaining traceability and to verify the preparation. The
information in section 8.1.8.3 must be documented and maintained by
the SGM. This documentation and the records of the preparation and
certification must be made available upon request by the appropriate
delegated authority.
8.1.7.1 The following information for the gravimetric
preparation information of the GMPS must be documented and
maintained as a record. This record should include but is not
limited to the: blend date, gravimetric concentration, gravimetric
concentration uncertainties as a percentage and absolute, reference
material information and purity, scale ID, scale accuracy, and
calculated gravimetric uncertainties associated with material,
balance, and environmental effects. You must include sufficient
information that will allow a 3rd party to recalculate the prepared
concentration and expanded uncertainties.
8.1.7.2 The following information for the analytical
verification of the GMPS must be recorded and maintained as a
record. This record should include the confirming methodology and
any associated SOPs, confirming concentration(s), instrumentation
used, calibration standards used and associated COAs, calibration
curve data, replicate analysis calculated, and expanded
uncertainties.
8.1.7.3 The following information must be documented for
inclusion on the COA for the GMACS.
(a) Manufacturer's company name and address of the producing
location
(b) Manufacturer's part number for the GMPS, lot number, and/or
production record.
(c) Cylinder number, cylinder type, cylinder preparation ID,
moisture dew point and cylinder pressure.
(d) Certification date and claimed expiration date.
(e) GMPS component(s) name, final certified concentration(s)
(GMPS-Cc), and balance gas.
(f) Gravimetric value and uncertainty
(g)Verification value and uncertainty
(h) GMPS final certified value and uncertainty absolute as a
percentage (GMPS-Cu)
8.2 Preparation and Certification of the GMACS. The preparation
and certification of the candidate GMACS is also based on the
independent verification of the gravimetrically prepared reference
value. However, the independent verification utilizes the GMPS to
perform the independent verification. This is accomplished by
following the procedures in section 2.1 and 2.2 of the EPA
Traceability Protocol, using the GMPS as the certified reference
material. The measured value of the independent verification
following the EPA Traceability Protocol procedures also establishes
the certified reference value, providing the relative agreement
performance criteria are met.
8.2.1 GMACS Gravimetric Cylinder Preparation/Creation. The
gravimetric preparation of the GMACS is identical to the procedures
used to gravimetrically prepare the GMPS. You must maintain the same
information required for the gravimetric preparation of GMPS, as
found in section 8.1.8.1 for GMACS, as a record.
8.2.2 GMACS Independent Verification and Certification. The
candidate GMACS independent verification of the gravimetrically
prepared reference value is contingent on the SGM following the
procedures in sections 2.1 and 2.2 of the EPA Traceability Protocol.
In addition, the EtO candidate GMACS certified reference value and
associated expanded uncertainty is based on the EPA Traceability
Protocol measured value. This is contingent upon the gravimetric and
measured values meeting the relative agreement performance criteria
established in section 8.1.5.3 and the uncertainty criteria
established in section 8.1.5.4. Gas Manufacturers Intermediate
Standards (GMIS) can be prepared by direct comparison to a GMPS that
has been prepared and certified according to section 2.1.3.1 and 2.2
of the EPA Traceability Protocol. The tagged value of the GMACS must
be based on the EPA Traceability Protocol measured value as long as
the performance criteria in sections 12.1 and 12.2 are met.
8.2.3 GMACS Stability Testing. The SGM must test and document
the stability of the GMACS to assure that the mixture stays within
claimed certified bounds for the entire claimed expiration period.
Use the procedures in section 8.1.6 to assess stability. The GMACS
must also meet the requirements in section 2.1.5.2 of the EPA
Traceability Protocol.
8.2.4 GMACS Expiration Date. The certification period of the
GMACS shall be based on the documented stability tests of the GMPS
in section 8.1.6. The expiration date shall be based on the
certification date, plus the certification period plus one day.
There is not a maximum period of expiration; however, expiration
periods must not be less than six months.
8.2.5 GMACS Documentation You must document and maintain the
same information required for the analytical verification of the
GMPS, as found in section 8.1.8 for GMACS, as a record. The records
of the preparation and certification must be made available upon
request by the appropriate delegated authority.
8.2.6 GMACS Certificate of Analysis (COA). You must provide
comprehensive documentation of the GMPS and GMACS development
process in the form of a GMACS Certificate of Analysis (COA) that
accompanies each commercially distributed GMACS. As a minimum, the
COA must contain the following information:
(a) Identification of the gas as a Gas Manufacturer Alternative
Certified Standard;
(b) The cylinder number;
(c) The certified concentration of the GMACS;
(d) The combined expanded uncertainty (k=2) of the GMACS
reference value (both absolute and relative);
(e) The expiration date;
(f) The reference materials or standards used (i.e., GMPS and
GMIS);
(g) The same information (cylinder number, certified
concentration, uncertainties, expiration dates, etc. for these
cylinders);
(h) The gravimetric and independent measured verification
reference concentration values and associated uncertainties for each
GMPS used;
(i) Associated measurement principles and uncertainties;
(j) Any additional information stipulated by the EPA
Traceability Protocol;
(k) Any comments/special instructions.
The SGM GMACS provider is encouraged to include additional
relevant information to the COA, as appropriate. An example GMACS
COA can be found in section 14 of this appendix.
9.0 Quality Control--Reserved
10.0 Calibration and Standardization
There is a myriad of instrumental and mechanical techniques used
in the
[[Page 24166]]
performance of this Appendix B. When reference methods are used, you
must follow the calibration requirements of those methods and as
defined in this appendix. For all other approaches, it is
recommended to develop internal SOPs and develop.
11.0 Calculations and Data Analysis--Reserved
12.0 Method Performance
12.1 GMPS/GMACS Relative Agreement. As part of the
certification/verification procedures for the candidate GMPS and
GMACS, the relative agreement between the gravimetrically prepared
reference value and the independently measured verification value
must agree within 4.0 percent (%).
12.2 GMACS/GMPS Uncertainty. Final certification of the GMPS and
GMACS reference concentrations must meet the combined expanded
uncertainty (k=2) of <=5.0 percent (%).
13.0 Pollution Prevention--Reserved
14.0 Waste Management--Reserved
15.0 Bibliography
1. EPA Traceability Protocol for Assay and Certification of
Gaseous Calibration Standards, Office of Research and Development,
National Risk Management Research Laboratory, May 2012, EPA 600/R-
12/531. https://www.epa.gov/air-research/epa-traceability-protocol-assay-and-certification-gaseous-calibration-standards.
2. EPA Alternative Method 114, Approval of Alternative Method
for preparation of HCl Gas Standards for PS-18 and Procedure 6,
February 22, 2016, https://www.epa.gov/sites/default/files/2020-08/documents/alt114.pdf.
3. Evaluation of Measurement Data--Guide to the Expression of
Uncertainty in Measurement, JCGM 100:2008, https://www.bipm.org/documents/20126/2071204/JCGM_100_2008_E.pdf/cb0ef43f-baa5-11cf-3f85-4dcd86f77bd6.
16.0 Tables and Figures
Figure B-1 Example Gravimetric Preparation Sheet for GMPS and GMACS
BILLING CODE 6560-50-P
[GRAPHIC] [TIFF OMITTED] TR05AP24.022
[[Page 24167]]
Figure B-2 Apparatus for the assay of the GMACs
[GRAPHIC] [TIFF OMITTED] TR05AP24.023
[[Page 24168]]
Figure B-3 Examples COA
[GRAPHIC] [TIFF OMITTED] TR05AP24.024
BILLING CODE 6560-50-C
0
3. Appendix F to part 60 is amended by adding Procedure 7 to read as
follows:
Appendix F to Part 60--Quality Assurance Procedures
* * * * *
Procedure 7. Quality Assurance Requirements for Gaseous Ethylene Exide
(ETO) Continuous Emission Monitoring Systems Used for Compliance
Determination
1.0 Applicability and Principle
1.1 Applicability. Procedure 7 is used to evaluate the
effectiveness of quality control (QC) and quality assurance (QA)
procedures and to evaluate the quality of data produced by any
ethylene oxide (EtO) gas, CAS: 75-21-8, continuous emission
monitoring system (CEMS) that is used for determining compliance
with emission standards for EtO on a continuous basis as specified
in an applicable permit or regulation.
1.1.1 This procedure specifies the minimum QA requirements
necessary for the control and assessment of the quality of CEMS data
submitted to the Environmental Protection Agency (EPA) or a
delegated authority. If you are responsible for one or more CEMS
used for EtO compliance monitoring you must meet these minimum
requirements and you are encouraged to develop and implement a more
extensive QA program or to continue such programs where they already
exist.
1.1.2 Data collected as a result of QA and quality control (QC)
measures required in this procedure are to be submitted to the EPA
or the delegated authority in accordance with the applicable
regulation or permit. These data are to be used by both the
delegated authority and you, as the CEMS operator, in assessing the
effectiveness of the CEMS QC and QA procedures in the maintenance of
acceptable CEMS operation and valid emission data.
1.2 Principle
1.2.1 The QA procedures consist of two distinct and equally
important functions. One function is the assessment of the quality
of the CEMS data by estimating accuracy. The other function is the
control and improvement of the quality of the CEMS data by
implementing QC policies and corrective actions. These two functions
form an iterative control loop. When the assessment function
indicates that the data quality is inadequate, the control effort
must be increased until the data quality is acceptable. In order to
provide uniformity in the assessment and reporting of data quality,
this procedure specifies the assessment procedures to evaluate
response drift and accuracy. The procedures specified are based on
Performance Specification 19 (PS-19) in appendix B to this part.
[[Page 24169]]
Note 1 to section 1.0: Because the control and corrective
action function encompasses a variety of policies, specifications,
standards and corrective measures, this procedure treats QC
requirements in general terms to allow you, as source owner or
operator to develop the most effective and efficient QC system for
your circumstances.
2.0 Definitions
See PS-19 in appendix B to this part for the primary definitions
used in this Procedure.
3.0 QC Requirements
3.1 You, as a source owner or operator, must develop and
implement a QC program. At a minimum, each QC program must include
written procedures and/or manufacturer's information which should
describe in detail, complete, step-by-step procedures and operations
for each of the following activities:
(a) Calibration Drift (CD) checks of CEMS;
(b) CD determination and adjustment of CEMS;
(c) Routine and preventative maintenance of CEMS (including
spare parts inventory);
(d) Data recording, calculations, and reporting;
(e) Accuracy audit procedures for CEMS including reference
method(s); and
(f) Program of corrective action for malfunctioning CEMS.
3.2 These written procedures must be kept on site and available
for inspection by the delegated authority. As described in section
5.4, whenever excessive inaccuracies occur for two consecutive
quarters, you must revise the current written procedures, or modify
or replace the CEMS to correct the deficiency causing the excessive
inaccuracies.
4.0 Daily Data Quality Requirements and Measurement Standardization
Procedures
4.1 CD Assessment. An upscale gas, used to meet a requirement in
this section must be a gas meeting the requirements in section 7.1
of PS-19 of appendix B to this part.
4.1.1 CD Requirement. Consistent with Sec. 60.13(d) and with
Sec. 63.8(c) of this chapter, you, as source owners or operators of
CEMS must check, record, and quantify the CD at two levels, using a
zero gas and high-level gas at least once daily (approximately every
24 hours). Perform the CD check in accordance with the procedure in
the applicable performance specification (e.g., section 11.3 of PS-
19 in appendix B to this part). The daily zero- and high-level CD
must not exceed two times the drift limits specified in the
applicable performance specification (e.g., section 13.2 of PS-19 in
appendix B to this part.)
4.1.2 Recording Requirement for CD Corrective action. Corrective
actions taken to bring a CEMS back in control after exceeding a CD
limit must be recorded and reported with the associated CEMS data.
Reporting of a corrective action must include the unadjusted
concentration measured prior to resetting the calibration and the
adjusted value after resetting the calibration to bring the CEMS
back into control.
4.1.3 Dynamic Spiking Option for high-level CD. You have the
option to conduct a daily dynamic spiking procedure found in section
11.5.8 of PS-19 of appendix B to this part in lieu of the daily
high-level CD check. If this option is selected, the daily zero CD
check is still required.
4.1.4 Out of Control Criteria for Excessive CD. Consistent with
Sec. 63.8(c)(7)(i)(A) of this chapter, an EtO CEMS is out of
control if the zero or high-level CD exceeds two times the
applicable CD specification in the applicable performance
specification or in the relevant standard. When a CEMS is out of
control, you as owner or operator of the affected source must take
the necessary corrective actions and repeat the tests that caused
the system to go out of control (in this case, the failed CD check)
until the applicable performance requirements are met.
4.1.5 Additional Quality Assurance for Data Above Span. This
procedure must be used when required by an applicable regulation and
may be used when significant data above span are being collected.
Furthermore, the terms of this procedure do not apply to the extent
that alternate terms are otherwise specified in an applicable rule
or permit.
4.1.5.1 Any time the average measured concentration of EtO
exceeds 200 percent of the span value for two consecutive one-hour
averages, conduct the following 'above span' CEMS response check.
4.1.5.1.1 Within a period of 24 hours (before or after) of the
'above span' period, introduce a higher, 'above span' EtO reference
gas standard to the CEMS. Use 'above span' reference gas that meets
the requirements of section 7.0 of PS-19 in appendix B to this part
and target a concentration level between 75 and 125 percent of the
highest hourly concentration measured during the period of
measurements above span or 5 ppmv whichever is greater.
4.1.5.1.2 Introduce the reference gas at the probe for
extractive CEMS.
4.1.5.1.3 At no time may the 'above span' concentration exceed
the analyzer full-scale range.
4.1.5.2 Record and report the results of this procedure as you
would for a daily calibration. The 'above span' response check is
successful if the value measured by the CEMS is within 20 percent of
the certified value of the reference gas.
4.1.5.3 If the 'above span' response check is conducted during
the period when measured emissions are above span and there is a
failure to collect at least one data point in an hour due to the
response check duration, then determine the emissions average for
that missed hour as the average of hourly averages for the hour
preceding the missed hour and the hour following the missed hour.
4.1.5.4 In the event that the 'above span' response check is not
successful (i.e., the CEMS measured value is not within 20 percent
of the certified value of the reference gas), then you must
normalize the one-hour average stack gas values measured above the
span during the 24-hour period preceding or following the 'above
span' response check for reporting based on the CEMS response to the
reference gas as shown in Eq. 7-1:
[GRAPHIC] [TIFF OMITTED] TR05AP24.025
4.2 Out of Control Period Duration for Daily Assessments. The
beginning of the out-of-control period is the hour in which the
owner or operator conducts a daily performance check (e.g.,
calibration drift) that indicates an exceedance of the performance
requirements established under this procedure. The end of the out-
of-control period is the completion of daily assessment of the same
type following corrective actions, which shows that the applicable
performance requirements have been met.
4.3 CEMS Data Status During Out-of-Control Period. During the
period the CEMS is out-of- control, the CEMS data may not be used in
calculating compliance with an emissions limit nor be counted
towards meeting minimum data availability as required and described
in the applicable regulation or permit.
5.0 Data Accuracy Assessment
You must audit your CEMS for the accuracy of EtO measurement on
a regular basis at the frequency described in this section, unless
otherwise specified in an applicable regulation or permit. Quarterly
audits are performed at least once each calendar quarter. Successive
quarterly audits, to the extent practicable, shall occur no closer
than 2 months apart. Annual audits are performed at least once every
four consecutive calendar quarters.
5.1 Concentration Accuracy Auditing Requirements. Unless
otherwise specified in an applicable regulation or permit, you must
audit the EtO measurement accuracy of each CEMS at least once each
calendar quarter, except in the case where the affected facility is
off-line (does not operate). In that case, the audit must be
performed as soon as is practicable in the quarter in which the unit
recommences operation. Successive quarterly audits must, to the
extent practicable, be performed no less than 2 months apart. The
[[Page 24170]]
accuracy audits shall be conducted as follows:
5.1.1 Relative Accuracy Test Audit (RATA). A RATA must be
conducted at least once every four calendar quarters, except as
otherwise noted in sections 5.1.5 or 5.5 of this procedure. Perform
the RATA as described in section 11.6 of PS-19 in appendix B to this
part. If the EtO concentration measured by the RM during a RATA (in
ppmv or other units of the standard) is less than or equal to 20
percent of the concentration equivalent to the applicable emission
standard, you must perform a Cylinder Gas Audit (CGA) or a Dynamic
Spike Audit (DSA) for at least one subsequent (one of the following
three) quarterly accuracy audits.
5.1.2 Quarterly Relative Accuracy Audit (RAA). A quarterly RAA
may be conducted as an option to conducting a RATA in three of four
calendar quarters, but in no more than three quarters in succession.
To conduct an RAA, follow the test procedures in section 11.6 of PS-
19 in appendix B to this part, except that only three test runs are
required. The difference between the mean of the RM values and the
mean of the CEMS responses relative to the mean of the values (or
alternatively the emission standard) is used to assess the accuracy
of the CEMS. Calculate the RAA results as described in section 6.2.
As an alternative to an RAA, a cylinder gas audit or a dynamic
spiking audit may be conducted.
5.1.3 Cylinder Gas Audit. A quarterly CGA may be conducted as an
option to conducting a RATA in three of four calendar quarters, but
in no more than three consecutive quarters. To perform a CGA,
challenge the CEMS with a zero-level and two upscale level audit
gases of known concentrations within the following ranges:
------------------------------------------------------------------------
Audit point Audit range
------------------------------------------------------------------------
1 (Mid-Level)......................... 50 to 60% of span value.
2 (High-Level)........................ 80 to 100% of span value.
------------------------------------------------------------------------
5.1.3.1 Inject each of the three audit gases (zero and two
upscale) three times each for a total of nine injections. Inject the
gases so that the entire measurement system is challenged. Do not
inject the same gas concentration twice in succession.
5.1.3.2 Use EtO audit gases that meet the requirements of
section 7 of PS-19 in appendix B to this part.
5.2.3.3 Calculate results as described in section 6.3.
5.1.4 Dynamic Spiking Audit. A quarterly DSA may be conducted as
an option to conducting a RATA in three of four calendar quarters,
but in no more than three quarters in succession.
5.1.4.1 To conduct a DSA, you must challenge the entire EtO CEMS
with a zero gas in accordance with the procedure in section 11.8 of
PS-19 in appendix B of this part. You must also conduct the DS
procedure as described in appendix A to PS-19 of appendix B to this
part. You must conduct three spike injections with each of two
upscale level audit gases. The upscale level gases must meet the
requirements of section 7 of PS-19 in appendix B to this part and
must be chosen to yield concentrations at the analyzer of 50 to 60
percent of span and 80 to 100 percent of span. Do not inject the
same spike gas concentration twice in succession.
5.1.4.2 Calculate results as described in section 6.4. To
determine CEMS accuracy, you must calculate the dynamic spiking
error (DSE) for each of the two upscale audit gases using equation
A5 in appendix A to PS-19 and equation 7-3 in section 6.4 of this
Procedure.
5.1.5 Other Alternative Quarterly Audits. Other alternative
audit procedures, as approved by the Administrator, may be used for
three of four calendar quarters.
5.2 Out of Control Criteria for Excessive Audit Inaccuracy. If
the results of the RATA, RAA, CGA, or DSA do not meet the applicable
performance criteria in section 5.2.4, the CEMS is out-of-control.
If the CEMS is out-of-control, take necessary corrective action to
eliminate the problem. Following corrective action, the CEMS must
pass a test of the same type that resulted in the out-of-control
period to determine if the CEMS is operating within the
specifications (e.g., a RATA must always follow an out-of-control
period resulting from a RATA).
5.2.1 If the audit results show the CEMS to be out-of-control,
you must report both the results of the audit showing the CEMS to be
out-of-control and the results of the audit following corrective
action showing the CEMS to be operating within specifications.
5.2.2 Out-Of-Control Period Duration for Excessive Audit
Inaccuracy. The beginning of the out-of-control period is the time
corresponding to the completion of the sampling for the failed RATA,
RAA, CGA or DSA. The end of the out-of-control period is the time
corresponding to the completion of the sampling of the subsequent
successful audit.
5.2.3 CEMS Data Status During Out-Of-Control Period. During the
period the CEMS is out-of- control, the CEMS data may not be used in
calculating emission compliance nor be counted towards meeting
minimum data availability as required and described in the
applicable regulation or permit.
5.2.4 Criteria for Excessive Quarterly and Yearly Audit
Inaccuracy. Unless specified otherwise in the applicable regulation
or permit, the criteria for excessive inaccuracy are:
5.2.4.1 For the RATA, the CEMS must meet the RA specifications
in section 13.4 of PS-19 in appendix B to this part.
5.2.4.2 For the CGA, the accuracy must not exceed 10.0 percent
of the span value at the zero gas and the mid- and high-level
reference gas concentrations.
5.2.4.3 For the RAA, the RA must not exceed 20.0 percent of the
RMavg as calculated using equation 7-2 in section 6.2 of this
procedure whether calculated in units of EtO concentration or in
units of the emission standard. In cases where the RA is calculated
on a concentration (ppbv) basis, if the average EtO concentration
measured by the RM during the test is less than 75 percent of the
EtO concentration equivalent to the applicable standard, you may
substitute the equivalent emission standard value (in ppbw) in the
denominator of equation 7-2 in the place of RMavg and the
result of this alternative calculation of RA must not exceed 15.0
percent.
5.2.4.4 For DSA, the accuracy must not exceed 5.0 percent of the
span value at the zero gas and the mid- and high-level reference gas
concentrations or 20.0 percent of the applicable emission standard,
whichever is greater.
5.3 Criteria for Acceptable QC Procedures. Repeated excessive
inaccuracies (i.e., out-of-control conditions resulting from the
quarterly or yearly audits) indicate that the QC procedures are
inadequate or that the CEMS is incapable of providing quality data.
Therefore, whenever excessive inaccuracies occur for two consecutive
quarters, you must revise the QC procedures (see section 3.0) or
modify or replace the CEMS.
5.4 Criteria for Optional QA Test Frequency. If all the quality
criteria are met in sections 4 and 5 of this procedure, the CEMS is
in-control.
5.5.1 Unless otherwise specified in an applicable rule or
permit, if the CEMS is in-control and if your source emits <=75
percent of the EtO emission limit for each averaging period as
specified in the relevant standard for eight consecutive quarters
that include a minimum of two RATAs, you may revise your auditing
procedures to use CGA, RAA or DSA each quarter for seven subsequent
quarters following a RATA.
5.5.2 You must perform at least one RATA that meets the
acceptance criteria every 2 years.
5.5.3 If you fail a RATA, RAA, CGA, or DSA, then the audit
schedule in section 5.2 must be followed until the audit results
meet the criteria in section 5.3.4 to start requalifying for the
optional QA test frequency in section 5.5.
6.0 Calculations for CEMS Data Accuracy
6.1 RATA RA Calculation. Follow equations 9 through 14 in
section 12 of PS-19 in appendix B to this part to calculate the RA
for the RATA. The RATA must be calculated either in units of the
applicable emission standard or in concentration units (ppbv).
6.2 RAA Accuracy Calculation. Use equation 7-2 to calculate the
accuracy for the RAA. The RA may be calculated in concentration
units (ppmv) or in the units of the applicable emission standard.
[GRAPHIC] [TIFF OMITTED] TR05AP24.026
[[Page 24171]]
Where:
RA = Accuracy of the CEMS (percent)
MNavg = Average measured CEMS response during the audit
in units of applicable standard or appropriate concentration.
RMavg = Average reference method value in units of
applicable standard or appropriate concentration.
6.3 CGA Accuracy Calculation. For each gas concentration,
determine the average of the three CEMS responses and subtract the
average response from the audit gas value. For extractive CEMS,
calculate the ME at each gas level using equation 3A in section 12.3
of PS-19 of appendix B to this part.
6.4 DSA Accuracy Calculation. DSA accuracy is calculated as a
percent of span. To calculate the DSA accuracy for each upscale
spike concentration, first calculate the DSE using equation A5 in
appendix A of PS-19 in appendix B to this part. Then use equation 7-
3 to calculate the average DSA accuracy for each upscale spike
concentration. To calculate DSA accuracy at the zero level, use
equation 3A in section 12.3 of PS-19 in appendix B to this part.
[GRAPHIC] [TIFF OMITTED] TR05AP24.027
7.0 Reporting Requirements
At the reporting interval specified in the applicable regulation
or permit, report for each CEMS the quarterly and annual accuracy
audit results from section 6 and the daily assessment results from
section 4. Unless otherwise specified in the applicable regulation
or permit, include all data sheets, calculations, CEMS data records
(i.e., charts, records of CEMS responses), reference gas
certifications and reference method results necessary to confirm
that the performance of the CEMS met the performance specifications.
7.1 Unless otherwise specified in the applicable regulations or
permit, report the daily assessments (CD and beam intensity) and
accuracy audit information at the interval for emissions reporting
required under the applicable regulations or permits.
7.1.1 At a minimum, the daily assessments and accuracy audit
information reporting must contain the following information:
a. Company name and address.
b. Identification and location of monitors in the CEMS.
c. Manufacturer and model number of each monitor in the CEMS.
d. Assessment of CEMS data accuracy and date of assessment as
determined by a RATA, RAA, CGA or DSA described in section 5
including:
i. The RA for the RATA;
ii. The accuracy for the CGA, RAA, or DSA;
iii. The RM results, the reference gas certified values;
iv. The CEMS responses;
v. The calculation results as defined in section 6; and
vi. Results from the performance audit samples described in
section 5 and the applicable RMs.
e. Summary of all out-of-control periods including corrective
actions taken when CEMS was determined out-of-control, as described
in sections 4 and 5. 7.1.2 If the accuracy audit results show the
CEMS to be out-of-control, you must report both the audit results
showing the CEMS to be out-of-control and the results of the audit
following corrective action showing the CEMS to be operating within
specifications.
7.1.2 If the accuracy audit results show the CEMS to be out-of-
control, you must report both the audit results showing the CEMS to
be out-of-control and the results of the audit following corrective
action showing the CEMS to be operating within specifications.
8.0 Bibliography
1. EPA Traceability Protocol for Assay and Certification of Gaseous
Calibration Standards, U.S. Environmental Protection Agency office
of Research and Development, EPA/600/R-12/531, May 2012.
2. Method 205, ``Verification of Gas Dilution Systems for Field
Instrument Calibrations,'' 40 CFR part 51, appendix M.
9.0 [Reserved]
PART 63--NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS
FOR SOURCE CATEGORIES
0
4. The authority citation for part 63 continues to read as follows:
Authority: 42 U.S.C. 7401 et seq.
Subpart A--General Provisions
0
5. Section 63.14 is amended by:
0
a. Revising paragraphs (a) and (f) and paragraph (i) introductory text;
0
b. Redesignating paragraphs (i)(88) through (119) as paragraphs (i)(89)
through (120), and;
0
c. Adding new paragraph (i)(88) and note 2 to paragraph (i).
The revisions and additions read as follows:
Sec. 63.14 Incorporations by reference.
(a) Certain material is incorporated by reference into this part
with the approval of the Director of the Federal Register under 5
U.S.C. 552(a) and 1 CFR part 51. To enforce any edition other than that
specified in this section, the EPA must publish a document in the
Federal Register and the material must be available to the public. All
approved incorporation by reference (IBR) material is available for
inspection at the EPA and at the National Archives and Records
Administration (NARA). Contact the EPA at: EPA Docket Center, Public
Reading Room, EPA WJC West, Room 3334, 1301 Constitution Ave. NW,
Washington, DC, telephone: 202-566-1744. For information on the
availability of this material at NARA, visit www.archives.gov/federal-register/cfr/ibr-locations or email [email protected]. The
material may be obtained from the sources in the following paragraphs
of this section.
* * * * *
(f) American Society of Mechanical Engineers (ASME), Two Park
Avenue, New York, NY 10016-5990; phone: (800) 843-2763; email:
[email protected]; website: www.asme.org.
(1) ANSI/ASME PTC 19.10-1981, Flue and Exhaust Gas Analyses [Part
10, Instruments and Apparatus], issued August 31, 1981; IBR approved
for Sec. Sec. 63.309(k); 63.365(b); 63.457(k); 63.772(e) and (h);
63.865(b); 63.997(e); 63.1282(d) and (g); 63.1625(b); table 5 to
subpart EEEE; Sec. Sec. 63.3166(a); 63.3360(e); 63.3545(a);
63.3555(a); 63.4166(a); 63.4362(a); 63.4766(a); 63.4965(a); 63.5160(d);
table 4 to subpart UUUU; table 3 to subpart YYYY; Sec. Sec.
63.7822(b); 63.7824(e); 63.7825(b); 63.8000(d); 63.9307(c); 63.9323(a);
63.9621(b) and (c); 63.11148(e); 63.11155(e); 63.11162(f); 63.11163(g);
63.11410(j); 63.11551(a); 63.11646(a); 63.11945; table 4 to subpart
AAAAA; table 5 to subpart DDDDD; table 4 to subpart JJJJJ; table 4 to
subpart KKKKK; table 4 to subpart SSSSS; tables 4 and 5 of subpart
UUUUU; table 1 to subpart ZZZZZ; and table 4 to subpart JJJJJJ.
(2) [Reserved]
* * * * *
(i) ASTM International, 100 Barr Harbor Drive, P.O. Box CB700, West
Conshohocken, Pennsylvania 19428-2959; phone: (800) 262-1373; website:
www.astm.org.
* * * * *
(88) ASTM D6348-12 (Reapproved 2020), Standard Test Method for
Determination of Gaseous Compounds by Extractive Direct Interface
Fourier Transform (FTIR) Spectroscopy,
[[Page 24172]]
Approved December 1, 2020; IBR approved for Sec. 63.365(b).
* * * * *
Note 2 to paragraph (i): Standards listed in this paragraph (i)
may also be available from standards resellers including the
Standards Store, https://global.ihs.com.
* * * * *
0
6. Subpart O is revised and republished to read as follows:
Subpart O--Ethylene Oxide Emissions Standards for Sterilization
Facilities
Sec.
63.360 Applicability.
63.361 Definitions.
63.362 Standards.
63.363 Compliance and performance provisions.
63.364 Monitoring requirements.
63.365 Test methods and procedures.
63.366 Reporting requirements.
63.367 Recordkeeping requirements.
63.368 Implementation and enforcement.
Table 1 to Subpart O of Part 63 Standards for SCVs
Table 2 to Subpart O of Part 63 Standards for ARVs
Table 3 to Subpart O of Part 63 Standards for CEVs
Table 4 to Subpart O of Part 63 Standards for Group 1 Room Air
Emissions
Table 5 to Subpart O of Part 63 Standards for Group 2 Room Air
Emissions
Table 6 to Subpart O of Part 63 Applicability of General Provisions
to Subpart O
Appendix A to Subpart O of Part 63--Monitoring Provisions for EtO
CEMS
Subpart O--Ethylene Oxide Emissions Standards for Sterilization
Facilities
Sec. 63.360 Applicability.
(a) You are subject to the requirements of this subpart if you own
or operate a sterilization facility that has an affected source
specified in paragraph (b) of this section. Table 6 to this subpart
shows which parts of the General Provisions in Sec. Sec. 63.1 through
63.15 apply to you.
(b) The affected sources subject to this subpart are:
(1) Each SCV at any sterilization facility;
(2) Each ARV at any sterilization facility;
(3) Each CEV at any sterilization facility;
(4) The collection of all Group 1 room air emissions at any
sterilization facility; and
(5) The collection of all Group 2 room air emissions at any
sterilization facility.
(c) An existing affected source is one the construction or
reconstruction of which was commenced on or before April 13, 2023.
(d) A new affected source is one the construction or reconstruction
of which is commenced after April 13, 2023.
(e) An SCV, ARV, or CEV is reconstructed if you meet the
reconstruction criteria as defined in Sec. 63.2, and if you commence
reconstruction after April 13, 2023.
(f) This subpart does not apply to beehive fumigators.
(g) This subpart does not apply to research or laboratory
facilities as defined in section 112(c)(7) of title III of the Clean
Air Act Amendment of 1990.
(h) This subpart does not apply to EtO sterilization operations at
stationary sources such as hospitals, doctor's offices, clinics, or
other facilities whose primary purpose is to provide medical or dental
services to humans or animals.
(i) If you are an owner or operator of an area source subject to
this subpart, you are exempt from the obligation to obtain a permit
under 40 CFR part 70 or 71, provided you are not required to obtain a
permit under 40 CFR 70.3(a) or 71.3(a) for a reason other than your
status as an area source under this subpart. Notwithstanding the
previous sentence, you must continue to comply with the provisions of
this subpart applicable to area sources.
(j) You must comply with the provisions of this subpart no later
than the dates specified in paragraphs (j)(1) through (17) of this
section:
(1) If you own or operate an existing affected source, you must
comply with the applicable provisions of this subpart no later than the
dates specified in tables 1 through 5 to this subpart, as applicable.
(2) If you own or operate a new affected source, and the initial
startup of your affected source is on or before April 5, 2024, you must
comply with the provisions of this subpart no later than April 5, 2024.
(3) If you own or operate a new affected source, and the initial
startup is after April 5, 2024, you must comply with the provisions of
this subpart upon startup of your affected source.
(4) If existing SCV, ARV, or CEV or parts of an existing collection
of Group 1 or Group 2 room air emissions are replaced such that the
replacement meets the definition of reconstruction in Sec. 63.2 and
the reconstruction commenced after April 13, 2023, then the existing
affected source becomes a new affected source. The reconstructed source
must comply with the requirements for a new affected source upon
initial startup of the reconstructed source or by April 5, 2024,
whichever is later.
(5) All existing SCVs at facilities that meet or exceed 1 tpy of
EtO use within any consecutive 12-month period after April 7, 2025,
that increase their EtO use after April 6, 2026, such that the SCV
becomes subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(6) All existing SCVs at facilities that do not exceed 1 tpy of EtO
use within any consecutive 12-month period after April 6, 2026, that
increase their EtO use thereafter, such that the SCV becomes subject to
a more stringent emission standard, immediately upon becoming subject
to the more stringent emission standard.
(7) All new SCVs at facilities that increase their EtO use over a
year after startup such that the SCV becomes subject to a more
stringent emission standard, immediately upon becoming subject to the
more stringent emission standard.
(8) All existing ARVs at facilities that meet or exceed 10 tpy of
EtO use within any consecutive 12-month period after April 7, 2025,
that increase their EtO use after April 6, 2026, such that the ARV
becomes subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(9) All existing ARVs at facilities that do not exceed 10 tpy of
EtO use within any consecutive 12-month period after April 6, 2026,
that increase their EtO use after thereafter, such that the ARV becomes
subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(10) All new ARVs at facilities that increase their EtO use over a
year after startup such that the ARV becomes subject to a more
stringent emission standard, immediately upon becoming subject to the
more stringent emission standard.
(11) All existing CEVs at facilities that do not exceed 60 tpy of
EtO use within any consecutive 12-month period after April 6, 2026,
that increase their EtO use thereafter, such that the CEV becomes
subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(12) All new CEVs at facilities that increase their EtO use over a
year after startup such that the CEV becomes subject to a more
stringent emission standard, immediately upon becoming subject to the
more stringent emission standard.
(13) All existing collections of Group 1 room air emissions at
facilities that do not exceed 40 tpy of EtO use within any consecutive
12-month period after April 6, 2026, that increase their EtO use
thereafter, such that the collection of Group 1 room air emissions
becomes subject to a more stringent emission
[[Page 24173]]
standard, immediately upon becoming subject to the more stringent
emission standard.
(14) All new Group 1 room air emissions at facilities that increase
their EtO use over a year after startup such that the Group 1 room air
emissions become subject to a more stringent emission standard,
immediately upon becoming subject to the more stringent emission
standard.
(15) All existing collections of Group 2 room air emissions at
facilities that meet or exceed 4 tpy of EtO use within any consecutive
12-month period after April 7, 2025, that increase their EtO use after
April 6, 2026, such that the collection of Group 2 room air emissions
becomes subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(16) All existing collections of Group 2 room air emissions at
facilities that do not exceed 4 tpy of EtO use within any consecutive
12-month period after April 6, 2026, that increase their EtO use
thereafter, such that the collection of Group 2 room air emissions
becomes subject to a more stringent emission standard, immediately upon
becoming subject to the more stringent emission standard.
(17) All new Group 2 room air emissions at facilities that increase
their EtO use over a year after startup such that the Group 2 room air
emissions become subject to a more stringent emission standard,
immediately upon becoming subject to the more stringent emission
standard.
Sec. 63.361 Definitions.
Terms and nomenclature used in this subpart are defined in the
Clean Air Act (the Act) as amended in 1990, Sec. Sec. 63.2 and 63.3,
or in this section. For the purposes of this subpart, if the same term
is defined in subpart A of this part and in this section, it shall have
the meaning given in this section.
Acid-water scrubber means an add-on air pollution control device
that uses an aqueous or alkaline scrubbing liquor to absorb and
neutralize acid gases.
Aeration means, for the purposes of this rule, exposing sterilized
material at elevated temperatures to drive EtO out of the material.
Aeration room means any vessel or room that is used to facilitate
off-gassing of EtO at a sterilization facility. If a facility uses only
combination sterilization units, for the purposes of this rule, there
are no aeration rooms at the facility.
Aeration room vent (ARV) means the point(s) through which the
evacuation of EtO-laden air from an aeration room occurs. For
combination sterilization units, there is no ARV.
Catalytic oxidizer means a combustion device that uses a solid-
phase catalyst to lower the temperature required to promote the
oxidization and achieve adequate reduction of volatile organic
compounds, as well as volatile hazardous air pollutants.
Chamber exhaust vent (CEV) means the point(s) through which EtO-
laden air is removed from the sterilization chamber during chamber
unloading following the completion of sterilization and associated air
washes. This may also be referred to as a ``backvent'' (or ``back
vent''). For combination sterilization units, there is no CEV.
Combination sterilization unit means any enclosed vessel in which
both sterilization and aeration of the same product occur within the
same vessel, i.e., the vessel is filled with ethylene oxide gas or an
ethylene oxide/inert gas mixture for the purpose of sterilizing and is
followed by aeration of ethylene oxide.
Combined emission stream means when the emissions from more than
one emission source are routed together using common ductwork prior to
the control system.
Continuous monitoring system (CMS) means, for the purposes of this
rule, the equipment necessary to continuously samples the regulated
parameter specified in Sec. 63.364 or Sec. 63.365 of this subpart
without interruption, evaluates the detector response at least once
every 15 seconds, and computes and records the average value at least
every 60 seconds, except during allowable periods of calibration and
except as defined otherwise by the continuous emission monitoring
system (CEMS) performance specifications (PS) in appendix B to part 60
of this chapter.
Control System Residence Time means the time elapsed from entrance
of flow into the control system until gaseous materials exit the
control system. For control systems with multiple exhaust streams
whereby the residence time may vary for the streams, the residence time
for purposes of complying with this subpart means the longest residence
time for any exhaust stream in use. If a peak shaver is used, it is
part of the control system, and its residence time must be considered.
Deviation means any instance in which an owner or operator of an
affected source, subject to this subpart:
(1) Fails to meet any requirement or obligation established by this
subpart including, but not limited to, any emission limitation,
parameter value, or best management practice; or
(2) Fails to meet any term or condition that is adopted to
implement an applicable requirement in this subpart or that is included
in the operating permit for any facility required to obtain such a
permit.
EtO dispensing means charging a sterilization chamber or chambers
with EtO from non-cartridge storage media (e.g., drums, cylinders) via
the use of piping, lines, and other equipment. This includes injection
rooms and post-injection handling of containers.
Gas/solid reactor means an add-on air pollution control device that
uses a dry, solid-phase system to chemically convert EtO so that it
becomes bound to the solid packing. This may also be referred to as a
``dry bed reactor'' or a ``dry bed scrubber.''
Group 1 room air emissions mean emissions from indoor EtO storage,
EtO dispensing, vacuum pump operations, and pre-aeration handling of
sterilized material.
Group 2 room air emissions mean emissions from post-aeration
handling of sterilized material.
Indoor EtO storage means the storage of EtO within non-cartridge
media (e.g., drums, cylinders) inside a sterilization building.
Initial startup means the moment when an affected source subject to
an emissions standard in Sec. 63.362 first begins operation.
Injection room means any room where EtO is injected into containers
(e.g., bags, pouches) that are filled with product to be sterilized.
Maximum ethylene glycol concentration means the concentration of
ethylene glycol in the scrubber liquor of an acid-water scrubber
control device established during a performance test when the scrubber
achieves the appropriate control of EtO emissions.
Maximum gas/solid reactor pressure drop means the pressure drop of
the gas/solid reactor established during a performance test when the
gas/solid reactor achieves the appropriate control of EtO emissions.
Maximum liquor tank level means the level of scrubber liquor in the
acid-water scrubber liquor recirculation tank established during a
performance test when the scrubber achieves the appropriate control of
EtO emissions.
Maximum scrubber liquor pH means the pH of the acid-water scrubber
liquor established during a performance test when the scrubber achieves
the appropriate control of EtO emissions.
Minimum stack volumetric flow rate means the stack volumetric flow
rate corrected established during a compliance demonstration when
[[Page 24174]]
permanent total enclosure (PTE) requirements are met.
Minimum temperature at the inlet to the catalyst bed means the
temperature at the inlet to the catalyst bed established during a
performance test when the catalytic oxidizer achieves the appropriate
control of EtO emissions.
Minimum temperature difference across the catalyst bed means the
temperature difference across the catalyst bed established during a
performance test when the catalytic oxidizer achieves the appropriate
control of EtO emissions.
Minimum temperature in or immediately downstream of the firebox
means the temperature in or immediately downstream of the firebox
established during a performance test when the thermal oxidizer
achieves the appropriate control of EtO emissions.
Natural draft opening (NDO) means any permanent opening in the
enclosure that remains open during operation of the facility and is not
connected to a duct in which a fan is installed.
Operating day means any day that a facility is engaged in a
sterilization operation.
Peak shaver means a device that is used to reduce high EtO
concentrations within an exhaust stream such that the downstream
control device is not overwhelmed.
Permanent total enclosure (PTE) means a permanently installed
enclosure that meets the criteria of Method 204 of appendix M, 40 CFR
part 51 for a PTE. A PTE completely surrounds a source of emissions
such that all EtO emissions are captured, contained, and directed to a
control system or to an outlet(s).
Post-aeration handling of sterilized material means the storage and
transportation of material that has been removed from aeration but has
not been placed in a vehicle for the sole purpose of distribution to
another facility. Post-aeration handling of sterilized material ends
when that vehicle is closed for the final time before leaving the
facility. This definition does not include handling of material that
has been both previously sterilized and not removed from aeration
following re-sterilization.
Post-injection handling of containers means the storage and
transportation of containers (e.g., bags, pouches) that have been
injected with EtO but have not been placed in a sterilization chamber.
Pre-aeration handling of sterilized material means the storage and
transportation of material that has been removed from a sterilization
chamber but has not been placed in an aeration room. If only
combination sterilization units are used, and if material is not moved
out of the vessel between sterilization and aeration, then emissions
from this source do not exist. This does not include post-injection
handling of containers.
Rolling sum means the weighted sum of all data, meeting QA/QC
requirements or otherwise normalized, collected during the applicable
rolling time period. The period of a rolling sum stipulates the
frequency of data collection, summing, and reporting. As an example, to
demonstrate compliance with a rolling 30-operating day sum emission
reduction standard determined from hourly data, you must (1) determine
the total mass of ethylene oxide prior to control and following control
for each operating day; (2) then sum the current daily total mass prior
to control with the previous 29 operating day total mass values and
repeat the same process for the current daily total mass following
control; and (3) then divide the 30-operating day total mass emissions
following control by the 30-operating day total mass prior to control
and subtract the resulting value from one to obtain the 30-operating
day emission reduction achieved.
Single-item sterilization means a process in which one or more
items are placed in a pouch, EtO is injected into the pouch, and the
sealed pouch is placed in a vessel to allow sterilization to occur.
Sterilization chamber means any enclosed vessel or room that is
filled with EtO gas, or an EtO/inert gas mixture, for the purpose of
sterilizing and/or fumigating at a sterilization facility. This does
not include injection rooms.
Sterilization chamber vent (SCV) means the point (prior to the
vacuum pump) through which the evacuation of EtO from the sterilization
chamber occurs following sterilization or fumigation, including any
subsequent air washes.
Sterilization facility means any stationary source where EtO is
used in the sterilization or fumigation of materials, including but not
limited to facilities that engage in single-item sterilization.
Sterilization operation means any time when EtO is removed from the
sterilization chamber through the SCV or the chamber exhaust vent, when
EtO is removed from the aeration room through the aeration room vent,
when EtO is stored within the building, when EtO is dispensed from a
container to a chamber, when material is moved from sterilization to
aeration, or when materials are handled post-aeration.
Thermal oxidizer means all combustion devices except flares.
Vacuum pump operation means the operation of vacuum pumps,
excluding dry seal vacuum pumps, for the purpose of removing EtO from a
sterilization chamber.
Sec. 63.362 Standards.
(a) Compliance date. If you own or operate an affected source, you
must comply with the applicable requirement by the compliance date
specified in Sec. 63.360(j). The standards of this section are
summarized in tables 1 through 5 to this subpart.
(b) Applicability of standards. The standards in paragraphs (c)
through (k) of this section apply at all times. If using EtO CEMS to
determine compliance with an applicable standard, this compliance
demonstration is based on the previous 30-operating days of data. If
using EtO CEMS to determine compliance with an applicable emission
reduction standard in paragraphs (c) through (g) and (i) of this
section for each operating day, you must determine the total inlet mass
to and outlet mass from the control system using the procedures laid
out in Sec. 63.364(f) and appendix A to this subpart, and you must
maintain the emission limit based on the inlet mass and the applicable
emission reduction standard. If using EtO CEMS to determine compliance
with an applicable emission reduction standard in paragraph (j) of this
section, you must continuously comply with the requirements of that
paragraph.
(c) SCV. You must comply with each applicable standard in table 1
to this subpart, and you must meet each applicable requirement
specified in Sec. 63.363. If a SCV is combined with a stream from
another emission source, you must comply with the appropriate emission
standard as prescribed in paragraph (i) of this section.
(d) ARV. You must comply with each applicable standard in table 2
to this subpart, and you must meet each applicable requirement
specified in Sec. 63.363. If an ARV is combined with a stream from
another emission source, you must comply with the appropriate emission
standard as prescribed in paragraph (i) of this section.
(e) CEV. You must comply with each applicable standard in table 3
to this subpart, and you must meet each applicable requirement
specified in Sec. 63.363. If a CEV is combined with a stream from
another emission source, you must comply with the appropriate emission
standard as prescribed in paragraph (i) of this section.
(f) Group 1 room air emissions. You must comply with the applicable
[[Page 24175]]
standard in table 4 to this subpart, and you must meet each applicable
requirement specified in Sec. 63.363. If Group 1 room air emissions
are combined with a stream from another emission source, you must
comply with the appropriate emission standard as prescribed in
paragraph (i) of this section.
(g) Group 2 room air emissions. You must comply with the applicable
standard in table 5 to this subpart, and you must meet each applicable
requirement specified in Sec. 63.363. If Group 2 room air emissions
are combined with a stream from another emission source, you must
comply with the appropriate emission standard as prescribed in
paragraph (i) of this section. If you are required to limit the
sterilization chamber concentration of EtO to 1 ppmv prior to opening
the sterilization chamber door, you must meet the monitoring
requirements specified in Sec. 63.364(h).
(h) Capture systems. Room air emissions for which numerical limits
are prescribed must be captured and routed under negative pressure to a
control system. You may assume the capture system efficiency is 100
percent if both conditions in paragraphs (h)(1) and (2) of this section
are met:
(1) The capture system meets the criteria in Method 204 of appendix
M to 40 CFR part 51 for a PTE and directs all the exhaust gases from
the enclosure to an add-on control system.
(2) All sterilization operations creating exhaust gases for which
the compliance demonstration is applicable are contained within the
capture system.
(i) Requirements for combined emission streams. When streams from
two or more emission sources are combined, you must demonstrate
compliance by either the approach specified in paragraph (i)(1) of this
section or the approach specified in paragraph (i)(2) of this section
in lieu of the applicable standards in paragraphs (c) through (g) of
this section for the affected source. The combined emission stream
limit is based on as 30-operating day rolling sum. In order to elect to
comply with a combined emission streams limit, you must use a CEMS on
each exhaust stack at the facility to determine compliance.
(1) Monitoring after emission streams are combined. You must follow
requirements of paragraphs (i)(1)(i) through (iii) of this section to
determine the applicable combined emission streams limitation and
demonstrate compliance. Under this approach, you must first determine
the 30-operating day rolling sum of mass inlet to the control system.
Then, the emission limitation is determined by applying the most
stringent emission reduction standard to the 30-operating day rolling
sum of the inlet mass. You must maintain actual emissions at or below
that rate. For example, suppose a facility controls all of its ARVs and
CEVs with one control system and that the emission reduction standards
that apply to the ARVs and CEVs are 99.9% and 99%, respectively.
Further suppose that the mass of uncontrolled EtO emissions from the
combined stream is 5 lb during the 30-operating day period. Under this
approach, the facility would need to apply an emission reduction of
99.9% to the combined stream, resulting in an emission limit of 0.005
lb for the 30-operating day period.
(i) The combined emission streams limit for each 30-operating day
period is determined daily by using equation 1 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.028
Where:
CESCombined = The combined emission stream limit based
upon monitoring after the emission streams are combined, in pounds.
M30day = The 30-operating day total mass sent to controls
for the combined emission stream (i.e., monitoring data at the inlet
of the control system), as calculated using equation A-3 and
determined in accordance with appendix A to this subpart. The term
``M30day'' as used in this equation is equivalent to the
term ``E30day'' as designated in equation A-3.
Max(ER) = The most stringent emission reduction standard specified
in tables 1 through 5 of this subpart applicable to any of the
constituent streams, in decimal format.
(ii) The 30-operating day rolling sum of emissions for the combined
emission stream (i.e., monitoring data at the outlet of the control
system) is calculated daily using equation A-3 and determined in
accordance with appendix A to this subpart. For purposes of this
section, this value is designated as ECombined. If the
combined emission stream is split between two or more control systems,
further sum the 30-operating day rolling sum of emissions from each
control system to obtain ECombined.
(iii) Compliance with the combined emission streams limitation
shall be determined by demonstrating that ECombined, as
calculated in accordance with paragraph (i)(1)(ii) of this section, for
each 30-operating day period is at or below CESCombined, as
calculated in paragraph (i)(1)(i) of this section.
(2) Monitoring before emission streams are combined. You must
follow requirements of paragraphs (i)(2)(i) through (iii) of this
section to determine the applicable combined emission streams
limitation and demonstrate compliance. Under this approach, you must
first determine 30-operating day rolling sum of inlet mass to the
control system for each component stream. Then, the emission limitation
is determined by applying the applicable emission reduction standards
to the 30-operating day rolling sum of each component stream and
summing across the components. You must maintain actual emissions at or
below that rate. For example, suppose a facility controls all of its
ARVs and CEVs with one control system and that the emission reduction
standards that apply to the ARVs and CEVs are 99.9% and 99%,
respectively. Further suppose that during a 30-operating day period the
mass of uncontrolled EtO emissions from the ARVs is 4 lb and the mass
of uncontrolled EtO emissions from the CEVs is 1 lb. Under this
approach, the facility would need to apply an emission reduction of
99.9% to the ARV stream and an emission reduction of 99% to the CEV
stream, resulting in an emission limit of 0.014 lb for the 30-operating
day period.
(i) The combined emission streams limit for each 30-operating day
period is determined daily by using equation 2 to this paragraph.
[[Page 24176]]
[GRAPHIC] [TIFF OMITTED] TR05AP24.029
Where:
CESStreams = The combined emission stream limit based
upon monitoring before the emission streams are combined, in pounds.
Mc,i = The 30-operating day total mass sent to controls
for each non-SCV constituent emission stream (i.e., monitoring data
at the inlet of the control system), as calculated using equation A-
3 and determined in accordance with appendix A to this subpart. The
term ``Mc,i'' as used in this equation is equivalent to
the term ``E30day'' as designated in equation A-3.
ERi = The applicable emission reduction standard from
tables 2 through 5 of this subpart to each non-SCV constituent
emission stream i.
i = Non-SCV constituent emission stream index.
n = Total number of non-SCV constituent emission streams.
Mc,j = The 30-operating day total mass sent to controls
for each SCV emission stream, as determined in accordance with
equation 10 of Sec. 63.364(f)(1)(i)(C)(1).
ERj = The applicable SCV emission reduction standard in
table 1 to this subpart, in decimal format.
j = SCV emission stream index.
m = Total number of SCV emission streams.
(ii) The 30-operating day rolling sum emissions for the combined
emission stream (i.e., monitoring data at the outlet of the control
system) is calculated daily using equation A-3 and determined in
accordance with appendix A to this subpart. For purposes of this
section, this value is designated as ECombined. If the
combined emission stream is split between two or more control systems,
then further sum the 30-operating day rolling sum emissions from each
control system to obtain ECombined.
(iii) Compliance with the combined emission streams limitation
shall be determined by demonstrating that ECombined, as
calculated in accordance with paragraph (i)(2)(ii) of this section, for
each 30-operating day period is at or below CESStreams, as
calculated paragraph (i)(2)(i) of this section.
(3) If room air emissions are both subject to an emission standard
and split between two or more control systems, then these control
systems must be treated as part of the same control system.
(j) Site-wide emission limitation. You may choose to comply with a
site-wide emission limitation (SWEL) specified in this paragraph (j) in
lieu of the applicable standards in paragraphs (c) through (g) of this
section for the facility. The SWEL, which is calculated daily, is based
on the previous 30 operating days of data. In order to elect to comply
with a SWEL, you must utilize an EtO CEMS on each exhaust stack at the
facility to determine compliance. The owner or operator may demonstrate
compliance via one of the two SWEL approaches in lieu of the applicable
standard(s) in paragraphs (c) through (g) of this section for the
facility. If electing to comply with a SWEL, you must comply with
paragraph (j)(3) of this section.
(1) SWEL based upon facility EtO use. If you elect to comply with a
SWEL based upon facility EtO use, you must follow requirements of
paragraphs (j)(1)(i) through (iii) of this section to determine the
applicable SWEL and demonstrate compliance. Under this approach, you
first determine the 30-operating day rolling sum of EtO use. The SWEL
is determined by multiplying by 0.99 and then applying the required SCV
percent emission reduction standard in table 1 to this subpart to the
30-operating day rolling sum of EtO usage. Then, for each CEMS at the
outlet of the control systems at the facility, determine the 30-
operating day rolling sum of emissions. Finally, determine the facility
actual emissions by summing the 30-operating day rolling sums for each
CEMS at the facility. You must maintain actual emissions at or below
the SWEL.
(i) The SWEL for each 30-operating day period is determined daily
by using equation 3 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.030
Where:
SWELFac = SWEL based upon facility EtO use, in pounds.
MFac = Facility EtO use over the previous 30 operating
days, in pounds, as determined in accordance with equation 11 of
Sec. 63.364(i)(2).
0.99 = Adjustment factor for EtO residual in sterilized product.
ERSCV = The applicable SCV emission reduction standard in
table 1 to this subpart, in decimal format.
(ii) The 30-operating day rolling sum of emissions are determined
daily using equation 4 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.031
Where:
EFac = The total emissions from the facility over the
previous 30-operating days, in pounds.
Eo,i = The 30-operating day rolling sum of emissions
calculated at each exhaust stack, i, monitored by an EtO CEMS, as
calculated using equation A-3 of appendix A to this subpart.
i = Exhaust stack index
n = Total number of exhaust stacks
(iii) Compliance with the SWEL based upon facility EtO usage shall
be
[[Page 24177]]
determined by demonstrating that EFac, as calculated in
accordance with paragraph (j)(1)(ii) of this section, for each 30-
operating day period is at or below the SWEL, as calculated paragraph
(j)(1)(i) of this section.
(2) SWEL based upon emissions streams. If you elect to comply with
a SWEL based upon emissions streams, you must follow requirements of
paragraphs (j)(2)(i) through (iii) of this section to determine the
applicable SWEL and demonstrate compliance. Under this approach, for
each non-SCV affected source, you must determine the mass of EtO sent
to controls and apply the applicable emission reduction standard. For
each SCV affected source, you must determine the mass of EtO sent to
controls as specified in Sec. 63.364(f)(1)(i)(C)(1) and apply the
applicable emission reduction standard. The SWEL is determined by
summing across the result of this calculation for each affected source
(both non-SCV and SCV). Then, for each CEMS at the outlet of the
control system(s) at the facility, determine the 30-operating day
rolling sum of emissions. Finally, determine the facility actual
emissions by summing the 30-operating day rolling sums for each CEMS at
the facility. You must maintain actual emissions at or below the SWEL.
(i) The SWEL for each 30-operating day period is determined daily
by using equation 5 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.032
Where:
SWELStreams = SWEL based upon individual emissions
streams, in pounds.
Mc,i = The 30-operating day total mass sent to controls
(i.e., monitoring data at the inlet of the control system) for each
non-SCV emission stream, as calculated using equation A-3 and
determined in accordance with appendix A to this subpart. The term
``Mc,i'' as used in this equation is equivalent to the
term ``E30day'' as designated in equation A-3.
ERi = The applicable emission reduction standard to each
non-SCV emission stream, i, specified in tables 1 through 5 of this
subpart, in decimal format.
i = Non-SCV emission streams index.
n = Total number of non-SCV emission streams.
Mc,j = The 30-operating day total mass sent to controls
for each SCV emission stream, as determined in accordance with
equation 10 in Sec. 63.364(f)(1)(i)(C)(1).
ERj = The applicable SCV emission reduction standard in
table 1 to this subpart, in decimal format.
j = SCV emission stream index.
m = Total number of SCV emission streams.
(ii) The 30-operating day rolling sum of emissions are determined
daily using equation 4 to this section.
(iii) Compliance with the SWEL based upon emission streams shall be
determined by demonstrating that EFac, as calculated in
accordance with paragraph (j)(2)(ii) of this section, for each 30-
operating day period is at or below SWELStreams, as
calculated in paragraph (j)(2)(i) of this section.
(3) Boundary. The boundary for this approach includes all affected
sources at the facility.
(k) General duty. At all times, you must operate and maintain any
affected source, including associated air pollution control equipment
and monitoring equipment, in a manner consistent with safety and good
air pollution control practices for minimizing emissions. The general
duty to minimize emissions does not require the owner or operator to
make any further efforts to reduce emissions if levels required by the
applicable standard have been achieved. Determination of whether a
source is operating in compliance with operation and maintenance
requirements will be based on information available to the
Administrator which may include, but is not limited to, monitoring
results, review of operation and maintenance procedures, review of
operation and maintenance records, and inspection of the source.
Sec. 63.363 Compliance and performance provisions.
(a) Continuous compliance. You must demonstrate continuous
compliance with the applicable emission standard(s) using an EtO CEMS,
including a shared EtO CEMS, installed and operated in accordance with
the requirements of Performance Specification 19 in appendix B and
Procedure 7 in appendix F to part 60 of this chapter. Alternatively, if
you own or operate a facility where EtO use is less than 100 pounds/yr,
you may demonstrate continuous compliance by conducting annual
performance tests using the performance testing requirements in Sec.
63.7, according to the applicability in table 6 to this subpart, the
procedures listed in this section, and the test methods listed in Sec.
63.365. If you elect to demonstrate compliance through periodic
performance testing, you must also demonstrate continuous compliance
with each operating limit required under this section according to the
methods specified in Sec. 63.364. If you own or operate an area source
facility where EtO use is less than 100 pounds/yr where an existing
collection of Group 2 room air emission is operated in accordance with
the PTE requirements of EPA Method 204 of appendix M to part 51 of this
chapter, you may instead conduct these performance tests once every
three years.
(b) Initial compliance for Facilities that use EtO CEMS. To
demonstrate initial compliance with an emission standard using a CEMS
that measures HAP concentrations directly (i.e., an EtO CEMS), the
initial performance test must consist of the first 30 operating days
after the certification of the CEMS according to Performance
Specification 19 in Appendix B to part 40 of this chapter. The initial
compliance demonstration period must be completed on or before the date
that compliance must be demonstrated (i.e., 180 days after the
applicable compliance date). You must follow the procedures in appendix
A to this subpart.
(1) The CEMS performance test must demonstrate compliance with the
applicable EtO standards in tables 1 through 5 to this subpart.
Alternatively, the CEMS performance test may demonstrate compliance
with Sec. 63.362(i) or (j).
(i) You may time-share your CEMS among different measurement points
provided that:
(A) The measurement points are approximately equidistant from the
CEMS;
(B) The sampling time at each measurement point is at least 3 times
as long as the CEMS response time;
(C) The CEMS completes at least one complete cycle of operation for
each shared measurement point within a 15-minute period; and
[[Page 24178]]
(D) The CEMS meets the other requirements of PS 19.
(2) You must collect hourly data from auxiliary monitoring systems
during the performance test period, to convert the pollutant
concentrations to pounds per hour.
(c) Initial compliance demonstration where facility EtO use is less
than 100 pounds per year. If you own or operate an affected source that
is both subject to an emission standard in Sec. 63.362 and located
within a facility where EtO use is less than 100 pounds per year, you
may comply with paragraphs (c)(1) and (2) of this section:
(1) Conduct an initial compliance demonstration using the
procedures listed in Sec. 63.7 of this part according to the
applicability in table 6 to this subpart, the procedures listed in this
section, and the test methods listed in Sec. 63.365;
(2) Complete the initial compliance demonstration within 180 days
after the compliance date for the affected source as determined in
Sec. 63.360(j).
(d) Operating limits for facility where EtO use is less than 100
lb/yr. If annual EtO use at the facility is less than 100 lb, the
procedures in paragraphs (d)(1) through (5) of this section may be used
to determine compliance with the standard(s) under Sec. 63.362(c)
through (g) and to establish operating limits for each of the control
devices, as applicable:
(1) You must determine the percent emission reduction of the
control system used to comply with Sec. 63.362(c) through (g) using
the test methods and procedures in Sec. 63.365(d)(1).
(2) If an acid-water scrubber(s) is used to comply with a standard,
then you must establish as an operating limit:
(i) The maximum ethylene glycol concentration using the procedures
described in Sec. 63.365(e)(1)(i);
(ii) The maximum liquor tank level using the procedures described
in Sec. 63.365(e)(1)(ii); or
(iii) The maximum scrubber liquor pH using the procedures described
in Sec. 63.365(e)(1)(iii).
(3) If a thermal oxidizer(s) is used to comply with a standard, you
must establish as an operating limit the minimum temperature in or
immediately downstream of the firebox using the procedures described in
Sec. 63.365(e)(2).
(4) If a catalytic oxidizer(s) is used to comply with the standard,
you must establish as operating limits both:
(i) The minimum temperature at the inlet to the catalyst bed using
the procedures described in Sec. 63.365(e)(3); and
(ii) The minimum temperature difference across the catalyst bed
using the procedures described in Sec. 63.365(e)(3).
(5) If a gas/solid reactor(s) is used to comply with the standard,
you must establish as an operating limit the pressure drop across the
media beds and conduct weekly sampling and analysis of the media.
Determine the maximum gas/solid reactor pressure drop using the
procedures described in Sec. 63.365(e)(4).
(e) Other control technology for facility where EtO use is less
than 100 lb/yr. If you are conducting a performance test using a
control technology other than an acid-water scrubber, catalytic
oxidizer, thermal oxidizer, or gas/solid reactor, you must provide to
the Administrator information describing the design and operation of
the air pollution control system, including recommendations for the
parameters to be monitored that will demonstrate continuous compliance.
Based on this information, the Administrator will determine the
parameter(s) to be measured during the performance test. During the
performance test required in paragraph (a) of this section, using the
methods approved in Sec. 63.365(e)(5), you must determine the site-
specific operating limit(s) for the operating parameters approved by
the Administrator. You must submit the information at least sixty days
before the performance test is scheduled to begin. The information on
the control technology must include the five items listed in paragraphs
(1) through (5) of this section:
(1) Identification of the specific parameters you propose to use as
additional operating limits;
(2) A discussion of the relationship between these parameters and
emissions of regulated pollutants, identifying how emissions of
regulated pollutants change with changes in these parameters and how
limits on these parameters will serve to limit emissions of regulated
pollutants;
(3) A discussion of how you will establish the upper and/or lower
values which will establish the operating limits for these parameters;
(4) A discussion identifying the methods you will use to measure
and the instruments you will use to monitor these parameters, as well
as the relative accuracy and precision of these methods and
instruments; and
(5) A discussion identifying the frequency and methods for
recalibrating the instruments you will use for monitoring these
parameters.
(f) Other emission streams. If the emission stream does not consist
only of an SCV(s), the procedures in paragraphs (f)(1) through (3) of
this section shall be used to determine initial compliance with the
emission limits under Sec. 63.362(d) through (g), as applicable:
(1) You must comply with paragraph (c) of this section, as
applicable.
(2) If you are complying with a percent emission reduction standard
as specified in tables 1 through 5 to this subpart, you must determine
compliance with Sec. 63.362(c) through (g), as applicable, using the
test methods and procedures in Sec. 63.365(d)(1).
(3) If you are required to operate any portion of the facility
under PTE, you must initially demonstrate that the PTE meets the
requirements of Method 204 of 40 CFR part 51, appendix M, and that all
exhaust gases from the enclosure are delivered to a control system or
stack(s). You must also meet the requirements in Sec. 63.363(f)(3)(i)
and either Sec. 63.363(f)(3)(ii) or (iii):
(i) Maintain direction of the airflow into the enclosure at all
times, verifying daily using the procedures described in Sec.
63.364(f)(5) and meet either of the requirements.
(ii) Establish as an operating limit the minimum volumetric flow
rate through the affected stack(s) using the procedures described in
Sec. 63.365(f)(1); or
(iii) Install, operate, calibrate, and maintain a continuous
pressure differential monitoring system using the procedures described
in Sec. 63.364(f)(4).
Sec. 63.364 Monitoring requirements.
(a) General requirements. (1) If you own or operate an affected
source subject to an emission standard in Sec. 63.362, you must comply
with the monitoring requirements in Sec. 63.8, according to the
applicability in table 6 to this subpart, and in this section.
(2) If you own or operate an affected source at a facility where
EtO use is less than 100 lb/yr that is subject to an emission standard
in Sec. 63.362, you may monitor the parameters specified in paragraphs
(b), (c), (d), (e), (g), and (i) of this section. All monitoring
equipment shall be installed such that representative measurements of
emissions or process parameters from the source are obtained. For
monitoring equipment purchased from a vendor, verification of the
operational status of the monitoring equipment shall include completion
of the manufacturer's written specifications or recommendations for
installation, operation, and calibration of the system.
(3) If you own or operate an affected source that is subject to an
emission standard in Sec. 63.362 and that is required to monitor using
EtO CEMS, you must
[[Page 24179]]
comply with paragraphs (f), (g), and (i) of this section.
(4) If you comply with the management practice for Group 2 room air
emissions at area sources, you must comply with paragraph (h) of this
section.
(5) You must keep the written procedures required by Sec.
63.8(d)(2) on record for the life of the affected source or until the
affected source is no longer subject to the provisions of this part, to
be made available for inspection, upon request, by the Administrator.
If the performance evaluation plan is revised, you must keep previous
(i.e., superseded) versions of the performance evaluation plan on
record to be made available for inspection, upon request, by the
Administrator, for a period of 5 years after each revision to the plan.
The program of corrective action should be included in the plan
required under Sec. 63.8(d)(2).
(b) Acid-water scrubbers. If you are demonstrating continuous
compliance through periodic performance testing on an acid-water
scrubber(s), you must:
(1) Ethylene glycol concentration. Sample the scrubber liquor from
the acid-water scrubber(s) and analyze and record at least once per
week the ethylene glycol concentration of the scrubber liquor using the
test methods and procedures in Sec. 63.365(e)(1). Monitoring is
required during a week only if the scrubber unit has been operated. You
must maintain the weekly ethylene glycol concentration below the
operating limit established during the most recent performance test;
(2) Scrubber liquor tank level. Measure and record at least once
per day the level of the scrubber liquor in the recirculation tank(s).
You must install, maintain, and use a liquid level indicator to measure
the scrubber liquor tank level (i.e., a marker on the tank wall, a
dipstick, a magnetic indicator, etc.). Monitoring is required during a
day only if the scrubber unit has been operated. You must maintain the
daily scrubber liquor height in each recirculation tank below the
applicable operating limit established during the most recent
performance test; or
(3) pH. Monitor and record at least every 15 minutes the scrubber
liquor pH. Monitoring is required when the scrubber is operating. A
data acquisition system for the pH monitor shall compute and record
each 3-hour average scrubber liquor pH value, rolled hourly. This must
be done by first averaging the scrubber liquor pH readings obtained
over a clock hour, i.e., beginning and ending on the hour. All data
collected during the operating hour must be used, even if the scrubber
unit is not operating for a complete hour. Then, the average of the
previous 3 operating hours must be calculated to determine the 3-hour
rolling average scrubber liquor pH. You must maintain the 3-hour
rolling average scrubber liquor pH below the applicable operating limit
established during the most recent performance test. You must ensure
the pH monitoring system meets the following requirements:
(i) The pH sensor must be installed in a position that provides a
representative measurement of scrubber liquor pH;
(ii) The sample must be properly mixed and representative of the
fluid to be measured; and
(iii) A performance evaluation (including a two-point calibration
with one of the two buffer solutions having a pH within 1 of the pH of
the operating limit) of the pH monitoring system must be conducted in
accordance with your monitoring plan at the time of each performance
test but no less frequently than quarterly.
(c) Oxidizers. If you are demonstrating continuous compliance
through periodic performance testing on a catalytic oxidizer or thermal
oxidizer, the requirements in paragraphs (c)(1) and (2) of this section
apply:
(1) For thermal oxidizers, you must monitor and record at least
every 15 minutes the temperature in or immediately downstream of the
firebox using the temperature monitor described in paragraph (c)(4) of
this section. Monitoring is required when the thermal oxidizer is
operating. A data acquisition system for the temperature monitor shall
compute and record each 3-hour average temperature value, rolled
hourly. This must be done by first averaging the temperature readings
over a clock hour, i.e., beginning and ending on the hour. All data
collected during the operating hour must be used, even if the thermal
oxidizer is not operating for a complete hour. Then, the average of the
previous 3 operating hours must be calculated to determine the 3-hour
rolling average temperature in or immediately downstream of the
firebox. You must maintain the 3-hour rolling average temperature above
the operating limit established during the most recent performance
test.
(2) For catalytic oxidizers, you must monitor and record at least
every 15 minutes the temperature at the inlet to the catalyst bed using
the temperature monitor described in paragraph (c)(4) of this section.
Monitoring is required when the catalytic oxidizer is operating. A data
acquisition system for the temperature monitor shall compute and record
each 3-hour average temperature, rolled hourly. This must be done by
first averaging the temperature readings over a clock hour, i.e.,
beginning and ending on the hour. All data collected during the
operating hour must be used, even if the catalytic oxidizer is not
operating for a complete hour. Then, the average of the previous 3
operating hours must be calculated to determine the 3-hour rolling
average temperature at the inlet to the catalyst bed. You must maintain
the 3-hour rolling average temperature above the operating limit
established during the most recent performance test.
(3) For catalytic oxidizers, you must monitor and record at least
every 15 minutes the temperature increase across the catalyst bed,
immediately downstream of the catalytic bed, using the temperature
monitor described in paragraph (c)(4) of this section. Monitoring is
required when the catalytic oxidizer is operating. A data acquisition
system for the temperature monitor shall compute and record each 3-hour
average temperature increase, rolled hourly. This must be done by first
computing the difference in outlet temperature minus inlet temperature
(monitored under paragraph (c)(2)), and second averaging the
temperature difference values over a clock hour, i.e., beginning and
ending on the hour. All data collected during the operating hour must
be used, even if the catalytic oxidizer is not operating for a complete
hour. Then, the average of the previous 3 operating hours must be
calculated to determine the 3-hour rolling average temperature increase
across the catalyst bed. You must maintain the 3-hour average
temperature increase above the operating limit established during the
most recent performance test.
(4) You must install, calibrate, operate, and maintain a
temperature monitor with a minimum accuracy of 1 percent
over the normal range of the temperature measured, expressed in degrees
Celsius, or 2.8 degrees Celsius, whichever is greater. You must verify
the accuracy of the temperature monitor twice each calendar year at
least five months apart with a reference temperature monitor (traceable
to National Institute of Standards and Technology (NIST) standards or
an independent temperature measurement device dedicated for this
purpose). During accuracy checking, the probe of the reference device
shall be at the same location as that of the temperature monitor being
tested. As an alternative, the accuracy of the temperature monitor may
be verified in a calibrated oven (traceable to NIST standards).
(5) For catalytic oxidizers, if the monitor indicates that the
temperature is below the operating limit, within 7 calendar days you
must:
[[Page 24180]]
(i) Correct the temperature or temperature increase so that it
falls within the established operating range; or
(ii) Replace the catalyst bed. Following replacement of the
catalyst bed, you must conduct a new performance test within 180 days
and re-establish the operating limits.
(d) Gas-solid reactors. If you are demonstrating continuous
compliance through periodic performance testing on a gas/solid
reactor(s), you must:
(1) Media analysis. Sample the media from the gas/solid reactor(s)
and have the manufacturer analyze at least once per week. Monitoring is
required during a week only if the gas/solid reactor unit has been
operated; and
(2) Pressure drop. Monitor and record at least every 15 minutes the
pressure drop. Monitoring is required when the gas/solid reactor is
operating. A data acquisition system for the pressure drop monitor
shall compute and record each 3-hour average gas/solid reactor pressure
drop value, rolled hourly. This must be done by first averaging the
gas/solid reactor pressure drop readings obtained over a clock hour,
i.e., beginning and ending on the hour. All data collected during the
operating hour must be used, even if the gas/solid reactor unit is not
operating for a complete hour. Then, the average of the previous 3
operating hours must be calculated to determine the 3-hour rolling
average gas/solid reactor pressure drop. You must maintain the 3-hour
rolling average gas/solid reactor pressure drop below the applicable
operating limit established during the most recent performance test.
(e) Performance testing, other control technology. If you are
complying with Sec. 63.363(d) or (e) using periodic performance
testing and the use of a control device other than acid-water
scrubbers, catalytic or thermal oxidizers, or gas/solid reactors, you
must monitor the parameters as approved by the Administrator using the
methods and procedures in Sec. 63.365(e).
(f) EtO CEMS configurations. If you are using EtO CEMS to
demonstrate compliance with an emission standard, you must install and
operate an EtO CEMS on each outlet for the control system in accordance
with the requirements of Appendix A to subpart O of this part. You must
also conduct monitoring for each inlet to the control system that is
used to demonstrate compliance with the emission reduction standard in
accordance with the requirements of appendix A to this subpart, with
the exception for SCV emission streams to the control system.
(1) EtO CEMS inlet configuration. The following caveats apply:
(i) SCVs. If you do not own or operate a single-item sterilizer, to
demonstrate compliance with the percent emission reduction standards
for emissions streams that are comprised only of SCVs, you may use the
following procedures as an alternative to monitoring the inlet emission
stream to determine the mass emissions of EtO being emitted via
sterilization chamber(s) vents prior to the controls.
(A) Determine the mass (MSCV,n) of EtO used for each
charge and at each sterilization chamber used during the previous 30
days using the procedures in either paragraph (f)(1)(i)(A)(1) or (2) of
this section.
(1) Weigh the EtO gas cylinder(s) used to charge the sterilizer(s)
before and after charging. Record these weights to the nearest 45 g
(0.1 lb) and calculate the theoretical mass (Mc) vented to
the controls using equation 1 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.033
Where:
MSCV,n = Theoretical total mass of EtO vented to controls
per charge, g (lb)
Mcharge = total mass of sterilizer gas charge, g (lb)
%EOw = weight percent of EtO
(2) Install a calibrated rate meter at the sterilizer inlet(s) and
continuously measure the flow rate (Qm) and duration of each
sterilizer charge. Calculate the theoretical mass (MSCV,n)
vented to the controls using equation 2 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.034
Where:
MSCV,n = theoretical total mass of EtO sent to controls
per charge
Qm = volumetric flow rate, liters per minute (L/min)
corrected to 20 [deg]C and 101.325 kilopascals (kPa) (scf per minute
(scfm) corrected to 68 [deg]F and 1 atmosphere of pressure (atm))
Tn = time duration of each charge, min
%EOv = volume fraction percent of EtO
n = number of EtO charges
MW = molecular weight of EtO, 44.05 grams per gram-mole (g/g-mole)
(44.05 pounds per pound-mole (lb/lb-mole))
SV = standard volume, 24.05 liters per gram-mole (L/g-mole) at 20
[deg]C and 101.325 kPa (385.1 scf per pound-mole (scf/lb-mole) at 68
[deg]F and 1 atm).
(B) Determine the adjustment factor (f) using equation 8 to this
paragraph. Determine the mass of EtO sent to controls from all non-SCV
affected sources, I, using equation 4 to this paragraph. For facilities
where EtO use is less than 4 tpy, if not all Group 2 room air emissions
are routed to a control device, do not include Group 2 room air
emissions in I, and subtract 0.002 from this factor.
[[Page 24181]]
[GRAPHIC] [TIFF OMITTED] TR05AP24.035
Where:
f = Adjustment factor.
I = Mass of non-SCV EtO routed to control devices over the previous
30 operating days
MFac = Facility EtO use over the previous 30-operating
days, in pounds, as determined in accordance with equation 11 of
Sec. 63.364(i)(2)
[GRAPHIC] [TIFF OMITTED] TR05AP24.036
Where:
I = Mass of non-SCV EtO routed to control devices over the previous
30 operating days
Mc,i = The 30-operating day total mass sent to controls
(i.e., monitoring data at the inlet of the control system) for each
non-SCV emission stream, as calculated using equation A-3 and
determined in accordance with appendix A to this subpart. The term
``Mc,i'' as used in this equation is equivalent to the
term ``E30day'' as designated in equation A-3.
i = Non-SCV emission stream index.
n = Total number of non-SCV emission streams.
(C)(1) Determine the mass rate of EtO sent to controls during the
previous 30 days using equation 5 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.037
Where:
MSCV = Total mass of EtO sent to controls over the
previous 30 operating days, g/hr (lb/hr)
f = Adjustment factor
MSCV,n = Theoretical mass of EtO sent to controls per
charge per chamber, g (lb)
n = Total number of charges during the previous 30 operating days
(2) If both this approach is chosen and the SCV is (or SCVs are)
combined with another emission stream, then the owner or operator
cannot monitor the point after the combination occurs.
(ii) Room air emissions. If room air emissions are both subject to
an emission standard and split between two or more control systems,
then monitoring must be conducted for room air emissions before they
are combined with other streams.
(2) EtO CEMS on exhaust configurations. Exhaust gases from the
emission sources under this subpart exhaust to the atmosphere through a
variety of different configurations, including but not limited to
individual stacks, a common stack configuration, or a main stack plus a
bypass stack. For the CEMS used to provide data under this subpart, the
continuous monitoring system installation requirements for these
exhaust configurations are as follows:
(i) Single unit-single stack configurations. For an emission source
that exhausts to the atmosphere through a single, dedicated stack, you
shall either install the required CEMS in the stack or at a location in
the ductwork downstream of all emissions control devices, where the
pollutant and diluents concentrations are representative of the
emissions that exit to the atmosphere.
(ii) Unit utilizing common stack with other emission source(s).
When an emission source utilizes a common stack with one or more other
emission sources, but no emission sources not subject to this rule, you
shall either:
(A) Install the required CEMS in the duct from each emission
source, leading to the common stack; or
(B) Install the required CEMS in the common stack.
(iii) Unit(s) utilizing common stack with non-commercial
sterilization emission source(s). (A) When one or more emission sources
shares a common stack with one or more emission sources not subject to
this rule, you shall either:
(1) Install the required CEMS in the ducts from each emission
source that is subject to this rule, leading to the common stack; or
(2) Install the required CEMS described in this section in the
common stack and attribute all of the emissions measured at the common
stack to the emission source(s).
(B) If you choose the common stack monitoring option:
(1) For each hour in which valid data are obtained for all
parameters, you must calculate the pollutant emission rate; and
(2) You must assign the calculated pollutant emission rate to each
of the units subject to the rule that share the common stack.
(iv) Unit with multiple parallel control devices with multiple
stacks. If the exhaust gases from an emission source, which is
configured such that emissions are controlled with multiple parallel
control devices or multiple series of control devices are discharged to
the atmosphere through more than one stack, you shall install the
required CEMS described in each of the multiple stacks. You shall
calculate hourly, flow-weighted, average pollutant emission rates for
the unit as follows:
(A) Calculate the pollutant emission rate at each stack or duct for
each hour in which valid data are obtained for all parameters;
(B) Multiply each calculated hourly pollutant emission rate at each
stack or duct by the corresponding hourly gas flow rate at that stack
or duct;
[[Page 24182]]
(C) Sum the products determined under paragraph (f)(2)(iv)(B) of
this section; and
(D) Divide the result obtained in paragraph (f)(2)(I(C) of this
section by the total hourly gas flow rate for the unit, summed across
all of the stacks or ducts.
(g) PTE monitoring. If you are required to operate all or a portion
of your sterilization facility under PTE conditions, you must:
(1) Initial compliance. Demonstrate initial procedures in Sec.
63.365(g)(1) and continued compliance with the provisions in this
section. You must follow the requirements of either paragraphs (g)(2)
and (3) of this section or paragraph (g)(4) of this section.
(2) Continuous compliance. If you choose to demonstrate continuous
compliance through volumetric flow rate monitoring, you must monitor
and record at least every 15 minutes the volumetric flow rate from each
outlet where air from the PTE is sent using a flow rate monitoring
system described in paragraph (g)(3) of this section. Monitoring is
required when the portion of the facility covered by PTE is operated. A
data acquisition system for the flow rate monitoring system shall
compute and record each 3-hour average flow rate value, rolled hourly.
This must be done by first averaging the flow rate readings over a
clock hour, i.e., beginning and ending on the hour. All data collected
during the operating hour must be used, even the portion of the
facility covered by PTE is not operated for a complete hour. Then, the
average of the previous 3 operating hours must be calculated to
determine the 3-hour rolling average flow rate. You must maintain the
3-hour rolling average flow rate above the applicable operating limits
established during the most recent compliance demonstration.
(3) Continuous flow rate monitoring system for PTE. You must
install, operate, calibrate, and maintain instruments, according to the
requirements in paragraphs (g)(3)(i) through (ix) of this section, for
continuously measuring and recording the stack gas flow rate to allow
determination of compliance with the minimum volumetric flow rate
through the affected stack operating limit(s).
(i) You must install each sensor of the flow rate monitoring system
in a location that provides representative measurement of the exhaust
gas flow rate. The flow rate sensor is that portion of the system that
senses the volumetric flow rate and generates an output proportional to
that flow rate.
(ii) The flow rate monitoring system must be designed to measure
the exhaust flow rate over a range that extends from a value of at
least 20 percent less than the lowest expected exhaust flow rate to a
value of at least 20 percent greater than the highest expected exhaust
flow rate.
(iii) The flow rate monitoring system must be equipped with a data
acquisition and recording system that is capable of recording values
over the entire range specified in paragraph (g)(3)(ii) of this
section.
(iv) The signal conditioner, wiring, power supply, and data
acquisition and recording system for the flow rate monitoring system
must be compatible with the output signal of the flow rate sensors used
in the monitoring system.
(v) The flow rate monitoring system must be designed to complete a
minimum of one cycle of operation for each successive 15-minute period.
(vi) The flow rate sensor must have provisions to determine the
daily zero and upscale calibration drift (CD) (see sections 3.1 and 8.3
of Performance Specification 2 in appendix B to Part 60 of this chapter
for a discussion of CD).
(A) Conduct the CD tests at two reference signal levels, zero
(e.g., 0 to 20 percent of span) and upscale (e.g., 50 to 70 percent of
span).
(B) The absolute value of the difference between the flow monitor
response and the reference signal must be equal to or less than 3
percent of the flow monitor span.
(vii) You must perform an initial relative accuracy test of the
flow rate monitoring system according to section 8.2 of Performance
Specification 6 of appendix B to part 60 of the chapter with the
exceptions in paragraphs (g)(3)(vii)(A) and (B) of this section.
(A) The relative accuracy test is to evaluate the flow rate
monitoring system alone rather than a continuous emission rate
monitoring system.
(B) The relative accuracy of the flow rate monitoring system shall
be no greater than 10 percent of the mean value of the reference method
data.
(viii) You must verify the accuracy of the flow rate monitoring
system at least once per year by repeating the relative accuracy test
specified in paragraph (g)(3)(vii) of this section.
(ix) You must operate the flow rate monitoring system and record
data during all periods of operation of the affected facility including
periods of startup, shutdown, and malfunction.
(4) Pressure differential monitor. You must instead install,
operate, calibrate, and maintain a continuous pressure differential
monitoring system, as follows, to verify the presence of PTE. You must
operate this system whenever the facility is in operation. You must
also maintain the pressure differential at or above 0.007 inches of
water over a three-hour rolling average.
(i) This monitoring system must measure the pressure differential
between the interior and exterior of the PTE, with at least one
monitoring device located in each room that borders the PTE. These
monitoring devices shall be designed to provide measurements of
pressure differential to at least the nearest 0.001 inches of water and
having a complete cycle time no greater than 5 minutes.
(ii) A data acquisition system for the monitoring system shall
compute and record each 3-hour average pressure differential value,
rolled hourly. This must be done by first averaging the pressure
differential readings over a clock hour, i.e., beginning and ending on
the hour. All data collected during the operating hour must be used,
even in portions of the facility covered by PTE that are not operated
for a complete hour. Then, the average of the previous 3 operating
hours must be calculated to determine the 3-hour rolling average
pressure differential. If data are not recorded from an alternative
monitoring device, during any malfunction of the principal monitoring
device(s) or the automatic recorder, you must manually record the
measured data at least hourly.
(h) Sterilization chamber end-cycle EtO concentration. As part of
your monitoring plan, you must document your approach for determining
the EtO sterilization chamber concentration. If you choose a parametric
approach you must meet the requirements in paragraph (h)(1) of this
section and if you choose a direct measurement approach you must meet
the requirements in paragraph (h)(2) of this section. Alternatively,
you may petition the administrator for an alternative monitoring
approach under Sec. 63.8(f).
(1) If you choose a parametric approach for determining chamber EtO
concentrations you must document parameter(s) used in the calculation
to determine of EtO concentrations and the calculation(s) used to
determine the chamber concentration. Any instrumentation used for
parametric monitoring must also be identified in the monitoring plan
and at a minimum this plan should include the following for each
instrument:
(i) Parameter measured and measurement principle of the monitor.
(ii) Instrument name, model number, serial number, and range.
(iii) Manufacturer recommended operation practices, including daily
operational check.
[[Page 24183]]
(iv) Procedures for calibration, the frequency of calibration, and
accuracy requirements of the calibration.
(v) Description for how the information from the parameter monitor
is being collected and stored.
(2) If you choose a direct measurement approach for determining
chamber EtO calibrations you must document the procedures used for the
operation of the instruments. Any instrument used for direct
measurement of EtO must be identified in the monitoring plan and at a
minimum this plan must include the following information:
(i) Instrument name, model number, serial number, and range.
(ii) Description of the measurement principle and any potential
interferences.
(iii) If applicable, the description of the sampling condition
system.
(iv) Procedures for calibration, the frequency of calibration, and
accuracy requirements of the calibration.
(v) Description for how the information from the parameter monitor
is being collected and stored.
(i) EtO usage. If you own or operate a sterilization facility
subject to the requirements of this subpart you must monitor and record
on a daily basis the daily and 30-operating day EtO usage according to
the requirements of this paragraph. Additionally, you must record EtO
usage for each calendar month.
(1) Monitor and record on a daily basis, the daily total mass of
ethylene oxide, in pounds, used at the facility. The daily total mass
must be determined using the methodology specified in Sec.
63.365(c)(1)(i) and (ii).
(2) Determine and record daily the 30-operating day rolling
ethylene oxide usage rate using equation 6 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.038
Where:
MFac = Facility EtO use over the previous 30 operating
days, in pounds.
mFac,i = Daily EtO use for operating day i, in pounds, as
determined in accordance with paragraph (i)(1) of this section
i = Operating day index.
(3) Determine and record the total mass of EtO used in each
calendar month.
Sec. 63.365 Test methods and procedures.
(a) General--(1) Performance testing for facility where EtO use is
less than 100 pounds per year. If you own or operate an affected source
at a facility where EtO use is less than 100 lb/yr that is subject to
an emission standard in Sec. 63.362, you must comply with the
performance testing requirements in Sec. 63.7, according to the
applicability in table 6 to this subpart, using the methods in
paragraph (b) or (c) of this section, following the applicable
procedures for initial compliance and continuous compliance in
paragraphs (d), (e), and (f) of this section.
(2) Facilities subject to capture efficiency. If you are subject to
capture efficiency requirements in Sec. 63.362, you must follow the
applicable procedures for initial and continuous compliance in
paragraph (f) of this section.
(b) Test methods for facility where EtO use is less than 100 pounds
per year. You must use the following test methods to determine the
average mass emissions of EtO in lb/hr at the inlet of a control system
(MAPCD, i) and/or outlet of a control system or stack
(EAPCD, o).
(1) Select the location of the sampling ports and the number of
traverse points according to Method 1 of appendix A-1 to part 60 of
this chapter. Alternatively, for ducts less than 0.3 meter (12 in.) in
diameter, you may choose to locate sample ports according to Method 1A
of appendix A-1 to part 60 of this chapter.
(2) Determine the flow rate through the control system exhaust(s)
continuously during the test period according to either Methods 2, 2A,
or 2C of appendix A-1 to part 60 of this chapter, as appropriate. If
using Method 2, 2A, or 2C, you must complete velocity traverses
immediately before and subsequently after each test run. If your test
run is greater than 1 hour, you must also complete a velocity traverse
at least every hour. Average the velocity collected during a test run
and calculate volumetric flow as outlined in the appropriate method.
(3) Determine the oxygen and carbon dioxide concentration of the
effluent according to Method 3A or 3B of appendix A-2 to part 60 of
this chapter. The manual procedures (but not instrumental procedures)
of voluntary consensus standard ANSI/ASME PTC 19.10-1981 (incorporated
by reference, see Sec. 63.14) may be used as an alternative to EPA
Method 3B.
(4) Determine the moisture content of the stack gas according to
Method 4 of appendix A-3 to part 60 of this chapter. Alternatively, you
may use an on-line technique that has been validated using Method 301
of appendix A to this part.
(5) Determine the EtO concentration according to either paragraph
(b)(5)(i) or (ii) of this section.
(i) Follow Method 320 of appendix A to this part and the following
paragraphs (5)(i)(A) through (D).
(A) The instrumentation used for measurement must have the
measurement range to properly quantify the EtO in the gas stream.
Additionally, for outlet emission streams, the instrumentation must
have a method detection limit an order of magnitude below concentration
equivalent of the emission limit.
(B) Instrumentation used must be continuous in nature with an
averaging time of one minute or less.
(C) Calibration Spectra and all other analyte spiking required in
the method must use EtO gaseous cylinder standard(s) which meet the
criteria found in Performance Specification 19 of appendix B to part 60
if this chapter.
(D) Other methods and materials may be used; however, these
alternative test methods are subject to Administrator approval.
(ii) Alternatively, ASTM D6348-12 (Reapproved 2020), (incorporated
by reference, see Sec. 63.14) may be used with the following
conditions:
(A) The test plan preparation and implementation in the Annexes to
ASTM D 6348-12 (R2020), Sections A1 through A8 are mandatory; and
(B) In ASTM D6348-12 (R2020) Annex A5 (Analyte Spiking Technique),
the percent (%) R must be determined for each target analyte (equation
A5.5). In order for the test data to be acceptable
[[Page 24184]]
for a compound, %R must be 70% >= R <= 130%. If the %R value does not
meet this criterion for a target compound, the test data is not
acceptable for that compound and the test must be repeated for that
analyte (i.e., the sampling and/or analytical procedure should be
adjusted before a retest). The %R value for each compound must be
reported in the test report, and all field measurements must be
corrected with the calculated %R value for that compound by using
equation 1 to this paragraph:
[GRAPHIC] [TIFF OMITTED] TR05AP24.039
(6) Calculate the mass emission of EtO by using equations 2 and 3
to this paragraph:
[GRAPHIC] [TIFF OMITTED] TR05AP24.040
Where:
MAPCD, i = average inlet mass rate of EtO per hour, lb/hr
CEtO,i = inlet EtO concentration, ppmdv.
Qi = average inlet volumetric flow per hour at standard conditions,
dscf/hr
44.05 = molecular weight (MW) of EtO, lb/lb-mole
MW/385.1 x 10\6\ = conversion factor, from ppmv at standard
conditions to lb/cf
EAPCD, o = average outlet mass rate of EtO per hour, lb/
hr
CEtO,o = outlet EtO concentration, ppbdv.
Qo = average outlet volumetric flow per hour at standard
conditions, dscf/hr
MW/385.1 x 10\9\ = conversion factor, from ppbv at standard
conditions to lb/cf
(c) Alternative approach for SCVs for facility where EtO use is
less than 100 pounds per year. If you do not own or operate a single-
item sterilizer, to demonstrate compliance with the percent emission
reduction standards for emissions streams that are comprised only of
SCVs, you may use the following procedures as an alternative to
paragraph (b) of this section to determine the mass emissions of EtO
being emitted via sterilization chamber(s) vents prior to the controls.
(1) Determine the mass (MSCV,n) of EtO used for each
charge and at each sterilization chamber used during the performance
tests using the procedures in either paragraph (c)(1)(i) or (ii) of
this section.
(i) Weigh the EtO gas cylinder(s) used to charge the sterilizer(s)
before and after charging. Record these weights to the nearest 45 g
(0.1 lb) and calculate the theoretical mass (MSCV,n) vented
to the controls using equation 4 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.041
Where:
MSCV,n = Theoretical total mass of EtO vented to
controls per charge, g (lb)
Mcharge = total mass of sterilizer gas charge, g
(lb)
%E.O.w = weight percent of EtO
(ii) Install a calibrated rate meter at the sterilizer inlet(s) and
continuously measure the flow rate (Qm) and duration of each
sterilizer charge. Calculate the theoretical mass (MSCV,n)
vented to the controls using equation 5 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.042
Where:
MSCV,n = Total mass of EtO sent to controls per
charge
Qm = volumetric flow rate, liters per minute (L/min)
corrected to 20 [deg]C and
[[Page 24185]]
101.325 kilopascals (kPa) (scf per minute (scfm) corrected to 68
[deg]F and 1 atmosphere of pressure (atm))
Tn = time duration of each charge, min
n = number of EtO charges
%E.O.v = volume fraction percent of EtO
MW = molecular weight of EtO, 44.05 grams per gram-mole (g/g-
mole) (44.05 pounds per pound-mole (lb/lb-mole))
SV = standard volume, 24.05 liters per gram-mole (L/g-mole) at
20 [deg]C and 101.325 kPa (385.1 scf per pound-mole (scf/lb-mole) at
68 [deg]F and 1 atm).
(2) Determine the mass rate of EtO sent to controls during the
performance test using equation 6 to this paragraph.
[GRAPHIC] [TIFF OMITTED] TR05AP24.043
Where:
MSCV = Total mass of EtO sent to controls per hour,
g/hr (lb/hr)
MSCV,n = Total mass of EtO sent to controls per
charge per chamber, g (lb)
Tt = Total time of the performance test, hour
n = Total number of charges during testing period
f = Portion of EtO use that is assumed to be routed to the
control system (0.93 if aeration is conducted in separate vessel;
0.98 otherwise)
(d) Compliance determination for facility where EtO use is less
than 100 pounds per year. Each compliance demonstration shall consist
of three separate runs using the applicable methods in paragraph (b) or
(c) of this section. To determine compliance with the relevant
standard, arithmetic mean of the three runs must be used. These
procedures may be performed over a run duration of 1-hour (for a total
of three 1-hour runs), except for the SCV testing from this category,
where each run shall consist of the entirety of the sterilizer chamber
evacuation and subsequent washes. The owner or operator may not conduct
performance tests during periods of malfunction. The owner or operator
must record the process information that is necessary to document
operating conditions during the test and include in such record an
explanation to support that such conditions represent the entire range
of normal operation, including operational conditions for maximum
emissions if such emissions are not expected during maximum production.
The owner or operator must also account for the control system
residence time when conducting the performance test. Upon request, the
owner or operator shall make available to the Administrator such
records as may be necessary to determine the conditions of performance
tests. The following procedures shall be used to demonstrate compliance
with a removal efficiency standard. In addition to these procedures,
the procedures in paragraph (e) of this section must be followed to
establish the operating parameter limits for each applicable emission
control(s).
(1) You may determine the mass rate emissions of the stream prior
to the control system and at the outlet of the control system using the
test methods in paragraph (b) of this section. If the vent stream is
comprised only of one or more SCVs, then you may use the procedures in
paragraph (c) of this section for the mass rate emissions at the inlet.
(2) Calculate the total mass of EtO per hour that is routed to the
control system by summing the mass of EtO per hour from each vent.
(3) Determine percent emission reduction (%ER) using the equation 7
to this paragraph:
[GRAPHIC] [TIFF OMITTED] TR05AP24.044
Where:
% ER = percent emission reduction
MAPCD,i = total mass of EtO per hour to the control
device
EAPCD,o = total mass of EtO per hour from the
control device
(4) Repeat these procedures two additional times. The arithmetic
average percent efficiency of the three runs shall determine the
overall efficiency of the control system.
(e) Determination of operating limits for control device(s). If you
are using performance testing to demonstrate compliance with removal
efficiency standards, and if you are not demonstrating continual
compliance with the applicable standard(s) using an EtO CEMS, you must
also determine the operating limit(s) for each control device and then
monitor the parameter(s) for each control device. The procedures in the
following paragraphs shall be used to establish the parameter operating
limits to be continually monitored in Sec. 63.364.
(1) Acid-water scrubbers. The procedures in paragraph (e)(1) of
this section shall be used to determine the operating limits for acid-
water scrubbers.
(i) Ethylene glycol concentration. For determining the ethylene
glycol concentration operating limit, you must establish the maximum
ethylene glycol concentration as the ethylene glycol concentration
averaged over three test runs; use the sampling and analysis procedures
in ASTM D3695-88 (incorporated by reference, see Sec. 63.14) to
determine the ethylene glycol concentration.
(ii) Scrubber liquor tank level. During the performance test, you
must monitor and record the scrubber liquor tank level to the nearest
\1/4\ inch at the end of each of the three test runs. Use the data
collected during the most recent performance test to calculate the
average scrubber liquor tank level. This scrubber liquor tank level is
the maximum operating limit for your scrubber liquor tank. Repeat this
procedure for every scrubber liquor tank that is included in the
performance test.
(iii) Scrubber liquor pH. During the performance test, you must
monitor and record the scrubber liquor pH at least once every 15
minutes during each of the three test runs. You must use pH
[[Page 24186]]
monitors as described in Sec. 63.364(b)(3). Use the data collected
during the most recent performance test to calculate the average
scrubber pH measured. This scrubber liquor pH is the maximum operating
limit for your acid-water scrubber. Repeat this procedure for every
scrubber liquor tank that is included in the performance test.
(2) Thermal oxidizers. The procedures in this paragraph shall be
used to determine the operating limits for thermal oxidizers.
(i) During the performance test, you must monitor and record the
temperature at least once every 15 minutes during each of the three
test runs. You must monitor the temperature in the firebox of the
thermal oxidizer or immediately downstream of the firebox. You must use
temperature monitors as described in Sec. 63.364(c)(4).
(ii) Use the data collected during the performance test to
calculate and record the average temperature for each test run
maintained during the performance test. The average temperature of the
test runs is the minimum operating limit for your thermal oxidizer,
unless it exceeds the recommended maximum oxidation temperature
provided by the oxidation unit manufacturer. If this occurs, the
minimum operating limit for your thermal oxidizer consists of the
recommended maximum oxidation temperature provided by the oxidation
unit manufacturer.
(iii) Paragraphs (e)(2)(i) and (ii) of this section must be
completed for each thermal oxidizer that is involved in the performance
test.
(3) Catalytic oxidizers. The procedures in this paragraph shall be
used to determine the operating limits for catalytic oxidizers.
(i) Prior to the start of the performance test, you must check the
catalyst bed for channeling, abrasion, and settling. If problems are
found during the inspection, you must replace the catalyst bed or take
other correction action consistent with the manufacturer's
recommendations.
(ii) During the performance test, you must monitor and record the
temperature at the inlet to the catalyst bed and the temperature
difference across the catalyst bed at least once every 15 minutes
during each of the three test runs. You must use temperature monitors
as described in Sec. 63.364(c)(4).
(iii) Use the data collected during the performance test to
calculate and record the average temperature at the inlet to the
catalyst bed and the average temperature difference across the catalyst
bed maintained for each test run, and then calculate the arithmetic
averages of the test runs. These arithmetic averages of the test runs
are the minimum operating limits for your catalytic oxidizer, unless it
exceeds the recommended maximum oxidation temperature provided by the
oxidation unit manufacturer. If this occurs, the minimum operating
limit for your catalytic oxidizer consists of the recommended maximum
oxidation temperature provided by the oxidation unit manufacturer.
(iv) Paragraphs (e)(3)(i) through (iii) of this section must be
completed for each catalytic oxidizer that is involved in the
performance test.
(4) Gas/solid reactors. During the performance test, you must
monitor and record the gas/solid reactor pressure drop at least once
every 15 minutes during each of the three test runs. Use the data
collected during the most recent performance test to calculate the gas/
solid reactor pressure measured. This gas/solid reactor pressure is the
maximum operating limit for your gas/solid. Repeat this procedure for
every gas/solid reactor that is included in the performance test.
(5) Other control system for facility where EtO use is less than
100 pounds per year. If you seek to demonstrate compliance with a
standard found at Sec. 63.362 with a control device other than an
acid-water scrubber, catalytic oxidizer, thermal oxidizer, or gas/solid
reactor, you must provide to the Administrator the information
requested under Sec. 63.363(e). You must submit a monitoring plan that
contains the following items: a description of the device; test results
collected in accordance with Sec. 63.363(e) verifying the performance
of the device for controlling EtO emissions to the atmosphere to the
levels required by the applicable standards; the appropriate operating
parameters that will be monitored, identifying the ongoing QA
procedures and performance specifications that will be conducted on the
instruments; the frequency of conducting QA and performance checks; and
the frequency of measuring and recording to establish continuous
compliance with the standards. Your monitoring plan is subject to the
Administrator's approval. Upon approval by the Administrator you must
install, calibrate, operate, and maintain the monitor(s) approved by
the Administrator based on the information submitted in your monitoring
plan. You must include in your monitoring plan proposed performance
specifications and quality assurance procedures for your monitors. The
Administrator may request further information and shall approve
appropriate test methods and procedures.
(f) Determination of compliance with PTE requirement. If you are
required to operate any portion of your facility with PTE, you must
demonstrate initial compliance with the requirements of this subpart by
following the procedures of paragraphs (f)(1) through (3) of this
section, as applicable, during the initial compliance demonstration or
during the initial certification of the CEMS tests.
(1) Determine the capture efficiency by verifying the capture
system meets the criteria in section 6 of Method 204 of appendix M to
part 51 of this chapter and directs all the exhaust gases from the
enclosure to an add-on control device.
(2) Ensure that the air passing through all NDOs flows into the
enclosure continuously. If the facial velocities (FVs) are less than or
equal to 9,000 meters per hour (492 feet per minute), the continuous
inward flow of air shall be verified by continuous observation using
smoke tubes, streamers, tracer gases, or other means approved by the
Administrator over the period that the volumetric flow rate tests
required to determine FVs are carried out. If the FVs are greater than
9,000 meters per hour (492 feet per minute), the direction of airflow
through the NDOs shall be presumed to be inward at all times without
verification.
(3) If you are demonstrating continuous compliance through
monitoring the volumetric flow rate, you must monitor and record the
volumetric flow rate (in cubic feet per second) from the PTE through
the stack(s) at least once every 15 minutes during each of the three
test runs. Use the data collected during the most recent compliance
demonstration to calculate the average volumetric flow rate measured
during the compliance demonstration. This volumetric flow rate is the
minimum operating limit for the stack. Repeat this procedure for every
stack that is included in the compliance demonstration.
Sec. 63.366 Reporting requirements.
(a) General requirements. The owner or operator of an affected
source subject to the emissions standards in Sec. 63.362 must fulfill
all reporting requirements in Sec. 63.10(a), (d), (e), and (f),
according to the applicability in table 6 to this subpart. These
reports will be made to the Administrator at the appropriate address
identified in Sec. 63.13 or submitted electronically.
(b) Initial compliance report submission. You must submit an
initial compliance report that provides summary, monitoring system
[[Page 24187]]
performance, and deviation information to the Administrator on April 5,
2027, or once the report template for this subpart has been available
on the Compliance and Emissions Data Reporting Interface (CEDRI)
website for one year, whichever date is later, to the EPA via CEDRI,
which can be accessed through the EPA's Central Data Exchange (CDX)
(https://cdx.epa.gov/). The EPA will make all the information submitted
through CEDRI available to the public without further notice to you. Do
not use CEDRI to submit information you claim as confidential business
information (CBI). Anything submitted using CEDRI cannot later be
claimed CBI. You must use the appropriate electronic report template on
the CEDRI website (https://www.epa.gov/electronic-reporting-air-emissions/cedri) for this subpart. The date report templates become
available will be listed on the CEDRI website. The report must be
submitted by the deadline specified in this subpart, regardless of the
method in which the report is submitted. Although we do not expect
persons to assert a claim of CBI, if you wish to assert a CBI claim,
submit a complete report, including information claimed to be CBI, to
the EPA. The CBI report must be generated using the appropriate form on
the CEDRI website or an alternate electronic file consistent with the
extensible markup language (XML) schema listed on the CEDRI website.
Submit the CBI file on a compact disc, flash drive, or other commonly
used electronic storage medium and clearly mark the medium as CBI. Mail
the electronic medium to U.S. EPA/OAQPS/CORE CBI Office, Attention:
Commercial Sterilization Facilities Sector Lead, MD C404-02, 4930 Old
Page Rd., Durham, NC 27703. The same file with the CBI omitted must be
submitted to the EPA via the EPA's CDX as described earlier in this
paragraph. All CBI claims must be asserted at the time of submission.
Furthermore, under CAA section 114(c), emissions data is not entitled
to confidential treatment, and the EPA is required to make emissions
data available to the public. Thus, emissions data will not be
protected as CBI and will be made publicly available. Reports of
deviations from an operating limit shall include all information
required in Sec. 63.10(c)(5) through (13), as applicable in table 6 to
this subpart, along with information from any calibration tests in
which the monitoring equipment is not in compliance with Performance
Specification 19 in appendix B and Procedure 7 in appendix F to part 60
of this chapter or the method used for parameter monitoring device
calibration. Reports shall also include the name, title, and signature
of the responsible official who is certifying the accuracy of the
report. If your report is submitted via CEDRI, the certifier's
electronic signature during the submission process replaces this
requirement. When no deviations have occurred or monitoring equipment
has not been inoperative, repaired, or adjusted, such information shall
be stated in the report. In addition, the summary report shall include:
(1) The following information:
(i) Date that facility commenced construction or reconstruction;
(ii) Hours of commercial sterilization operation over the previous
12 months; and
(iii) Monthly EtO use, in tons, over the previous 36 months.
(iv) If you are electing to determine the mass of EtO sent to the
control device from the SCV(s) via the procedure in Sec.
63.364(f)(1)(i), you must report the daily EtO use from each applicable
chamber for the previous 7 months.
(v) An indication if you are required to comply with one or more
combined emission stream limitations. If so, indicate the affected
sources that are included in each combined emission stream limitation.
(vi) An indication if you are electing to comply with a site-wide
emission limit. If you are electing to comply with a site-wide emission
limit, report the daily EtO use over the previous 7 months.
(2) If your sterilization facility is demonstrating continuous
compliance through periodic performance testing, you must report the
following:
(i) Control system ID;
(ii) Control device ID;
(iii) Control device type; and
(iv) Recirculation tank ID if an acid-water scrubber is used to
meet the emission standard and you elect to comply with the maximum
scrubber liquor height limit;
(3) You must report the following for each sterilization chamber at
your facility:
(i) The sterilization chamber ID;
(ii) The ID of the control system that the SCV was routed to, if
applicable;
(iii) The portion of SCV exhaust that was routed to the control
system, if applicable;
(iv) The ID of the EtO CEMS that was used to monitor SCV emissions,
if applicable;
(v) The portion of SCV exhaust that was monitored with the EtO
CEMS, if applicable;
(vi) The ID of the control system that the CEV was routed to, if
applicable;
(vii) The portion of CEV exhaust that was routed to the control
system, if applicable;
(viii) The ID of the EtO CEMS that was used to monitor CEV
emissions, if applicable;
(ix) The portion of CEV exhaust that was monitored with the EtO
CEMS, if applicable;
(4) If emissions from any room in your facility are subject to an
emission standard, you must report the following for each room where
there is the potential for EtO emissions:
(i) Room ID;
(ii) Documentation of emissions occurring within the room,
including aeration, EtO storage, EtO dispensing, pre-aeration handling
of sterilized material, and post-aeration handling of sterilized
material;
(iii) The ID of the control system that the room air was routed to,
if applicable;
(iv) The portion of room air that was routed to the control system,
if applicable;
(v) The ID of the EtO CEMS that was used to monitor room air
emissions, if applicable;
(vi) The portion of room air that was monitored with the EtO CEMS,
if applicable;
(5) If an EtO CEMS was used to demonstrate continuous compliance
with an emission standard for more than 30-operating days, you must
report the following:
(i) The information specified in section 11 of appendix A to this
subpart.
(ii) The affected sources that are included in each inlet that is
being monitored with EtO CEMS;
(iii) The IDs of each inlet(s) to and outlet(s) from each control
system.
(iv) The daily sum of EtO for each inlet, along with 30-operating
day rolling sums.
(v) The daily sum of EtO emissions from each outlet of the control
system, along with 30-operating day rolling sums.
(vi) For each day, calculate and report the daily mass emission
limit that the control system must achieve based on the previous 30
days of data. For control systems with multiple emission streams, and
complying with a combined emission stream limitation in Sec. 63.362(i)
or a SWEL in Sec. 63.362(j), report the daily 30-operating day mass
emission limit as determined in accordance with CES in Sec.
63.362(i)(1)(i) and (i)(2)(i) or with Sec. 63.362(j)(1)(i) and
(j)(2)(i), as applicable.
(vii) For each day, the mass of EtO emitted from the control system
over the previous 30 operating days.
(6) If any portion of your facility is required to be operated with
PTE, you must report the following:
[[Page 24188]]
(i) If you are choosing to demonstrate continuous compliance
through the use of volumetric flow rate monitoring, you must report the
3-hr rolling average, rolled hourly volumetric flow from each outlet
where air from the PTE is sent, in cubic feet per second.
(ii) If you are choosing to demonstrate continuous compliance
through use of differential pressure monitoring, you must report the 3-
hr rolling average, rolled hourly pressure differential reading, in
inches water.
(7) If you are complying with the requirement to follow the best
management practice to limit sterilization chamber concentration of EtO
to 1 ppmv prior to opening the sterilization chamber door, you must
provide a certification from your responsible official that this
approach is being followed and you are meeting the monitoring
requirements at Sec. 63.362(h).
(8) If you own or operate an existing collection of Group 2 room
air emissions at an area source facility and facility EtO use is less
than 4 tpy, you must report the following for each room where there are
Group 2 room air emissions:
(i) Room ID;
(ii) Number of room air changes per hour;
(iii) Room temperature, in degrees Celsius; and
(iv) EtO concentration, in ppmv dry basis (ppbvd).
(9) If you own or operate an existing collection of Group 2 room
air emissions at an area source facility and EtO use is less than 4
tpy, you are not required to report the information in paragraph (b)(8)
of this section if you meet the following requirements:
(i) You are complying with the best management practice to limit
sterilization chamber concentration of EtO to 1 ppmv prior to opening
the sterilization chamber door; and
(ii) The requirements of Sec. 63.363 are met.
(10) Report the number of deviations to meet an applicable
standard. For each instance, report the date, time, the cause and
duration of each deviation. For each deviation the report must include
a list of the affected sources or equipment, an estimate of the
quantity of each regulated pollutant emitted over any emission limit,
and a description of the method used to determine the emissions.
(c) Quarterly compliance report submission. You must submit
compliance reports that provide summary, monitoring system performance,
and deviation information to the Administrator within 30 days following
the end of each calendar quarter. Beginning on April 5, 2027, or once
the report template for this subpart has been available on the
Compliance and Emissions Data Reporting Interface (CEDRI) website for 1
year, whichever date is later, submit all subsequent reports to the EPA
via CEDRI, which can be accessed through the EPA's CDX (https://cdx.epa.gov/). The EPA will make all the information submitted through
CEDRI available to the public without further notice to you. Do not use
CEDRI to submit information you claim as CBI. Anything submitted using
CEDRI cannot later be claimed CBI. You must use the appropriate
electronic report template on the CEDRI website (https://www.epa.gov/electronic-reporting-air-emissions/cedri) for this subpart. The date
report templates become available will be listed on the CEDRI website.
The report must be submitted by the deadline specified in this subpart,
regardless of the method in which the report is submitted. Although we
do not expect persons to assert a claim of CBI, if you wish to assert a
CBI claim, submit a complete report, including information claimed to
be CBI, to the EPA. The CBI report must be generated using the
appropriate form on the CEDRI website or an alternate electronic file
consistent with the XML schema listed on the CEDRI website. Submit the
CBI file on a compact disc, flash drive, or other commonly used
electronic storage medium and clearly mark the medium as CBI. Mail the
electronic medium to U.S. EPA/OAQPS/CORE CBI Office, Attention:
Commercial Sterilization Facilities Sector Lead, MD C404-02, 4930 Old
Page Rd., Durham, NC 27703. The same file with the CBI omitted must be
submitted to the EPA via the EPA's CDX as described earlier in this
paragraph. All CBI claims must be asserted at the time of submission.
Furthermore, under CAA section 114(c), emissions data is not entitled
to confidential treatment, and the EPA is required to make emissions
data available to the public. Reports of deviations from an operating
limit shall include all information required in Sec. 63.10(c)(5)
through (13), as applicable in table 6 to this subpart, and information
from any calibration tests in which the monitoring equipment is not in
compliance with Performance Specification 19 in appendix B and
Procedure 7 in appendix F to part 60 of this chapter or the method used
for parameter monitoring device calibration. Reports shall also include
the name, title, and signature of the responsible official who is
certifying the accuracy of the report. If your report is submitted via
CEDRI, the certifier's electronic signature during the submission
process replaces this requirement. When no deviations have occurred or
monitoring equipment has not been inoperative, repaired, or adjusted,
such information shall be stated in the report. In addition, the
summary report shall include:
(1) The information listed in paragraphs (b)(1)(i) through (vi) of
this section, with the exception that monthly EtO use, in tons, only
needs reported for the previous 12 months;
(2) If your sterilization facility is demonstrating continuous
compliance through periodic performance testing, you must report the ID
for any control system that has not operated since the end of the
period covered by the previous compliance report. If a control system
has commenced operation since end of the period covered by the previous
compliance report, or if any of the information in paragraphs (b)(2)(i)
through (iv) of this section has changed for a control system that was
included in the previous compliance report, you must report the
information in paragraphs (b)(2)(i) through (iv) of this section for
those control systems;
(3) You must report the ID for any sterilization chamber that has
not operated since then end of the period covered by the previous
compliance report. If a sterilization chamber has commenced operation
since the end of the period covered by the previous compliance report,
or if any of the information in paragraphs (b)(3)(i) through (ix) of
this section has changed for a sterilization chamber that was included
in the previous compliance report, you must report the information in
paragraphs (b)(3)(i) through (ix) of this section for those
sterilization chambers;
(4) If emissions from any room in your facility are subject to an
emission standard, you must report the ID for any room where there has
not been the potential for EtO emissions since the end of the period
covered by the previous compliance report. If a room has had the
potential for EtO emissions since the end of the period covered by the
previous compliance report, or if any of the information in paragraphs
(b)(4)(i) through (vi) of this section has changed for a room where
there is the potential for EtO emissions that was included in the
previous compliance report, you must report the information in
paragraphs (b)(4)(i) through (vi) of this section for those rooms;
(5) If an EtO CEMS was used to demonstrate continuous compliance,
you must report the information specified in paragraphs (b)(5)(i)
through (vi) of this section.
[[Page 24189]]
(6) If any portion of your facility is required to be operated with
PTE, you must report the information listed in paragraph (b)(6) of this
section.
(7) If you are complying with the requirement to follow the best
management practice to limit sterilization chamber concentration of EtO
to 1 ppmv prior to opening the sterilization chamber door, you must
provide a certification from your responsible official that this
approach is being followed and you are meeting the monitoring
requirements at Sec. 63.362(h).
(8) If you own or operate an existing collection of Group 2 room
air emissions at an area source facility and facility EtO use is less
than 4 tpy, you must report the ID for any room where Group 2 room air
emissions have ceased since end of the period covered by the previous
compliance report. If a room has had Group 2 room air emissions since
the end of the period covered by the previous compliance report, or if
any of the information in paragraphs (b)(8)(i) through (iv) of this
section has changed for a room where there are Group 2 room air
emissions that were included in the previous compliance report, you
must report the information in paragraphs (b)(8)(i) through (iv) of
this section for each room where there are Group 2 room air emissions.
(9) If you own or operate an existing collection of Group 2 room
air emissions at an area source facility and facility EtO use is less
than 4 tpy, you are not required to report the information in paragraph
(c)(8) of this section if you meet the requirements in paragraph (b)(9)
of this section.
(10) Report the number of deviations to meet an applicable
standard. For each instance, report the date, time, the cause, and
duration of each deviation. For each deviation, the report must include
a list of the affected sources or equipment, the quantity of each
regulated pollutant emitted over any emission limit, and a description
of the method used to determine the emissions.
(d) Construction and reconstruction application. You must fulfill
all requirements for construction or reconstruction of a facility in
Sec. 63.5, according to the applicability in table 6 to this subpart,
and in this paragraph.
(1) Applicability. (i) This paragraph (d) and Sec. 63.5 implement
the preconstruction review requirements of section 112(i)(1) for
facilities subject to these emissions standards. In addition, this
paragraph (d) and Sec. 63.5 include other requirements for constructed
and reconstructed facilities that are or become subject to these
emissions standards.
(ii) After April 5, 2024, the requirements in this section and in
Sec. 63.5 apply to owners or operators who construct a new facility or
reconstruct a facility subject to these emissions standards after April
5, 2024. New or reconstructed facilities subject to these emissions
standards with an initial startup date before the effective date are
not subject to the preconstruction review requirements specified in
paragraphs (b)(2) and (3) of this section and Sec. 63.5(d)(3) and (4)
and (e).
(2) Advance approval. After April 5, 2024, whether or not an
approved permit program is effective in the jurisdictional authority in
which a facility is (or would be) located, no person may construct a
new facility or reconstruct a facility subject to these emissions
standards, or reconstruct a facility such that the facility becomes a
facility subject to these emissions standards, without obtaining
advance written approval from the Administrator in accordance with the
procedures specified in paragraph (b)(3) of this section and Sec.
63.5(d)(3) and (4) and (e).
(3) Application for approval of construction or reconstruction. The
provisions of paragraph (b)(3) of this section and Sec. 63.5(d)(3) and
(4) implement section 112(i)(1) of the Act.
(i) General application requirements. (A) An owner or operator who
is subject to the requirements of paragraph (b)(2) of this section
shall submit to the Administrator an application for approval of the
construction of a new facility subject to these emissions standards,
the reconstruction of a facility subject to these emissions standards,
or the reconstruction of a facility such that the facility becomes a
facility subject to these emissions standards. The application shall be
submitted as soon as practicable before the construction or
reconstruction is planned to commence (but not sooner than the
effective date) if the construction or reconstruction commences after
the effective date. The application shall be submitted as soon as
practicable before the initial startup date but no later than 60 days
after the effective date if the construction or reconstruction had
commenced and the initial startup date had not occurred before the
effective date. The application for approval of construction or
reconstruction may be used to fulfill the initial notification
requirements of paragraph (e)(1)(iii) of this section. The owner or
operator may submit the application for approval well in advance of the
date construction or reconstruction is planned to commence in order to
ensure a timely review by the Administrator and that the planned
commencement date will not be delayed.
(B) A separate application shall be submitted for each construction
or reconstruction. Each application for approval of construction or
reconstruction shall include at a minimum:
(1) The applicant's name and address.
(2) A notification of intention to construct a new facility subject
to these emissions standards or make any physical or operational change
to a facility subject to these emissions standards that may meet or has
been determined to meet the criteria for a reconstruction, as defined
in Sec. 63.2.
(3) The address (i.e., physical location) or proposed address of
the facility.
(4) An identification of the relevant standard that is the basis of
the application.
(5) The expected commencement date of the construction or
reconstruction.
(6) The expected completion date of the construction or
reconstruction.
(7) The anticipated date of (initial) startup of the facility.
(8) The type and quantity of hazardous air pollutants emitted by
the facility, reported in units and averaging times and in accordance
with the test methods specified in the standard, or if actual emissions
data are not yet available, an estimate of the type and quantity of
hazardous air pollutants expected to be emitted by the facility
reported in units and averaging times specified. The owner or operator
may submit percent reduction information, if the standard is
established in terms of percent reduction. However, operating
parameters, such as flow rate, shall be included in the submission to
the extent that they demonstrate performance and compliance.
(9) Other information as specified in paragraph (b)(3)(ii) of this
section and Sec. 63.5(d)(3).
(C) An owner or operator who submits estimates or preliminary
information in place of the actual emissions data and analysis required
in paragraphs (b)(3)(i)(B)(8) and (b)(3)(ii) of this section shall
submit the actual, measured emissions data and other correct
information as soon as available but no later than with the
notification of compliance status required in paragraph (c)(2) of this
section.
(ii) Application for approval of construction. Each application for
approval of construction shall include, in addition to the information
required in paragraph (b)(3)(i)(B) of this section, technical
information describing the proposed nature, size, design, operating
design capacity, and method of
[[Page 24190]]
operation of the facility subject to these emissions standards,
including an identification of each point of emission for each
hazardous air pollutant that is emitted (or could be emitted) and a
description of the planned air pollution control system (equipment or
method) for each emission point. The description of the equipment to be
used for the control of emissions shall include each control device for
each hazardous air pollutant and the estimated control efficiency
(percent) for each control device. The description of the method to be
used for the control of emissions shall include an estimated control
efficiency (percent) for that method. Such technical information shall
include calculations of emission estimates in sufficient detail to
permit assessment of the validity of the calculations. An owner or
operator who submits approximations of control efficiencies under
paragraph (b)(3) of this section shall submit the actual control
efficiencies as specified in paragraph (b)(3)(i)(C) of this section.
(4) Approval of construction or reconstruction based on prior
jurisdictional authority preconstruction review. (i) The Administrator
may approve an application for construction or reconstruction specified
in paragraphs (b)(2) and (3) of this section and Sec. 63.5(d)(3) and
(4) if the owner or operator of a new or reconstructed facility who is
subject to such requirement demonstrates to the Administrator's
satisfaction that the following conditions have been (or will be) met:
(A) The owner or operator of the new or reconstructed facility
subject to these emissions standards has undergone a preconstruction
review and approval process in the jurisdictional authority in which
the facility is (or would be) located before the effective date and has
received a federally enforceable construction permit that contains a
finding that the facility will meet these emissions standards as
proposed, if the facility is properly built and operated;
(B) In making its finding, the jurisdictional authority has
considered factors substantially equivalent to those specified in Sec.
63.5(e)(1).
(ii) The owner or operator shall submit to the Administrator the
request for approval of construction or reconstruction no later than
the application deadline specified in paragraph (b)(3)(i) of this
section. The owner or operator shall include in the request information
sufficient for the Administrator's determination. The Administrator
will evaluate the owner or operator's request in accordance with the
procedures specified in Sec. 63.5. The Administrator may request
additional relevant information after the submittal of a request for
approval of construction or reconstruction.
(e) Notification requirements. The owner or operator of an affected
source subject to an emissions standard in Sec. 63.362 shall fulfill
all notification requirements in Sec. 63.9, according to the
applicability in table 6 to this subpart, and in this paragraph (e).
(1) Initial notifications. (i) If you own or operate an affected
source subject to an emissions standard in Sec. 63.362, you may use
the application for approval of construction or reconstruction under
paragraph (d)(3)(ii) of this section and Sec. 63.5(d)(3),
respectively, if relevant to fulfill the initial notification
requirements.
(ii) The owner or operator of a new or reconstructed facility
subject to these emissions standards that has an initial startup date
after the effective date and for which an application for approval of
construction or reconstruction is required under paragraph (d)(3) of
this section and Sec. 63.5(d)(3) and (4) shall provide the following
information in writing to the Administrator:
(A) A notification of intention to construct a new facility subject
to these emissions standards, reconstruct a facility subject to these
emissions standards, or reconstruct a facility such that the facility
becomes a facility subject to these emissions standards with the
application for approval of construction or reconstruction as specified
in paragraph (d)(3)(i)(A) of this section;
(B) A notification of the date when construction or reconstruction
was commenced, submitted simultaneously with the application for
approval of construction or reconstruction, if construction or
reconstruction was commenced before the effective date of these
standards;
(C) A notification of the date when construction or reconstruction
was commenced, delivered or postmarked no later than 30 days after such
date, if construction or reconstruction was commenced after the
effective date of these standards;
(D) A notification of the anticipated date of startup of the
facility, delivered or postmarked not more than 60 days nor less than
30 days before such date; and
(E) A notification of the actual date of initial startup of the
facility, delivered or postmarked within 15 calendar days after that
date.
(iii) After the effective date, whether or not an approved permit
program is effective in the jurisdictional authority in which a
facility subject to these emissions standards is (or would be) located,
an owner or operator who intends to construct a new facility subject to
these emissions standards or reconstruct a facility subject to these
emissions standards, or reconstruct a facility such that it becomes a
facility subject to these emissions standards, shall notify the
Administrator in writing of the intended construction or
reconstruction. The notification shall be submitted as soon as
practicable before the construction or reconstruction is planned to
commence (but no sooner than the effective date of these standards) if
the construction or reconstruction commences after the effective date
of the standard. The notification shall be submitted as soon as
practicable before the initial startup date but no later than 60 days
after the effective date of this standard if the construction or
reconstruction had commenced and the initial startup date has not
occurred before the standard's effective date. The notification shall
include all the information required for an application for approval of
construction or reconstruction as specified in paragraph (d)(3) of this
section and Sec. 63.5(d)(3) and (4). For facilities subject to these
emissions standards, the application for approval of construction or
reconstruction may be used to fulfill the initial notification
requirements of Sec. 63.9.
(2) If an owner or operator of a facility subject to these
emissions standards submits estimates or preliminary information in the
application for approval of construction or reconstruction required in
paragraph (d)(3)(ii) of this section and Sec. 63.5(d)(3),
respectively, in place of the actual emissions data or control
efficiencies required in paragraphs (d)(3)(i)(B)(8) and (b)(3)(ii) of
this section, the owner or operator shall submit the actual emissions
data and other correct information as soon as available but no later
than with the initial notification of compliance status.
(3) If you own or operate an affected source subject to an
emissions standard in Sec. 63.362, you must also include the amount of
EtO used at the facility during the previous consecutive 12-month
period in the initial notification report required by Sec. 63.9(b)(2)
and (3). For new sterilization facilities subject to this subpart, the
amount of EtO used at the facility shall be an estimate of expected use
during the first consecutive 12-month period of operation.
(4) Beginning October 7, 2024, you must submit all subsequent
Notification of Compliance Status reports in PDF formatto the EPA
following the
[[Page 24191]]
procedure specified in Sec. 63.9(k), except any medium submitted
through mail must be sent to the attention of the Commercial
Sterilization Sector Lead.
(f) Performance test submission. Beginning on June 4, 2024, within
60 days after the date of completing each performance test required by
this subpart, you must submit the results of the performance test
following the procedures specified in paragraphs (f)(1) through (3) of
this section.
(1) Data collected using test methods supported by the EPA's
Electronic Reporting Tool (ERT) as listed on the EPA's ERT website
(https://www.epa.gov/electronic-reporting-air-emissions/electronic-reporting-tool-ert) at the time of the test. Submit the results of the
performance test to the EPA via the CEDRI, which can be accessed
through the EPA's CDX (https://cdx.epa.gov/). The data must be
submitted in a file format generated using the EPA's ERT.
Alternatively, you may submit an electronic file consistent with the
XML schema listed on the EPA's ERT website.
(2) Data collected using test methods that are not supported by the
EPA's ERT as listed on the EPA's ERT website at the time of the test.
The results of the performance test must be included as an attachment
in the ERT or an alternate electronic file consistent with the XML
schema listed on the EPA's ERT website. Submit the ERT generated
package or alternative file to the EPA via CEDRI.
(3) CBI. Do not use CEDRI to submit information you claim as CBI.
Anything submitted using CEDRI cannot later be claimed CBI. Although we
do not expect persons to assert a claim of CBI, if you wish to assert a
CBI claim for some of the information submitted under paragraph
(f)(1)(i) or (ii) of this section, you must submit a complete file,
including information claimed to be CBI, to the EPA. The file must be
generated using the EPA's ERT or an alternate electronic file
consistent with the XML schema listed on the EPA's ERT website. Submit
the file on a compact disc, flash drive, or other commonly used
electronic storage medium and clearly mark the medium as CBI. Mail the
electronic medium to U.S. EPA/OAQPS/CORE CBI Office, Attention: Group
Leader, Measurement Policy Group, MD C404-02, 4930 Old Page Rd.,
Durham, NC 27703. The same file with the CBI omitted must be submitted
to the EPA via the EPA's CDX as described in paragraphs (f)(1)(i) and
(ii) of this section. All CBI claims must be asserted at the time of
submission. Furthermore, under CAA section 114(c), emissions data is
not entitled to confidential treatment, and the EPA is required to make
emissions data available to the public. Thus, emissions data will not
be protected as CBI and will be made publicly available.
(g) Performance evaluation submission. Beginning on June 4, 2024,
within 60 days after the date of completing each CEMS performance
evaluation (as defined in Sec. 63.2), you must submit the results of
the performance evaluation following the procedures specified in
paragraphs (g)(1) through (3) of this section.
(1) Performance evaluations of CEMS measuring relative accuracy
test audit (RATA) pollutants that are supported by the EPA's ERT as
listed on the EPA's ERT website at the time of the evaluation. Submit
the results of the performance evaluation to the EPA via CEDRI, which
can be accessed through the EPA's CDX. The data must be submitted in a
file format generated using the EPA's ERT. Alternatively, you may
submit an electronic file consistent with the XML schema listed on the
EPA's ERT website.
(2) Performance evaluations of CEMS measuring RATA pollutants that
are not supported by the EPA's ERT as listed on the EPA's ERT website
at the time of the evaluation. The results of the performance
evaluation must be included as an attachment in the ERT or an alternate
electronic file consistent with the XML schema listed on the EPA's ERT
website. Submit the ERT generated package or alternative file to the
EPA via CEDRI.
(3) CBI. Do not use CEDRI to submit information you claim as CBI.
Anything submitted using CEDRI cannot later be claimed CBI. Although we
do not expect persons to assert a claim of CBI, if you wish to assert a
CBI claim for some of the information submitted under paragraph
(g)(1)(i) or (ii) of this section, you must submit a complete file,
including information claimed to be CBI, to the EPA. The CBI file must
be generated using the EPA's ERT or an alternate electronic file
consistent with the XML schema listed on the EPA's ERT website. Submit
the CBI file on a compact disc, flash drive, or other commonly used
electronic storage medium and clearly mark the medium as CBI. Mail the
electronic medium to U.S. EPA/OAQPS/CORE CBI Office, Attention: Group
Leader, Measurement Policy Group, MD C404-02, 4930 Old Page Rd.,
Durham, NC 27703. The same file with the CBI omitted must be submitted
to the EPA via the EPA's CDX as described in paragraphs (g)(1)(i) and
(ii) of this section. All CBI claims must be asserted at the time of
submission. Furthermore, under CAA section 114(c), emissions data is
not entitled to confidential treatment, and the EPA is required to make
emissions data available to the public. Thus, emissions data will not
be protected as CBI and will be made publicly available.
(h) Extensions for CDX/CEDRI outages. If you are required to
electronically submit a report through CEDRI in the EPA's CDX, you may
assert a claim of EPA system outage for failure to timely comply with
that reporting requirement. To assert a claim of EPA system outage, you
must meet the requirements outlined in paragraphs (h)(1) through (7) of
this section.
(1) You must have been or will be precluded from accessing CEDRI
and submitting a required report within the time prescribed due to an
outage of either the EPA's CEDRI or CDX systems.
(2) The outage must have occurred within the period of time
beginning five business days prior to the date that the submission is
due.
(3) The outage may be planned or unplanned.
(4) You must submit notification to the Administrator in writing as
soon as possible following the date you first knew, or through due
diligence should have known, that the event may cause or has caused a
delay in reporting.
(5) You must provide to the Administrator a written description
identifying:
(i) The date(s) and time(s) when CDX or CEDRI was accessed and the
system was unavailable;
(ii) A rationale for attributing the delay in reporting beyond the
regulatory deadline to EPA system outage;
(iii) A description of measures taken or to be taken to minimize
the delay in reporting; and
(iv) The date by which you propose to report, or if you have
already met the reporting requirement at the time of the notification,
the date you reported.
(6) The decision to accept the claim of EPA system outage and allow
an extension to the reporting deadline is solely within the discretion
of the Administrator.
(7) In any circumstance, the report must be submitted
electronically as soon as possible after the outage is resolved.
(i) Extensions for force majeure events. If you are required to
electronically submit a report through CEDRI in the EPA's CDX, you may
assert a claim of force majeure for failure to timely comply with that
reporting requirement. To assert a claim of force majeure, you must
meet the requirements outlined in paragraphs (i)(1) through (5) of this
section.
[[Page 24192]]
(1) You may submit a claim if a force majeure event is about to
occur, occurs, or has occurred or there are lingering effects from such
an event within the period of time beginning five business days prior
to the date the submission is due. For the purposes of this section, a
force majeure event is defined as an event that will be or has been
caused by circumstances beyond the control of the affected facility,
its contractors, or any entity controlled by the affected facility that
prevents you from complying with the requirement to submit a report
electronically within the time period prescribed. Examples of such
events are acts of nature (e.g., hurricanes, earthquakes, or floods),
acts of war or terrorism, or equipment failure or safety hazard beyond
the control of the affected facility (e.g., large scale power outage).
(2) You must submit notification to the Administrator in writing as
soon as possible following the date you first knew, or through due
diligence should have known, that the event may cause or has caused a
delay in reporting.
(3) You must provide to the Administrator:
(i) A written description of the force majeure event;
(ii) A rationale for attributing the delay in reporting beyond the
regulatory deadline to the force majeure event;
(iii) A description of measures taken or to be taken to minimize
the delay in reporting; and
(iv) The date by which you propose to report, or if you have
already met the reporting requirement at the time of the notification,
the date you reported.
(4) The decision to accept the claim of force majeure and allow an
extension to the reporting deadline is solely within the discretion of
the Administrator.
(5) In any circumstance, the reporting must occur as soon as
possible after the force majeure event occurs.
Sec. 63.367 Recordkeeping requirements.
(a) If you own or operate an affected source subject to Sec.
63.362, you must comply with the recordkeeping requirements in Sec.
63.10(a) through (c), according to the applicability in table 6 to this
subpart, and in this section. All records required to be maintained by
this subpart or a subpart referenced by this subpart shall be
maintained in such a manner that they can be readily accessed and are
suitable for inspection.
(b) You must maintain the previous five years of records specified
in Sec. 63.366(b) and (c), as applicable.
(c) You must maintain the previous five years of records for
compliance tests and associated data analysis, as applicable.
(d) Any records required to be maintained by this subpart that are
submitted electronically via the EPA's CEDRI may be maintained in
electronic format. This ability to maintain electronic copies does not
affect the requirement for facilities to make records, data, and
reports available upon request to a delegated air agency or the EPA as
part of an on-site compliance evaluation.
(e) If you are using an EtO CEMS to demonstrate continuous
compliance, you must maintain the previous five years of records for
all required certification and QA tests.
(f) For each deviation from an emission limit, operating limit, or
best management practice, you must keep a record of the information
specified in paragraph (g)(1) through (4) of this section. The records
shall be maintained as specified in Sec. 63.10(b)(1).
(1) The occurrence and duration of each startup, shutdown, or
malfunction of process, air pollution control, and monitoring
equipment.
(2) In the event that an affected unit does not meet an applicable
standard, record the number of deviations. For each deviation, record
the date, time, cause, and duration of each deviation.
(3) For each failure to meet an applicable standard, record and
retain a list of the affected sources or equipment, an estimate of the
quantity of each regulated pollutant emitted over any emission limit
and a description of the method used to estimate the emissions.
(4) Record actions taken to minimize emissions in accordance with
Sec. 63.362(k) and any corrective actions taken to return the affected
unit to its normal or usual manner of operation.
Sec. 63.368 Implementation and enforcement.
(a) This subpart can be implemented and enforced by the U.S. EPA or
a delegated authority such as the applicable State, local, or Tribal
agency. If the U.S. EPA Administrator has delegated authority to a
State, local, or Tribal agency, then that agency, in addition to the
U.S. EPA, has the authority to implement and enforce this subpart.
Contact the applicable U.S. EPA Regional Office to find out whether
implementation and enforcement of this subpart are delegated to a
State, local, or Tribal agency.
(b) In delegating implementation and enforcement authority of this
subpart to a State, local, or Tribal agency under subpart E of this
part, the authorities contained in paragraph (c) of this section are
retained by the Administrator of U.S. EPA and cannot be transferred to
the State, local, or Tribal agency.
(c) The authorities that cannot be delegated to State, local, or
Tribal agencies are as specified in paragraphs (c)(1) through (5) of
this section.
(1) Approval of alternatives to the requirements in Sec. Sec.
63.360 and 63.362.
(2) Approval of major alternatives to test methods under Sec.
63.7(e)(2)(ii) and (f), as defined in Sec. 63.90, and as required in
this subpart.
(3) Approval of major alternatives to monitoring under Sec.
63.8(f), as defined in Sec. 63.90, and as required in this subpart.
(4) Approval of major alternatives to recordkeeping and reporting
under Sec. 63.10(f), as defined in Sec. 63.90, and as required in
this subpart.
(5) Approval of an alternative to any electronic reporting to the
EPA required by this subpart.
Table 1 to Subpart O of Part 63--Standards for SCVs
As required in Sec. 63.362(c), for each SCV, you must meet the
applicable standard in the following table:
----------------------------------------------------------------------------------------------------------------
You must comply with
For each . . . For which . . . You must . . . the standard . . .
----------------------------------------------------------------------------------------------------------------
1. Existing SCV...................... a. Facility EtO use is i. Continuously reduce Until April 6, 2026.
at least 10 tpy. EtO emissions by 99
percent \1\.
b. Facility EtO use is i. Continuously reduce Until April 6, 2026.
at least 1 tpy but EtO emissions by 99
less than 10 tpy. percent \1\.
ii. Continuously reduce No later than April 6,
EtO emissions by 99.8 2026.
percent 2 3.
c. Facility EtO use is i. Continuously reduce No later than April 6,
at least 30 tpy. EtO emissions by 99.99 2026.
percent 2 3.
d. Facility EtO use is i. Continuously reduce No later than April 6,
at least 10 tpy but EtO emissions by 99.9 2026.
less than 30 tpy. percent 2 3.
e. Facility EtO use is i. Continuously reduce No later than April 5,
less than 1 tpy. EtO emissions by 99 2027.
percent 2 4.
[[Page 24193]]
2. New SCV........................... a. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.99 2024.
2024, and facility EtO percent 2 5.
use is at least 30 tpy.
b. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.9 2024.
2024, and facility EtO percent 2 5.
use is at least 10 tpy
but less than 30 tpy.
c. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.8 2024.
2024, and facility EtO percent 2 5.
use is at least 1 tpy
but less than 10 tpy.
d. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99 2024.
2024, and facility EtO percent 2 6.
use is less than 1 tpy.
e. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99.99 source.
and facility EtO use percent 2 5.
is at least 30 tpy.
f. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99.9 source.
and facility EtO use percent 2 5.
is at least 10 tpy but
less than 30 tpy.
g. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99.8 source.
and facility EtO use percent 2 5.
is at least 1 tpy but
less than 10 tpy.
h. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99 source.
and facility EtO use percent 2 6.
is less than 1 tpy.
----------------------------------------------------------------------------------------------------------------
\1\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after December 6, 1996.
\2\ If using EtO CEMS to determine compliance, this standard is based on the previous 30 operating days of data.
\3\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after April 7, 2025.
\4\ The standard applies if the facility has used less than 1 tpy of EtO within all consecutive 12-month periods
after April 6, 2026.
\5\ The standard applies if the facility is expected to meet or exceed the specified EtO use within one year
after startup. Afterwards, the standard applies if the facility has met or exceeded the specified EtO use
within any consecutive 12-month period after startup.
\6\ The standard applies if the facility is not expected to meet or exceed 1 tpy of EtO use within one year
after startup. Afterwards, the standard applies if the facility has used less than 1 tpy of EtO within all
consecutive 12-month periods after startup.
Table 2 to Subpart O of Part 63--Standards for ARVs
As required in Sec. 63.362(d), for each ARV, you must meet the
applicable standard in the following table:
----------------------------------------------------------------------------------------------------------------
You must comply with
For each . . . For which . . . You must . . . the standard . . .
----------------------------------------------------------------------------------------------------------------
1. Existing ARV...................... a. Facility EtO use is i. Continuously reduce Until April 6, 2026.
at least 10 tpy. EtO emissions by 99
percent \1\.
b. Facility EtO use is i. Continuously reduce No later than April 6,
at least 30 tpy. EtO emissions by 99.9 2026.
percent 2 3.
c. Facility EtO use is i. Continuously reduce No later than April 6,
at least 10 tpy but EtO emissions by 99.6 2026.
less than 30 tpy. percent 2 3.
d. Facility EtO use is i. Continuously reduce No later than April 5,
less than 10 tpy. EtO emissions by 99 2027.
percent 2 4.
2. New ARV........................... a. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.9 2024.
2024, and facility EtO percent 2 5.
use is at least 10 tpy.
b. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99 2024.
2024, and facility EtO percent 2 6.
use is less than 10
tpy.
c. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99.9 source.
and facility EtO use percent 2 5.
is at least 10 tpy.
d. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99 source.
and facility EtO use percent 2 6.
is less than 10 tpy.
----------------------------------------------------------------------------------------------------------------
\1\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after December 6, 1996.
\2\ If using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
\3\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after April 7, 2025.
\4\ The standard applies if the facility has used less than 10 tpy of EtO within all consecutive 12-month
periods after April 6, 2026.
\5\ The standard applies if the facility is expected to meet or exceed the specified EtO use within one year
after startup. Afterwards, the standard applies if the facility has met or exceeded the specified EtO use
within any consecutive 12-month period after startup.
\6\ The standard applies if the facility is not expected to meet or exceed 10 tpy of EtO use within one year
after startup. Afterwards, the standard applies if the facility has used less than 10 tpy of EtO within all
consecutive 12-month periods after startup.
Table 3 to Subpart O of Part 63--Standards for CEVs
As required in Sec. 63.362(e), for each CEV, you must meet the
applicable standard in the following table:
----------------------------------------------------------------------------------------------------------------
You must comply with
For each . . . For which . . . You must . . . the standard . . .
----------------------------------------------------------------------------------------------------------------
1. Existing CEV at a major source a. Not applicable...... i. Continuously reduce No later than April 5,
facility. EtO emissions by 99.94 2027.
percent \1\.
2. Existing CEV at an area source a. Facility EtO use is i. Continuously reduce No later than April 6,
facility. at least 60 tpy. EtO emissions by 99.9 2026.
percent 1 2.
b. Facility EtO use is i. Continuously reduce No later than April 5,
less than 60 tpy. EtO emissions by 99 2027.
percent 1 3.
3. New CEV at a major source facility a. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.94 2024.
2024. percent \1\.
[[Page 24194]]
b. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024. EtO emissions by 99.94 source.
percent \1\.
4. New CEV at an area source facility a. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99.9 2024.
2024, and facility EtO percent 1 4.
use is at least 60 tpy.
b. Initial startup is i. Continuously reduce No later than April 5,
on or before April 5, EtO emissions by 99 2024.
2024, facility EtO use percent 1 5.
is less than 60 tpy.
c. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99.9 source.
and facility EtO use percent 1 4.
is at least 60 tpy.
d. Initial startup is i. Continuously reduce Upon startup of the
after April 5, 2024, EtO emissions by 99 source.
facility EtO use is percent 1 5.
less than 60 tpy.
----------------------------------------------------------------------------------------------------------------
\1\ If using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
\2\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after April 7, 2025.
\3\ The standard applies if the facility has used less than 60 tpy of EtO within all consecutive 12-month
periods after April 6, 2026.
\4\ The standard applies if the facility is expected to meet or exceed the specified EtO use within one year
after startup. Afterwards, the standard applies if the facility has met or exceeded the specified EtO use
within any consecutive 12-month period after startup.
\5\ The standard applies if the facility is not expected to meet or exceed 60 tpy of EtO use within one year
after startup. Afterwards, the standard applies if the facility has used less than 60 tpy of EtO within all
consecutive 12-month periods after startup.
Table 4 to Subpart O of Part 63--Standards for Group 1 Room Air
Emissions
As required in Sec. 63.362(f), for your collection of Group 1 room
air emissions at each facility, you must meet the applicable standard
in the following table:
----------------------------------------------------------------------------------------------------------------
You must comply with
For each . . . For which . . . You must . . . the requirement(s) . .
.
----------------------------------------------------------------------------------------------------------------
1. Existing collection of Group 1 a. Not applicable...... i. Operate all areas of No later than April 5,
room air emissions at a major source the facility that 2027.
facility. contain Group 1 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 97
percent \1\.
2. Existing collection of Group 1 a. Facility EtO use is i. Operate all areas of No later than April 6,
room air emissions at an area source at least 40 tpy. the facility that 2026.
facility. contain Group 1 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\2\
Also,
ii. Continuously reduce
EtO emissions by 98
percent \1\ \2\.
b. Facility EtO use is i. Operate all areas of No later than April 5,
less than 40 tpy. the facility that 2027.
contain Group 1 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \3\.
3. New collection of Group 1 room air a. Initial startup is i. Operate all areas of No later than April 5,
emissions at a major source facility. on or before April 5, the facility that 2024.
2024. contain Group 1 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 97
percent \1\.
b. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024. the facility that source.
contain Group 1 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 97
percent \1\.
4. New collection of Group 1 room air a. Initial startup is i. Operate all areas of No later than April 5,
emissions at an area source facility. on or before April 5, the facility that 2024.
2024, and facility EtO contain Group 1 room
use is at least 40 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\4\
Also,
ii. Continuously reduce
EtO emissions by 98
percent \1\ \4\.
b. Initial startup is i. Operate all areas of No later than April 5,
on or before April 5, the facility that 2024.
2024, and facility EtO contain Group 1 room
use is less than 40 air emissions with
tpy. PTE, with all exhaust
gas streams being
captured and routed to
a control system.\5\
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \5\.
c. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024, the facility that source.
and facility EtO use contain Group 1 room
is at least 40 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\4\
Also,
ii. Continuously reduce
EtO emissions by 98
percent \1\ \4\.
d. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024, the facility that source.
and facility EtO use contain Group 1 room
is less than 40 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\5\
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \5\.
----------------------------------------------------------------------------------------------------------------
\1\ If using CEMS to determine compliance, this standard is based on a rolling 30-operating day average.
\2\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after April 7, 2025.
\3\ The standard applies if the facility has used less than 40 tpy of EtO within all consecutive 12-month
periods after April 6, 2026.
\4\ The standard applies if the facility is expected to meet or exceed the specified EtO use within one year
after startup. Afterwards, the standard applies if the facility has met or exceeded the specified EtO use
within any consecutive 12-month period after startup.
\5\ The standard applies if the facility is not expected to meet or exceed 40 tpy of EtO use within one year
after startup. Afterwards, the standard applies if the facility has used less than 40 tpy of EtO within all
consecutive 12-month periods after startup.
[[Page 24195]]
Table 5 to Subpart O of Part 63--Standards for Group 2 Room Air
Emissions
As required in Sec. 63.362(g), for your collection of Group 2 room
air emissions, you must meet the applicable standard in the following
table:
----------------------------------------------------------------------------------------------------------------
You must comply with
For each . . . For which . . . You must . . . the requirement(s) . .
.
----------------------------------------------------------------------------------------------------------------
1. Existing collection of Group 2 a. Not applicable...... i. Operate all areas of No later than April 5,
room air emissions at a major source the facility that 2027.
facility. contain Group 2 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 86
percent \1\.
2. Existing collection of Group 2 a. Facility EtO use is i. Operate all areas of No later than April 6,
room air emissions at an area source at least 20 tpy. the facility that 2026.
facility. contain Group 2 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\2\
Also,.
ii. Continuously reduce
EtO emissions by 98
percent \1\ \2\.
b. Facility EtO use is i. Operate all areas of No later than April 6,
at least 4 tpy but the facility that 2026.
less than 20 tpy. contain Group 2 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\2\
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \2\.
c. Facility EtO use is Lower the EtO No later than April 5,
less than 4 tpy. concentration within 2027.
each sterilization
chamber to 1 ppm
before the chamber can
be opened \3\.
3. New collection of Group 2 room air a. Initial startup is i. Operate all areas of No later than April 5,
emissions at a major source facility. on or before April 5, the facility that 2024.
2024. contain Group 2 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 86
percent \1\.
b. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024. the facility that source.
contain Group 2 room
air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.
Also,
ii. Continuously reduce
EtO emissions by 86
percent \1\.
4. New collection of Group 2 room air a. Initial startup is i. Operate all areas of No later than April 5,
emissions at an area source facility. on or before April 5, the facility that 2024.
2024, and facility EtO contain Group 2 room
use is at least 20 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\5\
Also,
ii. Continuously reduce
EtO emissions by 98
percent \1\ \5\.
b. Initial startup is i. Operate all areas of No later than April 5,
on or before April 5, the facility that 2024.
2024, and facility EtO contain Group 2 room
use is less than 20 air emissions with
tpy. PTE, with all exhaust
gas streams being
captured and routed to
a control system.\6\
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \6\.
c. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024, the facility that source.
and facility EtO use contain Group 2 room
is at least 20 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\5\
Also,
ii. Continuously reduce
EtO emissions by 98
percent \1\ \5\.
d. Initial startup is i. Operate all areas of Upon startup of the
after April 5, 2024, the facility that source.
and facility EtO use contain Group 2 room
is less than 20 tpy. air emissions with
PTE, with all exhaust
gas streams being
captured and routed to
a control system.\6\
Also,
ii. Continuously reduce
EtO emissions by 80
percent \1\ \6\.
----------------------------------------------------------------------------------------------------------------
\1\ This standard is based on a rolling 30-operating day average.
\2\ The standard applies if the facility has met or exceeded the specified EtO use within any consecutive 12-
month period after April 7, 2025.
\3\ The standard applies if the facility has used less than 4 tpy of EtO within all consecutive 12-month periods
after April 6, 2026.
\4\ The standard applies if the facility is expected to meet or exceed the specified EtO use within one year
after startup. Afterwards, the standard applies if the facility has met or exceeded the specified EtO use
within any consecutive 12-month period after startup.
\5\ The standard applies if the facility is not expected to meet or exceed 20 tpy of EtO use within one year
after startup. Afterwards, the standard applies if the facility has used less than 20 tpy of EtO within all
consecutive 12-month periods after startup.
Table 6 to Subpart O of Part 63--Applicability of General Provisions to
This Subpart
As specified in Sec. 63.360, the parts of the General Provisions
that apply to you are shown in the following table:
------------------------------------------------------------------------
Citation Subject Applies to subpart O
------------------------------------------------------------------------
Sec. 63.1(a)(1)............ Applicability.. Yes, additional terms
defined in Sec.
63.361; when overlap
between subparts A and
O occurs, subpart O
takes precedence.
Sec. 63.1(a)(2)-(3)........ ............... Yes.
Sec. 63.1(a)(4)............ ............... Yes. Subpart O clarifies
the applicability of
each paragraph in
subpart A to facilities
subject to subpart O.
Sec. 63.1(a)(5)............ [Reserved]..... No.
Sec. 63.1(a)(6)-(8)........ ............... Yes.
Sec. 63.1(a)(9)............ [Reserved].....
Sec. 63.1(a)(10)-(14)...... ............... Yes.
Sec. 63.1(b)(1)-(2)........ ............... Yes.
Sec. 63.1(b)(3)............ ............... No.
Sec. 63.1(c)(1)............ ............... No. Subpart O clarifies
the applicability of
each paragraph in
subpart A to facilities
subject to subpart O in
this table.
Sec. 63.1(c)(2)............ ............... Yes.
[[Page 24196]]
Sec. 63.1(c)(3)............ [Reserved]..... No.
Sec. 63.1(c)(4)............ ............... Yes.
Sec. 63.1(c)(5)............ ............... No. Sec. 63.360
specifies
applicability.
Sec. 63.1(c)(6)............ ............... Yes.
Sec. 63.1(d)............... [Reserved]..... No.
Sec. 63.1(e)............... ............... Yes.
Sec. 63.2.................. Definitions.... Yes, additional terms
defined in Sec.
63.361; when overlap
between subparts A and
O occurs, subpart O
takes precedence.
Sec. 63.3.................. Units and Yes, other units used in
abbreviations. subpart O are defined
in the text of subpart
O.
Sec. 63.4(a)(1)-(3)........ Prohibited Yes.
activities.
Sec. 63.5(a)............... Construction/ No. Sec. 63.366(b)(1)
Reconstruction. contains applicability
requirements for
constructed or
reconstructed
facilities.
Sec. 63.5(b)(1)............ ............... Yes.
Sec. 63.5(b)(2)............ [Reserved].....
Sec. 63.5(b)(3)............ ............... No. See Sec.
63.366(b)(2).
Sec. 63.5(b)(4)-(6)........ ............... Yes.
Sec. 63.5(c)............... [Reserved].....
Sec. 63.5(d)(1)-(2)........ ............... No. See Sec.
63.366(b)(3).
Sec. 63.5(d)(3)-(4)........ ............... Yes.
Sec. 63.5(e)............... ............... Yes.
Sec. 63.5(f)(1)-(2)........ ............... No. See Sec.
63.366(b)(4).
Sec. 63.6(a)............... Applicability.. Yes.
Sec. 63.6(b)-(c)........... ............... No. Sec. 63.360(j)
specifies compliance
dates for facilities.
Sec. 63.6(d)............... [Reserved].....
Sec. 63.6(e)(1)(i)......... ............... No.
Sec. 63.6(e)(1)(ii)........ Requirement to No.
correct
malfunctions
ASAP.
Sec. 63.6(e)(1)(iii)....... ............... Yes.
Sec. 63.6(e)(2)............ [Reserved]..... No.
Sec. 63.6(e)(3)............ SSM Plan No.
Requirements.
Sec. 63.6(f)(1)............ SSM exemption.. No.
Sec. 63.6(f)(2)(i)......... Methods for Yes.
Determining
Compliance.
Sec. 63.6(f)(2)(ii)........ ............... No. Sec. 63.363
specifies parameters
for determining
compliance.
Sec. 63.6(f)(2)(iii)-(iv).. ............... Yes.
Sec. 63.6(f)(2)(v)......... ............... No.
Sec. 63.6(f)(3)............ ............... Yes.
Sec. 63.6(g)............... Alternative Yes.
Standard.
Sec. 63.6(h)............... Compliance with No. Subpart O does not
opacity and contain any opacity or
visible visible emission
emission standards.
standards.
Sec. 63.6(i)(1)-(14), and Compliance Yes.
(16). Extension.
Sec. 63.6(j)............... Presidential Yes.
Compliance
Exemption.
Sec. 63.7(a)............... Applicability Yes.
and
Performance
Test Dates.
Sec. 63.7(b)............... Notification of Yes.
Performance
Test.
Sec. 63.7(c)............... Quality Yes.
Assurance/Test
Plan.
Sec. 63.7(d)............... Testing Yes.
Facilities.
Sec. 63.7(e)(1)............ SSM exemption.. No.
Sec. 63.7(e)(2)-(4)........ Conduct of Yes. Sec. 63.365 also
Performance contains test methods
Tests. specific to facilities
subject to the
emissions standards.
Sec. 63.7(f)............... Alternative Yes.
Test Method.
Sec. 63.7(g)............... Performance Yes, except this subpart
Test Data specifies how and when
Analysis. the performance test
and performance
evaluation results are
reported.
Sec. 63.7(h)............... Waiver of Tests Yes.
Sec. 63.8(a)(1)............ Applicability Yes.
of Monitoring
Requirements.
Sec. 63.8(a)(2)............ Performance Yes.
Specifications.
Sec. 63.8(a)(3)............ [Reserved]..... No.
Sec. 63.8(a)(4)............ Monitoring with Yes.
Flares.
Sec. 63.8(b)(1)............ Monitoring..... Yes.
Sec. 63.8(b)(2)-(3)........ Multiple Yes.
Effluents and
Multiple
Monitoring
Systems.
Sec. 63.8(c)(1)(i)......... General duty to No.
minimize
emissions and
CMS operation.
Sec. 63.8(c)(1)(ii)........ ............... No. A startup, shutdown,
and malfunction plan is
not required for these
standards.
Sec. 63.8(c)(1)(iii)....... Requirement to No.
develop SSM
Plan for CMS.
Sec. 63.8(c)(2)-(3)........ ............... Yes.
Sec. 63.8(c)(4)-(5)........ ............... No. Frequency of
monitoring measurements
is provided in Sec.
63.364; opacity
monitors are not
required for these
standards.
Sec. 63.8(c)(6)............ ............... No. Performance
specifications are
contained in Sec.
63.365.
[[Page 24197]]
Sec. 63.8(c)(7)(i)(A)-(B).. ............... No. Performance
specifications are
contained in Sec.
63.365.
Sec. 63.8(c)(7)(i)(C)...... ............... No. Opacity monitors are
not required for these
standards.
Sec. 63.8(c)(7)(ii)........ ............... No. Performance
specifications are
contained in Sec.
63.365.
Sec. 63.8(c)(8)............ ............... No.
Sec. 63.8(d)(1)-(2)........ ............... Yes.
Sec. 63.8(d)(3)............ Written No.
procedures for
CMS.
Sec. 63.8(e)(1)............ CMS Performance Yes, but only applies
Evaluation. for CEMS, except this
subpart specifies how
and when the
performance evaluation
results are reported.
Sec. 63.8(e)(2)............ ............... Yes.
Sec. 63.8(e)(3)............ ............... Yes.
Sec. 63.8(e)(4)............ ............... Yes.
Sec. 63.8(e)(5)(i)......... ............... Yes.
Sec. 63.8(e)(5)(ii)........ ............... No. Opacity monitors are
not required for these
standards.
Sec. 63.8(f)(1)-(5)........ ............... Yes.
Sec. 63.8(f)(6)............ ............... No.
Sec. 63.8(g)(1)............ ............... Yes.
Sec. 63.8(g)(2)............ ............... No.
Sec. 63.8(g)(3)-(5)........ ............... Yes.
Sec. 63.9(a)............... Notification Yes.
requirements.
Sec. 63.9(b)(1)-(i)........ ............... Yes.
Sec. 63.9(b)(1)(ii)-(iii).. Initial No. Sec.
Notifications. 63.366(c)(1)(i)
contains language for
facilities that
increase usage such
that the source becomes
subject to the
emissions standards.
Sec. 63.9(b)(2)-(3)........ Initial Yes. Sec. 63.366(c)(3)
Notifications. contains additional
information to be
included in the initial
report for existing and
new facilities.
Sec. 63.9(b)(4)-(5)........ Initial No. Sec.
Notifications. 63.366(c)(1)(ii) and
(iii) contains
requirements for new or
reconstructed
facilities subject to
the emissions
standards.
Sec. 63.9(c)............... Request for Yes.
Compliance
Extension.
Sec. 63.9(d)............... Notification of No.
Special
Compliance
Requirements
for New
Sources.
Sec. 63.9(e)............... Notification of Yes.
Performance
Test.
Sec. 63.9(f)............... Notification of No. Opacity monitors are
VE/Opacity not required for these
Test. standards.
Sec. 63.9(g)(1)............ Additional Yes.
Notifications
When Using CMS.
Sec. 63.9(g)(2)-(3)........ Additional No. Opacity monitors and
Notifications relative accuracy
When Using CMS. testing are not
required for these
standards.
Sec. 63.9(h)(1)-(3)........ Notification of Yes, except Sec.
Compliance 63.9(h)(5) does not
Status. apply because Sec.
63.366(c)(2) instructs
facilities to submit
actual data.
Sec. 63.9(i)............... Adjustment of Yes.
Submittal
Deadlines.
Sec. 63.9(j)............... Change in Yes.
previous
information.
Sec. 63.9(k)............... Electronic Yes, as specified in
reporting Sec. 63.9(j).
procedures.
Sec. 63.10(a).............. Recordkeeping/ Yes.
Reporting.
Sec. 63.10(b)(1)........... Recordkeeping/ Yes.
Reporting.
Sec. 63.10(b)(2)(i)........ Recordkeeping No. See 63.367(f) for
for startup recordkeeping
and shutdown. requirements.
Sec. 63.10(b)(2)(ii)....... Recordkeeping No. See 63.367(f) for
for SSM and recordkeeping
failures to requirements.
meet standards.
Sec. 63.10(b)(2)(iii)...... Records related Yes.
to maintenance
of air
pollution
control
equipment.
Sec. 63.10(b)(2)(iv)-(v)... Actions taken No.
to minimize
emissions
during SSM.
Sec. 63.10(b)(2)(vi)....... CMS Records.... Yes.
Sec. 63.10(b)(2)(vii)-(ix). Records........ Yes.
Sec. 63.10(b)(2)(x)-(xi)... CMS Records.... Yes.
Sec. 63.10(b)(2)(xii)...... Records........ Yes.
Sec. 63.10(b)(2)(xiii)..... Records........ Yes.
Sec. 63.10(b)(2)(xiv)...... Records........ Yes.
Sec. 63.10(b)(3)........... Records........ Yes.
Sec. 63.10(c)(1)-(14)...... Records........ Yes.
Sec. 63.10(c)(15).......... Use of SSM Plan No.
Sec. 63.10(d)(1)........... General Yes.
Reporting
Requirements.
Sec. 63.10(d)(2)........... Report of No. This subpart
Performance specifies how and when
Test Results. the performance test
results are reported.
Sec. 63.10(d)(3)........... Reporting No. Subpart O does not
Opacity or VE contain opacity or
Observations. visible emissions
standards.
Sec. 63.10(d)(4)........... Progress Yes.
Reports.
Sec. 63.10(d)(5)........... SSM Reports.... No. See Sec. 63.366
for malfunction
reporting requirements.
Sec. 63.10(e)(1)........... Additional CEMS Yes.
Reports.
[[Page 24198]]
Sec. 63.10(e)(2)(i)........ Additional CMS Yes, except this subpart
Reports. specifies how and when
the performance
evaluation results are
reported.
Sec. 63.10(e)(2)(ii)....... Additional COMS No. Opacity monitors are
Reports. not required for these
standards.
Sec. 63.10(e)(3)(i)-(iv)... Reports........ Yes.
Sec. 63.10(e)(3)(v)........ Excess No. Sec. 63.366(b) and
Emissions (c) specify contents
Reports. and submittal dates for
excess emissions and
monitoring system
performance reports.
Sec. 63.10(e)(3)(vi)-(viii) Excess Yes.
Emissions
Report and
Summary Report.
Sec. 63.10(e)(4)........... Reporting COMS No. Opacity monitors are
data. not required for these
standards.
Sec. 63.10(f).............. Waiver for Yes.
Recordkeeping/
Reporting.
Sec. 63.11................. Control device Yes.
requirements
for flares and
work practice
requirements
for equipment
leaks.
Sec. 63.12................. Delegation..... Yes.
Sec. 63.13................. Addresses...... Yes.
Sec. 63.14................. Incorporation Yes.
by Reference.
Sec. 63.15................. Availability of Yes.
Information.
------------------------------------------------------------------------
Appendix A to Subpart O of Part 63--Monitoring Provisions for EtO CEMS
1. Applicability
These monitoring provisions apply to the measurement of EtO
emissions from commercial sterilization facilities, using CEMS. The
CEMS must be capable of measuring EtO in lb/hr.
2. Monitoring of EtO Emissions
2.1 Monitoring System Installation Requirements. Install EtO
CEMS and any additional monitoring systems needed to convert
pollutant concentrations to lb/hr in accordance with Sec. 63.365
and Performance Specification 19 (PS 19) of appendix B to part 60 of
this chapter.
2.2 Primary and Backup Monitoring Systems. In the electronic
monitoring plan described in section 10.1.1.2.1 of this appendix,
you must designate a primary EtO CEMS. The primary EtO CEMS must be
used to report hourly EtO concentration values when the system is
able to provide quality-assured data, i.e., when the system is ``in
control''. However, to increase data availability in the event of a
primary monitoring system outage, you may install, operate,
maintain, and calibrate backup monitoring systems, as follows:
2.2.1 Redundant Backup Systems. A redundant backup monitoring
system is a separate EtO CEMS with its own probe, sample interface,
and analyzer. A redundant backup system is one that is permanently
installed at the unit or stack location and is kept on ``hot
standby'' in case the primary monitoring system is unable to provide
quality-assured data. A redundant backup system must be represented
as a unique monitoring system in the electronic monitoring plan.
Each redundant backup monitoring system must be certified according
to the applicable provisions in section 3 of this appendix and must
meet the applicable on-going QA requirements in section 5 of this
appendix.
2.2.2 Non-redundant Backup Monitoring Systems. A non-redundant
backup monitoring system is a separate EtO CEMS that has been
certified at a particular unit or stack location but is not
permanently installed at that location. Rather, the system is kept
on ``cold standby'' and may be reinstalled in the event of a primary
monitoring system outage. A nonredundant backup monitoring system
must be represented as a unique monitoring system in the electronic
monitoring plan. Non-redundant backup EtO CEMS must complete the
same certification tests as the primary monitoring system, with one
exception. The 7-day calibration error test is not required for a
non-redundant backup EtO CEMS. Except as otherwise provided in
section 2.2.4.4 of this appendix, a non-redundant backup monitoring
system may only be used for 720 hours per year at a particular unit
or stack location.
2.2.3 Temporary Like-kind Replacement Analyzers. When a primary
EtO analyzer needs repair or maintenance, you may temporarily
install a like-kind replacement analyzer, to minimize data loss.
Except as otherwise provided in section 2.2.4.4 of this appendix, a
temporary like-kind replacement analyzer may only be used for 720
hours per year at a particular unit or stack location. The analyzer
must be represented as a component of the primary EtO CEMS and must
be assigned a 3-character component ID number, beginning with the
prefix ``LK''.
2.2.4 Quality Assurance Requirements for Non-redundant Backup
Monitoring Systems and Temporary Like-kind Replacement Analyzers. To
quality-assure the data from non-redundant backup EtO monitoring
systems and temporary like-kind replacement EtO analyzers, the
following provisions apply:
2.2.4.1 When a certified non-redundant backup EtO CEMS or a
temporary like-kind replacement EtO analyzer is brought into
service, a calibration error test and a linearity check must be
performed and passed. A single point system integrity check is also
required.
2.2.4.2 Each non-redundant backup EtO CEMS or temporary like-
kind replacement EtO analyzer shall comply with all required daily,
weekly, and quarterly quality-assurance test requirements in section
5 of this appendix, for as long as the system or analyzer remains in
service.
2.2.4.3 For the routine, on-going quality-assurance of a non-
redundant backup EtO monitoring system, a relative accuracy test
audit (RATA) must be performed and passed at least once every 8
calendar quarters at the unit or stack location(s) where the system
will be used.
2.2.4.4 To use a non-redundant backup EtO monitoring system or a
temporary like-kind replacement analyzer for more than 720 hours per
year at a particular unit or stack location, a RATA must first be
performed and passed at that location.
2.3 Monitoring System Equipment, Supplies, Definitions, and
General Operation.
The following provisions apply:
2.3.1 PS 19, Sections 3.0, 6.0, and 11.0 of appendix B to part
60 of this chapter.
3. Initial Certification Procedures
The initial certification procedures for the EtO CEMS used to
provide data under this subpart are as follows:
3.1 Your EtO CEMS must be certified according to PS 19,
section(s) 13.
3.2 Any additional stack gas flow rate monitoring system(s)
needed to express pollutant concentrations in lb/hr must be
certified according to part 75 of this chapter.
4. Recertification Procedures
Whenever the owner or operator makes a replacement,
modification, or change to a certified CEMS that may significantly
affect the ability of the system to accurately measure or record
pollutant gas concentrations or stack gas flow rates, the owner or
operator shall recertify the monitoring system. Furthermore,
whenever the owner or operator makes a replacement, modification, or
change to the flue gas handling system or the unit operation that
may significantly change the concentration or flow profile, the
owner or operator shall recertify the monitoring system. The same
tests performed for the initial certification of the monitoring
system shall be repeated for recertification, unless otherwise
specified by the Administrator. Examples of changes that require
recertification include: Replacement of a gas analyzer; complete
monitoring
[[Page 24199]]
system replacement, and changing the location or orientation of the
sampling probe.
5. On-Going Quality Assurance Requirements
On-going QA test requirements for EtO CEMS must be implemented
as follows:
5.1 The quality assurance/quality control procedures in
Procedure 7 of appendix F to part 60 of this chapter shall apply.
5.2 Stack gas flow rate, diluent gas, and moisture monitoring
systems must meet the applicable ongoing QA test requirements of
part 75 of this chapter.
5.2.1 Out-of-Control Periods. A EtO CEMS that is used to provide
data under this appendix is considered to be out-of-control, and
data from the CEMS may not be reported as quality-assured, when any
acceptance criteria for a required QA test is not met. The EtO CEMS
is also considered to be out-of-control when a required QA test is
not performed on schedule or within an allotted grace period. To end
an out-of-control period, the QA test that was either failed or not
done on time must be performed and passed. Out-of-control periods
are counted as hours of monitoring system downtime.
5.2.2 Grace Periods. For the purposes of this appendix, a
``grace period'' is defined as a specified number of unit or stack
operating hours after the deadline for a required quality-assurance
test of a continuous monitor has passed, in which the test may be
performed and passed without loss of data.
5.2.2.1 For the flow rate monitoring systems described in
section 5.1 of this appendix, a 168 unit or stack operating hour
grace period is available for quarterly linearity checks, and a 720
unit or stack operating hour grace period is available for RATAs, as
provided, respectively, in sections 2.2.4 and 2.3.3 of appendix B to
part 75 of this chapter.
5.2.2.2 For the purposes of this appendix, if the deadline for a
required gas audit or RATA of a EtO CEMS cannot be met due to
circumstances beyond the control of the owner or operator:
5.2.2.2.1 A 168 unit or stack operating hour grace period is
available in which to perform the gas audit; or
5.2.2.2.2 A 720 unit or stack operating hour grace period is
available in which to perform the RATA.
5.2.2.3 If a required QA test is performed during a grace
period, the deadline for the next test shall be determined as
follows:
5.2.2.3.1 For the gas audit of an EtO CEMS, the grace period
test only satisfies the audit requirement for the calendar quarter
in which the test was originally due. If the calendar quarter in
which the grace period audit is performed is a QA operating quarter,
an additional gas audit is required for that quarter.
5.2.2.3.2 For the RATA of an EtO CEMS, the next RATA is due
within three QA operating quarters after the calendar quarter in
which the grace period test is performed.
5.2.3 Conditional Data Validation. For recertification and
diagnostic testing of the monitoring systems that are used to
provide data under this appendix, and for the required QA tests when
nonredundant backup monitoring systems or temporary like-kind
replacement analyzers are brought into service, the conditional data
validation provisions in Sec. Sec. 75.20(b)(3)(ii) through
(b)(3)(ix) of this chapter may be used to avoid or minimize data
loss. The allotted window of time to complete calibration tests and
RATAs shall be as specified in Sec. 75.20(b)(3)(iv) of this
chapter; the allotted window of time to complete a gas audit shall
be the same as for a linearity check (i.e., 168 unit or stack
operating hours).
5.3 Data Validation.
5.3.1 Out-of-Control Periods. An EtO CEMS that is used to
provide data under this appendix is considered to be out-of-control,
and data from the CEMS may not be reported as quality-assured, when
any acceptance criteria for a required QA test is not met. The EtO
CEMS is also considered to be out-of-control when a required QA test
is not performed on schedule or within an allotted grace period. To
end an out-of-control period, the QA test that was either failed or
not done on time must be performed and passed. Out-of-control
periods are counted as hours of monitoring system downtime.
5.3.2 Grace Periods. For the purposes of this appendix, a
``grace period'' is defined as a specified number of unit or stack
operating hours after the deadline for a required quality-assurance
test of a continuous monitor has passed, in which the test may be
performed and passed without loss of data.
5.3.2.1 For the monitoring systems described in section 5.1 of
this appendix, a 168 unit or stack operating hour grace period is
available for quarterly linearity checks, and a 720 unit or stack
operating hour grace period is available for RATAs, as provided,
respectively, in sections 2.2.4 and 2.3.3 of appendix B to part 75
of this chapter.
5.3.2.2 For the purposes of this appendix, if the deadline for a
required gas audit/data accuracy assessment or RATA of an EtO CEMS
cannot be met due to circumstances beyond the control of the owner
or operator:
5.3.2.2.1 A 168 unit or stack operating hour grace period is
available in which to perform the gas audit or other quarterly data
accuracy assessment; or
5.3.2.2.2 A 720 unit or stack operating hour grace period is
available in which to perform the RATA.
5.3.2.3 If a required QA test is performed during a grace
period, the deadline for the next test shall be determined as
follows:
5.3.2.3.1 For a gas audit or RATA of the monitoring systems
described in sections 5.1 and 5.2 of this appendix, determine the
deadline for the next gas audit or RATA (as applicable) in
accordance with section 2.2.4(b) or 2.3.3(d) of appendix B to part
75 of this chapter; treat a gas audit in the same manner as a
linearity check.
5.3.2.3.2 For the gas audit or other quarterly data accuracy
assessment of an EtO CEMS, the grace period test only satisfies the
audit requirement for the calendar quarter in which the test was
originally due. If the calendar quarter in which the grace period
audit is performed is a QA operating quarter, an additional gas
audit/data accuracy assessment is required for that quarter.
5.3.2.3.3 For the RATA of an EtO CEMS, the next RATA is due
within three QA operating quarters after the calendar quarter in
which the grace period test is performed.
5.3.3 Conditional Data Validation. For recertification and
diagnostic testing of the monitoring systems that are used to
provide data under this appendix, the conditional data validation
provisions in Sec. 75.20(b)(3)(ii) through (ix) of this chapter may
be used to avoid or minimize data loss. The allotted window of time
to complete calibration tests and RATAs shall be as specified in
Sec. 75.20(b)(3)(iv) of this chapter; the allotted window of time
to complete a quarterly gas audit or data accuracy assessment shall
be the same as for a linearity check (i.e., 168 unit or stack
operating hours).
6. Missing Data Requirements
For the purposes of this appendix, the owner or operator of an
affected unit shall not substitute for missing data from EtO CEMS.
Any process operating hour for which quality-assured EtO
concentration data are not obtained is counted as an hour of
monitoring system downtime.
7. Bias Adjustment
Bias adjustment of hourly emissions data from an EtO CEMS is not
required.
8. QA/QC Program Requirements
The owner or operator shall develop and implement a quality
assurance/quality control (QA/QC) program for the EtO CEMS that are
used to provide data under this subpart. At a minimum, the program
shall include a written plan that describes in detail (or that
refers to separate documents containing) complete, step-by-step
procedures and operations for the most important QA/QC activities.
Electronic storage of the QA/QC plan is permissible, provided that
the information can be made available in hard copy to auditors and
inspectors. The QA/QC program requirements for the other monitoring
systems described in section 5.2 of this appendix are specified in
section 1 of appendix B to part 75 of this chapter.
8.1 General Requirements for EtO CEMS.
8.1.1 Preventive Maintenance. Keep a written record of
procedures needed to maintain the EtO CEMS in proper operating
condition and a schedule for those procedures. This shall, at a
minimum, include procedures specified by the manufacturers of the
equipment and, if applicable, additional or alternate procedures
developed for the equipment.
8.1.2 Recordkeeping and Reporting. Keep a written record
describing procedures that will be used to implement the
recordkeeping and reporting requirements of this appendix.
8.1.3 Maintenance Records. Keep a record of all testing,
maintenance, or repair activities performed on any EtO CEMS in a
location and format suitable for inspection. A maintenance log may
be used for this purpose. The following records should be
maintained: Date, time, and description of any testing, adjustment,
repair, replacement, or preventive maintenance action performed on
any monitoring system and records of any corrective actions
associated with a monitor outage period. Additionally, any
adjustment that may significantly affect a system's ability to
accurately measure emissions data must be recorded and a written
explanation of the
[[Page 24200]]
procedures used to make the adjustment(s) shall be kept.
8.2 Specific Requirements for EtO CEMS. The following
requirements are specific to EtO CEMS:
8.2.1 Keep a written record of the procedures used for each type
of QA test required for each EtO CEMS. Explain how the results of
each type of QA test are calculated and evaluated.
8.2.2 Explain how each component of the EtO CEMS will be
adjusted to provide correct responses to calibration gases after
routine maintenance, repairs, or corrective actions.
9. Data Reduction and Calculations
9.1 Design and operate the EtO CEMS to complete a minimum of one
cycle of operation (sampling, analyzing, and data recording) for
each successive 15-minute period.
9.2 Reduce the EtO concentration data to hourly averages in
accordance with Sec. 60.13(h)(2) of this chapter.
9.3 Convert each hourly average EtO concentration to an EtO mass
emission rate (lb/hr) using an equation that has the general form of
equation A-1 of this appendix:
[GRAPHIC] [TIFF OMITTED] TR05AP24.045
Where:
Eho = EtO mass emission rate for the hour, lb/hr
K = Units conversion constant, 1.144E-10 lb/scf-ppbv,
Ch = Hourly average EtO concentration, ppbv,
Qh = Stack gas volumetric flow rate for the hour, scfh.
(Note: Use unadjusted flow rate values; bias adjustment is not
required.)
9.4 Use equation A-2 of this appendix to calculate the daily
total EtO emissions. Report each daily total to the same precision
as the most stringent standard that applies to any affected source
exhausting to the emission stream (e.g., if the emission stream
includes contributions from an SCV and ARV subject to 99.99% and
99.9% emission reduction standards, respectively, report to four
significant figures), expressed in scientific notation.
[GRAPHIC] [TIFF OMITTED] TR05AP24.046
Where:
Eday = Total daily EtO emissions, lb.
Eho = Hourly EtO emission rate for unit or stack
sampling hour ``h'' in the averaging period, from equation A-1 of
this appendix, lb/hr.
9.5 Use equation A-3 of this appendix to calculate the 30-
operating day rolling total EtO emissions. Report each 30-operating
day rolling total to the same precision as the most stringent
standard that applies to any affected source exhausting to the
emission stream (e.g., if the emission stream includes contributions
from an SCV and ARV subject to 99.99% and 99.9% emission reduction
standards, respectively, report to four significant figures),
expressed in scientific notation.
[GRAPHIC] [TIFF OMITTED] TR05AP24.047
Where:
E30day = Total EtO emissions during the 30-operating
day, lb.
Eday,i = Total daily EtO emissions, in lbs, for each
operating day i from equation A-2 of this appendix, lb.
i = Operating day index.
10. Recordkeeping Requirements
10.1 For each EtO CEMS installed at an affected source, and for
any other monitoring system(s) needed to convert pollutant
concentrations to units of the applicable emissions limit, the owner
or operator must maintain a file of all measurements, data, reports,
and other information required by this appendix in a form suitable
for inspection, for 5 years from the date of each record, in
accordance with Sec. 63.367. The file shall contain the information
in paragraphs 10.1.1 through 10.1.8 of this section.
10.1.1 Monitoring Plan Records. For each affected source or
group of sources monitored at a common stack, the owner or operator
shall prepare and maintain a monitoring plan for the EtO CEMS and
any other monitoring system(s) (i.e., flow rate, diluent gas, or
moisture systems) needed to convert pollutant concentrations to
units of the applicable emission standard. The monitoring plan shall
contain essential information on the continuous monitoring systems
and shall explain how the data derived from these systems ensure
that all EtO emissions from the unit or stack are monitored and
reported.
10.1.1.1 Updates. Whenever the owner or operator makes a
replacement, modification, or change in a certified continuous EtO
monitoring system that is used to provide data under this subpart
(including a change in the automated data acquisition and handling
system or the flue gas handling system) which affects information
reported in the monitoring plan (e.g., a change to a serial number
for a component of a monitoring system), the owner or operator shall
update the monitoring plan.
10.1.1.2 Contents of the Monitoring Plan. For EtO CEMS, the
monitoring plan shall contain the applicable electronic and hard
copy information in sections 10.1.1.2.1 and 10.1.1.2.2 of this
appendix. For stack gas flow rate, diluent gas, and moisture
monitoring systems, the monitoring plan shall include the electronic
and hard copy information required for those systems under Sec.
75.53(g) of this chapter. The electronic monitoring plan shall be
evaluated using CEDRI.
10.1.1.2.1 Electronic. Record the unit or stack ID number(s);
monitoring location(s); the EtO monitoring methodology used (i.e.,
CEMS); EtO monitoring system information, including, but not limited
to: unique system and component ID numbers; the make, model, and
serial number of the monitoring equipment; the sample acquisition
method; formulas used to calculate emissions; monitor span and range
information (if applicable).
10.1.1.2.2 Hard Copy. Keep records of the following: schematics
and/or blueprints showing the location of the monitoring system(s)
and test ports; data flow diagrams; test protocols; monitor span and
range calculations (if applicable); miscellaneous technical
justifications.
10.1.2 EtO Emissions Records. For EtO CEMS, the owner or
operator must record the following information for each unit or
stack operating hour:
10.1.2.1 The date and hour;
10.1.2.2 Monitoring system and component identification codes,
as provided in the electronic monitoring plan, for each hour in
which the CEMS provides a quality-assured value of EtO concentration
(as applicable);
10.1.2.3 The pollutant concentration, for each hour in which a
quality-assured value is obtained. Record the data in parts per
billion by volume (ppbv), with one leading non-zero digit and one
decimal place, expressed in scientific notation. Use the following
rounding convention: If the digit immediately following the first
decimal place
[[Page 24201]]
is 5 or greater, round the first decimal place upward (increase it
by one); if the digit immediately following the first decimal place
is 4 or less, leave the first decimal place unchanged.
10.1.2.4 A special code, indicating whether or not a quality-
assured EtO concentration value is obtained for the hour. This code
may be entered manually when a temporary like-kind replacement EtO
analyzer is used for reporting; and
10.1.2.5 Monitor data availability, as a percentage of unit or
stack operating hours, calculated according to Sec. 75.32 of this
chapter.
10.1.3 Stack Gas Volumetric Flow Rate Records.
10.1.3.1 Hourly measurements of stack gas volumetric flow rate
during unit operation are required to demonstrate compliance with
EtO emission standards.
10.1.3.2 Use a flow rate monitor that meets the requirements of
part 75 of this chapter to record the required data. You must keep
hourly flow rate records, as specified in Sec. 75.57(c)(2) of this
chapter.
10.1.4 EtO Emission Rate Records. Record the following
information for each affected unit or common stack:
10.1.4.1 The date and hour;
10.1.4.2 The hourly EtO emissions rate (lb/hr), for each hour in
which valid values of EtO concentration and stack gas volumetric
flow rate are obtained for the hour. Report each emission rate to
the same precision as the most stringent standard that applies to
any affected source exhausting to the emission stream (e.g., if the
emission stream includes contributions from an SCV and ARV subject
to 99.99% and 99.9% emission reduction standards, respectively,
report to four significant figures), expressed in scientific
notation. Use the following rounding convention: If the digit
immediately following the first decimal place is 5 or greater, round
the first decimal place upward (increase it by one); if the digit
immediately following the first decimal place is 4 or less, leave
the first decimal place unchanged;
10.1.4.4 A code indicating that the EtO emission rate was not
calculated for the hour, if valid data for EtO concentration and/or
any of the other necessary parameters are not obtained for the hour.
For the purposes of this appendix, the substitute data values
required under part 75 of this chapter for stack gas flow rate are
not considered to be valid data.
10.1.5 Certification and Quality Assurance Test Records. For the
EtO CEMS used to provide data under this subpart at each affected
unit (or group of units monitored at a common stack), record the
following information for all required certification,
recertification, diagnostic, and quality-assurance tests:
10.1.5.1 EtO CEMS.
10.1.5.1.1 For each required 7-day and daily calibration drift
(CD) test or daily calibration error test (including daily
calibration transfer standard tests) of the EtO CEMS, record the
test date(s) and time(s), reference gas value(s), monitor
response(s), and calculated calibration drift or calibration error
value(s). If you use the dynamic spiking option for the mid-level
calibration drift check under PS 19, you must also record the
measured concentration of the native EtO in the flue gas before and
after the spike and the spiked gas dilution factor.
10.1.5.1.2 or each required RATA of an EtO CEMS, record the
beginning and ending date and time of each test run, the reference
method(s) used, and the reference method and EtO CEMS run values.
Keep records of stratification tests performed (if any), all of the
raw field data, relevant process operating data, and all of the
calculations used to determine the relative accuracy.
10.1.5.1.3 For each required measurement error (ME) test of an
EtO monitor, record the date and time of each gas injection, the
reference gas concentration (low, mid, or high) and the monitor
response for each of the three injections at each of the three
levels. Also record the average monitor response and the ME at each
gas level and the related calculations.
10.1.5.1.4 For each required level of detection (LOD) test of an
EtO monitor performed in a controlled environment, record the test
date, the concentrations of the reference gas and interference
gases, the results of the seven (or more) consecutive measurements
of EtO, the standard deviation, and the LOD value. For each required
LOD test performed in the field, record the test date, the three
measurements of the native source EtO concentration, the results of
the three independent standard addition (SA) measurements known as
standard addition response (SAR), the effective spike addition gas
concentration, the resulting standard addition detection level
(SADL) value and all related calculations. For extractive CEMS
performing the SA using dynamic spiking, you must record the spiked
gas dilution factor.
10.1.5.1.5 For each required ME/level of detection response time
test of an EtO monitor, record the test date, the native EtO
concentration of the flue gas, the reference gas value, the stable
reference gas readings, the upscale/downscale start and end times,
and the results of the upscale and downscale stages of the test.
10.1.5.1.6 For each required interference test of an EtO
monitor, record (or obtain from the analyzer manufacturer records
of): The date of the test; the gas volume/rate, temperature, and
pressure used to conduct the test; the EtO concentration of the
reference gas used; the concentrations of the interference test
gases; the baseline EtO responses for each interferent combination
spiked; and the total percent interference as a function of span or
EtO concentration.
10.1.5.1.7 For each quarterly relative accuracy audit (RAA) of
an EtO monitor, record the beginning and ending date and time of
each test run, the reference method used, the EtO concentrations
measured by the reference method and CEMS for each test run, the
average concentrations measured by the reference method and the
CEMS, and the calculated relative accuracy. Keep records of the raw
field data, relevant process operating data, and the calculations
used to determine the relative accuracy.
10.1.5.1.8 For each quarterly cylinder gas audit (CGA) of an EtO
monitor, record the date and time of each injection, and the
reference gas concentration (zero, mid, or high) and the monitor
response for each injection. Also record the average monitor
response and the calculated ME at each gas level.
10.1.5.1.9 For each quarterly dynamic spiking audit (DSA) of an
EtO monitor, record the date and time of the zero gas injection and
each spike injection, the results of the zero gas injection, the gas
concentrations (mid and high) and the dilution factors and the
monitor response for each of the six upscale injections as well as
the corresponding native EtO concentrations measured before and
after each injection. Also record the average dynamic spiking error
for each of the upscale gases, the calculated average DSA Accuracy
at each upscale gas concentration, and all calculations leading to
the DSA Accuracy.
10.1.5.2 Additional Monitoring Systems. For the stack gas flow
rate monitoring systems described in section 3.2 of this appendix,
you must keep records of all certification, recertification,
diagnostic, and on-going quality-assurance tests of these systems,
as specified in Sec. 75.59(a) of this chapter.
11. Reporting Requirements
11.1 General Reporting Provisions. The owner or operator shall
comply with the following requirements for reporting EtO emissions
from each affected unit (or group of units monitored at a common
stack):
11.1.1 Notifications, in accordance with paragraph 11.2 of this
section;
11.1.2 Monitoring plan reporting, in accordance with paragraph
11.3 of this section;
11.1.3 Certification, recertification, and QA test submittals,
in accordance with paragraph 11.4 of this section; and
11.1.4 Electronic quarterly report submittals, in accordance
with paragraph 11.5 of this section.
11.2 Notifications. The owner or operator shall provide
notifications for each affected unit (or group of units monitored at
a common stack) in accordance with Sec. 63.366.
11.3 Monitoring Plan Reporting. For each affected unit (or group
of units monitored at a common stack) using EtO CEMS, the owner or
operator shall make electronic and hard copy monitoring plan
submittals as follows:
11.3.1 For a sterilization facility that begins reporting hourly
EtO concentrations with a previously certified CEMS, submit the
monitoring plan information in section 10.1.1.2 of this appendix
prior to or concurrent with the first required quarterly emissions
report. For a new sterilization facility, submit the information in
section 10.1.1.2 of this appendix at least 21 days prior to the
start of initial certification testing of the CEMS. Also submit the
monitoring plan information in Sec. 75.53(g) of this chapter
pertaining to any required flow rate monitoring systems within the
applicable timeframe specified in this section, if the required
records are not already in place.
11.3.2 Update the monitoring plan when required, as provided in
paragraph 10.1.1.1 of this appendix. An electronic monitoring plan
information update must be submitted either
[[Page 24202]]
prior to or concurrent with the quarterly report for the calendar
quarter in which the update is required.
11.3.3 All electronic monitoring plan submittals and updates
shall be made to the Administrator using CEDRI. Hard copy portions
of the monitoring plan shall be kept on record according to section
10.1 of this appendix.
11.4 Certification, Recertification, and Quality-Assurance Test
Reporting Requirements. Use CEDRI to submit the results of all
required certification, recertification, quality-assurance, and
diagnostic tests of the monitoring systems required under this
appendix electronically. Submit the test results concurrent with the
quarterly electronic emissions report. However, for RATAs of the EtO
monitor, if this is not possible, you have up to 60 days after the
test completion date to submit the test results; in this case, you
may claim provisional status for the emissions data affected by the
test, starting from the date and hour in which the test was
completed and continuing until the date and hour in which the test
results are submitted. If the test is successful, the status of the
data in that time period changes from provisional to quality-
assured, and no further action is required. However, if the test is
unsuccessful, the provisional data must be invalidated and
resubmission of the affected emission report(s) is required.
11.4.1 For each daily CD (or calibration error) assessment
(including daily calibration transfer standard tests), and for each
seven-day calibration drift (CD) test of an EtO monitor, report:
11.4.1.1 Facility ID information;
11.4.1.2 The monitoring component ID;
11.4.1.3 The instrument span and span scale;
11.4.1.4 For each gas injection, the date and time, the
calibration gas level (zero or high-level), the reference gas value
(ppbv), and the monitor response (ppbv);
11.4.1.5 A flag to indicate whether dynamic spiking was used for
the high-level value;
11.4.1.6 Calibration drift (percent of span or reference gas, as
applicable);
11.4.1.7 When using the dynamic spiking option, the measured
concentration of native EtO before and after each mid-level spike
and the spiked gas dilution factor; and
11.4.1.8 Reason for test.
11.4.2 For each RATA of an EtO CEMS, report:
11.4.2.1 Facility ID information;
11.4.2.2 Monitoring system ID number;
11.4.2.3 Type of test (i.e., initial or annual RATA);
11.4.2.4 Reason for test;
11.4.2.5 The reference method used;
11.4.2.6 Starting and ending date and time for each test run;
11.4.2.7 Units of measure;
11.4.2.8 The measured reference method and CEMS values for each
test run, on a consistent moisture basis, in appropriate units of
measure;
11.4.2.9 Flags to indicate which test runs were used in the
calculations;
11.4.2.10 Arithmetic mean of the CEMS values, of the reference
method values, and of their differences;
11.4.2.11 Standard deviation, using equation 7 in section 12.6
of PS 19 in appendix B to part 60 of this chapter;
11.4.2.12 Confidence coefficient, using equation 8 in section
12.6 of PS 19 in appendix B to part 60 of this chapter;
11.4.2.13 t-value; and
11.4.2.14 Relative accuracy calculated using equation 11 in
section 12.6 of PS 19 in appendix B to part 60 of this chapter.
11.4.3 For each measurement error (ME) test of an EtO monitor,
report:
11.4.3.1 Facility ID information;
11.4.3.2 Monitoring component ID;
11.4.3.3 Instrument span and span scale;
11.4.3.4 For each gas injection, the date and time, the
calibration gas level (zero, low, mid, or high), the reference gas
value in ppbv and the monitor response.
11.4.3.5 For extractive CEMS, the mean reference value and mean
of measured values at each reference gas level (ppbv).
11.4.3.6 ME at each reference gas level; and
11.4.3.7 Reason for test.
11.4.4 For each interference test of an EtO monitoring system,
report:
11.4.4.1 Facility ID information;
11.4.4.2 Date of test;
11.4.4.3 Monitoring system ID;
11.4.4.4 Results of the test (pass or fail);
11.4.4.5 Reason for test; and
11.4.4.6 A flag to indicate whether the test was performed: On
this particular monitoring system; on one of multiple systems of the
same type; or by the manufacturer on a system with components of the
same make and model(s) as this system.
11.4.5 For each LOD test of an EtO monitor, report:
11.4.5.1 Facility ID information;
11.4.5.2 Date of test;
11.4.5.3 Reason for test;
11.4.5.4 Monitoring system ID;
11.4.5.5 A code to indicate whether the test was done in a
controlled environment or in the field;
11.4.5.6 EtO reference gas concentration;
11.4.5.7 EtO responses with interference gas (seven
repetitions);
11.4.5.8 Standard deviation of EtO responses;
11.4.5.9 Effective spike addition gas concentrations;
11.4.5.10 EtO concentration measured without spike;
11.4.5.11 EtO concentration measured with spike;
11.4.5.12 Dilution factor for spike;
11.4.5.13 The controlled environment LOD value (ppbv or ppbv-
meters);
11.4.5.14 The field determined standard addition detection level
(SADL in ppbv or ppbv-meters); and
11.4.5.15 Result of LOD/SADL test (pass/fail).
11.4.6 For each ME or LOD response time test of an EtO monitor,
report:
11.4.6.1 Facility ID information;
11.4.6.2 Date of test;
11.4.6.3 Monitoring component ID;
11.4.6.4 The higher of the upscale or downscale tests, in
minutes; and
11.4.6.5 Reason for test.
11.4.7 For each quarterly RAA of an EtO monitor, report:
11.4.7.1 Facility ID information;
11.4.7.2 Monitoring system ID;
11.4.7.3 Begin and end time of each test run;
11.4.7.4 The reference method used;
11.4.7.5 The reference method and CEMS values for each test run,
including the units of measure;
11.4.7.6 The mean reference method and CEMS values for the three
test runs;
11.4.7.7 The calculated relative accuracy, percent; and
11.4.7.8 Reason for test.
11.4.8 For each quarterly cylinder gas audit of an EtO monitor,
report:
11.4.8.1 Facility ID information;
11.4.8.2 Monitoring component ID;
11.4.8.3 Instrument span and span scale;
11.4.8.4 For each gas injection, the date and time, the
reference gas level (zero, mid, or high), the reference gas value in
ppbv, and the monitor response.
11.4.8.5 For extractive CEMS, the mean reference gas value and
mean monitor response at each reference gas level (ppbv).
11.4.8.6 ME at each reference gas level; and
11.4.8.7 Reason for test.
11.4.9 For each quarterly DSA of an EtO monitor, report:
11.4.9.1 Facility ID information;
11.4.9.2 Monitoring component ID;
11.4.9.3 Instrument span and span scale;
11.4.9.4 For the zero gas injection, the date and time, and the
monitor response (Note: The zero gas injection from a calibration
drift check performed on the same day as the upscale spikes may be
used for this purpose.);
11.4.9.5 Zero spike error;
11.4.9.6 For the upscale gas spiking, the date and time of each
spike, the reference gas level (mid- or high-), the reference gas
value (ppbv), the dilution factor, the native EtO concentrations
before and after each spike, and the monitor response for each gas
spike;
11.4.9.7 Upscale spike error;
11.4.9.8 DSA at the zero level and at each upscale gas level;
and
11.4.9.9 Reason for test.
11.4.10 Reporting Requirements for Diluent Gas, Flow Rate, and
Moisture Monitoring Systems. For the certification, recertification,
diagnostic, and QA tests of stack gas flow rate, moisture, and
diluent gas monitoring systems that are certified and quality-
assured according to part 75 of this chapter, report the information
in section 10.1.8.2 of this appendix.
11.5 Quarterly Reports.
11.5.1 The owner or operator of any affected unit shall use
CEDRI to submit electronic quarterly reports to the Administrator in
an XML format specified by the Administrator, for each affected unit
(or group of units monitored at a common stack). If the certified
EtO CEMS is used for the initial compliance demonstration, EtO
emissions reporting shall begin with the first operating hour of the
30-operating day compliance demonstration period. Otherwise, EtO
emissions reporting shall begin with the first operating hour after
successfully completing all required certification tests of the
CEMS.
11.5.2 The electronic reports must be submitted within 30 days
following the end
[[Page 24203]]
of each calendar quarter, except for units that have been placed in
long-term cold storage.
11.5.3 Each electronic quarterly report shall include the
following information:
11.5.3.1 The date of report generation;
11.5.3.2 Facility identification information;
11.5.3.3 The information in sections 10.1.2 through 10.1.4 of
this appendix, as applicable to the type(s) of monitoring system(s)
used to measure the pollutant concentrations and other necessary
parameters.
11.5.3.4 The results of all daily calibrations (including
calibration transfer standard tests) of the EtO monitor as described
in section 10.1.8.1.1 of this appendix; and
11.5.3.5 If applicable, the results of all daily flow monitor
interference checks, in accordance with section 10.1.8.2 of this
appendix.
11.5.4 Compliance Certification. Based on reasonable inquiry of
those persons with primary responsibility for ensuring that all EtO
emissions from the affected unit(s) have been correctly and fully
monitored, the owner or operator shall submit a compliance
certification in support of each electronic quarterly emissions
monitoring report. The compliance certification shall include a
statement by a responsible official with that official's name,
title, and signature, certifying that, to the best of his or her
knowledge, the report is true, accurate, and complete.
[FR Doc. 2024-05905 Filed 4-4-24; 8:45 am]
BILLING CODE 6560-50-P